data_2kcp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kcp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.468 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 42.3 m . . . . . 0 N--CA 1.471 0.605 0 CA-C-O 120.549 0.214 . . . . 75.420000000000002 111.505 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 23' ' ' THR . 50.4 mtm180 -162.83 169.96 19.01 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.249 0.62 . . . . 65.019999999999996 111.19 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.0 tt -147.03 139.26 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.386 -0.37 . . . . 74.129999999999995 111.51 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.43 ' OD1' HG12 ' A' ' 37' ' ' ILE . 75.5 m-20 -74.03 106.84 5.89 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.788 0.328 . . . . 72.140000000000001 110.659 176.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -97.56 123.62 50.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.109 0.481 . . . . 75.340000000000003 112.07 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.6 t -95.23 112.83 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.995 0.426 . . . . 74.030000000000001 110.594 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.53 114.99 50.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.01 -0.541 . . . . 75.140000000000001 111.077 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -82.58 -11.78 10.34 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.706 2.271 . . . . 75.310000000000002 113.007 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.44 ' CD ' HH12 ' A' ' 89' ' ' ARG . 10.9 mm-40 -77.57 -39.63 45.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.161 0.505 . . . . 75.310000000000002 110.863 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.1 p -121.27 -27.08 4.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.712 -0.677 . . . . 75.040000000000006 112.258 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.96 29.21 11.95 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.38 -0.438 . . . . 40.340000000000003 113.302 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -99.44 142.02 31.47 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 122.478 -0.425 . . . . 74.109999999999999 111.182 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.1 t -107.46 112.05 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.841 0.353 . . . . 63.049999999999997 110.774 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -133.52 141.64 47.84 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.915 0.388 . . . . 71.329999999999998 111.496 -177.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.43 HG12 ' OD1' ' A' ' 26' ' ' ASN . 45.9 mt -83.06 111.34 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.85 0.357 . . . . 71.329999999999998 111.331 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.38 157.17 17.21 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.027 0.441 . . . . 74.319999999999993 112.046 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -83.25 135.31 34.81 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.185 -0.461 . . . . 72.450000000000003 110.986 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -83.73 112.06 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 121.267 0.556 . . . . 74.310000000000002 111.016 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 41' ' ' ARG . 44.4 mtp85 -82.83 -53.41 5.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.027 -0.533 . . . . 72.439999999999998 111.018 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -124.8 132.31 53.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.261 -0.427 . . . . 74.019999999999996 110.842 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 120.929 0.395 . . . . 65.109999999999999 111.928 179.173 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.597 HG21 HD11 ' A' ' 83' ' ' ILE . 69.9 mt . . . . . 0 CA--C 1.544 0.731 0 CA-C-O 121.314 0.578 . . . . 74.030000000000001 111.226 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.6 p -135.26 159.6 41.04 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.208 -0.451 . . . . 54.200000000000003 112.078 -174.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -54.51 129.06 34.71 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.122 -0.49 . . . . 65.019999999999996 111.725 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.11 -11.41 72.18 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.137 -0.554 . . . . 38.640000000000001 113.465 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 145.38 31.62 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.859 0.361 . . . . 63.140000000000001 111.124 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.0 t -109.02 124.59 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.025 0.44 . . . . 74.420000000000002 111.593 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -107.43 154.93 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.982 0.42 . . . . 64.329999999999998 111.39 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.53 133.38 38.21 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.503 -0.317 . . . . 61.240000000000002 110.782 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.5 p -136.8 179.14 6.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.989 0.423 . . . . 65.219999999999999 111.637 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -69.09 -15.38 63.43 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.757 0.313 . . . . 75.310000000000002 111.78 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.71 -13.9 20.03 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.684 0.278 . . . . 73.010000000000005 111.512 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.44 -151.94 18.63 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.383 -0.437 . . . . 53.439999999999998 112.733 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -82.81 129.18 34.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.463 -0.434 . . . . 75.329999999999998 111.162 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.78 133.66 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.8 0.333 . . . . 74.329999999999998 111.459 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.475 ' HB2' HD12 ' A' ' 88' ' ' ILE . 42.1 ttm180 -94.56 121.1 35.77 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.756 0.28 . . . . 72.340000000000003 111.756 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.442 HG23 HG22 ' A' ' 58' ' ' ILE . 39.0 t -65.9 111.32 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 116.415 -0.357 . . . . 75.319999999999993 111.08 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.467 HG21 ' HA2' ' A' ' 85' ' ' GLY . 44.1 p -91.54 -39.26 12.02 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.861 0.363 . . . . 65.400000000000006 111.808 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.246 0.546 . . . . 74.140000000000001 112.22 -178.78 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.408 HG22 ' N ' ' A' ' 83' ' ' ILE . 8.3 p . . . . . 0 CA--C 1.545 0.763 0 CA-C-O 121.144 0.497 . . . . 60.25 111.576 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.597 HD11 HG21 ' A' ' 58' ' ' ILE . 48.2 mt -105.0 143.75 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.366 -0.379 . . . . 75.230000000000004 110.37 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -123.55 135.84 54.22 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.827 0.346 . . . . 73.340000000000003 111.239 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.467 ' HA2' HG21 ' A' ' 74' ' ' THR . . . -154.23 179.33 30.5 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.922 -0.656 . . . . 63.539999999999999 113.801 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.26 141.52 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 122.564 -0.374 . . . . 61.140000000000001 111.049 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 tp -77.06 124.42 27.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.817 0.341 . . . . 55.109999999999999 110.854 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 72' ' ' ARG . 10.6 pt -140.31 -175.87 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.03 0.443 . . . . 73.209999999999994 111.4 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.44 HH12 ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.665 0 CA-C-N 116.368 -0.378 . . . . 70.040000000000006 110.903 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 42.9 p . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 121.163 0.506 . . . . 65.420000000000002 111.386 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -152.42 151.94 31.4 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.725 -0.67 . . . . 73.140000000000001 110.6 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.529 ' HB ' HD11 ' A' ' 40' ' ' ILE . 10.8 tt -138.03 141.06 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.063 0.459 . . . . 74.140000000000001 112.17 -174.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -74.19 103.48 4.63 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.049 -0.523 . . . . 73.040000000000006 110.114 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 71' ' ' VAL . 22.6 t -102.62 136.96 32.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.335 0.495 . . . . 74.319999999999993 112.335 -173.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.55 113.52 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.881 0.372 . . . . 72.349999999999994 110.387 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -77.15 114.03 36.2 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.153 -0.476 . . . . 52.509999999999998 110.452 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.85 -8.99 15.73 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.595 2.196 . . . . 75.450000000000003 113.399 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -89.42 -33.28 16.89 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.937 0.399 . . . . 75.310000000000002 111.574 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.451 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 68.0 p -116.76 -31.41 5.48 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.356 0.502 . . . . 64.310000000000002 112.356 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.55 12.58 50.52 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.138 -0.553 . . . . 62.140000000000001 113.872 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 16.1 ptpt -89.88 162.32 15.51 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.183 0.516 . . . . 71.010000000000005 111.995 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.71 95.57 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-O 121.203 0.525 . . . . 73.299999999999997 109.938 171.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.24 138.55 41.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.321 -0.4 . . . . 74.450000000000003 111.215 -174.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -84.96 121.42 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.687 0.279 . . . . 72.409999999999997 111.216 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.483 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -108.05 150.47 27.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.73 0.3 . . . . 64.040000000000006 111.648 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -94.03 120.93 34.96 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.778 0.323 . . . . 75.040000000000006 110.76 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.529 HD11 ' HB ' ' A' ' 25' ' ' ILE . 57.8 mt -81.86 119.95 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 112.403 0.519 . . . . 63.399999999999999 112.403 -173.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.8 mmm-85 -81.68 -56.11 4.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.044 0.449 . . . . 73.030000000000001 111.048 174.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -144.61 155.45 43.64 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.199 -0.455 . . . . 71.200000000000003 111.365 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.437 ' O ' HG22 ' A' ' 43' ' ' VAL . 12.2 p . . . . . 0 CA--C 1.55 0.943 0 CA-C-O 121.913 0.863 . . . . 75.040000000000006 110.818 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.7 mt . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 109.946 -0.391 . . . . 72.209999999999994 109.946 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 t -133.11 167.48 20.24 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.05 0.452 . . . . 71.439999999999998 112.157 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -61.46 128.0 34.18 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.236 -0.438 . . . . 72.010000000000005 111.297 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.25 -13.51 67.17 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.229 -0.51 . . . . 52.520000000000003 112.951 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.89 132.15 43.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.021 0.438 . . . . 74.340000000000003 111.281 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.9 t -97.13 120.23 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.844 0.354 . . . . 74.129999999999995 111.319 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 43' ' ' VAL . 34.9 m -103.53 136.23 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.034 0.445 . . . . 73.319999999999993 111.337 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.27 119.49 25.12 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.955 0.407 . . . . 44.109999999999999 110.435 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 40' ' ' ILE . 34.0 p -125.72 175.73 7.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.367 -0.378 . . . . 74.340000000000003 111.471 -175.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -61.41 -28.68 69.43 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.331 -0.395 . . . . 71.25 111.739 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 38' ' ' ALA . 83.9 mt -86.72 -22.82 25.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.755 0.312 . . . . 71.200000000000003 111.45 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.57 -153.13 21.9 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.923 -0.656 . . . . 75.319999999999993 113.511 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.419 ' H ' ' HD2' ' A' ' 89' ' ' ARG . 15.1 m120 -83.66 102.87 12.53 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.922 0.391 . . . . 72.430000000000007 111.098 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 27' ' ' VAL . 47.6 t -97.62 119.73 46.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.962 0.41 . . . . 61.020000000000003 111.326 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -86.93 117.61 25.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.495 -0.321 . . . . 74.0 111.171 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.75 121.1 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.178 -0.464 . . . . 71.120000000000005 112.111 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -107.3 -41.79 5.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.249 -0.432 . . . . 71.400000000000006 111.799 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.9 m . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 121.283 0.564 . . . . 71.420000000000002 112.176 -179.279 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.799 0.333 . . . . 74.409999999999997 110.615 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.2 mt -96.08 143.87 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.299 -0.41 . . . . 62.399999999999999 111.588 -177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -118.92 148.96 42.37 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.301 0.24 . . . . 62.520000000000003 110.749 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.3 -170.25 26.82 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 121.089 -0.576 . . . . 53.420000000000002 113.641 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 2.3 t -121.08 147.73 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 122.487 -0.419 . . . . 72.230000000000004 111.126 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.416 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 50.5 tp -89.74 113.55 25.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.412 0.523 . . . . 73.420000000000002 112.412 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.5 pt -136.75 -173.51 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.077 0.465 . . . . 51.210000000000001 110.815 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HD2' ' H ' ' A' ' 70' ' ' ASN . 24.0 mmm180 . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.111 0.481 . . . . 75.409999999999997 111.35 176.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 m . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 120.88 0.371 . . . . 60.310000000000002 111.134 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -145.36 166.86 24.35 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.159 -0.473 . . . . 71.519999999999996 111.369 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 tt -151.85 131.9 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.088 0.471 . . . . 62.030000000000001 112.265 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -72.03 104.63 3.62 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.296 -0.411 . . . . 74.439999999999998 110.687 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -100.72 129.35 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.007 0.432 . . . . 71.319999999999993 111.817 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.2 t -95.6 117.64 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.351 -0.386 . . . . 75.400000000000006 111.062 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -75.58 115.01 41.88 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.251 -0.431 . . . . 74.430000000000007 110.345 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.26 -19.46 15.29 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.571 2.181 . . . . 72.040000000000006 112.727 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -85.43 -43.03 13.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.178 -0.465 . . . . 71.430000000000007 111.675 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.6 p -105.57 -19.5 13.75 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.325 0.491 . . . . 65.150000000000006 112.325 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.67 11.37 79.84 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.088 -0.577 . . . . 63.0 113.638 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -88.7 162.72 16.13 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.954 0.407 . . . . 73.329999999999998 111.63 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.3 t -112.5 115.64 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.776 0.322 . . . . 75.319999999999993 110.473 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -126.31 141.35 51.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 122.56 0.344 . . . . 64.340000000000003 110.833 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 mt -94.0 120.07 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.83 0.347 . . . . 71.519999999999996 111.657 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.484 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -107.32 160.91 15.26 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.166 0.508 . . . . 62.439999999999998 112.188 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -102.77 124.32 48.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.311 -0.404 . . . . 73.439999999999998 110.55 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.415 HG22 ' HB ' ' A' ' 64' ' ' VAL . 68.2 mt -78.58 112.65 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.356 0.598 . . . . 73.150000000000006 112.411 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -83.55 -53.8 5.41 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.033 -0.53 . . . . 74.040000000000006 111.517 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 38.5 m-80 -120.98 152.88 38.03 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.893 0.378 . . . . 71.439999999999998 111.709 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.544 0.733 0 CA-C-O 121.33 0.586 . . . . 73.329999999999998 110.97 174.673 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 61.1 mt . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 120.948 0.404 . . . . 74.239999999999995 110.216 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -106.69 163.71 12.69 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.668 0.618 . . . . 53.219999999999999 112.668 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.6 ttp-105 -56.99 116.65 3.34 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.392 -0.822 . . . . 74.239999999999995 111.837 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.23 -12.45 55.27 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.157 -0.544 . . . . 51.43 113.749 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.03 159.71 32.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.32 0.56 . . . . 71.430000000000007 111.47 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.6 t -118.15 124.41 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.128 0.49 . . . . 61.310000000000002 111.226 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.415 ' HB ' HG22 ' A' ' 40' ' ' ILE . 35.3 m -108.14 147.45 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.931 0.396 . . . . 62.039999999999999 111.761 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 28.5 tt0 -87.7 126.67 35.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.428 -0.351 . . . . 72.519999999999996 110.138 174.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.408 HG21 ' HA ' ' A' ' 40' ' ' ILE . 33.6 p -129.46 176.0 8.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.996 0.427 . . . . 74.010000000000005 111.387 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -62.23 -20.68 64.46 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.404 -0.362 . . . . 71.450000000000003 111.553 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.484 HD13 ' HB3' ' A' ' 38' ' ' ALA . 71.7 mt -101.18 8.61 42.56 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.655 0.264 . . . . 64.430000000000007 111.696 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.09 -154.74 16.88 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.301 -0.476 . . . . 54.130000000000003 112.907 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -80.78 137.69 36.24 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.258 -0.554 . . . . 60.25 111.571 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.2 t -126.51 130.63 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.337 -0.392 . . . . 75.329999999999998 111.105 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.54 ' HB2' HD11 ' A' ' 88' ' ' ILE . 41.5 ttm180 -91.32 114.21 26.68 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.711 0.291 . . . . 73.340000000000003 110.739 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.7 t -66.54 131.35 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 112.834 0.679 . . . . 74.450000000000003 112.834 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.4 p -108.98 -61.33 1.63 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.942 -0.572 . . . . 60.25 111.627 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 121.125 0.488 . . . . 73.129999999999995 112.128 -178.394 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 121.063 0.459 . . . . 63.439999999999998 111.683 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.4 mt -123.15 147.53 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.681 -0.488 . . . . 75.25 109.681 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -128.54 145.94 50.98 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.892 -0.505 . . . . 75.329999999999998 112.276 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.38 -179.39 38.5 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 121.386 -0.435 . . . . 72.340000000000003 113.205 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.6 t -116.64 142.41 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 116.962 0.381 . . . . 65.150000000000006 111.381 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.41 HD11 HH12 ' A' ' 89' ' ' ARG . 51.5 tp -76.99 115.31 16.68 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.675 0.274 . . . . 72.340000000000003 111.621 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' ' 72' ' ' ARG . 22.2 pt -133.82 -176.59 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.297 0.57 . . . . 73.319999999999993 111.844 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.41 HH12 HD11 ' A' ' 87' ' ' LEU . 31.8 mmt180 . . . . . 0 CA--C 1.539 0.541 0 CA-C-N 116.094 -0.503 . . . . 74.140000000000001 111.451 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 120.624 0.25 . . . . 64.010000000000005 110.81 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 34.6 ttm180 -148.02 154.0 39.69 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.929 0.395 . . . . 74.120000000000005 111.968 -172.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.0 tt -148.87 146.16 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.945 0.402 . . . . 73.230000000000004 111.619 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.632 ' ND2' HG21 ' A' ' 82' ' ' VAL . 29.9 m-80 -94.16 112.71 24.55 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.88 0.371 . . . . 72.540000000000006 110.064 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.3 t -102.39 130.99 51.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.053 -0.521 . . . . 72.540000000000006 112.055 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.7 t -95.11 120.47 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.073 0.464 . . . . 71.439999999999998 110.882 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.21 116.71 61.16 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.974 -0.557 . . . . 73.150000000000006 111.028 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.9 -17.04 11.06 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.693 2.262 . . . . 74.040000000000006 112.927 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -87.96 -43.17 11.95 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.834 0.35 . . . . 55.229999999999997 111.559 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 p -106.25 -26.9 11.34 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.583 0.586 . . . . 74.340000000000003 112.583 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.61 15.97 57.5 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.126 -0.559 . . . . 70.349999999999994 114.325 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -97.41 143.86 27.73 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.243 -0.563 . . . . 74.400000000000006 111.397 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.4 t -88.51 98.33 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.171 0.51 . . . . 71.010000000000005 109.894 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -101.32 138.61 38.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.933 -0.576 . . . . 62.109999999999999 110.94 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 55.1 mt -92.31 127.72 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.071 0.462 . . . . 74.540000000000006 111.439 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.89 160.0 35.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 53.520000000000003 110.995 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 39.0 mt-10 -109.17 134.69 51.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.873 0.368 . . . . 64.239999999999995 110.48 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.487 ' HA ' HG23 ' A' ' 66' ' ' THR . 60.6 mt -71.52 113.68 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.512 0.672 . . . . 72.439999999999998 112.046 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -37.32 41.45 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.107 -0.951 . . . . 73.010000000000005 110.302 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.636 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 59.9 t30 -141.04 119.12 11.95 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.939 -0.573 . . . . 64.409999999999997 110.545 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 112.619 0.6 . . . . 64.129999999999995 112.619 -176.878 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 73' ' ' VAL . 62.9 mt . . . . . 0 CA--C 1.545 0.759 0 CA-C-O 121.207 0.527 . . . . 74.519999999999996 111.852 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.418 ' O ' ' HB ' ' A' ' 73' ' ' VAL . 30.2 p -128.21 162.73 26.3 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.461 0.541 . . . . 74.340000000000003 112.461 -175.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -57.32 116.92 3.6 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.123 -0.489 . . . . 74.209999999999994 111.717 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.1 -11.36 60.38 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.211 -0.519 . . . . 63.32 113.217 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.02 131.06 40.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.817 0.341 . . . . 74.439999999999998 111.137 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -94.3 112.37 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 120.774 0.321 . . . . 61.329999999999998 111.348 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -103.04 148.52 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.119 0.485 . . . . 74.200000000000003 111.253 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.636 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 43.8 tt0 -92.52 123.99 36.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.386 -0.37 . . . . 61.299999999999997 110.885 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.487 HG23 ' HA ' ' A' ' 40' ' ' ILE . 44.1 p -126.24 176.16 7.28 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.071 0.462 . . . . 61.200000000000003 111.879 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -65.09 -15.39 62.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.337 -0.392 . . . . 73.200000000000003 111.962 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -92.31 -32.35 15.04 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.221 0.534 . . . . 73.329999999999998 111.085 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.81 -150.05 21.88 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.905 -0.588 . . . . 62.409999999999997 112.26 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -80.53 130.49 35.17 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.444 -0.445 . . . . 70.129999999999995 111.193 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.4 t -126.41 128.66 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.417 -0.356 . . . . 74.230000000000004 111.457 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HB2' HD12 ' A' ' 88' ' ' ILE . 42.0 ttm180 -91.29 117.44 29.65 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.251 -0.28 . . . . 75.230000000000004 110.91 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.449 HG23 HG23 ' A' ' 58' ' ' ILE . 45.9 t -66.3 133.83 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.73 0.3 . . . . 55.149999999999999 111.754 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -110.39 -73.2 0.69 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.707 0.289 . . . . 73.040000000000006 111.61 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 121.231 0.539 . . . . 71.420000000000002 111.81 -179.202 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.632 HG21 ' ND2' ' A' ' 26' ' ' ASN . 10.9 p . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 112.834 0.679 . . . . 73.230000000000004 112.834 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.0 mt -122.98 147.4 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.479 -0.782 . . . . 73.409999999999997 109.588 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -122.21 139.95 53.17 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.471 0.545 . . . . 72.329999999999998 112.471 -175.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.72 171.43 37.67 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 116.133 -0.485 . . . . 54.299999999999997 112.915 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.38 141.24 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 122.522 -0.399 . . . . 71.319999999999993 111.424 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.07 117.53 18.72 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.751 0.31 . . . . 60.310000000000002 111.311 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.443 HD12 ' HB2' ' A' ' 72' ' ' ARG . 18.0 pt -132.2 175.07 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.25 0.548 . . . . 73.129999999999995 111.314 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 . . . . . 0 N--CA 1.472 0.665 0 CA-C-N 116.051 -0.522 . . . . 65.549999999999997 111.418 -178.127 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 112.189 0.44 . . . . 75.420000000000002 112.189 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 24' ' ' ARG . 55.9 mtt180 -151.04 161.6 42.42 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.05 0.452 . . . . 72.209999999999994 111.918 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.5 tt -149.15 144.12 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 115.883 -0.599 . . . . 73.200000000000003 111.308 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -79.04 108.25 12.4 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.297 -0.41 . . . . 74.219999999999999 110.989 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 71' ' ' VAL . 28.5 t -94.63 120.44 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.312 -0.404 . . . . 72.230000000000004 111.865 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.02 118.17 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.935 0.398 . . . . 74.200000000000003 111.053 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 87' ' ' LEU . 14.9 t0 -73.86 118.87 72.87 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.455 -0.339 . . . . 74.030000000000001 111.147 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.58 -28.13 21.68 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.885 2.39 . . . . 74.400000000000006 113.391 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.23 -44.06 11.73 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.41 0.522 . . . . 73.340000000000003 112.41 -173.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.7 p -104.73 -15.36 15.26 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.326 0.491 . . . . 71.530000000000001 112.326 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.04 28.15 69.03 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.144 -0.55 . . . . 63.25 114.021 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -100.38 145.69 27.88 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.152 0.476 . . . . 72.129999999999995 111.445 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -110.73 133.09 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 120.892 0.377 . . . . 72.519999999999996 111.352 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -147.24 139.69 24.71 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.47 -0.332 . . . . 73.299999999999997 111.074 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 61.3 mt -86.88 125.61 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.962 0.411 . . . . 74.219999999999999 111.11 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.501 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -122.51 154.38 37.93 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.381 0.512 . . . . 43.25 112.381 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -90.55 133.24 35.22 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.743 0.306 . . . . 42.039999999999999 110.502 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.464 ' HA ' HG21 ' A' ' 66' ' ' THR . 57.9 mt -83.1 114.71 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.838 0.352 . . . . 61.299999999999997 111.563 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -73.95 -46.68 42.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.392 -0.367 . . . . 74.299999999999997 111.208 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -140.18 139.59 35.72 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.563 -0.29 . . . . 62.509999999999998 110.815 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 t . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 112.585 0.587 . . . . 64.519999999999996 112.585 -175.798 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.737 HG21 HD12 ' A' ' 83' ' ' ILE . 59.5 mt . . . . . 0 CA--C 1.542 0.641 0 CA-C-O 121.367 0.603 . . . . 62.219999999999999 110.759 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -134.06 173.05 12.0 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.145 -0.479 . . . . 74.439999999999998 111.338 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -58.74 115.95 3.41 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.999 0.428 . . . . 62.310000000000002 111.277 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.22 -13.19 52.01 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.228 -0.511 . . . . 63.439999999999998 113.665 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.25 139.31 48.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 117.061 0.43 . . . . 73.439999999999998 111.683 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.9 t -110.78 119.5 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 116.359 -0.382 . . . . 75.540000000000006 111.703 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 70' ' ' ASN . 32.6 m -114.8 159.23 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.77 0.319 . . . . 72.310000000000002 111.85 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.22 126.8 43.85 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.814 0.34 . . . . 71.140000000000001 110.806 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.464 HG21 ' HA ' ' A' ' 40' ' ' ILE . 34.7 p -125.59 178.81 5.45 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.504 -0.316 . . . . 61.210000000000001 111.067 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.501 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 16.9 p-10 -67.68 -16.1 63.98 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.725 0.298 . . . . 75.310000000000002 111.771 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.4 mt -95.73 -22.31 17.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.984 0.421 . . . . 70.209999999999994 111.193 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.27 -154.76 21.78 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 112.079 -0.408 . . . . 72.219999999999999 112.079 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 13.4 m120 -81.18 133.34 35.44 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 122.094 -0.65 . . . . 65.230000000000004 111.711 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 27' ' ' VAL . 23.8 t -121.63 119.5 59.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.922 -0.581 . . . . 72.230000000000004 110.594 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.511 ' HB2' HD12 ' A' ' 88' ' ' ILE . 33.4 ttt-85 -91.21 116.52 28.88 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.675 0.274 . . . . 74.329999999999998 110.375 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.406 HG23 HG22 ' A' ' 58' ' ' ILE . 45.7 t -61.02 118.27 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.049 0.452 . . . . 63.229999999999997 112.141 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.6 p -97.21 -47.1 5.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.205 -0.452 . . . . 75.439999999999998 111.427 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.471 0.593 0 CA-C-N 116.253 -0.43 . . . . 62.210000000000001 111.377 179.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.421 HG21 ' N ' ' A' ' 83' ' ' ILE . 11.5 p . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 120.897 0.38 . . . . 73.109999999999999 111.413 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.737 HD12 HG21 ' A' ' 58' ' ' ILE . 37.1 mt -106.51 129.15 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 122.52 0.328 . . . . 74.319999999999993 111.273 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -113.73 141.24 47.51 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.977 0.417 . . . . 72.340000000000003 111.465 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.55 173.69 34.32 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.36 -0.448 . . . . 73.310000000000002 113.049 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -105.05 150.76 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 113.082 0.771 . . . . 64.109999999999999 113.082 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 29' ' ' ASP . 66.4 tp -82.02 107.62 14.87 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.188 -0.914 . . . . 74.319999999999993 111.893 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.511 HD12 ' HB2' ' A' ' 72' ' ' ARG . 10.2 pt -120.5 173.31 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.005 0.431 . . . . 73.030000000000001 110.492 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 88' ' ' ILE . 19.3 mmm180 . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 120.954 0.407 . . . . 73.109999999999999 110.855 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.639 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 77.8 p . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 120.85 0.357 . . . . 72.239999999999995 110.791 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -118.86 118.75 32.39 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.995 0.426 . . . . 75.5 111.749 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.8 tt -126.59 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.04 0.448 . . . . 74.299999999999997 112.065 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -70.21 103.82 2.46 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.309 -0.405 . . . . 63.299999999999997 110.831 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.04 115.58 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.125 0.488 . . . . 70.5 111.592 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.3 t -102.61 126.67 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.043 -0.526 . . . . 74.219999999999999 111.054 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.603 ' HB2' ' HG2' ' A' ' 34' ' ' LYS . 10.7 t0 -83.33 121.82 76.96 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 120.623 0.249 . . . . 72.340000000000003 110.443 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HD3' HG13 ' A' ' 86' ' ' VAL . 59.7 Cg_endo -69.87 -32.08 18.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.756 2.304 . . . . 72.319999999999993 112.843 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -89.63 -43.46 10.73 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.688 0.625 . . . . 75.019999999999996 112.688 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.6 p -97.54 -31.83 12.12 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.396 0.517 . . . . 74.450000000000003 112.396 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.96 29.75 16.88 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.984 -0.626 . . . . 71.150000000000006 113.985 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.603 ' HG2' ' HB2' ' A' ' 29' ' ' ASP . 10.6 ptpp? -90.29 137.86 32.01 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.399 0.599 . . . . 65.099999999999994 111.074 177.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.8 t -115.17 102.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.019 0.438 . . . . 61.350000000000001 110.693 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -131.69 140.64 49.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.448 -0.342 . . . . 60.219999999999999 111.13 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.3 mt -86.5 121.04 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.858 0.361 . . . . 61.009999999999998 110.542 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.427 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . . . -116.17 152.83 32.93 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.861 0.689 . . . . 72.030000000000001 112.861 -175.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 23' ' ' THR . 1.9 mp0 -83.4 130.76 35.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.002 -0.544 . . . . 74.349999999999994 110.831 175.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.468 HG22 ' HB ' ' A' ' 64' ' ' VAL . 60.6 mt -88.31 114.4 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.689 0.28 . . . . 64.420000000000002 111.443 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -83.41 -53.67 5.54 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.126 0.489 . . . . 71.319999999999993 111.831 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 84.7 m-20 -122.42 135.69 54.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.989 0.424 . . . . 73.319999999999993 111.82 -174.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 121.174 0.511 . . . . 71.150000000000006 111.148 176.879 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.8 mt . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 120.658 0.266 . . . . 73.299999999999997 111.064 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.4 p -134.63 160.38 38.27 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.296 0.238 . . . . 64.120000000000005 111.514 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 48.8 ttp180 -53.83 119.69 5.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.84 0.353 . . . . 73.219999999999999 111.316 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.91 -20.45 14.63 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.215 -0.448 . . . . 45.200000000000003 112.646 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.99 153.9 29.94 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.089 0.471 . . . . 72.219999999999999 112.23 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.8 t -105.99 114.19 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.097 -0.501 . . . . 71.510000000000005 111.636 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 40' ' ' ILE . 30.6 m -103.33 118.79 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.374 0.607 . . . . 73.219999999999999 111.368 177.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 32.4 tt0 -77.72 108.63 11.07 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.995 0.426 . . . . 72.430000000000007 111.169 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.428 HG21 HG12 ' A' ' 40' ' ' ILE . 24.1 p -102.96 169.81 8.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.287 -0.415 . . . . 54.299999999999997 111.124 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -59.01 -20.89 57.28 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.616 0.598 . . . . 64.329999999999998 112.616 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.7 mt -89.62 -25.3 21.36 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.965 0.412 . . . . 73.040000000000006 111.269 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 147.95 -176.61 26.7 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 116.103 -0.499 . . . . 73.299999999999997 112.738 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -72.74 119.46 17.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.22 0.533 . . . . 61.200000000000003 111.773 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.57 135.14 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.03 -0.532 . . . . 72.439999999999998 111.213 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.518 ' HB2' HD12 ' A' ' 88' ' ' ILE . 30.9 ttm180 -91.94 126.91 37.2 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.204 -0.31 . . . . 73.040000000000006 111.001 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 30.2 t -68.86 100.64 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.767 0.318 . . . . 73.310000000000002 110.255 174.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.8 p -102.18 -26.01 13.5 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 122.052 -0.405 . . . . 71.439999999999998 111.666 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.4 t . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 120.898 0.38 . . . . 63.130000000000003 110.623 175.739 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.405 HG21 ' N ' ' A' ' 83' ' ' ILE . 7.2 p . . . . . 0 CA--C 1.547 0.829 0 CA-C-O 121.103 0.477 . . . . 74.540000000000006 111.897 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.405 ' N ' HG21 ' A' ' 82' ' ' VAL . 29.5 mt -116.62 136.37 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.421 -0.354 . . . . 74.519999999999996 110.721 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -115.9 141.82 47.59 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.079 0.466 . . . . 64.439999999999998 111.741 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.58 174.2 30.76 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 116.102 -0.499 . . . . 43.450000000000003 112.968 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.484 HG13 ' HD3' ' A' ' 30' ' ' PRO . 6.3 t -120.46 132.31 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 122.299 -0.53 . . . . 75.409999999999997 111.813 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.65 105.76 3.81 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.88 0.371 . . . . 73.319999999999993 111.033 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 72' ' ' ARG . 11.5 pt -104.69 172.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.452 0.644 . . . . 71.209999999999994 112.194 -174.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.423 ' HD2' ' C ' ' A' ' 88' ' ' ILE . 7.8 mpt_? . . . . . 0 N--CA 1.473 0.721 0 CA-C-N 115.791 -0.641 . . . . 72.349999999999994 112.195 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.7 p . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.009 0.433 . . . . 73.400000000000006 111.891 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 24' ' ' ARG . 49.1 mtm180 -143.9 163.46 33.35 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.374 -0.375 . . . . 65.099999999999994 111.019 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.469 ' HB ' HD13 ' A' ' 40' ' ' ILE . 14.0 tt -150.5 143.78 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.884 0.373 . . . . 63.340000000000003 111.767 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.4 ' HB2' HD21 ' A' ' 84' ' ' ASN . 3.8 m-20 -72.82 103.4 3.67 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.044 0.45 . . . . 64.430000000000007 110.262 173.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.417 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 55.2 t -91.25 113.79 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 63.520000000000003 111.904 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.9 t -95.62 113.02 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.021 -0.536 . . . . 74.310000000000002 110.774 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.79 118.72 74.08 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 61.109999999999999 111.56 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.61 -1.73 10.7 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.832 2.355 . . . . 73.430000000000007 113.705 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.87 -44.0 13.61 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.252 -0.28 . . . . 64.329999999999998 111.664 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.4 p -124.55 -11.41 7.32 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.803 0.668 . . . . 64.299999999999997 112.803 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.22 24.66 39.61 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 120.974 -0.631 . . . . 64.329999999999998 113.785 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -93.01 145.59 24.25 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.411 -0.464 . . . . 72.519999999999996 111.21 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.51 132.96 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.772 0.32 . . . . 73.409999999999997 111.196 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -147.83 143.03 27.18 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.6 0.238 . . . . 75.25 111.161 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.8 mt -86.22 111.41 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 122.25 -0.281 . . . . 64.319999999999993 111.12 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.483 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -110.54 155.2 22.63 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.118 0.414 . . . . 74.129999999999995 112.118 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -85.46 122.65 29.9 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.896 0.379 . . . . 63.229999999999997 111.495 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.544 ' HA ' HG21 ' A' ' 66' ' ' THR . 62.2 mt -73.04 116.59 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.423 -0.353 . . . . 61.210000000000001 110.726 176.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -81.04 -54.33 5.64 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.817 0.341 . . . . 75.530000000000001 111.367 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -145.41 152.8 40.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.872 0.368 . . . . 74.349999999999994 111.254 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.455 ' O ' HG22 ' A' ' 43' ' ' VAL . 13.8 p . . . . . 0 CA--C 1.549 0.917 0 CA-C-O 121.443 0.64 . . . . 74.129999999999995 111.712 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.549 HG23 HD13 ' A' ' 83' ' ' ILE . 46.4 mm . . . . . 0 CA--C 1.541 0.628 0 CA-C-O 120.714 0.292 . . . . 75.219999999999999 111.337 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -147.85 167.57 24.43 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.184 -0.322 . . . . 70.219999999999999 111.586 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -62.35 127.29 30.66 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.057 0.456 . . . . 65.239999999999995 111.675 -176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.55 -22.09 42.18 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.286 -0.483 . . . . 42.5 112.909 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.86 129.36 37.75 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.911 0.386 . . . . 54.32 111.3 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.03 115.27 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.307 -0.406 . . . . 65.439999999999998 111.396 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.436 ' HB ' HG21 ' A' ' 40' ' ' ILE . 35.2 m -103.59 129.02 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.232 0.539 . . . . 72.540000000000006 111.341 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -76.44 110.27 10.85 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.891 0.377 . . . . 42.340000000000003 110.767 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.544 HG21 ' HA ' ' A' ' 40' ' ' ILE . 33.3 p -107.78 171.9 7.13 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.841 0.353 . . . . 73.219999999999999 111.267 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.483 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 10.1 p-10 -55.78 -33.9 64.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.439 -0.346 . . . . 73.420000000000002 111.545 176.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.9 mt -81.23 -29.82 34.36 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.744 0.276 . . . . 62.240000000000002 111.744 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.01 -166.96 29.42 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.528 -0.844 . . . . 52.530000000000001 113.921 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -71.17 101.69 2.34 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.841 0.353 . . . . 61.340000000000003 111.523 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.9 t -99.61 117.0 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.086 0.47 . . . . 61.140000000000001 111.342 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -87.16 117.76 26.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.839 0.352 . . . . 74.010000000000005 110.61 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.95 140.17 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 112.61 0.596 . . . . 51.219999999999999 112.61 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.0 p -117.95 -43.47 2.76 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.404 0.52 . . . . 75.099999999999994 112.404 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 121.099 0.476 . . . . 61.420000000000002 112.139 -177.175 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 121.078 0.466 . . . . 65.420000000000002 111.533 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.549 HD13 HG23 ' A' ' 58' ' ' ILE . 62.9 mt -121.69 145.43 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 120.988 0.423 . . . . 72.329999999999998 110.985 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.4 HD21 ' HB2' ' A' ' 26' ' ' ASN . 9.8 m120 -120.04 147.52 44.72 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.117 -0.364 . . . . 74.120000000000005 111.206 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.23 176.81 40.13 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.221 -0.514 . . . . 54.520000000000003 112.915 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.82 146.88 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.579 0.704 . . . . 71.420000000000002 112.899 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.417 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 63.8 tp -85.68 112.66 21.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.294 -0.866 . . . . 74.129999999999995 112.204 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.4 pt -134.43 -174.78 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.954 0.407 . . . . 53.219999999999999 111.182 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.82 0.343 . . . . 73.299999999999997 111.089 177.002 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.521 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 30.6 p . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.143 0.497 . . . . 75.329999999999998 111.947 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -144.63 155.59 43.69 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.208 -0.451 . . . . 72.120000000000005 111.101 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.44 ' HB ' HD13 ' A' ' 40' ' ' ILE . 13.1 tt -145.45 145.82 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.792 0.33 . . . . 52.32 111.537 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.501 ' N ' HD21 ' A' ' 26' ' ' ASN . 0.8 OUTLIER -80.3 103.78 10.41 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.425 0.631 . . . . 73.230000000000004 110.506 174.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.478 HG11 ' HB2' ' A' ' 87' ' ' LEU . 23.0 t -95.36 121.88 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.429 -0.805 . . . . 74.030000000000001 111.922 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.5 112.28 26.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.931 0.396 . . . . 64.409999999999997 110.571 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -74.26 118.24 68.16 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.477 -0.329 . . . . 72.439999999999998 111.142 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.93 -12.36 17.85 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.554 2.17 . . . . 71.150000000000006 113.116 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -81.67 -44.73 16.75 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.818 0.342 . . . . 63.340000000000003 111.907 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -107.18 -31.0 8.43 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.785 0.291 . . . . 61.509999999999998 111.785 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.8 16.96 34.36 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.333 -0.461 . . . . 71.510000000000005 113.733 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -87.21 150.67 23.76 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 117.234 0.517 . . . . 74.329999999999998 111.813 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.86 95.31 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.522 0.677 . . . . 63.109999999999999 110.49 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -93.02 170.03 9.97 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.504 -0.771 . . . . 75.239999999999995 110.868 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 mt -125.16 124.77 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 122.035 -0.416 . . . . 73.329999999999998 111.09 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.85 163.13 19.73 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.554 0.576 . . . . 75.340000000000003 112.554 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.82 123.39 36.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.01 -0.541 . . . . 71.530000000000001 110.648 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.521 ' HB ' ' HB ' ' A' ' 23' ' ' THR . 57.7 mt -78.79 106.19 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 120.022 -0.671 . . . . 73.430000000000007 110.341 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -88.08 -37.05 16.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.789 -0.641 . . . . 74.450000000000003 112.573 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 46.2 m-80 -133.31 146.84 51.72 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.115 0.483 . . . . 72.209999999999994 111.322 173.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 112.44 0.533 . . . . 74.230000000000004 112.44 -176.443 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 120.823 0.344 . . . . 70.120000000000005 111.165 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -147.81 174.12 12.14 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.009 0.433 . . . . 72.310000000000002 111.827 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -71.89 118.72 15.09 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 111.381 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.93 30.68 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.42 -0.419 . . . . 54.520000000000003 112.914 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.08 142.34 31.35 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.968 0.413 . . . . 63.350000000000001 111.927 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.07 141.13 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.78 0.324 . . . . 64.519999999999996 111.155 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.62 173.34 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.971 0.415 . . . . 71.319999999999993 111.469 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 34.5 tt0 -112.52 133.26 54.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.41 -0.359 . . . . 72.420000000000002 110.791 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.401 HG23 ' HA ' ' A' ' 40' ' ' ILE . 41.6 p -135.68 178.67 6.86 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.328 0.585 . . . . 72.239999999999995 111.804 -176.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -69.89 -14.41 62.72 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.99 -0.55 . . . . 62.329999999999998 112.383 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.58 -17.23 18.77 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.809 0.338 . . . . 74.430000000000007 111.247 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.99 -149.29 20.17 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.41 -0.676 . . . . 72.140000000000001 111.41 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -94.16 148.53 22.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 117.646 0.723 . . . . 71.010000000000005 111.276 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.6 t -133.89 127.07 51.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.65 -0.25 . . . . 74.340000000000003 111.241 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 72' ' ' ARG . 15.5 ttm180 -96.28 115.95 28.24 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.557 0.217 . . . . 73.420000000000002 110.832 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.76 126.99 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.448 0.536 . . . . 74.109999999999999 112.448 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.5 p -100.96 -41.37 6.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.634 0.605 . . . . 74.019999999999996 112.634 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 121.018 0.437 . . . . 75.310000000000002 111.855 -177.792 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 120.849 0.357 . . . . 62.240000000000002 111.269 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.2 mt -102.83 144.99 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.734 0.302 . . . . 72.010000000000005 110.71 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -126.94 151.23 48.77 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.584 0.231 . . . . 70.129999999999995 111.421 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -167.44 175.88 42.38 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.277 -0.487 . . . . 74.219999999999999 113.239 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.1 t -106.3 142.11 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 117.078 0.439 . . . . 71.549999999999997 111.405 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.478 ' HB2' HG11 ' A' ' 27' ' ' VAL . 40.7 tp -76.36 114.35 14.95 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.157 0.503 . . . . 74.040000000000006 111.456 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 72' ' ' ARG . 8.0 pt -133.51 179.22 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.189 0.518 . . . . 64.030000000000001 111.166 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 . . . . . 0 N--CA 1.473 0.696 0 O-C-N 122.207 -0.308 . . . . 62.43 111.239 -176.807 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.422 ' CG2' ' HB ' ' A' ' 40' ' ' ILE . 25.8 m . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 120.914 0.387 . . . . 63.5 111.729 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -129.11 165.83 20.49 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.521 -0.308 . . . . 71.230000000000004 111.485 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.535 ' HB ' HD12 ' A' ' 40' ' ' ILE . 15.5 tt -155.17 139.74 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.762 0.315 . . . . 74.140000000000001 111.419 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.442 ' OD1' HG12 ' A' ' 37' ' ' ILE . 90.3 m-20 -80.93 103.61 10.87 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.015 0.436 . . . . 70.219999999999999 110.841 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.472 HG23 HG23 ' A' ' 71' ' ' VAL . 60.3 t -85.35 121.44 37.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.98 -0.554 . . . . 73.5 112.013 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.01 111.37 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.113 -0.494 . . . . 65.329999999999998 110.788 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -77.77 115.8 53.08 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.413 -0.358 . . . . 73.129999999999995 110.283 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.28 -20.05 21.66 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.388 2.058 . . . . 73.109999999999999 113.791 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -86.01 -33.54 21.02 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.942 0.401 . . . . 65.019999999999996 111.885 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.5 p -116.4 -21.27 9.34 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.155 0.428 . . . . 62.109999999999999 112.155 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.34 25.72 50.21 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.391 0.516 . . . . 61.310000000000002 114.391 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -87.6 155.97 19.71 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.52 0.66 . . . . 75.549999999999997 111.705 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.1 t -118.7 111.5 34.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.138 -0.483 . . . . 64.510000000000005 109.909 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -133.38 136.6 45.4 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.132 0.419 . . . . 73.219999999999999 112.132 -173.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.442 HG12 ' OD1' ' A' ' 26' ' ' ASN . 61.5 mt -76.76 123.84 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.269 0.557 . . . . 54.240000000000002 112.105 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HB2' ' OD1' ' A' ' 67' ' ' ASN . . . -117.81 170.32 8.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.032 -0.531 . . . . 70.140000000000001 111.606 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -104.69 127.27 52.4 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.418 -0.356 . . . . 73.450000000000003 110.466 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.535 HD12 ' HB ' ' A' ' 25' ' ' ILE . 53.8 mt -83.91 124.23 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.093 0.473 . . . . 64.349999999999994 111.617 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -81.11 -53.8 6.08 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.007 -0.542 . . . . 72.5 111.301 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -143.93 152.47 41.14 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.923 0.392 . . . . 71.400000000000006 111.553 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.512 HG12 HG11 ' A' ' 64' ' ' VAL . 48.6 t . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 109.555 -0.535 . . . . 72.430000000000007 109.555 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.576 HG21 HD12 ' A' ' 83' ' ' ILE . 62.2 mt . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.075 0.464 . . . . 74.019999999999996 110.726 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.3 t -142.24 169.4 17.65 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.051 0.453 . . . . 73.120000000000005 111.574 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -61.51 126.15 26.34 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.288 -0.415 . . . . 74.420000000000002 111.753 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.06 -24.91 21.98 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.387 -0.435 . . . . 64.209999999999994 112.97 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.24 141.64 35.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.874 0.368 . . . . 51.210000000000001 111.694 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.3 m -100.57 133.11 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.296 0.57 . . . . 60.399999999999999 111.833 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.512 HG11 HG12 ' A' ' 43' ' ' VAL . 32.1 m -111.92 146.76 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.177 0.513 . . . . 74.109999999999999 111.685 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -89.84 112.65 24.05 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.254 -0.43 . . . . 74.230000000000004 110.259 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 p -115.01 174.84 5.77 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.962 0.411 . . . . 63.100000000000001 111.593 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.531 ' OD1' ' HB2' ' A' ' 38' ' ' ALA . 19.5 p-10 -62.9 -31.78 72.9 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.992 0.425 . . . . 72.140000000000001 111.444 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.403 HD13 ' HB1' ' A' ' 38' ' ' ALA . 88.5 mt -82.6 -19.03 39.21 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.291 -0.413 . . . . 62.130000000000003 111.464 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.18 -150.32 19.6 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.828 -0.701 . . . . 74.430000000000007 113.853 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -83.44 119.26 24.44 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.563 -0.375 . . . . 73.450000000000003 111.207 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.472 HG23 HG23 ' A' ' 27' ' ' VAL . 47.6 t -123.69 122.93 66.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.608 0.242 . . . . 73.540000000000006 111.494 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -91.22 116.09 28.55 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.284 -0.26 . . . . 72.030000000000001 111.407 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.63 134.02 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 112.336 0.495 . . . . 74.109999999999999 112.336 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.3 p -118.65 -66.9 1.03 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.331 -0.395 . . . . 61.350000000000001 111.916 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 120.787 0.327 . . . . 75.430000000000007 111.737 179.813 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 CA--C 1.543 0.69 0 CA-C-O 120.857 0.361 . . . . 73.040000000000006 110.956 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.576 HD12 HG21 ' A' ' 58' ' ' ILE . 60.2 mt -91.75 126.98 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.533 -0.303 . . . . 74.340000000000003 111.3 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -119.31 157.41 28.14 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.774 0.321 . . . . 73.409999999999997 111.337 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.33 177.94 39.12 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.107 -0.568 . . . . 36.619999999999997 113.407 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.5 t -111.08 138.98 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 122.454 -0.439 . . . . 71.340000000000003 111.627 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.8 tp -81.08 115.66 20.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.94 0.4 . . . . 73.140000000000001 111.362 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.6 pt -141.29 -166.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 120.94 0.4 . . . . 65.140000000000001 111.759 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 120.821 0.343 . . . . 73.239999999999995 111.295 178.663 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.474 HG22 ' HB ' ' A' ' 40' ' ' ILE . 18.9 m . . . . . 0 CA--C 1.538 0.481 0 CA-C-O 121.262 0.553 . . . . 45.409999999999997 112.373 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -148.14 162.9 38.5 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.713 -0.676 . . . . 70.140000000000001 110.487 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 tt -150.55 141.81 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 112.047 0.388 . . . . 64.310000000000002 112.047 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -80.45 103.24 10.18 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.102 0.477 . . . . 73.420000000000002 110.035 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 61.3 t -90.81 125.22 43.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.506 . . . . 70.230000000000004 111.847 -175.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.38 119.86 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.066 -0.515 . . . . 62.140000000000001 110.834 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -77.49 121.45 84.41 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 116.122 -0.49 . . . . 72.319999999999993 110.98 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.32 -17.56 8.94 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.579 2.186 . . . . 71.109999999999999 112.951 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -85.21 -43.68 13.58 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.911 0.386 . . . . 54.43 111.476 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.509 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 37.2 p -114.32 -10.83 12.64 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.154 0.798 . . . . 74.140000000000001 113.154 -176.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.84 22.87 78.78 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 120.86 -0.686 . . . . 54.399999999999999 114.202 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 21.2 pttp -102.82 142.6 33.67 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.27 0.535 . . . . 70.409999999999997 111.49 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.8 t -102.88 119.86 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.824 0.345 . . . . 74.209999999999994 111.081 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -132.38 146.09 51.71 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.983 0.42 . . . . 75.430000000000007 111.579 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 53.4 mt -82.71 125.78 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.844 0.354 . . . . 75.439999999999998 111.589 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.486 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -118.55 162.41 18.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.245 0.545 . . . . 65.200000000000003 112.195 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -102.86 114.36 28.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.966 -0.561 . . . . 74.409999999999997 110.511 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.474 ' HB ' HG22 ' A' ' 23' ' ' THR . 58.7 mt -76.1 113.38 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.738 0.304 . . . . 62.340000000000003 111.372 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -83.1 -53.87 5.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.037 0.446 . . . . 75.239999999999995 111.368 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -121.32 151.47 40.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.109 -0.496 . . . . 70.200000000000003 111.69 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 m . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 121.141 0.496 . . . . 74.040000000000006 112.05 -177.146 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.449 HG22 HG23 ' A' ' 73' ' ' VAL . 61.5 mt . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.143 0.497 . . . . 71.430000000000007 111.095 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.0 t -135.56 160.25 39.07 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.13 -0.486 . . . . 74.409999999999997 111.25 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -58.66 127.08 30.4 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.001 0.429 . . . . 74.140000000000001 111.876 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.37 -22.14 37.15 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.137 -0.483 . . . . 38.960000000000001 112.7 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.27 150.71 35.29 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.924 0.392 . . . . 74.099999999999994 111.529 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -107.19 116.26 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 120.945 0.402 . . . . 75.430000000000007 111.152 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 m -103.46 137.71 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 120.898 0.38 . . . . 70.409999999999997 110.65 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -90.82 110.68 21.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.264 0.554 . . . . 64.230000000000004 111.377 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.437 HG22 HG12 ' A' ' 40' ' ' ILE . 32.5 p -102.6 170.32 8.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.622 -0.717 . . . . 74.219999999999999 110.862 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -56.22 -33.56 65.48 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.986 0.422 . . . . 71.430000000000007 111.465 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.486 HD13 ' HB2' ' A' ' 38' ' ' ALA . 65.4 mt -79.91 -15.31 57.59 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.411 -0.359 . . . . 73.299999999999997 111.806 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.14 -161.08 23.83 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.321 -0.466 . . . . 74.450000000000003 113.235 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -70.0 134.35 48.21 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.563 -0.375 . . . . 64.349999999999994 111.235 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 96.0 t -130.64 125.7 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.778 0.323 . . . . 73.310000000000002 111.328 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.589 ' HB2' HD12 ' A' ' 88' ' ' ILE . 43.0 ttm180 -89.81 117.41 28.63 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.712 -0.222 . . . . 74.140000000000001 110.597 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.449 HG23 HG22 ' A' ' 58' ' ' ILE . 42.5 t -66.78 133.53 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.815 0.341 . . . . 63.43 111.767 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.4 p -109.9 -50.05 3.02 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.171 0.51 . . . . 72.409999999999997 111.908 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 121.078 0.466 . . . . 74.040000000000006 111.757 -178.352 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 112.407 0.521 . . . . 74.420000000000002 112.407 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.0 mt -122.38 140.07 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 122.879 0.472 . . . . 74.049999999999997 110.224 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -124.29 141.35 52.14 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.202 0.445 . . . . 75.239999999999995 112.202 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.1 176.36 37.68 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.113 -0.565 . . . . 41.240000000000002 113.377 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 18.0 t -118.63 135.81 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 122.64 -0.33 . . . . 73.430000000000007 111.57 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.41 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 38.7 tp -72.87 106.05 4.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.795 0.331 . . . . 74.310000000000002 111.077 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.589 HD12 ' HB2' ' A' ' 72' ' ' ARG . 30.5 pt -118.65 -175.92 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.169 0.509 . . . . 72.140000000000001 111.785 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.175 -0.466 . . . . 73.010000000000005 111.09 178.618 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.519 HG22 ' HB ' ' A' ' 40' ' ' ILE . 75.0 m . . . . . 0 N--CA 1.472 0.635 0 CA-C-O 120.817 0.341 . . . . 71.019999999999996 111.822 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.485 ' O ' HD13 ' A' ' 83' ' ' ILE . 59.1 mtt180 -142.58 168.94 18.54 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.734 0.302 . . . . 63.399999999999999 111.288 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.05 145.71 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.947 0.403 . . . . 64.299999999999997 111.758 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.484 ' N ' HD21 ' A' ' 26' ' ' ASN . 0.8 OUTLIER -79.35 104.28 9.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.077 0.465 . . . . 65.239999999999995 110.298 174.055 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -90.1 123.4 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.986 -0.552 . . . . 70.120000000000005 111.841 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.6 t -107.72 116.82 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.299 -0.409 . . . . 63.299999999999997 111.353 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.518 ' HB2' ' HG2' ' A' ' 34' ' ' LYS . 9.8 t70 -71.56 122.53 87.43 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 110.276 -0.268 . . . . 74.019999999999996 110.276 176.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.96 -30.86 32.03 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.075 1.85 . . . . 74.310000000000002 113.19 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -89.62 -43.87 10.46 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.814 0.672 . . . . 74.049999999999997 112.814 -175.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.0 p -96.61 -26.55 15.18 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.147 0.425 . . . . 61.240000000000002 112.147 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.71 22.0 58.83 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.915 -0.659 . . . . 64.239999999999995 113.901 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HG2' ' HB2' ' A' ' 29' ' ' ASP . 10.7 ptpp? -78.06 135.3 37.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.359 0.579 . . . . 71.329999999999998 110.596 177.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -115.66 101.34 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.906 0.384 . . . . 72.040000000000006 110.943 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -125.15 144.41 50.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.902 0.382 . . . . 70.129999999999995 111.417 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.0 mt -84.92 111.34 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.897 0.379 . . . . 74.510000000000005 111.191 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.48 148.38 32.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.976 0.417 . . . . 65.409999999999997 112.015 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -80.27 130.97 35.57 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.336 -0.393 . . . . 63.539999999999999 110.668 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.577 ' HA ' HG23 ' A' ' 66' ' ' THR . 69.4 mt -80.99 113.65 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.049 0.452 . . . . 64.129999999999995 111.053 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -82.56 -48.66 10.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.201 0.524 . . . . 64.400000000000006 111.192 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -125.21 145.22 50.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.988 -0.551 . . . . 72.420000000000002 110.526 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.408 ' HA ' HG11 ' A' ' 64' ' ' VAL . 32.6 m . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 113.37 0.878 . . . . 73.239999999999995 113.37 -173.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.5 mm . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 120.61 0.243 . . . . 62.299999999999997 110.968 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.1 t -147.39 169.71 18.89 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.981 0.42 . . . . 73.530000000000001 111.896 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -63.16 125.05 22.79 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.131 -0.486 . . . . 75.030000000000001 111.132 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.55 -14.88 57.71 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.193 -0.527 . . . . 61.439999999999998 113.139 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.43 137.88 41.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.878 0.371 . . . . 40.329999999999998 111.569 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.97 112.11 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.909 0.385 . . . . 74.219999999999999 110.987 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.504 ' HB ' HG21 ' A' ' 40' ' ' ILE . 32.5 m -105.65 139.58 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.548 0.573 . . . . 74.120000000000005 112.548 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -82.54 116.43 21.96 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.511 -0.313 . . . . 75.510000000000005 110.674 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.577 HG23 ' HA ' ' A' ' 40' ' ' ILE . 32.1 p -121.16 179.42 4.4 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 120.905 0.383 . . . . 75.200000000000003 111.741 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.58 -19.43 65.92 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.91 0.337 . . . . 71.030000000000001 111.91 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.6 mt -93.27 -23.69 18.42 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.946 0.403 . . . . 72.200000000000003 111.045 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.438 ' HA2' ' NH1' ' A' ' 89' ' ' ARG . . . 135.87 -162.03 24.91 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.134 -0.555 . . . . 65.140000000000001 113.381 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -71.29 117.39 12.76 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.805 0.336 . . . . 61.399999999999999 110.596 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 40.6 t -110.96 120.75 62.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.854 0.359 . . . . 73.420000000000002 111.118 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -84.87 109.67 18.28 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.876 0.37 . . . . 74.409999999999997 110.421 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -65.2 120.15 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.456 0.539 . . . . 74.010000000000005 112.456 -173.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.3 p -89.86 -40.43 12.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.129 -0.487 . . . . 63.119999999999997 111.633 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.936 0.398 . . . . 64.030000000000001 111.659 -178.346 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 120.991 0.424 . . . . 71.120000000000005 111.856 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 24' ' ' ARG . 20.6 mt -92.75 135.1 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.3 -0.409 . . . . 74.219999999999999 110.739 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -128.36 145.15 51.16 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 122.212 -0.305 . . . . 72.530000000000001 111.514 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.55 172.46 39.48 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.022 -0.608 . . . . 53.439999999999998 113.515 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.6 t -109.15 147.41 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 122.545 -0.386 . . . . 73.140000000000001 111.754 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 tp -84.65 119.27 25.04 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.129 0.49 . . . . 73.409999999999997 112.089 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.489 ' O ' ' HD2' ' A' ' 89' ' ' ARG . 17.3 pt -144.64 -173.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 122.996 0.518 . . . . 73.409999999999997 110.595 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 88' ' ' ILE . 18.2 mmm180 . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 120.789 0.328 . . . . 74.200000000000003 110.739 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 94.1 m . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 121.016 0.436 . . . . 73.340000000000003 111.68 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HG2' HG23 ' A' ' 37' ' ' ILE . 2.3 ttm105 -166.85 155.64 10.38 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.282 -0.417 . . . . 75.549999999999997 110.943 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.519 ' HB ' HD11 ' A' ' 40' ' ' ILE . 9.8 tt -133.71 142.85 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.101 0.408 . . . . 73.219999999999999 112.101 -175.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.425 ' N ' HD21 ' A' ' 26' ' ' ASN . 0.9 OUTLIER -76.61 103.61 6.68 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.076 0.465 . . . . 74.319999999999993 110.634 174.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.458 HG23 HG12 ' A' ' 71' ' ' VAL . 45.3 t -104.75 125.35 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.177 0.513 . . . . 71.549999999999997 111.576 -176.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.48 118.53 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.19 -0.459 . . . . 75.219999999999999 110.782 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -75.59 112.69 20.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.29 -0.414 . . . . 51.100000000000001 109.897 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.58 -14.6 15.9 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.359 2.039 . . . . 71.349999999999994 112.833 -177.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.97 -42.97 12.1 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.777 0.322 . . . . 74.439999999999998 111.26 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 25.9 p -107.19 -15.35 14.68 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.234 0.457 . . . . 73.319999999999993 112.234 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.54 18.38 73.62 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.361 -0.447 . . . . 71.140000000000001 114.099 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 21.7 pttm -92.36 159.56 15.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.494 0.647 . . . . 74.310000000000002 111.946 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.6 t -107.24 109.26 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.402 -0.363 . . . . 72.439999999999998 110.722 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -117.01 141.6 48.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.543 -0.298 . . . . 74.120000000000005 111.021 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.506 HG23 ' HG2' ' A' ' 24' ' ' ARG . 38.1 mt -100.04 105.94 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.921 0.391 . . . . 54.420000000000002 110.852 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.08 151.92 19.28 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.999 0.74 . . . . 62.229999999999997 112.999 -172.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.61 126.35 34.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.243 -0.435 . . . . 54.130000000000003 110.955 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.519 HD11 ' HB ' ' A' ' 25' ' ' ILE . 56.2 mt -83.44 113.35 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.199 0.444 . . . . 63.049999999999997 112.199 -176.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -82.84 -53.62 5.74 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.034 0.445 . . . . 72.239999999999995 110.583 176.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.646 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 40.4 t30 -118.99 147.57 43.93 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.107 -0.497 . . . . 65.439999999999998 110.686 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 113.024 0.75 . . . . 73.510000000000005 113.024 -172.915 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.5 mt . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.592 0.234 . . . . 73.430000000000007 110.522 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.0 p -118.26 159.68 22.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.245 0.545 . . . . 73.319999999999993 112.184 -174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.81 136.47 56.92 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.317 -0.401 . . . . 73.219999999999999 111.23 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 -14.51 45.67 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.071 -0.585 . . . . 60.109999999999999 113.183 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.47 147.95 33.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.026 0.441 . . . . 75.420000000000002 111.386 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.11 119.5 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.94 0.4 . . . . 61.32 111.319 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.96 156.63 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.108 0.48 . . . . 72.340000000000003 111.317 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 36.1 tt0 -97.88 105.92 18.14 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.863 0.363 . . . . 72.109999999999999 110.964 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.0 p -103.38 170.72 7.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.856 0.36 . . . . 72.420000000000002 111.576 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -57.52 -30.85 65.49 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.33 -0.395 . . . . 73.349999999999994 111.473 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.4 mt -77.91 -36.82 49.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.035 0.445 . . . . 73.329999999999998 111.014 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.99 -150.87 23.08 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.265 -0.493 . . . . 37.020000000000003 112.7 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -75.88 128.77 35.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.932 0.396 . . . . 61.130000000000003 111.314 -178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.458 HG12 HG23 ' A' ' 27' ' ' VAL . 90.1 t -129.01 126.93 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.535 -0.302 . . . . 74.109999999999999 111.297 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -95.98 120.6 36.55 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.626 0.251 . . . . 72.540000000000006 111.508 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.5 t -65.12 133.85 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 112.051 0.389 . . . . 73.409999999999997 112.051 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.4 p -96.9 -50.12 4.77 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.259 0.466 . . . . 73.010000000000005 112.259 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 112.096 0.406 . . . . 72.310000000000002 112.096 -179.122 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 121.298 0.57 . . . . 73.329999999999998 112.509 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 83' ' ' ILE . 3.9 mp -113.11 125.34 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.096 -0.502 . . . . 74.140000000000001 110.266 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -102.22 143.07 32.48 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.836 0.351 . . . . 74.25 111.825 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.86 173.96 36.62 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 121.282 -0.485 . . . . 63.119999999999997 113.446 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 12.6 t -115.8 139.09 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 117.001 0.4 . . . . 65.349999999999994 111.548 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HB2' HG13 ' A' ' 27' ' ' VAL . 50.6 tp -79.16 106.95 11.56 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.737 0.303 . . . . 75.329999999999998 111.4 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 pt -133.67 -171.24 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.252 0.548 . . . . 64.530000000000001 111.789 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 76.7 mmt-85 . . . . . 0 CA--C 1.536 0.432 0 CA-C-N 116.039 -0.528 . . . . 61.350000000000001 110.983 176.025 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.8 m . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.853 0.358 . . . . 75.109999999999999 111.463 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.42 151.14 48.1 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.85 0.357 . . . . 75.439999999999998 111.586 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.9 tt -146.26 139.08 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.028 0.442 . . . . 51.210000000000001 111.374 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.57 103.69 9.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.438 -0.346 . . . . 71.010000000000005 110.429 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.82 113.91 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.898 0.38 . . . . 72.420000000000002 111.549 -177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.7 t -95.16 118.09 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.396 -0.365 . . . . 74.400000000000006 110.688 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.23 128.93 81.65 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 120.536 0.208 . . . . 71.5 110.982 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.79 -22.79 11.51 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.426 2.084 . . . . 73.519999999999996 113.592 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -88.27 -35.32 17.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.969 0.414 . . . . 37.140000000000001 111.859 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.7 p -107.91 -31.72 7.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.373 -0.376 . . . . 74.400000000000006 111.803 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.91 10.19 65.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.208 -0.52 . . . . 61.340000000000003 113.603 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -79.63 138.12 37.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.192 0.496 . . . . 71.540000000000006 111.919 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.9 t -97.66 106.42 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 116.27 -0.423 . . . . 74.430000000000007 110.319 176.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -128.65 132.87 48.12 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.952 0.406 . . . . 62.439999999999998 111.583 -173.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 57.0 mt -81.06 140.43 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 112.427 0.528 . . . . 74.219999999999999 112.427 -175.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.47 167.14 22.91 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.239 -0.437 . . . . 43.539999999999999 111.124 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.472 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 3.3 mp0 -98.24 140.56 32.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.819 0.343 . . . . 73.099999999999994 111.081 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.16 115.1 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.969 0.414 . . . . 71.129999999999995 111.687 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.528 HH21 ' HB3' ' A' ' 67' ' ' ASN . 21.4 mmt180 -81.21 -53.83 6.03 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.222 0.534 . . . . 72.5 110.802 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 15.7 m120 -119.5 131.17 55.52 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 111.657 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.434 HG21 HG12 ' A' ' 58' ' ' ILE . 10.5 p . . . . . 0 CA--C 1.548 0.897 0 N-CA-C 113.046 0.758 . . . . 74.5 113.046 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.434 HG12 HG21 ' A' ' 43' ' ' VAL . 64.2 mt . . . . . 0 CA--C 1.542 0.644 0 CA-C-O 120.611 0.243 . . . . 72.129999999999995 111.132 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -147.53 166.31 27.7 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.833 0.349 . . . . 71.409999999999997 111.584 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -65.01 134.38 53.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.973 0.416 . . . . 72.329999999999998 111.37 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.87 -26.4 24.6 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.271 -0.422 . . . . 73.430000000000007 112.462 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.77 156.93 38.77 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.936 0.398 . . . . 75.409999999999997 111.804 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.1 114.1 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.907 0.385 . . . . 73.510000000000005 111.361 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.56 154.47 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.973 0.416 . . . . 74.430000000000007 112.012 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 34.0 tt0 -92.96 127.31 38.42 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.224 -0.298 . . . . 73.319999999999993 110.771 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.6 p -129.63 176.35 8.07 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.609 0.364 . . . . 74.400000000000006 110.717 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.528 ' HB3' HH21 ' A' ' 41' ' ' ARG . 3.8 p-10 -65.09 -27.47 68.78 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.782 0.325 . . . . 75.450000000000003 111.863 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.74 -22.75 37.12 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.081 0.467 . . . . 73.400000000000006 111.103 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.63 -152.16 21.52 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 116.241 -0.436 . . . . 44.140000000000001 112.504 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -85.91 131.21 34.34 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 122.241 -0.564 . . . . 63.219999999999999 110.994 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.27 122.34 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 111.851 0.315 . . . . 73.420000000000002 111.851 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.423 ' HB2' HD12 ' A' ' 88' ' ' ILE . 40.7 ttm180 -86.36 112.16 21.18 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.655 0.264 . . . . 72.439999999999998 110.402 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -63.98 127.14 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.568 0.581 . . . . 61.520000000000003 112.568 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 73.8 p -103.04 -33.09 9.39 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.056 0.455 . . . . 65.519999999999996 111.656 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.6 ' HB3' ' H ' ' A' ' 84' ' ' ASN . 35.8 t . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 121.36 0.6 . . . . 63.439999999999998 111.831 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 CA--C 1.545 0.762 0 CA-C-O 120.971 0.415 . . . . 73.219999999999999 111.628 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.7 mt -121.53 143.06 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 122.526 0.33 . . . . 75.209999999999994 110.835 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.6 ' H ' ' HB3' ' A' ' 75' ' ' SER . 2.4 m-20 -119.72 153.08 36.16 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.731 0.301 . . . . 73.109999999999999 111.257 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.9 177.83 37.98 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.453 -0.34 . . . . 44.009999999999998 112.887 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 t -116.39 138.86 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 117.218 0.509 . . . . 74.409999999999997 111.279 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.0 tp -78.93 106.54 11.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.036 0.446 . . . . 72.530000000000001 111.807 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' A' ' 72' ' ' ARG . 16.5 pt -121.5 179.91 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.188 0.518 . . . . 53.329999999999998 111.236 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.59 0 CA-C-N 116.368 -0.378 . . . . 73.239999999999995 110.983 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.484 HG21 ' HB ' ' A' ' 40' ' ' ILE . 51.6 m . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.893 0.377 . . . . 51.210000000000001 111.385 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -139.49 170.01 16.7 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.12 0.486 . . . . 60.340000000000003 111.881 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.442 ' HB ' HD11 ' A' ' 40' ' ' ILE . 13.2 tt -152.0 142.8 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.97 -0.559 . . . . 65.129999999999995 111.111 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -77.21 103.7 7.29 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.248 0.547 . . . . 73.129999999999995 110.573 174.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.46 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 39.3 t -86.24 136.68 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.718 . . . . 74.430000000000007 111.263 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.496 HG22 HG23 ' A' ' 35' ' ' VAL . 47.2 t -110.85 104.83 17.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.66 0.267 . . . . 63.219999999999999 111.053 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 35.2 t70 -65.09 115.43 21.1 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.48 -0.327 . . . . 72.239999999999995 111.16 176.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.37 -11.71 22.77 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.34 2.027 . . . . 72.340000000000003 113.733 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -80.78 -43.19 20.52 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.1 0.476 . . . . 75.230000000000004 111.4 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.402 ' OG1' ' HE3' ' A' ' 34' ' ' LYS . 59.6 p -101.24 -29.49 12.06 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.132 -0.485 . . . . 71.310000000000002 111.67 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.79 63.13 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 116.248 -0.433 . . . . 44.130000000000003 112.739 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 17.6 ptpt -82.82 163.12 21.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.867 0.365 . . . . 72.109999999999999 111.322 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.496 HG23 HG22 ' A' ' 28' ' ' VAL . 47.9 t -117.63 97.39 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.38 -0.373 . . . . 73.549999999999997 111.164 174.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.46 ' HG2' ' HB ' ' A' ' 27' ' ' VAL . 1.5 pm0 -93.79 170.86 9.25 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.051 0.453 . . . . 64.120000000000005 111.33 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.7 mt -111.78 134.51 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 121.849 -0.532 . . . . 62.450000000000003 111.098 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.49 ' HB1' HD11 ' A' ' 68' ' ' LEU . . . -130.99 153.56 49.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.96 0.41 . . . . 72.099999999999994 111.977 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -91.91 126.11 36.87 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.13 -0.486 . . . . 71.340000000000003 110.485 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.484 ' HB ' HG21 ' A' ' 23' ' ' THR . 61.2 mt -79.13 113.54 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.042 0.448 . . . . 75.129999999999995 111.458 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -83.05 -47.83 11.26 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.063 0.458 . . . . 75.510000000000005 111.383 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.514 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 51.7 m-80 -138.15 163.94 30.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.265 -0.425 . . . . 71.340000000000003 111.443 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.273 0.558 . . . . 74.030000000000001 111.312 179.776 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.8 mt . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 121.011 0.434 . . . . 74.409999999999997 111.281 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -147.83 -179.96 7.28 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.226 -0.443 . . . . 75.349999999999994 111.085 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -64.18 135.99 56.81 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.828 0.347 . . . . 74.209999999999994 111.807 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.06 -20.89 47.07 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.29 -0.481 . . . . 53.350000000000001 113.251 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.82 153.11 29.34 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.028 0.442 . . . . 72.439999999999998 111.676 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.7 t -110.91 119.3 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.354 -0.384 . . . . 75.400000000000006 110.793 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.47 ' HB ' HG21 ' A' ' 40' ' ' ILE . 27.6 m -103.39 131.49 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.42 0.628 . . . . 63.210000000000001 112.17 -177.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 9.7 tp10 -79.81 102.32 9.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.931 -0.577 . . . . 63.32 110.894 177.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.6 p -100.74 173.21 6.63 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.774 0.321 . . . . 74.120000000000005 111.045 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -61.12 -29.07 69.54 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.87 0.367 . . . . 63.420000000000002 111.655 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.49 HD11 ' HB1' ' A' ' 38' ' ' ALA . 92.6 mt -80.78 -31.14 35.88 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.926 0.393 . . . . 70.319999999999993 111.088 176.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.18 -162.9 28.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.915 -0.66 . . . . 44.520000000000003 112.889 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -80.93 120.05 24.25 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.216 0.531 . . . . 74.310000000000002 111.713 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.448 HG21 HG22 ' A' ' 27' ' ' VAL . 47.6 t -113.56 120.52 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.208 -0.451 . . . . 73.430000000000007 111.509 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -86.7 116.19 24.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.851 0.358 . . . . 74.239999999999995 111.21 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.36 109.84 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.19 -0.459 . . . . 75.5 112.123 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.7 p -87.75 -59.29 2.28 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.254 0.549 . . . . 74.439999999999998 110.729 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.556 ' HB2' ' HB2' ' A' ' 84' ' ' ASN . 54.8 m . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.846 -0.616 . . . . 72.409999999999997 111.082 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.453 HG22 ' N ' ' A' ' 83' ' ' ILE . 12.7 p . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 120.906 0.384 . . . . 60.420000000000002 111.307 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.453 ' N ' HG22 ' A' ' 82' ' ' VAL . 40.1 mt -97.26 144.75 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.579 0.351 . . . . 63.109999999999999 110.438 175.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 75' ' ' SER . 16.2 m-80 -135.19 142.49 46.09 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 122.252 -0.28 . . . . 52.210000000000001 111.329 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.81 175.79 39.16 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.038 -0.601 . . . . 72.140000000000001 113.647 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.0 t -99.27 144.49 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.088 0.403 . . . . 73.150000000000006 112.088 -177.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.41 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 49.5 tp -79.59 106.63 11.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.824 0.345 . . . . 62.520000000000003 110.973 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.0 pt -126.88 -179.65 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.178 0.513 . . . . 65.219999999999999 111.153 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 120.911 0.386 . . . . 73.099999999999994 111.456 -179.886 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.483 HG21 ' HB ' ' A' ' 40' ' ' ILE . 27.1 m . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 110.213 -0.292 . . . . 71.310000000000002 110.213 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -133.83 165.39 25.09 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.23 0.456 . . . . 74.010000000000005 112.23 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.521 ' HB ' HD12 ' A' ' 40' ' ' ILE . 12.7 tt -151.46 131.29 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.127 -0.488 . . . . 71.109999999999999 111.782 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -72.81 103.82 3.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.072 0.463 . . . . 72.239999999999995 110.328 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 71' ' ' VAL . 46.8 t -95.92 126.97 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.029 -0.532 . . . . 75.129999999999995 112.349 -174.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.01 114.17 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.224 -0.444 . . . . 73.0 110.82 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.412 ' HA ' ' HB3' ' A' ' 87' ' ' LEU . 11.3 t70 -76.84 126.12 86.16 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.558 -0.292 . . . . 62.240000000000002 111.624 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.99 -9.89 9.5 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.949 2.433 . . . . 75.400000000000006 113.226 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -75.03 -43.7 52.09 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.929 0.395 . . . . 75.209999999999994 111.685 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.9 p -123.28 -31.5 3.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.463 -0.335 . . . . 70.5 111.686 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.07 3.49 29.73 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.406 -0.426 . . . . 71.239999999999995 113.125 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -71.53 143.63 49.87 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.933 0.397 . . . . 61.32 112.002 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.4 t -114.91 129.28 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.897 0.38 . . . . 72.120000000000005 111.514 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -140.38 145.83 37.6 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.345 -0.389 . . . . 74.409999999999997 110.818 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.4 mt -87.94 101.82 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.263 0.554 . . . . 72.129999999999995 111.515 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.51 165.14 16.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.315 0.578 . . . . 72.040000000000006 112.273 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -103.69 123.79 47.66 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.842 -0.617 . . . . 72.040000000000006 110.651 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.521 HD12 ' HB ' ' A' ' 25' ' ' ILE . 70.0 mt -84.09 115.94 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.609 0.596 . . . . 74.120000000000005 112.609 -174.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 41' ' ' ARG . 56.2 mtt180 -83.64 -54.12 5.16 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.073 0.463 . . . . 55.020000000000003 111.49 172.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -130.78 167.86 18.18 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.284 0.476 . . . . 73.510000000000005 112.284 -173.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.648 HG12 HG11 ' A' ' 64' ' ' VAL . 17.1 m . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 121.534 0.683 . . . . 71.129999999999995 111.027 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.6 mt . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 120.721 0.296 . . . . 73.329999999999998 110.829 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -147.74 173.16 13.05 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.613 -0.267 . . . . 73.120000000000005 111.367 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -56.85 140.42 48.23 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.851 0.358 . . . . 72.200000000000003 111.697 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.5 -26.44 15.83 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.144 -0.551 . . . . 62.310000000000002 113.454 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.72 155.75 29.25 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.09 0.445 . . . . 75.319999999999993 111.281 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -113.36 127.85 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.626 0.727 . . . . 74.099999999999994 111.908 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.648 HG11 HG12 ' A' ' 43' ' ' VAL . 28.9 m -103.17 127.7 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 121.185 0.516 . . . . 73.439999999999998 111.077 177.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.02 110.86 12.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.218 -0.446 . . . . 74.319999999999993 110.362 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.9 p -115.61 176.04 5.26 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.364 0.602 . . . . 75.120000000000005 112.431 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.421 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 19.3 p-10 -59.25 -30.21 68.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.017 -0.538 . . . . 74.519999999999996 111.225 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.4 mt -81.28 -28.94 34.46 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.16 0.505 . . . . 63.229999999999997 110.728 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.413 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 131.08 -150.5 19.41 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.204 -0.453 . . . . 75.439999999999998 113.161 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.487 HD21 ' N ' ' A' ' 70' ' ' ASN . 1.0 OUTLIER -67.07 120.36 13.55 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.784 0.326 . . . . 64.439999999999998 111.777 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 27' ' ' VAL . 57.4 t -125.71 121.87 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.618 0.246 . . . . 70.319999999999993 111.478 178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.522 ' HB2' HD13 ' A' ' 88' ' ' ILE . 38.1 ttm180 -89.55 118.09 28.93 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.276 -0.265 . . . . 73.319999999999993 111.439 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.95 128.43 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.261 0.467 . . . . 70.099999999999994 112.261 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -109.86 -63.04 1.42 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.185 -0.462 . . . . 75.420000000000002 111.996 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.529 ' HB3' ' HB2' ' A' ' 84' ' ' ASN . 43.5 t . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 120.649 0.261 . . . . 74.409999999999997 111.233 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.408 HG21 ' N ' ' A' ' 83' ' ' ILE . 14.1 p . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 120.747 0.308 . . . . 74.310000000000002 111.277 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.408 ' N ' HG21 ' A' ' 82' ' ' VAL . 45.3 mt -116.56 140.36 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 122.572 0.349 . . . . 72.230000000000004 110.361 175.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 13.4 m120 -127.57 146.73 50.43 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.155 -0.341 . . . . 75.25 111.461 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.99 179.83 38.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.898 -0.668 . . . . 73.329999999999998 113.598 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 13.7 t -113.2 139.71 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 116.831 0.315 . . . . 73.439999999999998 111.402 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 29' ' ' ASP . 62.5 tp -74.16 106.8 5.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.08 0.467 . . . . 45.140000000000001 110.923 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.522 HD13 ' HB2' ' A' ' 72' ' ' ARG . 20.2 pt -124.48 -178.96 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.308 0.575 . . . . 60.340000000000003 111.182 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.413 ' NH1' ' HA3' ' A' ' 69' ' ' GLY . 40.5 mmt180 . . . . . 0 CA--C 1.538 0.511 0 CA-C-N 116.232 -0.44 . . . . 62.530000000000001 111.002 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.473 HG21 ' HB ' ' A' ' 40' ' ' ILE . 91.3 m . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 121.052 0.453 . . . . 72.129999999999995 110.857 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -145.15 163.16 35.2 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.31 -0.404 . . . . 74.319999999999993 111.27 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 tt -147.9 135.9 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.111 0.481 . . . . 71.329999999999998 111.86 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -74.84 103.47 5.09 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.027 0.441 . . . . 75.219999999999999 110.356 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 48.8 t -93.87 145.81 7.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.954 -0.566 . . . . 65.310000000000002 111.528 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 35' ' ' VAL . 48.6 t -117.16 106.9 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.044 -0.526 . . . . 72.140000000000001 110.806 176.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.459 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 12.9 t70 -70.04 112.83 13.8 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.611 0.243 . . . . 75.209999999999994 110.659 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.82 -14.21 11.32 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.774 2.316 . . . . 75.540000000000006 113.286 -176.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -74.71 -37.37 62.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.311 0.577 . . . . 72.549999999999997 110.838 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.8 p -110.1 -32.36 7.03 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.878 -0.601 . . . . 72.310000000000002 111.475 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.81 45.05 4.34 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.299 -0.477 . . . . 74.340000000000003 112.514 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 19.7 ptpt -118.39 162.92 17.51 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.594 -0.356 . . . . 73.109999999999999 111.1 177.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.534 HG23 HG22 ' A' ' 28' ' ' VAL . 58.1 t -120.51 113.85 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.932 0.396 . . . . 63.5 111.202 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -117.26 170.14 8.92 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.073 0.464 . . . . 64.25 111.731 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.2 mt -107.46 116.61 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.554 -0.294 . . . . 73.319999999999993 110.822 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.44 157.72 19.95 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.185 0.517 . . . . 63.119999999999997 112.208 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -97.34 124.14 41.38 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 54.530000000000001 110.719 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.473 ' HB ' HG21 ' A' ' 23' ' ' THR . 60.0 mt -75.34 114.07 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.057 0.455 . . . . 72.530000000000001 111.468 -178.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -82.92 -44.09 15.75 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.246 -0.434 . . . . 74.329999999999998 111.183 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 44.0 m-80 -138.89 146.09 40.72 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.717 0.294 . . . . 74.430000000000007 111.351 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 121.214 0.53 . . . . 75.430000000000007 111.702 179.6 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.492 ' CG2' HG21 ' A' ' 73' ' ' VAL . 60.8 mt . . . . . 0 CA--C 1.54 0.562 0 CA-C-O 120.911 0.386 . . . . 73.25 111.016 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -94.5 156.01 16.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.995 0.426 . . . . 71.340000000000003 111.74 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -64.33 116.33 5.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.815 0.341 . . . . 74.109999999999999 111.149 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.0 -16.04 23.13 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.406 -0.426 . . . . 55.420000000000002 112.68 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.82 150.87 48.06 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.046 0.451 . . . . 74.230000000000004 111.907 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.16 115.31 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.3 -0.409 . . . . 62.439999999999998 111.276 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.69 143.36 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.123 0.487 . . . . 74.329999999999998 111.908 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 8.0 tp10 -87.97 116.52 26.2 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.294 -0.412 . . . . 54.420000000000002 110.509 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.9 p -115.74 176.07 5.25 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.107 0.479 . . . . 74.519999999999996 111.81 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -65.67 -13.22 58.75 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.23 0.456 . . . . 63.219999999999999 112.23 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.8 mt -104.98 -18.18 14.26 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.2 0.524 . . . . 74.019999999999996 111.369 177.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.447 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 139.07 -161.18 25.94 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.282 -0.485 . . . . 73.409999999999997 112.977 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -77.08 137.61 39.04 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.405 -0.468 . . . . 63.049999999999997 110.949 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 58.5 t -130.58 127.98 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.372 -0.205 . . . . 72.019999999999996 111.549 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.456 ' HB2' HD12 ' A' ' 88' ' ' ILE . 59.2 ttm-85 -92.67 113.23 25.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.646 0.26 . . . . 73.420000000000002 110.742 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.492 HG21 ' CG2' ' A' ' 58' ' ' ILE . 48.5 t -61.37 120.14 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.497 0.554 . . . . 75.230000000000004 112.497 -176.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.3 p -96.58 -32.3 12.31 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.438 0.533 . . . . 65.310000000000002 112.438 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.891 0.376 . . . . 75.239999999999995 111.786 -176.874 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 CA--C 1.545 0.764 0 CA-C-O 120.961 0.41 . . . . 75.510000000000005 111.995 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.9 mt -123.51 147.79 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.798 0.439 . . . . 64.420000000000002 110.874 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -121.23 148.93 43.61 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.3 -0.25 . . . . 64.510000000000005 111.03 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -168.54 167.15 40.11 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.861 -0.685 . . . . 53.310000000000002 114.078 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 24.2 t -101.85 140.34 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.68 0.392 . . . . 54.119999999999997 111.672 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.434 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 43.0 tp -78.58 106.88 10.85 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.284 0.564 . . . . 63.530000000000001 111.445 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 72' ' ' ARG . 16.5 pt -128.25 -177.5 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.063 0.459 . . . . 73.349999999999994 110.947 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.447 ' NH1' ' HA3' ' A' ' 69' ' ' GLY . 28.1 mmt180 . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 120.698 0.285 . . . . 73.310000000000002 110.856 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.525 HG22 ' HB ' ' A' ' 40' ' ' ILE . 38.4 m . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.049 0.452 . . . . 74.109999999999999 110.725 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.1 mtm-85 -148.68 163.55 36.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.253 -0.43 . . . . 54.340000000000003 111.384 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.6 tt -147.6 132.7 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.219 -0.446 . . . . 73.200000000000003 111.764 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.504 ' OD1' HG12 ' A' ' 37' ' ' ILE . 77.3 m-20 -65.99 103.23 0.91 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.111 0.481 . . . . 54.219999999999999 110.209 171.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.77 121.99 37.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.024 -0.535 . . . . 63.399999999999999 111.601 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.4 t -94.95 106.79 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.159 0.504 . . . . 75.409999999999997 110.669 176.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.76 113.56 24.05 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 115.843 -0.617 . . . . 61.030000000000001 110.794 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.23 -11.31 17.63 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.589 2.193 . . . . 75.319999999999993 113.431 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -88.05 -37.3 16.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.009 0.433 . . . . 73.219999999999999 111.879 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.406 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 30.5 p -115.17 -26.25 7.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.101 -0.499 . . . . 65.219999999999999 112.24 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.43 15.87 57.96 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.328 -0.463 . . . . 75.209999999999994 113.704 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 22.8 pttm -90.31 152.41 21.04 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.406 -0.467 . . . . 54.130000000000003 111.512 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.5 t -116.42 119.97 63.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.417 -0.356 . . . . 74.030000000000001 110.737 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -133.37 136.73 45.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.912 0.387 . . . . 71.129999999999995 111.614 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.504 HG12 ' OD1' ' A' ' 26' ' ' ASN . 41.8 mt -77.65 112.66 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.914 0.388 . . . . 53.350000000000001 111.258 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.481 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -112.23 145.8 39.28 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.474 -0.33 . . . . 71.010000000000005 111.393 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.78 133.83 36.33 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.667 0.27 . . . . 74.25 110.737 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.525 ' HB ' HG22 ' A' ' 23' ' ' THR . 68.2 mt -82.77 109.95 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.378 0.609 . . . . 73.120000000000005 110.313 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 mtp85 -85.7 -39.53 17.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.719 -0.673 . . . . 71.310000000000002 111.463 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.623 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 41.0 t30 -114.74 120.79 41.28 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.928 -0.578 . . . . 61.109999999999999 110.455 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.416 ' O ' HG22 ' A' ' 43' ' ' VAL . 7.8 p . . . . . 0 CA--C 1.547 0.853 0 N-CA-C 112.488 0.551 . . . . 71.010000000000005 112.488 -173.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.634 HG23 HD11 ' A' ' 83' ' ' ILE . 49.4 mt . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 120.752 0.31 . . . . 64.329999999999998 111.43 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.1 t -147.18 167.94 22.91 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.699 -0.228 . . . . 72.400000000000006 110.753 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 42.5 ttm180 -59.47 126.45 27.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.133 0.492 . . . . 72.530000000000001 111.536 -176.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.32 -24.06 31.31 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.139 -0.553 . . . . 60.109999999999999 112.724 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.8 139.8 38.32 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.493 -0.416 . . . . 55.340000000000003 111.186 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 m -106.31 119.11 55.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.435 0.636 . . . . 61.109999999999999 111.441 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.445 ' HB ' HG21 ' A' ' 40' ' ' ILE . 35.7 m -106.33 152.57 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.241 -0.436 . . . . 74.340000000000003 111.378 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 44.0 tt0 -95.01 120.0 34.49 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.124 0.488 . . . . 75.439999999999998 111.045 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 p -113.39 179.31 4.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.02 -0.536 . . . . 70.530000000000001 110.632 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.481 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 3.2 p-10 -65.87 -11.84 49.86 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.798 0.333 . . . . 73.409999999999997 111.481 174.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.42 ' O ' HD13 ' A' ' 87' ' ' LEU . 87.3 mt -102.7 2.36 35.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.817 0.342 . . . . 72.340000000000003 111.417 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.475 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 104.07 -162.98 15.16 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.477 -0.392 . . . . 74.200000000000003 112.961 -178.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -66.05 130.3 42.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.264 0.554 . . . . 63.329999999999998 112.098 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.8 t -126.99 127.28 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.022 -0.536 . . . . 64.329999999999998 110.374 177.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -88.4 117.31 27.24 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.294 -0.254 . . . . 75.439999999999998 110.807 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.469 HG23 HG21 ' A' ' 58' ' ' ILE . 46.1 t -66.42 127.84 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.931 0.396 . . . . 74.299999999999997 111.699 -177.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.6 p -112.42 -49.6 2.95 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.274 -0.421 . . . . 71.030000000000001 111.792 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.126 0.489 . . . . 71.329999999999998 111.685 -179.203 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 121.127 0.489 . . . . 62.109999999999999 111.439 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.634 HD11 HG23 ' A' ' 58' ' ' ILE . 29.3 mt -118.46 148.15 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.013 0.525 . . . . 70.340000000000003 109.812 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -121.82 140.85 51.85 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.779 -0.575 . . . . 62.32 111.532 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.19 176.17 38.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 121.081 -0.58 . . . . 73.219999999999999 113.518 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.53 145.28 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 117.069 0.434 . . . . 64.109999999999999 111.253 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.506 HD13 HH12 ' A' ' 89' ' ' ARG . 37.7 tp -81.3 111.87 18.08 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.998 0.428 . . . . 63.130000000000003 111.952 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.0 pt -128.37 -178.95 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.182 0.515 . . . . 75.530000000000001 111.499 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.506 HH12 HD13 ' A' ' 87' ' ' LEU . 26.0 mmt180 . . . . . 0 CA--C 1.542 0.645 0 O-C-N 122.157 -0.339 . . . . 64.040000000000006 111.675 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.3 m . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.802 0.334 . . . . 75.329999999999998 111.84 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -115.7 159.95 20.7 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.281 0.474 . . . . 74.010000000000005 112.281 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.426 ' HB ' HD13 ' A' ' 40' ' ' ILE . 12.5 tt -155.4 133.97 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.098 -0.501 . . . . 73.329999999999998 111.225 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -77.02 102.81 6.63 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.041 0.448 . . . . 70.129999999999995 110.196 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.2 t -94.08 119.14 41.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 72.040000000000006 111.686 -176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 42.3 t -95.47 115.43 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.383 -0.372 . . . . 74.299999999999997 110.709 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.466 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 33.3 t70 -82.75 119.88 75.34 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-O 120.542 0.21 . . . . 62.520000000000003 110.696 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.61 -17.07 30.13 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.685 2.257 . . . . 62.549999999999997 113.411 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -82.13 -44.45 16.46 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 111.9 0.333 . . . . 60.450000000000003 111.9 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.4 p -100.06 -28.26 13.14 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.016 0.436 . . . . 73.329999999999998 111.714 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.75 22.49 49.77 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.268 -0.492 . . . . 62.219999999999999 112.979 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.466 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 63.6 pttt -87.34 145.89 26.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.922 0.361 . . . . 73.25 111.834 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.417 HG23 HG22 ' A' ' 28' ' ' VAL . 48.8 t -105.32 94.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 109.746 -0.465 . . . . 74.430000000000007 109.746 170.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.02 124.38 52.06 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.282 -0.417 . . . . 62.210000000000001 111.384 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.0 mt -79.37 113.06 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.495 -0.32 . . . . 75.040000000000006 111.629 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.417 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -113.86 170.99 7.86 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.912 0.387 . . . . 74.200000000000003 111.916 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.85 137.16 37.83 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.496 -0.32 . . . . 71.540000000000006 111.001 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.426 HD13 ' HB ' ' A' ' 25' ' ' ILE . 63.5 mt -90.71 114.61 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.741 0.305 . . . . 74.230000000000004 111.424 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -83.51 -45.44 13.59 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.263 0.468 . . . . 63.329999999999998 112.263 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 41.7 m-80 -123.57 115.39 21.43 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.788 0.328 . . . . 52.200000000000003 111.76 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.0 t . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 121.176 0.512 . . . . 73.420000000000002 110.814 174.06 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.439 HG21 HG23 ' A' ' 73' ' ' VAL . 68.7 mt . . . . . 0 CA--C 1.54 0.578 0 CA-C-O 120.523 0.201 . . . . 72.030000000000001 110.81 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -147.8 172.2 14.49 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.262 0.467 . . . . 65.439999999999998 112.262 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -72.49 116.03 12.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.209 -0.45 . . . . 71.450000000000003 111.368 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 109.42 -7.65 32.34 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.258 -0.496 . . . . 38.590000000000003 112.88 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.18 139.46 30.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.763 0.316 . . . . 73.319999999999993 111.405 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.64 114.07 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.988 0.423 . . . . 73.409999999999997 111.307 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -102.56 154.42 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.987 0.423 . . . . 73.209999999999994 111.582 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 8.8 tp10 -95.6 120.71 36.33 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.874 0.369 . . . . 74.239999999999995 111.386 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.9 p -122.82 172.89 8.12 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.841 0.353 . . . . 74.120000000000005 111.421 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.417 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 32.2 p30 -57.59 -33.22 67.96 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.885 0.374 . . . . 75.129999999999995 111.627 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.9 mt -75.63 -33.15 60.46 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.9 0.381 . . . . 74.340000000000003 111.02 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 140.7 -156.49 25.37 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.137 -0.483 . . . . 75.319999999999993 112.983 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -68.63 125.76 27.55 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.746 0.308 . . . . 61.140000000000001 111.214 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.7 t -125.98 119.28 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.046 0.388 . . . . 74.310000000000002 112.046 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.471 ' HB2' HD13 ' A' ' 88' ' ' ILE . 59.0 ttp180 -84.19 111.31 19.24 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.66 0.267 . . . . 73.430000000000007 110.925 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.439 HG23 HG21 ' A' ' 58' ' ' ILE . 58.5 t -71.55 131.16 34.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.559 0.578 . . . . 75.329999999999998 112.559 -174.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.0 p -106.04 -33.09 8.0 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.965 -0.561 . . . . 75.230000000000004 111.826 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 120.654 0.264 . . . . 74.510000000000005 111.478 -178.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.405 HG21 ' N ' ' A' ' 83' ' ' ILE . 14.5 p . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.14 0.495 . . . . 73.540000000000006 111.631 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.405 ' N ' HG21 ' A' ' 82' ' ' VAL . 46.4 mt -105.86 143.57 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.437 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -126.28 146.3 50.07 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.297 -0.252 . . . . 70.219999999999999 111.287 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.22 -179.02 30.05 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.201 -0.523 . . . . 53.32 113.039 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 t -124.35 129.88 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.838 0.319 . . . . 64.109999999999999 110.935 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.9 tp -74.45 106.34 6.01 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.101 0.477 . . . . 70.019999999999996 111.488 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 72' ' ' ARG . 7.9 pt -120.05 176.53 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.313 0.578 . . . . 73.329999999999998 111.408 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 . . . . . 0 N--CA 1.469 0.508 0 CA-C-N 116.313 -0.403 . . . . 74.150000000000006 110.667 -178.304 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.494 HG22 ' HB ' ' A' ' 40' ' ' ILE . 86.6 m . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.007 0.432 . . . . 72.140000000000001 110.8 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -138.58 154.89 48.73 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.016 0.436 . . . . 73.120000000000005 111.738 -173.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.441 ' HB ' HD13 ' A' ' 40' ' ' ILE . 15.3 tt -143.77 138.4 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.089 0.471 . . . . 73.140000000000001 111.618 -177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -90.46 112.76 24.52 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.274 0.559 . . . . 71.439999999999998 110.102 175.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.0 t -106.28 144.12 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.649 0.611 . . . . 75.400000000000006 112.649 -169.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 t -104.87 129.91 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.234 -0.439 . . . . 71.040000000000006 111.058 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -84.63 122.8 74.89 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 116.428 -0.351 . . . . 71.340000000000003 110.945 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.58 -17.12 11.43 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.784 2.322 . . . . 72.219999999999999 114.283 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.23 -43.81 11.32 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.281 0.563 . . . . 63.409999999999997 111.558 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 p -105.64 -31.26 9.0 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.885 -0.598 . . . . 64.209999999999994 112.084 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.26 12.97 56.81 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.022 -0.608 . . . . 60.409999999999997 113.617 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -86.56 143.14 27.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.007 0.404 . . . . 72.510000000000005 111.34 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.78 103.53 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.074 0.464 . . . . 65.409999999999997 110.656 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -108.43 135.81 49.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.952 0.406 . . . . 73.409999999999997 111.363 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.6 mt -90.6 129.04 42.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.86 0.362 . . . . 73.340000000000003 111.229 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.442 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -126.99 159.14 35.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.893 0.378 . . . . 74.329999999999998 111.713 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -107.5 139.97 41.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.853 0.359 . . . . 73.430000000000007 110.759 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.494 ' HB ' HG22 ' A' ' 23' ' ' THR . 58.0 mt -93.04 116.41 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.286 0.565 . . . . 73.530000000000001 112.485 -172.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 41' ' ' ARG . 8.0 mtp180 -82.48 -53.35 6.05 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.668 -0.696 . . . . 71.25 111.639 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.557 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 92.1 m-20 -116.56 122.86 45.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.431 -0.35 . . . . 74.120000000000005 111.144 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.543 0.69 0 N-CA-C 112.095 0.406 . . . . 75.219999999999999 112.095 -179.013 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 CA--C 1.539 0.533 0 CA-C-O 120.804 0.335 . . . . 74.409999999999997 111.288 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -132.36 166.76 21.23 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.959 0.409 . . . . 72.450000000000003 111.934 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -64.19 126.88 29.16 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.241 -0.436 . . . . 71.310000000000002 111.386 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.19 5.25 65.87 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.217 -0.516 . . . . 72.519999999999996 113.44 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.28 153.15 19.42 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.013 0.435 . . . . 71.430000000000007 111.367 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.8 t -112.69 128.83 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.419 -0.355 . . . . 75.329999999999998 110.906 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.28 154.26 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.764 0.653 . . . . 73.430000000000007 112.764 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 29.9 tt0 -89.32 109.29 20.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.892 -0.594 . . . . 74.549999999999997 110.789 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.437 HG21 HG12 ' A' ' 40' ' ' ILE . 45.5 p -110.96 168.43 9.49 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.954 0.407 . . . . 75.040000000000006 111.336 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -60.26 -19.32 54.28 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.128 0.418 . . . . 74.25 112.128 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.442 HD13 ' HB3' ' A' ' 38' ' ' ALA . 83.9 mt -93.44 -30.63 14.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.85 0.315 . . . . 73.319999999999993 111.85 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.72 -149.59 21.23 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.013 -0.613 . . . . 70.310000000000002 113.105 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -91.27 119.47 31.36 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.354 -0.497 . . . . 64.319999999999993 110.83 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.08 124.78 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.982 0.42 . . . . 65.409999999999997 111.608 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -91.76 115.05 27.73 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.241 -0.436 . . . . 65.510000000000005 110.617 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.16 121.91 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.064 0.459 . . . . 74.230000000000004 112.143 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.1 p -103.45 -43.56 5.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.16 -0.473 . . . . 64.450000000000003 111.902 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 121.101 0.477 . . . . 70.019999999999996 111.972 -176.862 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.409 HG23 ' N ' ' A' ' 83' ' ' ILE . 8.2 p . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 120.795 0.331 . . . . 73.450000000000003 111.172 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.409 ' N ' HG23 ' A' ' 82' ' ' VAL . 34.4 mt -101.85 148.19 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.844 0.354 . . . . 61.329999999999998 111.225 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -119.3 134.75 55.05 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.668 0.271 . . . . 73.140000000000001 111.485 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.24 178.31 31.96 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.001 -0.618 . . . . 54.149999999999999 113.4 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 t -110.44 141.48 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 111.964 0.357 . . . . 71.109999999999999 111.964 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.0 tp -82.78 111.33 18.6 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.032 0.382 . . . . 70.510000000000005 112.032 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.8 pt -143.57 -169.62 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.22 0.533 . . . . 73.120000000000005 111.593 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 . . . . . 0 N--CA 1.473 0.678 0 CA-C-N 116.264 -0.425 . . . . 73.450000000000003 111.0 176.19 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.4 ' CG2' ' HB ' ' A' ' 40' ' ' ILE . 90.4 m . . . . . 0 N--CA 1.469 0.485 0 CA-C-O 120.929 0.395 . . . . 75.129999999999995 111.878 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -149.81 148.18 28.87 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.287 -0.415 . . . . 72.420000000000002 110.771 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.6 tt -143.08 139.48 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 121.192 0.52 . . . . 64.239999999999995 112.018 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -83.92 105.32 14.71 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.187 0.517 . . . . 72.409999999999997 110.781 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.481 HG23 HG11 ' A' ' 71' ' ' VAL . 48.7 t -105.61 120.53 56.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 112.49 0.552 . . . . 75.310000000000002 112.49 -172.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -95.59 122.46 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 116.587 -0.279 . . . . 74.340000000000003 110.876 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.447 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 31.6 t70 -82.53 116.47 63.98 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 120.547 0.213 . . . . 70.230000000000004 110.733 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.03 -15.07 29.27 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.606 2.204 . . . . 71.099999999999994 113.249 -177.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -78.71 -45.44 21.25 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.786 0.327 . . . . 54.020000000000003 111.742 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.3 p -104.12 -20.69 13.74 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.017 0.377 . . . . 74.0 112.017 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.28 20.8 66.22 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.199 -0.524 . . . . 71.319999999999993 112.973 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.447 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 65.5 pttt -88.07 139.39 30.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.044 0.45 . . . . 65.140000000000001 111.628 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.8 t -86.72 95.58 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.076 0.465 . . . . 74.510000000000005 110.21 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -99.87 165.97 11.3 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.085 0.469 . . . . 73.230000000000004 111.179 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.09 129.87 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.164 -0.335 . . . . 65.230000000000004 110.621 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.38 170.2 15.43 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.485 0.66 . . . . 43.520000000000003 112.38 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.73 131.86 56.84 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.665 -0.698 . . . . 72.530000000000001 110.431 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.4 ' HB ' ' CG2' ' A' ' 23' ' ' THR . 59.9 mt -77.32 114.52 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.142 0.496 . . . . 75.25 112.275 -175.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.449 ' HA ' ' HE ' ' A' ' 41' ' ' ARG . 2.5 mmp_? -71.26 -50.05 36.81 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.915 -0.584 . . . . 71.430000000000007 110.695 173.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -133.11 130.94 39.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.952 -0.567 . . . . 73.420000000000002 110.754 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 112.598 0.592 . . . . 74.439999999999998 112.598 -177.808 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.6 mt . . . . . 0 CA--C 1.538 0.511 0 CA-C-O 121.024 0.44 . . . . 74.439999999999998 110.809 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -87.57 165.76 15.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.062 0.458 . . . . 73.340000000000003 112.033 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 74' ' ' THR . 63.0 ttt180 -67.79 116.71 8.77 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.424 -0.353 . . . . 61.210000000000001 110.694 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.39 -6.72 46.1 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.281 -0.485 . . . . 72.319999999999993 112.927 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.49 138.79 49.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.83 0.348 . . . . 70.439999999999998 111.168 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.1 t -96.3 116.26 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.999 0.428 . . . . 71.109999999999999 111.606 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.9 m -103.52 148.11 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.125 0.488 . . . . 52.049999999999997 111.678 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' ARG . 9.6 tp10 -84.91 127.99 34.42 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.086 -0.506 . . . . 73.230000000000004 110.179 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.0 p -129.73 174.78 9.38 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.933 0.397 . . . . 72.430000000000007 111.794 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.33 -18.48 64.67 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.649 0.261 . . . . 72.010000000000005 111.687 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.41 -27.77 18.1 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.991 0.424 . . . . 73.030000000000001 111.155 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.55 -150.09 21.15 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.982 -0.554 . . . . 37.590000000000003 112.242 -175.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -77.91 128.85 34.58 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.98 0.419 . . . . 74.120000000000005 111.239 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.481 HG11 HG23 ' A' ' 27' ' ' VAL . 91.7 t -126.45 119.42 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 122.113 -0.367 . . . . 73.230000000000004 111.654 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -85.16 113.0 21.21 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.713 0.292 . . . . 61.5 110.902 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.12 127.83 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 112.386 0.513 . . . . 73.120000000000005 112.386 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.46 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 77.8 p -98.79 -62.61 1.21 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 111.0 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.45 ' HB2' ' H ' ' A' ' 84' ' ' ASN . 55.3 m . . . . . 0 N--CA 1.472 0.664 0 CA-C-N 116.432 -0.349 . . . . 63.340000000000003 111.396 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 121.195 0.521 . . . . 73.329999999999998 111.668 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.28 116.6 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.099 -0.5 . . . . 64.140000000000001 110.361 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.45 ' H ' ' HB2' ' A' ' 75' ' ' SER . 13.7 m120 -103.51 154.27 19.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.808 0.337 . . . . 74.239999999999995 111.531 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.93 178.75 35.88 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.177 -0.535 . . . . 63.039999999999999 113.135 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.19 133.11 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 122.719 -0.283 . . . . 65.420000000000002 111.204 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.9 tp -76.42 106.22 7.93 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.036 0.446 . . . . 70.129999999999995 111.472 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.8 pt -122.81 179.7 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.133 0.492 . . . . 75.209999999999994 111.405 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 . . . . . 0 N--CA 1.468 0.463 0 CA-C-N 116.525 -0.307 . . . . 75.430000000000007 110.617 -178.874 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 3' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.308 0 CA-C-O 119.802 -0.443 . . . . 72.140000000000001 112.756 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 43.57 -67.99 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 114.891 1.441 . . . . 73.209999999999994 114.891 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 1' ' ' GLY . 7.8 mmt180 -57.0 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.475 0.546 . . . . 71.239999999999995 112.475 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 50.1 mtm105 -102.52 123.35 46.1 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.773 0.32 . . . . 71.349999999999994 111.039 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -99.5 -176.95 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 121.018 0.437 . . . . 75.099999999999994 112.128 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -74.0 -41.52 61.77 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.037 0.754 . . . . 75.510000000000005 113.037 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.9 mt 72.28 -27.3 0.18 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 113.778 1.029 . . . . 74.409999999999997 113.778 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 tp -51.81 122.43 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 N-CA-C 112.927 0.714 . . . . 71.209999999999994 112.927 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -100.42 -72.22 0.68 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.015 -0.539 . . . . 74.239999999999995 111.685 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.5 p -106.75 150.38 26.36 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.617 0.599 . . . . 51.149999999999999 112.617 -172.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.404 ' HE ' ' HB3' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -169.24 122.8 0.79 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.687 -0.688 . . . . 60.340000000000003 110.35 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.69 156.46 8.2 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.603 -0.332 . . . . 71.510000000000005 112.524 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.96 -153.0 15.45 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.232 -0.508 . . . . 64.239999999999995 114.082 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -158.43 -169.89 2.91 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 110.092 -0.336 . . . . 73.310000000000002 110.092 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.6 m -65.03 114.58 4.68 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.946 -0.471 . . . . 74.129999999999995 111.137 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.94 158.19 29.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.166 0.508 . . . . 75.329999999999998 111.775 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.415 HG21 ' N ' ' A' ' 18' ' ' ARG . 14.9 p -85.48 161.95 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.026 -0.534 . . . . 44.119999999999997 110.35 174.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.415 ' N ' HG21 ' A' ' 17' ' ' VAL . 45.0 ptt85 -66.33 168.82 8.18 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.169 0.509 . . . . 65.239999999999995 111.897 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.1 tt -58.57 101.61 0.09 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.239 0.542 . . . . 70.420000000000002 110.285 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.9 -53.85 0.06 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.532 -0.758 . . . . 53.530000000000001 110.201 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.9 m -91.75 14.46 15.27 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.883 -0.598 . . . . 73.209999999999994 111.033 174.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -163.08 158.64 22.24 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.274 -0.421 . . . . 74.129999999999995 110.781 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.468 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 42.3 m -131.96 113.55 13.56 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.549 0.214 . . . . 75.420000000000002 111.505 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 23' ' ' THR . 50.4 mtm180 -162.83 169.96 19.01 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.249 0.62 . . . . 65.019999999999996 111.19 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.0 tt -147.03 139.26 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.386 -0.37 . . . . 74.129999999999995 111.51 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.43 ' OD1' HG12 ' A' ' 37' ' ' ILE . 75.5 m-20 -74.03 106.84 5.89 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.788 0.328 . . . . 72.140000000000001 110.659 176.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -97.56 123.62 50.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.109 0.481 . . . . 75.340000000000003 112.07 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.6 t -95.23 112.83 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.995 0.426 . . . . 74.030000000000001 110.594 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.53 114.99 50.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.01 -0.541 . . . . 75.140000000000001 111.077 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -82.58 -11.78 10.34 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.706 2.271 . . . . 75.310000000000002 113.007 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.44 ' CD ' HH12 ' A' ' 89' ' ' ARG . 10.9 mm-40 -77.57 -39.63 45.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.161 0.505 . . . . 75.310000000000002 110.863 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.1 p -121.27 -27.08 4.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.712 -0.677 . . . . 75.040000000000006 112.258 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.96 29.21 11.95 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.38 -0.438 . . . . 40.340000000000003 113.302 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -99.44 142.02 31.47 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 122.478 -0.425 . . . . 74.109999999999999 111.182 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.1 t -107.46 112.05 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.841 0.353 . . . . 63.049999999999997 110.774 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -133.52 141.64 47.84 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.915 0.388 . . . . 71.329999999999998 111.496 -177.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.43 HG12 ' OD1' ' A' ' 26' ' ' ASN . 45.9 mt -83.06 111.34 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.85 0.357 . . . . 71.329999999999998 111.331 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.38 157.17 17.21 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.027 0.441 . . . . 74.319999999999993 112.046 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -83.25 135.31 34.81 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.185 -0.461 . . . . 72.450000000000003 110.986 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -83.73 112.06 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 121.267 0.556 . . . . 74.310000000000002 111.016 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 41' ' ' ARG . 44.4 mtp85 -82.83 -53.41 5.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.027 -0.533 . . . . 72.439999999999998 111.018 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -124.8 132.31 53.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.261 -0.427 . . . . 74.019999999999996 110.842 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -88.08 11.95 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.929 0.395 . . . . 65.109999999999999 111.928 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.73 136.45 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.291 0.567 . . . . 64.420000000000002 111.745 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.81 34.55 0.28 Allowed 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.846 0.684 . . . . 75.129999999999995 112.846 -177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.5 t30 57.42 26.14 12.2 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.132 0.491 . . . . 74.5 112.217 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.4 t -82.09 167.98 18.23 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.885 -0.51 . . . . 74.540000000000006 111.564 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.2 109.63 21.49 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.745 0.276 . . . . 74.230000000000004 111.745 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 55.39 88.17 0.13 Allowed Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 122.815 0.446 . . . . 62.439999999999998 111.679 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.38 110.3 1.03 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.59 2.193 . . . . 73.510000000000005 112.837 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -76.52 -1.14 25.85 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.244 0.461 . . . . 74.0 112.244 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -96.02 16.77 17.0 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.134 0.492 . . . . 72.209999999999994 111.019 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 53' ' ' VAL . 11.5 t 62.4 26.94 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.723 0.773 . . . . 64.540000000000006 111.366 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -77.97 72.62 4.51 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.755 -0.591 . . . . 75.040000000000006 111.727 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -73.2 75.06 1.29 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.192 0.52 . . . . 72.200000000000003 110.496 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 54.39 17.41 1.56 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.748 -0.66 . . . . 44.439999999999998 112.44 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.4 tt -92.49 125.5 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.446 0.641 . . . . 62.200000000000003 111.649 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.597 HG21 HD11 ' A' ' 83' ' ' ILE . 69.9 mt -68.05 113.59 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.75 -0.659 . . . . 74.030000000000001 111.226 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.6 p -135.26 159.6 41.04 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.208 -0.451 . . . . 54.200000000000003 112.078 -174.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -54.51 129.06 34.71 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.122 -0.49 . . . . 65.019999999999996 111.725 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.11 -11.41 72.18 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.137 -0.554 . . . . 38.640000000000001 113.465 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 145.38 31.62 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.859 0.361 . . . . 63.140000000000001 111.124 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.657 HG23 ' HG3' ' A' ' 90' ' ' GLU . 54.0 t -109.02 124.59 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.025 0.44 . . . . 74.420000000000002 111.593 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -107.43 154.93 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.982 0.42 . . . . 64.329999999999998 111.39 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.53 133.38 38.21 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.503 -0.317 . . . . 61.240000000000002 110.782 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.5 p -136.8 179.14 6.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.989 0.423 . . . . 65.219999999999999 111.637 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -69.09 -15.38 63.43 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.757 0.313 . . . . 75.310000000000002 111.78 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.71 -13.9 20.03 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.684 0.278 . . . . 73.010000000000005 111.512 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.44 -151.94 18.63 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.383 -0.437 . . . . 53.439999999999998 112.733 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -82.81 129.18 34.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.463 -0.434 . . . . 75.329999999999998 111.162 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.78 133.66 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.8 0.333 . . . . 74.329999999999998 111.459 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.475 ' HB2' HD12 ' A' ' 88' ' ' ILE . 42.1 ttm180 -94.56 121.1 35.77 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.756 0.28 . . . . 72.340000000000003 111.756 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.442 HG23 HG22 ' A' ' 58' ' ' ILE . 39.0 t -65.9 111.32 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 116.415 -0.357 . . . . 75.319999999999993 111.08 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.467 HG21 ' HA2' ' A' ' 85' ' ' GLY . 44.1 p -91.54 -39.26 12.02 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.861 0.363 . . . . 65.400000000000006 111.808 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.7 m -118.25 162.46 18.22 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.246 0.546 . . . . 74.140000000000001 112.22 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -68.46 138.16 91.29 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 115.867 -0.606 . . . . 74.239999999999995 111.803 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.427 ' HA ' HG12 ' A' ' 83' ' ' ILE . 28.8 Cg_endo -61.77 100.37 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.59 2.194 . . . . 70.129999999999995 112.853 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.74 -25.66 0.37 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.228 -0.511 . . . . 63.420000000000002 112.888 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -60.15 119.41 7.79 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.563 0.22 . . . . 72.340000000000003 111.112 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.49 13.02 5.82 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.332 0.586 . . . . 75.310000000000002 111.096 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.04 8.31 87.4 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 116.217 -0.447 . . . . 41.520000000000003 113.094 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.408 HG22 ' N ' ' A' ' 83' ' ' ILE . 8.3 p -135.02 168.19 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.144 0.497 . . . . 60.25 111.576 -175.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.597 HD11 HG21 ' A' ' 58' ' ' ILE . 48.2 mt -105.0 143.75 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.366 -0.379 . . . . 75.230000000000004 110.37 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -123.55 135.84 54.22 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.827 0.346 . . . . 73.340000000000003 111.239 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.467 ' HA2' HG21 ' A' ' 74' ' ' THR . . . -154.23 179.33 30.5 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.922 -0.656 . . . . 63.539999999999999 113.801 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.26 141.52 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 122.564 -0.374 . . . . 61.140000000000001 111.049 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 tp -77.06 124.42 27.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.817 0.341 . . . . 55.109999999999999 110.854 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.475 HD12 ' HB2' ' A' ' 72' ' ' ARG . 10.6 pt -140.31 -175.87 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.03 0.443 . . . . 73.209999999999994 111.4 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.44 HH12 ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -122.68 99.83 6.6 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.368 -0.378 . . . . 70.040000000000006 110.903 178.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.657 ' HG3' HG23 ' A' ' 63' ' ' VAL . 27.8 mm-40 -111.32 -57.08 2.3 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.178 -0.327 . . . . 74.129999999999995 111.766 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 84.7 mt -81.37 155.78 25.78 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.033 0.444 . . . . 74.5 111.747 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -90.6 136.67 32.91 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.343 -0.614 . . . . 73.239999999999995 109.343 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -150.09 83.64 1.38 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.207 0.447 . . . . 74.400000000000006 112.207 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -110.83 169.44 8.76 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.567 -0.288 . . . . 73.230000000000004 110.361 170.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -76.52 147.94 37.44 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.961 0.41 . . . . 73.430000000000007 112.009 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -117.01 117.54 29.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.921 0.391 . . . . 75.409999999999997 111.803 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -64.07 90.92 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.822 0.344 . . . . 75.510000000000005 110.85 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 19.7 p80 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 119.11 -0.472 . . . . 75.040000000000006 112.172 178.486 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.576 -0.21 . . . . 74.329999999999998 112.576 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 45.09 73.0 0.17 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.288 0.566 . . . . 37.359999999999999 112.463 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -80.24 0.2 33.62 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.123 0.487 . . . . 75.109999999999999 111.192 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -68.54 143.7 54.84 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.622 -0.717 . . . . 74.549999999999997 111.759 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.0 t 65.51 126.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.724 0.639 . . . . 70.200000000000003 112.724 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -100.42 117.99 35.73 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.361 0.6 . . . . 61.409999999999997 111.131 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.4 tp -105.84 4.22 29.51 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.105 -0.498 . . . . 75.299999999999997 111.681 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.1 tp -59.31 136.16 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.302 0.572 . . . . 75.5 112.241 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -110.25 174.54 5.81 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.941 0.401 . . . . 70.200000000000003 111.339 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.6 t -142.34 167.02 23.1 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.364 -0.38 . . . . 61.310000000000002 111.185 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -99.93 154.63 18.21 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.195 0.443 . . . . 71.349999999999994 112.195 -174.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.2 141.34 15.23 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.368 -0.444 . . . . 50.229999999999997 112.489 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.57 123.22 7.84 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.04 -0.6 . . . . 54.140000000000001 113.769 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -117.59 159.8 22.31 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.095 0.474 . . . . 71.400000000000006 111.538 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.8 m -81.65 132.68 35.3 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.31 -0.405 . . . . 71.329999999999998 110.392 174.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HZ2' ' HB2' ' A' ' 16' ' ' LYS . 7.4 mtmp? -95.48 179.08 5.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.536 0.684 . . . . 75.209999999999994 112.37 -174.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -80.03 162.16 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 115.437 -0.801 . . . . 72.109999999999999 109.9 169.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? -53.07 143.57 17.27 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.439 0.533 . . . . 73.540000000000006 112.439 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.512 HD13 ' HA ' ' A' ' 23' ' ' THR . 10.1 tt -35.28 106.18 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.852 0.861 . . . . 73.430000000000007 112.952 -174.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.61 74.99 9.13 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.005 -0.543 . . . . 63.340000000000003 112.076 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.6 m 74.35 -41.97 0.49 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.408 0.892 . . . . 72.299999999999997 113.408 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -66.17 97.92 0.42 Allowed 'General case' 0 CA--C 1.536 0.415 0 O-C-N 122.179 -0.326 . . . . 65.439999999999998 110.897 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.512 ' HA ' HD13 ' A' ' 19' ' ' LEU . 42.9 p -71.02 110.74 5.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.163 0.506 . . . . 65.420000000000002 111.386 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -152.42 151.94 31.4 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.725 -0.67 . . . . 73.140000000000001 110.6 -178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.529 ' HB ' HD11 ' A' ' 40' ' ' ILE . 10.8 tt -138.03 141.06 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.063 0.459 . . . . 74.140000000000001 112.17 -174.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -74.19 103.48 4.63 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.049 -0.523 . . . . 73.040000000000006 110.114 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.476 HG22 HG12 ' A' ' 71' ' ' VAL . 22.6 t -102.62 136.96 32.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.335 0.495 . . . . 74.319999999999993 112.335 -173.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.55 113.52 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.881 0.372 . . . . 72.349999999999994 110.387 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -77.15 114.03 36.2 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.153 -0.476 . . . . 52.509999999999998 110.452 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.85 -8.99 15.73 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.595 2.196 . . . . 75.450000000000003 113.399 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -89.42 -33.28 16.89 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.937 0.399 . . . . 75.310000000000002 111.574 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.451 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 68.0 p -116.76 -31.41 5.48 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.356 0.502 . . . . 64.310000000000002 112.356 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.55 12.58 50.52 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.138 -0.553 . . . . 62.140000000000001 113.872 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 16.1 ptpt -89.88 162.32 15.51 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.183 0.516 . . . . 71.010000000000005 111.995 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.71 95.57 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-O 121.203 0.525 . . . . 73.299999999999997 109.938 171.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.24 138.55 41.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.321 -0.4 . . . . 74.450000000000003 111.215 -174.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -84.96 121.42 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.687 0.279 . . . . 72.409999999999997 111.216 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.483 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -108.05 150.47 27.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.73 0.3 . . . . 64.040000000000006 111.648 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -94.03 120.93 34.96 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.778 0.323 . . . . 75.040000000000006 110.76 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.529 HD11 ' HB ' ' A' ' 25' ' ' ILE . 57.8 mt -81.86 119.95 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 112.403 0.519 . . . . 63.399999999999999 112.403 -173.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.8 mmm-85 -81.68 -56.11 4.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.044 0.449 . . . . 73.030000000000001 111.048 174.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -144.61 155.45 43.64 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.199 -0.455 . . . . 71.200000000000003 111.365 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.437 ' O ' HG22 ' A' ' 43' ' ' VAL . 12.2 p -97.0 32.14 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-O 121.913 0.863 . . . . 75.040000000000006 110.818 176.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.419 ' O ' HG12 ' A' ' 44' ' ' VAL . 7.3 p -74.71 82.3 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-O 121.842 0.829 . . . . 71.510000000000005 111.768 -176.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -76.01 85.77 2.91 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.991 0.737 . . . . 74.310000000000002 112.991 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 m120 49.54 37.35 12.16 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.04 0.448 . . . . 54.420000000000002 111.79 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 72.9 p -73.12 81.09 1.26 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.709 0.633 . . . . 64.340000000000003 112.709 -170.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.61 -11.03 38.31 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.038 0.447 . . . . 64.439999999999998 110.76 171.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -67.14 119.39 64.24 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 115.796 -0.638 . . . . 72.340000000000003 111.718 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.28 -23.11 39.11 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.514 2.143 . . . . 74.010000000000005 112.822 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -93.42 11.75 27.34 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.058 0.456 . . . . 61.399999999999999 111.377 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -69.65 105.02 2.55 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.023 0.44 . . . . 75.030000000000001 111.724 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.63 115.43 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.182 0.515 . . . . 74.329999999999998 110.596 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -164.2 147.25 9.35 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 122.15 -0.344 . . . . 72.010000000000005 111.234 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -75.91 -170.91 1.48 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.149 0.5 . . . . 74.450000000000003 111.288 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -71.08 77.91 0.67 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.02 0.438 . . . . 64.099999999999994 111.791 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.16 96.82 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.293 0.568 . . . . 73.239999999999995 110.986 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.7 mt -78.79 123.01 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.953 -0.567 . . . . 72.209999999999994 109.946 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 t -133.11 167.48 20.24 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.05 0.452 . . . . 71.439999999999998 112.157 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -61.46 128.0 34.18 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.236 -0.438 . . . . 72.010000000000005 111.297 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.25 -13.51 67.17 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.229 -0.51 . . . . 52.520000000000003 112.951 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.89 132.15 43.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.021 0.438 . . . . 74.340000000000003 111.281 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.9 t -97.13 120.23 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.844 0.354 . . . . 74.129999999999995 111.319 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 43' ' ' VAL . 34.9 m -103.53 136.23 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.034 0.445 . . . . 73.319999999999993 111.337 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.27 119.49 25.12 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.955 0.407 . . . . 44.109999999999999 110.435 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 40' ' ' ILE . 34.0 p -125.72 175.73 7.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.367 -0.378 . . . . 74.340000000000003 111.471 -175.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -61.41 -28.68 69.43 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.331 -0.395 . . . . 71.25 111.739 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.483 HD13 ' HB2' ' A' ' 38' ' ' ALA . 83.9 mt -86.72 -22.82 25.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.755 0.312 . . . . 71.200000000000003 111.45 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.57 -153.13 21.9 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.923 -0.656 . . . . 75.319999999999993 113.511 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.419 ' H ' ' HD2' ' A' ' 89' ' ' ARG . 15.1 m120 -83.66 102.87 12.53 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.922 0.391 . . . . 72.430000000000007 111.098 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 27' ' ' VAL . 47.6 t -97.62 119.73 46.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.962 0.41 . . . . 61.020000000000003 111.326 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -86.93 117.61 25.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.495 -0.321 . . . . 74.0 111.171 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.75 121.1 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.178 -0.464 . . . . 71.120000000000005 112.111 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -107.3 -41.79 5.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.249 -0.432 . . . . 71.400000000000006 111.799 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.9 m -93.14 162.43 14.03 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.283 0.564 . . . . 71.420000000000002 112.176 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -76.59 128.54 81.8 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.856 -0.611 . . . . 72.310000000000002 111.222 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.598 ' HA ' HG12 ' A' ' 83' ' ' ILE . 73.1 Cg_exo -49.35 -41.41 43.05 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.863 2.375 . . . . 71.319999999999993 113.6 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.28 34.44 4.7 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.895 -0.669 . . . . 74.200000000000003 113.335 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -77.7 -81.14 0.1 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.592 -0.357 . . . . 63.0 110.796 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -100.9 22.21 12.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.956 0.408 . . . . 74.030000000000001 110.773 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.74 7.99 87.95 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.178 -0.534 . . . . 53.149999999999999 112.434 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.4 151.64 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 122.859 0.464 . . . . 74.409999999999997 110.615 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.598 HG12 ' HA ' ' A' ' 77' ' ' PRO . 54.2 mt -96.08 143.87 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.299 -0.41 . . . . 62.399999999999999 111.588 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -118.92 148.96 42.37 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.301 0.24 . . . . 62.520000000000003 110.749 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.3 -170.25 26.82 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 121.089 -0.576 . . . . 53.420000000000002 113.641 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 2.3 t -121.08 147.73 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 122.487 -0.419 . . . . 72.230000000000004 111.126 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.416 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 50.5 tp -89.74 113.55 25.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.412 0.523 . . . . 73.420000000000002 112.412 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.5 pt -136.75 -173.51 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.077 0.465 . . . . 51.210000000000001 110.815 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HD2' ' H ' ' A' ' 70' ' ' ASN . 24.0 mmm180 -144.7 95.36 2.69 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.111 0.481 . . . . 75.409999999999997 111.35 176.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -94.37 -5.2 47.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.381 0.61 . . . . 74.030000000000001 110.431 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.8 mt -116.3 174.45 6.05 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.75 -0.659 . . . . 72.409999999999997 110.921 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -41.0 118.32 0.98 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.881 1.067 . . . . 72.140000000000001 113.881 -177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -119.01 12.92 12.9 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.414 0.626 . . . . 74.230000000000004 110.566 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -82.77 8.61 11.76 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.197 -0.456 . . . . 71.319999999999993 112.206 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -61.56 -18.71 60.41 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.153 0.427 . . . . 71.329999999999998 112.153 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -76.26 -15.75 59.95 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.936 0.398 . . . . 63.210000000000001 111.461 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -115.4 147.25 40.76 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.049 0.452 . . . . 75.099999999999994 111.678 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.888 -0.577 . . . . 72.109999999999999 111.143 173.279 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.44 0 CA-C-O 120.656 0.031 . . . . 36.299999999999997 113.162 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.465 ' HB2' ' HG2' ' A' ' 4' ' ' ARG . 4.3 p-10 -165.29 -40.29 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 111.887 0.328 . . . . 74.010000000000005 111.887 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 57.22 26.27 12.04 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.005 0.431 . . . . 75.030000000000001 112.04 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.465 ' HG2' ' HB2' ' A' ' 2' ' ' ASP . 13.3 mmt180 -80.89 49.8 1.27 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.099 0.476 . . . . 74.540000000000006 111.269 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 m -82.92 143.56 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.258 -0.428 . . . . 72.549999999999997 111.366 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -60.83 114.21 2.92 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.01 0.434 . . . . 73.099999999999994 111.441 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 mp -55.17 -39.69 69.82 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.148 -0.478 . . . . 62.350000000000001 111.316 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.421 ' O ' HG21 ' A' ' 8' ' ' ILE . 6.9 tp -91.48 95.15 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.587 0.708 . . . . 74.150000000000006 110.817 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.04 72.14 1.29 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.626 0.727 . . . . 63.420000000000002 112.237 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.9 p -85.46 32.41 0.57 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.003 -0.544 . . . . 64.209999999999994 111.609 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.58 32.33 0.19 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.821 0.675 . . . . 71.109999999999999 112.821 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.72 144.16 47.83 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.3 -0.476 . . . . 43.310000000000002 113.445 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.75 -69.44 3.3 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.016 -0.611 . . . . 41.149999999999999 113.426 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -80.65 89.27 5.71 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.303 0.573 . . . . 74.019999999999996 111.78 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.9 m -157.51 102.07 1.88 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.898 -0.592 . . . . 72.420000000000002 109.903 176.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.442 ' O ' ' HD2' ' A' ' 16' ' ' LYS . 1.5 tmmm? -67.3 -47.51 70.37 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.033 0.444 . . . . 43.119999999999997 110.832 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.616 HG21 ' H ' ' A' ' 19' ' ' LEU . 11.4 p -64.97 137.85 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.228 0.537 . . . . 63.119999999999997 111.218 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -61.32 -22.76 65.19 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.469 0.544 . . . . 72.329999999999998 112.469 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.616 ' H ' HG21 ' A' ' 17' ' ' VAL . 8.6 tt -152.87 119.59 5.69 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.895 0.378 . . . . 64.109999999999999 111.195 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.19 -72.22 0.73 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.959 0.409 . . . . 74.140000000000001 111.495 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.6 t -133.51 11.26 4.09 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.437 0.636 . . . . 61.399999999999999 110.121 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.89 144.21 40.28 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.271 -0.877 . . . . 62.329999999999998 110.858 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 m -144.04 112.64 6.56 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 122.044 -0.41 . . . . 60.310000000000002 111.134 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -145.36 166.86 24.35 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.159 -0.473 . . . . 71.519999999999996 111.369 -176.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 tt -151.85 131.9 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.088 0.471 . . . . 62.030000000000001 112.265 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -72.03 104.63 3.62 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.296 -0.411 . . . . 74.439999999999998 110.687 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -100.72 129.35 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.007 0.432 . . . . 71.319999999999993 111.817 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.2 t -95.6 117.64 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.351 -0.386 . . . . 75.400000000000006 111.062 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -75.58 115.01 41.88 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.251 -0.431 . . . . 74.430000000000007 110.345 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.26 -19.46 15.29 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.571 2.181 . . . . 72.040000000000006 112.727 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -85.43 -43.03 13.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.178 -0.465 . . . . 71.430000000000007 111.675 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.6 p -105.57 -19.5 13.75 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.325 0.491 . . . . 65.150000000000006 112.325 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.67 11.37 79.84 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.088 -0.577 . . . . 63.0 113.638 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -88.7 162.72 16.13 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.954 0.407 . . . . 73.329999999999998 111.63 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.3 t -112.5 115.64 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.776 0.322 . . . . 75.319999999999993 110.473 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -126.31 141.35 51.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 122.56 0.344 . . . . 64.340000000000003 110.833 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 mt -94.0 120.07 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.83 0.347 . . . . 71.519999999999996 111.657 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.484 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -107.32 160.91 15.26 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.166 0.508 . . . . 62.439999999999998 112.188 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -102.77 124.32 48.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.311 -0.404 . . . . 73.439999999999998 110.55 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.415 HG22 ' HB ' ' A' ' 64' ' ' VAL . 68.2 mt -78.58 112.65 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.356 0.598 . . . . 73.150000000000006 112.411 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -83.55 -53.8 5.41 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.033 -0.53 . . . . 74.040000000000006 111.517 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 38.5 m-80 -120.98 152.88 38.03 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.893 0.378 . . . . 71.439999999999998 111.709 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.405 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 3.9 p -123.61 82.22 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 121.33 0.586 . . . . 73.329999999999998 110.97 174.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 43' ' ' VAL . 12.0 p 175.8 142.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 115.958 -0.565 . . . . 62.009999999999998 111.447 -177.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.624 ' HG3' ' HB ' ' A' ' 63' ' ' VAL . 3.3 mp0 -84.92 141.07 30.65 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 110.297 -0.26 . . . . 73.209999999999994 110.297 172.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.12 89.57 1.99 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.103 0.478 . . . . 60.100000000000001 110.621 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 t -159.66 140.72 12.54 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.219 -0.446 . . . . 71.420000000000002 111.563 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.12 111.86 11.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.343 0.497 . . . . 73.010000000000005 112.343 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 54.15 74.95 0.67 Allowed Pre-proline 0 N--CA 1.474 0.745 0 N-CA-C 112.582 0.586 . . . . 65.299999999999997 112.582 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.21 -51.79 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.002 1.802 . . . . 74.019999999999996 112.419 175.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -159.45 150.37 19.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.06 -0.518 . . . . 74.420000000000002 110.081 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.43 99.48 0.3 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.388 0.613 . . . . 71.439999999999998 111.808 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.46 146.94 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.496 -0.774 . . . . 75.019999999999996 110.566 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -125.05 -23.04 4.31 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 111.901 0.334 . . . . 71.340000000000003 111.901 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -108.2 149.24 28.82 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.8 0.333 . . . . 70.239999999999995 111.244 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -74.95 108.02 7.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.735 0.303 . . . . 74.239999999999995 111.139 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.0 tp -131.35 113.74 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.43 0.633 . . . . 72.219999999999999 111.822 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.724 ' HB ' ' HG3' ' A' ' 77' ' ' PRO . 61.1 mt -70.64 91.62 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.101 -0.499 . . . . 74.239999999999995 110.216 175.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -106.69 163.71 12.69 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.668 0.618 . . . . 53.219999999999999 112.668 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.6 ttp-105 -56.99 116.65 3.34 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.392 -0.822 . . . . 74.239999999999995 111.837 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.23 -12.45 55.27 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.157 -0.544 . . . . 51.43 113.749 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.03 159.71 32.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.32 0.56 . . . . 71.430000000000007 111.47 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.624 ' HB ' ' HG3' ' A' ' 45' ' ' GLU . 63.6 t -118.15 124.41 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.128 0.49 . . . . 61.310000000000002 111.226 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.415 ' HB ' HG22 ' A' ' 40' ' ' ILE . 35.3 m -108.14 147.45 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.931 0.396 . . . . 62.039999999999999 111.761 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 28.5 tt0 -87.7 126.67 35.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.428 -0.351 . . . . 72.519999999999996 110.138 174.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.408 HG21 ' HA ' ' A' ' 40' ' ' ILE . 33.6 p -129.46 176.0 8.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.996 0.427 . . . . 74.010000000000005 111.387 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -62.23 -20.68 64.46 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.404 -0.362 . . . . 71.450000000000003 111.553 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.484 HD13 ' HB3' ' A' ' 38' ' ' ALA . 71.7 mt -101.18 8.61 42.56 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.655 0.264 . . . . 64.430000000000007 111.696 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.09 -154.74 16.88 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.301 -0.476 . . . . 54.130000000000003 112.907 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -80.78 137.69 36.24 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.258 -0.554 . . . . 60.25 111.571 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.2 t -126.51 130.63 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.337 -0.392 . . . . 75.329999999999998 111.105 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.54 ' HB2' HD11 ' A' ' 88' ' ' ILE . 41.5 ttm180 -91.32 114.21 26.68 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.711 0.291 . . . . 73.340000000000003 110.739 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.7 t -66.54 131.35 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 112.834 0.679 . . . . 74.450000000000003 112.834 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.4 p -108.98 -61.33 1.63 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.942 -0.572 . . . . 60.25 111.627 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.1 m -91.51 160.15 15.57 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.125 0.488 . . . . 73.129999999999995 112.128 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -76.46 135.95 68.49 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 116.255 -0.43 . . . . 75.150000000000006 111.413 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.724 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 73.5 Cg_endo -72.2 137.91 29.57 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.866 2.377 . . . . 61.539999999999999 113.336 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 110.2 -31.5 7.39 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.053 -0.594 . . . . 62.439999999999998 113.221 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -59.32 118.72 6.28 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.795 0.297 . . . . 73.439999999999998 110.923 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 62.53 10.63 4.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.263 0.468 . . . . 74.129999999999995 112.263 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.31 31.22 66.24 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.214 -0.517 . . . . 72.409999999999997 113.027 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.2 p -137.97 150.59 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.063 0.459 . . . . 63.439999999999998 111.683 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.41 HG12 ' HA ' ' A' ' 77' ' ' PRO . 36.4 mt -123.15 147.53 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.681 -0.488 . . . . 75.25 109.681 175.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -128.54 145.94 50.98 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.892 -0.505 . . . . 75.329999999999998 112.276 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.38 -179.39 38.5 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 121.386 -0.435 . . . . 72.340000000000003 113.205 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.6 t -116.64 142.41 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 116.962 0.381 . . . . 65.150000000000006 111.381 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.41 HD11 HH12 ' A' ' 89' ' ' ARG . 51.5 tp -76.99 115.31 16.68 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.675 0.274 . . . . 72.340000000000003 111.621 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' ' 72' ' ' ARG . 22.2 pt -133.82 -176.59 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.297 0.57 . . . . 73.319999999999993 111.844 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.41 HH12 HD11 ' A' ' 87' ' ' LEU . 31.8 mmt180 -135.21 94.83 3.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.094 -0.503 . . . . 74.140000000000001 111.451 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.455 ' HG3' HG13 ' A' ' 63' ' ' VAL . 12.0 mm-40 -91.4 -34.62 14.79 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.45 0.643 . . . . 70.209999999999994 110.43 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.4 mt -102.15 137.4 40.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.68 -0.691 . . . . 73.420000000000002 110.235 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 133.43 36.34 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.78 0.324 . . . . 74.140000000000001 110.451 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -73.91 75.44 1.65 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.82 0.819 . . . . 73.420000000000002 112.072 -173.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -73.37 -45.76 53.02 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.822 -0.626 . . . . 74.540000000000006 111.233 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -78.79 114.3 17.6 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.956 -0.565 . . . . 73.340000000000003 111.484 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -82.58 165.34 20.17 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.866 0.365 . . . . 65.230000000000004 111.323 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -96.86 -179.65 4.64 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.9 0.381 . . . . 74.439999999999998 111.191 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.6 t60 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 119.047 -0.502 . . . . 74.140000000000001 110.82 175.611 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 113.687 0.235 . . . . 37.549999999999997 113.687 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -78.96 102.48 8.33 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 117.109 0.455 . . . . 73.219999999999999 110.593 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 76.9 mtt85 -114.3 98.09 6.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.95 0.405 . . . . 73.420000000000002 111.768 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -87.05 109.3 19.32 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.809 0.338 . . . . 73.510000000000005 110.152 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.24 117.87 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.791 0.329 . . . . 61.119999999999997 111.494 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -108.14 -55.35 2.38 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.603 0.239 . . . . 71.329999999999998 110.918 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 26.2 tp 61.86 6.5 1.68 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.81 0.67 . . . . 75.209999999999994 112.81 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.4 tp -54.74 124.31 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 112.794 0.664 . . . . 73.150000000000006 112.794 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -149.38 146.65 27.59 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.251 -0.431 . . . . 75.409999999999997 110.972 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -62.32 166.03 5.4 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.282 0.845 . . . . 74.400000000000006 113.282 -174.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -85.84 133.58 33.96 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.839 -0.619 . . . . 75.5 111.71 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.55 148.19 5.36 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.143 -0.551 . . . . 72.109999999999999 112.923 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.86 55.68 0.31 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.524 -0.369 . . . . 55.210000000000001 113.468 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -60.94 120.4 10.12 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 122.303 -0.528 . . . . 74.409999999999997 111.364 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.0 m -69.01 105.68 2.5 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.03 0.443 . . . . 71.209999999999994 111.935 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -88.87 151.26 22.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.313 0.578 . . . . 63.439999999999998 111.787 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -95.12 144.27 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.104 0.478 . . . . 64.239999999999995 111.784 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.403 ' H ' ' HD3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -66.41 -172.76 0.17 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.094 0.473 . . . . 74.120000000000005 111.892 173.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 23' ' ' THR . 2.6 pt? -56.76 -2.4 0.08 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.068 1.136 . . . . 71.219999999999999 114.068 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.52 -42.55 78.61 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.182 0.438 . . . . 41.100000000000001 112.182 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.1 m -96.43 -35.07 11.29 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.982 0.42 . . . . 45.140000000000001 111.36 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 5.2 p-10 -128.69 96.43 4.38 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.547 0.689 . . . . 73.200000000000003 111.044 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.521 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 17.8 m -76.24 113.47 13.84 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.946 -0.57 . . . . 64.010000000000005 110.81 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.492 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 34.6 ttm180 -148.02 154.0 39.69 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.929 0.395 . . . . 74.120000000000005 111.968 -172.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.0 tt -148.87 146.16 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.945 0.402 . . . . 73.230000000000004 111.619 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.632 ' ND2' HG21 ' A' ' 82' ' ' VAL . 29.9 m-80 -94.16 112.71 24.55 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.88 0.371 . . . . 72.540000000000006 110.064 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.3 t -102.39 130.99 51.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.053 -0.521 . . . . 72.540000000000006 112.055 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.7 t -95.11 120.47 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.073 0.464 . . . . 71.439999999999998 110.882 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.21 116.71 61.16 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.974 -0.557 . . . . 73.150000000000006 111.028 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.9 -17.04 11.06 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.693 2.262 . . . . 74.040000000000006 112.927 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -87.96 -43.17 11.95 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.834 0.35 . . . . 55.229999999999997 111.559 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 p -106.25 -26.9 11.34 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.583 0.586 . . . . 74.340000000000003 112.583 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.61 15.97 57.5 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.126 -0.559 . . . . 70.349999999999994 114.325 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -97.41 143.86 27.73 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.243 -0.563 . . . . 74.400000000000006 111.397 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.4 t -88.51 98.33 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.171 0.51 . . . . 71.010000000000005 109.894 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -101.32 138.61 38.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.933 -0.576 . . . . 62.109999999999999 110.94 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 55.1 mt -92.31 127.72 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.071 0.462 . . . . 74.540000000000006 111.439 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.89 160.0 35.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 53.520000000000003 110.995 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 39.0 mt-10 -109.17 134.69 51.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.873 0.368 . . . . 64.239999999999995 110.48 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.487 ' HA ' HG23 ' A' ' 66' ' ' THR . 60.6 mt -71.52 113.68 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.512 0.672 . . . . 72.439999999999998 112.046 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -37.32 41.45 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.107 -0.951 . . . . 73.010000000000005 110.302 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.636 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 59.9 t30 -141.04 119.12 11.95 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.939 -0.573 . . . . 64.409999999999997 110.545 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 m -74.34 -26.69 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 112.619 0.6 . . . . 64.129999999999995 112.619 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.8 p -93.57 144.93 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.941 0.4 . . . . 53.140000000000001 111.205 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.97 147.96 32.4 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.109 0.48 . . . . 75.129999999999995 112.045 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -72.52 63.15 0.56 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.372 -0.376 . . . . 75.200000000000003 110.78 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.4 t -134.77 -172.82 3.13 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.838 0.351 . . . . 72.299999999999997 111.871 -173.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.62 -73.99 0.62 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.804 0.668 . . . . 72.439999999999998 112.804 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.3 m120 60.74 90.6 0.09 OUTLIER Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 122.632 0.373 . . . . 71.019999999999996 111.477 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -58.22 -24.94 69.77 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 123.023 2.482 . . . . 65.400000000000006 113.474 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -104.89 162.76 13.05 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.018 0.437 . . . . 64.200000000000003 111.349 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -58.54 -18.68 31.49 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.309 0.485 . . . . 74.329999999999998 112.309 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.3 t -70.81 84.84 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.458 0.646 . . . . 72.140000000000001 111.617 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -136.82 138.12 40.49 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.792 -0.64 . . . . 75.230000000000004 109.918 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -81.06 86.18 6.18 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.844 0.83 . . . . 74.209999999999994 112.261 -173.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -83.9 -23.64 31.12 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.398 -0.819 . . . . 75.239999999999995 111.155 173.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 25.1 pt -74.33 130.12 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 115.784 -0.644 . . . . 72.340000000000003 111.98 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 73' ' ' VAL . 62.9 mt -57.68 92.24 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 115.78 -0.645 . . . . 74.519999999999996 111.852 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.57 ' HA ' ' NH2' ' A' ' 76' ' ' ARG . 30.2 p -128.21 162.73 26.3 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.461 0.541 . . . . 74.340000000000003 112.461 -175.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -57.32 116.92 3.6 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.123 -0.489 . . . . 74.209999999999994 111.717 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.1 -11.36 60.38 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.211 -0.519 . . . . 63.32 113.217 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.02 131.06 40.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.817 0.341 . . . . 74.439999999999998 111.137 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -94.3 112.37 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 120.774 0.321 . . . . 61.329999999999998 111.348 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -103.04 148.52 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.119 0.485 . . . . 74.200000000000003 111.253 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.636 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 43.8 tt0 -92.52 123.99 36.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.386 -0.37 . . . . 61.299999999999997 110.885 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.487 HG23 ' HA ' ' A' ' 40' ' ' ILE . 44.1 p -126.24 176.16 7.28 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.071 0.462 . . . . 61.200000000000003 111.879 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -65.09 -15.39 62.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.337 -0.392 . . . . 73.200000000000003 111.962 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -92.31 -32.35 15.04 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.221 0.534 . . . . 73.329999999999998 111.085 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.81 -150.05 21.88 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.905 -0.588 . . . . 62.409999999999997 112.26 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -80.53 130.49 35.17 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.444 -0.445 . . . . 70.129999999999995 111.193 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.4 t -126.41 128.66 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.417 -0.356 . . . . 74.230000000000004 111.457 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HB2' HD12 ' A' ' 88' ' ' ILE . 42.0 ttm180 -91.29 117.44 29.65 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.251 -0.28 . . . . 75.230000000000004 110.91 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.449 HG23 HG23 ' A' ' 58' ' ' ILE . 45.9 t -66.3 133.83 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.73 0.3 . . . . 55.149999999999999 111.754 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -110.39 -73.2 0.69 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.707 0.289 . . . . 73.040000000000006 111.61 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.1 m -73.27 -177.05 2.4 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.231 0.539 . . . . 71.420000000000002 111.81 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.575 ' HA ' ' NE ' ' A' ' 76' ' ' ARG . 2.8 mmp_? -94.19 132.33 29.5 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.431 -0.349 . . . . 74.120000000000005 111.327 177.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -72.95 150.81 49.57 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.689 2.259 . . . . 74.109999999999999 113.291 -175.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.95 11.43 46.34 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.937 -0.649 . . . . 43.340000000000003 114.053 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.634 ' O ' HG13 ' A' ' 82' ' ' VAL . 59.1 mm-40 -71.66 78.23 0.83 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 117.537 0.668 . . . . 74.310000000000002 110.038 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.7 t70 64.81 13.19 8.3 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.425 0.631 . . . . 64.040000000000006 111.128 -172.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.83 -35.41 3.7 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.2 -0.455 . . . . 37.549999999999997 113.529 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.634 HG13 ' O ' ' A' ' 79' ' ' GLN . 10.9 p -68.87 136.07 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 112.834 0.679 . . . . 73.230000000000004 112.834 -174.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.0 mt -122.98 147.4 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.479 -0.782 . . . . 73.409999999999997 109.588 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -122.21 139.95 53.17 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.471 0.545 . . . . 72.329999999999998 112.471 -175.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.72 171.43 37.67 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 116.133 -0.485 . . . . 54.299999999999997 112.915 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.38 141.24 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 122.522 -0.399 . . . . 71.319999999999993 111.424 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.07 117.53 18.72 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.751 0.31 . . . . 60.310000000000002 111.311 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.443 HD12 ' HB2' ' A' ' 72' ' ' ARG . 18.0 pt -132.2 175.07 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.25 0.548 . . . . 73.129999999999995 111.314 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -149.27 70.17 1.08 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.051 -0.522 . . . . 65.549999999999997 111.418 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.96 -11.25 59.92 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.317 -0.401 . . . . 70.030000000000001 111.887 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.0 mt -89.93 -175.86 4.73 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.899 0.38 . . . . 64.140000000000001 111.315 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -58.88 129.26 41.27 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.507 0.67 . . . . 73.420000000000002 111.798 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -85.54 35.39 0.61 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.761 -0.654 . . . . 74.109999999999999 111.368 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.3 p80 39.73 72.69 0.14 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.712 1.004 . . . . 60.310000000000002 113.712 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -145.31 129.21 17.38 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.797 -0.638 . . . . 75.329999999999998 110.621 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -65.87 118.41 9.65 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.868 0.366 . . . . 73.450000000000003 111.503 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -91.88 169.03 11.01 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.032 0.382 . . . . 74.340000000000003 112.032 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.697 -0.668 . . . . 74.450000000000003 111.269 177.316 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 113.467 0.147 . . . . 63.100000000000001 113.467 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -98.13 83.86 3.18 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.55 0.69 . . . . 73.430000000000007 112.462 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -114.33 38.01 3.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.767 0.794 . . . . 73.340000000000003 109.782 171.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -66.42 96.44 0.36 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.91 -1.041 . . . . 44.119999999999997 111.992 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.8 m -98.3 152.23 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.403 -0.362 . . . . 63.520000000000003 110.464 174.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -109.79 -10.4 14.78 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.303 0.482 . . . . 72.519999999999996 112.303 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tt 53.43 82.66 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.389 0.614 . . . . 72.409999999999997 110.89 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.73 126.58 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.522 0.677 . . . . 74.340000000000003 111.267 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -128.89 145.45 51.21 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.753 -0.658 . . . . 75.519999999999996 110.51 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -178.01 171.83 1.7 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.111 0.481 . . . . 50.229999999999997 111.956 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.474 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -160.37 -40.51 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.178 -0.465 . . . . 61.420000000000002 110.955 177.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.14 -176.7 51.34 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.173 -0.537 . . . . 62.140000000000001 113.035 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.25 52.48 4.53 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.049 -0.596 . . . . 75.239999999999995 112.743 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -116.65 -170.13 1.76 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.068 0.461 . . . . 73.450000000000003 111.844 -175.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.2 m -78.94 104.82 9.84 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.037 0.446 . . . . 74.219999999999999 112.089 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HE2' ' O ' ' A' ' 17' ' ' VAL . 19.3 ptmt -85.26 160.49 19.84 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.0 0.429 . . . . 74.400000000000006 110.958 175.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.421 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 49.1 t -70.53 145.76 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 116.515 -0.311 . . . . 74.299999999999997 110.204 173.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -41.98 -39.87 2.03 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.97 0.73 . . . . 75.409999999999997 112.97 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.452 HD21 ' OG1' ' A' ' 23' ' ' THR . 7.5 tt -145.24 128.43 16.7 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.307 -0.406 . . . . 71.140000000000001 109.934 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.8 -65.54 0.87 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.948 0.404 . . . . 72.120000000000005 111.56 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -142.77 17.19 1.98 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.937 0.875 . . . . 74.209999999999994 110.142 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -112.04 22.77 14.48 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.902 -1.045 . . . . 64.150000000000006 112.011 -173.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.452 ' OG1' HD21 ' A' ' 19' ' ' LEU . 7.5 m -64.72 113.12 3.56 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.128 -0.487 . . . . 75.420000000000002 112.189 -176.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 24' ' ' ARG . 55.9 mtt180 -151.04 161.6 42.42 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.05 0.452 . . . . 72.209999999999994 111.918 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.5 tt -149.15 144.12 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 115.883 -0.599 . . . . 73.200000000000003 111.308 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -79.04 108.25 12.4 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.297 -0.41 . . . . 74.219999999999999 110.989 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 71' ' ' VAL . 28.5 t -94.63 120.44 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.312 -0.404 . . . . 72.230000000000004 111.865 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.02 118.17 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.935 0.398 . . . . 74.200000000000003 111.053 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 87' ' ' LEU . 14.9 t0 -73.86 118.87 72.87 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.455 -0.339 . . . . 74.030000000000001 111.147 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.58 -28.13 21.68 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.885 2.39 . . . . 74.400000000000006 113.391 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.23 -44.06 11.73 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.41 0.522 . . . . 73.340000000000003 112.41 -173.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.7 p -104.73 -15.36 15.26 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.326 0.491 . . . . 71.530000000000001 112.326 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.04 28.15 69.03 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.144 -0.55 . . . . 63.25 114.021 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -100.38 145.69 27.88 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.152 0.476 . . . . 72.129999999999995 111.445 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -110.73 133.09 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 120.892 0.377 . . . . 72.519999999999996 111.352 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -147.24 139.69 24.71 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.47 -0.332 . . . . 73.299999999999997 111.074 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 61.3 mt -86.88 125.61 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.962 0.411 . . . . 74.219999999999999 111.11 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.501 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -122.51 154.38 37.93 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.381 0.512 . . . . 43.25 112.381 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -90.55 133.24 35.22 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.743 0.306 . . . . 42.039999999999999 110.502 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.464 ' HA ' HG21 ' A' ' 66' ' ' THR . 57.9 mt -83.1 114.71 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.838 0.352 . . . . 61.299999999999997 111.563 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -73.95 -46.68 42.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.392 -0.367 . . . . 74.299999999999997 111.208 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -140.18 139.59 35.72 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.563 -0.29 . . . . 62.509999999999998 110.815 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 t -106.23 -4.34 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 112.585 0.587 . . . . 64.519999999999996 112.585 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 44' ' ' VAL . 9.2 p -63.47 104.81 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.626 0.726 . . . . 73.319999999999993 111.253 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.44 155.47 37.41 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.703 -0.681 . . . . 73.340000000000003 111.851 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -78.83 41.03 0.41 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.427 0.529 . . . . 70.150000000000006 112.427 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.473 HG21 ' HB2' ' A' ' 55' ' ' ARG . 1.8 t -63.79 -54.98 26.65 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.165 0.431 . . . . 71.25 112.165 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . 66.98 1.58 2.37 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.317 0.858 . . . . 74.239999999999995 113.317 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -139.99 77.75 25.6 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 121.331 0.586 . . . . 63.130000000000003 111.809 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.81 108.22 1.43 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.522 2.148 . . . . 74.120000000000005 111.837 175.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -72.79 -40.1 66.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.794 0.331 . . . . 70.129999999999995 111.58 -174.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -139.99 -18.42 0.92 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.993 0.368 . . . . 75.200000000000003 111.993 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.25 154.73 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 122.292 -0.255 . . . . 65.0 111.109 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.22 134.82 52.4 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.023 0.44 . . . . 74.140000000000001 111.131 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.473 ' HB2' HG21 ' A' ' 47' ' ' THR . 31.0 mtp180 -104.02 128.35 51.61 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.366 0.876 . . . . 75.319999999999993 113.366 -173.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -145.84 38.82 1.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.924 -1.034 . . . . 55.009999999999998 108.615 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.7 mt -90.73 118.72 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.217 -0.902 . . . . 75.439999999999998 111.946 -171.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.737 HG21 HD12 ' A' ' 83' ' ' ILE . 59.5 mt -69.53 88.66 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.367 0.603 . . . . 62.219999999999999 110.759 176.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -134.06 173.05 12.0 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.145 -0.479 . . . . 74.439999999999998 111.338 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -58.74 115.95 3.41 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.999 0.428 . . . . 62.310000000000002 111.277 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.22 -13.19 52.01 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.228 -0.511 . . . . 63.439999999999998 113.665 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.25 139.31 48.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 117.061 0.43 . . . . 73.439999999999998 111.683 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.9 t -110.78 119.5 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 116.359 -0.382 . . . . 75.540000000000006 111.703 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 70' ' ' ASN . 32.6 m -114.8 159.23 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.77 0.319 . . . . 72.310000000000002 111.85 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.22 126.8 43.85 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.814 0.34 . . . . 71.140000000000001 110.806 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.464 HG21 ' HA ' ' A' ' 40' ' ' ILE . 34.7 p -125.59 178.81 5.45 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.504 -0.316 . . . . 61.210000000000001 111.067 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.501 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 16.9 p-10 -67.68 -16.1 63.98 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.725 0.298 . . . . 75.310000000000002 111.771 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.4 mt -95.73 -22.31 17.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.984 0.421 . . . . 70.209999999999994 111.193 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.27 -154.76 21.78 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 112.079 -0.408 . . . . 72.219999999999999 112.079 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 13.4 m120 -81.18 133.34 35.44 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 122.094 -0.65 . . . . 65.230000000000004 111.711 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 27' ' ' VAL . 23.8 t -121.63 119.5 59.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.922 -0.581 . . . . 72.230000000000004 110.594 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.511 ' HB2' HD12 ' A' ' 88' ' ' ILE . 33.4 ttt-85 -91.21 116.52 28.88 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.675 0.274 . . . . 74.329999999999998 110.375 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.406 HG23 HG22 ' A' ' 58' ' ' ILE . 45.7 t -61.02 118.27 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.049 0.452 . . . . 63.229999999999997 112.141 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.6 p -97.21 -47.1 5.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.205 -0.452 . . . . 75.439999999999998 111.427 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.6 m -101.95 138.33 39.06 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.253 -0.43 . . . . 62.210000000000001 111.377 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -64.39 133.93 95.82 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 111.904 0.335 . . . . 70.230000000000004 111.904 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.8 100.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.803 2.336 . . . . 64.549999999999997 112.863 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.81 -30.98 0.46 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.802 -0.635 . . . . 54.219999999999999 111.853 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -60.16 112.97 2.11 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.62 0.248 . . . . 72.109999999999999 110.429 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.438 ' HB3' HG12 ' A' ' 82' ' ' VAL . 31.4 t70 65.13 15.64 10.11 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.45 0.643 . . . . 74.420000000000002 110.89 -175.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.27 2.53 63.08 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 116.001 -0.545 . . . . 71.109999999999999 113.202 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.438 HG12 ' HB3' ' A' ' 80' ' ' ASP . 11.5 p -123.38 167.79 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 120.897 0.38 . . . . 73.109999999999999 111.413 -175.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.737 HD12 HG21 ' A' ' 58' ' ' ILE . 37.1 mt -106.51 129.15 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 122.52 0.328 . . . . 74.319999999999993 111.273 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -113.73 141.24 47.51 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.977 0.417 . . . . 72.340000000000003 111.465 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.55 173.69 34.32 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.36 -0.448 . . . . 73.310000000000002 113.049 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -105.05 150.76 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 113.082 0.771 . . . . 64.109999999999999 113.082 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 29' ' ' ASP . 66.4 tp -82.02 107.62 14.87 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.188 -0.914 . . . . 74.319999999999993 111.893 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.511 HD12 ' HB2' ' A' ' 72' ' ' ARG . 10.2 pt -120.5 173.31 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.005 0.431 . . . . 73.030000000000001 110.492 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 88' ' ' ILE . 19.3 mmm180 -131.35 72.66 1.51 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 120.954 0.407 . . . . 73.109999999999999 110.855 -174.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -83.93 -56.89 3.44 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.948 0.351 . . . . 74.239999999999995 111.948 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . 84.8 mt -61.88 146.02 51.02 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.689 0.28 . . . . 62.32 111.369 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.431 ' HG3' ' CD2' ' A' ' 93' ' ' HIS . 14.5 tp10 -53.35 -80.19 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.731 0.641 . . . . 74.209999999999994 112.731 -172.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.431 ' CD2' ' HG3' ' A' ' 92' ' ' GLU . 96.6 m-70 -111.14 117.56 33.58 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.902 -0.499 . . . . 72.540000000000006 111.229 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.449 ' CE1' ' HB2' ' A' ' 91' ' ' LEU . 92.5 m-70 -86.25 18.89 2.93 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.131 0.491 . . . . 75.209999999999994 111.869 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -87.85 26.78 1.26 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.228 0.537 . . . . 74.140000000000001 110.066 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -53.73 105.3 0.13 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.808 -0.633 . . . . 74.120000000000005 112.6 -174.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -69.71 -22.11 63.42 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.003 -0.544 . . . . 75.040000000000006 110.586 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 19.6 p80 . . . . . 0 C--O 1.249 1.072 0 CA-C-N 116.092 -0.504 . . . . 74.040000000000006 111.115 173.685 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 CA-C-O 120.563 -0.021 . . . . 39.109999999999999 113.141 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.99 71.12 4.45 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.416 0.524 . . . . 71.140000000000001 112.416 -176.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.63 87.8 1.32 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.23 0.538 . . . . 64.040000000000006 110.714 172.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 4' ' ' ARG . 44.6 mtm180 60.12 87.3 0.09 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.668 -0.696 . . . . 74.530000000000001 112.09 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.86 -178.05 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.88 -0.6 . . . . 74.420000000000002 111.097 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -58.1 127.43 32.08 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.9 0.381 . . . . 63.210000000000001 111.408 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.53 50.33 1.76 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.453 0.644 . . . . 73.150000000000006 111.4 -172.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.8 tt -81.19 141.6 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.246 -0.434 . . . . 73.409999999999997 110.242 171.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -53.32 162.87 0.66 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.757 0.651 . . . . 75.549999999999997 112.757 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.0 p -62.38 148.66 44.66 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.767 -0.651 . . . . 73.329999999999998 112.298 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -125.71 -176.66 3.67 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.091 -0.504 . . . . 74.219999999999999 111.014 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.14 89.33 0.08 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.339 -0.458 . . . . 64.150000000000006 113.036 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.8 38.45 1.56 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.444 -0.408 . . . . 40.25 112.816 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -134.92 84.95 2.14 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.15 0.5 . . . . 65.25 110.306 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.8 m -97.14 123.62 40.96 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.009 0.374 . . . . 63.25 112.009 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -71.11 164.69 25.1 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.201 0.524 . . . . 74.5 111.997 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.01 155.05 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 115.992 -0.549 . . . . 53.329999999999998 109.896 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -45.5 -33.85 2.93 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.978 0.733 . . . . 75.299999999999997 112.978 -176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.3 tt -145.63 111.21 5.43 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.477 -0.329 . . . . 74.430000000000007 110.486 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.6 74.5 1.06 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.914 0.387 . . . . 43.399999999999999 110.855 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.0 t 71.7 -38.57 0.42 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.245 0.618 . . . . 71.540000000000006 112.211 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -92.11 130.88 37.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.304 0.573 . . . . 70.299999999999997 111.571 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.639 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 77.8 p -98.15 114.48 26.71 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.969 -0.56 . . . . 72.239999999999995 110.791 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -118.86 118.75 32.39 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.995 0.426 . . . . 75.5 111.749 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.8 tt -126.59 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.04 0.448 . . . . 74.299999999999997 112.065 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -70.21 103.82 2.46 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.309 -0.405 . . . . 63.299999999999997 110.831 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.04 115.58 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.125 0.488 . . . . 70.5 111.592 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.3 t -102.61 126.67 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.043 -0.526 . . . . 74.219999999999999 111.054 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.603 ' HB2' ' HG2' ' A' ' 34' ' ' LYS . 10.7 t0 -83.33 121.82 76.96 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 120.623 0.249 . . . . 72.340000000000003 110.443 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HD3' HG13 ' A' ' 86' ' ' VAL . 59.7 Cg_endo -69.87 -32.08 18.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.756 2.304 . . . . 72.319999999999993 112.843 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -89.63 -43.46 10.73 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.688 0.625 . . . . 75.019999999999996 112.688 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.6 p -97.54 -31.83 12.12 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.396 0.517 . . . . 74.450000000000003 112.396 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.96 29.75 16.88 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.984 -0.626 . . . . 71.150000000000006 113.985 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.603 ' HG2' ' HB2' ' A' ' 29' ' ' ASP . 10.6 ptpp? -90.29 137.86 32.01 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.399 0.599 . . . . 65.099999999999994 111.074 177.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.8 t -115.17 102.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.019 0.438 . . . . 61.350000000000001 110.693 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -131.69 140.64 49.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.448 -0.342 . . . . 60.219999999999999 111.13 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.3 mt -86.5 121.04 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.858 0.361 . . . . 61.009999999999998 110.542 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.427 ' HB2' ' ND2' ' A' ' 67' ' ' ASN . . . -116.17 152.83 32.93 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.861 0.689 . . . . 72.030000000000001 112.861 -175.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.639 ' HA ' ' O ' ' A' ' 23' ' ' THR . 1.9 mp0 -83.4 130.76 35.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.002 -0.544 . . . . 74.349999999999994 110.831 175.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.468 HG22 ' HB ' ' A' ' 64' ' ' VAL . 60.6 mt -88.31 114.4 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.689 0.28 . . . . 64.420000000000002 111.443 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -83.41 -53.67 5.54 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.126 0.489 . . . . 71.319999999999993 111.831 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 84.7 m-20 -122.42 135.69 54.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.989 0.424 . . . . 73.319999999999993 111.82 -174.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.7 m -108.8 31.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 121.174 0.511 . . . . 71.150000000000006 111.148 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.904 HG23 ' HB3' ' A' ' 50' ' ' PRO . 10.5 p -99.66 138.13 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 113.323 0.861 . . . . 70.239999999999995 113.323 -171.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -81.43 163.21 22.94 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.206 -0.906 . . . . 74.030000000000001 111.803 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -70.43 83.42 0.58 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.251 0.548 . . . . 72.140000000000001 110.897 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.3 p -120.22 168.92 10.74 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.861 -0.609 . . . . 72.430000000000007 111.623 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.77 99.02 0.76 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.668 0.271 . . . . 65.409999999999997 111.289 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 62.28 93.51 0.06 OUTLIER Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 122.947 0.499 . . . . 75.230000000000004 111.583 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.904 ' HB3' HG23 ' A' ' 44' ' ' VAL . 72.5 Cg_exo -52.87 113.18 1.14 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.19 2.593 . . . . 75.140000000000001 113.549 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -141.1 162.43 35.51 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.314 0.578 . . . . 71.230000000000004 112.509 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -70.91 -2.58 15.58 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.518 -0.764 . . . . 74.310000000000002 112.205 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.2 p -55.46 -30.85 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 112.36 0.504 . . . . 64.230000000000004 112.36 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -105.28 160.36 15.17 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.58 0.229 . . . . 60.210000000000001 110.659 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.641 ' HA ' ' NE ' ' A' ' 55' ' ' ARG . 3.4 mmp_? -74.33 106.79 6.12 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.406 0.622 . . . . 72.200000000000003 112.548 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -74.55 60.59 0.89 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.226 -0.897 . . . . 73.5 112.125 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.1 tp -94.04 137.32 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.275 0.559 . . . . 74.329999999999998 111.591 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.8 mt -86.46 103.09 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.212 -0.449 . . . . 73.299999999999997 111.064 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.4 p -134.63 160.38 38.27 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.296 0.238 . . . . 64.120000000000005 111.514 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 48.8 ttp180 -53.83 119.69 5.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.84 0.353 . . . . 73.219999999999999 111.316 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.91 -20.45 14.63 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.215 -0.448 . . . . 45.200000000000003 112.646 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.99 153.9 29.94 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.089 0.471 . . . . 72.219999999999999 112.23 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.8 t -105.99 114.19 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.097 -0.501 . . . . 71.510000000000005 111.636 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 40' ' ' ILE . 30.6 m -103.33 118.79 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.374 0.607 . . . . 73.219999999999999 111.368 177.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 32.4 tt0 -77.72 108.63 11.07 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.995 0.426 . . . . 72.430000000000007 111.169 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.428 HG21 HG12 ' A' ' 40' ' ' ILE . 24.1 p -102.96 169.81 8.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.287 -0.415 . . . . 54.299999999999997 111.124 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -59.01 -20.89 57.28 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.616 0.598 . . . . 64.329999999999998 112.616 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.7 mt -89.62 -25.3 21.36 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.965 0.412 . . . . 73.040000000000006 111.269 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 147.95 -176.61 26.7 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 116.103 -0.499 . . . . 73.299999999999997 112.738 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -72.74 119.46 17.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.22 0.533 . . . . 61.200000000000003 111.773 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.57 135.14 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.03 -0.532 . . . . 72.439999999999998 111.213 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.518 ' HB2' HD12 ' A' ' 88' ' ' ILE . 30.9 ttm180 -91.94 126.91 37.2 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.204 -0.31 . . . . 73.040000000000006 111.001 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 30.2 t -68.86 100.64 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.767 0.318 . . . . 73.310000000000002 110.255 174.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.8 p -102.18 -26.01 13.5 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 122.052 -0.405 . . . . 71.439999999999998 111.666 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.4 t -100.34 -177.41 3.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.898 0.38 . . . . 63.130000000000003 110.623 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 44.2 mtp180 -100.02 130.19 26.79 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 122.264 -0.272 . . . . 73.430000000000007 111.192 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.544 ' HA ' HG12 ' A' ' 83' ' ' ILE . 21.1 Cg_exo -63.89 83.01 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.335 2.023 . . . . 72.349999999999994 112.218 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.08 -9.31 0.17 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.894 -0.67 . . . . 74.239999999999995 113.547 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 11.2 mm100 -59.22 103.66 0.2 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.023 0.412 . . . . 72.439999999999998 110.879 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.8 t70 61.91 23.05 13.5 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 121.727 0.775 . . . . 73.200000000000003 110.681 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.5 -25.51 15.27 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 115.766 -0.652 . . . . 55.399999999999999 113.479 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.405 HG21 ' N ' ' A' ' 83' ' ' ILE . 7.2 p -96.3 165.59 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.103 0.477 . . . . 74.540000000000006 111.897 -174.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.544 HG12 ' HA ' ' A' ' 77' ' ' PRO . 29.5 mt -116.62 136.37 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.421 -0.354 . . . . 74.519999999999996 110.721 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -115.9 141.82 47.59 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.079 0.466 . . . . 64.439999999999998 111.741 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.58 174.2 30.76 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 116.102 -0.499 . . . . 43.450000000000003 112.968 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.484 HG13 ' HD3' ' A' ' 30' ' ' PRO . 6.3 t -120.46 132.31 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 122.299 -0.53 . . . . 75.409999999999997 111.813 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.65 105.76 3.81 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.88 0.371 . . . . 73.319999999999993 111.033 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 72' ' ' ARG . 11.5 pt -104.69 172.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.452 0.644 . . . . 71.209999999999994 112.194 -174.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.423 ' HD2' ' C ' ' A' ' 88' ' ' ILE . 7.8 mpt_? -141.43 16.33 2.2 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.791 -0.641 . . . . 72.349999999999994 112.195 -175.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -73.37 -15.71 61.36 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.862 0.69 . . . . 74.409999999999997 112.862 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -61.66 -176.07 0.07 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.013 0.745 . . . . 61.350000000000001 113.013 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -46.07 108.08 0.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.401 0.68 . . . . 74.310000000000002 112.377 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -84.99 128.02 34.45 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.28 -0.418 . . . . 73.120000000000005 111.394 -175.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.436 ' C ' ' H ' ' A' ' 96' ' ' HIS . 83.5 t60 -89.79 78.19 6.92 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 120.789 0.328 . . . . 75.209999999999994 110.924 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 68.6 -23.8 0.13 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.094 0.776 . . . . 64.299999999999997 113.094 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.436 ' H ' ' C ' ' A' ' 94' ' ' HIS . 45.0 t-80 -62.26 107.49 0.91 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.364 0.505 . . . . 73.129999999999995 112.364 -175.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -102.0 -43.38 5.79 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.942 0.401 . . . . 74.140000000000001 110.666 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 41.3 t60 . . . . . 0 C--O 1.252 1.227 0 CA-C-O 118.435 -0.793 . . . . 63.420000000000002 110.995 177.987 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.622 -0.191 . . . . 45.030000000000001 112.622 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -75.16 166.27 23.9 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.387 0.613 . . . . 73.209999999999994 112.245 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.83 155.28 31.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.626 -0.715 . . . . 73.109999999999999 110.025 174.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -163.99 103.69 0.89 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.147 0.498 . . . . 75.420000000000002 111.438 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 m -72.61 132.24 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.981 -0.554 . . . . 54.340000000000003 111.686 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.528 ' HA ' ' HE ' ' A' ' 6' ' ' ARG . 2.5 mmp_? -124.28 95.94 4.73 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.885 0.374 . . . . 72.150000000000006 111.017 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 7' ' ' LEU . 2.7 mm? -98.36 -5.52 32.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.26 -0.427 . . . . 64.219999999999999 111.003 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.9 tp -65.1 91.39 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 121.868 0.842 . . . . 71.510000000000005 112.108 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -104.13 126.11 50.98 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.864 -0.607 . . . . 74.540000000000006 111.866 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.6 t -79.51 142.56 35.67 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.198 0.523 . . . . 75.329999999999998 111.405 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.4 ttt180 -134.73 128.57 33.19 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.416 -0.356 . . . . 71.420000000000002 110.725 -177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.9 145.01 4.25 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.633 -0.794 . . . . 74.120000000000005 113.902 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.1 87.43 0.07 OUTLIER Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.367 -0.444 . . . . 62.229999999999997 112.799 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -116.39 170.73 8.32 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.238 0.542 . . . . 71.540000000000006 111.99 -177.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.9 m -137.08 140.07 41.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.849 -0.614 . . . . 70.409999999999997 111.147 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -67.17 151.05 48.26 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.161 0.505 . . . . 71.319999999999993 112.16 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 19' ' ' LEU . 48.7 t -80.21 143.35 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.036 -0.529 . . . . 73.099999999999994 111.696 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 19' ' ' LEU . 3.9 ppt_? -58.52 -17.48 21.69 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.648 0.61 . . . . 74.230000000000004 112.648 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.616 ' H ' HG12 ' A' ' 17' ' ' VAL . 8.6 tt -164.28 107.12 0.91 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.849 -0.426 . . . . 72.340000000000003 109.849 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.47 24.53 7.26 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.965 0.728 . . . . 72.420000000000002 112.965 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.8 t -155.51 -75.62 0.1 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.57 0.582 . . . . 72.230000000000004 112.57 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -141.98 177.77 7.98 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.212 0.449 . . . . 73.200000000000003 112.212 -174.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.7 p -101.83 112.49 25.12 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.009 0.433 . . . . 73.400000000000006 111.891 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 24' ' ' ARG . 49.1 mtm180 -143.9 163.46 33.35 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.374 -0.375 . . . . 65.099999999999994 111.019 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.469 ' HB ' HD13 ' A' ' 40' ' ' ILE . 14.0 tt -150.5 143.78 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.884 0.373 . . . . 63.340000000000003 111.767 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.4 ' HB2' HD21 ' A' ' 84' ' ' ASN . 3.8 m-20 -72.82 103.4 3.67 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.044 0.45 . . . . 64.430000000000007 110.262 173.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.417 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 55.2 t -91.25 113.79 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 63.520000000000003 111.904 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.9 t -95.62 113.02 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.021 -0.536 . . . . 74.310000000000002 110.774 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.79 118.72 74.08 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 61.109999999999999 111.56 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.61 -1.73 10.7 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.832 2.355 . . . . 73.430000000000007 113.705 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.87 -44.0 13.61 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.252 -0.28 . . . . 64.329999999999998 111.664 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.4 p -124.55 -11.41 7.32 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.803 0.668 . . . . 64.299999999999997 112.803 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.22 24.66 39.61 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 120.974 -0.631 . . . . 64.329999999999998 113.785 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -93.01 145.59 24.25 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.411 -0.464 . . . . 72.519999999999996 111.21 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.51 132.96 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.772 0.32 . . . . 73.409999999999997 111.196 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -147.83 143.03 27.18 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.6 0.238 . . . . 75.25 111.161 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.8 mt -86.22 111.41 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 122.25 -0.281 . . . . 64.319999999999993 111.12 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.483 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -110.54 155.2 22.63 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.118 0.414 . . . . 74.129999999999995 112.118 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -85.46 122.65 29.9 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.896 0.379 . . . . 63.229999999999997 111.495 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.544 ' HA ' HG21 ' A' ' 66' ' ' THR . 62.2 mt -73.04 116.59 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.423 -0.353 . . . . 61.210000000000001 110.726 176.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -81.04 -54.33 5.64 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.817 0.341 . . . . 75.530000000000001 111.367 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -145.41 152.8 40.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.872 0.368 . . . . 74.349999999999994 111.254 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.455 ' O ' HG22 ' A' ' 43' ' ' VAL . 13.8 p -90.81 13.09 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-O 121.443 0.64 . . . . 74.129999999999995 111.712 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.9 p -65.81 99.25 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.489 0.661 . . . . 71.340000000000003 111.166 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.421 ' HB3' ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -86.33 -28.79 23.46 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.503 0.557 . . . . 72.140000000000001 112.503 -175.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -174.22 -30.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.115 0.413 . . . . 64.409999999999997 112.115 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.498 HG22 ' HD3' ' A' ' 54' ' ' ARG . 13.0 t -60.99 157.77 14.81 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.594 0.59 . . . . 71.329999999999998 112.594 -177.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.94 -14.66 27.25 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.293 -0.412 . . . . 73.450000000000003 111.081 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.539 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 14.5 t-20 54.03 56.22 12.68 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 115.669 -0.696 . . . . 73.219999999999999 112.336 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 49' ' ' ASN . 6.2 Cg_exo -80.24 -26.61 4.09 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.674 2.25 . . . . 55.340000000000003 112.595 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -130.93 132.09 44.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.334 -0.394 . . . . 63.299999999999997 110.58 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -77.21 73.02 3.79 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.607 0.718 . . . . 73.340000000000003 111.957 -175.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.7 p -127.21 -22.34 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.654 -0.703 . . . . 71.420000000000002 110.978 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.498 ' HD3' HG22 ' A' ' 47' ' ' THR . 34.5 ttt85 -79.23 124.54 28.46 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.711 -0.677 . . . . 72.129999999999995 111.406 -176.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -79.69 87.03 5.23 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.215 0.531 . . . . 74.310000000000002 111.157 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -69.52 103.87 2.18 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.124 -0.489 . . . . 70.129999999999995 110.953 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 tt -141.98 145.69 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.985 0.421 . . . . 63.240000000000002 111.651 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.549 HG23 HD13 ' A' ' 83' ' ' ILE . 46.4 mm -65.12 112.06 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.256 -0.429 . . . . 75.219999999999999 111.337 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -147.85 167.57 24.43 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.184 -0.322 . . . . 70.219999999999999 111.586 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -62.35 127.29 30.66 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.057 0.456 . . . . 65.239999999999995 111.675 -176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.55 -22.09 42.18 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.286 -0.483 . . . . 42.5 112.909 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.86 129.36 37.75 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.911 0.386 . . . . 54.32 111.3 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.421 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 57.8 t -94.03 115.27 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.307 -0.406 . . . . 65.439999999999998 111.396 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.436 ' HB ' HG21 ' A' ' 40' ' ' ILE . 35.2 m -103.59 129.02 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.232 0.539 . . . . 72.540000000000006 111.341 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -76.44 110.27 10.85 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.891 0.377 . . . . 42.340000000000003 110.767 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.544 HG21 ' HA ' ' A' ' 40' ' ' ILE . 33.3 p -107.78 171.9 7.13 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.841 0.353 . . . . 73.219999999999999 111.267 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.483 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 10.1 p-10 -55.78 -33.9 64.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.439 -0.346 . . . . 73.420000000000002 111.545 176.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 74.9 mt -81.23 -29.82 34.36 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.744 0.276 . . . . 62.240000000000002 111.744 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.01 -166.96 29.42 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.528 -0.844 . . . . 52.530000000000001 113.921 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -71.17 101.69 2.34 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.841 0.353 . . . . 61.340000000000003 111.523 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.9 t -99.61 117.0 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.086 0.47 . . . . 61.140000000000001 111.342 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -87.16 117.76 26.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.839 0.352 . . . . 74.010000000000005 110.61 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 51.8 t -67.95 140.17 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 112.61 0.596 . . . . 51.219999999999999 112.61 -173.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.0 p -117.95 -43.47 2.76 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.404 0.52 . . . . 75.099999999999994 112.404 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p -85.81 -179.35 6.81 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.099 0.476 . . . . 61.420000000000002 112.139 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -99.96 132.78 22.29 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.337 -0.392 . . . . 71.430000000000007 110.829 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.433 ' HG3' ' O ' ' A' ' 58' ' ' ILE . 60.1 Cg_endo -70.63 108.9 2.35 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.432 2.088 . . . . 65.409999999999997 112.877 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.57 -33.51 0.76 Allowed Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.906 -0.664 . . . . 75.25 113.363 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.5 ' O ' HG13 ' A' ' 82' ' ' VAL . 85.4 mm-40 -57.59 97.67 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.719 0.26 . . . . 75.319999999999993 111.532 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 56.82 17.08 3.03 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.558 0.577 . . . . 73.25 112.558 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.56 25.16 70.84 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 121.398 -0.429 . . . . 63.32 114.041 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 79' ' ' GLN . 9.1 p -121.37 140.43 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 117.237 0.519 . . . . 65.420000000000002 111.533 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.549 HD13 HG23 ' A' ' 58' ' ' ILE . 62.9 mt -121.69 145.43 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 120.988 0.423 . . . . 72.329999999999998 110.985 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.4 HD21 ' HB2' ' A' ' 26' ' ' ASN . 9.8 m120 -120.04 147.52 44.72 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.117 -0.364 . . . . 74.120000000000005 111.206 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.23 176.81 40.13 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.221 -0.514 . . . . 54.520000000000003 112.915 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.82 146.88 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.579 0.704 . . . . 71.420000000000002 112.899 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.417 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 63.8 tp -85.68 112.66 21.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.294 -0.866 . . . . 74.129999999999995 112.204 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.4 pt -134.43 -174.78 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.954 0.407 . . . . 53.219999999999999 111.182 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -136.58 90.48 2.56 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.82 0.343 . . . . 73.299999999999997 111.089 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -80.96 -27.2 36.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.181 0.515 . . . . 75.420000000000002 110.615 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.6 mt -90.54 138.17 31.77 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.323 0.583 . . . . 74.099999999999994 111.497 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.811 ' HB3' ' HB2' ' A' ' 95' ' ' HIS . 36.0 tt0 -52.73 142.13 19.4 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.375 -0.83 . . . . 75.209999999999994 111.832 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -67.53 -22.11 65.44 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.91 0.707 . . . . 75.230000000000004 112.91 -172.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -122.99 37.33 4.44 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.225 0.536 . . . . 73.420000000000002 110.462 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.811 ' HB2' ' HB3' ' A' ' 92' ' ' GLU . 56.6 t60 -86.83 123.53 32.07 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.142 -0.481 . . . . 73.519999999999996 112.245 -172.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 97' ' ' HIS . 23.1 p-80 -153.87 156.28 37.29 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.113 -0.494 . . . . 74.120000000000005 111.297 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 35.7 m80 73.66 29.5 1.51 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.467 0.707 . . . . 65.329999999999998 112.022 -175.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 . . . . . 0 C--O 1.253 1.263 0 CA-C-O 118.773 -0.632 . . . . 74.420000000000002 111.587 174.011 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 CA-C-O 120.669 0.038 . . . . 53.399999999999999 113.145 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.31 -160.36 0.78 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 120.963 0.411 . . . . 73.340000000000003 111.301 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.24 82.85 7.87 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.158 -0.338 . . . . 73.319999999999993 111.245 -177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -123.38 152.97 41.0 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.91 0.337 . . . . 74.129999999999995 111.91 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 8' ' ' ILE . 10.3 m 48.74 11.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 114.952 1.464 . . . . 65.239999999999995 114.952 174.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -82.58 -0.69 48.06 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.758 -0.589 . . . . 63.109999999999999 111.635 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.487 ' N ' HD13 ' A' ' 7' ' ' LEU . 5.4 mp -86.55 2.04 49.52 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.423 -0.353 . . . . 74.129999999999995 111.929 -176.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 5' ' ' VAL . 11.4 tt -98.11 118.86 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.323 0.582 . . . . 74.219999999999999 111.472 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -117.07 147.32 42.48 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.167 -0.47 . . . . 75.430000000000007 111.141 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -101.95 179.66 4.26 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.43 0.633 . . . . 75.319999999999993 112.376 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -79.24 -32.04 43.75 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.782 -0.644 . . . . 63.329999999999998 110.772 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.42 39.86 6.21 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.999 -0.546 . . . . 60.329999999999998 112.398 -176.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.68 137.14 24.04 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.734 -0.27 . . . . 53.200000000000003 113.684 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -149.07 124.34 10.2 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.619 -0.342 . . . . 73.040000000000006 110.86 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.7 m -81.73 121.2 26.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.554 -0.294 . . . . 71.409999999999997 111.438 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -91.43 169.2 10.98 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.756 0.312 . . . . 71.25 111.245 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.438 HG23 ' N ' ' A' ' 18' ' ' ARG . 12.5 p -118.01 165.06 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-O 120.855 0.36 . . . . 74.299999999999997 111.735 -175.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.438 ' N ' HG23 ' A' ' 17' ' ' VAL . 74.7 mtp180 -60.4 170.97 1.18 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.226 0.536 . . . . 62.509999999999998 112.109 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -58.64 -9.69 1.85 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.979 0.733 . . . . 64.540000000000006 112.979 -177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.61 -23.96 12.58 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.12 0.415 . . . . 64.430000000000007 112.12 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.9 t -108.06 -37.17 6.13 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.415 -0.357 . . . . 74.219999999999999 111.94 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -136.42 116.23 13.11 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.969 0.414 . . . . 71.420000000000002 111.458 -175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.521 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 30.6 p -109.94 112.36 24.33 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.143 0.497 . . . . 75.329999999999998 111.947 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -144.63 155.59 43.69 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.208 -0.451 . . . . 72.120000000000005 111.101 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.44 ' HB ' HD13 ' A' ' 40' ' ' ILE . 13.1 tt -145.45 145.82 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.792 0.33 . . . . 52.32 111.537 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.501 ' N ' HD21 ' A' ' 26' ' ' ASN . 0.8 OUTLIER -80.3 103.78 10.41 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.425 0.631 . . . . 73.230000000000004 110.506 174.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.478 HG11 ' HB2' ' A' ' 87' ' ' LEU . 23.0 t -95.36 121.88 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.429 -0.805 . . . . 74.030000000000001 111.922 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.5 112.28 26.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.931 0.396 . . . . 64.409999999999997 110.571 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -74.26 118.24 68.16 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.477 -0.329 . . . . 72.439999999999998 111.142 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.93 -12.36 17.85 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.554 2.17 . . . . 71.150000000000006 113.116 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -81.67 -44.73 16.75 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.818 0.342 . . . . 63.340000000000003 111.907 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -107.18 -31.0 8.43 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.785 0.291 . . . . 61.509999999999998 111.785 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.8 16.96 34.36 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.333 -0.461 . . . . 71.510000000000005 113.733 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -87.21 150.67 23.76 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 117.234 0.517 . . . . 74.329999999999998 111.813 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.86 95.31 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.522 0.677 . . . . 63.109999999999999 110.49 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -93.02 170.03 9.97 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.504 -0.771 . . . . 75.239999999999995 110.868 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 mt -125.16 124.77 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 122.035 -0.416 . . . . 73.329999999999998 111.09 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.85 163.13 19.73 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.554 0.576 . . . . 75.340000000000003 112.554 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.82 123.39 36.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.01 -0.541 . . . . 71.530000000000001 110.648 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.521 ' HB ' ' HB ' ' A' ' 23' ' ' THR . 57.7 mt -78.79 106.19 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 120.022 -0.671 . . . . 73.430000000000007 110.341 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -88.08 -37.05 16.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.789 -0.641 . . . . 74.450000000000003 112.573 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 46.2 m-80 -133.31 146.84 51.72 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.115 0.483 . . . . 72.209999999999994 111.322 173.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.7 m -104.99 10.81 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.44 0.533 . . . . 74.230000000000004 112.44 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.1 p -85.23 140.96 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.94 0.4 . . . . 74.230000000000004 111.679 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -118.53 172.82 7.21 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.327 -0.397 . . . . 74.439999999999998 111.173 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -63.61 99.23 0.21 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.005 0.431 . . . . 71.310000000000002 111.005 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.7 t -160.19 167.41 27.7 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.265 -0.425 . . . . 62.439999999999998 111.734 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.64 20.85 0.55 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.319 0.488 . . . . 63.299999999999997 112.319 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -113.11 82.64 5.61 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-O 120.758 0.313 . . . . 51.140000000000001 111.393 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.74 -60.03 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.486 2.124 . . . . 73.129999999999995 113.737 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -89.11 12.87 14.49 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.077 0.399 . . . . 72.540000000000006 112.077 -176.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -88.23 122.0 31.26 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.767 0.318 . . . . 75.150000000000006 110.756 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 p -90.18 13.06 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 121.351 0.596 . . . . 65.530000000000001 111.54 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -111.42 -177.95 3.33 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.153 -0.342 . . . . 75.519999999999996 111.227 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.504 ' NE ' ' O ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER 77.4 -13.27 0.97 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.257 0.623 . . . . 73.019999999999996 110.722 -171.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -41.64 -21.56 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.223 1.194 . . . . 71.420000000000002 114.223 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 55' ' ' ARG . 69.1 mt -52.49 120.21 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 120.946 0.403 . . . . 73.109999999999999 111.717 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm -75.03 131.7 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.823 0.344 . . . . 70.120000000000005 111.165 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -147.81 174.12 12.14 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.009 0.433 . . . . 72.310000000000002 111.827 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -71.89 118.72 15.09 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 111.381 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.93 30.68 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.42 -0.419 . . . . 54.520000000000003 112.914 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.08 142.34 31.35 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.968 0.413 . . . . 63.350000000000001 111.927 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.07 141.13 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.78 0.324 . . . . 64.519999999999996 111.155 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.62 173.34 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.971 0.415 . . . . 71.319999999999993 111.469 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 34.5 tt0 -112.52 133.26 54.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.41 -0.359 . . . . 72.420000000000002 110.791 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.401 HG23 ' HA ' ' A' ' 40' ' ' ILE . 41.6 p -135.68 178.67 6.86 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.328 0.585 . . . . 72.239999999999995 111.804 -176.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -69.89 -14.41 62.72 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.99 -0.55 . . . . 62.329999999999998 112.383 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.58 -17.23 18.77 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.809 0.338 . . . . 74.430000000000007 111.247 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.99 -149.29 20.17 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.41 -0.676 . . . . 72.140000000000001 111.41 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.442 ' ND2' HD13 ' A' ' 91' ' ' LEU . 23.5 m120 -94.16 148.53 22.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 117.646 0.723 . . . . 71.010000000000005 111.276 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.6 t -133.89 127.07 51.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.65 -0.25 . . . . 74.340000000000003 111.241 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 72' ' ' ARG . 15.5 ttm180 -96.28 115.95 28.24 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.557 0.217 . . . . 73.420000000000002 110.832 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.76 126.99 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.448 0.536 . . . . 74.109999999999999 112.448 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.5 p -100.96 -41.37 6.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.634 0.605 . . . . 74.019999999999996 112.634 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.5 m -101.5 178.64 4.58 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.018 0.437 . . . . 75.310000000000002 111.855 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -88.35 117.34 68.27 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 111.986 0.365 . . . . 70.230000000000004 111.986 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.96 140.97 82.16 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.596 2.197 . . . . 71.340000000000003 112.313 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.69 -39.26 3.06 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.795 -0.717 . . . . 62.140000000000001 113.471 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -45.42 -74.96 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.984 0.514 . . . . 71.310000000000002 111.447 -177.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -78.67 -13.38 59.85 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.27 0.557 . . . . 72.340000000000003 110.844 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.05 -27.44 19.42 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 116.113 -0.494 . . . . 51.240000000000002 112.388 -175.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p -104.02 145.37 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.849 0.357 . . . . 62.240000000000002 111.269 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.2 mt -102.83 144.99 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.734 0.302 . . . . 72.010000000000005 110.71 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -126.94 151.23 48.77 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.584 0.231 . . . . 70.129999999999995 111.421 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -167.44 175.88 42.38 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.277 -0.487 . . . . 74.219999999999999 113.239 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.1 t -106.3 142.11 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 117.078 0.439 . . . . 71.549999999999997 111.405 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.478 ' HB2' HG11 ' A' ' 27' ' ' VAL . 40.7 tp -76.36 114.35 14.95 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.157 0.503 . . . . 74.040000000000006 111.456 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.411 HD13 ' OE2' ' A' ' 90' ' ' GLU . 8.0 pt -133.51 179.22 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.189 0.518 . . . . 64.030000000000001 111.166 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -139.26 32.13 2.13 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.207 -0.308 . . . . 62.43 111.239 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.411 ' OE2' HD13 ' A' ' 88' ' ' ILE . 43.2 mt-10 -59.76 -53.91 52.46 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.849 0.685 . . . . 74.129999999999995 112.849 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.442 HD13 ' ND2' ' A' ' 70' ' ' ASN . 81.0 mt -64.75 145.71 55.84 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.779 -0.452 . . . . 74.319999999999993 109.779 173.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.78 97.01 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.408 0.623 . . . . 72.340000000000003 111.689 -170.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -144.11 99.01 3.31 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.688 -0.687 . . . . 75.340000000000003 110.68 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -64.25 115.98 5.56 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 111.783 0.29 . . . . 74.430000000000007 111.783 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -71.24 -17.48 62.49 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.401 0.619 . . . . 75.310000000000002 110.563 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -130.84 125.34 33.39 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.388 -0.823 . . . . 71.409999999999997 109.323 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -54.3 131.68 42.26 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.992 0.367 . . . . 73.439999999999998 111.992 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.8 p80 . . . . . 0 C--O 1.254 1.334 0 CA-C-O 118.649 -0.691 . . . . 71.030000000000001 112.574 -178.028 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 112.972 -0.051 . . . . 73.409999999999997 112.972 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -81.31 -179.77 7.51 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 112.351 0.5 . . . . 74.019999999999996 112.351 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -129.44 175.66 8.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.344 -0.389 . . . . 73.219999999999999 111.286 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? 61.82 78.86 0.27 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.964 0.506 . . . . 75.530000000000001 111.622 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -86.53 157.15 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.963 0.411 . . . . 73.109999999999999 111.865 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 58.79 23.81 11.63 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.072 -0.513 . . . . 74.219999999999999 111.804 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.6 tp -72.3 -14.75 61.83 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 116.272 -0.422 . . . . 74.319999999999993 111.682 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.499 HD11 ' N ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -95.74 140.46 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.278 0.561 . . . . 74.340000000000003 111.251 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.499 ' N ' HD11 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -159.3 155.39 26.81 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.005 -0.543 . . . . 74.239999999999995 111.174 178.379 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.8 m -153.05 146.47 24.91 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 111.937 0.347 . . . . 74.219999999999999 111.937 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -120.98 -20.0 7.02 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.084 0.402 . . . . 73.219999999999999 112.084 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.03 -99.82 0.89 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.23 -0.509 . . . . 75.040000000000006 113.273 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.88 114.59 1.32 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.42 -0.419 . . . . 36.619999999999997 113.429 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -148.38 174.88 11.6 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 122.737 -0.273 . . . . 72.409999999999997 110.374 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.2 m -63.73 108.01 1.32 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.102 0.477 . . . . 75.510000000000005 111.495 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -123.3 179.06 4.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.148 0.499 . . . . 73.510000000000005 112.009 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.2 p -68.53 160.33 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.886 -0.597 . . . . 64.150000000000006 110.795 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 18' ' ' ARG . 5.8 ptp180 -46.9 -32.53 3.86 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.237 0.829 . . . . 65.209999999999994 113.237 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 tt -160.94 109.0 1.55 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.9 0.381 . . . . 72.409999999999997 110.477 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.35 79.93 1.64 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.087 0.47 . . . . 74.340000000000003 111.635 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.4 m 62.94 14.9 7.89 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.377 0.88 . . . . 65.129999999999995 113.377 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -141.31 129.85 22.64 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.006 -0.434 . . . . 71.319999999999993 110.388 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.422 ' CG2' ' HB ' ' A' ' 40' ' ' ILE . 25.8 m -90.42 113.57 25.52 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.914 0.387 . . . . 63.5 111.729 -175.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -129.11 165.83 20.49 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.521 -0.308 . . . . 71.230000000000004 111.485 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.535 ' HB ' HD12 ' A' ' 40' ' ' ILE . 15.5 tt -155.17 139.74 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.762 0.315 . . . . 74.140000000000001 111.419 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.442 ' OD1' HG12 ' A' ' 37' ' ' ILE . 90.3 m-20 -80.93 103.61 10.87 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.015 0.436 . . . . 70.219999999999999 110.841 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.472 HG23 HG23 ' A' ' 71' ' ' VAL . 60.3 t -85.35 121.44 37.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.98 -0.554 . . . . 73.5 112.013 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.01 111.37 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.113 -0.494 . . . . 65.329999999999998 110.788 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -77.77 115.8 53.08 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.413 -0.358 . . . . 73.129999999999995 110.283 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.28 -20.05 21.66 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.388 2.058 . . . . 73.109999999999999 113.791 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -86.01 -33.54 21.02 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.942 0.401 . . . . 65.019999999999996 111.885 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.5 p -116.4 -21.27 9.34 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.155 0.428 . . . . 62.109999999999999 112.155 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.34 25.72 50.21 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.391 0.516 . . . . 61.310000000000002 114.391 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -87.6 155.97 19.71 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.52 0.66 . . . . 75.549999999999997 111.705 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.1 t -118.7 111.5 34.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.138 -0.483 . . . . 64.510000000000005 109.909 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -133.38 136.6 45.4 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.132 0.419 . . . . 73.219999999999999 112.132 -173.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.442 HG12 ' OD1' ' A' ' 26' ' ' ASN . 61.5 mt -76.76 123.84 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.269 0.557 . . . . 54.240000000000002 112.105 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HB2' ' OD1' ' A' ' 67' ' ' ASN . . . -117.81 170.32 8.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.032 -0.531 . . . . 70.140000000000001 111.606 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -104.69 127.27 52.4 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.418 -0.356 . . . . 73.450000000000003 110.466 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.535 HD12 ' HB ' ' A' ' 25' ' ' ILE . 53.8 mt -83.91 124.23 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.093 0.473 . . . . 64.349999999999994 111.617 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -81.11 -53.8 6.08 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.007 -0.542 . . . . 72.5 111.301 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -143.93 152.47 41.14 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.923 0.392 . . . . 71.400000000000006 111.553 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.512 HG12 HG11 ' A' ' 64' ' ' VAL . 48.6 t -120.08 88.87 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 109.555 -0.535 . . . . 72.430000000000007 109.555 176.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 p -160.2 142.4 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 112.522 0.564 . . . . 74.439999999999998 112.522 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -147.45 133.72 19.51 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.207 0.527 . . . . 63.420000000000002 112.11 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 61.62 13.89 5.59 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.061 1.134 . . . . 74.5 114.061 171.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 p -88.01 -169.6 2.64 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.829 -0.544 . . . . 64.019999999999996 111.571 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.38 -44.38 65.09 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.06 0.393 . . . . 71.200000000000003 112.06 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -125.06 128.02 24.92 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 116.638 -0.256 . . . . 71.099999999999994 111.682 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.02 51.82 3.58 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 122.921 2.414 . . . . 73.329999999999998 113.095 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -132.76 -169.93 2.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 122.494 0.318 . . . . 71.310000000000002 110.42 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -66.43 84.46 0.1 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.339 0.59 . . . . 75.409999999999997 110.428 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 56' ' ' ASN . 11.4 p -106.78 152.25 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.733 -0.667 . . . . 73.530000000000001 110.43 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -54.12 158.15 2.32 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 111.844 0.313 . . . . 72.540000000000006 111.844 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? 76.6 12.74 2.46 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.477 0.656 . . . . 74.420000000000002 110.15 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 53' ' ' VAL . 3.4 p-10 -74.71 53.82 0.59 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.443 -0.799 . . . . 75.420000000000002 112.485 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 57' ' ' ILE . 37.8 pt -83.35 116.31 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.318 0.58 . . . . 75.200000000000003 111.885 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.576 HG21 HD12 ' A' ' 83' ' ' ILE . 62.2 mt -74.23 100.47 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.075 0.464 . . . . 74.019999999999996 110.726 176.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.3 t -142.24 169.4 17.65 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.051 0.453 . . . . 73.120000000000005 111.574 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -61.51 126.15 26.34 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.288 -0.415 . . . . 74.420000000000002 111.753 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.06 -24.91 21.98 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.387 -0.435 . . . . 64.209999999999994 112.97 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.24 141.64 35.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.874 0.368 . . . . 51.210000000000001 111.694 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.534 HG12 ' HG3' ' A' ' 90' ' ' GLU . 35.3 m -100.57 133.11 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.296 0.57 . . . . 60.399999999999999 111.833 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.512 HG11 HG12 ' A' ' 43' ' ' VAL . 32.1 m -111.92 146.76 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.177 0.513 . . . . 74.109999999999999 111.685 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -89.84 112.65 24.05 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.254 -0.43 . . . . 74.230000000000004 110.259 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 p -115.01 174.84 5.77 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.962 0.411 . . . . 63.100000000000001 111.593 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.531 ' OD1' ' HB2' ' A' ' 38' ' ' ALA . 19.5 p-10 -62.9 -31.78 72.9 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.992 0.425 . . . . 72.140000000000001 111.444 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.403 HD13 ' HB1' ' A' ' 38' ' ' ALA . 88.5 mt -82.6 -19.03 39.21 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.291 -0.413 . . . . 62.130000000000003 111.464 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.18 -150.32 19.6 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.828 -0.701 . . . . 74.430000000000007 113.853 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -83.44 119.26 24.44 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.563 -0.375 . . . . 73.450000000000003 111.207 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.472 HG23 HG23 ' A' ' 27' ' ' VAL . 47.6 t -123.69 122.93 66.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.608 0.242 . . . . 73.540000000000006 111.494 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -91.22 116.09 28.55 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.284 -0.26 . . . . 72.030000000000001 111.407 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.63 134.02 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 112.336 0.495 . . . . 74.109999999999999 112.336 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.3 p -118.65 -66.9 1.03 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.331 -0.395 . . . . 61.350000000000001 111.916 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.3 m -64.24 133.43 52.78 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.787 0.327 . . . . 75.430000000000007 111.737 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -59.75 120.65 51.49 Favored Pre-proline 0 N--CA 1.472 0.642 0 CA-C-N 116.353 -0.385 . . . . 72.239999999999995 111.922 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.546 ' HB3' HG12 ' A' ' 83' ' ' ILE . 27.8 Cg_exo -61.56 94.94 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.769 2.313 . . . . 75.239999999999995 112.585 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.86 -63.71 0.42 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.556 -0.83 . . . . 55.119999999999997 113.168 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -53.71 -55.59 24.84 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 111.888 0.329 . . . . 75.129999999999995 111.888 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.21 -25.79 67.08 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.299 0.571 . . . . 64.319999999999993 110.902 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.91 -25.57 26.94 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 116.045 -0.525 . . . . 36.619999999999997 112.936 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -135.08 160.94 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 120.857 0.361 . . . . 73.040000000000006 110.956 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.576 HD12 HG21 ' A' ' 58' ' ' ILE . 60.2 mt -91.75 126.98 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.533 -0.303 . . . . 74.340000000000003 111.3 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -119.31 157.41 28.14 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.774 0.321 . . . . 73.409999999999997 111.337 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.33 177.94 39.12 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.107 -0.568 . . . . 36.619999999999997 113.407 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.5 t -111.08 138.98 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 122.454 -0.439 . . . . 71.340000000000003 111.627 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.8 tp -81.08 115.66 20.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.94 0.4 . . . . 73.140000000000001 111.362 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.551 HG13 ' HG2' ' A' ' 90' ' ' GLU . 5.6 pt -141.29 -166.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 120.94 0.4 . . . . 65.140000000000001 111.759 -176.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -122.8 100.87 7.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.821 0.343 . . . . 73.239999999999995 111.295 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.551 ' HG2' HG13 ' A' ' 88' ' ' ILE . 6.8 mm-40 -120.82 -64.0 1.29 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.392 0.615 . . . . 43.149999999999999 111.398 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.44 -158.29 0.66 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.746 -0.661 . . . . 72.409999999999997 112.102 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.21 168.22 0.25 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.273 0.559 . . . . 74.049999999999997 112.403 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -98.17 31.5 2.74 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.75 0.648 . . . . 62.549999999999997 112.75 -171.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -69.71 89.98 0.57 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.939 -0.475 . . . . 74.530000000000001 111.349 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -118.21 133.42 55.91 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.211 -0.449 . . . . 73.040000000000006 111.192 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -175.43 125.93 0.24 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.022 0.439 . . . . 64.030000000000001 111.286 172.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -82.33 -18.08 43.44 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.306 -0.407 . . . . 74.400000000000006 110.731 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 . . . . . 0 C--O 1.254 1.308 0 CA-C-O 118.537 -0.744 . . . . 74.319999999999993 111.143 -179.566 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 CA-C-O 120.571 -0.016 . . . . 72.329999999999998 113.105 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -117.28 126.38 52.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.946 0.403 . . . . 74.209999999999994 111.963 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.478 ' HD3' ' O ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -153.22 143.73 22.57 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.977 0.417 . . . . 72.329999999999998 110.918 173.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -123.62 171.26 9.69 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.987 0.422 . . . . 65.120000000000005 111.382 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.414 HG21 ' N ' ' A' ' 6' ' ' ARG . 14.0 p -132.25 163.03 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.106 -0.497 . . . . 74.340000000000003 110.671 -177.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.414 ' N ' HG21 ' A' ' 5' ' ' VAL . 96.5 mtt180 -77.29 118.05 19.4 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.783 0.325 . . . . 65.239999999999995 111.122 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 7' ' ' LEU . 6.8 mp -83.51 39.02 0.65 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.406 0.622 . . . . 75.319999999999993 110.736 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.1 tt -71.36 127.29 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.031 -0.531 . . . . 72.109999999999999 111.718 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -96.35 94.95 7.74 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.84 0.352 . . . . 74.530000000000001 110.658 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.2 m -67.75 87.78 0.23 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.139 0.495 . . . . 75.230000000000004 111.205 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -94.79 153.61 17.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.261 0.553 . . . . 74.349999999999994 112.289 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.02 -153.94 11.52 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 115.759 -0.655 . . . . 60.409999999999997 112.168 172.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.22 151.79 6.05 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.82 -0.705 . . . . 72.230000000000004 113.579 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -139.99 170.56 15.63 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.352 0.261 . . . . 63.32 110.481 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 93.8 m -48.44 121.92 4.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.18 0.514 . . . . 64.310000000000002 112.332 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -97.54 -170.51 2.02 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.137 -0.483 . . . . 55.219999999999999 111.175 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.404 HG22 ' H ' ' A' ' 19' ' ' LEU . 7.3 p -67.68 130.28 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.013 0.435 . . . . 71.109999999999999 110.903 173.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.508 ' HD3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -68.7 -25.12 64.61 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.007 0.743 . . . . 72.200000000000003 113.007 -176.174 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 23' ' ' THR . 7.7 tt -176.87 135.71 0.22 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.866 0.365 . . . . 73.409999999999997 111.307 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.16 -63.27 1.43 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.12 0.485 . . . . 65.219999999999999 111.125 175.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.6 p -139.43 20.01 2.56 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.409 0.623 . . . . 73.109999999999999 110.207 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.0 28.2 2.86 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.439 -0.801 . . . . 65.439999999999998 111.812 -171.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.538 ' HA ' HD12 ' A' ' 19' ' ' LEU . 18.9 m -64.66 112.11 3.05 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.262 0.553 . . . . 45.409999999999997 112.373 -172.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -148.14 162.9 38.5 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.713 -0.676 . . . . 70.140000000000001 110.487 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 tt -150.55 141.81 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 112.047 0.388 . . . . 64.310000000000002 112.047 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -80.45 103.24 10.18 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.102 0.477 . . . . 73.420000000000002 110.035 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.41 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 61.3 t -90.81 125.22 43.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.506 . . . . 70.230000000000004 111.847 -175.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.38 119.86 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.066 -0.515 . . . . 62.140000000000001 110.834 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -77.49 121.45 84.41 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 116.122 -0.49 . . . . 72.319999999999993 110.98 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.32 -17.56 8.94 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.579 2.186 . . . . 71.109999999999999 112.951 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -85.21 -43.68 13.58 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.911 0.386 . . . . 54.43 111.476 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.509 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 37.2 p -114.32 -10.83 12.64 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.154 0.798 . . . . 74.140000000000001 113.154 -176.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.84 22.87 78.78 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 120.86 -0.686 . . . . 54.399999999999999 114.202 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 21.2 pttp -102.82 142.6 33.67 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.27 0.535 . . . . 70.409999999999997 111.49 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.8 t -102.88 119.86 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.824 0.345 . . . . 74.209999999999994 111.081 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -132.38 146.09 51.71 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.983 0.42 . . . . 75.430000000000007 111.579 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 53.4 mt -82.71 125.78 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.844 0.354 . . . . 75.439999999999998 111.589 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.486 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -118.55 162.41 18.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.245 0.545 . . . . 65.200000000000003 112.195 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -102.86 114.36 28.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.966 -0.561 . . . . 74.409999999999997 110.511 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.474 ' HB ' HG22 ' A' ' 23' ' ' THR . 58.7 mt -76.1 113.38 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.738 0.304 . . . . 62.340000000000003 111.372 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -83.1 -53.87 5.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.037 0.446 . . . . 75.239999999999995 111.368 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -121.32 151.47 40.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.109 -0.496 . . . . 70.200000000000003 111.69 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 56' ' ' ASN . 9.1 m -129.8 93.59 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 121.141 0.496 . . . . 74.040000000000006 112.05 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 p -178.87 139.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 116.03 -0.532 . . . . 74.329999999999998 110.636 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.07 -178.56 6.0 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.22 0.533 . . . . 75.319999999999993 112.053 -176.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -55.97 110.5 0.75 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.22 0.533 . . . . 74.030000000000001 111.461 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.612 HG22 HG11 ' A' ' 53' ' ' VAL . 50.4 p -127.93 134.74 49.34 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.126 -0.488 . . . . 72.439999999999998 111.567 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.71 138.44 35.99 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.174 -0.466 . . . . 52.030000000000001 111.04 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 62.74 107.63 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 123.057 0.543 . . . . 52.020000000000003 111.391 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.59 101.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.194 2.596 . . . . 74.310000000000002 114.343 -173.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -123.66 73.59 1.21 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.153 0.502 . . . . 73.329999999999998 111.888 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.1 t80 57.26 18.02 4.01 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 113.093 0.775 . . . . 73.510000000000005 113.093 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.612 HG11 HG22 ' A' ' 47' ' ' THR . 75.8 t -82.24 109.13 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 121.434 -0.791 . . . . 70.019999999999996 112.769 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -137.72 27.45 2.73 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.241 1.02 . . . . 74.219999999999999 109.02 168.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.501 HH21 HG22 ' A' ' 59' ' ' THR . 21.2 ttt180 -80.22 72.23 7.04 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.892 -1.049 . . . . 74.530000000000001 111.325 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.433 ' HB3' HG21 ' A' ' 43' ' ' VAL . 18.6 m120 -89.72 22.72 2.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.188 0.518 . . . . 61.119999999999997 111.161 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.6 mt -86.29 129.73 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.291 -0.413 . . . . 72.530000000000001 111.293 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.449 HG22 HG23 ' A' ' 73' ' ' VAL . 61.5 mt -69.45 98.17 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.143 0.497 . . . . 71.430000000000007 111.095 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.501 HG22 HH21 ' A' ' 55' ' ' ARG . 5.0 t -135.56 160.25 39.07 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.13 -0.486 . . . . 74.409999999999997 111.25 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -58.66 127.08 30.4 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.001 0.429 . . . . 74.140000000000001 111.876 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.37 -22.14 37.15 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.137 -0.483 . . . . 38.960000000000001 112.7 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.27 150.71 35.29 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.924 0.392 . . . . 74.099999999999994 111.529 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -107.19 116.26 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 120.945 0.402 . . . . 75.430000000000007 111.152 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 m -103.46 137.71 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 120.898 0.38 . . . . 70.409999999999997 110.65 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -90.82 110.68 21.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.264 0.554 . . . . 64.230000000000004 111.377 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.437 HG22 HG12 ' A' ' 40' ' ' ILE . 32.5 p -102.6 170.32 8.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.622 -0.717 . . . . 74.219999999999999 110.862 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -56.22 -33.56 65.48 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.986 0.422 . . . . 71.430000000000007 111.465 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.486 HD13 ' HB2' ' A' ' 38' ' ' ALA . 65.4 mt -79.91 -15.31 57.59 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.411 -0.359 . . . . 73.299999999999997 111.806 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.14 -161.08 23.83 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.321 -0.466 . . . . 74.450000000000003 113.235 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -70.0 134.35 48.21 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.563 -0.375 . . . . 64.349999999999994 111.235 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 96.0 t -130.64 125.7 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.778 0.323 . . . . 73.310000000000002 111.328 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.589 ' HB2' HD12 ' A' ' 88' ' ' ILE . 43.0 ttm180 -89.81 117.41 28.63 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.712 -0.222 . . . . 74.140000000000001 110.597 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.449 HG23 HG22 ' A' ' 58' ' ' ILE . 42.5 t -66.78 133.53 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.815 0.341 . . . . 63.43 111.767 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.4 p -109.9 -50.05 3.02 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.171 0.51 . . . . 72.409999999999997 111.908 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.439 ' HG ' ' HG3' ' A' ' 79' ' ' GLN . 38.4 t -103.28 -176.53 3.11 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.078 0.466 . . . . 74.040000000000006 111.757 -178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -79.69 142.53 57.27 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.43 -0.35 . . . . 73.420000000000002 111.191 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.536 ' HA ' HG12 ' A' ' 83' ' ' ILE . 59.6 Cg_endo -71.57 -4.35 14.85 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.549 2.166 . . . . 64.420000000000002 112.979 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -116.82 27.79 7.7 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.402 -0.428 . . . . 54.539999999999999 113.387 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.507 ' O ' HG13 ' A' ' 82' ' ' VAL . 15.7 mm100 -72.62 86.41 1.2 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 122.36 -0.494 . . . . 72.310000000000002 110.233 175.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t70 63.74 -69.81 0.08 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.269 0.628 . . . . 74.340000000000003 110.998 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.09 25.54 0.21 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.276 -0.488 . . . . 38.960000000000001 112.713 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 79' ' ' GLN . 7.4 p -130.76 149.36 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 112.407 0.521 . . . . 74.420000000000002 112.407 -174.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.536 HG12 ' HA ' ' A' ' 77' ' ' PRO . 36.0 mt -122.38 140.07 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 122.879 0.472 . . . . 74.049999999999997 110.224 176.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -124.29 141.35 52.14 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.202 0.445 . . . . 75.239999999999995 112.202 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.1 176.36 37.68 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.113 -0.565 . . . . 41.240000000000002 113.377 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 18.0 t -118.63 135.81 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 122.64 -0.33 . . . . 73.430000000000007 111.57 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.41 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 38.7 tp -72.87 106.05 4.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.795 0.331 . . . . 74.310000000000002 111.077 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.589 HD12 ' HB2' ' A' ' 72' ' ' ARG . 30.5 pt -118.65 -175.92 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.169 0.509 . . . . 72.140000000000001 111.785 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.495 ' NH2' ' HA ' ' A' ' 92' ' ' GLU . 24.7 mmm180 -137.86 89.65 2.42 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.175 -0.466 . . . . 73.010000000000005 111.09 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -87.63 -39.78 14.75 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.295 0.569 . . . . 73.219999999999999 110.436 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.6 pp -137.27 148.48 46.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.347 -0.842 . . . . 71.5 110.182 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.495 ' HA ' ' NH2' ' A' ' 89' ' ' ARG . 34.5 tt0 -77.63 -44.58 27.77 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 111.962 0.356 . . . . 75.409999999999997 111.962 -177.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -141.87 127.0 18.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.856 0.36 . . . . 70.129999999999995 111.253 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -70.77 91.02 0.81 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.213 0.53 . . . . 75.430000000000007 112.235 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -138.93 -178.22 5.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.211 -0.45 . . . . 72.549999999999997 110.801 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -95.12 98.31 10.56 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.119 0.485 . . . . 74.219999999999999 111.432 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -114.9 115.74 27.42 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.425 -0.352 . . . . 64.310000000000002 110.932 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.4 t60 . . . . . 0 C--O 1.255 1.362 0 CA-C-O 118.82 -0.61 . . . . 70.209999999999994 111.536 -178.301 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 113.306 0.082 . . . . 53.420000000000002 113.306 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -108.63 128.86 55.21 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 122.217 -0.578 . . . . 75.409999999999997 111.239 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.46 108.48 15.9 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.954 -0.566 . . . . 71.200000000000003 111.759 -172.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -137.43 98.12 3.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.737 -0.665 . . . . 74.109999999999999 110.418 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -102.11 163.77 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 121.237 0.541 . . . . 74.530000000000001 112.362 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -86.08 88.54 7.61 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.209 -0.451 . . . . 72.519999999999996 110.972 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -63.22 -22.19 66.71 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.123 0.416 . . . . 75.030000000000001 112.123 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.5 tp -95.36 108.39 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.411 0.624 . . . . 62.240000000000002 111.392 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 78.84 3.22 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.55 0.69 . . . . 74.25 112.304 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.4 p -69.84 84.42 0.48 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.801 -0.562 . . . . 74.010000000000005 111.327 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -135.12 128.02 31.35 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.335 -0.393 . . . . 70.400000000000006 110.857 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.58 -96.67 2.28 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.163 -0.541 . . . . 55.210000000000001 113.021 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.64 75.61 0.05 OUTLIER Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.157 -0.544 . . . . 61.100000000000001 113.185 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -113.23 119.21 36.94 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.426 -0.456 . . . . 72.239999999999995 111.302 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.5 m -106.47 125.99 51.7 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.825 0.345 . . . . 62.43 110.314 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -95.3 4.85 53.04 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.092 0.775 . . . . 63.119999999999997 113.092 -171.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.649 HG22 ' H ' ' A' ' 19' ' ' LEU . 13.2 p -149.52 145.44 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.098 0.475 . . . . 74.25 112.264 -176.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.657 ' HB3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -64.61 -21.32 66.68 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.972 0.731 . . . . 72.230000000000004 112.972 177.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.649 ' H ' HG22 ' A' ' 17' ' ' VAL . 6.4 tt -177.55 129.02 0.15 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.477 0.311 . . . . 73.209999999999994 110.261 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.432 ' N ' HD22 ' A' ' 19' ' ' LEU . . . -167.19 111.99 0.73 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.838 0.31 . . . . 44.329999999999998 111.838 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 p 72.12 -44.37 0.59 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.648 1.179 . . . . 40.450000000000003 113.231 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -102.96 123.37 46.45 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.839 0.352 . . . . 65.010000000000005 110.727 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.519 HG22 ' HB ' ' A' ' 40' ' ' ILE . 75.0 m -104.23 113.0 26.25 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.817 0.341 . . . . 71.019999999999996 111.822 -175.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.485 ' O ' HD13 ' A' ' 83' ' ' ILE . 59.1 mtt180 -142.58 168.94 18.54 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.734 0.302 . . . . 63.399999999999999 111.288 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.05 145.71 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.947 0.403 . . . . 64.299999999999997 111.758 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.484 ' N ' HD21 ' A' ' 26' ' ' ASN . 0.8 OUTLIER -79.35 104.28 9.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.077 0.465 . . . . 65.239999999999995 110.298 174.055 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.3 t -90.1 123.4 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.986 -0.552 . . . . 70.120000000000005 111.841 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.6 t -107.72 116.82 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.299 -0.409 . . . . 63.299999999999997 111.353 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.518 ' HB2' ' HG2' ' A' ' 34' ' ' LYS . 9.8 t70 -71.56 122.53 87.43 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 110.276 -0.268 . . . . 74.019999999999996 110.276 176.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.96 -30.86 32.03 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.075 1.85 . . . . 74.310000000000002 113.19 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -89.62 -43.87 10.46 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.814 0.672 . . . . 74.049999999999997 112.814 -175.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.0 p -96.61 -26.55 15.18 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.147 0.425 . . . . 61.240000000000002 112.147 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.71 22.0 58.83 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.915 -0.659 . . . . 64.239999999999995 113.901 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.518 ' HG2' ' HB2' ' A' ' 29' ' ' ASP . 10.7 ptpp? -78.06 135.3 37.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.359 0.579 . . . . 71.329999999999998 110.596 177.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -115.66 101.34 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.906 0.384 . . . . 72.040000000000006 110.943 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -125.15 144.41 50.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.902 0.382 . . . . 70.129999999999995 111.417 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.0 mt -84.92 111.34 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.897 0.379 . . . . 74.510000000000005 111.191 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.48 148.38 32.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.976 0.417 . . . . 65.409999999999997 112.015 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -80.27 130.97 35.57 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.336 -0.393 . . . . 63.539999999999999 110.668 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.577 ' HA ' HG23 ' A' ' 66' ' ' THR . 69.4 mt -80.99 113.65 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.049 0.452 . . . . 64.129999999999995 111.053 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -82.56 -48.66 10.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.201 0.524 . . . . 64.400000000000006 111.192 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.401 ' OD1' HG12 ' A' ' 44' ' ' VAL . 38.7 t-20 -125.21 145.22 50.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.988 -0.551 . . . . 72.420000000000002 110.526 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.496 HG23 ' HA ' ' A' ' 56' ' ' ASN . 32.6 m -116.48 2.13 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 113.37 0.878 . . . . 73.239999999999995 113.37 -173.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.401 HG12 ' OD1' ' A' ' 42' ' ' ASN . 9.6 p -76.1 122.26 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 121.786 -0.572 . . . . 72.200000000000003 111.452 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.537 ' HG3' HG22 ' A' ' 47' ' ' THR . 8.7 pt-20 -96.04 -175.58 3.43 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.096 0.474 . . . . 74.019999999999996 111.344 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -67.54 90.62 0.26 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.08 0.467 . . . . 74.409999999999997 110.828 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.537 HG22 ' HG3' ' A' ' 45' ' ' GLU . 52.2 p -130.05 167.85 17.65 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.385 -0.371 . . . . 74.340000000000003 111.148 178.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.36 -30.97 19.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.077 0.465 . . . . 75.409999999999997 110.58 173.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -119.33 95.4 49.26 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.031 -0.531 . . . . 71.140000000000001 111.823 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.18 93.54 0.56 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.659 2.239 . . . . 74.310000000000002 111.713 172.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -132.39 140.64 48.56 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.247 -0.433 . . . . 72.209999999999994 111.832 -174.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.64 ' HD2' HD11 ' A' ' 57' ' ' ILE . 21.0 t80 67.44 12.97 9.18 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.113 0.482 . . . . 74.439999999999998 111.374 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.3 -19.82 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 116.164 -0.471 . . . . 73.120000000000005 112.034 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.608 ' HE ' ' HA ' ' A' ' 54' ' ' ARG . 1.7 tpm_? -61.36 -17.93 56.32 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.175 0.512 . . . . 74.420000000000002 111.224 176.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -112.4 118.56 35.53 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.016 -0.735 . . . . 73.439999999999998 109.016 175.509 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.496 ' HA ' HG23 ' A' ' 43' ' ' VAL . 79.5 m-20 -60.13 101.11 0.11 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.152 0.797 . . . . 75.129999999999995 113.152 -170.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.64 HD11 ' HD2' ' A' ' 52' ' ' PHE . 65.8 mt -99.85 100.69 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.958 -0.564 . . . . 74.030000000000001 110.737 174.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.544 ' HB ' ' HG3' ' A' ' 77' ' ' PRO . 48.5 mm -104.59 122.79 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.61 0.243 . . . . 62.299999999999997 110.968 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.1 t -147.39 169.71 18.89 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.981 0.42 . . . . 73.530000000000001 111.896 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -63.16 125.05 22.79 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.131 -0.486 . . . . 75.030000000000001 111.132 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.55 -14.88 57.71 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.193 -0.527 . . . . 61.439999999999998 113.139 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.43 137.88 41.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.878 0.371 . . . . 40.329999999999998 111.569 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.97 112.11 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.909 0.385 . . . . 74.219999999999999 110.987 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.504 ' HB ' HG21 ' A' ' 40' ' ' ILE . 32.5 m -105.65 139.58 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.548 0.573 . . . . 74.120000000000005 112.548 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -82.54 116.43 21.96 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.511 -0.313 . . . . 75.510000000000005 110.674 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.577 HG23 ' HA ' ' A' ' 40' ' ' ILE . 32.1 p -121.16 179.42 4.4 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 120.905 0.383 . . . . 75.200000000000003 111.741 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -65.58 -19.43 65.92 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.91 0.337 . . . . 71.030000000000001 111.91 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.6 mt -93.27 -23.69 18.42 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.946 0.403 . . . . 72.200000000000003 111.045 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.438 ' HA2' ' NH1' ' A' ' 89' ' ' ARG . . . 135.87 -162.03 24.91 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.134 -0.555 . . . . 65.140000000000001 113.381 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -71.29 117.39 12.76 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.805 0.336 . . . . 61.399999999999999 110.596 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 40.6 t -110.96 120.75 62.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.854 0.359 . . . . 73.420000000000002 111.118 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -84.87 109.67 18.28 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.876 0.37 . . . . 74.409999999999997 110.421 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -65.2 120.15 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.456 0.539 . . . . 74.010000000000005 112.456 -173.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.3 p -89.86 -40.43 12.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.129 -0.487 . . . . 63.119999999999997 111.633 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.8 t -123.44 140.45 53.0 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.936 0.398 . . . . 64.030000000000001 111.659 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.439 ' HB2' HE21 ' A' ' 79' ' ' GLN . 96.8 mtt180 -65.75 154.1 89.54 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 116.171 -0.468 . . . . 73.409999999999997 112.224 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.544 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 86.7 Cg_endo -75.34 40.14 0.66 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.391 2.728 . . . . 62.439999999999998 114.646 -172.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.46 27.15 0.09 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.496 -0.859 . . . . 53.210000000000001 113.664 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.439 HE21 ' HB2' ' A' ' 76' ' ' ARG . 78.2 mm-40 -93.81 -63.95 1.14 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 117.073 0.436 . . . . 73.409999999999997 111.155 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -102.58 17.14 24.44 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.313 0.578 . . . . 70.450000000000003 111.207 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.657 ' HA2' ' HB3' ' A' ' 18' ' ' ARG . . . 80.25 17.84 73.11 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.193 -0.527 . . . . 74.099999999999994 113.339 -178.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.2 p -157.43 148.77 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.991 0.424 . . . . 71.120000000000005 111.856 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.534 HG12 ' HA ' ' A' ' 77' ' ' PRO . 20.6 mt -92.75 135.1 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.3 -0.409 . . . . 74.219999999999999 110.739 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -128.36 145.15 51.16 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 122.212 -0.305 . . . . 72.530000000000001 111.514 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.55 172.46 39.48 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.022 -0.608 . . . . 53.439999999999998 113.515 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.6 t -109.15 147.41 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 122.545 -0.386 . . . . 73.140000000000001 111.754 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 tp -84.65 119.27 25.04 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.129 0.49 . . . . 73.409999999999997 112.089 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.489 ' O ' ' HD2' ' A' ' 89' ' ' ARG . 17.3 pt -144.64 -173.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 122.996 0.518 . . . . 73.409999999999997 110.595 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 88' ' ' ILE . 18.2 mmm180 -142.65 89.44 2.14 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.789 0.328 . . . . 74.200000000000003 110.739 171.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.41 -27.06 63.99 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.266 0.555 . . . . 72.349999999999994 110.61 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.403 HD21 ' N ' ' A' ' 91' ' ' LEU . 2.3 pt? -141.72 161.42 37.99 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.583 -0.735 . . . . 62.32 109.839 172.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -106.06 -64.16 1.19 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.297 0.57 . . . . 75.109999999999999 111.273 177.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -74.18 81.49 1.8 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.771 -0.65 . . . . 54.450000000000003 111.871 -174.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -75.5 70.71 2.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.561 0.696 . . . . 75.230000000000004 110.812 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -177.38 -46.7 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.041 -0.982 . . . . 74.25 109.522 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -69.23 109.34 4.04 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.574 -0.739 . . . . 73.25 111.099 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -80.02 159.42 26.22 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.112 0.482 . . . . 75.239999999999995 111.928 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 . . . . . 0 C--O 1.252 1.208 0 CA-C-N 115.96 -0.564 . . . . 71.150000000000006 111.045 -179.844 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 CA-C-O 120.637 0.021 . . . . 70.329999999999998 113.124 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -84.69 177.01 8.2 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.124 0.488 . . . . 72.219999999999999 111.559 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -116.88 92.75 3.95 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.875 0.369 . . . . 73.150000000000006 111.202 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -86.25 125.35 33.51 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.96 0.41 . . . . 63.32 111.43 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.67 132.45 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.229 0.538 . . . . 72.340000000000003 111.579 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -79.11 110.28 14.22 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.321 0.581 . . . . 72.340000000000003 110.996 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.5 tp -83.63 -23.57 31.79 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.18 -0.464 . . . . 75.319999999999993 111.149 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.0 tt -49.76 121.59 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.169 0.509 . . . . 65.310000000000002 112.059 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -164.43 144.51 7.75 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.25 -0.432 . . . . 72.209999999999994 110.994 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.7 p -134.43 163.56 29.4 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.923 0.392 . . . . 72.430000000000007 111.423 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -76.14 -58.72 3.12 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.979 0.419 . . . . 73.430000000000007 111.486 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.76 49.62 75.84 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 116.198 -0.456 . . . . 37.020000000000003 113.586 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.65 166.47 32.34 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.686 -0.769 . . . . 73.340000000000003 113.596 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -152.58 119.35 5.72 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.632 0.253 . . . . 72.140000000000001 110.665 -178.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.1 t -77.32 157.37 30.74 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.184 0.438 . . . . 72.049999999999997 112.184 -175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.517 ' HB2' ' HZ1' ' A' ' 16' ' ' LYS . 10.1 mtmp? -104.21 -178.3 3.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.924 0.392 . . . . 74.299999999999997 111.879 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.99 83.63 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 114.026 1.121 . . . . 63.039999999999999 114.026 -171.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.663 ' HG2' ' HA2' ' A' ' 81' ' ' GLY . 96.4 mtt180 55.5 -172.7 0.06 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.519 1.304 . . . . 75.140000000000001 114.519 170.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.3 tt -78.24 128.14 33.29 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.447 -1.252 . . . . 72.239999999999995 110.726 174.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.59 -76.79 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.149 -0.478 . . . . 61.43 110.476 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.6 m -83.9 -30.6 26.25 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.342 0.592 . . . . 70.310000000000002 110.397 172.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -91.61 92.15 8.34 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.762 -0.653 . . . . 75.040000000000006 109.654 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 94.1 m -97.31 113.69 25.36 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.016 0.436 . . . . 73.340000000000003 111.68 -175.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HG2' HG23 ' A' ' 37' ' ' ILE . 2.3 ttm105 -166.85 155.64 10.38 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.282 -0.417 . . . . 75.549999999999997 110.943 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.519 ' HB ' HD11 ' A' ' 40' ' ' ILE . 9.8 tt -133.71 142.85 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.101 0.408 . . . . 73.219999999999999 112.101 -175.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.425 ' N ' HD21 ' A' ' 26' ' ' ASN . 0.9 OUTLIER -76.61 103.61 6.68 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.076 0.465 . . . . 74.319999999999993 110.634 174.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.458 HG23 HG12 ' A' ' 71' ' ' VAL . 45.3 t -104.75 125.35 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.177 0.513 . . . . 71.549999999999997 111.576 -176.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.48 118.53 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.19 -0.459 . . . . 75.219999999999999 110.782 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -75.59 112.69 20.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.29 -0.414 . . . . 51.100000000000001 109.897 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.58 -14.6 15.9 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.359 2.039 . . . . 71.349999999999994 112.833 -177.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.97 -42.97 12.1 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.777 0.322 . . . . 74.439999999999998 111.26 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.412 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 25.9 p -107.19 -15.35 14.68 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.234 0.457 . . . . 73.319999999999993 112.234 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.54 18.38 73.62 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.361 -0.447 . . . . 71.140000000000001 114.099 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 21.7 pttm -92.36 159.56 15.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.494 0.647 . . . . 74.310000000000002 111.946 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.6 t -107.24 109.26 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.402 -0.363 . . . . 72.439999999999998 110.722 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -117.01 141.6 48.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.543 -0.298 . . . . 74.120000000000005 111.021 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.506 HG23 ' HG2' ' A' ' 24' ' ' ARG . 38.1 mt -100.04 105.94 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.921 0.391 . . . . 54.420000000000002 110.852 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.08 151.92 19.28 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.999 0.74 . . . . 62.229999999999997 112.999 -172.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.61 126.35 34.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.243 -0.435 . . . . 54.130000000000003 110.955 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.519 HD11 ' HB ' ' A' ' 25' ' ' ILE . 56.2 mt -83.44 113.35 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.199 0.444 . . . . 63.049999999999997 112.199 -176.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -82.84 -53.62 5.74 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.034 0.445 . . . . 72.239999999999995 110.583 176.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.646 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 40.4 t30 -118.99 147.57 43.93 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.107 -0.497 . . . . 65.439999999999998 110.686 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.29 12.0 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 113.024 0.75 . . . . 73.510000000000005 113.024 -172.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.06 136.02 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 112.497 0.554 . . . . 62.350000000000001 112.497 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -84.39 176.33 8.76 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.256 0.55 . . . . 71.439999999999998 111.502 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -84.1 39.73 0.72 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.238 0.542 . . . . 72.0 110.902 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.9 t -59.97 -31.85 70.28 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.501 0.926 . . . . 55.420000000000002 113.501 -173.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.86 163.02 40.74 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.6 0.593 . . . . 73.400000000000006 112.6 -174.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -124.21 78.78 60.07 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.712 -0.676 . . . . 72.5 110.248 173.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -90.61 -166.49 0.2 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.916 2.41 . . . . 75.120000000000005 114.103 -173.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -79.87 -159.74 0.23 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.767 -0.651 . . . . 73.420000000000002 110.674 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -69.68 72.07 0.35 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.093 0.473 . . . . 71.329999999999998 111.059 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -163.31 135.73 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.827 0.346 . . . . 73.109999999999999 111.385 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.92 173.22 3.28 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.306 -0.406 . . . . 64.340000000000003 110.276 177.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.1 157.55 43.64 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.848 -0.532 . . . . 74.340000000000003 112.095 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -98.76 21.1 11.9 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.827 -0.624 . . . . 53.32 112.019 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.2 mt -88.04 118.53 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 120.924 0.392 . . . . 73.519999999999996 111.459 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.5 mt -73.41 123.23 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 116.402 -0.363 . . . . 73.430000000000007 110.522 177.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.0 p -118.26 159.68 22.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.245 0.545 . . . . 73.319999999999993 112.184 -174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.81 136.47 56.92 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.317 -0.401 . . . . 73.219999999999999 111.23 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 -14.51 45.67 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.071 -0.585 . . . . 60.109999999999999 113.183 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.47 147.95 33.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.026 0.441 . . . . 75.420000000000002 111.386 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.484 HG23 ' HG3' ' A' ' 90' ' ' GLU . 61.9 t -101.11 119.5 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.94 0.4 . . . . 61.32 111.319 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.96 156.63 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.108 0.48 . . . . 72.340000000000003 111.317 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 36.1 tt0 -97.88 105.92 18.14 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.863 0.363 . . . . 72.109999999999999 110.964 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.0 p -103.38 170.72 7.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.856 0.36 . . . . 72.420000000000002 111.576 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -57.52 -30.85 65.49 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.33 -0.395 . . . . 73.349999999999994 111.473 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.4 mt -77.91 -36.82 49.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.035 0.445 . . . . 73.329999999999998 111.014 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.99 -150.87 23.08 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.265 -0.493 . . . . 37.020000000000003 112.7 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -75.88 128.77 35.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.932 0.396 . . . . 61.130000000000003 111.314 -178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.458 HG12 HG23 ' A' ' 27' ' ' VAL . 90.1 t -129.01 126.93 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.535 -0.302 . . . . 74.109999999999999 111.297 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -95.98 120.6 36.55 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.626 0.251 . . . . 72.540000000000006 111.508 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.487 HG13 ' HG3' ' A' ' 77' ' ' PRO . 23.5 t -65.12 133.85 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 112.051 0.389 . . . . 73.409999999999997 112.051 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.4 p -96.9 -50.12 4.77 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.259 0.466 . . . . 73.010000000000005 112.259 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.5 m -104.56 -169.63 1.65 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.096 0.406 . . . . 72.310000000000002 112.096 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.63 110.42 22.13 Favored Pre-proline 0 N--CA 1.472 0.66 0 O-C-N 122.253 -0.279 . . . . 73.340000000000003 111.125 176.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.487 ' HG3' HG13 ' A' ' 73' ' ' VAL . 33.0 Cg_exo -60.08 105.59 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.79 2.327 . . . . 53.409999999999997 113.307 -176.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.91 -33.38 1.63 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.939 -0.648 . . . . 73.219999999999999 112.694 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -60.45 132.77 54.94 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 120.825 0.345 . . . . 61.520000000000003 111.342 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 60.71 9.26 2.09 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.006 -0.543 . . . . 72.450000000000003 111.907 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.663 ' HA2' ' HG2' ' A' ' 18' ' ' ARG . . . 81.24 -0.9 86.89 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.266 -0.492 . . . . 63.329999999999998 113.59 -178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p -115.09 144.7 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.298 0.57 . . . . 73.329999999999998 112.509 -174.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.454 HD12 ' N ' ' A' ' 83' ' ' ILE . 3.9 mp -113.11 125.34 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.096 -0.502 . . . . 74.140000000000001 110.266 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -102.22 143.07 32.48 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.836 0.351 . . . . 74.25 111.825 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.86 173.96 36.62 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 121.282 -0.485 . . . . 63.119999999999997 113.446 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 12.6 t -115.8 139.09 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 117.001 0.4 . . . . 65.349999999999994 111.548 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HB2' HG13 ' A' ' 27' ' ' VAL . 50.6 tp -79.16 106.95 11.56 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.737 0.303 . . . . 75.329999999999998 111.4 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 pt -133.67 -171.24 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.252 0.548 . . . . 64.530000000000001 111.789 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 76.7 mmt-85 -137.78 107.27 6.16 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.039 -0.528 . . . . 61.350000000000001 110.983 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.484 ' HG3' HG23 ' A' ' 63' ' ' VAL . 17.8 mm-40 -103.19 -19.7 14.41 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.151 -0.477 . . . . 73.530000000000001 111.081 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 93.9 mt -96.8 -176.01 3.45 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.123 0.487 . . . . 74.409999999999997 111.831 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -61.9 142.82 57.17 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.668 0.618 . . . . 70.150000000000006 112.668 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -90.14 99.16 12.23 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.7 -0.682 . . . . 71.310000000000002 109.407 169.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -62.73 122.25 15.43 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.031 0.382 . . . . 74.099999999999994 112.031 -172.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -149.93 86.69 1.45 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.435 0.636 . . . . 72.219999999999999 111.63 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -101.51 106.97 18.13 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.368 -0.378 . . . . 71.120000000000005 110.403 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -59.79 126.75 28.81 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.082 0.468 . . . . 63.350000000000001 112.19 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.767 -0.635 . . . . 74.239999999999995 111.024 174.64 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.869 -0.092 . . . . 72.5 112.869 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -96.42 123.36 40.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.996 0.398 . . . . 71.420000000000002 110.87 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -109.85 8.54 24.48 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.182 0.438 . . . . 61.049999999999997 112.182 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -70.9 155.34 40.92 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.657 0.614 . . . . 71.430000000000007 112.657 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -82.09 154.38 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 115.701 -0.681 . . . . 72.120000000000005 112.227 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -65.28 144.51 57.1 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.122 0.486 . . . . 64.120000000000005 112.034 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.4 mt -112.86 1.04 15.37 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.427 -0.351 . . . . 75.129999999999995 111.824 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.4 tp -83.78 124.92 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.27 0.557 . . . . 75.430000000000007 112.403 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.451 ' HD3' ' N ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -112.41 171.21 7.65 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.931 0.396 . . . . 74.5 111.321 175.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.3 p -87.99 -76.38 0.39 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.695 0.628 . . . . 53.140000000000001 112.695 -173.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? 68.98 124.9 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.265 0.555 . . . . 71.129999999999995 111.972 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.76 172.16 36.05 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.24 -0.505 . . . . 52.509999999999998 112.798 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.11 140.31 2.85 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.762 -0.732 . . . . 44.340000000000003 113.415 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -106.94 164.89 11.75 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.229 0.538 . . . . 72.329999999999998 111.866 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.1 m -117.37 132.18 56.64 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.183 -0.462 . . . . 73.430000000000007 112.103 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -88.8 145.59 25.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.009 0.433 . . . . 64.310000000000002 111.27 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.497 HG22 ' H ' ' A' ' 19' ' ' LEU . 8.5 p -72.98 138.36 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.477 0.655 . . . . 75.430000000000007 112.383 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -61.01 -7.75 2.73 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.039 1.125 . . . . 72.450000000000003 114.039 -178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.497 ' H ' HG22 ' A' ' 17' ' ' VAL . 6.2 tt -156.99 114.36 3.12 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 122.022 -0.424 . . . . 72.239999999999995 111.162 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.52 102.79 3.21 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.962 -0.563 . . . . 75.129999999999995 111.115 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.9 m 74.43 -45.9 0.6 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.657 0.783 . . . . 72.129999999999995 112.489 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -110.31 149.31 30.37 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.405 0.282 . . . . 65.439999999999998 111.003 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.8 m -124.42 114.68 19.81 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.853 0.358 . . . . 75.109999999999999 111.463 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.42 151.14 48.1 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.85 0.357 . . . . 75.439999999999998 111.586 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.9 tt -146.26 139.08 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.028 0.442 . . . . 51.210000000000001 111.374 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.57 103.69 9.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.438 -0.346 . . . . 71.010000000000005 110.429 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.82 113.91 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.898 0.38 . . . . 72.420000000000002 111.549 -177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.7 t -95.16 118.09 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.396 -0.365 . . . . 74.400000000000006 110.688 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.23 128.93 81.65 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 120.536 0.208 . . . . 71.5 110.982 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.79 -22.79 11.51 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.426 2.084 . . . . 73.519999999999996 113.592 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -88.27 -35.32 17.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.969 0.414 . . . . 37.140000000000001 111.859 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.7 p -107.91 -31.72 7.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.373 -0.376 . . . . 74.400000000000006 111.803 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.91 10.19 65.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.208 -0.52 . . . . 61.340000000000003 113.603 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -79.63 138.12 37.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.192 0.496 . . . . 71.540000000000006 111.919 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.9 t -97.66 106.42 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 116.27 -0.423 . . . . 74.430000000000007 110.319 176.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -128.65 132.87 48.12 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.952 0.406 . . . . 62.439999999999998 111.583 -173.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 57.0 mt -81.06 140.43 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 112.427 0.528 . . . . 74.219999999999999 112.427 -175.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.47 167.14 22.91 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.239 -0.437 . . . . 43.539999999999999 111.124 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.472 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 3.3 mp0 -98.24 140.56 32.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.819 0.343 . . . . 73.099999999999994 111.081 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.16 115.1 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.969 0.414 . . . . 71.129999999999995 111.687 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.528 HH21 ' HB3' ' A' ' 67' ' ' ASN . 21.4 mmt180 -81.21 -53.83 6.03 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.222 0.534 . . . . 72.5 110.802 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 15.7 m120 -119.5 131.17 55.52 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 111.657 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.434 HG21 HG12 ' A' ' 58' ' ' ILE . 10.5 p -83.32 -23.35 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 113.046 0.758 . . . . 74.5 113.046 -178.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -96.43 147.08 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.14 0.422 . . . . 74.340000000000003 112.14 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.42 -165.21 1.19 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.377 0.608 . . . . 72.219999999999999 111.902 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.518 ' HB3' HD21 ' A' ' 91' ' ' LEU . 11.8 p-10 -68.06 108.29 3.04 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.428 0.632 . . . . 55.32 111.531 178.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.5 p -84.54 142.69 29.83 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.106 -0.497 . . . . 71.319999999999993 111.981 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.58 -11.74 44.69 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.014 0.376 . . . . 50.140000000000001 112.014 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -147.37 97.93 4.02 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.514 -0.312 . . . . 75.230000000000004 111.003 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.488 ' HB2' ' HD2' ' A' ' 51' ' ' HIS . 9.9 Cg_exo -72.75 166.06 30.99 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.838 2.359 . . . . 62.140000000000001 112.833 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.488 ' HD2' ' HB2' ' A' ' 50' ' ' PRO . 59.3 m-70 72.02 -13.89 0.57 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.992 0.738 . . . . 75.140000000000001 112.992 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -130.41 107.36 9.18 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 122.162 -0.336 . . . . 74.510000000000005 111.716 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.0 t 68.99 136.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.597 0.713 . . . . 62.450000000000003 112.765 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -151.38 150.25 30.25 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.132 -0.485 . . . . 74.200000000000003 110.651 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -114.22 137.94 51.12 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.758 0.313 . . . . 64.439999999999998 111.227 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -117.13 5.68 12.77 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.835 0.68 . . . . 72.129999999999995 112.835 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.8 tt -112.96 142.62 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.131 0.491 . . . . 65.519999999999996 111.964 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.434 HG12 HG21 ' A' ' 43' ' ' VAL . 64.2 mt -80.79 130.2 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.122 -0.49 . . . . 72.129999999999995 111.132 177.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -147.53 166.31 27.7 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.833 0.349 . . . . 71.409999999999997 111.584 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -65.01 134.38 53.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.973 0.416 . . . . 72.329999999999998 111.37 -178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.87 -26.4 24.6 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.271 -0.422 . . . . 73.430000000000007 112.462 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.77 156.93 38.77 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.936 0.398 . . . . 75.409999999999997 111.804 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.509 HG12 ' HG3' ' A' ' 90' ' ' GLU . 48.1 t -119.1 114.1 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.907 0.385 . . . . 73.510000000000005 111.361 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.56 154.47 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.973 0.416 . . . . 74.430000000000007 112.012 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 34.0 tt0 -92.96 127.31 38.42 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.224 -0.298 . . . . 73.319999999999993 110.771 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.6 p -129.63 176.35 8.07 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.609 0.364 . . . . 74.400000000000006 110.717 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.528 ' HB3' HH21 ' A' ' 41' ' ' ARG . 3.8 p-10 -65.09 -27.47 68.78 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.782 0.325 . . . . 75.450000000000003 111.863 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.74 -22.75 37.12 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.081 0.467 . . . . 73.400000000000006 111.103 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.63 -152.16 21.52 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 116.241 -0.436 . . . . 44.140000000000001 112.504 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -85.91 131.21 34.34 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 122.241 -0.564 . . . . 63.219999999999999 110.994 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.27 122.34 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 111.851 0.315 . . . . 73.420000000000002 111.851 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.423 ' HB2' HD12 ' A' ' 88' ' ' ILE . 40.7 ttm180 -86.36 112.16 21.18 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.655 0.264 . . . . 72.439999999999998 110.402 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -63.98 127.14 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.568 0.581 . . . . 61.520000000000003 112.568 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 73.8 p -103.04 -33.09 9.39 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.056 0.455 . . . . 65.519999999999996 111.656 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.6 ' HB3' ' H ' ' A' ' 84' ' ' ASN . 35.8 t -94.76 -177.07 4.07 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.36 0.6 . . . . 63.439999999999998 111.831 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.422 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 7.7 tpt180 -122.03 126.12 26.42 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.956 -0.565 . . . . 73.099999999999994 109.781 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -47.56 99.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.512 2.141 . . . . 50.210000000000001 113.435 -177.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.53 -29.06 1.19 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.858 -0.61 . . . . 64.109999999999999 112.642 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 76.0 mm-40 -58.16 105.32 0.27 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.765 0.317 . . . . 74.510000000000005 111.263 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 56.97 21.48 6.28 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.16 0.429 . . . . 64.109999999999999 112.16 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.28 19.4 79.83 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.238 -0.506 . . . . 70.310000000000002 113.988 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.95 163.22 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 117.536 0.668 . . . . 73.219999999999999 111.628 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.7 mt -121.53 143.06 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 122.526 0.33 . . . . 75.209999999999994 110.835 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.6 ' H ' ' HB3' ' A' ' 75' ' ' SER . 2.4 m-20 -119.72 153.08 36.16 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.731 0.301 . . . . 73.109999999999999 111.257 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.9 177.83 37.98 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.453 -0.34 . . . . 44.009999999999998 112.887 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 t -116.39 138.86 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 117.218 0.509 . . . . 74.409999999999997 111.279 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.0 tp -78.93 106.54 11.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.036 0.446 . . . . 72.530000000000001 111.807 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' A' ' 72' ' ' ARG . 16.5 pt -121.5 179.91 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.188 0.518 . . . . 53.329999999999998 111.236 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.62 113.42 20.22 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.368 -0.378 . . . . 73.239999999999995 110.983 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.509 ' HG3' HG12 ' A' ' 63' ' ' VAL . 70.9 mm-40 -122.21 -72.35 0.69 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.16 0.43 . . . . 74.329999999999998 112.16 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 46' ' ' ASN . 93.6 mt -100.75 -175.37 2.88 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.202 0.525 . . . . 64.340000000000003 112.212 -176.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -71.64 135.66 47.01 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.948 -0.569 . . . . 62.210000000000001 110.938 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -102.08 -14.4 17.12 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.398 0.518 . . . . 73.150000000000006 112.398 -176.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -62.0 154.34 26.87 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.164 0.507 . . . . 64.319999999999993 112.214 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -61.74 114.05 3.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.264 -0.426 . . . . 74.549999999999997 109.882 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -55.59 -74.7 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.53 0.567 . . . . 75.109999999999999 112.53 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -85.77 104.87 15.87 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.194 0.521 . . . . 73.310000000000002 111.151 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 . . . . . 0 C--O 1.248 0.984 0 CA-C-N 116.379 -0.373 . . . . 70.409999999999997 111.758 -179.563 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.68 -0.168 . . . . 64.409999999999997 112.68 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.24 171.32 15.23 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.192 0.52 . . . . 64.230000000000004 112.287 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.455 ' HD3' ' N ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -115.97 124.3 50.17 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.106 0.479 . . . . 72.109999999999999 111.41 -176.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.92 6.28 45.26 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.044 -0.525 . . . . 73.219999999999999 112.183 -173.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 5' ' ' VAL . 7.2 p -68.39 87.27 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 CA-C-O 121.522 0.677 . . . . 64.299999999999997 111.982 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? 54.55 48.09 21.22 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.958 -0.565 . . . . 61.219999999999999 111.614 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.8 tp -81.45 -47.23 13.46 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.073 -0.512 . . . . 55.530000000000001 112.046 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.7 tp -77.11 133.01 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.153 0.502 . . . . 75.010000000000005 111.504 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -130.04 27.15 5.16 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.094 0.405 . . . . 62.329999999999998 112.094 -174.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.8 m -37.41 105.76 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.257 0.836 . . . . 75.409999999999997 113.257 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -149.9 133.86 17.0 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.243 -0.435 . . . . 74.230000000000004 111.172 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.27 147.1 4.5 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.118 -0.563 . . . . 53.109999999999999 113.194 177.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.5 93.94 2.31 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.26 -0.495 . . . . 72.129999999999995 113.611 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -145.95 113.32 6.26 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.918 0.389 . . . . 53.43 110.867 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -67.95 164.19 20.47 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.174 0.805 . . . . 71.349999999999994 113.174 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -122.64 -8.12 8.51 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.393 -0.822 . . . . 65.540000000000006 110.614 176.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.553 HG22 ' H ' ' A' ' 19' ' ' LEU . 11.5 p -138.12 150.41 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.288 -0.414 . . . . 71.230000000000004 111.722 -174.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -64.99 -33.05 75.12 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.253 -0.431 . . . . 72.019999999999996 112.094 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.553 ' H ' HG22 ' A' ' 17' ' ' VAL . 7.4 tt -174.23 129.17 0.37 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.922 -0.399 . . . . 73.010000000000005 109.922 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.03 126.4 6.68 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.776 0.288 . . . . 61.210000000000001 111.776 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.1 t 74.6 -52.64 0.68 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.649 0.78 . . . . 70.019999999999996 111.841 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -106.1 125.17 50.67 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.82 0.343 . . . . 75.239999999999995 110.312 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.484 HG21 ' HB ' ' A' ' 40' ' ' ILE . 51.6 m -98.07 112.78 24.61 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.893 0.377 . . . . 51.210000000000001 111.385 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -139.49 170.01 16.7 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.12 0.486 . . . . 60.340000000000003 111.881 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.442 ' HB ' HD11 ' A' ' 40' ' ' ILE . 13.2 tt -152.0 142.8 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.97 -0.559 . . . . 65.129999999999995 111.111 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -77.21 103.7 7.29 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.248 0.547 . . . . 73.129999999999995 110.573 174.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.46 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 39.3 t -86.24 136.68 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.718 . . . . 74.430000000000007 111.263 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.496 HG22 HG23 ' A' ' 35' ' ' VAL . 47.2 t -110.85 104.83 17.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.66 0.267 . . . . 63.219999999999999 111.053 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 35.2 t70 -65.09 115.43 21.1 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.48 -0.327 . . . . 72.239999999999995 111.16 176.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.37 -11.71 22.77 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.34 2.027 . . . . 72.340000000000003 113.733 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -80.78 -43.19 20.52 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.1 0.476 . . . . 75.230000000000004 111.4 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.402 ' OG1' ' HE3' ' A' ' 34' ' ' LYS . 59.6 p -101.24 -29.49 12.06 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.132 -0.485 . . . . 71.310000000000002 111.67 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.79 63.13 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 116.248 -0.433 . . . . 44.130000000000003 112.739 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 17.6 ptpt -82.82 163.12 21.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.867 0.365 . . . . 72.109999999999999 111.322 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.496 HG23 HG22 ' A' ' 28' ' ' VAL . 47.9 t -117.63 97.39 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.38 -0.373 . . . . 73.549999999999997 111.164 174.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.46 ' HG2' ' HB ' ' A' ' 27' ' ' VAL . 1.5 pm0 -93.79 170.86 9.25 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.051 0.453 . . . . 64.120000000000005 111.33 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.7 mt -111.78 134.51 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 121.849 -0.532 . . . . 62.450000000000003 111.098 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.49 ' HB1' HD11 ' A' ' 68' ' ' LEU . . . -130.99 153.56 49.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.96 0.41 . . . . 72.099999999999994 111.977 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -91.91 126.11 36.87 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.13 -0.486 . . . . 71.340000000000003 110.485 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.484 ' HB ' HG21 ' A' ' 23' ' ' THR . 61.2 mt -79.13 113.54 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.042 0.448 . . . . 75.129999999999995 111.458 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -83.05 -47.83 11.26 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.063 0.458 . . . . 75.510000000000005 111.383 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.514 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 51.7 m-80 -138.15 163.94 30.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.265 -0.425 . . . . 71.340000000000003 111.443 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -116.32 2.43 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.273 0.558 . . . . 74.030000000000001 111.312 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 96' ' ' HIS . 6.2 p -70.41 102.35 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-O 121.44 0.638 . . . . 71.319999999999993 112.073 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -72.73 -167.1 0.33 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.89 -0.596 . . . . 54.43 111.678 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.61 85.58 0.07 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.266 0.555 . . . . 64.049999999999997 111.114 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.3 t -162.06 -179.95 7.51 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.763 -0.653 . . . . 55.210000000000001 110.775 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.78 175.18 2.52 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.157 0.503 . . . . 74.019999999999996 112.344 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 48.8 m-80 -80.47 128.75 71.5 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.528 -0.306 . . . . 74.109999999999999 111.099 176.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 7.7 Cg_exo -72.89 138.43 28.59 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.813 2.342 . . . . 73.099999999999994 113.542 -177.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -119.86 -45.21 2.49 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.183 0.516 . . . . 65.109999999999999 110.798 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -101.66 94.88 6.08 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.253 -0.431 . . . . 74.530000000000001 111.153 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.1 p -165.34 147.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 116.072 -0.513 . . . . 75.340000000000003 110.489 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 0.4 OUTLIER -100.57 -48.89 4.38 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.438 0.533 . . . . 65.140000000000001 112.438 -178.105 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 55' ' ' ARG . 15.7 ptt180 -138.14 175.76 9.3 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.452 0.644 . . . . 74.409999999999997 112.647 -177.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -92.42 107.54 19.29 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.508 -0.769 . . . . 73.430000000000007 112.187 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 57' ' ' ILE . 2.9 mp -85.16 100.96 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.006 0.431 . . . . 74.329999999999998 111.083 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.8 mt -95.98 115.77 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.011 0.434 . . . . 74.409999999999997 111.281 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -147.83 -179.96 7.28 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.226 -0.443 . . . . 75.349999999999994 111.085 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -64.18 135.99 56.81 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.828 0.347 . . . . 74.209999999999994 111.807 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.06 -20.89 47.07 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.29 -0.481 . . . . 53.350000000000001 113.251 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.82 153.11 29.34 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.028 0.442 . . . . 72.439999999999998 111.676 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.7 t -110.91 119.3 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.354 -0.384 . . . . 75.400000000000006 110.793 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.47 ' HB ' HG21 ' A' ' 40' ' ' ILE . 27.6 m -103.39 131.49 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.42 0.628 . . . . 63.210000000000001 112.17 -177.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.698 ' HG2' ' HB3' ' A' ' 95' ' ' HIS . 9.7 tp10 -79.81 102.32 9.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.931 -0.577 . . . . 63.32 110.894 177.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.6 p -100.74 173.21 6.63 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.774 0.321 . . . . 74.120000000000005 111.045 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -61.12 -29.07 69.54 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.87 0.367 . . . . 63.420000000000002 111.655 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.49 HD11 ' HB1' ' A' ' 38' ' ' ALA . 92.6 mt -80.78 -31.14 35.88 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.926 0.393 . . . . 70.319999999999993 111.088 176.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.18 -162.9 28.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.915 -0.66 . . . . 44.520000000000003 112.889 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -80.93 120.05 24.25 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.216 0.531 . . . . 74.310000000000002 111.713 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.448 HG21 HG22 ' A' ' 27' ' ' VAL . 47.6 t -113.56 120.52 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.208 -0.451 . . . . 73.430000000000007 111.509 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -86.7 116.19 24.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.851 0.358 . . . . 74.239999999999995 111.21 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.36 109.84 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.19 -0.459 . . . . 75.5 112.123 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.7 p -87.75 -59.29 2.28 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.254 0.549 . . . . 74.439999999999998 110.729 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.7 ' HB3' ' HG3' ' A' ' 79' ' ' GLN . 54.8 m -90.35 113.79 25.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.846 -0.616 . . . . 72.409999999999997 111.082 177.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.1 ttt85 -54.28 139.95 55.4 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 112.07 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.516 ' HB3' HG12 ' A' ' 83' ' ' ILE . 4.4 Cg_exo -39.23 107.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 123.697 2.931 . . . . 74.140000000000001 113.64 177.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.65 -34.9 0.63 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.999 -0.619 . . . . 73.319999999999993 112.798 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.7 ' HG3' ' HB3' ' A' ' 75' ' ' SER . 15.8 mm100 -55.04 114.02 1.59 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.312 0.245 . . . . 71.430000000000007 111.22 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.1 t70 62.16 15.56 7.56 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.44 0.638 . . . . 70.25 111.472 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.72 34.12 54.13 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.31 -0.472 . . . . 73.409999999999997 112.785 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.453 HG22 ' N ' ' A' ' 83' ' ' ILE . 12.7 p -154.78 166.88 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 120.906 0.384 . . . . 60.420000000000002 111.307 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.516 HG12 ' HB3' ' A' ' 77' ' ' PRO . 40.1 mt -97.26 144.75 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.579 0.351 . . . . 63.109999999999999 110.438 175.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 75' ' ' SER . 16.2 m-80 -135.19 142.49 46.09 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 122.252 -0.28 . . . . 52.210000000000001 111.329 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.81 175.79 39.16 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.038 -0.601 . . . . 72.140000000000001 113.647 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.0 t -99.27 144.49 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.088 0.403 . . . . 73.150000000000006 112.088 -177.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.41 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 49.5 tp -79.59 106.63 11.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.824 0.345 . . . . 62.520000000000003 110.973 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.0 pt -126.88 -179.65 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.178 0.513 . . . . 65.219999999999999 111.153 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -130.01 85.68 2.32 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.911 0.386 . . . . 73.099999999999994 111.456 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -84.43 -37.1 21.84 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.653 0.739 . . . . 72.140000000000001 110.349 175.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.8 mt -124.9 151.24 45.63 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.977 -1.01 . . . . 61.299999999999997 109.303 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -79.03 58.76 2.51 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.506 0.669 . . . . 64.129999999999995 109.873 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.8 m80 58.48 7.95 0.79 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.528 -0.76 . . . . 74.109999999999999 111.955 -171.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -79.46 68.01 5.37 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.542 0.687 . . . . 73.540000000000006 110.802 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.698 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . 20.6 p-80 -54.98 125.33 19.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.239 -0.891 . . . . 73.430000000000007 111.806 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.417 ' HB2' HG13 ' A' ' 44' ' ' VAL . 53.1 m170 -64.51 139.28 58.75 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.099 0.476 . . . . 73.420000000000002 110.946 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -136.5 133.98 37.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.291 -0.413 . . . . 72.340000000000003 112.038 -173.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.751 -0.643 . . . . 70.430000000000007 111.612 176.134 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.685 -0.166 . . . . 70.030000000000001 112.685 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -151.12 147.41 27.03 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 122.459 -0.436 . . . . 71.219999999999999 111.636 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.459 ' HD2' ' N ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -145.71 81.31 1.61 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.722 0.772 . . . . 73.120000000000005 111.048 177.565 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.6 86.94 7.25 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.532 0.682 . . . . 75.530000000000001 111.36 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 m -76.14 54.96 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 115.57 -0.741 . . . . 63.119999999999997 112.903 -175.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -83.39 68.27 9.64 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.856 -0.528 . . . . 74.430000000000007 110.728 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.8 tt -76.89 -38.65 53.18 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.963 0.411 . . . . 74.319999999999993 110.593 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.4 125.68 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.418 0.628 . . . . 73.040000000000006 112.065 -176.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -122.52 173.78 7.47 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.722 -0.672 . . . . 62.299999999999997 110.574 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -58.72 146.93 34.85 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.001 0.429 . . . . 64.430000000000007 111.937 175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -96.68 -22.59 16.91 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.432 0.634 . . . . 73.439999999999998 110.626 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 144.51 -148.26 19.93 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.542 -0.753 . . . . 38.479999999999997 112.19 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.27 -75.03 0.04 OUTLIER Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.959 -0.638 . . . . 73.409999999999997 112.455 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -86.22 -171.41 3.55 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.52 -0.4 . . . . 42.43 110.636 176.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.7 m -69.74 107.76 3.62 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.862 0.363 . . . . 74.329999999999998 110.892 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.615 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -66.87 169.85 7.5 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.02 -0.536 . . . . 74.120000000000005 111.972 -177.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.01 146.2 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.062 -0.517 . . . . 74.319999999999993 111.918 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.31 168.8 0.98 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.132 0.79 . . . . 75.209999999999994 113.132 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.1 tt -60.42 119.74 8.58 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.887 -0.597 . . . . 75.530000000000001 110.787 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.18 -60.52 0.16 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.2 -0.455 . . . . 75.420000000000002 111.142 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.6 m -80.91 -50.68 9.45 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.451 -0.34 . . . . 71.409999999999997 111.458 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -110.63 138.18 47.35 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.655 0.264 . . . . 72.040000000000006 111.067 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.483 HG21 ' HB ' ' A' ' 40' ' ' ILE . 27.1 m -81.89 112.7 19.25 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 110.213 -0.292 . . . . 71.310000000000002 110.213 175.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -133.83 165.39 25.09 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.23 0.456 . . . . 74.010000000000005 112.23 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.521 ' HB ' HD12 ' A' ' 40' ' ' ILE . 12.7 tt -151.46 131.29 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.127 -0.488 . . . . 71.109999999999999 111.782 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -72.81 103.82 3.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.072 0.463 . . . . 72.239999999999995 110.328 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 71' ' ' VAL . 46.8 t -95.92 126.97 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.029 -0.532 . . . . 75.129999999999995 112.349 -174.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.01 114.17 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.224 -0.444 . . . . 73.0 110.82 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.412 ' HA ' ' HB3' ' A' ' 87' ' ' LEU . 11.3 t70 -76.84 126.12 86.16 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.558 -0.292 . . . . 62.240000000000002 111.624 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.99 -9.89 9.5 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.949 2.433 . . . . 75.400000000000006 113.226 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -75.03 -43.7 52.09 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.929 0.395 . . . . 75.209999999999994 111.685 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.9 p -123.28 -31.5 3.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.463 -0.335 . . . . 70.5 111.686 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.07 3.49 29.73 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.406 -0.426 . . . . 71.239999999999995 113.125 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -71.53 143.63 49.87 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.933 0.397 . . . . 61.32 112.002 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.4 t -114.91 129.28 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.897 0.38 . . . . 72.120000000000005 111.514 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -140.38 145.83 37.6 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.345 -0.389 . . . . 74.409999999999997 110.818 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.4 mt -87.94 101.82 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.263 0.554 . . . . 72.129999999999995 111.515 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.51 165.14 16.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.315 0.578 . . . . 72.040000000000006 112.273 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -103.69 123.79 47.66 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.842 -0.617 . . . . 72.040000000000006 110.651 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.521 HD12 ' HB ' ' A' ' 25' ' ' ILE . 70.0 mt -84.09 115.94 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.609 0.596 . . . . 74.120000000000005 112.609 -174.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 41' ' ' ARG . 56.2 mtt180 -83.64 -54.12 5.16 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.073 0.463 . . . . 55.020000000000003 111.49 172.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -130.78 167.86 18.18 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.284 0.476 . . . . 73.510000000000005 112.284 -173.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.648 HG12 HG11 ' A' ' 64' ' ' VAL . 17.1 m -134.09 96.26 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.534 0.683 . . . . 71.129999999999995 111.027 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 45' ' ' GLU . 7.4 p -141.03 -179.79 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 116.039 -0.528 . . . . 75.209999999999994 111.019 -174.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.411 ' H ' HG22 ' A' ' 44' ' ' VAL . 12.1 pt-20 -140.14 169.42 17.73 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.546 -0.721 . . . . 60.520000000000003 111.193 172.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -62.7 87.17 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.527 0.68 . . . . 71.239999999999995 112.205 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.0 t -135.97 159.53 41.4 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.182 -0.463 . . . . 71.430000000000007 111.58 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.6 123.44 31.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.497 -0.319 . . . . 53.439999999999998 111.006 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 65.31 94.39 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 120.931 0.396 . . . . 73.140000000000001 110.677 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.78 44.53 0.95 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.103 2.535 . . . . 73.120000000000005 114.518 -172.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -91.37 2.43 56.41 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.791 -0.568 . . . . 74.349999999999994 111.384 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -87.46 3.21 48.15 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.461 0.541 . . . . 74.230000000000004 112.461 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.4 t -67.39 94.0 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.388 0.614 . . . . 73.530000000000001 109.98 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -88.55 -63.7 1.26 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.823 0.675 . . . . 74.040000000000006 112.823 -170.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -127.26 10.11 6.78 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.204 0.446 . . . . 72.030000000000001 112.204 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 61.07 17.91 8.47 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.583 0.957 . . . . 65.25 113.583 171.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.6 mt -65.4 106.33 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.161 0.505 . . . . 74.219999999999999 111.714 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.6 mt -72.06 118.29 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.034 -0.53 . . . . 73.329999999999998 110.829 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -147.74 173.16 13.05 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.613 -0.267 . . . . 73.120000000000005 111.367 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -56.85 140.42 48.23 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.851 0.358 . . . . 72.200000000000003 111.697 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.5 -26.44 15.83 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.144 -0.551 . . . . 62.310000000000002 113.454 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.72 155.75 29.25 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.09 0.445 . . . . 75.319999999999993 111.281 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -113.36 127.85 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.626 0.727 . . . . 74.099999999999994 111.908 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.648 HG11 HG12 ' A' ' 43' ' ' VAL . 28.9 m -103.17 127.7 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 121.185 0.516 . . . . 73.439999999999998 111.077 177.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.02 110.86 12.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.218 -0.446 . . . . 74.319999999999993 110.362 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.9 p -115.61 176.04 5.26 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.364 0.602 . . . . 75.120000000000005 112.431 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.421 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 19.3 p-10 -59.25 -30.21 68.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.017 -0.538 . . . . 74.519999999999996 111.225 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.4 mt -81.28 -28.94 34.46 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.16 0.505 . . . . 63.229999999999997 110.728 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.413 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 131.08 -150.5 19.41 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.204 -0.453 . . . . 75.439999999999998 113.161 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.487 HD21 ' N ' ' A' ' 70' ' ' ASN . 1.0 OUTLIER -67.07 120.36 13.55 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.784 0.326 . . . . 64.439999999999998 111.777 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 27' ' ' VAL . 57.4 t -125.71 121.87 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.618 0.246 . . . . 70.319999999999993 111.478 178.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.522 ' HB2' HD13 ' A' ' 88' ' ' ILE . 38.1 ttm180 -89.55 118.09 28.93 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.276 -0.265 . . . . 73.319999999999993 111.439 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.95 128.43 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.261 0.467 . . . . 70.099999999999994 112.261 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -109.86 -63.04 1.42 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.185 -0.462 . . . . 75.420000000000002 111.996 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.529 ' HB3' ' HB2' ' A' ' 84' ' ' ASN . 43.5 t -78.27 154.87 30.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.649 0.261 . . . . 74.409999999999997 111.233 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.52 109.1 2.2 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-O 120.793 0.33 . . . . 73.400000000000006 110.83 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.512 ' HB3' HG23 ' A' ' 83' ' ' ILE . 30.3 Cg_endo -61.33 129.21 27.43 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.708 2.272 . . . . 73.409999999999997 112.8 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.57 -18.07 51.5 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.113 -0.565 . . . . 54.399999999999999 113.949 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -58.51 -44.9 89.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.503 0.652 . . . . 74.230000000000004 111.376 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -106.71 23.44 14.29 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.293 0.568 . . . . 74.310000000000002 110.434 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.59 9.01 73.35 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.347 -0.454 . . . . 38.479999999999997 113.4 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.408 HG21 ' N ' ' A' ' 83' ' ' ILE . 14.1 p -136.27 160.7 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 122.495 0.318 . . . . 74.310000000000002 111.277 -177.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.512 HG23 ' HB3' ' A' ' 77' ' ' PRO . 45.3 mt -116.56 140.36 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 122.572 0.349 . . . . 72.230000000000004 110.361 175.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.529 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 13.4 m120 -127.57 146.73 50.43 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.155 -0.341 . . . . 75.25 111.461 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.99 179.83 38.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.898 -0.668 . . . . 73.329999999999998 113.598 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 13.7 t -113.2 139.71 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 116.831 0.315 . . . . 73.439999999999998 111.402 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 29' ' ' ASP . 62.5 tp -74.16 106.8 5.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.08 0.467 . . . . 45.140000000000001 110.923 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.522 HD13 ' HB2' ' A' ' 72' ' ' ARG . 20.2 pt -124.48 -178.96 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.308 0.575 . . . . 60.340000000000003 111.182 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.413 ' NH1' ' HA3' ' A' ' 69' ' ' GLY . 40.5 mmt180 -139.83 70.71 1.37 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.232 -0.44 . . . . 62.530000000000001 111.002 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -75.29 -31.76 60.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.198 0.523 . . . . 71.200000000000003 109.842 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.56 158.26 17.08 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.687 -0.688 . . . . 73.140000000000001 109.557 164.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.9 160.84 27.68 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.272 0.558 . . . . 60.299999999999997 112.197 -172.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -57.83 108.74 0.61 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.243 0.544 . . . . 73.209999999999994 111.771 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.41 72.57 10.66 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.392 0.515 . . . . 73.019999999999996 112.392 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -146.69 125.04 12.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.306 -0.406 . . . . 74.219999999999999 110.885 173.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -76.11 64.34 1.95 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.408 -0.36 . . . . 63.409999999999997 110.98 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 63.96 -67.72 0.1 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.217 0.607 . . . . 73.519999999999996 112.142 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.1 t60 . . . . . 0 C--O 1.254 1.3 0 CA-C-O 118.84 -0.6 . . . . 71.420000000000002 111.317 178.31 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 CA-C-O 120.866 0.148 . . . . 72.340000000000003 113.07 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -96.02 29.27 2.81 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.182 0.515 . . . . 72.209999999999994 111.524 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -87.72 91.54 8.79 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.079 0.4 . . . . 73.349999999999994 112.079 -175.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.646 ' HD3' ' H ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -89.38 102.02 14.7 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.312 0.577 . . . . 64.209999999999994 110.18 173.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.8 m -96.0 7.92 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 113.269 0.841 . . . . 52.340000000000003 113.269 -172.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -78.73 82.23 4.98 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.297 0.57 . . . . 73.439999999999998 112.216 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.7 tp -94.81 -28.14 15.4 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.999 -0.546 . . . . 73.329999999999998 110.91 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.0 tp -76.44 157.81 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 116.188 -0.46 . . . . 71.439999999999998 111.292 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.84 166.1 24.85 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.05 -0.406 . . . . 74.099999999999994 111.661 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -125.1 177.41 6.1 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.551 0.575 . . . . 73.200000000000003 112.551 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -169.13 147.19 3.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.101 -0.499 . . . . 74.349999999999994 110.624 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.56 146.17 5.05 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.345 -0.931 . . . . 53.539999999999999 114.366 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.65 -34.95 6.35 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.53 -0.366 . . . . 42.340000000000003 112.345 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -136.77 155.51 49.73 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.669 -0.493 . . . . 71.319999999999993 109.669 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 15' ' ' THR . 11.9 m -133.65 2.58 3.47 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.37 0.878 . . . . 71.310000000000002 113.37 -174.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 17' ' ' VAL . 39.3 ttmt -175.95 91.69 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.52 0.933 . . . . 54.229999999999997 113.52 -175.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 16' ' ' LYS . 5.2 p 48.88 167.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 114.674 1.361 . . . . 62.520000000000003 114.674 168.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -84.77 -171.94 3.91 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.684 -0.635 . . . . 72.030000000000001 111.236 174.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 24' ' ' ARG . 7.4 tt -74.73 109.12 7.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.999 0.428 . . . . 75.140000000000001 110.762 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.32 -73.35 0.38 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.158 0.504 . . . . 65.340000000000003 110.049 173.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.2 t -92.19 -28.18 17.21 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.246 0.546 . . . . 63.200000000000003 110.302 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -95.82 99.14 10.99 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.71 -0.677 . . . . 72.439999999999998 111.085 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.473 HG21 ' HB ' ' A' ' 40' ' ' ILE . 91.3 m -69.06 112.64 5.81 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.052 0.453 . . . . 72.129999999999995 110.857 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.477 ' O ' HD13 ' A' ' 19' ' ' LEU . 90.0 mtm180 -145.15 163.16 35.2 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.31 -0.404 . . . . 74.319999999999993 111.27 -173.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 tt -147.9 135.9 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.111 0.481 . . . . 71.329999999999998 111.86 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -74.84 103.47 5.09 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.027 0.441 . . . . 75.219999999999999 110.356 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.434 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 48.8 t -93.87 145.81 7.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.954 -0.566 . . . . 65.310000000000002 111.528 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 35' ' ' VAL . 48.6 t -117.16 106.9 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.044 -0.526 . . . . 72.140000000000001 110.806 176.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.459 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 12.9 t70 -70.04 112.83 13.8 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.611 0.243 . . . . 75.209999999999994 110.659 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.82 -14.21 11.32 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.774 2.316 . . . . 75.540000000000006 113.286 -176.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -74.71 -37.37 62.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.311 0.577 . . . . 72.549999999999997 110.838 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.8 p -110.1 -32.36 7.03 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.878 -0.601 . . . . 72.310000000000002 111.475 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.81 45.05 4.34 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.299 -0.477 . . . . 74.340000000000003 112.514 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 19.7 ptpt -118.39 162.92 17.51 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.594 -0.356 . . . . 73.109999999999999 111.1 177.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.534 HG23 HG22 ' A' ' 28' ' ' VAL . 58.1 t -120.51 113.85 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.932 0.396 . . . . 63.5 111.202 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -117.26 170.14 8.92 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.073 0.464 . . . . 64.25 111.731 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.2 mt -107.46 116.61 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.554 -0.294 . . . . 73.319999999999993 110.822 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.44 157.72 19.95 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.185 0.517 . . . . 63.119999999999997 112.208 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -97.34 124.14 41.38 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 54.530000000000001 110.719 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.473 ' HB ' HG21 ' A' ' 23' ' ' THR . 60.0 mt -75.34 114.07 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.057 0.455 . . . . 72.530000000000001 111.468 -178.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -82.92 -44.09 15.75 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.246 -0.434 . . . . 74.329999999999998 111.183 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.525 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 44.0 m-80 -138.89 146.09 40.72 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.717 0.294 . . . . 74.430000000000007 111.351 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.4 m -108.57 18.06 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.214 0.53 . . . . 75.430000000000007 111.702 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 53' ' ' VAL . 7.5 p -92.74 109.49 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.33 0.586 . . . . 64.239999999999995 112.157 -177.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.437 ' HG2' HH21 ' A' ' 55' ' ' ARG . 9.3 pt-20 -86.62 27.05 1.01 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.993 0.425 . . . . 73.319999999999993 111.083 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.8 t30 60.51 72.48 0.52 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.403 0.621 . . . . 75.349999999999994 111.558 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.4 p -89.79 -73.1 0.53 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.071 -0.513 . . . . 72.5 109.972 175.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.13 -140.73 0.19 Allowed 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 109.217 -0.66 . . . . 52.43 109.217 168.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.494 ' HB2' ' CD1' ' A' ' 52' ' ' PHE . 14.0 m120 -69.08 147.3 97.59 Favored Pre-proline 0 CA--C 1.543 0.708 0 O-C-N 121.973 -0.454 . . . . 74.319999999999993 110.364 171.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.34 -29.09 37.35 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.205 2.603 . . . . 71.310000000000002 114.874 -171.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -102.23 9.47 40.01 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.53 0.567 . . . . 75.409999999999997 112.53 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 49' ' ' ASN . 35.8 m-85 -104.97 43.31 1.12 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.401 0.62 . . . . 72.420000000000002 111.488 178.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 44' ' ' VAL . 4.4 p -86.87 96.93 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.589 0.709 . . . . 75.230000000000004 111.818 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -95.09 -42.68 8.48 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.108 -0.497 . . . . 75.150000000000006 111.686 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 55' ' ' ARG . 21.6 ptt180 -67.45 128.14 35.32 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.235 0.54 . . . . 71.049999999999997 111.306 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -106.11 14.92 27.08 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.173 0.511 . . . . 74.310000000000002 110.599 173.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.3 mp -83.57 98.14 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.959 -0.564 . . . . 71.510000000000005 110.751 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.492 ' CG2' HG21 ' A' ' 73' ' ' VAL . 60.8 mt -80.26 107.38 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.243 -0.435 . . . . 73.25 111.016 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -94.5 156.01 16.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.995 0.426 . . . . 71.340000000000003 111.74 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -64.33 116.33 5.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.815 0.341 . . . . 74.109999999999999 111.149 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.0 -16.04 23.13 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.406 -0.426 . . . . 55.420000000000002 112.68 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.82 150.87 48.06 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.046 0.451 . . . . 74.230000000000004 111.907 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' A' ' 90' ' ' GLU . 60.5 t -104.16 115.31 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.3 -0.409 . . . . 62.439999999999998 111.276 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.69 143.36 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.123 0.487 . . . . 74.329999999999998 111.908 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 8.0 tp10 -87.97 116.52 26.2 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.294 -0.412 . . . . 54.420000000000002 110.509 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.9 p -115.74 176.07 5.25 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.107 0.479 . . . . 74.519999999999996 111.81 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -65.67 -13.22 58.75 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.23 0.456 . . . . 63.219999999999999 112.23 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.8 mt -104.98 -18.18 14.26 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.2 0.524 . . . . 74.019999999999996 111.369 177.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.447 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 139.07 -161.18 25.94 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.282 -0.485 . . . . 73.409999999999997 112.977 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -77.08 137.61 39.04 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.405 -0.468 . . . . 63.049999999999997 110.949 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 58.5 t -130.58 127.98 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.372 -0.205 . . . . 72.019999999999996 111.549 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.456 ' HB2' HD12 ' A' ' 88' ' ' ILE . 59.2 ttm-85 -92.67 113.23 25.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.646 0.26 . . . . 73.420000000000002 110.742 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.492 HG21 ' CG2' ' A' ' 58' ' ' ILE . 48.5 t -61.37 120.14 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.497 0.554 . . . . 75.230000000000004 112.497 -176.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.3 p -96.58 -32.3 12.31 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.438 0.533 . . . . 65.310000000000002 112.438 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.2 t -108.76 -174.44 2.51 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.891 0.376 . . . . 75.239999999999995 111.786 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -97.29 113.88 63.91 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.399 -0.364 . . . . 65.310000000000002 111.573 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.45 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 50.4 Cg_exo -56.72 120.79 8.93 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.596 2.197 . . . . 72.25 112.682 176.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.22 -33.03 2.99 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.187 -0.53 . . . . 61.219999999999999 112.369 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -61.09 114.59 3.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.575 0.226 . . . . 74.239999999999995 110.739 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 60.94 15.57 6.18 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.168 0.509 . . . . 62.109999999999999 111.303 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.85 40.21 95.41 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.157 -0.474 . . . . 75.019999999999996 113.315 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.0 p -146.08 160.36 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 117.198 0.499 . . . . 75.510000000000005 111.995 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 31.9 mt -123.51 147.79 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.798 0.439 . . . . 64.420000000000002 110.874 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -121.23 148.93 43.61 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.3 -0.25 . . . . 64.510000000000005 111.03 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -168.54 167.15 40.11 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.861 -0.685 . . . . 53.310000000000002 114.078 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 24.2 t -101.85 140.34 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.68 0.392 . . . . 54.119999999999997 111.672 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.434 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 43.0 tp -78.58 106.88 10.85 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.284 0.564 . . . . 63.530000000000001 111.445 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 72' ' ' ARG . 16.5 pt -128.25 -177.5 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.063 0.459 . . . . 73.349999999999994 110.947 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.447 ' NH1' ' HA3' ' A' ' 69' ' ' GLY . 28.1 mmt180 -134.54 76.21 1.63 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.698 0.285 . . . . 73.310000000000002 110.856 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.524 ' HG3' HG23 ' A' ' 63' ' ' VAL . 11.2 mm-40 -79.5 -47.63 15.27 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.2 0.524 . . . . 64.329999999999998 110.926 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.4 mt -70.76 178.66 2.97 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.962 -0.563 . . . . 73.430000000000007 111.014 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.95 91.59 0.09 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.383 0.611 . . . . 73.140000000000001 111.179 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -62.34 117.58 6.32 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.76 -0.655 . . . . 74.329999999999998 111.785 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -86.71 85.06 7.27 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.985 -0.552 . . . . 64.420000000000002 112.277 -173.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -174.87 124.05 0.26 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.518 -0.31 . . . . 75.099999999999994 111.288 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -84.06 133.23 34.66 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.846 0.355 . . . . 65.230000000000004 111.427 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -158.07 155.37 29.14 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.429 -0.35 . . . . 73.25 111.202 -177.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.54 -0.743 . . . . 73.219999999999999 111.308 175.165 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 112.825 -0.11 . . . . 60.229999999999997 112.825 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -88.11 171.97 9.86 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.063 0.458 . . . . 75.549999999999997 111.611 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 -115.27 135.68 53.9 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.656 0.613 . . . . 74.409999999999997 112.656 -175.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.421 ' HD2' ' N ' ' A' ' 4' ' ' ARG . 2.2 mpt_? -119.17 161.74 19.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.089 -0.505 . . . . 73.319999999999993 110.499 173.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.71 102.61 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.118 0.485 . . . . 74.510000000000005 111.244 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 -87.68 94.08 9.63 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.269 -0.423 . . . . 73.140000000000001 111.345 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pp -115.84 11.94 15.71 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.131 0.419 . . . . 74.329999999999998 112.131 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.4 tt -68.91 112.7 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.497 0.665 . . . . 71.109999999999999 110.936 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.422 HH11 ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -119.23 160.32 22.4 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.248 0.547 . . . . 73.310000000000002 112.425 -172.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 t -75.78 107.39 7.92 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.833 -0.621 . . . . 74.099999999999994 112.388 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.432 ' HD3' ' HA ' ' A' ' 11' ' ' ARG . 29.0 mmt180 -146.72 146.84 30.46 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.125 0.488 . . . . 70.439999999999998 111.187 175.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.4 92.63 0.27 Allowed Glycine 0 CA--C 1.527 0.83 0 CA-C-N 116.085 -0.507 . . . . 54.530000000000001 113.045 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.96 66.19 0.02 OUTLIER Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.174 -0.536 . . . . 52.130000000000003 113.258 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -153.31 -74.37 0.13 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.807 0.336 . . . . 71.409999999999997 110.996 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -153.04 156.47 38.83 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.203 0.525 . . . . 73.140000000000001 111.944 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.547 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 9.9 mmpt? -99.4 -178.66 3.97 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.942 -0.572 . . . . 74.439999999999998 110.5 175.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -76.07 155.09 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.949 0.404 . . . . 74.219999999999999 110.803 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -63.99 161.58 15.59 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.246 0.546 . . . . 75.140000000000001 112.141 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -64.01 4.67 0.29 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.148 1.166 . . . . 75.239999999999995 114.148 -172.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.67 -54.89 10.69 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.162 0.43 . . . . 63.439999999999998 112.162 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.5 m -110.46 10.96 23.22 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.236 0.541 . . . . 65.129999999999995 110.898 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' HB3' ' NH2' ' A' ' 24' ' ' ARG . 3.5 m-20 -132.82 42.08 3.1 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.683 -0.69 . . . . 73.409999999999997 111.409 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.525 HG22 ' HB ' ' A' ' 40' ' ' ILE . 38.4 m -67.93 110.89 4.07 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.049 0.452 . . . . 74.109999999999999 110.725 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.482 ' NH2' ' HB3' ' A' ' 22' ' ' ASP . 43.1 mtm-85 -148.68 163.55 36.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.253 -0.43 . . . . 54.340000000000003 111.384 -175.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.6 tt -147.6 132.7 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.219 -0.446 . . . . 73.200000000000003 111.764 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.504 ' OD1' HG12 ' A' ' 37' ' ' ILE . 77.3 m-20 -65.99 103.23 0.91 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.111 0.481 . . . . 54.219999999999999 110.209 171.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.77 121.99 37.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.024 -0.535 . . . . 63.399999999999999 111.601 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.4 t -94.95 106.79 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.159 0.504 . . . . 75.409999999999997 110.669 176.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.76 113.56 24.05 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 115.843 -0.617 . . . . 61.030000000000001 110.794 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.23 -11.31 17.63 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.589 2.193 . . . . 75.319999999999993 113.431 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -88.05 -37.3 16.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.009 0.433 . . . . 73.219999999999999 111.879 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.406 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 30.5 p -115.17 -26.25 7.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.101 -0.499 . . . . 65.219999999999999 112.24 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.43 15.87 57.96 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.328 -0.463 . . . . 75.209999999999994 113.704 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 22.8 pttm -90.31 152.41 21.04 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.406 -0.467 . . . . 54.130000000000003 111.512 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.5 t -116.42 119.97 63.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.417 -0.356 . . . . 74.030000000000001 110.737 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -133.37 136.73 45.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.912 0.387 . . . . 71.129999999999995 111.614 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.504 HG12 ' OD1' ' A' ' 26' ' ' ASN . 41.8 mt -77.65 112.66 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.914 0.388 . . . . 53.350000000000001 111.258 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.481 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -112.23 145.8 39.28 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.474 -0.33 . . . . 71.010000000000005 111.393 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.78 133.83 36.33 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.667 0.27 . . . . 74.25 110.737 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.525 ' HB ' HG22 ' A' ' 23' ' ' THR . 68.2 mt -82.77 109.95 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.378 0.609 . . . . 73.120000000000005 110.313 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 mtp85 -85.7 -39.53 17.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.719 -0.673 . . . . 71.310000000000002 111.463 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.623 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 41.0 t30 -114.74 120.79 41.28 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.928 -0.578 . . . . 61.109999999999999 110.455 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 56' ' ' ASN . 7.8 p -93.86 11.91 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 N-CA-C 112.488 0.551 . . . . 71.010000000000005 112.488 -173.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.52 146.32 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 121.853 -0.529 . . . . 63.009999999999998 111.859 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.485 ' HG3' HG22 ' A' ' 47' ' ' THR . 13.3 pt-20 -75.47 -167.13 0.61 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.194 -0.457 . . . . 75.099999999999994 110.964 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -71.03 74.44 0.64 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.266 0.555 . . . . 64.200000000000003 111.707 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.485 HG22 ' HG3' ' A' ' 45' ' ' GLU . 9.0 t -177.0 -178.66 0.84 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.96 -0.563 . . . . 71.540000000000006 110.795 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.88 -57.98 1.76 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.896 0.379 . . . . 71.530000000000001 110.872 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -161.47 88.21 1.58 Allowed Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 112.633 0.605 . . . . 72.400000000000006 112.633 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.03 -37.96 30.65 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.219 1.946 . . . . 70.0 111.354 170.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -137.68 172.18 13.34 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.577 -0.738 . . . . 71.329999999999998 110.35 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -73.33 87.98 1.53 Allowed 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.297 0.57 . . . . 74.019999999999996 111.313 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.0 t -114.68 133.45 60.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.878 -0.601 . . . . 74.209999999999994 111.152 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.5 mtp180 -67.67 168.33 11.45 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.1 0.476 . . . . 64.209999999999994 111.948 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.2 mtp85 -66.6 167.73 10.5 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.132 -0.486 . . . . 71.540000000000006 111.44 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.508 ' HA ' HG23 ' A' ' 43' ' ' VAL . 85.7 m-20 62.73 62.28 1.09 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.443 0.639 . . . . 63.009999999999998 110.529 -170.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.444 HG23 ' O ' ' A' ' 57' ' ' ILE . 17.3 mt -83.04 19.8 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-O 121.685 0.755 . . . . 72.140000000000001 111.556 -175.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.634 HG23 HD11 ' A' ' 83' ' ' ILE . 49.4 mt -68.6 103.35 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.073 -0.512 . . . . 64.329999999999998 111.43 -178.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.1 t -147.18 167.94 22.91 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.699 -0.228 . . . . 72.400000000000006 110.753 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 42.5 ttm180 -59.47 126.45 27.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.133 0.492 . . . . 72.530000000000001 111.536 -176.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.32 -24.06 31.31 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.139 -0.553 . . . . 60.109999999999999 112.724 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.8 139.8 38.32 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.493 -0.416 . . . . 55.340000000000003 111.186 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 m -106.31 119.11 55.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.435 0.636 . . . . 61.109999999999999 111.441 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.445 ' HB ' HG21 ' A' ' 40' ' ' ILE . 35.7 m -106.33 152.57 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.241 -0.436 . . . . 74.340000000000003 111.378 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 44.0 tt0 -95.01 120.0 34.49 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.124 0.488 . . . . 75.439999999999998 111.045 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 p -113.39 179.31 4.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.02 -0.536 . . . . 70.530000000000001 110.632 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.481 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 3.2 p-10 -65.87 -11.84 49.86 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.798 0.333 . . . . 73.409999999999997 111.481 174.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.42 ' O ' HD13 ' A' ' 87' ' ' LEU . 87.3 mt -102.7 2.36 35.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.817 0.342 . . . . 72.340000000000003 111.417 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.475 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 104.07 -162.98 15.16 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.477 -0.392 . . . . 74.200000000000003 112.961 -178.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -66.05 130.3 42.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.264 0.554 . . . . 63.329999999999998 112.098 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.8 t -126.99 127.28 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.022 -0.536 . . . . 64.329999999999998 110.374 177.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -88.4 117.31 27.24 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.294 -0.254 . . . . 75.439999999999998 110.807 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.469 HG23 HG21 ' A' ' 58' ' ' ILE . 46.1 t -66.42 127.84 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.931 0.396 . . . . 74.299999999999997 111.699 -177.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.6 p -112.42 -49.6 2.95 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.274 -0.421 . . . . 71.030000000000001 111.792 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.0 p -84.54 154.69 22.51 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.126 0.489 . . . . 71.329999999999998 111.685 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.92 118.44 65.42 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.703 -0.48 . . . . 73.420000000000002 109.703 175.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.418 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 75.9 Cg_exo -50.85 121.21 7.72 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.626 2.217 . . . . 63.329999999999998 113.25 -178.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.03 -20.72 3.38 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.101 -0.571 . . . . 74.299999999999997 112.879 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.461 ' O ' HG13 ' A' ' 82' ' ' VAL . 87.2 mm-40 -55.47 112.09 1.04 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 111.859 0.318 . . . . 54.109999999999999 111.859 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 56.64 20.34 4.94 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.788 0.435 . . . . 71.430000000000007 112.077 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.02 33.38 45.71 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.166 -0.54 . . . . 52.119999999999997 113.114 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 79' ' ' GLN . 9.0 p -151.64 167.89 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.127 0.489 . . . . 62.109999999999999 111.439 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.634 HD11 HG23 ' A' ' 58' ' ' ILE . 29.3 mt -118.46 148.15 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.013 0.525 . . . . 70.340000000000003 109.812 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -121.82 140.85 51.85 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.779 -0.575 . . . . 62.32 111.532 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.19 176.17 38.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 121.081 -0.58 . . . . 73.219999999999999 113.518 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.53 145.28 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 117.069 0.434 . . . . 64.109999999999999 111.253 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.506 HD13 HH12 ' A' ' 89' ' ' ARG . 37.7 tp -81.3 111.87 18.08 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.998 0.428 . . . . 63.130000000000003 111.952 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.0 pt -128.37 -178.95 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.182 0.515 . . . . 75.530000000000001 111.499 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.506 HH12 HD13 ' A' ' 87' ' ' LEU . 26.0 mmt180 -136.2 86.2 2.21 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.157 -0.339 . . . . 64.040000000000006 111.675 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -88.72 -45.12 10.06 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 122.054 -0.404 . . . . 73.310000000000002 111.639 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.82 174.88 7.08 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.115 0.483 . . . . 73.219999999999999 111.564 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -64.17 134.02 54.03 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.127 -0.488 . . . . 64.0 112.021 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -69.6 100.85 1.51 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.887 -0.783 . . . . 74.230000000000004 108.887 170.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -77.44 37.09 0.21 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.233 0.827 . . . . 73.010000000000005 113.233 -169.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -112.97 76.64 0.99 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.227 0.537 . . . . 73.099999999999994 110.565 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -86.09 -18.96 30.98 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.144 0.424 . . . . 72.519999999999996 112.144 -174.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -78.71 70.94 5.14 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.56 0.695 . . . . 74.25 111.886 -173.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 . . . . . 0 C--O 1.252 1.208 0 CA-C-N 115.401 -0.818 . . . . 75.25 110.095 176.592 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 CA-C-O 120.453 -0.082 . . . . 75.019999999999996 113.117 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -99.99 -1.23 37.62 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.394 0.516 . . . . 70.319999999999993 112.394 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 3' ' ' ARG . 3.7 mpt_? -79.16 127.95 32.68 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.922 0.391 . . . . 64.099999999999994 111.3 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.474 ' H ' ' HD2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -101.66 110.66 22.7 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.403 0.62 . . . . 73.109999999999999 110.84 -179.262 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.18 42.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 112.898 0.703 . . . . 75.310000000000002 112.898 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.3 ptt85 -159.58 98.93 1.41 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.121 0.486 . . . . 71.319999999999993 111.779 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.402 ' N ' HD13 ' A' ' 7' ' ' LEU . 7.1 mp -104.01 -0.5 28.75 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.452 -0.34 . . . . 73.430000000000007 111.516 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.76 134.06 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 121.114 0.483 . . . . 73.510000000000005 111.029 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -126.87 130.51 50.33 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.431 0.53 . . . . 73.349999999999994 112.431 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 t -143.1 163.6 32.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.85 -0.614 . . . . 74.200000000000003 110.64 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -162.28 115.64 1.76 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.009 0.433 . . . . 75.340000000000003 111.621 -177.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.9 96.19 0.78 Allowed Glycine 0 CA--C 1.527 0.801 0 CA-C-N 116.361 -0.381 . . . . 55.240000000000002 112.511 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.84 -152.81 7.06 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.903 -0.665 . . . . 70.209999999999994 113.474 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -72.97 121.81 20.68 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.964 0.412 . . . . 62.420000000000002 112.086 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -90.97 171.01 9.58 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.098 0.475 . . . . 62.409999999999997 111.565 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.475 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -73.89 146.97 43.62 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.077 -0.51 . . . . 72.319999999999993 111.64 178.635 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.4 153.02 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 120.866 0.365 . . . . 74.329999999999998 111.313 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.459 ' NH2' ' HB2' ' A' ' 77' ' ' PRO . 9.7 ptm180 -55.84 -32.11 63.32 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.542 0.571 . . . . 73.510000000000005 112.542 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 tt -163.76 128.16 2.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.546 -0.297 . . . . 74.230000000000004 110.463 -175.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.07 80.2 1.9 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.577 0.227 . . . . 53.119999999999997 111.52 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.6 m 72.2 -45.26 0.62 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.496 0.718 . . . . 73.129999999999995 112.353 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -76.43 131.06 38.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.487 0.315 . . . . 71.200000000000003 110.554 176.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.3 m -120.87 114.83 22.14 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.802 0.334 . . . . 75.329999999999998 111.84 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -115.7 159.95 20.7 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.281 0.474 . . . . 74.010000000000005 112.281 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.426 ' HB ' HD13 ' A' ' 40' ' ' ILE . 12.5 tt -155.4 133.97 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.098 -0.501 . . . . 73.329999999999998 111.225 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -77.02 102.81 6.63 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.041 0.448 . . . . 70.129999999999995 110.196 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.2 t -94.08 119.14 41.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 72.040000000000006 111.686 -176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 42.3 t -95.47 115.43 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.383 -0.372 . . . . 74.299999999999997 110.709 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.466 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 33.3 t70 -82.75 119.88 75.34 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-O 120.542 0.21 . . . . 62.520000000000003 110.696 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.61 -17.07 30.13 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.685 2.257 . . . . 62.549999999999997 113.411 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -82.13 -44.45 16.46 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 111.9 0.333 . . . . 60.450000000000003 111.9 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.4 p -100.06 -28.26 13.14 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.016 0.436 . . . . 73.329999999999998 111.714 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.75 22.49 49.77 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.268 -0.492 . . . . 62.219999999999999 112.979 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.466 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 63.6 pttt -87.34 145.89 26.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.922 0.361 . . . . 73.25 111.834 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.417 HG23 HG22 ' A' ' 28' ' ' VAL . 48.8 t -105.32 94.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 109.746 -0.465 . . . . 74.430000000000007 109.746 170.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.02 124.38 52.06 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.282 -0.417 . . . . 62.210000000000001 111.384 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.0 mt -79.37 113.06 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.495 -0.32 . . . . 75.040000000000006 111.629 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.417 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -113.86 170.99 7.86 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.912 0.387 . . . . 74.200000000000003 111.916 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.85 137.16 37.83 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.496 -0.32 . . . . 71.540000000000006 111.001 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.426 HD13 ' HB ' ' A' ' 25' ' ' ILE . 63.5 mt -90.71 114.61 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.741 0.305 . . . . 74.230000000000004 111.424 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -83.51 -45.44 13.59 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.263 0.468 . . . . 63.329999999999998 112.263 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 41.7 m-80 -123.57 115.39 21.43 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.788 0.328 . . . . 52.200000000000003 111.76 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 82.0 t -70.83 -30.13 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.176 0.512 . . . . 73.420000000000002 110.814 174.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.71 140.45 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 116.23 -0.441 . . . . 64.540000000000006 111.02 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -75.71 32.05 0.11 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.258 0.466 . . . . 52.240000000000002 112.258 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 56.46 29.25 15.0 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.201 0.524 . . . . 63.43 112.001 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.0 t -127.41 -179.87 5.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.16 -0.473 . . . . 60.43 111.148 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.43 177.28 2.44 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.301 0.572 . . . . 71.530000000000001 111.789 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -92.57 119.4 68.0 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.371 -0.377 . . . . 72.549999999999997 111.287 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.51 -28.14 82.97 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.397 2.065 . . . . 65.400000000000006 111.83 173.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -143.74 140.75 30.13 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.903 -0.59 . . . . 63.310000000000002 110.666 171.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -69.05 1.9 3.16 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.968 0.729 . . . . 74.310000000000002 112.968 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.559 HG13 ' H ' ' A' ' 55' ' ' ARG . 12.2 p -63.62 -20.23 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 120.867 0.365 . . . . 75.420000000000002 111.836 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 62.76 22.42 13.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.709 0.403 . . . . 63.240000000000002 112.028 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.559 ' H ' HG13 ' A' ' 53' ' ' VAL . 44.1 ttm180 -68.94 93.16 0.54 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.191 0.519 . . . . 75.219999999999999 111.551 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -77.45 101.12 6.27 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.256 -0.429 . . . . 52.25 110.741 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.0 tt -128.65 132.56 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 121.114 0.483 . . . . 63.43 111.406 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.531 ' HB ' ' HG3' ' A' ' 77' ' ' PRO . 68.7 mt -87.61 134.99 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.994 -0.548 . . . . 72.030000000000001 110.81 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -147.8 172.2 14.49 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.262 0.467 . . . . 65.439999999999998 112.262 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -72.49 116.03 12.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.209 -0.45 . . . . 71.450000000000003 111.368 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 109.42 -7.65 32.34 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.258 -0.496 . . . . 38.590000000000003 112.88 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.18 139.46 30.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.763 0.316 . . . . 73.319999999999993 111.405 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.64 114.07 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.988 0.423 . . . . 73.409999999999997 111.307 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -102.56 154.42 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.987 0.423 . . . . 73.209999999999994 111.582 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 8.8 tp10 -95.6 120.71 36.33 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.874 0.369 . . . . 74.239999999999995 111.386 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.9 p -122.82 172.89 8.12 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.841 0.353 . . . . 74.120000000000005 111.421 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.417 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 32.2 p30 -57.59 -33.22 67.96 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.885 0.374 . . . . 75.129999999999995 111.627 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.9 mt -75.63 -33.15 60.46 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.9 0.381 . . . . 74.340000000000003 111.02 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 140.7 -156.49 25.37 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.137 -0.483 . . . . 75.319999999999993 112.983 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -68.63 125.76 27.55 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.746 0.308 . . . . 61.140000000000001 111.214 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.7 t -125.98 119.28 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.046 0.388 . . . . 74.310000000000002 112.046 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.471 ' HB2' HD13 ' A' ' 88' ' ' ILE . 59.0 ttp180 -84.19 111.31 19.24 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.66 0.267 . . . . 73.430000000000007 110.925 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.439 HG23 HG21 ' A' ' 58' ' ' ILE . 58.5 t -71.55 131.16 34.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.559 0.578 . . . . 75.329999999999998 112.559 -174.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.0 p -106.04 -33.09 8.0 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.965 -0.561 . . . . 75.230000000000004 111.826 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t -112.91 134.71 54.3 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.654 0.264 . . . . 74.510000000000005 111.478 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.2 mtm-85 -80.75 142.81 53.26 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 112.383 0.512 . . . . 74.530000000000001 112.383 -175.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.531 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 37.9 Cg_endo -63.52 97.24 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.261 2.641 . . . . 74.099999999999994 113.66 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.93 -28.59 2.13 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.866 -0.683 . . . . 60.299999999999997 113.565 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -53.81 -68.26 0.19 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.037 0.446 . . . . 74.200000000000003 111.67 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -99.1 18.25 17.84 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.931 0.396 . . . . 72.019999999999996 110.977 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.8 -33.33 1.67 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 121.227 -0.511 . . . . 73.040000000000006 112.805 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.405 HG21 ' N ' ' A' ' 83' ' ' ILE . 14.5 p -99.85 158.47 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.14 0.495 . . . . 73.540000000000006 111.631 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.405 ' N ' HG21 ' A' ' 82' ' ' VAL . 46.4 mt -105.86 143.57 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.437 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -126.28 146.3 50.07 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.297 -0.252 . . . . 70.219999999999999 111.287 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.22 -179.02 30.05 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.201 -0.523 . . . . 53.32 113.039 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 t -124.35 129.88 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.838 0.319 . . . . 64.109999999999999 110.935 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.9 tp -74.45 106.34 6.01 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.101 0.477 . . . . 70.019999999999996 111.488 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 72' ' ' ARG . 7.9 pt -120.05 176.53 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.313 0.578 . . . . 73.329999999999998 111.408 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -128.81 91.06 3.15 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.313 -0.403 . . . . 74.150000000000006 110.667 -178.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -106.37 -50.14 3.2 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.223 0.535 . . . . 75.430000000000007 111.481 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.6 178.16 4.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.565 0.698 . . . . 70.519999999999996 112.431 -176.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -56.55 116.88 3.37 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.608 -0.724 . . . . 72.239999999999995 112.283 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -90.71 136.11 33.28 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.826 0.346 . . . . 55.439999999999998 110.764 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -107.74 139.23 42.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.026 0.441 . . . . 74.450000000000003 111.608 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -106.55 -50.18 3.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.343 -0.39 . . . . 73.530000000000001 112.013 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.3 t-80 -78.1 84.14 4.36 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.34 0.591 . . . . 73.230000000000004 110.339 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -100.48 171.95 7.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.436 -0.802 . . . . 74.329999999999998 112.4 -172.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 80.9 t60 . . . . . 0 C--O 1.25 1.084 0 CA-C-N 116.053 -0.521 . . . . 73.150000000000006 110.95 176.555 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.429 -0.268 . . . . 74.209999999999994 112.429 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -85.48 -175.79 5.82 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.934 0.397 . . . . 44.329999999999998 111.373 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.559 ' HD3' ' N ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -113.94 -53.5 2.67 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.092 0.405 . . . . 73.5 112.092 -175.758 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.41 ' H ' ' HG2' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -166.32 142.19 4.75 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.837 0.351 . . . . 73.430000000000007 111.437 176.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.9 t -107.87 113.89 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.013 0.435 . . . . 73.129999999999995 111.262 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.509 ' HA ' ' NE ' ' A' ' 6' ' ' ARG . 3.9 mmp_? -112.32 80.08 1.29 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.954 0.407 . . . . 75.530000000000001 111.793 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.19 -68.7 0.38 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.084 0.468 . . . . 71.120000000000005 109.896 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.7 tt -98.78 127.9 50.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.967 0.413 . . . . 71.129999999999995 110.722 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.458 ' HD3' ' N ' ' A' ' 9' ' ' ARG . 1.3 mpp_? -105.31 -49.66 3.4 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.814 0.34 . . . . 75.129999999999995 111.076 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.9 t -96.25 126.05 41.2 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.13 0.49 . . . . 75.510000000000005 111.675 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.428 ' HD3' ' O ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -120.66 19.51 11.87 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.178 0.513 . . . . 70.409999999999997 110.608 177.701 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.97 -112.99 0.81 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 116.028 -0.533 . . . . 74.129999999999995 113.52 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.65 -89.52 0.12 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.283 -0.484 . . . . 64.329999999999998 112.994 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -90.26 1.4 56.53 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.053 0.454 . . . . 75.439999999999998 111.193 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.5 m -131.03 154.33 48.33 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.17 -0.468 . . . . 74.019999999999996 111.06 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -57.86 153.86 13.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.187 0.518 . . . . 64.230000000000004 112.067 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 19' ' ' LEU . 7.6 p -73.82 78.6 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 CA-C-O 121.399 0.619 . . . . 73.430000000000007 111.953 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.451 ' HD3' ' N ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 45.9 -68.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.174 1.546 . . . . 72.129999999999995 115.174 176.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 23' ' ' THR . 7.4 tt -141.13 114.4 8.68 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.679 -0.638 . . . . 74.120000000000005 111.091 -175.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.28 125.86 11.75 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.558 -0.292 . . . . 74.230000000000004 111.159 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.3 t 65.64 10.25 6.57 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.129 0.49 . . . . 73.0 111.74 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -96.05 -77.03 0.49 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.236 -0.438 . . . . 55.119999999999997 111.579 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.494 HG22 ' HB ' ' A' ' 40' ' ' ILE . 86.6 m -95.58 113.95 25.65 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.007 0.432 . . . . 72.140000000000001 110.8 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -138.58 154.89 48.73 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.016 0.436 . . . . 73.120000000000005 111.738 -173.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.441 ' HB ' HD13 ' A' ' 40' ' ' ILE . 15.3 tt -143.77 138.4 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.089 0.471 . . . . 73.140000000000001 111.618 -177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -90.46 112.76 24.52 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.274 0.559 . . . . 71.439999999999998 110.102 175.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.0 t -106.28 144.12 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.649 0.611 . . . . 75.400000000000006 112.649 -169.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 t -104.87 129.91 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.234 -0.439 . . . . 71.040000000000006 111.058 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -84.63 122.8 74.89 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 116.428 -0.351 . . . . 71.340000000000003 110.945 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.58 -17.12 11.43 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.784 2.322 . . . . 72.219999999999999 114.283 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.23 -43.81 11.32 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.281 0.563 . . . . 63.409999999999997 111.558 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 p -105.64 -31.26 9.0 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.885 -0.598 . . . . 64.209999999999994 112.084 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.26 12.97 56.81 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.022 -0.608 . . . . 60.409999999999997 113.617 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -86.56 143.14 27.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.007 0.404 . . . . 72.510000000000005 111.34 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.78 103.53 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.074 0.464 . . . . 65.409999999999997 110.656 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -108.43 135.81 49.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.952 0.406 . . . . 73.409999999999997 111.363 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.6 mt -90.6 129.04 42.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.86 0.362 . . . . 73.340000000000003 111.229 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.442 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -126.99 159.14 35.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.893 0.378 . . . . 74.329999999999998 111.713 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -107.5 139.97 41.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.853 0.359 . . . . 73.430000000000007 110.759 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.494 ' HB ' HG22 ' A' ' 23' ' ' THR . 58.0 mt -93.04 116.41 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.286 0.565 . . . . 73.530000000000001 112.485 -172.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 41' ' ' ARG . 8.0 mtp180 -82.48 -53.35 6.05 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.668 -0.696 . . . . 71.25 111.639 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.557 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 92.1 m-20 -116.56 122.86 45.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.431 -0.35 . . . . 74.120000000000005 111.144 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.83 21.95 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 112.095 0.406 . . . . 75.219999999999999 112.095 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.54 139.04 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.103 0.478 . . . . 74.140000000000001 112.021 -176.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.2 -174.43 5.23 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 116.166 -0.47 . . . . 61.32 111.908 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -89.28 67.42 7.83 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.547 0.689 . . . . 73.329999999999998 112.479 -172.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.9 p -83.39 110.99 18.61 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.174 -0.466 . . . . 72.129999999999995 111.069 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.98 -53.95 48.46 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.956 0.354 . . . . 71.109999999999999 111.956 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -113.64 93.99 30.62 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 120.854 0.359 . . . . 71.420000000000002 110.268 172.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.59 156.7 36.07 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.706 2.271 . . . . 75.010000000000005 113.858 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -85.84 154.43 21.56 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.384 -0.371 . . . . 73.209999999999994 110.908 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -61.87 -16.64 52.09 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.453 0.538 . . . . 75.340000000000003 112.453 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.02 123.82 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.621 0.248 . . . . 63.210000000000001 111.304 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -166.01 137.34 3.73 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.783 0.325 . . . . 74.209999999999994 111.064 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -127.03 -178.01 4.26 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.986 0.422 . . . . 75.219999999999999 111.802 -177.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -90.15 -8.71 50.56 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.263 -0.426 . . . . 70.420000000000002 111.894 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.4 mm -79.61 116.55 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.266 0.555 . . . . 74.319999999999993 112.291 -177.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.5 mt -70.29 148.85 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.717 -0.674 . . . . 74.409999999999997 111.288 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -132.36 166.76 21.23 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.959 0.409 . . . . 72.450000000000003 111.934 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -64.19 126.88 29.16 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.241 -0.436 . . . . 71.310000000000002 111.386 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.19 5.25 65.87 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.217 -0.516 . . . . 72.519999999999996 113.44 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.28 153.15 19.42 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.013 0.435 . . . . 71.430000000000007 111.367 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.634 HG12 ' HG3' ' A' ' 90' ' ' GLU . 59.8 t -112.69 128.83 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.419 -0.355 . . . . 75.329999999999998 110.906 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.28 154.26 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.764 0.653 . . . . 73.430000000000007 112.764 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 29.9 tt0 -89.32 109.29 20.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.892 -0.594 . . . . 74.549999999999997 110.789 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.437 HG21 HG12 ' A' ' 40' ' ' ILE . 45.5 p -110.96 168.43 9.49 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.954 0.407 . . . . 75.040000000000006 111.336 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -60.26 -19.32 54.28 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.128 0.418 . . . . 74.25 112.128 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.442 HD13 ' HB3' ' A' ' 38' ' ' ALA . 83.9 mt -93.44 -30.63 14.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.85 0.315 . . . . 73.319999999999993 111.85 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.72 -149.59 21.23 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.013 -0.613 . . . . 70.310000000000002 113.105 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -91.27 119.47 31.36 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.354 -0.497 . . . . 64.319999999999993 110.83 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.08 124.78 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.982 0.42 . . . . 65.409999999999997 111.608 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -91.76 115.05 27.73 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.241 -0.436 . . . . 65.510000000000005 110.617 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.16 121.91 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.064 0.459 . . . . 74.230000000000004 112.143 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.1 p -103.45 -43.56 5.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.16 -0.473 . . . . 64.450000000000003 111.902 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 t -93.66 -176.77 4.17 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.101 0.477 . . . . 70.019999999999996 111.972 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -84.37 126.26 69.81 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.268 -0.424 . . . . 60.439999999999998 111.806 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.454 ' HA ' HG12 ' A' ' 83' ' ' ILE . 17.9 Cg_endo -60.99 125.32 16.8 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.989 1.793 . . . . 64.099999999999994 111.692 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.08 -4.32 77.77 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.993 -0.623 . . . . 71.319999999999993 113.734 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -50.24 -64.07 0.92 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 117.271 0.535 . . . . 62.439999999999998 110.905 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -101.99 24.8 9.51 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.85 0.833 . . . . 71.200000000000003 109.636 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.43 -29.52 5.24 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 115.821 -0.627 . . . . 60.5 112.438 -173.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.409 HG23 ' N ' ' A' ' 83' ' ' ILE . 8.2 p -109.97 165.74 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 122.74 0.416 . . . . 73.450000000000003 111.172 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 77' ' ' PRO . 34.4 mt -101.85 148.19 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.844 0.354 . . . . 61.329999999999998 111.225 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -119.3 134.75 55.05 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.668 0.271 . . . . 73.140000000000001 111.485 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.24 178.31 31.96 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.001 -0.618 . . . . 54.149999999999999 113.4 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 t -110.44 141.48 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 111.964 0.357 . . . . 71.109999999999999 111.964 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.0 tp -82.78 111.33 18.6 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.032 0.382 . . . . 70.510000000000005 112.032 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.8 pt -143.57 -169.62 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.22 0.533 . . . . 73.120000000000005 111.593 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -137.92 99.14 3.82 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.264 -0.425 . . . . 73.450000000000003 111.0 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.634 ' HG3' HG12 ' A' ' 63' ' ' VAL . 11.8 mm-40 -78.3 -34.35 48.84 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.236 0.541 . . . . 74.530000000000001 111.242 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.442 ' N ' HD21 ' A' ' 91' ' ' LEU . 1.7 pt? -137.14 146.88 45.54 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.843 -0.617 . . . . 72.420000000000002 110.72 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.571 ' HG2' ' N ' ' A' ' 93' ' ' HIS . 32.2 tt0 -77.7 165.27 24.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.946 0.403 . . . . 70.340000000000003 111.075 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.571 ' N ' ' HG2' ' A' ' 92' ' ' GLU . 21.3 t-80 -45.52 -33.33 2.67 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.84 0.456 . . . . 74.409999999999997 111.745 173.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -125.64 105.75 9.23 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.498 -0.319 . . . . 37.259999999999998 110.65 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -78.78 -175.12 4.27 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.812 0.339 . . . . 64.310000000000002 111.884 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -48.73 128.51 15.52 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.673 0.62 . . . . 75.420000000000002 112.673 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -120.91 -31.19 4.25 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.455 0.539 . . . . 72.120000000000005 112.455 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.798 -0.62 . . . . 73.540000000000006 112.601 -176.282 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.582 -0.207 . . . . 65.310000000000002 112.582 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -92.49 108.56 20.06 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.073 0.463 . . . . 64.450000000000003 111.374 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -142.54 81.77 1.75 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.368 0.604 . . . . 74.510000000000005 109.617 174.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.5 mtm-85 -80.92 99.37 8.34 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.356 0.598 . . . . 72.230000000000004 112.291 -172.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 p -79.14 137.53 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 115.909 -0.587 . . . . 63.409999999999997 111.474 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -124.19 106.17 10.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.741 -0.466 . . . . 74.540000000000006 109.741 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.8 tp -127.16 76.95 1.7 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.557 0.694 . . . . 72.010000000000005 111.455 -170.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.64 136.1 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.555 -0.748 . . . . 63.130000000000003 110.258 174.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -115.21 145.89 41.97 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.058 0.456 . . . . 74.340000000000003 111.43 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.0 p -118.19 164.57 14.96 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.102 -0.499 . . . . 72.510000000000005 111.081 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -146.9 154.16 40.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.829 0.347 . . . . 72.420000000000002 111.37 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.99 -178.4 15.29 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.023 -0.608 . . . . 71.439999999999998 113.386 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -124.28 140.06 12.36 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.4 -0.429 . . . . 70.140000000000001 112.283 177.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -67.41 90.51 0.24 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.064 0.459 . . . . 64.540000000000006 111.358 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.8 m -119.71 113.75 21.12 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.243 -0.435 . . . . 73.400000000000006 110.654 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.444 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -134.65 155.64 50.14 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.961 0.41 . . . . 72.420000000000002 111.755 -176.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.05 150.82 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 116.47 -0.332 . . . . 70.129999999999995 111.244 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -60.38 165.58 3.55 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.134 0.492 . . . . 75.420000000000002 112.022 176.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 tt -61.65 112.16 2.13 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.18 0.514 . . . . 71.519999999999996 111.016 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.11 -54.95 1.69 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.871 -0.604 . . . . 54.32 110.923 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.2 m -117.03 -49.19 2.62 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.167 -0.47 . . . . 75.349999999999994 110.576 175.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.36 105.63 0.37 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.218 -0.446 . . . . 75.5 111.112 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.4 ' CG2' ' HB ' ' A' ' 40' ' ' ILE . 90.4 m -89.87 114.86 26.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.929 0.395 . . . . 75.129999999999995 111.878 -175.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -149.81 148.18 28.87 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.287 -0.415 . . . . 72.420000000000002 110.771 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.6 tt -143.08 139.48 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 121.192 0.52 . . . . 64.239999999999995 112.018 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -83.92 105.32 14.71 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.187 0.517 . . . . 72.409999999999997 110.781 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.481 HG23 HG11 ' A' ' 71' ' ' VAL . 48.7 t -105.61 120.53 56.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 112.49 0.552 . . . . 75.310000000000002 112.49 -172.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -95.59 122.46 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 116.587 -0.279 . . . . 74.340000000000003 110.876 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.447 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 31.6 t70 -82.53 116.47 63.98 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 120.547 0.213 . . . . 70.230000000000004 110.733 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.03 -15.07 29.27 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.606 2.204 . . . . 71.099999999999994 113.249 -177.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -78.71 -45.44 21.25 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.786 0.327 . . . . 54.020000000000003 111.742 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.3 p -104.12 -20.69 13.74 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.017 0.377 . . . . 74.0 112.017 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.28 20.8 66.22 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.199 -0.524 . . . . 71.319999999999993 112.973 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.447 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 65.5 pttt -88.07 139.39 30.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.044 0.45 . . . . 65.140000000000001 111.628 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.8 t -86.72 95.58 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.076 0.465 . . . . 74.510000000000005 110.21 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -99.87 165.97 11.3 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.085 0.469 . . . . 73.230000000000004 111.179 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.09 129.87 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.164 -0.335 . . . . 65.230000000000004 110.621 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.38 170.2 15.43 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.485 0.66 . . . . 43.520000000000003 112.38 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.73 131.86 56.84 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.665 -0.698 . . . . 72.530000000000001 110.431 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.4 ' HB ' ' CG2' ' A' ' 23' ' ' THR . 59.9 mt -77.32 114.52 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.142 0.496 . . . . 75.25 112.275 -175.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.449 ' HA ' ' HE ' ' A' ' 41' ' ' ARG . 2.5 mmp_? -71.26 -50.05 36.81 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.915 -0.584 . . . . 71.430000000000007 110.695 173.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -133.11 130.94 39.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.952 -0.567 . . . . 73.420000000000002 110.754 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.5 m -87.73 14.18 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 112.598 0.592 . . . . 74.439999999999998 112.598 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.57 131.59 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-O 121.342 0.592 . . . . 74.120000000000005 112.546 -175.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 63' ' ' VAL . 5.9 pt-20 -91.53 -157.57 0.51 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.769 -0.65 . . . . 75.409999999999997 110.897 176.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -77.96 58.62 1.98 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.249 0.547 . . . . 65.239999999999995 111.323 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.9 p -72.58 99.09 2.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.072 0.463 . . . . 72.430000000000007 111.463 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.15 73.12 2.28 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.188 0.518 . . . . 73.530000000000001 110.729 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.443 ' HB3' ' HB2' ' A' ' 52' ' ' PHE . 14.7 m120 -131.94 65.2 74.92 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 116.272 -0.422 . . . . 71.349999999999994 111.852 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 51' ' ' HIS . 59.3 Cg_endo -71.06 118.19 5.56 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.199 1.933 . . . . 63.140000000000001 112.182 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 50' ' ' PRO . 73.3 m80 70.47 7.05 6.07 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.869 0.468 . . . . 62.439999999999998 111.787 -173.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.443 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 47.3 m-85 -116.73 16.11 15.36 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.892 0.377 . . . . 73.120000000000005 110.769 177.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.1 t -55.99 129.09 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.983 -0.553 . . . . 71.310000000000002 112.471 -175.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -106.84 -160.79 0.75 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.939 -0.573 . . . . 73.299999999999997 111.145 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -78.09 166.33 22.91 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.18 0.514 . . . . 73.109999999999999 111.969 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -77.68 49.17 0.73 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 116.121 -0.491 . . . . 74.540000000000006 111.787 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.9 tp -92.15 106.22 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.524 0.678 . . . . 74.349999999999994 111.593 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.6 mt -70.8 105.64 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.004 -0.544 . . . . 74.439999999999998 110.809 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -87.57 165.76 15.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.062 0.458 . . . . 73.340000000000003 112.033 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 74' ' ' THR . 63.0 ttt180 -67.79 116.71 8.77 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.424 -0.353 . . . . 61.210000000000001 110.694 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.39 -6.72 46.1 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.281 -0.485 . . . . 72.319999999999993 112.927 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.49 138.79 49.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.83 0.348 . . . . 70.439999999999998 111.168 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 55.1 t -96.3 116.26 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.999 0.428 . . . . 71.109999999999999 111.606 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.9 m -103.52 148.11 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.125 0.488 . . . . 52.049999999999997 111.678 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' ARG . 9.6 tp10 -84.91 127.99 34.42 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.086 -0.506 . . . . 73.230000000000004 110.179 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.0 p -129.73 174.78 9.38 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.933 0.397 . . . . 72.430000000000007 111.794 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.33 -18.48 64.67 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.649 0.261 . . . . 72.010000000000005 111.687 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.41 -27.77 18.1 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.991 0.424 . . . . 73.030000000000001 111.155 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.55 -150.09 21.15 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.982 -0.554 . . . . 37.590000000000003 112.242 -175.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -77.91 128.85 34.58 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.98 0.419 . . . . 74.120000000000005 111.239 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.481 HG11 HG23 ' A' ' 27' ' ' VAL . 91.7 t -126.45 119.42 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 122.113 -0.367 . . . . 73.230000000000004 111.654 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -85.16 113.0 21.21 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.713 0.292 . . . . 61.5 110.902 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.12 127.83 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 112.386 0.513 . . . . 73.120000000000005 112.386 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.46 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 77.8 p -98.79 -62.61 1.21 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 111.0 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.45 ' HB2' ' H ' ' A' ' 84' ' ' ASN . 55.3 m -76.45 117.1 17.76 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.432 -0.349 . . . . 63.340000000000003 111.396 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -59.8 130.12 88.19 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 116.58 -0.282 . . . . 75.409999999999997 110.877 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HA ' HG12 ' A' ' 83' ' ' ILE . 10.6 Cg_endo -52.04 122.59 10.81 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.312 2.675 . . . . 73.439999999999998 113.533 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.38 -36.18 1.88 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.069 -0.586 . . . . 75.019999999999996 113.009 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.51 ' O ' HG13 ' A' ' 82' ' ' VAL . 48.3 mt-30 -59.21 100.91 0.08 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.644 0.259 . . . . 63.43 111.301 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 57.41 19.31 5.05 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.061 0.393 . . . . 71.049999999999997 112.061 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.04 4.5 78.09 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.315 -0.469 . . . . 55.539999999999999 114.176 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.51 HG13 ' O ' ' A' ' 79' ' ' GLN . 13.8 p -100.54 141.49 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 117.53 0.665 . . . . 73.329999999999998 111.668 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 77' ' ' PRO . 59.2 mt -123.28 116.6 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.099 -0.5 . . . . 64.140000000000001 110.361 177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.45 ' H ' ' HB2' ' A' ' 75' ' ' SER . 13.7 m120 -103.51 154.27 19.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.808 0.337 . . . . 74.239999999999995 111.531 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.93 178.75 35.88 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.177 -0.535 . . . . 63.039999999999999 113.135 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.19 133.11 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 122.719 -0.283 . . . . 65.420000000000002 111.204 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.9 tp -76.42 106.22 7.93 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.036 0.446 . . . . 70.129999999999995 111.472 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.8 pt -122.81 179.7 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.133 0.492 . . . . 75.209999999999994 111.405 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -138.27 91.56 2.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.525 -0.307 . . . . 75.430000000000007 110.617 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -105.53 -50.94 3.1 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.811 0.3 . . . . 72.450000000000003 111.811 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.6 mt -56.58 150.21 15.95 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.866 0.365 . . . . 72.420000000000002 111.271 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.55 109.78 0.86 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.654 0.613 . . . . 60.509999999999998 112.654 -171.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -71.55 -30.31 65.74 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.054 -0.521 . . . . 73.120000000000005 112.279 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -75.03 94.34 2.86 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 110.285 -0.265 . . . . 63.509999999999998 110.285 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -47.21 105.8 0.07 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.515 0.674 . . . . 74.519999999999996 112.516 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -90.67 119.81 31.21 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.865 -0.607 . . . . 75.329999999999998 112.118 -175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -140.57 134.72 30.96 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.234 -0.439 . . . . 73.299999999999997 110.121 172.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.903 -0.57 . . . . 70.310000000000002 111.378 -176.484 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.474 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 42.3 m . . . . . 0 N--CA 1.471 0.605 0 CA-C-O 120.549 0.214 . . . . 55.31 111.505 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 23' ' ' THR . 50.4 mtm180 -162.83 169.96 19.01 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.249 0.62 . . . . 63.23 111.19 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.0 tt -147.03 139.26 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.386 -0.37 . . . . 71.32 111.51 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.426 ' OD1' HG12 ' A' ' 37' ' ' ILE . 75.5 m-20 -74.03 106.84 5.89 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.788 0.328 . . . . 72.14 110.659 176.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -97.56 123.62 50.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.109 0.481 . . . . 75.34 112.07 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.6 t -95.23 112.83 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.995 0.426 . . . . 60.43 110.594 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.53 114.99 50.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.01 -0.541 . . . . 75.14 111.077 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -82.58 -11.78 10.34 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.706 2.271 . . . . 75.31 113.007 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.461 ' CD ' HH12 ' A' ' 89' ' ' ARG . 10.9 mm-40 -77.57 -39.63 45.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.161 0.505 . . . . 75.31 110.863 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.1 p -121.27 -27.08 4.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.712 -0.677 . . . . 75.04 112.258 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.96 29.21 11.95 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.38 -0.438 . . . . 40.34 113.302 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -99.44 142.02 31.47 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 122.478 -0.425 . . . . 74.11 111.182 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.1 t -107.46 112.05 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.841 0.353 . . . . 63.05 110.774 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -133.52 141.64 47.84 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.915 0.388 . . . . 71.33 111.496 -177.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.426 HG12 ' OD1' ' A' ' 26' ' ' ASN . 45.9 mt -83.06 111.34 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.85 0.357 . . . . 71.33 111.331 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.38 157.17 17.21 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.027 0.441 . . . . 62.12 112.046 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -83.25 135.31 34.81 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.185 -0.461 . . . . 72.45 110.986 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -83.73 112.06 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 121.267 0.556 . . . . 60.14 111.016 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.451 ' HD2' HH11 ' A' ' 41' ' ' ARG . 44.4 mtp85 -82.83 -53.41 5.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.027 -0.533 . . . . 72.44 111.018 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -124.8 132.31 53.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.261 -0.427 . . . . 74.02 110.842 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 120.929 0.395 . . . . 65.11 111.928 179.173 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.612 HG21 HD13 ' A' ' 83' ' ' ILE . 69.9 mt . . . . . 0 CA--C 1.544 0.731 0 CA-C-O 121.314 0.578 . . . . 74.03 111.226 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.6 p -135.26 159.6 41.04 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.208 -0.451 . . . . 53.24 112.078 -174.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -54.51 129.06 34.71 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.122 -0.49 . . . . 65.02 111.725 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.11 -11.41 72.18 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.137 -0.554 . . . . 23.12 113.465 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 145.38 31.62 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.859 0.361 . . . . 63.14 111.124 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.0 t -109.02 124.59 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.025 0.44 . . . . 74.42 111.593 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -107.43 154.93 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.982 0.42 . . . . 64.33 111.39 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.53 133.38 38.21 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.503 -0.317 . . . . 61.24 110.782 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.5 p -136.8 179.14 6.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.989 0.423 . . . . 65.22 111.637 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -69.09 -15.38 63.43 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.757 0.313 . . . . 74.41 111.78 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.71 -13.9 20.03 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.684 0.278 . . . . 73.01 111.512 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.44 -151.94 18.63 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.383 -0.437 . . . . 53.44 112.733 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -82.81 129.18 34.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.463 -0.434 . . . . 75.33 111.162 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.78 133.66 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.8 0.333 . . . . 74.33 111.459 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.478 ' HB2' HD13 ' A' ' 88' ' ' ILE . 42.1 ttm180 -94.56 121.1 35.77 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.756 0.28 . . . . 72.34 111.756 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.491 HG21 HG23 ' A' ' 58' ' ' ILE . 39.0 t -65.9 111.32 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 116.415 -0.357 . . . . 75.32 111.08 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.493 HG23 ' HA2' ' A' ' 85' ' ' GLY . 44.1 p -91.54 -39.26 12.02 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.861 0.363 . . . . 50.42 111.808 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.246 0.546 . . . . 74.14 112.22 -178.78 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 83' ' ' ILE . 8.3 p . . . . . 0 CA--C 1.545 0.763 0 CA-C-O 121.144 0.497 . . . . 60.25 111.576 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.612 HD13 HG21 ' A' ' 58' ' ' ILE . 48.2 mt -105.0 143.75 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.366 -0.379 . . . . 75.23 110.37 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -123.55 135.84 54.22 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.827 0.346 . . . . 73.34 111.239 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.493 ' HA2' HG23 ' A' ' 74' ' ' THR . . . -154.23 179.33 30.5 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.922 -0.656 . . . . 63.54 113.801 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.26 141.52 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 122.564 -0.374 . . . . 61.14 111.049 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 tp -77.06 124.42 27.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.817 0.341 . . . . 55.11 110.854 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' A' ' 72' ' ' ARG . 10.6 pt -140.31 -175.87 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.03 0.443 . . . . 73.21 111.4 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.461 HH12 ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.665 0 CA-C-N 116.368 -0.378 . . . . 70.04 110.903 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.524 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 42.9 p . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 121.163 0.506 . . . . 65.42 111.386 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HG2' ' HG2' ' A' ' 39' ' ' GLU . 68.5 mtt180 -152.42 151.94 31.4 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.725 -0.67 . . . . 73.14 110.6 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.533 ' HB ' HD11 ' A' ' 40' ' ' ILE . 10.8 tt -138.03 141.06 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.063 0.459 . . . . 74.14 112.17 -174.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -74.19 103.48 4.63 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.049 -0.523 . . . . 73.04 110.114 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.524 HG22 HG11 ' A' ' 71' ' ' VAL . 22.6 t -102.62 136.96 32.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.335 0.495 . . . . 74.32 112.335 -173.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.55 113.52 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.881 0.372 . . . . 62.42 110.387 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -77.15 114.03 36.2 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.153 -0.476 . . . . 52.51 110.452 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.85 -8.99 15.73 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.595 2.196 . . . . 75.45 113.399 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -89.42 -33.28 16.89 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.937 0.399 . . . . 75.31 111.574 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 68.0 p -116.76 -31.41 5.48 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.356 0.502 . . . . 64.31 112.356 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.55 12.58 50.52 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.138 -0.553 . . . . 62.14 113.872 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 16.1 ptpt -89.88 162.32 15.51 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.183 0.516 . . . . 71.01 111.995 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.71 95.57 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-O 121.203 0.525 . . . . 73.3 109.938 171.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.24 138.55 41.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.321 -0.4 . . . . 74.45 111.215 -174.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -84.96 121.42 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.687 0.279 . . . . 72.41 111.216 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.534 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -108.05 150.47 27.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.73 0.3 . . . . 64.04 111.648 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 24' ' ' ARG . 33.9 mt-10 -94.03 120.93 34.96 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.778 0.323 . . . . 75.04 110.76 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.533 HD11 ' HB ' ' A' ' 25' ' ' ILE . 57.8 mt -81.86 119.95 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 112.403 0.519 . . . . 63.4 112.403 -173.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.8 mmm-85 -81.68 -56.11 4.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.044 0.449 . . . . 60.43 111.048 174.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -144.61 155.45 43.64 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.199 -0.455 . . . . 71.2 111.365 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 43' ' ' VAL . 12.2 p . . . . . 0 CA--C 1.55 0.943 0 CA-C-O 121.913 0.863 . . . . 75.04 110.818 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.7 mt . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 109.946 -0.391 . . . . 72.21 109.946 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 t -133.11 167.48 20.24 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.05 0.452 . . . . 71.11 112.157 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -61.46 128.0 34.18 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.236 -0.438 . . . . 71.21 111.297 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.25 -13.51 67.17 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.229 -0.51 . . . . 52.52 112.951 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.89 132.15 43.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.021 0.438 . . . . 74.34 111.281 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.9 t -97.13 120.23 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.844 0.354 . . . . 74.13 111.319 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 43' ' ' VAL . 34.9 m -103.53 136.23 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.034 0.445 . . . . 73.32 111.337 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.27 119.49 25.12 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.955 0.407 . . . . 44.11 110.435 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 40' ' ' ILE . 34.0 p -125.72 175.73 7.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.367 -0.378 . . . . 63.43 111.471 -175.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -61.41 -28.68 69.43 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.331 -0.395 . . . . 71.25 111.739 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 38' ' ' ALA . 83.9 mt -86.72 -22.82 25.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.755 0.312 . . . . 71.2 111.45 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.57 -153.13 21.9 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.923 -0.656 . . . . 75.32 113.511 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.495 ' H ' ' HD2' ' A' ' 89' ' ' ARG . 15.1 m120 -83.66 102.87 12.53 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.922 0.391 . . . . 72.43 111.098 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.524 HG11 HG22 ' A' ' 27' ' ' VAL . 47.6 t -97.62 119.73 46.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.962 0.41 . . . . 61.02 111.326 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -86.93 117.61 25.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.495 -0.321 . . . . 64.24 111.171 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.75 121.1 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.178 -0.464 . . . . 71.12 112.111 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -107.3 -41.79 5.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.249 -0.432 . . . . 71.4 111.799 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.9 m . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 121.283 0.564 . . . . 71.42 112.176 -179.279 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.799 0.333 . . . . 64.11 110.615 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.2 mt -96.08 143.87 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.299 -0.41 . . . . 62.4 111.588 -177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -118.92 148.96 42.37 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.301 0.24 . . . . 62.52 110.749 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.3 -170.25 26.82 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 121.089 -0.576 . . . . 53.42 113.641 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 2.3 t -121.08 147.73 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 122.487 -0.419 . . . . 72.23 111.126 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 50.5 tp -89.74 113.55 25.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.412 0.523 . . . . 73.42 112.412 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.5 pt -136.75 -173.51 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.077 0.465 . . . . 51.21 110.815 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HD2' ' H ' ' A' ' 70' ' ' ASN . 24.0 mmm180 . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.111 0.481 . . . . 75.41 111.35 176.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 m . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 120.88 0.371 . . . . 60.02 111.134 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 24' ' ' ARG . 21.1 mtp180 -145.36 166.86 24.35 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.159 -0.473 . . . . 64.0 111.369 -176.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 tt -151.85 131.9 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.088 0.471 . . . . 62.03 112.265 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -72.03 104.63 3.62 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.296 -0.411 . . . . 74.44 110.687 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -100.72 129.35 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.007 0.432 . . . . 63.33 111.817 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.2 t -95.6 117.64 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.351 -0.386 . . . . 75.4 111.062 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -75.58 115.01 41.88 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.251 -0.431 . . . . 74.43 110.345 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.26 -19.46 15.29 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.571 2.181 . . . . 72.04 112.727 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -85.43 -43.03 13.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.178 -0.465 . . . . 71.43 111.675 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.6 p -105.57 -19.5 13.75 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.325 0.491 . . . . 65.15 112.325 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.67 11.37 79.84 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.088 -0.577 . . . . 63.0 113.638 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -88.7 162.72 16.13 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.954 0.407 . . . . 73.33 111.63 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.3 t -112.5 115.64 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.776 0.322 . . . . 72.24 110.473 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -126.31 141.35 51.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 122.56 0.344 . . . . 64.34 110.833 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 mt -94.0 120.07 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.83 0.347 . . . . 71.52 111.657 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.508 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -107.32 160.91 15.26 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.166 0.508 . . . . 62.44 112.188 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -102.77 124.32 48.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.311 -0.404 . . . . 73.44 110.55 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.433 ' HA ' HG22 ' A' ' 66' ' ' THR . 68.2 mt -78.58 112.65 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.356 0.598 . . . . 73.15 112.411 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -83.55 -53.8 5.41 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.033 -0.53 . . . . 74.04 111.517 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 38.5 m-80 -120.98 152.88 38.03 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.893 0.378 . . . . 71.44 111.709 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.544 0.733 0 CA-C-O 121.33 0.586 . . . . 64.23 110.97 174.673 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 61.1 mt . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 120.948 0.404 . . . . 74.24 110.216 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -106.69 163.71 12.69 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.668 0.618 . . . . 53.22 112.668 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.6 ttp-105 -56.99 116.65 3.34 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.392 -0.822 . . . . 74.24 111.837 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.23 -12.45 55.27 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.157 -0.544 . . . . 51.43 113.749 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.03 159.71 32.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.32 0.56 . . . . 32.24 111.47 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.6 t -118.15 124.41 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.128 0.49 . . . . 61.31 111.226 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.418 ' HB ' HG23 ' A' ' 40' ' ' ILE . 35.3 m -108.14 147.45 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.931 0.396 . . . . 62.04 111.761 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 28.5 tt0 -87.7 126.67 35.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.428 -0.351 . . . . 72.52 110.138 174.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 40' ' ' ILE . 33.6 p -129.46 176.0 8.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.996 0.427 . . . . 74.01 111.387 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -62.23 -20.68 64.46 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.404 -0.362 . . . . 71.45 111.553 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' A' ' 38' ' ' ALA . 71.7 mt -101.18 8.61 42.56 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.655 0.264 . . . . 64.43 111.696 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.09 -154.74 16.88 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.301 -0.476 . . . . 54.13 112.907 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -80.78 137.69 36.24 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.258 -0.554 . . . . 60.25 111.571 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.2 t -126.51 130.63 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.337 -0.392 . . . . 75.33 111.105 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.585 ' HB2' HD13 ' A' ' 88' ' ' ILE . 41.5 ttm180 -91.32 114.21 26.68 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.711 0.291 . . . . 73.34 110.739 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.7 t -66.54 131.35 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 112.834 0.679 . . . . 74.45 112.834 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.4 p -108.98 -61.33 1.63 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.942 -0.572 . . . . 51.54 111.627 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 121.125 0.488 . . . . 73.13 112.128 -178.394 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 121.063 0.459 . . . . 63.44 111.683 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.4 mt -123.15 147.53 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.681 -0.488 . . . . 75.25 109.681 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -128.54 145.94 50.98 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.892 -0.505 . . . . 75.33 112.276 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.38 -179.39 38.5 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 121.386 -0.435 . . . . 72.34 113.205 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.6 t -116.64 142.41 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 116.962 0.381 . . . . 65.15 111.381 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.469 HD11 HH12 ' A' ' 89' ' ' ARG . 51.5 tp -76.99 115.31 16.68 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.675 0.274 . . . . 72.34 111.621 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 72' ' ' ARG . 22.2 pt -133.82 -176.59 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.297 0.57 . . . . 73.2 111.844 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.469 HH12 HD11 ' A' ' 87' ' ' LEU . 31.8 mmt180 . . . . . 0 CA--C 1.539 0.541 0 CA-C-N 116.094 -0.503 . . . . 74.14 111.451 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.435 HG22 ' HB ' ' A' ' 40' ' ' ILE . 17.8 m . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 120.624 0.25 . . . . 64.01 110.81 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 34.6 ttm180 -148.02 154.0 39.69 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.929 0.395 . . . . 74.12 111.968 -172.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.0 tt -148.87 146.16 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.945 0.402 . . . . 73.23 111.619 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.637 ' ND2' HG23 ' A' ' 82' ' ' VAL . 29.9 m-80 -94.16 112.71 24.55 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.88 0.371 . . . . 72.54 110.064 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.3 t -102.39 130.99 51.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.053 -0.521 . . . . 72.54 112.055 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.7 t -95.11 120.47 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.073 0.464 . . . . 64.35 110.882 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.21 116.71 61.16 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.974 -0.557 . . . . 73.15 111.028 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.9 -17.04 11.06 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.693 2.262 . . . . 74.04 112.927 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -87.96 -43.17 11.95 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.834 0.35 . . . . 55.23 111.559 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 p -106.25 -26.9 11.34 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.583 0.586 . . . . 74.34 112.583 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.61 15.97 57.5 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.126 -0.559 . . . . 70.35 114.325 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -97.41 143.86 27.73 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.243 -0.563 . . . . 74.4 111.397 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.4 t -88.51 98.33 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.171 0.51 . . . . 71.01 109.894 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -101.32 138.61 38.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.933 -0.576 . . . . 62.11 110.94 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 55.1 mt -92.31 127.72 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.071 0.462 . . . . 64.43 111.439 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.89 160.0 35.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 53.52 110.995 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 39.0 mt-10 -109.17 134.69 51.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.873 0.368 . . . . 64.24 110.48 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.504 ' HA ' HG22 ' A' ' 66' ' ' THR . 60.6 mt -71.52 113.68 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.512 0.672 . . . . 72.44 112.046 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -37.32 41.45 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.107 -0.951 . . . . 73.01 110.302 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.667 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 59.9 t30 -141.04 119.12 11.95 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.939 -0.573 . . . . 64.41 110.545 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 112.619 0.6 . . . . 64.13 112.619 -176.878 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.508 HG23 HG21 ' A' ' 73' ' ' VAL . 62.9 mt . . . . . 0 CA--C 1.545 0.759 0 CA-C-O 121.207 0.527 . . . . 74.52 111.852 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.428 ' O ' ' HB ' ' A' ' 73' ' ' VAL . 30.2 p -128.21 162.73 26.3 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.461 0.541 . . . . 74.34 112.461 -175.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -57.32 116.92 3.6 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.123 -0.489 . . . . 74.21 111.717 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.1 -11.36 60.38 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.211 -0.519 . . . . 63.32 113.217 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.02 131.06 40.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.817 0.341 . . . . 74.44 111.137 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -94.3 112.37 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 120.774 0.321 . . . . 61.33 111.348 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -103.04 148.52 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.119 0.485 . . . . 71.34 111.253 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 43.8 tt0 -92.52 123.99 36.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.386 -0.37 . . . . 53.55 110.885 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 40' ' ' ILE . 44.1 p -126.24 176.16 7.28 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.071 0.462 . . . . 61.2 111.879 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -65.09 -15.39 62.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.337 -0.392 . . . . 73.2 111.962 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -92.31 -32.35 15.04 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.221 0.534 . . . . 73.33 111.085 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.81 -150.05 21.88 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.905 -0.588 . . . . 62.41 112.26 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -80.53 130.49 35.17 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.444 -0.445 . . . . 63.31 111.193 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.4 t -126.41 128.66 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.417 -0.356 . . . . 74.23 111.457 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.477 ' HB2' HD13 ' A' ' 88' ' ' ILE . 42.0 ttm180 -91.29 117.44 29.65 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.251 -0.28 . . . . 44.42 110.91 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.508 HG21 HG23 ' A' ' 58' ' ' ILE . 45.9 t -66.3 133.83 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.73 0.3 . . . . 43.2 111.754 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -110.39 -73.2 0.69 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.707 0.289 . . . . 73.04 111.61 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 121.231 0.539 . . . . 64.33 111.81 -179.202 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.637 HG23 ' ND2' ' A' ' 26' ' ' ASN . 10.9 p . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 112.834 0.679 . . . . 73.23 112.834 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.0 mt -122.98 147.4 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.479 -0.782 . . . . 73.41 109.588 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -122.21 139.95 53.17 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.471 0.545 . . . . 72.33 112.471 -175.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.72 171.43 37.67 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 116.133 -0.485 . . . . 54.3 112.915 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.38 141.24 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 122.522 -0.399 . . . . 71.32 111.424 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.07 117.53 18.72 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.751 0.31 . . . . 60.31 111.311 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.477 HD13 ' HB2' ' A' ' 72' ' ' ARG . 18.0 pt -132.2 175.07 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.25 0.548 . . . . 73.13 111.314 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 . . . . . 0 N--CA 1.472 0.665 0 CA-C-N 116.051 -0.522 . . . . 65.55 111.418 -178.127 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 112.189 0.44 . . . . 75.42 112.189 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 24' ' ' ARG . 55.9 mtt180 -151.04 161.6 42.42 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.05 0.452 . . . . 72.21 111.918 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.5 tt -149.15 144.12 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 115.883 -0.599 . . . . 73.2 111.308 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -79.04 108.25 12.4 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.297 -0.41 . . . . 74.22 110.989 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 71' ' ' VAL . 28.5 t -94.63 120.44 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.312 -0.404 . . . . 72.23 111.865 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.02 118.17 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.935 0.398 . . . . 74.2 111.053 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 14.9 t0 -73.86 118.87 72.87 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.455 -0.339 . . . . 74.03 111.147 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 29' ' ' ASP . 12.9 Cg_exo -70.58 -28.13 21.68 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.885 2.39 . . . . 74.4 113.391 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.23 -44.06 11.73 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.41 0.522 . . . . 73.34 112.41 -173.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.7 p -104.73 -15.36 15.26 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.326 0.491 . . . . 71.53 112.326 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.04 28.15 69.03 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.144 -0.55 . . . . 63.25 114.021 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -100.38 145.69 27.88 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.152 0.476 . . . . 72.13 111.445 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -110.73 133.09 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 120.892 0.377 . . . . 72.52 111.352 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -147.24 139.69 24.71 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.47 -0.332 . . . . 73.3 111.074 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 61.3 mt -86.88 125.61 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.962 0.411 . . . . 74.22 111.11 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.468 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -122.51 154.38 37.93 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.381 0.512 . . . . 43.25 112.381 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -90.55 133.24 35.22 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.743 0.306 . . . . 42.04 110.502 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.474 ' HA ' HG22 ' A' ' 66' ' ' THR . 57.9 mt -83.1 114.71 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.838 0.352 . . . . 61.3 111.563 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -73.95 -46.68 42.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.392 -0.367 . . . . 74.3 111.208 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -140.18 139.59 35.72 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.563 -0.29 . . . . 62.51 110.815 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 t . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 112.585 0.587 . . . . 64.52 112.585 -175.798 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.762 HG21 HD13 ' A' ' 83' ' ' ILE . 59.5 mt . . . . . 0 CA--C 1.542 0.641 0 CA-C-O 121.367 0.603 . . . . 62.22 110.759 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -134.06 173.05 12.0 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.145 -0.479 . . . . 71.41 111.338 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -58.74 115.95 3.41 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.999 0.428 . . . . 62.31 111.277 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.22 -13.19 52.01 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.228 -0.511 . . . . 63.44 113.665 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.25 139.31 48.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 117.061 0.43 . . . . 73.44 111.683 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.9 t -110.78 119.5 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 116.359 -0.382 . . . . 72.33 111.703 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 70' ' ' ASN . 32.6 m -114.8 159.23 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.77 0.319 . . . . 72.31 111.85 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.22 126.8 43.85 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.814 0.34 . . . . 71.14 110.806 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 40' ' ' ILE . 34.7 p -125.59 178.81 5.45 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.504 -0.316 . . . . 42.5 111.067 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.468 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 16.9 p-10 -67.68 -16.1 63.98 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.725 0.298 . . . . 72.33 111.771 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.4 mt -95.73 -22.31 17.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.984 0.421 . . . . 61.34 111.193 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.27 -154.76 21.78 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 112.079 -0.408 . . . . 72.22 112.079 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 93.5 m-20 -81.18 133.34 35.44 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 122.094 -0.65 . . . . 65.23 111.711 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 27' ' ' VAL . 23.8 t -121.63 119.5 59.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.922 -0.581 . . . . 61.25 110.594 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.539 ' HB2' HD13 ' A' ' 88' ' ' ILE . 33.4 ttt-85 -91.21 116.52 28.88 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.675 0.274 . . . . 74.33 110.375 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.428 HG21 HG23 ' A' ' 58' ' ' ILE . 45.7 t -61.02 118.27 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.049 0.452 . . . . 63.23 112.141 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.6 p -97.21 -47.1 5.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.205 -0.452 . . . . 71.24 111.427 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.471 0.593 0 CA-C-N 116.253 -0.43 . . . . 62.21 111.377 179.947 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 83' ' ' ILE . 11.5 p . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 120.897 0.38 . . . . 72.21 111.413 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.762 HD13 HG21 ' A' ' 58' ' ' ILE . 37.1 mt -106.51 129.15 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 122.52 0.328 . . . . 74.32 111.273 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -113.73 141.24 47.51 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.977 0.417 . . . . 72.34 111.465 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.55 173.69 34.32 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.36 -0.448 . . . . 73.31 113.049 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -105.05 150.76 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 113.082 0.771 . . . . 64.11 113.082 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 29' ' ' ASP . 66.4 tp -82.02 107.62 14.87 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.188 -0.914 . . . . 74.32 111.893 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 72' ' ' ARG . 10.2 pt -120.5 173.31 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.005 0.431 . . . . 73.03 110.492 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.457 ' HD2' ' O ' ' A' ' 88' ' ' ILE . 19.3 mmm180 . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 120.954 0.407 . . . . 73.11 110.855 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.649 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 77.8 p . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 120.85 0.357 . . . . 72.24 110.791 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -118.86 118.75 32.39 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.995 0.426 . . . . 75.5 111.749 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.8 tt -126.59 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.04 0.448 . . . . 74.3 112.065 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -70.21 103.82 2.46 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.309 -0.405 . . . . 63.3 110.831 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.04 115.58 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.125 0.488 . . . . 70.5 111.592 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.3 t -102.61 126.67 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.043 -0.526 . . . . 74.22 111.054 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.645 ' HB2' ' HG2' ' A' ' 34' ' ' LYS . 10.7 t0 -83.33 121.82 76.96 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 120.623 0.249 . . . . 72.34 110.443 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.476 ' HD3' HG12 ' A' ' 86' ' ' VAL . 59.7 Cg_endo -69.87 -32.08 18.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.756 2.304 . . . . 72.32 112.843 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -89.63 -43.46 10.73 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.688 0.625 . . . . 75.02 112.688 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.6 p -97.54 -31.83 12.12 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.396 0.517 . . . . 73.31 112.396 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.96 29.75 16.88 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.984 -0.626 . . . . 71.15 113.985 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.645 ' HG2' ' HB2' ' A' ' 29' ' ' ASP . 10.6 ptpp? -90.29 137.86 32.01 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.399 0.599 . . . . 64.12 111.074 177.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.8 t -115.17 102.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.019 0.438 . . . . 61.35 110.693 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -131.69 140.64 49.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.448 -0.342 . . . . 60.22 111.13 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.3 mt -86.5 121.04 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.858 0.361 . . . . 61.01 110.542 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.17 152.83 32.93 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.861 0.689 . . . . 62.44 112.861 -175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 23' ' ' THR . 1.9 mp0 -83.4 130.76 35.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.002 -0.544 . . . . 74.35 110.831 175.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.464 HG12 HG22 ' A' ' 66' ' ' THR . 60.6 mt -88.31 114.4 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.689 0.28 . . . . 64.42 111.443 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -83.41 -53.67 5.54 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.126 0.489 . . . . 71.32 111.831 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 84.7 m-20 -122.42 135.69 54.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.989 0.424 . . . . 73.32 111.82 -174.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 121.174 0.511 . . . . 71.15 111.148 176.879 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.8 mt . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 120.658 0.266 . . . . 73.3 111.064 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.4 p -134.63 160.38 38.27 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.296 0.238 . . . . 64.12 111.514 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 48.8 ttp180 -53.83 119.69 5.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.84 0.353 . . . . 65.31 111.316 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.91 -20.45 14.63 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.215 -0.448 . . . . 45.2 112.646 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.99 153.9 29.94 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.089 0.471 . . . . 64.13 112.23 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.8 t -105.99 114.19 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.097 -0.501 . . . . 71.51 111.636 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.434 ' HB ' HG23 ' A' ' 40' ' ' ILE . 30.6 m -103.33 118.79 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.374 0.607 . . . . 52.2 111.368 177.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 32.4 tt0 -77.72 108.63 11.07 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.995 0.426 . . . . 72.43 111.169 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.464 HG22 HG12 ' A' ' 40' ' ' ILE . 24.1 p -102.96 169.81 8.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.287 -0.415 . . . . 41.44 111.124 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -59.01 -20.89 57.28 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.616 0.598 . . . . 64.33 112.616 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.7 mt -89.62 -25.3 21.36 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.965 0.412 . . . . 73.04 111.269 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 147.95 -176.61 26.7 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 116.103 -0.499 . . . . 73.3 112.738 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -72.74 119.46 17.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.22 0.533 . . . . 61.2 111.773 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.57 135.14 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.03 -0.532 . . . . 72.44 111.213 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.533 ' HB2' HD13 ' A' ' 88' ' ' ILE . 30.9 ttm180 -91.94 126.91 37.2 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.204 -0.31 . . . . 73.04 111.001 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 30.2 t -68.86 100.64 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.767 0.318 . . . . 70.22 110.255 174.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.8 p -102.18 -26.01 13.5 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 122.052 -0.405 . . . . 71.2 111.666 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.405 ' CB ' ' HB2' ' A' ' 84' ' ' ASN . 37.4 t . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 120.898 0.38 . . . . 63.13 110.623 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 83' ' ' ILE . 7.2 p . . . . . 0 CA--C 1.547 0.829 0 CA-C-O 121.103 0.477 . . . . 74.54 111.897 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.435 ' N ' HG22 ' A' ' 82' ' ' VAL . 29.5 mt -116.62 136.37 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.421 -0.354 . . . . 74.52 110.721 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.405 ' HB2' ' CB ' ' A' ' 75' ' ' SER . 4.4 m-20 -115.9 141.82 47.59 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.079 0.466 . . . . 64.44 111.741 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.58 174.2 30.76 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 116.102 -0.499 . . . . 43.45 112.968 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.476 HG12 ' HD3' ' A' ' 30' ' ' PRO . 6.3 t -120.46 132.31 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 122.299 -0.53 . . . . 75.41 111.813 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.65 105.76 3.81 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.88 0.371 . . . . 73.32 111.033 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.533 HD13 ' HB2' ' A' ' 72' ' ' ARG . 11.5 pt -104.69 172.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.452 0.644 . . . . 71.21 112.194 -174.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.425 ' HD2' ' C ' ' A' ' 88' ' ' ILE . 7.8 mpt_? . . . . . 0 N--CA 1.473 0.721 0 CA-C-N 115.791 -0.641 . . . . 72.0 112.195 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.7 p . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.009 0.433 . . . . 73.4 111.891 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 24' ' ' ARG . 49.1 mtm180 -143.9 163.46 33.35 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.374 -0.375 . . . . 65.1 111.019 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.482 ' HB ' HD11 ' A' ' 40' ' ' ILE . 14.0 tt -150.5 143.78 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.884 0.373 . . . . 63.34 111.767 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -72.82 103.4 3.67 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.044 0.45 . . . . 64.43 110.262 173.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 55.2 t -91.25 113.79 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 63.52 111.904 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.9 t -95.62 113.02 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.021 -0.536 . . . . 74.31 110.774 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.79 118.72 74.08 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 61.11 111.56 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.61 -1.73 10.7 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.832 2.355 . . . . 73.43 113.705 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.87 -44.0 13.61 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.252 -0.28 . . . . 64.33 111.664 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.4 p -124.55 -11.41 7.32 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.803 0.668 . . . . 64.3 112.803 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.22 24.66 39.61 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 120.974 -0.631 . . . . 64.33 113.785 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -93.01 145.59 24.25 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.411 -0.464 . . . . 72.52 111.21 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.51 132.96 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.772 0.32 . . . . 73.41 111.196 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -147.83 143.03 27.18 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.6 0.238 . . . . 75.25 111.161 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.8 mt -86.22 111.41 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 122.25 -0.281 . . . . 64.32 111.12 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.485 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -110.54 155.2 22.63 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.118 0.414 . . . . 74.13 112.118 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -85.46 122.65 29.9 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.896 0.379 . . . . 62.14 111.495 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.563 ' HA ' HG22 ' A' ' 66' ' ' THR . 62.2 mt -73.04 116.59 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.423 -0.353 . . . . 61.21 110.726 176.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -81.04 -54.33 5.64 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.817 0.341 . . . . 75.53 111.367 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -145.41 152.8 40.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.872 0.368 . . . . 74.35 111.254 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.475 ' O ' HG22 ' A' ' 43' ' ' VAL . 13.8 p . . . . . 0 CA--C 1.549 0.917 0 CA-C-O 121.443 0.64 . . . . 74.13 111.712 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.559 HG21 HD13 ' A' ' 83' ' ' ILE . 46.4 mm . . . . . 0 CA--C 1.541 0.628 0 CA-C-O 120.714 0.292 . . . . 75.22 111.337 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -147.85 167.57 24.43 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.184 -0.322 . . . . 70.22 111.586 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -62.35 127.29 30.66 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.057 0.456 . . . . 65.24 111.675 -176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.55 -22.09 42.18 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.286 -0.483 . . . . 42.5 112.909 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.86 129.36 37.75 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.911 0.386 . . . . 54.32 111.3 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.03 115.27 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.307 -0.406 . . . . 65.44 111.396 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' A' ' 40' ' ' ILE . 35.2 m -103.59 129.02 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.232 0.539 . . . . 72.54 111.341 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -76.44 110.27 10.85 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.891 0.377 . . . . 42.34 110.767 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 40' ' ' ILE . 33.3 p -107.78 171.9 7.13 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.841 0.353 . . . . 73.22 111.267 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.485 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 10.1 p-10 -55.78 -33.9 64.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.439 -0.346 . . . . 73.42 111.545 176.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' A' ' 38' ' ' ALA . 74.9 mt -81.23 -29.82 34.36 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.744 0.276 . . . . 62.21 111.744 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.01 -166.96 29.42 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.528 -0.844 . . . . 52.53 113.921 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -71.17 101.69 2.34 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.841 0.353 . . . . 61.34 111.523 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.9 t -99.61 117.0 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.086 0.47 . . . . 61.14 111.342 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -87.16 117.76 26.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.839 0.352 . . . . 61.15 110.61 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.432 HG21 HG23 ' A' ' 58' ' ' ILE . 51.8 t -67.95 140.17 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 112.61 0.596 . . . . 51.22 112.61 -173.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.0 p -117.95 -43.47 2.76 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.404 0.52 . . . . 75.1 112.404 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 121.099 0.476 . . . . 61.42 112.139 -177.175 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 121.078 0.466 . . . . 63.11 111.533 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.559 HD13 HG21 ' A' ' 58' ' ' ILE . 62.9 mt -121.69 145.43 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 120.988 0.423 . . . . 72.33 110.985 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -120.04 147.52 44.72 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.117 -0.364 . . . . 74.12 111.206 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.23 176.81 40.13 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.221 -0.514 . . . . 54.52 112.915 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.82 146.88 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.579 0.704 . . . . 63.24 112.899 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 63.8 tp -85.68 112.66 21.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.294 -0.866 . . . . 74.13 112.204 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.4 pt -134.43 -174.78 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.954 0.407 . . . . 53.22 111.182 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.82 0.343 . . . . 73.3 111.089 177.002 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 30.6 p . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.143 0.497 . . . . 75.33 111.947 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -144.63 155.59 43.69 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.208 -0.451 . . . . 62.41 111.101 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.446 ' HB ' HD11 ' A' ' 40' ' ' ILE . 13.1 tt -145.45 145.82 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.792 0.33 . . . . 52.32 111.537 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -80.3 103.78 10.41 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.425 0.631 . . . . 73.23 110.506 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' A' ' 87' ' ' LEU . 23.0 t -95.36 121.88 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.429 -0.805 . . . . 74.03 111.922 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.5 112.28 26.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.931 0.396 . . . . 64.41 110.571 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -74.26 118.24 68.16 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.477 -0.329 . . . . 61.31 111.142 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.93 -12.36 17.85 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.554 2.17 . . . . 71.15 113.116 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -81.67 -44.73 16.75 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.818 0.342 . . . . 63.34 111.907 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -107.18 -31.0 8.43 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.785 0.291 . . . . 61.51 111.785 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.8 16.96 34.36 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.333 -0.461 . . . . 71.51 113.733 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -87.21 150.67 23.76 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 117.234 0.517 . . . . 74.33 111.813 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.86 95.31 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.522 0.677 . . . . 63.11 110.49 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -93.02 170.03 9.97 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.504 -0.771 . . . . 75.24 110.868 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 mt -125.16 124.77 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 122.035 -0.416 . . . . 73.33 111.09 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.85 163.13 19.73 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.554 0.576 . . . . 75.34 112.554 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.82 123.39 36.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.01 -0.541 . . . . 71.53 110.648 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 23' ' ' THR . 57.7 mt -78.79 106.19 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 120.022 -0.671 . . . . 64.43 110.341 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -88.08 -37.05 16.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.789 -0.641 . . . . 74.45 112.573 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.557 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 46.2 m-80 -133.31 146.84 51.72 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.115 0.483 . . . . 72.21 111.322 173.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 112.44 0.533 . . . . 74.23 112.44 -176.443 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 120.823 0.344 . . . . 70.12 111.165 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -147.81 174.12 12.14 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.009 0.433 . . . . 72.31 111.827 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -71.89 118.72 15.09 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.188 -0.46 . . . . 73.54 111.381 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.93 30.68 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.42 -0.419 . . . . 54.52 112.914 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.08 142.34 31.35 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.968 0.413 . . . . 63.35 111.927 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.07 141.13 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.78 0.324 . . . . 64.52 111.155 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.62 173.34 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.971 0.415 . . . . 71.32 111.469 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 34.5 tt0 -112.52 133.26 54.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.41 -0.359 . . . . 72.42 110.791 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.421 HG22 ' HA ' ' A' ' 40' ' ' ILE . 41.6 p -135.68 178.67 6.86 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.328 0.585 . . . . 52.34 111.804 -176.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -69.89 -14.41 62.72 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.99 -0.55 . . . . 62.33 112.383 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.58 -17.23 18.77 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.809 0.338 . . . . 74.43 111.247 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.99 -149.29 20.17 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.41 -0.676 . . . . 72.14 111.41 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -94.16 148.53 22.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 117.646 0.723 . . . . 71.01 111.276 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.6 t -133.89 127.07 51.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.65 -0.25 . . . . 74.34 111.241 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 72' ' ' ARG . 15.5 ttm180 -96.28 115.95 28.24 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.557 0.217 . . . . 65.43 110.832 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.76 126.99 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.448 0.536 . . . . 74.11 112.448 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.5 p -100.96 -41.37 6.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.634 0.605 . . . . 74.02 112.634 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 121.018 0.437 . . . . 75.31 111.855 -177.792 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 120.849 0.357 . . . . 62.24 111.269 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.2 mt -102.83 144.99 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.734 0.302 . . . . 72.01 110.71 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -126.94 151.23 48.77 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.584 0.231 . . . . 70.13 111.421 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -167.44 175.88 42.38 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.277 -0.487 . . . . 74.22 113.239 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.1 t -106.3 142.11 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 117.078 0.439 . . . . 71.34 111.405 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.495 ' HB2' HG12 ' A' ' 27' ' ' VAL . 40.7 tp -76.36 114.35 14.95 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.157 0.503 . . . . 74.04 111.456 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' A' ' 72' ' ' ARG . 8.0 pt -133.51 179.22 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.189 0.518 . . . . 64.02 111.166 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 . . . . . 0 N--CA 1.473 0.696 0 O-C-N 122.207 -0.308 . . . . 62.43 111.239 -176.807 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.517 HG22 ' HB ' ' A' ' 40' ' ' ILE . 25.8 m . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 120.914 0.387 . . . . 63.5 111.729 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -129.11 165.83 20.49 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.521 -0.308 . . . . 71.23 111.485 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.541 ' HB ' HD11 ' A' ' 40' ' ' ILE . 15.5 tt -155.17 139.74 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.762 0.315 . . . . 74.14 111.419 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.459 ' OD1' HG12 ' A' ' 37' ' ' ILE . 90.3 m-20 -80.93 103.61 10.87 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.015 0.436 . . . . 70.22 110.841 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.447 HG22 HG21 ' A' ' 71' ' ' VAL . 60.3 t -85.35 121.44 37.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.98 -0.554 . . . . 73.5 112.013 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.01 111.37 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.113 -0.494 . . . . 65.33 110.788 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.425 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 11.2 t70 -77.77 115.8 53.08 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.413 -0.358 . . . . 63.12 110.283 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.28 -20.05 21.66 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.388 2.058 . . . . 73.11 113.791 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -86.01 -33.54 21.02 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.942 0.401 . . . . 65.02 111.885 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.5 p -116.4 -21.27 9.34 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.155 0.428 . . . . 62.11 112.155 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.34 25.72 50.21 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.391 0.516 . . . . 61.31 114.391 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 58.0 pttt -87.6 155.97 19.71 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.52 0.66 . . . . 75.55 111.705 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.1 t -118.7 111.5 34.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.138 -0.483 . . . . 64.51 109.909 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -133.38 136.6 45.4 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.132 0.419 . . . . 73.22 112.132 -173.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.459 HG12 ' OD1' ' A' ' 26' ' ' ASN . 61.5 mt -76.76 123.84 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.269 0.557 . . . . 50.24 112.105 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.526 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -117.81 170.32 8.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.032 -0.531 . . . . 70.14 111.606 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -104.69 127.27 52.4 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.418 -0.356 . . . . 73.45 110.466 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.541 HD11 ' HB ' ' A' ' 25' ' ' ILE . 53.8 mt -83.91 124.23 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.093 0.473 . . . . 64.35 111.617 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -81.11 -53.8 6.08 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.007 -0.542 . . . . 71.32 111.301 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -143.93 152.47 41.14 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.923 0.392 . . . . 71.4 111.553 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.516 HG13 HG12 ' A' ' 64' ' ' VAL . 48.6 t . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 109.555 -0.535 . . . . 72.43 109.555 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.589 HG21 HD13 ' A' ' 83' ' ' ILE . 62.2 mt . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.075 0.464 . . . . 74.02 110.726 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.3 t -142.24 169.4 17.65 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.051 0.453 . . . . 73.12 111.574 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -61.51 126.15 26.34 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.288 -0.415 . . . . 74.42 111.753 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.06 -24.91 21.98 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.387 -0.435 . . . . 64.21 112.97 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.24 141.64 35.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.874 0.368 . . . . 51.21 111.694 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.3 m -100.57 133.11 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.296 0.57 . . . . 60.4 111.833 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.516 HG12 HG13 ' A' ' 43' ' ' VAL . 32.1 m -111.92 146.76 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.177 0.513 . . . . 74.11 111.685 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -89.84 112.65 24.05 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.254 -0.43 . . . . 74.23 110.259 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 p -115.01 174.84 5.77 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.962 0.411 . . . . 53.11 111.593 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.526 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 19.5 p-10 -62.9 -31.78 72.9 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.992 0.425 . . . . 72.14 111.444 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 38' ' ' ALA . 88.5 mt -82.6 -19.03 39.21 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.291 -0.413 . . . . 62.13 111.464 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.18 -150.32 19.6 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.828 -0.701 . . . . 74.43 113.853 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -83.44 119.26 24.44 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.563 -0.375 . . . . 73.45 111.207 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.447 HG21 HG22 ' A' ' 27' ' ' VAL . 47.6 t -123.69 122.93 66.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.608 0.242 . . . . 73.02 111.494 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -91.22 116.09 28.55 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.284 -0.26 . . . . 63.44 111.407 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.63 134.02 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 112.336 0.495 . . . . 74.11 112.336 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.3 p -118.65 -66.9 1.03 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.331 -0.395 . . . . 61.35 111.916 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 120.787 0.327 . . . . 54.14 111.737 179.813 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.421 HG11 HD21 ' A' ' 26' ' ' ASN . 12.7 p . . . . . 0 CA--C 1.543 0.69 0 CA-C-O 120.857 0.361 . . . . 60.5 110.956 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.589 HD13 HG21 ' A' ' 58' ' ' ILE . 60.2 mt -91.75 126.98 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.533 -0.303 . . . . 74.34 111.3 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -119.31 157.41 28.14 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.774 0.321 . . . . 73.41 111.337 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.33 177.94 39.12 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.107 -0.568 . . . . 30.0 113.407 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.5 t -111.08 138.98 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 122.454 -0.439 . . . . 71.34 111.627 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.8 tp -81.08 115.66 20.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.94 0.4 . . . . 52.42 111.362 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.6 pt -141.29 -166.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 120.94 0.4 . . . . 65.14 111.759 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 120.821 0.343 . . . . 73.24 111.295 178.663 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.551 HG22 ' HB ' ' A' ' 40' ' ' ILE . 18.9 m . . . . . 0 CA--C 1.538 0.481 0 CA-C-O 121.262 0.553 . . . . 45.41 112.373 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -148.14 162.9 38.5 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.713 -0.676 . . . . 70.14 110.487 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 tt -150.55 141.81 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 112.047 0.388 . . . . 64.31 112.047 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -80.45 103.24 10.18 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.102 0.477 . . . . 73.42 110.035 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.413 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 61.3 t -90.81 125.22 43.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.506 . . . . 70.23 111.847 -175.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.38 119.86 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.066 -0.515 . . . . 62.14 110.834 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -77.49 121.45 84.41 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 116.122 -0.49 . . . . 72.32 110.98 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.32 -17.56 8.94 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.579 2.186 . . . . 71.11 112.951 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -85.21 -43.68 13.58 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.911 0.386 . . . . 54.43 111.476 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.517 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 37.2 p -114.32 -10.83 12.64 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.154 0.798 . . . . 74.14 113.154 -176.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.84 22.87 78.78 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 120.86 -0.686 . . . . 54.4 114.202 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 21.2 pttp -102.82 142.6 33.67 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.27 0.535 . . . . 70.41 111.49 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.8 t -102.88 119.86 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.824 0.345 . . . . 74.21 111.081 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -132.38 146.09 51.71 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.983 0.42 . . . . 75.43 111.579 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 53.4 mt -82.71 125.78 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.844 0.354 . . . . 75.44 111.589 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.533 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -118.55 162.41 18.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.245 0.545 . . . . 65.2 112.195 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -102.86 114.36 28.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.966 -0.561 . . . . 64.24 110.511 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.551 ' HB ' HG22 ' A' ' 23' ' ' THR . 58.7 mt -76.1 113.38 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.738 0.304 . . . . 61.23 111.372 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -83.1 -53.87 5.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.037 0.446 . . . . 45.41 111.368 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -121.32 151.47 40.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.109 -0.496 . . . . 70.2 111.69 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 m . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 121.141 0.496 . . . . 74.04 112.05 -177.146 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.483 HG23 HG21 ' A' ' 73' ' ' VAL . 61.5 mt . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.143 0.497 . . . . 71.43 111.095 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.0 t -135.56 160.25 39.07 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.13 -0.486 . . . . 74.41 111.25 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -58.66 127.08 30.4 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.001 0.429 . . . . 74.14 111.876 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.37 -22.14 37.15 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.137 -0.483 . . . . 33.24 112.7 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.27 150.71 35.29 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.924 0.392 . . . . 74.1 111.529 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -107.19 116.26 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 120.945 0.402 . . . . 75.43 111.152 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 m -103.46 137.71 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 120.898 0.38 . . . . 70.41 110.65 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -90.82 110.68 21.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.264 0.554 . . . . 64.23 111.377 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.465 HG22 HG12 ' A' ' 40' ' ' ILE . 32.5 p -102.6 170.32 8.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.622 -0.717 . . . . 74.22 110.862 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -56.22 -33.56 65.48 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.986 0.422 . . . . 63.44 111.465 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.533 HD12 ' HB2' ' A' ' 38' ' ' ALA . 65.4 mt -79.91 -15.31 57.59 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.411 -0.359 . . . . 71.52 111.806 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.14 -161.08 23.83 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.321 -0.466 . . . . 74.45 113.235 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -70.0 134.35 48.21 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.563 -0.375 . . . . 64.35 111.235 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 96.0 t -130.64 125.7 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.778 0.323 . . . . 73.31 111.328 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.679 ' HB2' HD13 ' A' ' 88' ' ' ILE . 43.0 ttm180 -89.81 117.41 28.63 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.712 -0.222 . . . . 74.14 110.597 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.483 HG21 HG23 ' A' ' 58' ' ' ILE . 42.5 t -66.78 133.53 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.815 0.341 . . . . 63.43 111.767 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.4 p -109.9 -50.05 3.02 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.171 0.51 . . . . 72.41 111.908 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 121.078 0.466 . . . . 74.04 111.757 -178.352 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 112.407 0.521 . . . . 74.42 112.407 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.0 mt -122.38 140.07 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 122.879 0.472 . . . . 71.43 110.224 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -124.29 141.35 52.14 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.202 0.445 . . . . 72.44 112.202 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.1 176.36 37.68 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.113 -0.565 . . . . 41.24 113.377 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 18.0 t -118.63 135.81 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 122.64 -0.33 . . . . 73.43 111.57 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 38.7 tp -72.87 106.05 4.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.795 0.331 . . . . 74.31 111.077 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.679 HD13 ' HB2' ' A' ' 72' ' ' ARG . 30.5 pt -118.65 -175.92 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.169 0.509 . . . . 72.14 111.785 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.175 -0.466 . . . . 73.01 111.09 178.618 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.617 HG22 ' HB ' ' A' ' 40' ' ' ILE . 75.0 m . . . . . 0 N--CA 1.472 0.635 0 CA-C-O 120.817 0.341 . . . . 71.02 111.822 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.493 ' O ' HD12 ' A' ' 83' ' ' ILE . 59.1 mtt180 -142.58 168.94 18.54 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.734 0.302 . . . . 63.4 111.288 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.05 145.71 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.947 0.403 . . . . 64.3 111.758 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -79.35 104.28 9.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.077 0.465 . . . . 65.24 110.298 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.402 HG22 HG21 ' A' ' 71' ' ' VAL . 38.3 t -90.1 123.4 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.986 -0.552 . . . . 70.12 111.841 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.6 t -107.72 116.82 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.299 -0.409 . . . . 63.3 111.353 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.557 ' HB2' ' HG2' ' A' ' 34' ' ' LYS . 9.8 t70 -71.56 122.53 87.43 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 110.276 -0.268 . . . . 74.02 110.276 176.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.96 -30.86 32.03 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.075 1.85 . . . . 74.31 113.19 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -89.62 -43.87 10.46 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.814 0.672 . . . . 74.05 112.814 -175.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.0 p -96.61 -26.55 15.18 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.147 0.425 . . . . 61.24 112.147 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.71 22.0 58.83 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.915 -0.659 . . . . 64.24 113.901 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.557 ' HG2' ' HB2' ' A' ' 29' ' ' ASP . 10.7 ptpp? -78.06 135.3 37.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.359 0.579 . . . . 71.33 110.596 177.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -115.66 101.34 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.906 0.384 . . . . 72.04 110.943 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -125.15 144.41 50.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.902 0.382 . . . . 70.13 111.417 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.0 mt -84.92 111.34 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.897 0.379 . . . . 74.51 111.191 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.48 148.38 32.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.976 0.417 . . . . 65.41 112.015 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -80.27 130.97 35.57 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.336 -0.393 . . . . 63.54 110.668 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.617 ' HB ' HG22 ' A' ' 23' ' ' THR . 69.4 mt -80.99 113.65 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.049 0.452 . . . . 64.13 111.053 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.415 HH21 ' HB3' ' A' ' 67' ' ' ASN . 28.0 mmt180 -82.56 -48.66 10.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.201 0.524 . . . . 64.4 111.192 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -125.21 145.22 50.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.988 -0.551 . . . . 72.42 110.526 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.413 ' HA ' HG12 ' A' ' 64' ' ' VAL . 32.6 m . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 113.37 0.878 . . . . 73.24 113.37 -173.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.5 mm . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 120.61 0.243 . . . . 43.01 110.968 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.1 t -147.39 169.71 18.89 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.981 0.42 . . . . 73.53 111.896 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -63.16 125.05 22.79 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.131 -0.486 . . . . 75.03 111.132 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.55 -14.88 57.71 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.193 -0.527 . . . . 61.44 113.139 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.43 137.88 41.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.878 0.371 . . . . 35.04 111.569 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.97 112.11 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.909 0.385 . . . . 74.11 110.987 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.526 ' HB ' HG23 ' A' ' 40' ' ' ILE . 32.5 m -105.65 139.58 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.548 0.573 . . . . 74.12 112.548 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -82.54 116.43 21.96 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.511 -0.313 . . . . 75.51 110.674 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.597 HG22 ' HA ' ' A' ' 40' ' ' ILE . 32.1 p -121.16 179.42 4.4 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 120.905 0.383 . . . . 71.21 111.741 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.415 ' HB3' HH21 ' A' ' 41' ' ' ARG . 4.0 p-10 -65.58 -19.43 65.92 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.91 0.337 . . . . 71.03 111.91 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.6 mt -93.27 -23.69 18.42 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.946 0.403 . . . . 72.11 111.045 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.454 ' HA2' ' NH1' ' A' ' 89' ' ' ARG . . . 135.87 -162.03 24.91 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.134 -0.555 . . . . 65.14 113.381 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -71.29 117.39 12.76 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.805 0.336 . . . . 61.4 110.596 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 40.6 t -110.96 120.75 62.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.854 0.359 . . . . 63.22 111.118 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 72' ' ' ARG . 42.5 ttm180 -84.87 109.67 18.28 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.876 0.37 . . . . 74.41 110.421 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -65.2 120.15 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.456 0.539 . . . . 74.01 112.456 -173.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.3 p -89.86 -40.43 12.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.129 -0.487 . . . . 63.12 111.633 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.936 0.398 . . . . 64.03 111.659 -178.346 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 120.991 0.424 . . . . 54.15 111.856 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 24' ' ' ARG . 20.6 mt -92.75 135.1 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.3 -0.409 . . . . 74.22 110.739 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -128.36 145.15 51.16 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 122.212 -0.305 . . . . 72.53 111.514 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.55 172.46 39.48 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.022 -0.608 . . . . 53.44 113.515 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.6 t -109.15 147.41 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 122.545 -0.386 . . . . 73.14 111.754 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 tp -84.65 119.27 25.04 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.129 0.49 . . . . 73.41 112.089 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.495 ' O ' ' HD2' ' A' ' 89' ' ' ARG . 17.3 pt -144.64 -173.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 122.996 0.518 . . . . 73.41 110.595 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HD2' ' O ' ' A' ' 88' ' ' ILE . 18.2 mmm180 . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 120.789 0.328 . . . . 64.31 110.739 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 94.1 m . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 121.016 0.436 . . . . 73.34 111.68 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HG2' HG22 ' A' ' 37' ' ' ILE . 2.3 ttm105 -166.85 155.64 10.38 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.282 -0.417 . . . . 75.55 110.943 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.521 ' HB ' HD11 ' A' ' 40' ' ' ILE . 9.8 tt -133.71 142.85 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.101 0.408 . . . . 73.22 112.101 -175.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -76.61 103.61 6.68 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.076 0.465 . . . . 74.32 110.634 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.47 HG22 HG11 ' A' ' 71' ' ' VAL . 45.3 t -104.75 125.35 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.177 0.513 . . . . 71.55 111.576 -176.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.48 118.53 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.19 -0.459 . . . . 75.22 110.782 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -75.59 112.69 20.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.29 -0.414 . . . . 51.1 109.897 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.58 -14.6 15.9 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.359 2.039 . . . . 63.11 112.833 -177.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.97 -42.97 12.1 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.777 0.322 . . . . 74.44 111.26 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.411 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 25.9 p -107.19 -15.35 14.68 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.234 0.457 . . . . 73.32 112.234 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.54 18.38 73.62 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.361 -0.447 . . . . 71.14 114.099 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 21.7 pttm -92.36 159.56 15.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.494 0.647 . . . . 74.31 111.946 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.6 t -107.24 109.26 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.402 -0.363 . . . . 72.2 110.722 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -117.01 141.6 48.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.543 -0.298 . . . . 74.12 111.021 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.506 HG22 ' HG2' ' A' ' 24' ' ' ARG . 38.1 mt -100.04 105.94 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.921 0.391 . . . . 54.42 110.852 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.08 151.92 19.28 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.999 0.74 . . . . 62.23 112.999 -172.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.61 126.35 34.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.243 -0.435 . . . . 54.13 110.955 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.521 HD11 ' HB ' ' A' ' 25' ' ' ILE . 56.2 mt -83.44 113.35 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.199 0.444 . . . . 63.05 112.199 -176.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -82.84 -53.62 5.74 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.034 0.445 . . . . 72.24 110.583 176.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 40.4 t30 -118.99 147.57 43.93 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.107 -0.497 . . . . 61.1 110.686 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 113.024 0.75 . . . . 64.34 113.024 -172.915 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.5 mt . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.592 0.234 . . . . 73.42 110.522 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.0 p -118.26 159.68 22.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.245 0.545 . . . . 73.15 112.184 -174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.81 136.47 56.92 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.317 -0.401 . . . . 62.04 111.23 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 -14.51 45.67 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.071 -0.585 . . . . 60.11 113.183 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.47 147.95 33.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.026 0.441 . . . . 75.42 111.386 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.11 119.5 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.94 0.4 . . . . 61.32 111.319 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.96 156.63 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.108 0.48 . . . . 72.34 111.317 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.684 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 36.1 tt0 -97.88 105.92 18.14 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.863 0.363 . . . . 72.11 110.964 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.0 p -103.38 170.72 7.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.856 0.36 . . . . 72.42 111.576 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -57.52 -30.85 65.49 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.33 -0.395 . . . . 73.35 111.473 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.4 mt -77.91 -36.82 49.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.035 0.445 . . . . 73.33 111.014 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.99 -150.87 23.08 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.265 -0.493 . . . . 14.15 112.7 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -75.88 128.77 35.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.932 0.396 . . . . 61.13 111.314 -178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.47 HG11 HG22 ' A' ' 27' ' ' VAL . 90.1 t -129.01 126.93 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.535 -0.302 . . . . 74.11 111.297 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -95.98 120.6 36.55 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.626 0.251 . . . . 72.54 111.508 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.5 t -65.12 133.85 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 112.051 0.389 . . . . 62.05 112.051 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.4 p -96.9 -50.12 4.77 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.259 0.466 . . . . 71.31 112.259 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 112.096 0.406 . . . . 72.31 112.096 -179.122 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 121.298 0.57 . . . . 73.33 112.509 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 83' ' ' ILE . 3.9 mp -113.11 125.34 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.096 -0.502 . . . . 74.14 110.266 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -102.22 143.07 32.48 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.836 0.351 . . . . 74.25 111.825 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.86 173.96 36.62 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 121.282 -0.485 . . . . 63.12 113.446 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.8 139.09 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 117.001 0.4 . . . . 54.15 111.548 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HB2' HG12 ' A' ' 27' ' ' VAL . 50.6 tp -79.16 106.95 11.56 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.737 0.303 . . . . 75.33 111.4 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 pt -133.67 -171.24 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.252 0.548 . . . . 64.53 111.789 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 76.7 mmt-85 . . . . . 0 CA--C 1.536 0.432 0 CA-C-N 116.039 -0.528 . . . . 61.35 110.983 176.025 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.8 m . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.853 0.358 . . . . 62.34 111.463 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.42 151.14 48.1 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.85 0.357 . . . . 75.44 111.586 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.9 tt -146.26 139.08 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.028 0.442 . . . . 50.32 111.374 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.57 103.69 9.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.438 -0.346 . . . . 71.01 110.429 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.82 113.91 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.898 0.38 . . . . 72.42 111.549 -177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.7 t -95.16 118.09 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.396 -0.365 . . . . 74.4 110.688 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.23 128.93 81.65 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 120.536 0.208 . . . . 52.42 110.982 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.79 -22.79 11.51 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.426 2.084 . . . . 73.52 113.592 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -88.27 -35.32 17.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.969 0.414 . . . . 32.23 111.859 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.7 p -107.91 -31.72 7.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.373 -0.376 . . . . 65.24 111.803 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.91 10.19 65.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.208 -0.52 . . . . 61.34 113.603 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -79.63 138.12 37.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.192 0.496 . . . . 71.54 111.919 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.9 t -97.66 106.42 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 116.27 -0.423 . . . . 74.43 110.319 176.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -128.65 132.87 48.12 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.952 0.406 . . . . 62.44 111.583 -173.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 57.0 mt -81.06 140.43 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 112.427 0.528 . . . . 62.43 112.427 -175.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.47 167.14 22.91 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.239 -0.437 . . . . 43.54 111.124 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.485 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 3.3 mp0 -98.24 140.56 32.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.819 0.343 . . . . 73.1 111.081 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.16 115.1 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.969 0.414 . . . . 52.14 111.687 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.562 HH21 ' HB3' ' A' ' 67' ' ' ASN . 21.4 mmt180 -81.21 -53.83 6.03 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.222 0.534 . . . . 72.5 110.802 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 15.7 m120 -119.5 131.17 55.52 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.184 -0.462 . . . . 74.43 111.657 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.462 HG23 HG12 ' A' ' 58' ' ' ILE . 10.5 p . . . . . 0 CA--C 1.548 0.897 0 N-CA-C 113.046 0.758 . . . . 74.5 113.046 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.462 HG12 HG23 ' A' ' 43' ' ' VAL . 64.2 mt . . . . . 0 CA--C 1.542 0.644 0 CA-C-O 120.611 0.243 . . . . 72.13 111.132 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -147.53 166.31 27.7 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.833 0.349 . . . . 71.41 111.584 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.411 ' HD3' HH11 ' A' ' 60' ' ' ARG . 44.7 ttp180 -65.01 134.38 53.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.973 0.416 . . . . 72.33 111.37 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.87 -26.4 24.6 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.271 -0.422 . . . . 73.43 112.462 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.77 156.93 38.77 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.936 0.398 . . . . 75.41 111.804 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.1 114.1 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.907 0.385 . . . . 73.51 111.361 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.56 154.47 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.973 0.416 . . . . 74.43 112.012 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 34.0 tt0 -92.96 127.31 38.42 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.224 -0.298 . . . . 73.32 110.771 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.6 p -129.63 176.35 8.07 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.609 0.364 . . . . 74.4 110.717 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.562 ' HB3' HH21 ' A' ' 41' ' ' ARG . 3.8 p-10 -65.09 -27.47 68.78 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.782 0.325 . . . . 75.45 111.863 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.74 -22.75 37.12 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.081 0.467 . . . . 73.4 111.103 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.63 -152.16 21.52 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 116.241 -0.436 . . . . 44.14 112.504 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -85.91 131.21 34.34 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 122.241 -0.564 . . . . 63.22 110.994 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.27 122.34 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 111.851 0.315 . . . . 73.42 111.851 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HB2' HD13 ' A' ' 88' ' ' ILE . 40.7 ttm180 -86.36 112.16 21.18 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.655 0.264 . . . . 72.44 110.402 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -63.98 127.14 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.568 0.581 . . . . 61.52 112.568 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 73.8 p -103.04 -33.09 9.39 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.056 0.455 . . . . 65.52 111.656 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.662 ' HB3' ' H ' ' A' ' 84' ' ' ASN . 35.8 t . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 121.36 0.6 . . . . 63.44 111.831 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 83' ' ' ILE . 7.5 p . . . . . 0 CA--C 1.545 0.762 0 CA-C-O 120.971 0.415 . . . . 73.22 111.628 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.409 ' N ' HG22 ' A' ' 82' ' ' VAL . 57.7 mt -121.53 143.06 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 122.526 0.33 . . . . 75.21 110.835 178.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.662 ' H ' ' HB3' ' A' ' 75' ' ' SER . 2.4 m-20 -119.72 153.08 36.16 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.731 0.301 . . . . 71.44 111.257 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.9 177.83 37.98 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.453 -0.34 . . . . 44.01 112.887 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 t -116.39 138.86 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 117.218 0.509 . . . . 74.41 111.279 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.0 tp -78.93 106.54 11.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.036 0.446 . . . . 72.53 111.807 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.443 HD13 ' HB2' ' A' ' 72' ' ' ARG . 16.5 pt -121.5 179.91 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.188 0.518 . . . . 53.33 111.236 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.59 0 CA-C-N 116.368 -0.378 . . . . 73.24 110.983 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.56 HG22 ' HB ' ' A' ' 40' ' ' ILE . 51.6 m . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.893 0.377 . . . . 51.21 111.385 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -139.49 170.01 16.7 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.12 0.486 . . . . 60.34 111.881 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.451 ' HB ' HD11 ' A' ' 40' ' ' ILE . 13.2 tt -152.0 142.8 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.97 -0.559 . . . . 65.13 111.111 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -77.21 103.7 7.29 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.248 0.547 . . . . 73.13 110.573 174.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.481 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 39.3 t -86.24 136.68 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.718 . . . . 74.43 111.263 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 35' ' ' VAL . 47.2 t -110.85 104.83 17.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.66 0.267 . . . . 63.22 111.053 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.514 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 35.2 t70 -65.09 115.43 21.1 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.48 -0.327 . . . . 72.24 111.16 176.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.37 -11.71 22.77 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.34 2.027 . . . . 72.34 113.733 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -80.78 -43.19 20.52 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.1 0.476 . . . . 75.23 111.4 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.419 ' OG1' ' HE3' ' A' ' 34' ' ' LYS . 59.6 p -101.24 -29.49 12.06 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.132 -0.485 . . . . 71.31 111.67 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.79 63.13 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 116.248 -0.433 . . . . 44.13 112.739 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 17.6 ptpt -82.82 163.12 21.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.867 0.365 . . . . 71.21 111.322 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 28' ' ' VAL . 47.9 t -117.63 97.39 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.38 -0.373 . . . . 73.55 111.164 174.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' HG2' ' HB ' ' A' ' 27' ' ' VAL . 1.5 pm0 -93.79 170.86 9.25 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.051 0.453 . . . . 64.12 111.33 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.7 mt -111.78 134.51 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 121.849 -0.532 . . . . 62.45 111.098 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -130.99 153.56 49.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.96 0.41 . . . . 72.1 111.977 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -91.91 126.11 36.87 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.13 -0.486 . . . . 71.34 110.485 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.56 ' HB ' HG22 ' A' ' 23' ' ' THR . 61.2 mt -79.13 113.54 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.042 0.448 . . . . 75.13 111.458 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -83.05 -47.83 11.26 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.063 0.458 . . . . 74.25 111.383 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.532 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 51.7 m-80 -138.15 163.94 30.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.265 -0.425 . . . . 71.34 111.443 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.273 0.558 . . . . 74.03 111.312 179.776 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.8 mt . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 121.011 0.434 . . . . 74.41 111.281 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -147.83 -179.96 7.28 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.226 -0.443 . . . . 75.35 111.085 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -64.18 135.99 56.81 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.828 0.347 . . . . 74.21 111.807 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.06 -20.89 47.07 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.29 -0.481 . . . . 53.35 113.251 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.82 153.11 29.34 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.028 0.442 . . . . 72.44 111.676 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.7 t -110.91 119.3 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.354 -0.384 . . . . 75.4 110.793 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.47 ' HB ' HG23 ' A' ' 40' ' ' ILE . 27.6 m -103.39 131.49 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.42 0.628 . . . . 63.21 112.17 -177.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 9.7 tp10 -79.81 102.32 9.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.931 -0.577 . . . . 63.32 110.894 177.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.6 p -100.74 173.21 6.63 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.774 0.321 . . . . 64.31 111.045 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -61.12 -29.07 69.54 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.87 0.367 . . . . 63.42 111.655 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 38' ' ' ALA . 92.6 mt -80.78 -31.14 35.88 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.926 0.393 . . . . 70.32 111.088 176.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.18 -162.9 28.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.915 -0.66 . . . . 44.52 112.889 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -80.93 120.05 24.25 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.216 0.531 . . . . 74.31 111.713 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.476 HG21 HG22 ' A' ' 27' ' ' VAL . 47.6 t -113.56 120.52 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.208 -0.451 . . . . 70.54 111.509 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -86.7 116.19 24.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.851 0.358 . . . . 74.24 111.21 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.36 109.84 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.19 -0.459 . . . . 62.43 112.123 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.7 p -87.75 -59.29 2.28 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.254 0.549 . . . . 72.42 110.729 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 84' ' ' ASN . 54.8 m . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.846 -0.616 . . . . 72.41 111.082 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 83' ' ' ILE . 12.7 p . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 120.906 0.384 . . . . 60.42 111.307 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.484 ' N ' HG22 ' A' ' 82' ' ' VAL . 40.1 mt -97.26 144.75 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.579 0.351 . . . . 63.11 110.438 175.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 75' ' ' SER . 16.2 m-80 -135.19 142.49 46.09 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 122.252 -0.28 . . . . 52.21 111.329 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.81 175.79 39.16 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.038 -0.601 . . . . 72.14 113.647 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.0 t -99.27 144.49 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.088 0.403 . . . . 65.31 112.088 -177.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.414 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 49.5 tp -79.59 106.63 11.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.824 0.345 . . . . 61.1 110.973 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.0 pt -126.88 -179.65 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.178 0.513 . . . . 65.22 111.153 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 120.911 0.386 . . . . 73.1 111.456 -179.886 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.557 HG22 ' HB ' ' A' ' 40' ' ' ILE . 27.1 m . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 110.213 -0.292 . . . . 71.31 110.213 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -133.83 165.39 25.09 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.23 0.456 . . . . 74.01 112.23 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.526 ' HB ' HD11 ' A' ' 40' ' ' ILE . 12.7 tt -151.46 131.29 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.127 -0.488 . . . . 71.11 111.782 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -72.81 103.82 3.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.072 0.463 . . . . 55.34 110.328 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.529 HG22 HG11 ' A' ' 71' ' ' VAL . 46.8 t -95.92 126.97 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.029 -0.532 . . . . 75.13 112.349 -174.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.01 114.17 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.224 -0.444 . . . . 73.0 110.82 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.429 ' HA ' ' HB3' ' A' ' 87' ' ' LEU . 11.3 t70 -76.84 126.12 86.16 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.558 -0.292 . . . . 62.24 111.624 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.99 -9.89 9.5 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.949 2.433 . . . . 75.4 113.226 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -75.03 -43.7 52.09 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.929 0.395 . . . . 75.21 111.685 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.9 p -123.28 -31.5 3.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.463 -0.335 . . . . 70.45 111.686 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.07 3.49 29.73 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.406 -0.426 . . . . 71.24 113.125 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -71.53 143.63 49.87 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.933 0.397 . . . . 61.32 112.002 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.4 t -114.91 129.28 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.897 0.38 . . . . 72.12 111.514 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -140.38 145.83 37.6 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.345 -0.389 . . . . 74.41 110.818 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.4 mt -87.94 101.82 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.263 0.554 . . . . 72.13 111.515 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.51 165.14 16.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.315 0.578 . . . . 72.04 112.273 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -103.69 123.79 47.66 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.842 -0.617 . . . . 72.04 110.651 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.557 ' HB ' HG22 ' A' ' 23' ' ' THR . 70.0 mt -84.09 115.94 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.609 0.596 . . . . 74.12 112.609 -174.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.456 HH11 ' HD2' ' A' ' 41' ' ' ARG . 56.2 mtt180 -83.64 -54.12 5.16 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.073 0.463 . . . . 53.31 111.49 172.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -130.78 167.86 18.18 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.284 0.476 . . . . 73.51 112.284 -173.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.67 HG12 HG12 ' A' ' 64' ' ' VAL . 17.1 m . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 121.534 0.683 . . . . 71.13 111.027 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.6 mt . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 120.721 0.296 . . . . 73.33 110.829 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -147.74 173.16 13.05 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.613 -0.267 . . . . 73.12 111.367 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -56.85 140.42 48.23 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.851 0.358 . . . . 72.2 111.697 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.5 -26.44 15.83 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.144 -0.551 . . . . 62.31 113.454 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.72 155.75 29.25 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.09 0.445 . . . . 75.32 111.281 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -113.36 127.85 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.626 0.727 . . . . 73.25 111.908 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.67 HG12 HG12 ' A' ' 43' ' ' VAL . 28.9 m -103.17 127.7 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 121.185 0.516 . . . . 73.44 111.077 177.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.02 110.86 12.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.218 -0.446 . . . . 74.32 110.362 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.9 p -115.61 176.04 5.26 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.364 0.602 . . . . 71.44 112.431 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.432 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 19.3 p-10 -59.25 -30.21 68.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.017 -0.538 . . . . 74.52 111.225 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.4 mt -81.28 -28.94 34.46 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.16 0.505 . . . . 63.23 110.728 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.419 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 131.08 -150.5 19.41 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.204 -0.453 . . . . 75.44 113.161 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -67.07 120.36 13.55 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.784 0.326 . . . . 64.44 111.777 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.529 HG11 HG22 ' A' ' 27' ' ' VAL . 57.4 t -125.71 121.87 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.618 0.246 . . . . 70.32 111.478 178.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.551 ' HB2' HD13 ' A' ' 88' ' ' ILE . 38.1 ttm180 -89.55 118.09 28.93 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.276 -0.265 . . . . 71.43 111.439 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.95 128.43 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.261 0.467 . . . . 51.31 112.261 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -109.86 -63.04 1.42 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.185 -0.462 . . . . 75.42 111.996 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 84' ' ' ASN . 43.5 t . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 120.649 0.261 . . . . 74.41 111.233 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 120.747 0.308 . . . . 74.31 111.277 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.3 mt -116.56 140.36 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 122.572 0.349 . . . . 72.23 110.361 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 13.4 m120 -127.57 146.73 50.43 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.155 -0.341 . . . . 75.25 111.461 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.99 179.83 38.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.898 -0.668 . . . . 73.33 113.598 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 t -113.2 139.71 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 116.831 0.315 . . . . 73.44 111.402 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 29' ' ' ASP . 62.5 tp -74.16 106.8 5.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.08 0.467 . . . . 35.52 110.923 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 72' ' ' ARG . 20.2 pt -124.48 -178.96 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.308 0.575 . . . . 42.15 111.182 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.419 ' NH1' ' HA3' ' A' ' 69' ' ' GLY . 40.5 mmt180 . . . . . 0 CA--C 1.538 0.511 0 CA-C-N 116.232 -0.44 . . . . 62.53 111.002 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.485 HG22 ' HB ' ' A' ' 40' ' ' ILE . 91.3 m . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 121.052 0.453 . . . . 72.13 110.857 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -145.15 163.16 35.2 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.31 -0.404 . . . . 71.42 111.27 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 tt -147.9 135.9 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.111 0.481 . . . . 71.33 111.86 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -74.84 103.47 5.09 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.027 0.441 . . . . 75.22 110.356 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 48.8 t -93.87 145.81 7.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.954 -0.566 . . . . 53.1 111.528 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 35' ' ' VAL . 48.6 t -117.16 106.9 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.044 -0.526 . . . . 72.14 110.806 176.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.489 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 12.9 t70 -70.04 112.83 13.8 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.611 0.243 . . . . 75.21 110.659 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.82 -14.21 11.32 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.774 2.316 . . . . 75.54 113.286 -176.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -74.71 -37.37 62.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.311 0.577 . . . . 72.55 110.838 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.8 p -110.1 -32.36 7.03 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.878 -0.601 . . . . 72.31 111.475 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.81 45.05 4.34 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.299 -0.477 . . . . 74.34 112.514 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 19.7 ptpt -118.39 162.92 17.51 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.594 -0.356 . . . . 71.05 111.1 177.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 28' ' ' VAL . 58.1 t -120.51 113.85 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.932 0.396 . . . . 63.5 111.202 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -117.26 170.14 8.92 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.073 0.464 . . . . 53.4 111.731 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.2 mt -107.46 116.61 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.554 -0.294 . . . . 73.32 110.822 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.414 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -111.44 157.72 19.95 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.185 0.517 . . . . 63.12 112.208 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -97.34 124.14 41.38 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 54.53 110.719 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.485 ' HB ' HG22 ' A' ' 23' ' ' THR . 60.0 mt -75.34 114.07 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.057 0.455 . . . . 72.11 111.468 -178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -82.92 -44.09 15.75 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.246 -0.434 . . . . 74.33 111.183 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 44.0 m-80 -138.89 146.09 40.72 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.717 0.294 . . . . 74.43 111.351 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 121.214 0.53 . . . . 75.43 111.702 179.6 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.502 ' CG2' HG21 ' A' ' 73' ' ' VAL . 60.8 mt . . . . . 0 CA--C 1.54 0.562 0 CA-C-O 120.911 0.386 . . . . 61.12 111.016 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -94.5 156.01 16.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.995 0.426 . . . . 71.34 111.74 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -64.33 116.33 5.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.815 0.341 . . . . 74.11 111.149 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.0 -16.04 23.13 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.406 -0.426 . . . . 55.42 112.68 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.82 150.87 48.06 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.046 0.451 . . . . 74.23 111.907 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.16 115.31 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.3 -0.409 . . . . 62.22 111.276 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.69 143.36 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.123 0.487 . . . . 74.33 111.908 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 8.0 tp10 -87.97 116.52 26.2 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.294 -0.412 . . . . 54.42 110.509 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.9 p -115.74 176.07 5.25 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.107 0.479 . . . . 74.52 111.81 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -65.67 -13.22 58.75 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.23 0.456 . . . . 63.22 112.23 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.414 HD12 ' HB2' ' A' ' 38' ' ' ALA . 85.8 mt -104.98 -18.18 14.26 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.2 0.524 . . . . 74.02 111.369 177.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.459 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 139.07 -161.18 25.94 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.282 -0.485 . . . . 73.41 112.977 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -77.08 137.61 39.04 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.405 -0.468 . . . . 63.05 110.949 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 58.5 t -130.58 127.98 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.372 -0.205 . . . . 72.02 111.549 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.463 ' HB2' HD13 ' A' ' 88' ' ' ILE . 59.2 ttm-85 -92.67 113.23 25.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.646 0.26 . . . . 71.55 110.742 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.502 HG21 ' CG2' ' A' ' 58' ' ' ILE . 48.5 t -61.37 120.14 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.497 0.554 . . . . 75.23 112.497 -176.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.3 p -96.58 -32.3 12.31 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.438 0.533 . . . . 65.31 112.438 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.891 0.376 . . . . 75.24 111.786 -176.874 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 83' ' ' ILE . 8.0 p . . . . . 0 CA--C 1.545 0.764 0 CA-C-O 120.961 0.41 . . . . 75.21 111.995 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.405 ' N ' HG22 ' A' ' 82' ' ' VAL . 31.9 mt -123.51 147.79 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.798 0.439 . . . . 64.42 110.874 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -121.23 148.93 43.61 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.3 -0.25 . . . . 64.12 111.03 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -168.54 167.15 40.11 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.861 -0.685 . . . . 53.31 114.078 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 24.2 t -101.85 140.34 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.68 0.392 . . . . 52.24 111.672 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.437 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 43.0 tp -78.58 106.88 10.85 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.284 0.564 . . . . 63.53 111.445 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 72' ' ' ARG . 16.5 pt -128.25 -177.5 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.063 0.459 . . . . 73.35 110.947 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.459 ' NH1' ' HA3' ' A' ' 69' ' ' GLY . 28.1 mmt180 . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 120.698 0.285 . . . . 73.31 110.856 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.591 HG22 ' HB ' ' A' ' 40' ' ' ILE . 38.4 m . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.049 0.452 . . . . 55.22 110.725 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.1 mtm-85 -148.68 163.55 36.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.253 -0.43 . . . . 54.34 111.384 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.6 tt -147.6 132.7 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.219 -0.446 . . . . 73.2 111.764 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.505 ' OD1' HG12 ' A' ' 37' ' ' ILE . 77.3 m-20 -65.99 103.23 0.91 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.111 0.481 . . . . 54.22 110.209 171.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.77 121.99 37.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.024 -0.535 . . . . 62.14 111.601 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.4 t -94.95 106.79 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.159 0.504 . . . . 75.41 110.669 176.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.76 113.56 24.05 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 115.843 -0.617 . . . . 61.03 110.794 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.23 -11.31 17.63 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.589 2.193 . . . . 75.32 113.431 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -88.05 -37.3 16.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.009 0.433 . . . . 73.22 111.879 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 30.5 p -115.17 -26.25 7.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.101 -0.499 . . . . 65.22 112.24 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.43 15.87 57.96 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.328 -0.463 . . . . 75.21 113.704 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.409 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 22.8 pttm -90.31 152.41 21.04 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.406 -0.467 . . . . 54.13 111.512 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.5 t -116.42 119.97 63.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.417 -0.356 . . . . 74.03 110.737 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -133.37 136.73 45.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.912 0.387 . . . . 71.13 111.614 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.505 HG12 ' OD1' ' A' ' 26' ' ' ASN . 41.8 mt -77.65 112.66 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.914 0.388 . . . . 53.35 111.258 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.467 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -112.23 145.8 39.28 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.474 -0.33 . . . . 71.01 111.393 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.78 133.83 36.33 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.667 0.27 . . . . 74.25 110.737 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.591 ' HB ' HG22 ' A' ' 23' ' ' THR . 68.2 mt -82.77 109.95 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.378 0.609 . . . . 73.12 110.313 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 mtp85 -85.7 -39.53 17.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.719 -0.673 . . . . 71.31 111.463 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 41.0 t30 -114.74 120.79 41.28 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.928 -0.578 . . . . 61.11 110.455 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.437 ' O ' HG22 ' A' ' 43' ' ' VAL . 7.8 p . . . . . 0 CA--C 1.547 0.853 0 N-CA-C 112.488 0.551 . . . . 61.54 112.488 -173.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.653 HG21 HD13 ' A' ' 83' ' ' ILE . 49.4 mt . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 120.752 0.31 . . . . 64.33 111.43 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.1 t -147.18 167.94 22.91 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.699 -0.228 . . . . 72.4 110.753 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 42.5 ttm180 -59.47 126.45 27.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.133 0.492 . . . . 72.53 111.536 -176.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.32 -24.06 31.31 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.139 -0.553 . . . . 60.11 112.724 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.8 139.8 38.32 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.493 -0.416 . . . . 55.34 111.186 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 m -106.31 119.11 55.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.435 0.636 . . . . 61.11 111.441 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.457 ' HB ' HG23 ' A' ' 40' ' ' ILE . 35.7 m -106.33 152.57 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.241 -0.436 . . . . 74.33 111.378 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 44.0 tt0 -95.01 120.0 34.49 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.124 0.488 . . . . 75.44 111.045 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 p -113.39 179.31 4.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.02 -0.536 . . . . 63.23 110.632 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.467 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 3.2 p-10 -65.87 -11.84 49.86 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.798 0.333 . . . . 73.41 111.481 174.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.438 ' O ' HD11 ' A' ' 87' ' ' LEU . 87.3 mt -102.7 2.36 35.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.817 0.342 . . . . 72.34 111.417 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.478 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 104.07 -162.98 15.16 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.477 -0.392 . . . . 74.2 112.961 -178.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -66.05 130.3 42.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.264 0.554 . . . . 63.33 112.098 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.8 t -126.99 127.28 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.022 -0.536 . . . . 64.33 110.374 177.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -88.4 117.31 27.24 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.294 -0.254 . . . . 75.44 110.807 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.49 HG21 HG23 ' A' ' 58' ' ' ILE . 46.1 t -66.42 127.84 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.931 0.396 . . . . 74.3 111.699 -177.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.6 p -112.42 -49.6 2.95 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.274 -0.421 . . . . 71.03 111.792 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.126 0.489 . . . . 71.33 111.685 -179.203 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 83' ' ' ILE . 9.0 p . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 121.127 0.489 . . . . 44.3 111.439 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 58' ' ' ILE . 29.3 mt -118.46 148.15 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.013 0.525 . . . . 70.34 109.812 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -121.82 140.85 51.85 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.779 -0.575 . . . . 62.32 111.532 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.19 176.17 38.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 121.081 -0.58 . . . . 73.22 113.518 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.53 145.28 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 117.069 0.434 . . . . 60.41 111.253 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.524 HD11 HH12 ' A' ' 89' ' ' ARG . 37.7 tp -81.3 111.87 18.08 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.998 0.428 . . . . 63.13 111.952 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.0 pt -128.37 -178.95 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.182 0.515 . . . . 75.53 111.499 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.524 HH12 HD11 ' A' ' 87' ' ' LEU . 26.0 mmt180 . . . . . 0 CA--C 1.542 0.645 0 O-C-N 122.157 -0.339 . . . . 64.04 111.675 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.3 m . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.802 0.334 . . . . 75.33 111.84 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -115.7 159.95 20.7 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.281 0.474 . . . . 72.43 112.281 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.438 ' HB ' HD11 ' A' ' 40' ' ' ILE . 12.5 tt -155.4 133.97 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.098 -0.501 . . . . 73.33 111.225 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -77.02 102.81 6.63 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.041 0.448 . . . . 70.13 110.196 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.2 t -94.08 119.14 41.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 70.31 111.686 -176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 35' ' ' VAL . 42.3 t -95.47 115.43 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.383 -0.372 . . . . 74.3 110.709 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.506 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 33.3 t70 -82.75 119.88 75.34 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-O 120.542 0.21 . . . . 62.52 110.696 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.61 -17.07 30.13 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.685 2.257 . . . . 62.55 113.411 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -82.13 -44.45 16.46 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 111.9 0.333 . . . . 60.45 111.9 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.4 p -100.06 -28.26 13.14 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.016 0.436 . . . . 73.33 111.714 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.75 22.49 49.77 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.268 -0.492 . . . . 62.22 112.979 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.506 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 63.6 pttt -87.34 145.89 26.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.922 0.361 . . . . 73.25 111.834 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 28' ' ' VAL . 48.8 t -105.32 94.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 109.746 -0.465 . . . . 74.43 109.746 170.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.02 124.38 52.06 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.282 -0.417 . . . . 62.21 111.384 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.0 mt -79.37 113.06 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.495 -0.32 . . . . 75.04 111.629 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -113.86 170.99 7.86 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.912 0.387 . . . . 71.31 111.916 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.85 137.16 37.83 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.496 -0.32 . . . . 71.54 111.001 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.438 HD11 ' HB ' ' A' ' 25' ' ' ILE . 63.5 mt -90.71 114.61 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.741 0.305 . . . . 74.23 111.424 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -83.51 -45.44 13.59 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.263 0.468 . . . . 63.33 112.263 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.567 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 41.7 m-80 -123.57 115.39 21.43 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.788 0.328 . . . . 52.2 111.76 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 58' ' ' ILE . 82.0 t . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 121.176 0.512 . . . . 73.42 110.814 174.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.443 HG23 HG21 ' A' ' 73' ' ' VAL . 68.7 mt . . . . . 0 CA--C 1.54 0.578 0 CA-C-O 120.523 0.201 . . . . 72.03 110.81 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -147.8 172.2 14.49 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.262 0.467 . . . . 65.44 112.262 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -72.49 116.03 12.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.209 -0.45 . . . . 71.45 111.368 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 109.42 -7.65 32.34 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.258 -0.496 . . . . 34.01 112.88 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.18 139.46 30.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.763 0.316 . . . . 73.32 111.405 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.64 114.07 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.988 0.423 . . . . 64.43 111.307 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -102.56 154.42 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.987 0.423 . . . . 73.21 111.582 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 8.8 tp10 -95.6 120.71 36.33 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.874 0.369 . . . . 74.24 111.386 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.9 p -122.82 172.89 8.12 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.841 0.353 . . . . 74.12 111.421 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.411 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 32.2 p30 -57.59 -33.22 67.96 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.885 0.374 . . . . 75.13 111.627 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.9 mt -75.63 -33.15 60.46 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.9 0.381 . . . . 70.13 111.02 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 140.7 -156.49 25.37 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.137 -0.483 . . . . 75.32 112.983 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -68.63 125.76 27.55 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.746 0.308 . . . . 61.14 111.214 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.7 t -125.98 119.28 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.046 0.388 . . . . 74.31 112.046 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.455 ' HB2' HD13 ' A' ' 88' ' ' ILE . 59.0 ttp180 -84.19 111.31 19.24 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.66 0.267 . . . . 73.43 110.925 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.443 HG21 HG23 ' A' ' 58' ' ' ILE . 58.5 t -71.55 131.16 34.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.559 0.578 . . . . 55.13 112.559 -174.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.0 p -106.04 -33.09 8.0 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.965 -0.561 . . . . 63.55 111.826 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 120.654 0.264 . . . . 74.35 111.478 -178.963 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 83' ' ' ILE . 14.5 p . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.14 0.495 . . . . 73.54 111.631 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.41 ' N ' HG22 ' A' ' 82' ' ' VAL . 46.4 mt -105.86 143.57 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.437 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -126.28 146.3 50.07 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.297 -0.252 . . . . 70.22 111.287 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.22 -179.02 30.05 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.201 -0.523 . . . . 53.32 113.039 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 t -124.35 129.88 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.838 0.319 . . . . 64.11 110.935 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.9 tp -74.45 106.34 6.01 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.101 0.477 . . . . 70.02 111.488 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 72' ' ' ARG . 7.9 pt -120.05 176.53 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.313 0.578 . . . . 73.33 111.408 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' A' ' 88' ' ' ILE . 15.6 mmm180 . . . . . 0 N--CA 1.469 0.508 0 CA-C-N 116.313 -0.403 . . . . 74.15 110.667 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.576 HG22 ' HB ' ' A' ' 40' ' ' ILE . 86.6 m . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.007 0.432 . . . . 72.14 110.8 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -138.58 154.89 48.73 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.016 0.436 . . . . 73.12 111.738 -173.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.436 ' HB ' HD11 ' A' ' 40' ' ' ILE . 15.3 tt -143.77 138.4 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.089 0.471 . . . . 73.14 111.618 -177.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -90.46 112.76 24.52 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.274 0.559 . . . . 71.44 110.102 175.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.0 t -106.28 144.12 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.649 0.611 . . . . 75.4 112.649 -169.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 t -104.87 129.91 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.234 -0.439 . . . . 60.31 111.058 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -84.63 122.8 74.89 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 116.428 -0.351 . . . . 71.34 110.945 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.58 -17.12 11.43 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.784 2.322 . . . . 72.22 114.283 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.23 -43.81 11.32 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.281 0.563 . . . . 63.41 111.558 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 p -105.64 -31.26 9.0 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.885 -0.598 . . . . 64.21 112.084 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.26 12.97 56.81 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.022 -0.608 . . . . 60.41 113.617 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -86.56 143.14 27.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.007 0.404 . . . . 72.51 111.34 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.78 103.53 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.074 0.464 . . . . 65.41 110.656 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -108.43 135.81 49.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.952 0.406 . . . . 73.41 111.363 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.6 mt -90.6 129.04 42.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.86 0.362 . . . . 73.34 111.229 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -126.99 159.14 35.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.893 0.378 . . . . 45.15 111.713 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -107.5 139.97 41.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.853 0.359 . . . . 73.43 110.759 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.576 ' HB ' HG22 ' A' ' 23' ' ' THR . 58.0 mt -93.04 116.41 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.286 0.565 . . . . 73.53 112.485 -172.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 41' ' ' ARG . 8.0 mtp180 -82.48 -53.35 6.05 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.668 -0.696 . . . . 71.25 111.639 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 92.1 m-20 -116.56 122.86 45.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.431 -0.35 . . . . 74.12 111.144 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.543 0.69 0 N-CA-C 112.095 0.406 . . . . 71.11 112.095 -179.013 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.4 HD13 HG11 ' A' ' 64' ' ' VAL . 68.5 mt . . . . . 0 CA--C 1.539 0.533 0 CA-C-O 120.804 0.335 . . . . 74.41 111.288 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -132.36 166.76 21.23 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.959 0.409 . . . . 72.45 111.934 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -64.19 126.88 29.16 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.241 -0.436 . . . . 71.31 111.386 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.19 5.25 65.87 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.217 -0.516 . . . . 72.52 113.44 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.28 153.15 19.42 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.013 0.435 . . . . 71.43 111.367 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.8 t -112.69 128.83 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.419 -0.355 . . . . 75.33 110.906 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.4 HG11 HD13 ' A' ' 58' ' ' ILE . 35.9 m -115.28 154.26 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.764 0.653 . . . . 73.43 112.764 -176.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 29.9 tt0 -89.32 109.29 20.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.892 -0.594 . . . . 74.55 110.789 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.465 HG22 HG12 ' A' ' 40' ' ' ILE . 45.5 p -110.96 168.43 9.49 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.954 0.407 . . . . 75.04 111.336 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -60.26 -19.32 54.28 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.128 0.418 . . . . 74.25 112.128 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' A' ' 38' ' ' ALA . 83.9 mt -93.44 -30.63 14.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.85 0.315 . . . . 73.32 111.85 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.72 -149.59 21.23 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.013 -0.613 . . . . 70.31 113.105 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -91.27 119.47 31.36 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.354 -0.497 . . . . 64.32 110.83 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.08 124.78 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.982 0.42 . . . . 64.14 111.608 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.42 ' HB2' HD11 ' A' ' 88' ' ' ILE . 21.5 ttm180 -91.76 115.05 27.73 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.241 -0.436 . . . . 65.51 110.617 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.16 121.91 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.064 0.459 . . . . 74.23 112.143 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.1 p -103.45 -43.56 5.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.16 -0.473 . . . . 61.42 111.902 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 121.101 0.477 . . . . 63.01 111.972 -176.862 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.434 HG22 ' N ' ' A' ' 83' ' ' ILE . 8.2 p . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 120.795 0.331 . . . . 73.45 111.172 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.434 ' N ' HG22 ' A' ' 82' ' ' VAL . 34.4 mt -101.85 148.19 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.844 0.354 . . . . 61.33 111.225 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -119.3 134.75 55.05 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.668 0.271 . . . . 73.14 111.485 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.24 178.31 31.96 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.001 -0.618 . . . . 54.15 113.4 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 t -110.44 141.48 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 111.964 0.357 . . . . 71.11 111.964 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.0 tp -82.78 111.33 18.6 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.032 0.382 . . . . 63.33 112.032 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 72' ' ' ARG . 13.8 pt -143.57 -169.62 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.22 0.533 . . . . 61.41 111.593 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 . . . . . 0 N--CA 1.473 0.678 0 CA-C-N 116.264 -0.425 . . . . 73.45 111.0 176.19 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.411 ' CG2' ' HB ' ' A' ' 40' ' ' ILE . 90.4 m . . . . . 0 N--CA 1.469 0.485 0 CA-C-O 120.929 0.395 . . . . 75.13 111.878 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -149.81 148.18 28.87 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.287 -0.415 . . . . 72.42 110.771 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.6 tt -143.08 139.48 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 121.192 0.52 . . . . 54.34 112.018 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -83.92 105.32 14.71 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.187 0.517 . . . . 72.41 110.781 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.503 HG22 HG11 ' A' ' 71' ' ' VAL . 48.7 t -105.61 120.53 56.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 112.49 0.552 . . . . 75.31 112.49 -172.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -95.59 122.46 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 116.587 -0.279 . . . . 74.34 110.876 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 31.6 t70 -82.53 116.47 63.98 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 120.547 0.213 . . . . 61.22 110.733 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.03 -15.07 29.27 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.606 2.204 . . . . 71.1 113.249 -177.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -78.71 -45.44 21.25 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.786 0.327 . . . . 54.02 111.742 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.3 p -104.12 -20.69 13.74 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.017 0.377 . . . . 74.0 112.017 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.28 20.8 66.22 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.199 -0.524 . . . . 71.32 112.973 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 65.5 pttt -88.07 139.39 30.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.044 0.45 . . . . 65.14 111.628 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.8 t -86.72 95.58 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.076 0.465 . . . . 54.43 110.21 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -99.87 165.97 11.3 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.085 0.469 . . . . 73.23 111.179 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.09 129.87 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.164 -0.335 . . . . 65.23 110.621 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.38 170.2 15.43 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.485 0.66 . . . . 43.52 112.38 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.73 131.86 56.84 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.665 -0.698 . . . . 72.53 110.431 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.411 ' HB ' ' CG2' ' A' ' 23' ' ' THR . 59.9 mt -77.32 114.52 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.142 0.496 . . . . 75.25 112.275 -175.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HE ' ' HA ' ' A' ' 41' ' ' ARG . 2.5 mmp_? -71.26 -50.05 36.81 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.915 -0.584 . . . . 71.43 110.695 173.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -133.11 130.94 39.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.952 -0.567 . . . . 73.42 110.754 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 112.598 0.592 . . . . 73.52 112.598 -177.808 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.6 mt . . . . . 0 CA--C 1.538 0.511 0 CA-C-O 121.024 0.44 . . . . 74.44 110.809 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -87.57 165.76 15.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.062 0.458 . . . . 73.34 112.033 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 74' ' ' THR . 63.0 ttt180 -67.79 116.71 8.77 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.424 -0.353 . . . . 61.21 110.694 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.39 -6.72 46.1 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.281 -0.485 . . . . 72.32 112.927 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.49 138.79 49.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.83 0.348 . . . . 70.44 111.168 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.1 t -96.3 116.26 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.999 0.428 . . . . 60.34 111.606 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.9 m -103.52 148.11 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.125 0.488 . . . . 50.32 111.678 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' ARG . 9.6 tp10 -84.91 127.99 34.42 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.086 -0.506 . . . . 73.23 110.179 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.0 p -129.73 174.78 9.38 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.933 0.397 . . . . 72.43 111.794 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.33 -18.48 64.67 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.649 0.261 . . . . 72.01 111.687 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.41 -27.77 18.1 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.991 0.424 . . . . 73.03 111.155 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.55 -150.09 21.15 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.982 -0.554 . . . . 33.44 112.242 -175.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -77.91 128.85 34.58 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.98 0.419 . . . . 74.12 111.239 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.503 HG11 HG22 ' A' ' 27' ' ' VAL . 91.7 t -126.45 119.42 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 122.113 -0.367 . . . . 73.23 111.654 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -85.16 113.0 21.21 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.713 0.292 . . . . 61.5 110.902 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.12 127.83 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 112.386 0.513 . . . . 73.12 112.386 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.46 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 77.8 p -98.79 -62.61 1.21 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.219 -0.446 . . . . 74.43 111.0 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.523 ' HB2' ' H ' ' A' ' 84' ' ' ASN . 55.3 m . . . . . 0 N--CA 1.472 0.664 0 CA-C-N 116.432 -0.349 . . . . 44.33 111.396 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 121.195 0.521 . . . . 73.33 111.668 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.28 116.6 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.099 -0.5 . . . . 64.14 110.361 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.523 ' H ' ' HB2' ' A' ' 75' ' ' SER . 13.7 m120 -103.51 154.27 19.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.808 0.337 . . . . 74.24 111.531 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.93 178.75 35.88 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.177 -0.535 . . . . 63.04 113.135 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.19 133.11 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 122.719 -0.283 . . . . 65.42 111.204 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.9 tp -76.42 106.22 7.93 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.036 0.446 . . . . 70.13 111.472 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.8 pt -122.81 179.7 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.133 0.492 . . . . 75.21 111.405 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 . . . . . 0 N--CA 1.468 0.463 0 CA-C-N 116.525 -0.307 . . . . 75.43 110.617 -178.874 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 3' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.308 0 CA-C-O 119.802 -0.443 . . . . 72.14 112.756 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 43.57 -67.99 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 114.891 1.441 . . . . 73.21 114.891 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 1' ' ' GLY . 7.8 mmt180 -57.0 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.475 0.546 . . . . 71.24 112.475 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 50.1 mtm105 -102.52 123.35 46.1 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.773 0.32 . . . . 71.35 111.039 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -99.5 -176.95 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 121.018 0.437 . . . . 75.1 112.128 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.418 ' HB3' HG22 ' A' ' 8' ' ' ILE . 45.8 mtm180 -74.0 -41.52 61.77 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.037 0.754 . . . . 75.51 113.037 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.9 mt 72.28 -27.3 0.18 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 113.778 1.029 . . . . 74.41 113.778 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.418 HG22 ' HB3' ' A' ' 6' ' ' ARG . 5.4 tp -51.81 122.43 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 N-CA-C 112.927 0.714 . . . . 63.0 112.927 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -100.42 -72.22 0.68 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.015 -0.539 . . . . 74.24 111.685 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.5 p -106.75 150.38 26.36 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.617 0.599 . . . . 43.3 112.617 -172.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.413 ' HE ' ' HB3' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -169.24 122.8 0.79 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.687 -0.688 . . . . 60.34 110.35 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.69 156.46 8.2 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.603 -0.332 . . . . 71.51 112.524 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.96 -153.0 15.45 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.232 -0.508 . . . . 64.24 114.082 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -158.43 -169.89 2.91 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 110.092 -0.336 . . . . 73.31 110.092 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.6 m -65.03 114.58 4.68 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.946 -0.471 . . . . 71.1 111.137 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.94 158.19 29.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.166 0.508 . . . . 75.33 111.775 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.423 HG22 ' N ' ' A' ' 18' ' ' ARG . 14.9 p -85.48 161.95 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.026 -0.534 . . . . 44.12 110.35 174.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.423 ' N ' HG22 ' A' ' 17' ' ' VAL . 45.0 ptt85 -66.33 168.82 8.18 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.169 0.509 . . . . 65.24 111.897 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.1 tt -58.57 101.61 0.09 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.239 0.542 . . . . 70.42 110.285 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.9 -53.85 0.06 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.532 -0.758 . . . . 53.53 110.201 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.9 m -91.75 14.46 15.27 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.883 -0.598 . . . . 73.21 111.033 174.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -163.08 158.64 22.24 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.274 -0.421 . . . . 74.13 110.781 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.474 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 42.3 m -131.96 113.55 13.56 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.549 0.214 . . . . 55.31 111.505 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 23' ' ' THR . 50.4 mtm180 -162.83 169.96 19.01 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.249 0.62 . . . . 63.23 111.19 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.0 tt -147.03 139.26 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.386 -0.37 . . . . 71.32 111.51 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.426 ' OD1' HG12 ' A' ' 37' ' ' ILE . 75.5 m-20 -74.03 106.84 5.89 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.788 0.328 . . . . 72.14 110.659 176.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -97.56 123.62 50.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.109 0.481 . . . . 75.34 112.07 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.6 t -95.23 112.83 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.995 0.426 . . . . 60.43 110.594 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.53 114.99 50.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.01 -0.541 . . . . 75.14 111.077 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -82.58 -11.78 10.34 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.706 2.271 . . . . 75.31 113.007 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.461 ' CD ' HH12 ' A' ' 89' ' ' ARG . 10.9 mm-40 -77.57 -39.63 45.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.161 0.505 . . . . 75.31 110.863 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.1 p -121.27 -27.08 4.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.712 -0.677 . . . . 75.04 112.258 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.96 29.21 11.95 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.38 -0.438 . . . . 40.34 113.302 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -99.44 142.02 31.47 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 122.478 -0.425 . . . . 74.11 111.182 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.1 t -107.46 112.05 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.841 0.353 . . . . 63.05 110.774 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -133.52 141.64 47.84 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.915 0.388 . . . . 71.33 111.496 -177.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.426 HG12 ' OD1' ' A' ' 26' ' ' ASN . 45.9 mt -83.06 111.34 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.85 0.357 . . . . 71.33 111.331 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.38 157.17 17.21 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.027 0.441 . . . . 62.12 112.046 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -83.25 135.31 34.81 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.185 -0.461 . . . . 72.45 110.986 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -83.73 112.06 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 121.267 0.556 . . . . 60.14 111.016 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.451 ' HD2' HH11 ' A' ' 41' ' ' ARG . 44.4 mtp85 -82.83 -53.41 5.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.027 -0.533 . . . . 72.44 111.018 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -124.8 132.31 53.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.261 -0.427 . . . . 74.02 110.842 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -88.08 11.95 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.929 0.395 . . . . 65.11 111.928 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.73 136.45 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.291 0.567 . . . . 64.42 111.745 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 63' ' ' VAL . 9.6 pt-20 -79.81 34.55 0.28 Allowed 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.846 0.684 . . . . 75.13 112.846 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 57.42 26.14 12.2 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.132 0.491 . . . . 70.4 112.217 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.4 t -82.09 167.98 18.23 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.885 -0.51 . . . . 74.54 111.564 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.2 109.63 21.49 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.745 0.276 . . . . 74.23 111.745 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 55.39 88.17 0.13 Allowed Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 122.815 0.446 . . . . 62.44 111.679 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.38 110.3 1.03 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.59 2.193 . . . . 73.51 112.837 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -76.52 -1.14 25.85 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.244 0.461 . . . . 74.0 112.244 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -96.02 16.77 17.0 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.134 0.492 . . . . 72.21 111.019 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 53' ' ' VAL . 11.5 t 62.4 26.94 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.723 0.773 . . . . 52.55 111.366 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -77.97 72.62 4.51 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.755 -0.591 . . . . 75.04 111.727 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -73.2 75.06 1.29 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.192 0.52 . . . . 72.2 110.496 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 54.39 17.41 1.56 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.748 -0.66 . . . . 44.44 112.44 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.4 tt -92.49 125.5 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.446 0.641 . . . . 62.2 111.649 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.612 HG21 HD13 ' A' ' 83' ' ' ILE . 69.9 mt -68.05 113.59 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.75 -0.659 . . . . 74.03 111.226 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.6 p -135.26 159.6 41.04 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.208 -0.451 . . . . 53.24 112.078 -174.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -54.51 129.06 34.71 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.122 -0.49 . . . . 65.02 111.725 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.11 -11.41 72.18 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.137 -0.554 . . . . 23.12 113.465 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 145.38 31.62 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.859 0.361 . . . . 63.14 111.124 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.67 HG21 ' HG3' ' A' ' 90' ' ' GLU . 54.0 t -109.02 124.59 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.025 0.44 . . . . 74.42 111.593 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -107.43 154.93 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.982 0.42 . . . . 64.33 111.39 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.53 133.38 38.21 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.503 -0.317 . . . . 61.24 110.782 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.5 p -136.8 179.14 6.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.989 0.423 . . . . 65.22 111.637 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -69.09 -15.38 63.43 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.757 0.313 . . . . 74.41 111.78 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.71 -13.9 20.03 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.684 0.278 . . . . 73.01 111.512 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.44 -151.94 18.63 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.383 -0.437 . . . . 53.44 112.733 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -82.81 129.18 34.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.463 -0.434 . . . . 75.33 111.162 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.78 133.66 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.8 0.333 . . . . 74.33 111.459 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.478 ' HB2' HD13 ' A' ' 88' ' ' ILE . 42.1 ttm180 -94.56 121.1 35.77 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.756 0.28 . . . . 72.34 111.756 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.491 HG21 HG23 ' A' ' 58' ' ' ILE . 39.0 t -65.9 111.32 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 116.415 -0.357 . . . . 75.32 111.08 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.493 HG23 ' HA2' ' A' ' 85' ' ' GLY . 44.1 p -91.54 -39.26 12.02 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.861 0.363 . . . . 50.42 111.808 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.7 m -118.25 162.46 18.22 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.246 0.546 . . . . 74.14 112.22 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -68.46 138.16 91.29 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 115.867 -0.606 . . . . 74.24 111.803 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.77 100.37 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.59 2.194 . . . . 70.13 112.853 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.74 -25.66 0.37 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.228 -0.511 . . . . 63.42 112.888 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -60.15 119.41 7.79 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.563 0.22 . . . . 72.34 111.112 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.49 13.02 5.82 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.332 0.586 . . . . 75.31 111.096 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.04 8.31 87.4 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 116.217 -0.447 . . . . 41.52 113.094 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 83' ' ' ILE . 8.3 p -135.02 168.19 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.144 0.497 . . . . 60.25 111.576 -175.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.612 HD13 HG21 ' A' ' 58' ' ' ILE . 48.2 mt -105.0 143.75 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.366 -0.379 . . . . 75.23 110.37 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -123.55 135.84 54.22 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.827 0.346 . . . . 73.34 111.239 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.493 ' HA2' HG23 ' A' ' 74' ' ' THR . . . -154.23 179.33 30.5 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.922 -0.656 . . . . 63.54 113.801 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.26 141.52 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 122.564 -0.374 . . . . 61.14 111.049 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 tp -77.06 124.42 27.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.817 0.341 . . . . 55.11 110.854 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' A' ' 72' ' ' ARG . 10.6 pt -140.31 -175.87 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.03 0.443 . . . . 73.21 111.4 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.461 HH12 ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -122.68 99.83 6.6 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.368 -0.378 . . . . 70.04 110.903 178.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.67 ' HG3' HG21 ' A' ' 63' ' ' VAL . 27.8 mm-40 -111.32 -57.08 2.3 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.178 -0.327 . . . . 74.13 111.766 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 84.7 mt -81.37 155.78 25.78 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.033 0.444 . . . . 74.5 111.747 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -90.6 136.67 32.91 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.343 -0.614 . . . . 73.24 109.343 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -150.09 83.64 1.38 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.207 0.447 . . . . 74.4 112.207 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -110.83 169.44 8.76 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.567 -0.288 . . . . 73.23 110.361 170.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -76.52 147.94 37.44 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.961 0.41 . . . . 73.43 112.009 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -117.01 117.54 29.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.921 0.391 . . . . 75.41 111.803 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -64.07 90.92 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.822 0.344 . . . . 75.51 110.85 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 19.7 p80 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 119.11 -0.472 . . . . 71.02 112.172 178.486 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.576 -0.21 . . . . 74.33 112.576 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 45.09 73.0 0.17 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.288 0.566 . . . . 32.4 112.463 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 3' ' ' ARG . 16.7 mmm180 -80.24 0.2 33.62 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.123 0.487 . . . . 75.11 111.192 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -68.54 143.7 54.84 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.622 -0.717 . . . . 74.55 111.759 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.0 t 65.51 126.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.724 0.639 . . . . 70.2 112.724 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -100.42 117.99 35.73 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.361 0.6 . . . . 61.41 111.131 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.4 tp -105.84 4.22 29.51 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.105 -0.498 . . . . 75.3 111.681 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.1 tp -59.31 136.16 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.302 0.572 . . . . 75.5 112.241 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -110.25 174.54 5.81 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.941 0.401 . . . . 70.2 111.339 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.6 t -142.34 167.02 23.1 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.364 -0.38 . . . . 61.31 111.185 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -99.93 154.63 18.21 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.195 0.443 . . . . 71.35 112.195 -174.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.2 141.34 15.23 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.368 -0.444 . . . . 50.23 112.489 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.57 123.22 7.84 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.04 -0.6 . . . . 54.14 113.769 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -117.59 159.8 22.31 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.095 0.474 . . . . 71.4 111.538 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.8 m -81.65 132.68 35.3 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.31 -0.405 . . . . 71.33 110.392 174.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -95.48 179.08 5.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.536 0.684 . . . . 75.21 112.37 -174.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -80.03 162.16 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 115.437 -0.801 . . . . 72.11 109.9 169.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? -53.07 143.57 17.27 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.439 0.533 . . . . 73.54 112.439 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 23' ' ' THR . 10.1 tt -35.28 106.18 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.852 0.861 . . . . 73.43 112.952 -174.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.61 74.99 9.13 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.005 -0.543 . . . . 63.34 112.076 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.6 m 74.35 -41.97 0.49 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.408 0.892 . . . . 54.43 113.408 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -66.17 97.92 0.42 Allowed 'General case' 0 CA--C 1.536 0.415 0 O-C-N 122.179 -0.326 . . . . 65.44 110.897 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.524 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 42.9 p -71.02 110.74 5.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.163 0.506 . . . . 65.42 111.386 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HG2' ' HG2' ' A' ' 39' ' ' GLU . 68.5 mtt180 -152.42 151.94 31.4 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.725 -0.67 . . . . 73.14 110.6 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.533 ' HB ' HD11 ' A' ' 40' ' ' ILE . 10.8 tt -138.03 141.06 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.063 0.459 . . . . 74.14 112.17 -174.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -74.19 103.48 4.63 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.049 -0.523 . . . . 73.04 110.114 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.524 HG22 HG11 ' A' ' 71' ' ' VAL . 22.6 t -102.62 136.96 32.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.335 0.495 . . . . 74.32 112.335 -173.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.55 113.52 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.881 0.372 . . . . 62.42 110.387 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -77.15 114.03 36.2 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.153 -0.476 . . . . 52.51 110.452 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.85 -8.99 15.73 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.595 2.196 . . . . 75.45 113.399 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -89.42 -33.28 16.89 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.937 0.399 . . . . 75.31 111.574 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 68.0 p -116.76 -31.41 5.48 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.356 0.502 . . . . 64.31 112.356 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.55 12.58 50.52 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.138 -0.553 . . . . 62.14 113.872 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 16.1 ptpt -89.88 162.32 15.51 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.183 0.516 . . . . 71.01 111.995 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.71 95.57 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-O 121.203 0.525 . . . . 73.3 109.938 171.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.24 138.55 41.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.321 -0.4 . . . . 74.45 111.215 -174.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -84.96 121.42 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.687 0.279 . . . . 72.41 111.216 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.534 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -108.05 150.47 27.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.73 0.3 . . . . 64.04 111.648 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 24' ' ' ARG . 33.9 mt-10 -94.03 120.93 34.96 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.778 0.323 . . . . 75.04 110.76 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.533 HD11 ' HB ' ' A' ' 25' ' ' ILE . 57.8 mt -81.86 119.95 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 112.403 0.519 . . . . 63.4 112.403 -173.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.8 mmm-85 -81.68 -56.11 4.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.044 0.449 . . . . 60.43 111.048 174.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -144.61 155.45 43.64 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.199 -0.455 . . . . 71.2 111.365 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 43' ' ' VAL . 12.2 p -97.0 32.14 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-O 121.913 0.863 . . . . 75.04 110.818 176.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.3 p -74.71 82.3 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-O 121.842 0.829 . . . . 71.51 111.768 -176.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -76.01 85.77 2.91 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.991 0.737 . . . . 74.31 112.991 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 m120 49.54 37.35 12.16 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.04 0.448 . . . . 54.42 111.79 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 72.9 p -73.12 81.09 1.26 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.709 0.633 . . . . 64.34 112.709 -170.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.61 -11.03 38.31 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.038 0.447 . . . . 64.44 110.76 171.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -67.14 119.39 64.24 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 115.796 -0.638 . . . . 72.34 111.718 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.28 -23.11 39.11 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.514 2.143 . . . . 74.01 112.822 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -93.42 11.75 27.34 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.058 0.456 . . . . 53.22 111.377 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -69.65 105.02 2.55 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.023 0.44 . . . . 75.03 111.724 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.63 115.43 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.182 0.515 . . . . 74.33 110.596 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -164.2 147.25 9.35 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 122.15 -0.344 . . . . 71.24 111.234 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -75.91 -170.91 1.48 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.149 0.5 . . . . 74.45 111.288 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -71.08 77.91 0.67 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.02 0.438 . . . . 64.1 111.791 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.16 96.82 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.293 0.568 . . . . 73.24 110.986 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.7 mt -78.79 123.01 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.953 -0.567 . . . . 72.21 109.946 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 t -133.11 167.48 20.24 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.05 0.452 . . . . 71.11 112.157 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -61.46 128.0 34.18 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.236 -0.438 . . . . 71.21 111.297 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.25 -13.51 67.17 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.229 -0.51 . . . . 52.52 112.951 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.89 132.15 43.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.021 0.438 . . . . 74.34 111.281 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.9 t -97.13 120.23 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.844 0.354 . . . . 74.13 111.319 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 43' ' ' VAL . 34.9 m -103.53 136.23 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.034 0.445 . . . . 73.32 111.337 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.27 119.49 25.12 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.955 0.407 . . . . 44.11 110.435 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 40' ' ' ILE . 34.0 p -125.72 175.73 7.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.367 -0.378 . . . . 63.43 111.471 -175.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -61.41 -28.68 69.43 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.331 -0.395 . . . . 71.25 111.739 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 38' ' ' ALA . 83.9 mt -86.72 -22.82 25.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.755 0.312 . . . . 71.2 111.45 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.57 -153.13 21.9 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.923 -0.656 . . . . 75.32 113.511 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.495 ' H ' ' HD2' ' A' ' 89' ' ' ARG . 15.1 m120 -83.66 102.87 12.53 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.922 0.391 . . . . 72.43 111.098 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.524 HG11 HG22 ' A' ' 27' ' ' VAL . 47.6 t -97.62 119.73 46.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.962 0.41 . . . . 61.02 111.326 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -86.93 117.61 25.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.495 -0.321 . . . . 64.24 111.171 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.75 121.1 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.178 -0.464 . . . . 71.12 112.111 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -107.3 -41.79 5.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.249 -0.432 . . . . 71.4 111.799 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.9 m -93.14 162.43 14.03 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.283 0.564 . . . . 71.42 112.176 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -76.59 128.54 81.8 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.856 -0.611 . . . . 72.31 111.222 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.568 ' HA ' HG12 ' A' ' 83' ' ' ILE . 73.1 Cg_exo -49.35 -41.41 43.05 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.863 2.375 . . . . 71.32 113.6 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.28 34.44 4.7 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.895 -0.669 . . . . 74.2 113.335 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -77.7 -81.14 0.1 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.592 -0.357 . . . . 63.0 110.796 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -100.9 22.21 12.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.956 0.408 . . . . 74.03 110.773 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.74 7.99 87.95 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.178 -0.534 . . . . 53.15 112.434 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.4 151.64 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 122.859 0.464 . . . . 64.11 110.615 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.568 HG12 ' HA ' ' A' ' 77' ' ' PRO . 54.2 mt -96.08 143.87 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.299 -0.41 . . . . 62.4 111.588 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -118.92 148.96 42.37 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.301 0.24 . . . . 62.52 110.749 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.3 -170.25 26.82 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 121.089 -0.576 . . . . 53.42 113.641 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 2.3 t -121.08 147.73 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 122.487 -0.419 . . . . 72.23 111.126 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 50.5 tp -89.74 113.55 25.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.412 0.523 . . . . 73.42 112.412 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.5 pt -136.75 -173.51 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.077 0.465 . . . . 51.21 110.815 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HD2' ' H ' ' A' ' 70' ' ' ASN . 24.0 mmm180 -144.7 95.36 2.69 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.111 0.481 . . . . 75.41 111.35 176.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -94.37 -5.2 47.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.381 0.61 . . . . 74.03 110.431 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.8 mt -116.3 174.45 6.05 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.75 -0.659 . . . . 72.41 110.921 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -41.0 118.32 0.98 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.881 1.067 . . . . 72.14 113.881 -177.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -119.01 12.92 12.9 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.414 0.626 . . . . 64.15 110.566 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -82.77 8.61 11.76 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.197 -0.456 . . . . 71.32 112.206 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -61.56 -18.71 60.41 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.153 0.427 . . . . 71.33 112.153 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -76.26 -15.75 59.95 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.936 0.398 . . . . 52.21 111.461 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -115.4 147.25 40.76 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.049 0.452 . . . . 71.15 111.678 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.888 -0.577 . . . . 71.25 111.143 173.279 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.44 0 CA-C-O 120.656 0.031 . . . . 33.43 113.162 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.487 ' HB2' ' HG2' ' A' ' 4' ' ' ARG . 4.3 p-10 -165.29 -40.29 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 111.887 0.328 . . . . 74.01 111.887 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 57.22 26.27 12.04 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.005 0.431 . . . . 71.31 112.04 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.487 ' HG2' ' HB2' ' A' ' 2' ' ' ASP . 13.3 mmt180 -80.89 49.8 1.27 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.099 0.476 . . . . 74.54 111.269 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 m -82.92 143.56 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.258 -0.428 . . . . 72.14 111.366 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -60.83 114.21 2.92 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.01 0.434 . . . . 72.31 111.441 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 mp -55.17 -39.69 69.82 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.148 -0.478 . . . . 62.35 111.316 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 8' ' ' ILE . 6.9 tp -91.48 95.15 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.587 0.708 . . . . 74.15 110.817 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.04 72.14 1.29 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.626 0.727 . . . . 63.42 112.237 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.9 p -85.46 32.41 0.57 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.003 -0.544 . . . . 64.21 111.609 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.58 32.33 0.19 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.821 0.675 . . . . 71.11 112.821 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.72 144.16 47.83 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.3 -0.476 . . . . 43.31 113.445 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.75 -69.44 3.3 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.016 -0.611 . . . . 41.15 113.426 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -80.65 89.27 5.71 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.303 0.573 . . . . 74.02 111.78 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.9 m -157.51 102.07 1.88 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.898 -0.592 . . . . 72.42 109.903 176.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.443 ' HD2' ' O ' ' A' ' 16' ' ' LYS . 1.5 tmmm? -67.3 -47.51 70.37 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.033 0.444 . . . . 43.12 110.832 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.673 HG22 ' H ' ' A' ' 19' ' ' LEU . 11.4 p -64.97 137.85 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.228 0.537 . . . . 62.53 111.218 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -61.32 -22.76 65.19 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.469 0.544 . . . . 72.33 112.469 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.673 ' H ' HG22 ' A' ' 17' ' ' VAL . 8.6 tt -152.87 119.59 5.69 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.895 0.378 . . . . 61.24 111.195 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.19 -72.22 0.73 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.959 0.409 . . . . 43.55 111.495 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.6 t -133.51 11.26 4.09 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.437 0.636 . . . . 61.4 110.121 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.89 144.21 40.28 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.271 -0.877 . . . . 62.33 110.858 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 m -144.04 112.64 6.56 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 122.044 -0.41 . . . . 60.02 111.134 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 24' ' ' ARG . 21.1 mtp180 -145.36 166.86 24.35 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.159 -0.473 . . . . 64.0 111.369 -176.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 tt -151.85 131.9 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.088 0.471 . . . . 62.03 112.265 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -72.03 104.63 3.62 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.296 -0.411 . . . . 74.44 110.687 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -100.72 129.35 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.007 0.432 . . . . 63.33 111.817 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.2 t -95.6 117.64 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.351 -0.386 . . . . 75.4 111.062 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -75.58 115.01 41.88 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.251 -0.431 . . . . 74.43 110.345 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.26 -19.46 15.29 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.571 2.181 . . . . 72.04 112.727 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -85.43 -43.03 13.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.178 -0.465 . . . . 71.43 111.675 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.6 p -105.57 -19.5 13.75 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.325 0.491 . . . . 65.15 112.325 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.67 11.37 79.84 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.088 -0.577 . . . . 63.0 113.638 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -88.7 162.72 16.13 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.954 0.407 . . . . 73.33 111.63 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.3 t -112.5 115.64 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.776 0.322 . . . . 72.24 110.473 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -126.31 141.35 51.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 122.56 0.344 . . . . 64.34 110.833 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 mt -94.0 120.07 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.83 0.347 . . . . 71.52 111.657 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.508 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -107.32 160.91 15.26 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.166 0.508 . . . . 62.44 112.188 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -102.77 124.32 48.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.311 -0.404 . . . . 73.44 110.55 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.433 ' HA ' HG22 ' A' ' 66' ' ' THR . 68.2 mt -78.58 112.65 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.356 0.598 . . . . 73.15 112.411 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -83.55 -53.8 5.41 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.033 -0.53 . . . . 74.04 111.517 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 38.5 m-80 -120.98 152.88 38.03 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.893 0.378 . . . . 71.44 111.709 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.412 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 3.9 p -123.61 82.22 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 121.33 0.586 . . . . 64.23 110.97 174.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 43' ' ' VAL . 12.0 p 175.8 142.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 115.958 -0.565 . . . . 62.01 111.447 -177.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.64 ' HG3' ' HB ' ' A' ' 63' ' ' VAL . 3.3 mp0 -84.92 141.07 30.65 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 110.297 -0.26 . . . . 73.21 110.297 172.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.12 89.57 1.99 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.103 0.478 . . . . 60.1 110.621 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 t -159.66 140.72 12.54 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.219 -0.446 . . . . 61.45 111.563 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.12 111.86 11.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.343 0.497 . . . . 73.01 112.343 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 54.15 74.95 0.67 Allowed Pre-proline 0 N--CA 1.474 0.745 0 N-CA-C 112.582 0.586 . . . . 65.3 112.582 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.21 -51.79 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.002 1.802 . . . . 74.02 112.419 175.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -159.45 150.37 19.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.06 -0.518 . . . . 74.42 110.081 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.43 99.48 0.3 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.388 0.613 . . . . 71.44 111.808 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.46 146.94 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.496 -0.774 . . . . 75.02 110.566 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -125.05 -23.04 4.31 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 111.901 0.334 . . . . 71.34 111.901 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -108.2 149.24 28.82 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.8 0.333 . . . . 70.24 111.244 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -74.95 108.02 7.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.735 0.303 . . . . 74.24 111.139 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.0 tp -131.35 113.74 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.43 0.633 . . . . 72.22 111.822 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.731 ' HB ' ' HG3' ' A' ' 77' ' ' PRO . 61.1 mt -70.64 91.62 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.101 -0.499 . . . . 74.24 110.216 175.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -106.69 163.71 12.69 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.668 0.618 . . . . 53.22 112.668 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.6 ttp-105 -56.99 116.65 3.34 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.392 -0.822 . . . . 74.24 111.837 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.23 -12.45 55.27 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.157 -0.544 . . . . 51.43 113.749 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.03 159.71 32.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.32 0.56 . . . . 32.24 111.47 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.64 ' HB ' ' HG3' ' A' ' 45' ' ' GLU . 63.6 t -118.15 124.41 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.128 0.49 . . . . 61.31 111.226 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.418 ' HB ' HG23 ' A' ' 40' ' ' ILE . 35.3 m -108.14 147.45 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.931 0.396 . . . . 62.04 111.761 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 28.5 tt0 -87.7 126.67 35.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.428 -0.351 . . . . 72.52 110.138 174.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 40' ' ' ILE . 33.6 p -129.46 176.0 8.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.996 0.427 . . . . 74.01 111.387 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -62.23 -20.68 64.46 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.404 -0.362 . . . . 71.45 111.553 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' A' ' 38' ' ' ALA . 71.7 mt -101.18 8.61 42.56 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.655 0.264 . . . . 64.43 111.696 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.09 -154.74 16.88 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.301 -0.476 . . . . 54.13 112.907 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -80.78 137.69 36.24 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.258 -0.554 . . . . 60.25 111.571 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.2 t -126.51 130.63 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.337 -0.392 . . . . 75.33 111.105 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.585 ' HB2' HD13 ' A' ' 88' ' ' ILE . 41.5 ttm180 -91.32 114.21 26.68 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.711 0.291 . . . . 73.34 110.739 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.7 t -66.54 131.35 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 112.834 0.679 . . . . 74.45 112.834 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.4 p -108.98 -61.33 1.63 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.942 -0.572 . . . . 51.54 111.627 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.1 m -91.51 160.15 15.57 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.125 0.488 . . . . 73.13 112.128 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -76.46 135.95 68.49 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 116.255 -0.43 . . . . 75.15 111.413 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.731 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 73.5 Cg_endo -72.2 137.91 29.57 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.866 2.377 . . . . 61.54 113.336 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 110.2 -31.5 7.39 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.053 -0.594 . . . . 62.44 113.221 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -59.32 118.72 6.28 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.795 0.297 . . . . 73.44 110.923 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 62.53 10.63 4.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.263 0.468 . . . . 74.13 112.263 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.31 31.22 66.24 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.214 -0.517 . . . . 72.41 113.027 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.2 p -137.97 150.59 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.063 0.459 . . . . 63.44 111.683 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.4 mt -123.15 147.53 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.681 -0.488 . . . . 75.25 109.681 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -128.54 145.94 50.98 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.892 -0.505 . . . . 75.33 112.276 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.38 -179.39 38.5 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 121.386 -0.435 . . . . 72.34 113.205 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.6 t -116.64 142.41 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 116.962 0.381 . . . . 65.15 111.381 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.469 HD11 HH12 ' A' ' 89' ' ' ARG . 51.5 tp -76.99 115.31 16.68 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.675 0.274 . . . . 72.34 111.621 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 72' ' ' ARG . 22.2 pt -133.82 -176.59 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.297 0.57 . . . . 73.2 111.844 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.469 HH12 HD11 ' A' ' 87' ' ' LEU . 31.8 mmt180 -135.21 94.83 3.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.094 -0.503 . . . . 74.14 111.451 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.482 ' HG3' HG11 ' A' ' 63' ' ' VAL . 12.0 mm-40 -91.4 -34.62 14.79 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.45 0.643 . . . . 70.21 110.43 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.4 mt -102.15 137.4 40.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.68 -0.691 . . . . 71.25 110.235 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 133.43 36.34 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.78 0.324 . . . . 74.14 110.451 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -73.91 75.44 1.65 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.82 0.819 . . . . 65.51 112.072 -173.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -73.37 -45.76 53.02 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.822 -0.626 . . . . 74.54 111.233 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -78.79 114.3 17.6 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.956 -0.565 . . . . 72.24 111.484 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -82.58 165.34 20.17 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.866 0.365 . . . . 62.02 111.323 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -96.86 -179.65 4.64 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.9 0.381 . . . . 74.44 111.191 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.6 t60 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 119.047 -0.502 . . . . 70.13 110.82 175.611 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 113.687 0.235 . . . . 23.25 113.687 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -78.96 102.48 8.33 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 117.109 0.455 . . . . 63.2 110.593 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 76.9 mtt85 -114.3 98.09 6.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.95 0.405 . . . . 73.42 111.768 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -87.05 109.3 19.32 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.809 0.338 . . . . 73.51 110.152 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.24 117.87 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.791 0.329 . . . . 61.12 111.494 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -108.14 -55.35 2.38 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.603 0.239 . . . . 71.33 110.918 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 26.2 tp 61.86 6.5 1.68 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.81 0.67 . . . . 75.21 112.81 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.4 tp -54.74 124.31 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 112.794 0.664 . . . . 72.53 112.794 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -149.38 146.65 27.59 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.251 -0.431 . . . . 75.41 110.972 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -62.32 166.03 5.4 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.282 0.845 . . . . 63.31 113.282 -174.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -85.84 133.58 33.96 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.839 -0.619 . . . . 75.5 111.71 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.55 148.19 5.36 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.143 -0.551 . . . . 72.11 112.923 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.86 55.68 0.31 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.524 -0.369 . . . . 55.21 113.468 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -60.94 120.4 10.12 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 122.303 -0.528 . . . . 74.41 111.364 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.0 m -69.01 105.68 2.5 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.03 0.443 . . . . 71.21 111.935 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -88.87 151.26 22.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.313 0.578 . . . . 63.44 111.787 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -95.12 144.27 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.104 0.478 . . . . 64.24 111.784 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.515 ' H ' ' HD3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -66.41 -172.76 0.17 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.094 0.473 . . . . 74.12 111.892 173.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 23' ' ' THR . 2.6 pt? -56.76 -2.4 0.08 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.068 1.136 . . . . 71.22 114.068 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.52 -42.55 78.61 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.182 0.438 . . . . 41.1 112.182 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.1 m -96.43 -35.07 11.29 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.982 0.42 . . . . 45.14 111.36 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 5.2 p-10 -128.69 96.43 4.38 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.547 0.689 . . . . 73.2 111.044 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.529 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 17.8 m -76.24 113.47 13.84 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.946 -0.57 . . . . 64.01 110.81 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 34.6 ttm180 -148.02 154.0 39.69 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.929 0.395 . . . . 74.12 111.968 -172.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.0 tt -148.87 146.16 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.945 0.402 . . . . 73.23 111.619 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.637 ' ND2' HG23 ' A' ' 82' ' ' VAL . 29.9 m-80 -94.16 112.71 24.55 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.88 0.371 . . . . 72.54 110.064 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.3 t -102.39 130.99 51.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.053 -0.521 . . . . 72.54 112.055 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.7 t -95.11 120.47 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.073 0.464 . . . . 64.35 110.882 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.21 116.71 61.16 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.974 -0.557 . . . . 73.15 111.028 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.9 -17.04 11.06 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.693 2.262 . . . . 74.04 112.927 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -87.96 -43.17 11.95 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.834 0.35 . . . . 55.23 111.559 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 p -106.25 -26.9 11.34 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.583 0.586 . . . . 74.34 112.583 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.61 15.97 57.5 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.126 -0.559 . . . . 70.35 114.325 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -97.41 143.86 27.73 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.243 -0.563 . . . . 74.4 111.397 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.4 t -88.51 98.33 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.171 0.51 . . . . 71.01 109.894 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -101.32 138.61 38.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.933 -0.576 . . . . 62.11 110.94 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 55.1 mt -92.31 127.72 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.071 0.462 . . . . 64.43 111.439 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.89 160.0 35.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 53.52 110.995 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 39.0 mt-10 -109.17 134.69 51.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.873 0.368 . . . . 64.24 110.48 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.504 ' HA ' HG22 ' A' ' 66' ' ' THR . 60.6 mt -71.52 113.68 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.512 0.672 . . . . 72.44 112.046 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -37.32 41.45 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.107 -0.951 . . . . 73.01 110.302 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.667 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 59.9 t30 -141.04 119.12 11.95 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.939 -0.573 . . . . 64.41 110.545 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 m -74.34 -26.69 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 112.619 0.6 . . . . 64.13 112.619 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.8 p -93.57 144.93 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.941 0.4 . . . . 53.14 111.205 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.97 147.96 32.4 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.109 0.48 . . . . 75.13 112.045 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -72.52 63.15 0.56 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.372 -0.376 . . . . 75.2 110.78 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.4 t -134.77 -172.82 3.13 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.838 0.351 . . . . 72.3 111.871 -173.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.62 -73.99 0.62 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.804 0.668 . . . . 70.23 112.804 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.3 m120 60.74 90.6 0.09 OUTLIER Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 122.632 0.373 . . . . 71.02 111.477 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -58.22 -24.94 69.77 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 123.023 2.482 . . . . 65.4 113.474 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -104.89 162.76 13.05 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.018 0.437 . . . . 64.2 111.349 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -58.54 -18.68 31.49 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.309 0.485 . . . . 74.33 112.309 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.3 t -70.81 84.84 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.458 0.646 . . . . 72.14 111.617 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -136.82 138.12 40.49 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.792 -0.64 . . . . 75.23 109.918 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -81.06 86.18 6.18 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.844 0.83 . . . . 65.03 112.261 -173.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -83.9 -23.64 31.12 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.398 -0.819 . . . . 63.3 111.155 173.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 25.1 pt -74.33 130.12 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 115.784 -0.644 . . . . 72.32 111.98 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.508 HG23 HG21 ' A' ' 73' ' ' VAL . 62.9 mt -57.68 92.24 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 115.78 -0.645 . . . . 74.52 111.852 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.588 ' HA ' ' NH2' ' A' ' 76' ' ' ARG . 30.2 p -128.21 162.73 26.3 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.461 0.541 . . . . 74.34 112.461 -175.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -57.32 116.92 3.6 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.123 -0.489 . . . . 74.21 111.717 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.1 -11.36 60.38 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.211 -0.519 . . . . 63.32 113.217 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.02 131.06 40.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.817 0.341 . . . . 74.44 111.137 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -94.3 112.37 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 120.774 0.321 . . . . 61.33 111.348 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -103.04 148.52 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.119 0.485 . . . . 71.34 111.253 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 43.8 tt0 -92.52 123.99 36.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.386 -0.37 . . . . 53.55 110.885 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 40' ' ' ILE . 44.1 p -126.24 176.16 7.28 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.071 0.462 . . . . 61.2 111.879 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -65.09 -15.39 62.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.337 -0.392 . . . . 73.2 111.962 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -92.31 -32.35 15.04 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.221 0.534 . . . . 73.33 111.085 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.81 -150.05 21.88 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.905 -0.588 . . . . 62.41 112.26 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -80.53 130.49 35.17 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.444 -0.445 . . . . 63.31 111.193 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.4 t -126.41 128.66 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.417 -0.356 . . . . 74.23 111.457 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.477 ' HB2' HD13 ' A' ' 88' ' ' ILE . 42.0 ttm180 -91.29 117.44 29.65 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.251 -0.28 . . . . 44.42 110.91 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.508 HG21 HG23 ' A' ' 58' ' ' ILE . 45.9 t -66.3 133.83 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.73 0.3 . . . . 43.2 111.754 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -110.39 -73.2 0.69 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.707 0.289 . . . . 73.04 111.61 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.1 m -73.27 -177.05 2.4 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.231 0.539 . . . . 64.33 111.81 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.588 ' NH2' ' HA ' ' A' ' 59' ' ' THR . 2.8 mmp_? -94.19 132.33 29.5 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.431 -0.349 . . . . 74.12 111.327 177.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -72.95 150.81 49.57 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.689 2.259 . . . . 74.11 113.291 -175.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.95 11.43 46.34 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.937 -0.649 . . . . 43.34 114.053 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.645 ' O ' HG12 ' A' ' 82' ' ' VAL . 59.1 mm-40 -71.66 78.23 0.83 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 117.537 0.668 . . . . 74.31 110.038 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.7 t70 64.81 13.19 8.3 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.425 0.631 . . . . 64.04 111.128 -172.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.83 -35.41 3.7 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.2 -0.455 . . . . 33.4 113.529 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.645 HG12 ' O ' ' A' ' 79' ' ' GLN . 10.9 p -68.87 136.07 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 112.834 0.679 . . . . 73.23 112.834 -174.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.0 mt -122.98 147.4 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.479 -0.782 . . . . 73.41 109.588 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -122.21 139.95 53.17 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.471 0.545 . . . . 72.33 112.471 -175.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.72 171.43 37.67 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 116.133 -0.485 . . . . 54.3 112.915 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.38 141.24 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 122.522 -0.399 . . . . 71.32 111.424 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.07 117.53 18.72 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.751 0.31 . . . . 60.31 111.311 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.477 HD13 ' HB2' ' A' ' 72' ' ' ARG . 18.0 pt -132.2 175.07 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.25 0.548 . . . . 73.13 111.314 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -149.27 70.17 1.08 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.051 -0.522 . . . . 65.55 111.418 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.96 -11.25 59.92 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.317 -0.401 . . . . 70.03 111.887 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.0 mt -89.93 -175.86 4.73 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.899 0.38 . . . . 64.14 111.315 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -58.88 129.26 41.27 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.507 0.67 . . . . 73.42 111.798 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -85.54 35.39 0.61 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.761 -0.654 . . . . 74.11 111.368 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.3 p80 39.73 72.69 0.14 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.712 1.004 . . . . 60.31 113.712 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -145.31 129.21 17.38 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.797 -0.638 . . . . 72.43 110.621 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -65.87 118.41 9.65 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.868 0.366 . . . . 62.31 111.503 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -91.88 169.03 11.01 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.032 0.382 . . . . 72.45 112.032 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.697 -0.668 . . . . 74.45 111.269 177.316 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 113.467 0.147 . . . . 63.1 113.467 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -98.13 83.86 3.18 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.55 0.69 . . . . 73.43 112.462 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -114.33 38.01 3.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.767 0.794 . . . . 73.34 109.782 171.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -66.42 96.44 0.36 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.91 -1.041 . . . . 44.12 111.992 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.8 m -98.3 152.23 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.403 -0.362 . . . . 63.52 110.464 174.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 6' ' ' ARG . 12.2 ptt180 -109.79 -10.4 14.78 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.303 0.482 . . . . 72.52 112.303 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tt 53.43 82.66 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.389 0.614 . . . . 72.41 110.89 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.73 126.58 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.522 0.677 . . . . 74.34 111.267 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -128.89 145.45 51.21 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.753 -0.658 . . . . 75.52 110.51 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -178.01 171.83 1.7 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.111 0.481 . . . . 43.11 111.956 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.481 ' N ' ' HD3' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -160.37 -40.51 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.178 -0.465 . . . . 61.42 110.955 177.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.14 -176.7 51.34 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.173 -0.537 . . . . 62.14 113.035 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.25 52.48 4.53 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.049 -0.596 . . . . 75.24 112.743 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -116.65 -170.13 1.76 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.068 0.461 . . . . 73.45 111.844 -175.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.2 m -78.94 104.82 9.84 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.037 0.446 . . . . 74.22 112.089 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 17' ' ' VAL . 19.3 ptmt -85.26 160.49 19.84 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.0 0.429 . . . . 74.4 110.958 175.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.443 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 49.1 t -70.53 145.76 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 116.515 -0.311 . . . . 74.3 110.204 173.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -41.98 -39.87 2.03 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.97 0.73 . . . . 75.41 112.97 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.473 HD21 ' OG1' ' A' ' 23' ' ' THR . 7.5 tt -145.24 128.43 16.7 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.307 -0.406 . . . . 71.14 109.934 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.8 -65.54 0.87 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.948 0.404 . . . . 72.12 111.56 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -142.77 17.19 1.98 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.937 0.875 . . . . 74.21 110.142 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -112.04 22.77 14.48 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.902 -1.045 . . . . 64.15 112.011 -173.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.473 ' OG1' HD21 ' A' ' 19' ' ' LEU . 7.5 m -64.72 113.12 3.56 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.128 -0.487 . . . . 75.42 112.189 -176.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 24' ' ' ARG . 55.9 mtt180 -151.04 161.6 42.42 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.05 0.452 . . . . 72.21 111.918 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.5 tt -149.15 144.12 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 115.883 -0.599 . . . . 73.2 111.308 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -79.04 108.25 12.4 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.297 -0.41 . . . . 74.22 110.989 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 71' ' ' VAL . 28.5 t -94.63 120.44 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.312 -0.404 . . . . 72.23 111.865 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.02 118.17 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.935 0.398 . . . . 74.2 111.053 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 14.9 t0 -73.86 118.87 72.87 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.455 -0.339 . . . . 74.03 111.147 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 29' ' ' ASP . 12.9 Cg_exo -70.58 -28.13 21.68 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.885 2.39 . . . . 74.4 113.391 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.23 -44.06 11.73 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.41 0.522 . . . . 73.34 112.41 -173.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.7 p -104.73 -15.36 15.26 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.326 0.491 . . . . 71.53 112.326 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.04 28.15 69.03 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.144 -0.55 . . . . 63.25 114.021 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -100.38 145.69 27.88 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.152 0.476 . . . . 72.13 111.445 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -110.73 133.09 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 120.892 0.377 . . . . 72.52 111.352 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -147.24 139.69 24.71 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.47 -0.332 . . . . 73.3 111.074 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 61.3 mt -86.88 125.61 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.962 0.411 . . . . 74.22 111.11 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.468 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -122.51 154.38 37.93 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.381 0.512 . . . . 43.25 112.381 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -90.55 133.24 35.22 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.743 0.306 . . . . 42.04 110.502 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.474 ' HA ' HG22 ' A' ' 66' ' ' THR . 57.9 mt -83.1 114.71 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.838 0.352 . . . . 61.3 111.563 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -73.95 -46.68 42.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.392 -0.367 . . . . 74.3 111.208 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' OD1' HG12 ' A' ' 44' ' ' VAL . 28.2 t-20 -140.18 139.59 35.72 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.563 -0.29 . . . . 62.51 110.815 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 t -106.23 -4.34 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 112.585 0.587 . . . . 64.52 112.585 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.2 p -63.47 104.81 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.626 0.726 . . . . 73.32 111.253 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.44 155.47 37.41 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.703 -0.681 . . . . 73.34 111.851 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -78.83 41.03 0.41 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.427 0.529 . . . . 63.51 112.427 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 55' ' ' ARG . 1.8 t -63.79 -54.98 26.65 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.165 0.431 . . . . 71.25 112.165 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.429 ' H ' HG23 ' A' ' 47' ' ' THR . . . 66.98 1.58 2.37 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.317 0.858 . . . . 74.24 113.317 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -139.99 77.75 25.6 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 121.331 0.586 . . . . 63.13 111.809 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.81 108.22 1.43 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.522 2.148 . . . . 74.12 111.837 175.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -72.79 -40.1 66.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.794 0.331 . . . . 51.21 111.58 -174.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -139.99 -18.42 0.92 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.993 0.368 . . . . 75.2 111.993 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.25 154.73 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 122.292 -0.255 . . . . 54.31 111.109 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.438 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -67.22 134.82 52.4 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.023 0.44 . . . . 74.14 111.131 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.448 ' HB2' HG21 ' A' ' 47' ' ' THR . 31.0 mtp180 -104.02 128.35 51.61 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.366 0.876 . . . . 74.33 113.366 -173.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -145.84 38.82 1.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.924 -1.034 . . . . 55.01 108.615 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.7 mt -90.73 118.72 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.217 -0.902 . . . . 75.44 111.946 -171.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.762 HG21 HD13 ' A' ' 83' ' ' ILE . 59.5 mt -69.53 88.66 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.367 0.603 . . . . 62.22 110.759 176.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -134.06 173.05 12.0 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.145 -0.479 . . . . 71.41 111.338 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -58.74 115.95 3.41 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.999 0.428 . . . . 62.31 111.277 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.22 -13.19 52.01 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.228 -0.511 . . . . 63.44 113.665 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.25 139.31 48.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 117.061 0.43 . . . . 73.44 111.683 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.9 t -110.78 119.5 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 116.359 -0.382 . . . . 72.33 111.703 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 70' ' ' ASN . 32.6 m -114.8 159.23 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.77 0.319 . . . . 72.31 111.85 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.22 126.8 43.85 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.814 0.34 . . . . 71.14 110.806 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 40' ' ' ILE . 34.7 p -125.59 178.81 5.45 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.504 -0.316 . . . . 42.5 111.067 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.468 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 16.9 p-10 -67.68 -16.1 63.98 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.725 0.298 . . . . 72.33 111.771 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.4 mt -95.73 -22.31 17.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.984 0.421 . . . . 61.34 111.193 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.27 -154.76 21.78 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 112.079 -0.408 . . . . 72.22 112.079 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 13.4 m120 -81.18 133.34 35.44 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 122.094 -0.65 . . . . 65.23 111.711 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 27' ' ' VAL . 23.8 t -121.63 119.5 59.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.922 -0.581 . . . . 61.25 110.594 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.539 ' HB2' HD13 ' A' ' 88' ' ' ILE . 33.4 ttt-85 -91.21 116.52 28.88 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.675 0.274 . . . . 74.33 110.375 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.428 HG21 HG23 ' A' ' 58' ' ' ILE . 45.7 t -61.02 118.27 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.049 0.452 . . . . 63.23 112.141 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.6 p -97.21 -47.1 5.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.205 -0.452 . . . . 71.24 111.427 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.6 m -101.95 138.33 39.06 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.253 -0.43 . . . . 62.21 111.377 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -64.39 133.93 95.82 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 111.904 0.335 . . . . 70.23 111.904 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.8 100.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.803 2.336 . . . . 64.55 112.863 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.81 -30.98 0.46 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.802 -0.635 . . . . 54.22 111.853 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -60.16 112.97 2.11 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.62 0.248 . . . . 54.11 110.429 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.452 ' HB3' HG12 ' A' ' 82' ' ' VAL . 31.4 t70 65.13 15.64 10.11 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.45 0.643 . . . . 74.42 110.89 -175.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.27 2.53 63.08 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 116.001 -0.545 . . . . 71.11 113.202 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 83' ' ' ILE . 11.5 p -123.38 167.79 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 120.897 0.38 . . . . 72.21 111.413 -175.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.762 HD13 HG21 ' A' ' 58' ' ' ILE . 37.1 mt -106.51 129.15 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 122.52 0.328 . . . . 74.32 111.273 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -113.73 141.24 47.51 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.977 0.417 . . . . 72.34 111.465 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.55 173.69 34.32 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.36 -0.448 . . . . 73.31 113.049 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -105.05 150.76 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 113.082 0.771 . . . . 64.11 113.082 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 29' ' ' ASP . 66.4 tp -82.02 107.62 14.87 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.188 -0.914 . . . . 74.32 111.893 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 72' ' ' ARG . 10.2 pt -120.5 173.31 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.005 0.431 . . . . 73.03 110.492 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.457 ' HD2' ' O ' ' A' ' 88' ' ' ILE . 19.3 mmm180 -131.35 72.66 1.51 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 120.954 0.407 . . . . 73.11 110.855 -174.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -83.93 -56.89 3.44 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.948 0.351 . . . . 74.24 111.948 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . 84.8 mt -61.88 146.02 51.02 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.689 0.28 . . . . 62.32 111.369 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -53.35 -80.19 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.731 0.641 . . . . 74.21 112.731 -172.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 64.1 m80 -111.14 117.56 33.58 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.902 -0.499 . . . . 72.54 111.229 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.453 ' CE1' ' HB2' ' A' ' 91' ' ' LEU . 92.5 m-70 -86.25 18.89 2.93 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.131 0.491 . . . . 75.21 111.869 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -87.85 26.78 1.26 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.228 0.537 . . . . 74.14 110.066 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -53.73 105.3 0.13 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.808 -0.633 . . . . 74.12 112.6 -174.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -69.71 -22.11 63.42 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.003 -0.544 . . . . 75.04 110.586 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 19.6 p80 . . . . . 0 C--O 1.249 1.072 0 CA-C-N 116.092 -0.504 . . . . 72.11 111.115 173.685 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 CA-C-O 120.563 -0.021 . . . . 35.23 113.141 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.99 71.12 4.45 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.416 0.524 . . . . 71.14 112.416 -176.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.401 ' HD3' ' N ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -152.63 87.8 1.32 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.23 0.538 . . . . 64.04 110.714 172.598 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 4' ' ' ARG . 44.6 mtm180 60.12 87.3 0.09 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.668 -0.696 . . . . 74.53 112.09 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.86 -178.05 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.88 -0.6 . . . . 74.42 111.097 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -58.1 127.43 32.08 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.9 0.381 . . . . 63.21 111.408 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.53 50.33 1.76 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.453 0.644 . . . . 73.15 111.4 -172.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.8 tt -81.19 141.6 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.246 -0.434 . . . . 73.41 110.242 171.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -53.32 162.87 0.66 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.757 0.651 . . . . 75.55 112.757 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.0 p -62.38 148.66 44.66 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.767 -0.651 . . . . 70.12 112.298 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -125.71 -176.66 3.67 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.091 -0.504 . . . . 74.22 111.014 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.14 89.33 0.08 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.339 -0.458 . . . . 64.15 113.036 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.8 38.45 1.56 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.444 -0.408 . . . . 40.25 112.816 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -134.92 84.95 2.14 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.15 0.5 . . . . 65.25 110.306 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.8 m -97.14 123.62 40.96 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.009 0.374 . . . . 63.25 112.009 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -71.11 164.69 25.1 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.201 0.524 . . . . 74.5 111.997 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.01 155.05 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 115.992 -0.549 . . . . 53.33 109.896 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -45.5 -33.85 2.93 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.978 0.733 . . . . 75.3 112.978 -176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.3 tt -145.63 111.21 5.43 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.477 -0.329 . . . . 74.43 110.486 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.6 74.5 1.06 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.914 0.387 . . . . 43.4 110.855 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.0 t 71.7 -38.57 0.42 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.245 0.618 . . . . 71.54 112.211 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -92.11 130.88 37.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.304 0.573 . . . . 70.3 111.571 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.649 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 77.8 p -98.15 114.48 26.71 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.969 -0.56 . . . . 72.24 110.791 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -118.86 118.75 32.39 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.995 0.426 . . . . 75.5 111.749 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.8 tt -126.59 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.04 0.448 . . . . 74.3 112.065 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -70.21 103.82 2.46 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.309 -0.405 . . . . 63.3 110.831 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.04 115.58 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.125 0.488 . . . . 70.5 111.592 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.3 t -102.61 126.67 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.043 -0.526 . . . . 74.22 111.054 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.645 ' HB2' ' HG2' ' A' ' 34' ' ' LYS . 10.7 t0 -83.33 121.82 76.96 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 120.623 0.249 . . . . 72.34 110.443 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.476 ' HD3' HG12 ' A' ' 86' ' ' VAL . 59.7 Cg_endo -69.87 -32.08 18.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.756 2.304 . . . . 72.32 112.843 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -89.63 -43.46 10.73 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.688 0.625 . . . . 75.02 112.688 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.6 p -97.54 -31.83 12.12 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.396 0.517 . . . . 73.31 112.396 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.96 29.75 16.88 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.984 -0.626 . . . . 71.15 113.985 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.645 ' HG2' ' HB2' ' A' ' 29' ' ' ASP . 10.6 ptpp? -90.29 137.86 32.01 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.399 0.599 . . . . 64.12 111.074 177.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.8 t -115.17 102.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.019 0.438 . . . . 61.35 110.693 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -131.69 140.64 49.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.448 -0.342 . . . . 60.22 111.13 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.3 mt -86.5 121.04 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.858 0.361 . . . . 61.01 110.542 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.17 152.83 32.93 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.861 0.689 . . . . 62.44 112.861 -175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 23' ' ' THR . 1.9 mp0 -83.4 130.76 35.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.002 -0.544 . . . . 74.35 110.831 175.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.464 HG12 HG22 ' A' ' 66' ' ' THR . 60.6 mt -88.31 114.4 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.689 0.28 . . . . 64.42 111.443 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -83.41 -53.67 5.54 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.126 0.489 . . . . 71.32 111.831 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 84.7 m-20 -122.42 135.69 54.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.989 0.424 . . . . 73.32 111.82 -174.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.7 m -108.8 31.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 121.174 0.511 . . . . 71.15 111.148 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.924 HG21 ' HB3' ' A' ' 50' ' ' PRO . 10.5 p -99.66 138.13 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 113.323 0.861 . . . . 70.24 113.323 -171.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -81.43 163.21 22.94 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.206 -0.906 . . . . 74.03 111.803 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -70.43 83.42 0.58 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.251 0.548 . . . . 72.14 110.897 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.3 p -120.22 168.92 10.74 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.861 -0.609 . . . . 72.43 111.623 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.77 99.02 0.76 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.668 0.271 . . . . 65.41 111.289 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 62.28 93.51 0.06 OUTLIER Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 122.947 0.499 . . . . 75.23 111.583 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.924 ' HB3' HG21 ' A' ' 44' ' ' VAL . 72.5 Cg_exo -52.87 113.18 1.14 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.19 2.593 . . . . 72.43 113.549 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -141.1 162.43 35.51 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.314 0.578 . . . . 71.23 112.509 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -70.91 -2.58 15.58 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.518 -0.764 . . . . 74.31 112.205 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.2 p -55.46 -30.85 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 112.36 0.504 . . . . 64.23 112.36 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -105.28 160.36 15.17 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.58 0.229 . . . . 54.44 110.659 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.633 ' NE ' ' HA ' ' A' ' 55' ' ' ARG . 3.4 mmp_? -74.33 106.79 6.12 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.406 0.622 . . . . 72.2 112.548 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -74.55 60.59 0.89 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.226 -0.897 . . . . 73.5 112.125 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.424 HG13 HG23 ' A' ' 59' ' ' THR . 8.1 tp -94.04 137.32 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.275 0.559 . . . . 74.33 111.591 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.8 mt -86.46 103.09 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.212 -0.449 . . . . 73.3 111.064 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.424 HG23 HG13 ' A' ' 57' ' ' ILE . 54.4 p -134.63 160.38 38.27 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.296 0.238 . . . . 64.12 111.514 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 48.8 ttp180 -53.83 119.69 5.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.84 0.353 . . . . 65.31 111.316 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.91 -20.45 14.63 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.215 -0.448 . . . . 45.2 112.646 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.99 153.9 29.94 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.089 0.471 . . . . 64.13 112.23 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.8 t -105.99 114.19 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.097 -0.501 . . . . 71.51 111.636 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.434 ' HB ' HG23 ' A' ' 40' ' ' ILE . 30.6 m -103.33 118.79 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.374 0.607 . . . . 52.2 111.368 177.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 32.4 tt0 -77.72 108.63 11.07 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.995 0.426 . . . . 72.43 111.169 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.464 HG22 HG12 ' A' ' 40' ' ' ILE . 24.1 p -102.96 169.81 8.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.287 -0.415 . . . . 41.44 111.124 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -59.01 -20.89 57.28 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.616 0.598 . . . . 64.33 112.616 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.7 mt -89.62 -25.3 21.36 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.965 0.412 . . . . 73.04 111.269 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 147.95 -176.61 26.7 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 116.103 -0.499 . . . . 73.3 112.738 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -72.74 119.46 17.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.22 0.533 . . . . 61.2 111.773 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.57 135.14 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.03 -0.532 . . . . 72.44 111.213 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.533 ' HB2' HD13 ' A' ' 88' ' ' ILE . 30.9 ttm180 -91.94 126.91 37.2 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.204 -0.31 . . . . 73.04 111.001 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 30.2 t -68.86 100.64 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.767 0.318 . . . . 70.22 110.255 174.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.8 p -102.18 -26.01 13.5 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 122.052 -0.405 . . . . 71.2 111.666 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.405 ' CB ' ' HB2' ' A' ' 84' ' ' ASN . 37.4 t -100.34 -177.41 3.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.898 0.38 . . . . 63.13 110.623 175.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 44.2 mtp180 -100.02 130.19 26.79 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 122.264 -0.272 . . . . 73.43 111.192 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.539 ' HA ' HG12 ' A' ' 83' ' ' ILE . 21.1 Cg_exo -63.89 83.01 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.335 2.023 . . . . 72.35 112.218 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.08 -9.31 0.17 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.894 -0.67 . . . . 74.24 113.547 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 11.2 mm100 -59.22 103.66 0.2 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.023 0.412 . . . . 72.44 110.879 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.8 t70 61.91 23.05 13.5 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 121.727 0.775 . . . . 73.2 110.681 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.5 -25.51 15.27 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 115.766 -0.652 . . . . 55.4 113.479 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 83' ' ' ILE . 7.2 p -96.3 165.59 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.103 0.477 . . . . 74.54 111.897 -174.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 77' ' ' PRO . 29.5 mt -116.62 136.37 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.421 -0.354 . . . . 74.52 110.721 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.405 ' HB2' ' CB ' ' A' ' 75' ' ' SER . 4.4 m-20 -115.9 141.82 47.59 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.079 0.466 . . . . 64.44 111.741 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.58 174.2 30.76 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 116.102 -0.499 . . . . 43.45 112.968 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.476 HG12 ' HD3' ' A' ' 30' ' ' PRO . 6.3 t -120.46 132.31 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 122.299 -0.53 . . . . 75.41 111.813 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.65 105.76 3.81 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.88 0.371 . . . . 73.32 111.033 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.533 HD13 ' HB2' ' A' ' 72' ' ' ARG . 11.5 pt -104.69 172.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.452 0.644 . . . . 71.21 112.194 -174.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.425 ' HD2' ' C ' ' A' ' 88' ' ' ILE . 7.8 mpt_? -141.43 16.33 2.2 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.791 -0.641 . . . . 72.0 112.195 -175.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -73.37 -15.71 61.36 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.862 0.69 . . . . 74.41 112.862 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 91' ' ' LEU . 2.0 pt? -61.66 -176.07 0.07 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.013 0.745 . . . . 61.35 113.013 -175.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -46.07 108.08 0.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.401 0.68 . . . . 74.31 112.377 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -84.99 128.02 34.45 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.28 -0.418 . . . . 73.12 111.394 -175.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.403 ' C ' ' H ' ' A' ' 96' ' ' HIS . 83.5 t60 -89.79 78.19 6.92 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 120.789 0.328 . . . . 75.21 110.924 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 68.6 -23.8 0.13 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.094 0.776 . . . . 64.3 113.094 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.403 ' H ' ' C ' ' A' ' 94' ' ' HIS . 45.0 t-80 -62.26 107.49 0.91 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.364 0.505 . . . . 73.13 112.364 -175.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -102.0 -43.38 5.79 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.942 0.401 . . . . 74.14 110.666 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 41.3 t60 . . . . . 0 C--O 1.252 1.227 0 CA-C-O 118.435 -0.793 . . . . 54.41 110.995 177.987 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.622 -0.191 . . . . 45.03 112.622 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -75.16 166.27 23.9 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.387 0.613 . . . . 73.21 112.245 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.83 155.28 31.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.626 -0.715 . . . . 73.11 110.025 174.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -163.99 103.69 0.89 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.147 0.498 . . . . 75.42 111.438 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 m -72.61 132.24 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.981 -0.554 . . . . 54.34 111.686 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.54 ' HA ' ' HE ' ' A' ' 6' ' ' ARG . 2.5 mmp_? -124.28 95.94 4.73 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.885 0.374 . . . . 72.15 111.017 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.459 HD22 ' N ' ' A' ' 7' ' ' LEU . 2.7 mm? -98.36 -5.52 32.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.26 -0.427 . . . . 64.22 111.003 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.9 tp -65.1 91.39 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 121.868 0.842 . . . . 71.51 112.108 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -104.13 126.11 50.98 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.864 -0.607 . . . . 74.54 111.866 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.6 t -79.51 142.56 35.67 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.198 0.523 . . . . 75.33 111.405 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 11' ' ' ARG . 32.4 ttt180 -134.73 128.57 33.19 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.416 -0.356 . . . . 71.42 110.725 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.9 145.01 4.25 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.633 -0.794 . . . . 74.12 113.902 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.1 87.43 0.07 OUTLIER Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.367 -0.444 . . . . 62.23 112.799 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -116.39 170.73 8.32 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.238 0.542 . . . . 64.12 111.99 -177.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.9 m -137.08 140.07 41.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.849 -0.614 . . . . 70.41 111.147 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -67.17 151.05 48.26 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.161 0.505 . . . . 71.32 112.16 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 19' ' ' LEU . 48.7 t -80.21 143.35 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.036 -0.529 . . . . 73.1 111.696 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 19' ' ' LEU . 3.9 ppt_? -58.52 -17.48 21.69 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.648 0.61 . . . . 74.23 112.648 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.678 ' H ' HG12 ' A' ' 17' ' ' VAL . 8.6 tt -164.28 107.12 0.91 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.849 -0.426 . . . . 72.0 109.849 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.47 24.53 7.26 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.965 0.728 . . . . 72.42 112.965 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.8 t -155.51 -75.62 0.1 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.57 0.582 . . . . 72.23 112.57 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -141.98 177.77 7.98 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.212 0.449 . . . . 71.42 112.212 -174.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.7 p -101.83 112.49 25.12 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.009 0.433 . . . . 73.4 111.891 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 24' ' ' ARG . 49.1 mtm180 -143.9 163.46 33.35 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.374 -0.375 . . . . 65.1 111.019 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.482 ' HB ' HD11 ' A' ' 40' ' ' ILE . 14.0 tt -150.5 143.78 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.884 0.373 . . . . 63.34 111.767 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -72.82 103.4 3.67 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.044 0.45 . . . . 64.43 110.262 173.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 55.2 t -91.25 113.79 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 63.52 111.904 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.9 t -95.62 113.02 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.021 -0.536 . . . . 74.31 110.774 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.79 118.72 74.08 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 61.11 111.56 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.61 -1.73 10.7 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.832 2.355 . . . . 73.43 113.705 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.87 -44.0 13.61 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.252 -0.28 . . . . 64.33 111.664 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.4 p -124.55 -11.41 7.32 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.803 0.668 . . . . 64.3 112.803 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.22 24.66 39.61 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 120.974 -0.631 . . . . 64.33 113.785 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -93.01 145.59 24.25 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.411 -0.464 . . . . 72.52 111.21 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.51 132.96 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.772 0.32 . . . . 73.41 111.196 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -147.83 143.03 27.18 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.6 0.238 . . . . 75.25 111.161 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.8 mt -86.22 111.41 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 122.25 -0.281 . . . . 64.32 111.12 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.485 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -110.54 155.2 22.63 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.118 0.414 . . . . 74.13 112.118 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -85.46 122.65 29.9 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.896 0.379 . . . . 62.14 111.495 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.563 ' HA ' HG22 ' A' ' 66' ' ' THR . 62.2 mt -73.04 116.59 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.423 -0.353 . . . . 61.21 110.726 176.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -81.04 -54.33 5.64 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.817 0.341 . . . . 75.53 111.367 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -145.41 152.8 40.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.872 0.368 . . . . 74.35 111.254 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 43' ' ' VAL . 13.8 p -90.81 13.09 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-O 121.443 0.64 . . . . 74.13 111.712 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 44' ' ' VAL . 5.9 p -65.81 99.25 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.489 0.661 . . . . 71.34 111.166 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HB3' ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -86.33 -28.79 23.46 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.503 0.557 . . . . 72.14 112.503 -175.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -174.22 -30.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.115 0.413 . . . . 64.41 112.115 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.519 HG21 ' HD3' ' A' ' 54' ' ' ARG . 13.0 t -60.99 157.77 14.81 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.594 0.59 . . . . 63.2 112.594 -177.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.94 -14.66 27.25 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.293 -0.412 . . . . 52.31 111.081 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.54 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 6.8 t30 54.03 56.22 12.68 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 115.669 -0.696 . . . . 73.22 112.336 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' A' ' 49' ' ' ASN . 6.2 Cg_exo -80.24 -26.61 4.09 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.674 2.25 . . . . 55.34 112.595 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -130.93 132.09 44.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.334 -0.394 . . . . 61.41 110.58 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -77.21 73.02 3.79 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.607 0.718 . . . . 73.34 111.957 -175.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.7 p -127.21 -22.34 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.654 -0.703 . . . . 71.42 110.978 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HD3' HG21 ' A' ' 47' ' ' THR . 34.5 ttt85 -79.23 124.54 28.46 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.711 -0.677 . . . . 72.13 111.406 -176.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -79.69 87.03 5.23 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.215 0.531 . . . . 71.22 111.157 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -69.52 103.87 2.18 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.124 -0.489 . . . . 70.13 110.953 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 tt -141.98 145.69 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.985 0.421 . . . . 63.24 111.651 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.559 HG21 HD13 ' A' ' 83' ' ' ILE . 46.4 mm -65.12 112.06 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.256 -0.429 . . . . 75.22 111.337 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -147.85 167.57 24.43 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.184 -0.322 . . . . 70.22 111.586 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -62.35 127.29 30.66 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.057 0.456 . . . . 65.24 111.675 -176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.55 -22.09 42.18 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.286 -0.483 . . . . 42.5 112.909 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.86 129.36 37.75 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.911 0.386 . . . . 54.32 111.3 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.478 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 57.8 t -94.03 115.27 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.307 -0.406 . . . . 65.44 111.396 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' A' ' 40' ' ' ILE . 35.2 m -103.59 129.02 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.232 0.539 . . . . 72.54 111.341 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -76.44 110.27 10.85 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.891 0.377 . . . . 42.34 110.767 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 40' ' ' ILE . 33.3 p -107.78 171.9 7.13 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.841 0.353 . . . . 73.22 111.267 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.485 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 10.1 p-10 -55.78 -33.9 64.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.439 -0.346 . . . . 73.42 111.545 176.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' A' ' 38' ' ' ALA . 74.9 mt -81.23 -29.82 34.36 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.744 0.276 . . . . 62.21 111.744 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.01 -166.96 29.42 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.528 -0.844 . . . . 52.53 113.921 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -71.17 101.69 2.34 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.841 0.353 . . . . 61.34 111.523 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.9 t -99.61 117.0 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.086 0.47 . . . . 61.14 111.342 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -87.16 117.76 26.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.839 0.352 . . . . 61.15 110.61 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.432 HG21 HG23 ' A' ' 58' ' ' ILE . 51.8 t -67.95 140.17 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 112.61 0.596 . . . . 51.22 112.61 -173.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.0 p -117.95 -43.47 2.76 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.404 0.52 . . . . 75.1 112.404 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p -85.81 -179.35 6.81 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.099 0.476 . . . . 61.42 112.139 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -99.96 132.78 22.29 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.337 -0.392 . . . . 71.43 110.829 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.441 ' HG3' ' O ' ' A' ' 58' ' ' ILE . 60.1 Cg_endo -70.63 108.9 2.35 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.432 2.088 . . . . 65.41 112.877 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.57 -33.51 0.76 Allowed Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.906 -0.664 . . . . 75.25 113.363 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.506 ' O ' HG12 ' A' ' 82' ' ' VAL . 85.4 mm-40 -57.59 97.67 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.719 0.26 . . . . 75.32 111.532 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 56.82 17.08 3.03 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.558 0.577 . . . . 73.25 112.558 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.56 25.16 70.84 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 121.398 -0.429 . . . . 63.32 114.041 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 79' ' ' GLN . 9.1 p -121.37 140.43 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 117.237 0.519 . . . . 63.11 111.533 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.559 HD13 HG21 ' A' ' 58' ' ' ILE . 62.9 mt -121.69 145.43 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 120.988 0.423 . . . . 72.33 110.985 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.1 m-20 -120.04 147.52 44.72 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.117 -0.364 . . . . 74.12 111.206 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.23 176.81 40.13 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.221 -0.514 . . . . 54.52 112.915 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.82 146.88 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.579 0.704 . . . . 63.24 112.899 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 63.8 tp -85.68 112.66 21.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.294 -0.866 . . . . 74.13 112.204 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.4 pt -134.43 -174.78 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.954 0.407 . . . . 53.22 111.182 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -136.58 90.48 2.56 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.82 0.343 . . . . 73.3 111.089 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -80.96 -27.2 36.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.181 0.515 . . . . 75.42 110.615 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.6 mt -90.54 138.17 31.77 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.323 0.583 . . . . 74.1 111.497 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.803 ' HB3' ' HB2' ' A' ' 95' ' ' HIS . 36.0 tt0 -52.73 142.13 19.4 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.375 -0.83 . . . . 75.21 111.832 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -67.53 -22.11 65.44 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.91 0.707 . . . . 75.23 112.91 -172.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.477 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 27.8 p-80 -122.99 37.33 4.44 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.225 0.536 . . . . 64.21 110.462 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.803 ' HB2' ' HB3' ' A' ' 92' ' ' GLU . 56.6 t60 -86.83 123.53 32.07 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.142 -0.481 . . . . 73.52 112.245 -172.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 97' ' ' HIS . 23.1 p-80 -153.87 156.28 37.29 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.113 -0.494 . . . . 63.32 111.297 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 35.7 m80 73.66 29.5 1.51 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.467 0.707 . . . . 65.33 112.022 -175.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 . . . . . 0 C--O 1.253 1.263 0 CA-C-O 118.773 -0.632 . . . . 74.42 111.587 174.011 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 CA-C-O 120.669 0.038 . . . . 53.4 113.145 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.31 -160.36 0.78 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 120.963 0.411 . . . . 73.34 111.301 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.24 82.85 7.87 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.158 -0.338 . . . . 63.11 111.245 -177.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -123.38 152.97 41.0 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.91 0.337 . . . . 74.13 111.91 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 8' ' ' ILE . 10.3 m 48.74 11.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 114.952 1.464 . . . . 65.24 114.952 174.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -82.58 -0.69 48.06 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.758 -0.589 . . . . 63.11 111.635 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.505 ' N ' HD12 ' A' ' 7' ' ' LEU . 5.4 mp -86.55 2.04 49.52 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.423 -0.353 . . . . 74.13 111.929 -176.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 5' ' ' VAL . 11.4 tt -98.11 118.86 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.323 0.582 . . . . 74.22 111.472 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -117.07 147.32 42.48 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.167 -0.47 . . . . 75.43 111.141 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -101.95 179.66 4.26 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.43 0.633 . . . . 75.32 112.376 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -79.24 -32.04 43.75 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.782 -0.644 . . . . 63.33 110.772 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.42 39.86 6.21 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.999 -0.546 . . . . 60.33 112.398 -176.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.68 137.14 24.04 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.734 -0.27 . . . . 53.2 113.684 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -149.07 124.34 10.2 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.619 -0.342 . . . . 73.04 110.86 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.7 m -81.73 121.2 26.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.554 -0.294 . . . . 71.41 111.438 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -91.43 169.2 10.98 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.756 0.312 . . . . 71.25 111.245 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 18' ' ' ARG . 12.5 p -118.01 165.06 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-O 120.855 0.36 . . . . 72.11 111.735 -175.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.456 ' N ' HG22 ' A' ' 17' ' ' VAL . 74.7 mtp180 -60.4 170.97 1.18 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.226 0.536 . . . . 62.51 112.109 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.5 pt? -58.64 -9.69 1.85 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.979 0.733 . . . . 64.54 112.979 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.61 -23.96 12.58 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.12 0.415 . . . . 64.43 112.12 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.9 t -108.06 -37.17 6.13 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.415 -0.357 . . . . 74.22 111.94 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -136.42 116.23 13.11 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.969 0.414 . . . . 71.42 111.458 -175.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 30.6 p -109.94 112.36 24.33 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.143 0.497 . . . . 75.33 111.947 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -144.63 155.59 43.69 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.208 -0.451 . . . . 62.41 111.101 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.446 ' HB ' HD11 ' A' ' 40' ' ' ILE . 13.1 tt -145.45 145.82 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.792 0.33 . . . . 52.32 111.537 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -80.3 103.78 10.41 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.425 0.631 . . . . 73.23 110.506 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' A' ' 87' ' ' LEU . 23.0 t -95.36 121.88 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.429 -0.805 . . . . 74.03 111.922 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.5 112.28 26.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.931 0.396 . . . . 64.41 110.571 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -74.26 118.24 68.16 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.477 -0.329 . . . . 61.31 111.142 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.93 -12.36 17.85 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.554 2.17 . . . . 71.15 113.116 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -81.67 -44.73 16.75 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.818 0.342 . . . . 63.34 111.907 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -107.18 -31.0 8.43 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.785 0.291 . . . . 61.51 111.785 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.8 16.96 34.36 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.333 -0.461 . . . . 71.51 113.733 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -87.21 150.67 23.76 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 117.234 0.517 . . . . 74.33 111.813 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.86 95.31 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.522 0.677 . . . . 63.11 110.49 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -93.02 170.03 9.97 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.504 -0.771 . . . . 75.24 110.868 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 mt -125.16 124.77 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 122.035 -0.416 . . . . 73.33 111.09 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.85 163.13 19.73 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.554 0.576 . . . . 75.34 112.554 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.82 123.39 36.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.01 -0.541 . . . . 71.53 110.648 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 23' ' ' THR . 57.7 mt -78.79 106.19 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 120.022 -0.671 . . . . 64.43 110.341 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -88.08 -37.05 16.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.789 -0.641 . . . . 74.45 112.573 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.557 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 46.2 m-80 -133.31 146.84 51.72 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.115 0.483 . . . . 72.21 111.322 173.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.7 m -104.99 10.81 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.44 0.533 . . . . 74.23 112.44 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.1 p -85.23 140.96 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.94 0.4 . . . . 74.23 111.679 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -118.53 172.82 7.21 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.327 -0.397 . . . . 74.44 111.173 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.412 HD21 ' HB3' ' A' ' 90' ' ' GLU . 1.9 m120 -63.61 99.23 0.21 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.005 0.431 . . . . 71.31 111.005 175.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.7 t -160.19 167.41 27.7 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.265 -0.425 . . . . 60.1 111.734 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.64 20.85 0.55 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.319 0.488 . . . . 62.12 112.319 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -113.11 82.64 5.61 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-O 120.758 0.313 . . . . 51.14 111.393 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.74 -60.03 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.486 2.124 . . . . 73.13 113.737 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -89.11 12.87 14.49 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.077 0.399 . . . . 72.54 112.077 -176.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -88.23 122.0 31.26 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.767 0.318 . . . . 75.15 110.756 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 p -90.18 13.06 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 121.351 0.596 . . . . 65.53 111.54 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -111.42 -177.95 3.33 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.153 -0.342 . . . . 74.43 111.227 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.504 ' O ' ' NE ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER 77.4 -13.27 0.97 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.257 0.623 . . . . 73.02 110.722 -171.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -41.64 -21.56 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.223 1.194 . . . . 71.13 114.223 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 55' ' ' ARG . 69.1 mt -52.49 120.21 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 120.946 0.403 . . . . 73.11 111.717 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm -75.03 131.7 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.823 0.344 . . . . 70.12 111.165 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -147.81 174.12 12.14 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.009 0.433 . . . . 72.31 111.827 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -71.89 118.72 15.09 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.188 -0.46 . . . . 73.54 111.381 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.93 30.68 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.42 -0.419 . . . . 54.52 112.914 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.08 142.34 31.35 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.968 0.413 . . . . 63.35 111.927 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.07 141.13 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.78 0.324 . . . . 64.52 111.155 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.62 173.34 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.971 0.415 . . . . 71.32 111.469 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 34.5 tt0 -112.52 133.26 54.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.41 -0.359 . . . . 72.42 110.791 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.421 HG22 ' HA ' ' A' ' 40' ' ' ILE . 41.6 p -135.68 178.67 6.86 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.328 0.585 . . . . 52.34 111.804 -176.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -69.89 -14.41 62.72 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.99 -0.55 . . . . 62.33 112.383 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.58 -17.23 18.77 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.809 0.338 . . . . 74.43 111.247 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.99 -149.29 20.17 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.41 -0.676 . . . . 72.14 111.41 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' ND2' HD12 ' A' ' 91' ' ' LEU . 23.5 m120 -94.16 148.53 22.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 117.646 0.723 . . . . 71.01 111.276 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.6 t -133.89 127.07 51.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.65 -0.25 . . . . 74.34 111.241 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 72' ' ' ARG . 15.5 ttm180 -96.28 115.95 28.24 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.557 0.217 . . . . 65.43 110.832 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.76 126.99 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.448 0.536 . . . . 74.11 112.448 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.5 p -100.96 -41.37 6.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.634 0.605 . . . . 74.02 112.634 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.5 m -101.5 178.64 4.58 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.018 0.437 . . . . 75.31 111.855 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -88.35 117.34 68.27 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 111.986 0.365 . . . . 70.23 111.986 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.96 140.97 82.16 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.596 2.197 . . . . 71.34 112.313 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.69 -39.26 3.06 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.795 -0.717 . . . . 62.14 113.471 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -45.42 -74.96 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.984 0.514 . . . . 71.31 111.447 -177.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -78.67 -13.38 59.85 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.27 0.557 . . . . 72.34 110.844 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.05 -27.44 19.42 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 116.113 -0.494 . . . . 51.24 112.388 -175.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p -104.02 145.37 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.849 0.357 . . . . 62.24 111.269 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.2 mt -102.83 144.99 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.734 0.302 . . . . 72.01 110.71 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -126.94 151.23 48.77 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.584 0.231 . . . . 70.13 111.421 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -167.44 175.88 42.38 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.277 -0.487 . . . . 74.22 113.239 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.1 t -106.3 142.11 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 117.078 0.439 . . . . 71.34 111.405 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.495 ' HB2' HG12 ' A' ' 27' ' ' VAL . 40.7 tp -76.36 114.35 14.95 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.157 0.503 . . . . 74.04 111.456 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' A' ' 72' ' ' ARG . 8.0 pt -133.51 179.22 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.189 0.518 . . . . 64.02 111.166 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -139.26 32.13 2.13 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.207 -0.308 . . . . 62.43 111.239 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.421 ' OE2' HD12 ' A' ' 88' ' ' ILE . 43.2 mt-10 -59.76 -53.91 52.46 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.849 0.685 . . . . 74.13 112.849 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.459 HD12 ' ND2' ' A' ' 70' ' ' ASN . 81.0 mt -64.75 145.71 55.84 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.779 -0.452 . . . . 71.42 109.779 173.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.78 97.01 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.408 0.623 . . . . 72.34 111.689 -170.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -144.11 99.01 3.31 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.688 -0.687 . . . . 55.43 110.68 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -64.25 115.98 5.56 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 111.783 0.29 . . . . 74.43 111.783 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -71.24 -17.48 62.49 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.401 0.619 . . . . 75.31 110.563 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -130.84 125.34 33.39 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.388 -0.823 . . . . 71.41 109.323 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -54.3 131.68 42.26 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.992 0.367 . . . . 73.44 111.992 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.8 p80 . . . . . 0 C--O 1.254 1.334 0 CA-C-O 118.649 -0.691 . . . . 71.03 112.574 -178.028 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 112.972 -0.051 . . . . 73.41 112.972 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -81.31 -179.77 7.51 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 112.351 0.5 . . . . 74.02 112.351 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -129.44 175.66 8.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.344 -0.389 . . . . 73.22 111.286 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? 61.82 78.86 0.27 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.964 0.506 . . . . 53.55 111.622 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -86.53 157.15 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.963 0.411 . . . . 73.11 111.865 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 58.79 23.81 11.63 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.072 -0.513 . . . . 74.22 111.804 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.6 tp -72.3 -14.75 61.83 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 116.272 -0.422 . . . . 74.32 111.682 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.507 HD13 ' N ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -95.74 140.46 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.278 0.561 . . . . 74.34 111.251 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.507 ' N ' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -159.3 155.39 26.81 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.005 -0.543 . . . . 74.24 111.174 178.379 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.8 m -153.05 146.47 24.91 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 111.937 0.347 . . . . 74.22 111.937 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -120.98 -20.0 7.02 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.084 0.402 . . . . 73.22 112.084 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.03 -99.82 0.89 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.23 -0.509 . . . . 75.04 113.273 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.88 114.59 1.32 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.42 -0.419 . . . . 31.35 113.429 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -148.38 174.88 11.6 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 122.737 -0.273 . . . . 72.41 110.374 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.2 m -63.73 108.01 1.32 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.102 0.477 . . . . 72.4 111.495 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -123.3 179.06 4.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.148 0.499 . . . . 73.51 112.009 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.2 p -68.53 160.33 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.886 -0.597 . . . . 64.15 110.795 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 18' ' ' ARG . 5.8 ptp180 -46.9 -32.53 3.86 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.237 0.829 . . . . 64.54 113.237 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 tt -160.94 109.0 1.55 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.9 0.381 . . . . 72.3 110.477 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.35 79.93 1.64 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.087 0.47 . . . . 74.34 111.635 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.4 m 62.94 14.9 7.89 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.377 0.88 . . . . 65.13 113.377 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -141.31 129.85 22.64 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.006 -0.434 . . . . 71.32 110.388 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.517 HG22 ' HB ' ' A' ' 40' ' ' ILE . 25.8 m -90.42 113.57 25.52 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.914 0.387 . . . . 63.5 111.729 -175.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -129.11 165.83 20.49 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.521 -0.308 . . . . 71.23 111.485 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.541 ' HB ' HD11 ' A' ' 40' ' ' ILE . 15.5 tt -155.17 139.74 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.762 0.315 . . . . 74.14 111.419 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.459 ' OD1' HG12 ' A' ' 37' ' ' ILE . 90.3 m-20 -80.93 103.61 10.87 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.015 0.436 . . . . 70.22 110.841 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.447 HG22 HG21 ' A' ' 71' ' ' VAL . 60.3 t -85.35 121.44 37.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.98 -0.554 . . . . 73.5 112.013 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.01 111.37 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.113 -0.494 . . . . 65.33 110.788 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.425 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 11.2 t70 -77.77 115.8 53.08 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.413 -0.358 . . . . 63.12 110.283 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.28 -20.05 21.66 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.388 2.058 . . . . 73.11 113.791 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -86.01 -33.54 21.02 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.942 0.401 . . . . 65.02 111.885 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.5 p -116.4 -21.27 9.34 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.155 0.428 . . . . 62.11 112.155 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.34 25.72 50.21 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.391 0.516 . . . . 61.31 114.391 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 58.0 pttt -87.6 155.97 19.71 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.52 0.66 . . . . 75.55 111.705 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.1 t -118.7 111.5 34.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.138 -0.483 . . . . 64.51 109.909 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -133.38 136.6 45.4 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.132 0.419 . . . . 73.22 112.132 -173.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.459 HG12 ' OD1' ' A' ' 26' ' ' ASN . 61.5 mt -76.76 123.84 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.269 0.557 . . . . 50.24 112.105 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.526 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -117.81 170.32 8.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.032 -0.531 . . . . 70.14 111.606 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -104.69 127.27 52.4 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.418 -0.356 . . . . 73.45 110.466 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.541 HD11 ' HB ' ' A' ' 25' ' ' ILE . 53.8 mt -83.91 124.23 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.093 0.473 . . . . 64.35 111.617 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -81.11 -53.8 6.08 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.007 -0.542 . . . . 71.32 111.301 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -143.93 152.47 41.14 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.923 0.392 . . . . 71.4 111.553 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.516 HG13 HG12 ' A' ' 64' ' ' VAL . 48.6 t -120.08 88.87 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 109.555 -0.535 . . . . 72.43 109.555 176.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 p -160.2 142.4 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 112.522 0.564 . . . . 72.13 112.522 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -147.45 133.72 19.51 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.207 0.527 . . . . 63.42 112.11 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 61.62 13.89 5.59 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.061 1.134 . . . . 74.5 114.061 171.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 p -88.01 -169.6 2.64 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.829 -0.544 . . . . 64.02 111.571 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.38 -44.38 65.09 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.06 0.393 . . . . 71.2 112.06 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -125.06 128.02 24.92 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 116.638 -0.256 . . . . 71.1 111.682 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.02 51.82 3.58 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 122.921 2.414 . . . . 73.33 113.095 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -132.76 -169.93 2.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 122.494 0.318 . . . . 71.31 110.42 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -66.43 84.46 0.1 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.339 0.59 . . . . 75.41 110.428 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 56' ' ' ASN . 11.4 p -106.78 152.25 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.733 -0.667 . . . . 73.53 110.43 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -54.12 158.15 2.32 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 111.844 0.313 . . . . 72.54 111.844 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 55' ' ' ARG . 2.0 tpm_? 76.6 12.74 2.46 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.477 0.656 . . . . 72.13 110.15 -171.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 53' ' ' VAL . 3.4 p-10 -74.71 53.82 0.59 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.443 -0.799 . . . . 75.42 112.485 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 57' ' ' ILE . 37.8 pt -83.35 116.31 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.318 0.58 . . . . 75.2 111.885 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.589 HG21 HD13 ' A' ' 83' ' ' ILE . 62.2 mt -74.23 100.47 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.075 0.464 . . . . 74.02 110.726 176.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.3 t -142.24 169.4 17.65 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.051 0.453 . . . . 73.12 111.574 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -61.51 126.15 26.34 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.288 -0.415 . . . . 74.42 111.753 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.06 -24.91 21.98 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.387 -0.435 . . . . 64.21 112.97 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.24 141.64 35.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.874 0.368 . . . . 51.21 111.694 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.527 HG11 ' HG3' ' A' ' 90' ' ' GLU . 35.3 m -100.57 133.11 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.296 0.57 . . . . 60.4 111.833 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.516 HG12 HG13 ' A' ' 43' ' ' VAL . 32.1 m -111.92 146.76 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.177 0.513 . . . . 74.11 111.685 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -89.84 112.65 24.05 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.254 -0.43 . . . . 74.23 110.259 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 p -115.01 174.84 5.77 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.962 0.411 . . . . 53.11 111.593 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.526 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 19.5 p-10 -62.9 -31.78 72.9 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.992 0.425 . . . . 72.14 111.444 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 38' ' ' ALA . 88.5 mt -82.6 -19.03 39.21 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.291 -0.413 . . . . 62.13 111.464 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.18 -150.32 19.6 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.828 -0.701 . . . . 74.43 113.853 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -83.44 119.26 24.44 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.563 -0.375 . . . . 73.45 111.207 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.447 HG21 HG22 ' A' ' 27' ' ' VAL . 47.6 t -123.69 122.93 66.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.608 0.242 . . . . 73.02 111.494 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -91.22 116.09 28.55 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.284 -0.26 . . . . 63.44 111.407 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.63 134.02 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 112.336 0.495 . . . . 74.11 112.336 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.3 p -118.65 -66.9 1.03 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.331 -0.395 . . . . 61.35 111.916 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.3 m -64.24 133.43 52.78 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.787 0.327 . . . . 54.14 111.737 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -59.75 120.65 51.49 Favored Pre-proline 0 N--CA 1.472 0.642 0 CA-C-N 116.353 -0.385 . . . . 72.24 111.922 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.535 ' HB3' HG12 ' A' ' 83' ' ' ILE . 27.8 Cg_exo -61.56 94.94 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.769 2.313 . . . . 75.24 112.585 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.86 -63.71 0.42 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.556 -0.83 . . . . 55.12 113.168 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -53.71 -55.59 24.84 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 111.888 0.329 . . . . 75.13 111.888 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.21 -25.79 67.08 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.299 0.571 . . . . 64.32 110.902 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.91 -25.57 26.94 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 116.045 -0.525 . . . . 34.32 112.936 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.421 HG11 HD21 ' A' ' 26' ' ' ASN . 12.7 p -135.08 160.94 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 120.857 0.361 . . . . 60.5 110.956 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.589 HD13 HG21 ' A' ' 58' ' ' ILE . 60.2 mt -91.75 126.98 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.533 -0.303 . . . . 74.34 111.3 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -119.31 157.41 28.14 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.774 0.321 . . . . 73.41 111.337 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.33 177.94 39.12 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.107 -0.568 . . . . 30.0 113.407 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.5 t -111.08 138.98 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 122.454 -0.439 . . . . 71.34 111.627 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.8 tp -81.08 115.66 20.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.94 0.4 . . . . 52.42 111.362 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.562 HG13 ' HG2' ' A' ' 90' ' ' GLU . 5.6 pt -141.29 -166.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 120.94 0.4 . . . . 65.14 111.759 -176.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -122.8 100.87 7.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.821 0.343 . . . . 73.24 111.295 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.562 ' HG2' HG13 ' A' ' 88' ' ' ILE . 6.8 mm-40 -120.82 -64.0 1.29 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.392 0.615 . . . . 42.24 111.398 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.44 -158.29 0.66 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.746 -0.661 . . . . 72.41 112.102 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.21 168.22 0.25 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.273 0.559 . . . . 72.02 112.403 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -98.17 31.5 2.74 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.75 0.648 . . . . 62.55 112.75 -171.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -69.71 89.98 0.57 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.939 -0.475 . . . . 74.53 111.349 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -118.21 133.42 55.91 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.211 -0.449 . . . . 63.54 111.192 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -175.43 125.93 0.24 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.022 0.439 . . . . 64.03 111.286 172.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -82.33 -18.08 43.44 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.306 -0.407 . . . . 74.4 110.731 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 . . . . . 0 C--O 1.254 1.308 0 CA-C-O 118.537 -0.744 . . . . 74.32 111.143 -179.566 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 CA-C-O 120.571 -0.016 . . . . 72.33 113.105 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -117.28 126.38 52.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.946 0.403 . . . . 74.21 111.963 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -153.22 143.73 22.57 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.977 0.417 . . . . 72.33 110.918 173.32 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.405 ' HD3' HH11 ' A' ' 4' ' ' ARG . 22.2 mtm180 -123.62 171.26 9.69 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.987 0.422 . . . . 65.12 111.382 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 6' ' ' ARG . 14.0 p -132.25 163.03 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.106 -0.497 . . . . 74.34 110.671 -177.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' N ' HG22 ' A' ' 5' ' ' VAL . 96.5 mtt180 -77.29 118.05 19.4 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.783 0.325 . . . . 65.24 111.122 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 7' ' ' LEU . 6.8 mp -83.51 39.02 0.65 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.406 0.622 . . . . 75.32 110.736 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.1 tt -71.36 127.29 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.031 -0.531 . . . . 72.11 111.718 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -96.35 94.95 7.74 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.84 0.352 . . . . 74.53 110.658 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.2 m -67.75 87.78 0.23 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.139 0.495 . . . . 75.23 111.205 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -94.79 153.61 17.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.261 0.553 . . . . 74.35 112.289 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.02 -153.94 11.52 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 115.759 -0.655 . . . . 60.41 112.168 172.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.22 151.79 6.05 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.82 -0.705 . . . . 72.23 113.579 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -139.99 170.56 15.63 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.352 0.261 . . . . 63.32 110.481 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 93.8 m -48.44 121.92 4.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.18 0.514 . . . . 64.31 112.332 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -97.54 -170.51 2.02 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.137 -0.483 . . . . 55.22 111.175 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 19' ' ' LEU . 7.3 p -67.68 130.28 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.013 0.435 . . . . 71.11 110.903 173.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.504 ' HD3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -68.7 -25.12 64.61 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.007 0.743 . . . . 72.2 113.007 -176.174 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.571 HD11 ' HA ' ' A' ' 23' ' ' THR . 7.7 tt -176.87 135.71 0.22 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.866 0.365 . . . . 73.41 111.307 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.16 -63.27 1.43 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.12 0.485 . . . . 65.22 111.125 175.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.6 p -139.43 20.01 2.56 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.409 0.623 . . . . 73.11 110.207 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.0 28.2 2.86 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.439 -0.801 . . . . 65.44 111.812 -171.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.571 ' HA ' HD11 ' A' ' 19' ' ' LEU . 18.9 m -64.66 112.11 3.05 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.262 0.553 . . . . 45.41 112.373 -172.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -148.14 162.9 38.5 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.713 -0.676 . . . . 70.14 110.487 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 tt -150.55 141.81 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 112.047 0.388 . . . . 64.31 112.047 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -80.45 103.24 10.18 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.102 0.477 . . . . 73.42 110.035 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.413 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 61.3 t -90.81 125.22 43.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.506 . . . . 70.23 111.847 -175.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.38 119.86 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.066 -0.515 . . . . 62.14 110.834 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -77.49 121.45 84.41 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 116.122 -0.49 . . . . 72.32 110.98 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.32 -17.56 8.94 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.579 2.186 . . . . 71.11 112.951 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -85.21 -43.68 13.58 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.911 0.386 . . . . 54.43 111.476 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.517 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 37.2 p -114.32 -10.83 12.64 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.154 0.798 . . . . 74.14 113.154 -176.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.84 22.87 78.78 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 120.86 -0.686 . . . . 54.4 114.202 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 21.2 pttp -102.82 142.6 33.67 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.27 0.535 . . . . 70.41 111.49 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.8 t -102.88 119.86 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.824 0.345 . . . . 74.21 111.081 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -132.38 146.09 51.71 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.983 0.42 . . . . 75.43 111.579 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 53.4 mt -82.71 125.78 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.844 0.354 . . . . 75.44 111.589 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.533 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -118.55 162.41 18.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.245 0.545 . . . . 65.2 112.195 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -102.86 114.36 28.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.966 -0.561 . . . . 64.24 110.511 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.551 ' HB ' HG22 ' A' ' 23' ' ' THR . 58.7 mt -76.1 113.38 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.738 0.304 . . . . 61.23 111.372 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -83.1 -53.87 5.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.037 0.446 . . . . 45.41 111.368 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -121.32 151.47 40.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.109 -0.496 . . . . 70.2 111.69 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 56' ' ' ASN . 9.1 m -129.8 93.59 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 121.141 0.496 . . . . 74.04 112.05 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 p -178.87 139.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 116.03 -0.532 . . . . 74.33 110.636 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.07 -178.56 6.0 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.22 0.533 . . . . 75.32 112.053 -176.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -55.97 110.5 0.75 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.22 0.533 . . . . 74.03 111.461 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.632 HG21 HG11 ' A' ' 53' ' ' VAL . 50.4 p -127.93 134.74 49.34 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.126 -0.488 . . . . 72.44 111.567 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.71 138.44 35.99 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.174 -0.466 . . . . 52.03 111.04 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 62.74 107.63 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 123.057 0.543 . . . . 52.02 111.391 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.59 101.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.194 2.596 . . . . 74.31 114.343 -173.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -123.66 73.59 1.21 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.153 0.502 . . . . 73.33 111.888 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.1 t80 57.26 18.02 4.01 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 113.093 0.775 . . . . 73.51 113.093 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.632 HG11 HG21 ' A' ' 47' ' ' THR . 75.8 t -82.24 109.13 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 121.434 -0.791 . . . . 70.02 112.769 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -137.72 27.45 2.73 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.241 1.02 . . . . 74.22 109.02 168.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.531 HH21 HG21 ' A' ' 59' ' ' THR . 21.2 ttt180 -80.22 72.23 7.04 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.892 -1.049 . . . . 74.53 111.325 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.458 ' HB3' HG23 ' A' ' 43' ' ' VAL . 18.6 m120 -89.72 22.72 2.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.188 0.518 . . . . 61.12 111.161 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.6 mt -86.29 129.73 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.291 -0.413 . . . . 72.53 111.293 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.483 HG23 HG21 ' A' ' 73' ' ' VAL . 61.5 mt -69.45 98.17 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.143 0.497 . . . . 71.43 111.095 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.531 HG21 HH21 ' A' ' 55' ' ' ARG . 5.0 t -135.56 160.25 39.07 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.13 -0.486 . . . . 74.41 111.25 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -58.66 127.08 30.4 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.001 0.429 . . . . 74.14 111.876 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.37 -22.14 37.15 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.137 -0.483 . . . . 33.24 112.7 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.27 150.71 35.29 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.924 0.392 . . . . 74.1 111.529 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -107.19 116.26 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 120.945 0.402 . . . . 75.43 111.152 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 m -103.46 137.71 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 120.898 0.38 . . . . 70.41 110.65 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -90.82 110.68 21.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.264 0.554 . . . . 64.23 111.377 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.465 HG22 HG12 ' A' ' 40' ' ' ILE . 32.5 p -102.6 170.32 8.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.622 -0.717 . . . . 74.22 110.862 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -56.22 -33.56 65.48 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.986 0.422 . . . . 63.44 111.465 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.533 HD12 ' HB2' ' A' ' 38' ' ' ALA . 65.4 mt -79.91 -15.31 57.59 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.411 -0.359 . . . . 71.52 111.806 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.14 -161.08 23.83 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.321 -0.466 . . . . 74.45 113.235 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -70.0 134.35 48.21 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.563 -0.375 . . . . 64.35 111.235 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 96.0 t -130.64 125.7 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.778 0.323 . . . . 73.31 111.328 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.679 ' HB2' HD13 ' A' ' 88' ' ' ILE . 43.0 ttm180 -89.81 117.41 28.63 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.712 -0.222 . . . . 74.14 110.597 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.483 HG21 HG23 ' A' ' 58' ' ' ILE . 42.5 t -66.78 133.53 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.815 0.341 . . . . 63.43 111.767 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.4 p -109.9 -50.05 3.02 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.171 0.51 . . . . 72.41 111.908 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t -103.28 -176.53 3.11 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.078 0.466 . . . . 74.04 111.757 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -79.69 142.53 57.27 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.43 -0.35 . . . . 73.42 111.191 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.558 ' HA ' HG12 ' A' ' 83' ' ' ILE . 59.6 Cg_endo -71.57 -4.35 14.85 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.549 2.166 . . . . 64.42 112.979 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -116.82 27.79 7.7 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.402 -0.428 . . . . 54.54 113.387 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.509 ' O ' HG12 ' A' ' 82' ' ' VAL . 15.7 mm100 -72.62 86.41 1.2 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 122.36 -0.494 . . . . 72.31 110.233 175.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t70 63.74 -69.81 0.08 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.269 0.628 . . . . 74.34 110.998 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.09 25.54 0.21 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.276 -0.488 . . . . 31.0 112.713 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 79' ' ' GLN . 7.4 p -130.76 149.36 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 112.407 0.521 . . . . 74.42 112.407 -174.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.558 HG12 ' HA ' ' A' ' 77' ' ' PRO . 36.0 mt -122.38 140.07 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 122.879 0.472 . . . . 71.43 110.224 176.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -124.29 141.35 52.14 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.202 0.445 . . . . 72.44 112.202 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.1 176.36 37.68 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.113 -0.565 . . . . 41.24 113.377 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 18.0 t -118.63 135.81 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 122.64 -0.33 . . . . 73.43 111.57 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 38.7 tp -72.87 106.05 4.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.795 0.331 . . . . 74.31 111.077 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.679 HD13 ' HB2' ' A' ' 72' ' ' ARG . 30.5 pt -118.65 -175.92 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.169 0.509 . . . . 72.14 111.785 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.511 ' NH2' ' HA ' ' A' ' 92' ' ' GLU . 24.7 mmm180 -137.86 89.65 2.42 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.175 -0.466 . . . . 73.01 111.09 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -87.63 -39.78 14.75 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.295 0.569 . . . . 73.22 110.436 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.6 pp -137.27 148.48 46.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.347 -0.842 . . . . 71.5 110.182 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.511 ' HA ' ' NH2' ' A' ' 89' ' ' ARG . 34.5 tt0 -77.63 -44.58 27.77 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 111.962 0.356 . . . . 75.41 111.962 -177.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -141.87 127.0 18.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.856 0.36 . . . . 70.13 111.253 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -70.77 91.02 0.81 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.213 0.53 . . . . 75.43 112.235 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -138.93 -178.22 5.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.211 -0.45 . . . . 72.55 110.801 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -95.12 98.31 10.56 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.119 0.485 . . . . 72.33 111.432 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -114.9 115.74 27.42 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.425 -0.352 . . . . 64.31 110.932 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.4 t60 . . . . . 0 C--O 1.255 1.362 0 CA-C-O 118.82 -0.61 . . . . 70.21 111.536 -178.301 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 113.306 0.082 . . . . 53.42 113.306 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -108.63 128.86 55.21 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 122.217 -0.578 . . . . 75.41 111.239 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.446 ' HE ' ' N ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -82.46 108.48 15.9 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.954 -0.566 . . . . 71.2 111.759 -172.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -137.43 98.12 3.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.737 -0.665 . . . . 74.11 110.418 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -102.11 163.77 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 121.237 0.541 . . . . 74.53 112.362 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -86.08 88.54 7.61 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.209 -0.451 . . . . 72.52 110.972 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.426 ' H ' HD23 ' A' ' 7' ' ' LEU . 2.4 pt? -63.22 -22.19 66.71 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.123 0.416 . . . . 75.03 112.123 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.5 tp -95.36 108.39 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.411 0.624 . . . . 62.24 111.392 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 78.84 3.22 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.55 0.69 . . . . 74.25 112.304 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.4 p -69.84 84.42 0.48 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.801 -0.562 . . . . 74.01 111.327 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -135.12 128.02 31.35 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.335 -0.393 . . . . 70.4 110.857 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.58 -96.67 2.28 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.163 -0.541 . . . . 55.21 113.021 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.64 75.61 0.05 OUTLIER Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.157 -0.544 . . . . 61.1 113.185 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -113.23 119.21 36.94 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.426 -0.456 . . . . 72.24 111.302 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.5 m -106.47 125.99 51.7 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.825 0.345 . . . . 62.43 110.314 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -95.3 4.85 53.04 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.092 0.775 . . . . 63.12 113.092 -171.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.713 HG22 ' H ' ' A' ' 19' ' ' LEU . 13.2 p -149.52 145.44 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.098 0.475 . . . . 74.25 112.264 -176.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.677 ' HB3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -64.61 -21.32 66.68 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.972 0.731 . . . . 72.23 112.972 177.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.713 ' H ' HG22 ' A' ' 17' ' ' VAL . 6.4 tt -177.55 129.02 0.15 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.477 0.311 . . . . 73.21 110.261 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.45 ' N ' HD23 ' A' ' 19' ' ' LEU . . . -167.19 111.99 0.73 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.838 0.31 . . . . 44.33 111.838 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 p 72.12 -44.37 0.59 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.648 1.179 . . . . 40.45 113.231 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -102.96 123.37 46.45 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.839 0.352 . . . . 65.01 110.727 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.617 HG22 ' HB ' ' A' ' 40' ' ' ILE . 75.0 m -104.23 113.0 26.25 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.817 0.341 . . . . 71.02 111.822 -175.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.493 ' O ' HD12 ' A' ' 83' ' ' ILE . 59.1 mtt180 -142.58 168.94 18.54 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.734 0.302 . . . . 63.4 111.288 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.05 145.71 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.947 0.403 . . . . 64.3 111.758 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -79.35 104.28 9.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.077 0.465 . . . . 65.24 110.298 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.402 HG22 HG21 ' A' ' 71' ' ' VAL . 38.3 t -90.1 123.4 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.986 -0.552 . . . . 70.12 111.841 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.6 t -107.72 116.82 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.299 -0.409 . . . . 63.3 111.353 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.557 ' HB2' ' HG2' ' A' ' 34' ' ' LYS . 9.8 t70 -71.56 122.53 87.43 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 110.276 -0.268 . . . . 74.02 110.276 176.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.96 -30.86 32.03 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.075 1.85 . . . . 74.31 113.19 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -89.62 -43.87 10.46 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.814 0.672 . . . . 74.05 112.814 -175.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.0 p -96.61 -26.55 15.18 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.147 0.425 . . . . 61.24 112.147 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.71 22.0 58.83 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.915 -0.659 . . . . 64.24 113.901 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.557 ' HG2' ' HB2' ' A' ' 29' ' ' ASP . 10.7 ptpp? -78.06 135.3 37.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.359 0.579 . . . . 71.33 110.596 177.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -115.66 101.34 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.906 0.384 . . . . 72.04 110.943 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -125.15 144.41 50.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.902 0.382 . . . . 70.13 111.417 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.0 mt -84.92 111.34 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.897 0.379 . . . . 74.51 111.191 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.48 148.38 32.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.976 0.417 . . . . 65.41 112.015 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -80.27 130.97 35.57 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.336 -0.393 . . . . 63.54 110.668 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.617 ' HB ' HG22 ' A' ' 23' ' ' THR . 69.4 mt -80.99 113.65 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.049 0.452 . . . . 64.13 111.053 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.415 HH21 ' HB3' ' A' ' 67' ' ' ASN . 28.0 mmt180 -82.56 -48.66 10.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.201 0.524 . . . . 64.4 111.192 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.415 ' OD1' HG12 ' A' ' 44' ' ' VAL . 38.7 t-20 -125.21 145.22 50.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.988 -0.551 . . . . 72.42 110.526 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.516 HG21 ' HA ' ' A' ' 56' ' ' ASN . 32.6 m -116.48 2.13 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 113.37 0.878 . . . . 73.24 113.37 -173.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.415 HG12 ' OD1' ' A' ' 42' ' ' ASN . 9.6 p -76.1 122.26 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 121.786 -0.572 . . . . 72.2 111.452 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.569 ' HG3' HG23 ' A' ' 47' ' ' THR . 8.7 pt-20 -96.04 -175.58 3.43 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.096 0.474 . . . . 74.02 111.344 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -67.54 90.62 0.26 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.08 0.467 . . . . 74.41 110.828 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.569 HG23 ' HG3' ' A' ' 45' ' ' GLU . 52.2 p -130.05 167.85 17.65 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.385 -0.371 . . . . 65.45 111.148 178.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.36 -30.97 19.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.077 0.465 . . . . 75.41 110.58 173.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -119.33 95.4 49.26 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.031 -0.531 . . . . 71.14 111.823 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.18 93.54 0.56 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.659 2.239 . . . . 74.31 111.713 172.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -132.39 140.64 48.56 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.247 -0.433 . . . . 72.21 111.832 -174.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.647 ' HD2' HD11 ' A' ' 57' ' ' ILE . 21.0 t80 67.44 12.97 9.18 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.113 0.482 . . . . 74.44 111.374 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.3 -19.82 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 116.164 -0.471 . . . . 73.12 112.034 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.647 ' HA ' ' HE ' ' A' ' 54' ' ' ARG . 1.7 tpm_? -61.36 -17.93 56.32 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.175 0.512 . . . . 74.42 111.224 176.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -112.4 118.56 35.53 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.016 -0.735 . . . . 73.44 109.016 175.509 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.516 ' HA ' HG21 ' A' ' 43' ' ' VAL . 79.5 m-20 -60.13 101.11 0.11 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.152 0.797 . . . . 75.13 113.152 -170.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.647 HD11 ' HD2' ' A' ' 52' ' ' PHE . 65.8 mt -99.85 100.69 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.958 -0.564 . . . . 53.45 110.737 174.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.544 ' HB ' ' HG3' ' A' ' 77' ' ' PRO . 48.5 mm -104.59 122.79 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.61 0.243 . . . . 43.01 110.968 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.1 t -147.39 169.71 18.89 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.981 0.42 . . . . 73.53 111.896 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -63.16 125.05 22.79 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.131 -0.486 . . . . 75.03 111.132 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.55 -14.88 57.71 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.193 -0.527 . . . . 61.44 113.139 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.43 137.88 41.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.878 0.371 . . . . 35.04 111.569 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.97 112.11 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.909 0.385 . . . . 74.11 110.987 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.526 ' HB ' HG23 ' A' ' 40' ' ' ILE . 32.5 m -105.65 139.58 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.548 0.573 . . . . 74.12 112.548 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -82.54 116.43 21.96 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.511 -0.313 . . . . 75.51 110.674 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.597 HG22 ' HA ' ' A' ' 40' ' ' ILE . 32.1 p -121.16 179.42 4.4 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 120.905 0.383 . . . . 71.21 111.741 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.415 ' HB3' HH21 ' A' ' 41' ' ' ARG . 4.0 p-10 -65.58 -19.43 65.92 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.91 0.337 . . . . 71.03 111.91 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.6 mt -93.27 -23.69 18.42 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.946 0.403 . . . . 72.11 111.045 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.454 ' HA2' ' NH1' ' A' ' 89' ' ' ARG . . . 135.87 -162.03 24.91 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.134 -0.555 . . . . 65.14 113.381 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -71.29 117.39 12.76 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.805 0.336 . . . . 61.4 110.596 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 40.6 t -110.96 120.75 62.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.854 0.359 . . . . 63.22 111.118 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 72' ' ' ARG . 42.5 ttm180 -84.87 109.67 18.28 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.876 0.37 . . . . 74.41 110.421 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -65.2 120.15 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.456 0.539 . . . . 74.01 112.456 -173.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.3 p -89.86 -40.43 12.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.129 -0.487 . . . . 63.12 111.633 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.8 t -123.44 140.45 53.0 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.936 0.398 . . . . 64.03 111.659 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -65.75 154.1 89.54 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 116.171 -0.468 . . . . 73.41 112.224 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.544 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 86.7 Cg_endo -75.34 40.14 0.66 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.391 2.728 . . . . 62.44 114.646 -172.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.46 27.15 0.09 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.496 -0.859 . . . . 53.21 113.664 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -93.81 -63.95 1.14 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 117.073 0.436 . . . . 73.41 111.155 179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -102.58 17.14 24.44 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.313 0.578 . . . . 70.45 111.207 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.677 ' HA2' ' HB3' ' A' ' 18' ' ' ARG . . . 80.25 17.84 73.11 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.193 -0.527 . . . . 74.1 113.339 -178.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.2 p -157.43 148.77 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.991 0.424 . . . . 54.15 111.856 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.505 HD11 HD12 ' A' ' 19' ' ' LEU . 20.6 mt -92.75 135.1 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.3 -0.409 . . . . 74.22 110.739 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -128.36 145.15 51.16 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 122.212 -0.305 . . . . 72.53 111.514 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.55 172.46 39.48 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.022 -0.608 . . . . 53.44 113.515 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.6 t -109.15 147.41 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 122.545 -0.386 . . . . 73.14 111.754 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 tp -84.65 119.27 25.04 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.129 0.49 . . . . 73.41 112.089 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.495 ' O ' ' HD2' ' A' ' 89' ' ' ARG . 17.3 pt -144.64 -173.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 122.996 0.518 . . . . 73.41 110.595 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HD2' ' O ' ' A' ' 88' ' ' ILE . 18.2 mmm180 -142.65 89.44 2.14 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.789 0.328 . . . . 64.31 110.739 171.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.41 -27.06 63.99 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.266 0.555 . . . . 72.35 110.61 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 91' ' ' LEU . 2.3 pt? -141.72 161.42 37.99 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.583 -0.735 . . . . 51.24 109.839 172.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -106.06 -64.16 1.19 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.297 0.57 . . . . 75.11 111.273 177.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -74.18 81.49 1.8 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.771 -0.65 . . . . 54.45 111.871 -174.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -75.5 70.71 2.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.561 0.696 . . . . 72.21 110.812 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -177.38 -46.7 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.041 -0.982 . . . . 74.25 109.522 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -69.23 109.34 4.04 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.574 -0.739 . . . . 73.25 111.099 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -80.02 159.42 26.22 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.112 0.482 . . . . 75.24 111.928 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 . . . . . 0 C--O 1.252 1.208 0 CA-C-N 115.96 -0.564 . . . . 71.15 111.045 -179.844 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 CA-C-O 120.637 0.021 . . . . 70.33 113.124 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -84.69 177.01 8.2 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.124 0.488 . . . . 72.22 111.559 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -116.88 92.75 3.95 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.875 0.369 . . . . 54.52 111.202 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -86.25 125.35 33.51 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.96 0.41 . . . . 52.33 111.43 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.67 132.45 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.229 0.538 . . . . 72.34 111.579 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -79.11 110.28 14.22 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.321 0.581 . . . . 72.34 110.996 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.5 tp -83.63 -23.57 31.79 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.18 -0.464 . . . . 75.32 111.149 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.0 tt -49.76 121.59 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.169 0.509 . . . . 64.23 112.059 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -164.43 144.51 7.75 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.25 -0.432 . . . . 72.21 110.994 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.7 p -134.43 163.56 29.4 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.923 0.392 . . . . 72.43 111.423 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -76.14 -58.72 3.12 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.979 0.419 . . . . 73.43 111.486 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.76 49.62 75.84 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 116.198 -0.456 . . . . 33.11 113.586 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.65 166.47 32.34 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.686 -0.769 . . . . 73.34 113.596 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -152.58 119.35 5.72 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.632 0.253 . . . . 64.44 110.665 -178.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.1 t -77.32 157.37 30.74 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.184 0.438 . . . . 72.05 112.184 -175.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -104.21 -178.3 3.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.924 0.392 . . . . 74.3 111.879 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.99 83.63 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 114.026 1.121 . . . . 63.04 114.026 -171.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.676 ' HG2' ' HA2' ' A' ' 81' ' ' GLY . 96.4 mtt180 55.5 -172.7 0.06 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.519 1.304 . . . . 75.14 114.519 170.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.415 ' C ' HD23 ' A' ' 19' ' ' LEU . 7.3 tt -78.24 128.14 33.29 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.447 -1.252 . . . . 71.41 110.726 174.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.59 -76.79 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.149 -0.478 . . . . 61.43 110.476 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.6 m -83.9 -30.6 26.25 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.342 0.592 . . . . 64.41 110.397 172.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -91.61 92.15 8.34 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.762 -0.653 . . . . 75.04 109.654 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 94.1 m -97.31 113.69 25.36 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.016 0.436 . . . . 73.34 111.68 -175.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HG2' HG22 ' A' ' 37' ' ' ILE . 2.3 ttm105 -166.85 155.64 10.38 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.282 -0.417 . . . . 75.55 110.943 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.521 ' HB ' HD11 ' A' ' 40' ' ' ILE . 9.8 tt -133.71 142.85 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.101 0.408 . . . . 73.22 112.101 -175.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -76.61 103.61 6.68 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.076 0.465 . . . . 74.32 110.634 174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.47 HG22 HG11 ' A' ' 71' ' ' VAL . 45.3 t -104.75 125.35 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.177 0.513 . . . . 71.55 111.576 -176.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.48 118.53 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.19 -0.459 . . . . 75.22 110.782 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -75.59 112.69 20.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.29 -0.414 . . . . 51.1 109.897 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.58 -14.6 15.9 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.359 2.039 . . . . 63.11 112.833 -177.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.97 -42.97 12.1 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.777 0.322 . . . . 74.44 111.26 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.411 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 25.9 p -107.19 -15.35 14.68 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.234 0.457 . . . . 73.32 112.234 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.54 18.38 73.62 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.361 -0.447 . . . . 71.14 114.099 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 21.7 pttm -92.36 159.56 15.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.494 0.647 . . . . 74.31 111.946 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.6 t -107.24 109.26 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.402 -0.363 . . . . 72.2 110.722 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -117.01 141.6 48.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.543 -0.298 . . . . 74.12 111.021 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.506 HG22 ' HG2' ' A' ' 24' ' ' ARG . 38.1 mt -100.04 105.94 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.921 0.391 . . . . 54.42 110.852 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.08 151.92 19.28 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.999 0.74 . . . . 62.23 112.999 -172.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.61 126.35 34.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.243 -0.435 . . . . 54.13 110.955 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.521 HD11 ' HB ' ' A' ' 25' ' ' ILE . 56.2 mt -83.44 113.35 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.199 0.444 . . . . 63.05 112.199 -176.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -82.84 -53.62 5.74 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.034 0.445 . . . . 72.24 110.583 176.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 40.4 t30 -118.99 147.57 43.93 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.107 -0.497 . . . . 61.1 110.686 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.29 12.0 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 113.024 0.75 . . . . 64.34 113.024 -172.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.06 136.02 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 112.497 0.554 . . . . 62.35 112.497 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.408 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 13.0 pt-20 -84.39 176.33 8.76 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.256 0.55 . . . . 71.44 111.502 177.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -84.1 39.73 0.72 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.238 0.542 . . . . 72.0 110.902 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.408 ' HB ' ' HG3' ' A' ' 45' ' ' GLU . 7.9 t -59.97 -31.85 70.28 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.501 0.926 . . . . 41.04 113.501 -173.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.86 163.02 40.74 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.6 0.593 . . . . 73.4 112.6 -174.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -124.21 78.78 60.07 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.712 -0.676 . . . . 64.42 110.248 173.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -90.61 -166.49 0.2 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.916 2.41 . . . . 75.12 114.103 -173.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -79.87 -159.74 0.23 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.767 -0.651 . . . . 73.42 110.674 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -69.68 72.07 0.35 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.093 0.473 . . . . 71.33 111.059 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -163.31 135.73 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.827 0.346 . . . . 64.42 111.385 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.92 173.22 3.28 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.306 -0.406 . . . . 64.34 110.276 177.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.1 157.55 43.64 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.848 -0.532 . . . . 74.34 112.095 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -98.76 21.1 11.9 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.827 -0.624 . . . . 53.32 112.019 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.2 mt -88.04 118.53 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 120.924 0.392 . . . . 73.52 111.459 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.5 mt -73.41 123.23 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 116.402 -0.363 . . . . 73.42 110.522 177.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.0 p -118.26 159.68 22.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.245 0.545 . . . . 73.15 112.184 -174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.81 136.47 56.92 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.317 -0.401 . . . . 62.04 111.23 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 -14.51 45.67 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.071 -0.585 . . . . 60.11 113.183 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.47 147.95 33.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.026 0.441 . . . . 75.42 111.386 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.501 HG21 ' HG3' ' A' ' 90' ' ' GLU . 61.9 t -101.11 119.5 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.94 0.4 . . . . 61.32 111.319 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.96 156.63 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.108 0.48 . . . . 72.34 111.317 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.684 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 36.1 tt0 -97.88 105.92 18.14 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.863 0.363 . . . . 72.11 110.964 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.0 p -103.38 170.72 7.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.856 0.36 . . . . 72.42 111.576 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -57.52 -30.85 65.49 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.33 -0.395 . . . . 73.35 111.473 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.4 mt -77.91 -36.82 49.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.035 0.445 . . . . 73.33 111.014 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.99 -150.87 23.08 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.265 -0.493 . . . . 14.15 112.7 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -75.88 128.77 35.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.932 0.396 . . . . 61.13 111.314 -178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.47 HG11 HG22 ' A' ' 27' ' ' VAL . 90.1 t -129.01 126.93 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.535 -0.302 . . . . 74.11 111.297 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -95.98 120.6 36.55 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.626 0.251 . . . . 72.54 111.508 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.553 HG11 ' HG3' ' A' ' 77' ' ' PRO . 23.5 t -65.12 133.85 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 112.051 0.389 . . . . 62.05 112.051 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.4 p -96.9 -50.12 4.77 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.259 0.466 . . . . 71.31 112.259 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.5 m -104.56 -169.63 1.65 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.096 0.406 . . . . 72.31 112.096 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.63 110.42 22.13 Favored Pre-proline 0 N--CA 1.472 0.66 0 O-C-N 122.253 -0.279 . . . . 73.34 111.125 176.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.553 ' HG3' HG11 ' A' ' 73' ' ' VAL . 33.0 Cg_exo -60.08 105.59 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.79 2.327 . . . . 53.41 113.307 -176.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.91 -33.38 1.63 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.939 -0.648 . . . . 73.22 112.694 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -60.45 132.77 54.94 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 120.825 0.345 . . . . 61.52 111.342 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 60.71 9.26 2.09 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.006 -0.543 . . . . 72.45 111.907 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.676 ' HA2' ' HG2' ' A' ' 18' ' ' ARG . . . 81.24 -0.9 86.89 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.266 -0.492 . . . . 63.33 113.59 -178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p -115.09 144.7 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.298 0.57 . . . . 73.33 112.509 -174.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 83' ' ' ILE . 3.9 mp -113.11 125.34 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.096 -0.502 . . . . 74.14 110.266 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -102.22 143.07 32.48 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.836 0.351 . . . . 74.25 111.825 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.86 173.96 36.62 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 121.282 -0.485 . . . . 63.12 113.446 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.8 139.09 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 117.001 0.4 . . . . 54.15 111.548 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HB2' HG12 ' A' ' 27' ' ' VAL . 50.6 tp -79.16 106.95 11.56 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.737 0.303 . . . . 75.33 111.4 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 pt -133.67 -171.24 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.252 0.548 . . . . 64.53 111.789 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 76.7 mmt-85 -137.78 107.27 6.16 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.039 -0.528 . . . . 61.35 110.983 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' HG3' HG21 ' A' ' 63' ' ' VAL . 17.8 mm-40 -103.19 -19.7 14.41 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.151 -0.477 . . . . 73.53 111.081 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 93.9 mt -96.8 -176.01 3.45 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.123 0.487 . . . . 74.41 111.831 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -61.9 142.82 57.17 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.668 0.618 . . . . 70.15 112.668 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -90.14 99.16 12.23 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.7 -0.682 . . . . 71.31 109.407 169.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -62.73 122.25 15.43 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.031 0.382 . . . . 74.1 112.031 -172.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -149.93 86.69 1.45 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.435 0.636 . . . . 72.22 111.63 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -101.51 106.97 18.13 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.368 -0.378 . . . . 71.12 110.403 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -59.79 126.75 28.81 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.082 0.468 . . . . 63.35 112.19 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.767 -0.635 . . . . 74.24 111.024 174.64 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.869 -0.092 . . . . 72.5 112.869 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -96.42 123.36 40.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.996 0.398 . . . . 71.42 110.87 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -109.85 8.54 24.48 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.182 0.438 . . . . 61.05 112.182 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -70.9 155.34 40.92 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.657 0.614 . . . . 71.43 112.657 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -82.09 154.38 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 115.701 -0.681 . . . . 72.12 112.227 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -65.28 144.51 57.1 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.122 0.486 . . . . 64.12 112.034 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.4 mt -112.86 1.04 15.37 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.427 -0.351 . . . . 75.13 111.824 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.4 tp -83.78 124.92 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.27 0.557 . . . . 75.43 112.403 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.447 ' HD3' ' N ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -112.41 171.21 7.65 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.931 0.396 . . . . 74.5 111.321 175.565 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.3 p -87.99 -76.38 0.39 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.695 0.628 . . . . 53.14 112.695 -173.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? 68.98 124.9 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.265 0.555 . . . . 71.13 111.972 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.76 172.16 36.05 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.24 -0.505 . . . . 52.51 112.798 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.11 140.31 2.85 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.762 -0.732 . . . . 44.34 113.415 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -106.94 164.89 11.75 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.229 0.538 . . . . 72.33 111.866 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.1 m -117.37 132.18 56.64 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.183 -0.462 . . . . 72.53 112.103 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -88.8 145.59 25.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.009 0.433 . . . . 64.31 111.27 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.538 HG22 ' H ' ' A' ' 19' ' ' LEU . 8.5 p -72.98 138.36 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.477 0.655 . . . . 75.43 112.383 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.416 ' H ' ' HG3' ' A' ' 18' ' ' ARG . 3.5 ppt_? -61.01 -7.75 2.73 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.039 1.125 . . . . 72.45 114.039 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.538 ' H ' HG22 ' A' ' 17' ' ' VAL . 6.2 tt -156.99 114.36 3.12 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 122.022 -0.424 . . . . 72.24 111.162 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.52 102.79 3.21 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.962 -0.563 . . . . 75.13 111.115 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.9 m 74.43 -45.9 0.6 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.657 0.783 . . . . 72.13 112.489 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -110.31 149.31 30.37 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.405 0.282 . . . . 65.44 111.003 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.8 m -124.42 114.68 19.81 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.853 0.358 . . . . 62.34 111.463 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.42 151.14 48.1 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.85 0.357 . . . . 75.44 111.586 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.9 tt -146.26 139.08 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.028 0.442 . . . . 50.32 111.374 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.57 103.69 9.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.438 -0.346 . . . . 71.01 110.429 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.82 113.91 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.898 0.38 . . . . 72.42 111.549 -177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.7 t -95.16 118.09 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.396 -0.365 . . . . 74.4 110.688 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.23 128.93 81.65 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 120.536 0.208 . . . . 52.42 110.982 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.79 -22.79 11.51 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.426 2.084 . . . . 73.52 113.592 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -88.27 -35.32 17.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.969 0.414 . . . . 32.23 111.859 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.7 p -107.91 -31.72 7.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.373 -0.376 . . . . 65.24 111.803 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.91 10.19 65.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.208 -0.52 . . . . 61.34 113.603 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -79.63 138.12 37.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.192 0.496 . . . . 71.54 111.919 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.9 t -97.66 106.42 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 116.27 -0.423 . . . . 74.43 110.319 176.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -128.65 132.87 48.12 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.952 0.406 . . . . 62.44 111.583 -173.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 57.0 mt -81.06 140.43 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 112.427 0.528 . . . . 62.43 112.427 -175.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.47 167.14 22.91 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.239 -0.437 . . . . 43.54 111.124 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.485 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 3.3 mp0 -98.24 140.56 32.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.819 0.343 . . . . 73.1 111.081 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.16 115.1 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.969 0.414 . . . . 52.14 111.687 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.562 HH21 ' HB3' ' A' ' 67' ' ' ASN . 21.4 mmt180 -81.21 -53.83 6.03 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.222 0.534 . . . . 72.5 110.802 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 15.7 m120 -119.5 131.17 55.52 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.184 -0.462 . . . . 74.43 111.657 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.462 HG23 HG12 ' A' ' 58' ' ' ILE . 10.5 p -83.32 -23.35 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 113.046 0.758 . . . . 74.5 113.046 -178.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -96.43 147.08 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.14 0.422 . . . . 74.34 112.14 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.42 -165.21 1.19 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.377 0.608 . . . . 72.22 111.902 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.534 ' HB3' HD21 ' A' ' 91' ' ' LEU . 11.8 p-10 -68.06 108.29 3.04 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.428 0.632 . . . . 55.32 111.531 178.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.5 p -84.54 142.69 29.83 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.106 -0.497 . . . . 71.32 111.981 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.58 -11.74 44.69 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.014 0.376 . . . . 50.14 112.014 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -147.37 97.93 4.02 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.514 -0.312 . . . . 75.23 111.003 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -72.75 166.06 30.99 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.838 2.359 . . . . 62.14 112.833 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 72.2 m80 72.02 -13.89 0.57 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.992 0.738 . . . . 75.14 112.992 177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -130.41 107.36 9.18 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 122.162 -0.336 . . . . 74.51 111.716 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.0 t 68.99 136.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.597 0.713 . . . . 62.45 112.765 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.527 ' N ' ' HD3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -151.38 150.25 30.25 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.132 -0.485 . . . . 74.2 110.651 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -114.22 137.94 51.12 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.758 0.313 . . . . 64.44 111.227 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -117.13 5.68 12.77 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.835 0.68 . . . . 72.13 112.835 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.8 tt -112.96 142.62 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.131 0.491 . . . . 64.32 111.964 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.462 HG12 HG23 ' A' ' 43' ' ' VAL . 64.2 mt -80.79 130.2 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.122 -0.49 . . . . 72.13 111.132 177.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -147.53 166.31 27.7 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.833 0.349 . . . . 71.41 111.584 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.411 ' HD3' HH11 ' A' ' 60' ' ' ARG . 44.7 ttp180 -65.01 134.38 53.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.973 0.416 . . . . 72.33 111.37 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.87 -26.4 24.6 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.271 -0.422 . . . . 73.43 112.462 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.77 156.93 38.77 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.936 0.398 . . . . 75.41 111.804 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.536 HG11 ' HG3' ' A' ' 90' ' ' GLU . 48.1 t -119.1 114.1 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.907 0.385 . . . . 73.51 111.361 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.56 154.47 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.973 0.416 . . . . 74.43 112.012 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 34.0 tt0 -92.96 127.31 38.42 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.224 -0.298 . . . . 73.32 110.771 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.6 p -129.63 176.35 8.07 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.609 0.364 . . . . 74.4 110.717 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.562 ' HB3' HH21 ' A' ' 41' ' ' ARG . 3.8 p-10 -65.09 -27.47 68.78 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.782 0.325 . . . . 75.45 111.863 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.74 -22.75 37.12 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.081 0.467 . . . . 73.4 111.103 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.63 -152.16 21.52 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 116.241 -0.436 . . . . 44.14 112.504 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -85.91 131.21 34.34 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 122.241 -0.564 . . . . 63.22 110.994 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.27 122.34 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 111.851 0.315 . . . . 73.42 111.851 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HB2' HD13 ' A' ' 88' ' ' ILE . 40.7 ttm180 -86.36 112.16 21.18 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.655 0.264 . . . . 72.44 110.402 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -63.98 127.14 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.568 0.581 . . . . 61.52 112.568 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 73.8 p -103.04 -33.09 9.39 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.056 0.455 . . . . 65.52 111.656 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.662 ' HB3' ' H ' ' A' ' 84' ' ' ASN . 35.8 t -94.76 -177.07 4.07 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.36 0.6 . . . . 63.44 111.831 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 7.7 tpt180 -122.03 126.12 26.42 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.956 -0.565 . . . . 63.31 109.781 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -47.56 99.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.512 2.141 . . . . 50.21 113.435 -177.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.53 -29.06 1.19 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.858 -0.61 . . . . 64.11 112.642 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 76.0 mm-40 -58.16 105.32 0.27 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.765 0.317 . . . . 74.51 111.263 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 56.97 21.48 6.28 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.16 0.429 . . . . 64.11 112.16 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.28 19.4 79.83 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.238 -0.506 . . . . 70.31 113.988 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 83' ' ' ILE . 7.5 p -139.95 163.22 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 117.536 0.668 . . . . 73.22 111.628 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.409 ' N ' HG22 ' A' ' 82' ' ' VAL . 57.7 mt -121.53 143.06 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 122.526 0.33 . . . . 75.21 110.835 178.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.662 ' H ' ' HB3' ' A' ' 75' ' ' SER . 2.4 m-20 -119.72 153.08 36.16 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.731 0.301 . . . . 71.44 111.257 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.9 177.83 37.98 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.453 -0.34 . . . . 44.01 112.887 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 t -116.39 138.86 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 117.218 0.509 . . . . 74.41 111.279 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.0 tp -78.93 106.54 11.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.036 0.446 . . . . 72.53 111.807 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.443 HD13 ' HB2' ' A' ' 72' ' ' ARG . 16.5 pt -121.5 179.91 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.188 0.518 . . . . 53.33 111.236 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.62 113.42 20.22 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.368 -0.378 . . . . 73.24 110.983 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.536 ' HG3' HG11 ' A' ' 63' ' ' VAL . 70.9 mm-40 -122.21 -72.35 0.69 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.16 0.43 . . . . 74.33 112.16 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.534 HD21 ' HB3' ' A' ' 46' ' ' ASN . 93.6 mt -100.75 -175.37 2.88 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.202 0.525 . . . . 64.34 112.212 -176.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -71.64 135.66 47.01 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.948 -0.569 . . . . 62.21 110.938 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -102.08 -14.4 17.12 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.398 0.518 . . . . 73.15 112.398 -176.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -62.0 154.34 26.87 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.164 0.507 . . . . 64.32 112.214 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -61.74 114.05 3.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.264 -0.426 . . . . 74.55 109.882 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -55.59 -74.7 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.53 0.567 . . . . 62.11 112.53 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -85.77 104.87 15.87 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.194 0.521 . . . . 73.31 111.151 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 . . . . . 0 C--O 1.248 0.984 0 CA-C-N 116.379 -0.373 . . . . 70.41 111.758 -179.563 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.68 -0.168 . . . . 64.41 112.68 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.24 171.32 15.23 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.192 0.52 . . . . 64.23 112.287 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.456 ' HD3' ' N ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -115.97 124.3 50.17 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.106 0.479 . . . . 72.11 111.41 -176.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.92 6.28 45.26 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.044 -0.525 . . . . 73.22 112.183 -173.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 5' ' ' VAL . 7.2 p -68.39 87.27 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 CA-C-O 121.522 0.677 . . . . 64.3 111.982 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? 54.55 48.09 21.22 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.958 -0.565 . . . . 61.22 111.614 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.8 tp -81.45 -47.23 13.46 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.073 -0.512 . . . . 43.44 112.046 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.7 tp -77.11 133.01 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.153 0.502 . . . . 75.01 111.504 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -130.04 27.15 5.16 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.094 0.405 . . . . 62.33 112.094 -174.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.8 m -37.41 105.76 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.257 0.836 . . . . 75.41 113.257 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -149.9 133.86 17.0 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.243 -0.435 . . . . 74.23 111.172 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.27 147.1 4.5 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.118 -0.563 . . . . 53.11 113.194 177.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.5 93.94 2.31 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.26 -0.495 . . . . 72.13 113.611 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -145.95 113.32 6.26 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.918 0.389 . . . . 53.43 110.867 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -67.95 164.19 20.47 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.174 0.805 . . . . 71.35 113.174 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -122.64 -8.12 8.51 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.393 -0.822 . . . . 65.54 110.614 176.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 19' ' ' LEU . 11.5 p -138.12 150.41 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.288 -0.414 . . . . 71.23 111.722 -174.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -64.99 -33.05 75.12 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.253 -0.431 . . . . 72.02 112.094 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.599 ' H ' HG22 ' A' ' 17' ' ' VAL . 7.4 tt -174.23 129.17 0.37 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.922 -0.399 . . . . 73.01 109.922 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.03 126.4 6.68 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.776 0.288 . . . . 61.21 111.776 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.1 t 74.6 -52.64 0.68 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.649 0.78 . . . . 70.02 111.841 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -106.1 125.17 50.67 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.82 0.343 . . . . 75.24 110.312 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.56 HG22 ' HB ' ' A' ' 40' ' ' ILE . 51.6 m -98.07 112.78 24.61 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.893 0.377 . . . . 51.21 111.385 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -139.49 170.01 16.7 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.12 0.486 . . . . 60.34 111.881 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.451 ' HB ' HD11 ' A' ' 40' ' ' ILE . 13.2 tt -152.0 142.8 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.97 -0.559 . . . . 65.13 111.111 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -77.21 103.7 7.29 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.248 0.547 . . . . 73.13 110.573 174.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.481 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 39.3 t -86.24 136.68 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.718 . . . . 74.43 111.263 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 35' ' ' VAL . 47.2 t -110.85 104.83 17.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.66 0.267 . . . . 63.22 111.053 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.514 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 35.2 t70 -65.09 115.43 21.1 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.48 -0.327 . . . . 72.24 111.16 176.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.37 -11.71 22.77 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.34 2.027 . . . . 72.34 113.733 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -80.78 -43.19 20.52 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.1 0.476 . . . . 75.23 111.4 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.419 ' OG1' ' HE3' ' A' ' 34' ' ' LYS . 59.6 p -101.24 -29.49 12.06 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.132 -0.485 . . . . 71.31 111.67 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.79 63.13 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 116.248 -0.433 . . . . 44.13 112.739 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 17.6 ptpt -82.82 163.12 21.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.867 0.365 . . . . 71.21 111.322 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 28' ' ' VAL . 47.9 t -117.63 97.39 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.38 -0.373 . . . . 73.55 111.164 174.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.481 ' HG2' ' HB ' ' A' ' 27' ' ' VAL . 1.5 pm0 -93.79 170.86 9.25 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.051 0.453 . . . . 64.12 111.33 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.7 mt -111.78 134.51 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 121.849 -0.532 . . . . 62.45 111.098 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -130.99 153.56 49.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.96 0.41 . . . . 72.1 111.977 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -91.91 126.11 36.87 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.13 -0.486 . . . . 71.34 110.485 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.56 ' HB ' HG22 ' A' ' 23' ' ' THR . 61.2 mt -79.13 113.54 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.042 0.448 . . . . 75.13 111.458 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -83.05 -47.83 11.26 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.063 0.458 . . . . 74.25 111.383 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.532 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 51.7 m-80 -138.15 163.94 30.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.265 -0.425 . . . . 71.34 111.443 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -116.32 2.43 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.273 0.558 . . . . 74.03 111.312 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.441 HG11 ' HB2' ' A' ' 96' ' ' HIS . 6.2 p -70.41 102.35 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-O 121.44 0.638 . . . . 71.32 112.073 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -72.73 -167.1 0.33 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.89 -0.596 . . . . 54.43 111.678 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.61 85.58 0.07 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.266 0.555 . . . . 64.05 111.114 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.3 t -162.06 -179.95 7.51 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.763 -0.653 . . . . 55.21 110.775 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.78 175.18 2.52 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.157 0.503 . . . . 74.02 112.344 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.426 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 48.8 m-80 -80.47 128.75 71.5 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.528 -0.306 . . . . 74.11 111.099 176.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 7.7 Cg_exo -72.89 138.43 28.59 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.813 2.342 . . . . 73.1 113.542 -177.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -119.86 -45.21 2.49 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.183 0.516 . . . . 65.11 110.798 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -101.66 94.88 6.08 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.253 -0.431 . . . . 72.52 111.153 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.1 p -165.34 147.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 116.072 -0.513 . . . . 72.43 110.489 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.57 -48.89 4.38 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.438 0.533 . . . . 65.14 112.438 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 55' ' ' ARG . 15.7 ptt180 -138.14 175.76 9.3 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.452 0.644 . . . . 74.41 112.647 -177.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -92.42 107.54 19.29 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.508 -0.769 . . . . 61.33 112.187 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 57' ' ' ILE . 2.9 mp -85.16 100.96 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.006 0.431 . . . . 72.44 111.083 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.8 mt -95.98 115.77 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.011 0.434 . . . . 74.41 111.281 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -147.83 -179.96 7.28 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.226 -0.443 . . . . 75.35 111.085 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -64.18 135.99 56.81 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.828 0.347 . . . . 74.21 111.807 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.06 -20.89 47.07 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.29 -0.481 . . . . 53.35 113.251 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.82 153.11 29.34 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.028 0.442 . . . . 72.44 111.676 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.7 t -110.91 119.3 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.354 -0.384 . . . . 75.4 110.793 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.47 ' HB ' HG23 ' A' ' 40' ' ' ILE . 27.6 m -103.39 131.49 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.42 0.628 . . . . 63.21 112.17 -177.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.726 ' HG2' ' HB3' ' A' ' 95' ' ' HIS . 9.7 tp10 -79.81 102.32 9.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.931 -0.577 . . . . 63.32 110.894 177.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.6 p -100.74 173.21 6.63 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.774 0.321 . . . . 64.31 111.045 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -61.12 -29.07 69.54 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.87 0.367 . . . . 63.42 111.655 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 38' ' ' ALA . 92.6 mt -80.78 -31.14 35.88 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.926 0.393 . . . . 70.32 111.088 176.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.18 -162.9 28.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.915 -0.66 . . . . 44.52 112.889 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -80.93 120.05 24.25 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.216 0.531 . . . . 74.31 111.713 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.476 HG21 HG22 ' A' ' 27' ' ' VAL . 47.6 t -113.56 120.52 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.208 -0.451 . . . . 70.54 111.509 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -86.7 116.19 24.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.851 0.358 . . . . 74.24 111.21 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.36 109.84 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.19 -0.459 . . . . 62.43 112.123 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.7 p -87.75 -59.29 2.28 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.254 0.549 . . . . 72.42 110.729 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.715 ' HB3' ' HG3' ' A' ' 79' ' ' GLN . 54.8 m -90.35 113.79 25.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.846 -0.616 . . . . 72.41 111.082 177.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.1 ttt85 -54.28 139.95 55.4 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 116.157 -0.474 . . . . 74.32 112.07 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.499 ' HB3' HG12 ' A' ' 83' ' ' ILE . 4.4 Cg_exo -39.23 107.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 123.697 2.931 . . . . 74.14 113.64 177.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.65 -34.9 0.63 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.999 -0.619 . . . . 73.32 112.798 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.715 ' HG3' ' HB3' ' A' ' 75' ' ' SER . 15.8 mm100 -55.04 114.02 1.59 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.312 0.245 . . . . 71.43 111.22 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.1 t70 62.16 15.56 7.56 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.44 0.638 . . . . 70.25 111.472 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.72 34.12 54.13 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.31 -0.472 . . . . 73.41 112.785 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 83' ' ' ILE . 12.7 p -154.78 166.88 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 120.906 0.384 . . . . 60.42 111.307 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.499 HG12 ' HB3' ' A' ' 77' ' ' PRO . 40.1 mt -97.26 144.75 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.579 0.351 . . . . 63.11 110.438 175.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 75' ' ' SER . 16.2 m-80 -135.19 142.49 46.09 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 122.252 -0.28 . . . . 52.21 111.329 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.81 175.79 39.16 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.038 -0.601 . . . . 72.14 113.647 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.0 t -99.27 144.49 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.088 0.403 . . . . 65.31 112.088 -177.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.414 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 49.5 tp -79.59 106.63 11.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.824 0.345 . . . . 61.1 110.973 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.0 pt -126.88 -179.65 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.178 0.513 . . . . 65.22 111.153 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -130.01 85.68 2.32 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.911 0.386 . . . . 73.1 111.456 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -84.43 -37.1 21.84 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.653 0.739 . . . . 72.14 110.349 175.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.8 mt -124.9 151.24 45.63 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.977 -1.01 . . . . 52.12 109.303 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -79.03 58.76 2.51 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.506 0.669 . . . . 54.53 109.873 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.8 m80 58.48 7.95 0.79 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.528 -0.76 . . . . 74.11 111.955 -171.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -79.46 68.01 5.37 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.542 0.687 . . . . 73.54 110.802 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.726 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . 20.6 p-80 -54.98 125.33 19.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.239 -0.891 . . . . 65.44 111.806 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.441 ' HB2' HG11 ' A' ' 44' ' ' VAL . 53.1 m170 -64.51 139.28 58.75 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.099 0.476 . . . . 73.42 110.946 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -136.5 133.98 37.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.291 -0.413 . . . . 72.34 112.038 -173.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.751 -0.643 . . . . 70.43 111.612 176.134 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.685 -0.166 . . . . 70.03 112.685 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -151.12 147.41 27.03 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 122.459 -0.436 . . . . 71.22 111.636 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -145.71 81.31 1.61 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.722 0.772 . . . . 73.12 111.048 177.565 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.6 86.94 7.25 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.532 0.682 . . . . 75.53 111.36 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 m -76.14 54.96 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 115.57 -0.741 . . . . 63.12 112.903 -175.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -83.39 68.27 9.64 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.856 -0.528 . . . . 74.43 110.728 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.8 tt -76.89 -38.65 53.18 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.963 0.411 . . . . 70.2 110.593 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.4 125.68 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.418 0.628 . . . . 73.04 112.065 -176.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -122.52 173.78 7.47 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.722 -0.672 . . . . 62.3 110.574 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -58.72 146.93 34.85 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.001 0.429 . . . . 62.34 111.937 175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -96.68 -22.59 16.91 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.432 0.634 . . . . 73.44 110.626 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 144.51 -148.26 19.93 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.542 -0.753 . . . . 35.13 112.19 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.27 -75.03 0.04 OUTLIER Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.959 -0.638 . . . . 73.41 112.455 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.1 m-20 -86.22 -171.41 3.55 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.52 -0.4 . . . . 42.43 110.636 176.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.7 m -69.74 107.76 3.62 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.862 0.363 . . . . 64.42 110.892 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.657 ' HD2' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -66.87 169.85 7.5 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.02 -0.536 . . . . 74.12 111.972 -177.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.01 146.2 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.062 -0.517 . . . . 73.11 111.918 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.31 168.8 0.98 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.132 0.79 . . . . 75.21 113.132 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.1 tt -60.42 119.74 8.58 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.887 -0.597 . . . . 75.53 110.787 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.18 -60.52 0.16 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.2 -0.455 . . . . 75.42 111.142 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.6 m -80.91 -50.68 9.45 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.451 -0.34 . . . . 71.41 111.458 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -110.63 138.18 47.35 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.655 0.264 . . . . 72.04 111.067 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.557 HG22 ' HB ' ' A' ' 40' ' ' ILE . 27.1 m -81.89 112.7 19.25 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 110.213 -0.292 . . . . 71.31 110.213 175.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -133.83 165.39 25.09 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.23 0.456 . . . . 74.01 112.23 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.526 ' HB ' HD11 ' A' ' 40' ' ' ILE . 12.7 tt -151.46 131.29 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.127 -0.488 . . . . 71.11 111.782 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -72.81 103.82 3.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.072 0.463 . . . . 55.34 110.328 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.529 HG22 HG11 ' A' ' 71' ' ' VAL . 46.8 t -95.92 126.97 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.029 -0.532 . . . . 75.13 112.349 -174.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.01 114.17 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.224 -0.444 . . . . 73.0 110.82 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.429 ' HA ' ' HB3' ' A' ' 87' ' ' LEU . 11.3 t70 -76.84 126.12 86.16 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.558 -0.292 . . . . 62.24 111.624 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.99 -9.89 9.5 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.949 2.433 . . . . 75.4 113.226 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -75.03 -43.7 52.09 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.929 0.395 . . . . 75.21 111.685 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.9 p -123.28 -31.5 3.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.463 -0.335 . . . . 70.45 111.686 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.07 3.49 29.73 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.406 -0.426 . . . . 71.24 113.125 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -71.53 143.63 49.87 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.933 0.397 . . . . 61.32 112.002 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.4 t -114.91 129.28 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.897 0.38 . . . . 72.12 111.514 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -140.38 145.83 37.6 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.345 -0.389 . . . . 74.41 110.818 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.4 mt -87.94 101.82 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.263 0.554 . . . . 72.13 111.515 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.51 165.14 16.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.315 0.578 . . . . 72.04 112.273 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -103.69 123.79 47.66 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.842 -0.617 . . . . 72.04 110.651 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.557 ' HB ' HG22 ' A' ' 23' ' ' THR . 70.0 mt -84.09 115.94 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.609 0.596 . . . . 74.12 112.609 -174.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.456 HH11 ' HD2' ' A' ' 41' ' ' ARG . 56.2 mtt180 -83.64 -54.12 5.16 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.073 0.463 . . . . 53.31 111.49 172.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -130.78 167.86 18.18 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.284 0.476 . . . . 73.51 112.284 -173.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.67 HG12 HG12 ' A' ' 64' ' ' VAL . 17.1 m -134.09 96.26 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.534 0.683 . . . . 71.13 111.027 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.587 HG22 ' H ' ' A' ' 45' ' ' GLU . 7.4 p -141.03 -179.79 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 116.039 -0.528 . . . . 75.21 111.019 -174.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.587 ' H ' HG22 ' A' ' 44' ' ' VAL . 12.1 pt-20 -140.14 169.42 17.73 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.546 -0.721 . . . . 60.52 111.193 172.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -62.7 87.17 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.527 0.68 . . . . 71.24 112.205 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.0 t -135.97 159.53 41.4 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.182 -0.463 . . . . 71.43 111.58 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.6 123.44 31.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.497 -0.319 . . . . 22.45 111.006 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 65.31 94.39 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 120.931 0.396 . . . . 54.54 110.677 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.78 44.53 0.95 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.103 2.535 . . . . 73.12 114.518 -172.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -91.37 2.43 56.41 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.791 -0.568 . . . . 73.43 111.384 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -87.46 3.21 48.15 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.461 0.541 . . . . 74.23 112.461 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.4 t -67.39 94.0 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.388 0.614 . . . . 73.53 109.98 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -88.55 -63.7 1.26 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.823 0.675 . . . . 74.04 112.823 -170.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -127.26 10.11 6.78 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.204 0.446 . . . . 72.03 112.204 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 61.07 17.91 8.47 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.583 0.957 . . . . 65.25 113.583 171.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.6 mt -65.4 106.33 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.161 0.505 . . . . 65.32 111.714 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.6 mt -72.06 118.29 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.034 -0.53 . . . . 73.33 110.829 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -147.74 173.16 13.05 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.613 -0.267 . . . . 73.12 111.367 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -56.85 140.42 48.23 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.851 0.358 . . . . 72.2 111.697 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.5 -26.44 15.83 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.144 -0.551 . . . . 62.31 113.454 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.72 155.75 29.25 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.09 0.445 . . . . 75.32 111.281 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -113.36 127.85 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.626 0.727 . . . . 73.25 111.908 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.67 HG12 HG12 ' A' ' 43' ' ' VAL . 28.9 m -103.17 127.7 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 121.185 0.516 . . . . 73.44 111.077 177.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.02 110.86 12.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.218 -0.446 . . . . 74.32 110.362 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.9 p -115.61 176.04 5.26 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.364 0.602 . . . . 71.44 112.431 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.432 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 19.3 p-10 -59.25 -30.21 68.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.017 -0.538 . . . . 74.52 111.225 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.4 mt -81.28 -28.94 34.46 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.16 0.505 . . . . 63.23 110.728 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.419 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 131.08 -150.5 19.41 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.204 -0.453 . . . . 75.44 113.161 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.503 HD22 ' N ' ' A' ' 70' ' ' ASN . 1.0 OUTLIER -67.07 120.36 13.55 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.784 0.326 . . . . 64.44 111.777 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.529 HG11 HG22 ' A' ' 27' ' ' VAL . 57.4 t -125.71 121.87 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.618 0.246 . . . . 70.32 111.478 178.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.551 ' HB2' HD13 ' A' ' 88' ' ' ILE . 38.1 ttm180 -89.55 118.09 28.93 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.276 -0.265 . . . . 71.43 111.439 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.95 128.43 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.261 0.467 . . . . 51.31 112.261 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -109.86 -63.04 1.42 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.185 -0.462 . . . . 75.42 111.996 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 84' ' ' ASN . 43.5 t -78.27 154.87 30.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.649 0.261 . . . . 74.41 111.233 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.52 109.1 2.2 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-O 120.793 0.33 . . . . 73.4 110.83 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.514 ' HB3' HG23 ' A' ' 83' ' ' ILE . 30.3 Cg_endo -61.33 129.21 27.43 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.708 2.272 . . . . 73.41 112.8 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.57 -18.07 51.5 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.113 -0.565 . . . . 54.4 113.949 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -58.51 -44.9 89.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.503 0.652 . . . . 72.55 111.376 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -106.71 23.44 14.29 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.293 0.568 . . . . 74.31 110.434 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.59 9.01 73.35 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.347 -0.454 . . . . 25.11 113.4 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.1 p -136.27 160.7 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 122.495 0.318 . . . . 74.31 111.277 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.514 HG23 ' HB3' ' A' ' 77' ' ' PRO . 45.3 mt -116.56 140.36 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 122.572 0.349 . . . . 72.23 110.361 175.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 13.4 m120 -127.57 146.73 50.43 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.155 -0.341 . . . . 75.25 111.461 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.99 179.83 38.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.898 -0.668 . . . . 73.33 113.598 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 t -113.2 139.71 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 116.831 0.315 . . . . 73.44 111.402 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 29' ' ' ASP . 62.5 tp -74.16 106.8 5.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.08 0.467 . . . . 35.52 110.923 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 72' ' ' ARG . 20.2 pt -124.48 -178.96 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.308 0.575 . . . . 42.15 111.182 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.419 ' NH1' ' HA3' ' A' ' 69' ' ' GLY . 40.5 mmt180 -139.83 70.71 1.37 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.232 -0.44 . . . . 62.53 111.002 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -75.29 -31.76 60.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.198 0.523 . . . . 71.2 109.842 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.56 158.26 17.08 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.687 -0.688 . . . . 73.14 109.557 164.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.9 160.84 27.68 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.272 0.558 . . . . 60.3 112.197 -172.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -57.83 108.74 0.61 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.243 0.544 . . . . 73.21 111.771 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.41 72.57 10.66 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.392 0.515 . . . . 73.02 112.392 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -146.69 125.04 12.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.306 -0.406 . . . . 74.21 110.885 173.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -76.11 64.34 1.95 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.408 -0.36 . . . . 63.41 110.98 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 63.96 -67.72 0.1 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.217 0.607 . . . . 73.52 112.142 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.1 t60 . . . . . 0 C--O 1.254 1.3 0 CA-C-O 118.84 -0.6 . . . . 55.44 111.317 178.31 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 CA-C-O 120.866 0.148 . . . . 72.34 113.07 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -96.02 29.27 2.81 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.182 0.515 . . . . 72.21 111.524 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -87.72 91.54 8.79 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.079 0.4 . . . . 73.35 112.079 -175.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.697 ' H ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -89.38 102.02 14.7 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.312 0.577 . . . . 64.21 110.18 173.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.8 m -96.0 7.92 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 113.269 0.841 . . . . 52.34 113.269 -172.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -78.73 82.23 4.98 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.297 0.57 . . . . 73.44 112.216 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.7 tp -94.81 -28.14 15.4 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.999 -0.546 . . . . 73.33 110.91 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.0 tp -76.44 157.81 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 116.188 -0.46 . . . . 71.44 111.292 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.84 166.1 24.85 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.05 -0.406 . . . . 74.1 111.661 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -125.1 177.41 6.1 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.551 0.575 . . . . 73.12 112.551 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -169.13 147.19 3.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.101 -0.499 . . . . 74.35 110.624 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.56 146.17 5.05 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.345 -0.931 . . . . 53.54 114.366 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.65 -34.95 6.35 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.53 -0.366 . . . . 42.34 112.345 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -136.77 155.51 49.73 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.669 -0.493 . . . . 71.32 109.669 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.455 ' O ' HG22 ' A' ' 15' ' ' THR . 11.9 m -133.65 2.58 3.47 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.37 0.878 . . . . 71.31 113.37 -174.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 17' ' ' VAL . 39.3 ttmt -175.95 91.69 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.52 0.933 . . . . 54.23 113.52 -175.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.431 HG22 ' N ' ' A' ' 18' ' ' ARG . 5.2 p 48.88 167.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 114.674 1.361 . . . . 62.52 114.674 168.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.431 ' N ' HG22 ' A' ' 17' ' ' VAL . 5.0 ppt_? -84.77 -171.94 3.91 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.684 -0.635 . . . . 72.03 111.236 174.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.485 HD12 ' O ' ' A' ' 24' ' ' ARG . 7.4 tt -74.73 109.12 7.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.999 0.428 . . . . 64.1 110.762 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.32 -73.35 0.38 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.158 0.504 . . . . 65.34 110.049 173.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.2 t -92.19 -28.18 17.21 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.246 0.546 . . . . 62.44 110.302 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -95.82 99.14 10.99 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.71 -0.677 . . . . 72.44 111.085 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.485 HG22 ' HB ' ' A' ' 40' ' ' ILE . 91.3 m -69.06 112.64 5.81 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.052 0.453 . . . . 72.13 110.857 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 19' ' ' LEU . 90.0 mtm180 -145.15 163.16 35.2 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.31 -0.404 . . . . 71.42 111.27 -173.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 tt -147.9 135.9 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.111 0.481 . . . . 71.33 111.86 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -74.84 103.47 5.09 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.027 0.441 . . . . 75.22 110.356 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 48.8 t -93.87 145.81 7.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.954 -0.566 . . . . 53.1 111.528 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 35' ' ' VAL . 48.6 t -117.16 106.9 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.044 -0.526 . . . . 72.14 110.806 176.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.489 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 12.9 t70 -70.04 112.83 13.8 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.611 0.243 . . . . 75.21 110.659 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.82 -14.21 11.32 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.774 2.316 . . . . 75.54 113.286 -176.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -74.71 -37.37 62.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.311 0.577 . . . . 72.55 110.838 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.8 p -110.1 -32.36 7.03 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.878 -0.601 . . . . 72.31 111.475 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.81 45.05 4.34 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.299 -0.477 . . . . 74.34 112.514 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 19.7 ptpt -118.39 162.92 17.51 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.594 -0.356 . . . . 71.05 111.1 177.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 28' ' ' VAL . 58.1 t -120.51 113.85 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.932 0.396 . . . . 63.5 111.202 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -117.26 170.14 8.92 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.073 0.464 . . . . 53.4 111.731 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.2 mt -107.46 116.61 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.554 -0.294 . . . . 73.32 110.822 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.414 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -111.44 157.72 19.95 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.185 0.517 . . . . 63.12 112.208 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -97.34 124.14 41.38 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 54.53 110.719 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.485 ' HB ' HG22 ' A' ' 23' ' ' THR . 60.0 mt -75.34 114.07 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.057 0.455 . . . . 72.11 111.468 -178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -82.92 -44.09 15.75 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.246 -0.434 . . . . 74.33 111.183 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 44.0 m-80 -138.89 146.09 40.72 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.717 0.294 . . . . 74.43 111.351 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.4 m -108.57 18.06 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.214 0.53 . . . . 75.43 111.702 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.536 HG22 ' H ' ' A' ' 46' ' ' ASN . 7.5 p -92.74 109.49 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.33 0.586 . . . . 64.24 112.157 -177.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.458 ' HG2' HH21 ' A' ' 55' ' ' ARG . 9.3 pt-20 -86.62 27.05 1.01 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.993 0.425 . . . . 73.32 111.083 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.536 ' H ' HG22 ' A' ' 44' ' ' VAL . 7.8 t30 60.51 72.48 0.52 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.403 0.621 . . . . 75.35 111.558 -173.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.4 p -89.79 -73.1 0.53 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.071 -0.513 . . . . 72.5 109.972 175.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.13 -140.73 0.19 Allowed 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 109.217 -0.66 . . . . 52.43 109.217 168.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.51 ' HB2' ' CD1' ' A' ' 52' ' ' PHE . 14.0 m120 -69.08 147.3 97.59 Favored Pre-proline 0 CA--C 1.543 0.708 0 O-C-N 121.973 -0.454 . . . . 74.32 110.364 171.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.34 -29.09 37.35 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.205 2.603 . . . . 71.31 114.874 -171.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -102.23 9.47 40.01 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.53 0.567 . . . . 75.41 112.53 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.51 ' CD1' ' HB2' ' A' ' 49' ' ' ASN . 35.8 m-85 -104.97 43.31 1.12 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.401 0.62 . . . . 72.42 111.488 178.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.513 ' HB ' ' HB ' ' A' ' 44' ' ' VAL . 4.4 p -86.87 96.93 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.589 0.709 . . . . 75.23 111.818 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -95.09 -42.68 8.48 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.108 -0.497 . . . . 75.15 111.686 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.458 HH21 ' HG2' ' A' ' 45' ' ' GLU . 21.6 ptt180 -67.45 128.14 35.32 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.235 0.54 . . . . 71.05 111.306 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -106.11 14.92 27.08 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.173 0.511 . . . . 74.31 110.599 173.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.3 mp -83.57 98.14 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.959 -0.564 . . . . 71.51 110.751 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.502 ' CG2' HG21 ' A' ' 73' ' ' VAL . 60.8 mt -80.26 107.38 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.243 -0.435 . . . . 61.12 111.016 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -94.5 156.01 16.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.995 0.426 . . . . 71.34 111.74 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -64.33 116.33 5.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.815 0.341 . . . . 74.11 111.149 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.0 -16.04 23.13 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.406 -0.426 . . . . 55.42 112.68 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.82 150.87 48.06 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.046 0.451 . . . . 74.23 111.907 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.564 HG21 ' HG3' ' A' ' 90' ' ' GLU . 60.5 t -104.16 115.31 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.3 -0.409 . . . . 62.22 111.276 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.69 143.36 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.123 0.487 . . . . 74.33 111.908 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 8.0 tp10 -87.97 116.52 26.2 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.294 -0.412 . . . . 54.42 110.509 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.9 p -115.74 176.07 5.25 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.107 0.479 . . . . 74.52 111.81 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -65.67 -13.22 58.75 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.23 0.456 . . . . 63.22 112.23 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.414 HD12 ' HB2' ' A' ' 38' ' ' ALA . 85.8 mt -104.98 -18.18 14.26 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.2 0.524 . . . . 74.02 111.369 177.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.459 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 139.07 -161.18 25.94 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.282 -0.485 . . . . 73.41 112.977 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -77.08 137.61 39.04 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.405 -0.468 . . . . 63.05 110.949 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 58.5 t -130.58 127.98 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.372 -0.205 . . . . 72.02 111.549 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.463 ' HB2' HD13 ' A' ' 88' ' ' ILE . 59.2 ttm-85 -92.67 113.23 25.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.646 0.26 . . . . 71.55 110.742 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.502 HG21 ' CG2' ' A' ' 58' ' ' ILE . 48.5 t -61.37 120.14 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.497 0.554 . . . . 75.23 112.497 -176.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.3 p -96.58 -32.3 12.31 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.438 0.533 . . . . 65.31 112.438 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.2 t -108.76 -174.44 2.51 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.891 0.376 . . . . 75.24 111.786 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.457 HH11 ' HD2' ' A' ' 76' ' ' ARG . 9.5 mmt180 -97.29 113.88 63.91 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.399 -0.364 . . . . 65.31 111.573 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.457 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 50.4 Cg_exo -56.72 120.79 8.93 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.596 2.197 . . . . 72.25 112.682 176.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.22 -33.03 2.99 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.187 -0.53 . . . . 61.22 112.369 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -61.09 114.59 3.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.575 0.226 . . . . 74.24 110.739 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 60.94 15.57 6.18 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.168 0.509 . . . . 62.11 111.303 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.85 40.21 95.41 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.157 -0.474 . . . . 75.02 113.315 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 83' ' ' ILE . 8.0 p -146.08 160.36 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 117.198 0.499 . . . . 75.21 111.995 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.405 ' N ' HG22 ' A' ' 82' ' ' VAL . 31.9 mt -123.51 147.79 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.798 0.439 . . . . 64.42 110.874 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -121.23 148.93 43.61 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.3 -0.25 . . . . 64.12 111.03 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -168.54 167.15 40.11 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.861 -0.685 . . . . 53.31 114.078 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 24.2 t -101.85 140.34 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.68 0.392 . . . . 52.24 111.672 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.437 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 43.0 tp -78.58 106.88 10.85 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.284 0.564 . . . . 63.53 111.445 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 72' ' ' ARG . 16.5 pt -128.25 -177.5 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.063 0.459 . . . . 73.35 110.947 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.459 ' NH1' ' HA3' ' A' ' 69' ' ' GLY . 28.1 mmt180 -134.54 76.21 1.63 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.698 0.285 . . . . 73.31 110.856 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.564 ' HG3' HG21 ' A' ' 63' ' ' VAL . 11.2 mm-40 -79.5 -47.63 15.27 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.2 0.524 . . . . 64.33 110.926 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.4 mt -70.76 178.66 2.97 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.962 -0.563 . . . . 71.44 111.014 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.95 91.59 0.09 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.383 0.611 . . . . 73.14 111.179 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -62.34 117.58 6.32 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.76 -0.655 . . . . 74.33 111.785 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -86.71 85.06 7.27 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.985 -0.552 . . . . 62.51 112.277 -173.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -174.87 124.05 0.26 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.518 -0.31 . . . . 75.1 111.288 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -84.06 133.23 34.66 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.846 0.355 . . . . 65.23 111.427 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -158.07 155.37 29.14 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.429 -0.35 . . . . 63.14 111.202 -177.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.54 -0.743 . . . . 73.22 111.308 175.165 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 112.825 -0.11 . . . . 60.23 112.825 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -88.11 171.97 9.86 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.063 0.458 . . . . 75.55 111.611 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 -115.27 135.68 53.9 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.656 0.613 . . . . 74.21 112.656 -175.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.42 ' HD2' ' N ' ' A' ' 4' ' ' ARG . 2.2 mpt_? -119.17 161.74 19.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.089 -0.505 . . . . 73.32 110.499 173.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.71 102.61 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.118 0.485 . . . . 74.51 111.244 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 -87.68 94.08 9.63 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.269 -0.423 . . . . 73.14 111.345 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pp -115.84 11.94 15.71 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.131 0.419 . . . . 60.13 112.131 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.4 tt -68.91 112.7 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.497 0.665 . . . . 64.05 110.936 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.439 ' HG3' HH11 ' A' ' 9' ' ' ARG . 0.0 OUTLIER -119.23 160.32 22.4 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.248 0.547 . . . . 73.31 112.425 -172.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 t -75.78 107.39 7.92 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.833 -0.621 . . . . 71.41 112.388 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.439 ' HD3' ' HA ' ' A' ' 11' ' ' ARG . 29.0 mmt180 -146.72 146.84 30.46 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.125 0.488 . . . . 70.44 111.187 175.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.4 92.63 0.27 Allowed Glycine 0 CA--C 1.527 0.83 0 CA-C-N 116.085 -0.507 . . . . 54.53 113.045 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.96 66.19 0.02 OUTLIER Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.174 -0.536 . . . . 52.13 113.258 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -153.31 -74.37 0.13 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.807 0.336 . . . . 71.41 110.996 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -153.04 156.47 38.83 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.203 0.525 . . . . 73.14 111.944 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.575 ' HE2' ' HA ' ' A' ' 16' ' ' LYS . 9.9 mmpt? -99.4 -178.66 3.97 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.942 -0.572 . . . . 74.44 110.5 175.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -76.07 155.09 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.949 0.404 . . . . 74.22 110.803 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -63.99 161.58 15.59 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.246 0.546 . . . . 75.14 112.141 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -64.01 4.67 0.29 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.148 1.166 . . . . 75.24 114.148 -172.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.67 -54.89 10.69 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.162 0.43 . . . . 63.44 112.162 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.5 m -110.46 10.96 23.22 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.236 0.541 . . . . 65.13 110.898 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' HB3' ' NH2' ' A' ' 24' ' ' ARG . 3.5 m-20 -132.82 42.08 3.1 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.683 -0.69 . . . . 73.41 111.409 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.591 HG22 ' HB ' ' A' ' 40' ' ' ILE . 38.4 m -67.93 110.89 4.07 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.049 0.452 . . . . 55.22 110.725 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.482 ' NH2' ' HB3' ' A' ' 22' ' ' ASP . 43.1 mtm-85 -148.68 163.55 36.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.253 -0.43 . . . . 54.34 111.384 -175.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.6 tt -147.6 132.7 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.219 -0.446 . . . . 73.2 111.764 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.505 ' OD1' HG12 ' A' ' 37' ' ' ILE . 77.3 m-20 -65.99 103.23 0.91 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.111 0.481 . . . . 54.22 110.209 171.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.77 121.99 37.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.024 -0.535 . . . . 62.14 111.601 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.4 t -94.95 106.79 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.159 0.504 . . . . 75.41 110.669 176.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.76 113.56 24.05 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 115.843 -0.617 . . . . 61.03 110.794 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.23 -11.31 17.63 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.589 2.193 . . . . 75.32 113.431 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -88.05 -37.3 16.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.009 0.433 . . . . 73.22 111.879 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 30.5 p -115.17 -26.25 7.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.101 -0.499 . . . . 65.22 112.24 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.43 15.87 57.96 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.328 -0.463 . . . . 75.21 113.704 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.409 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 22.8 pttm -90.31 152.41 21.04 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.406 -0.467 . . . . 54.13 111.512 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.5 t -116.42 119.97 63.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.417 -0.356 . . . . 74.03 110.737 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -133.37 136.73 45.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.912 0.387 . . . . 71.13 111.614 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.505 HG12 ' OD1' ' A' ' 26' ' ' ASN . 41.8 mt -77.65 112.66 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.914 0.388 . . . . 53.35 111.258 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.467 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -112.23 145.8 39.28 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.474 -0.33 . . . . 71.01 111.393 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.78 133.83 36.33 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.667 0.27 . . . . 74.25 110.737 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.591 ' HB ' HG22 ' A' ' 23' ' ' THR . 68.2 mt -82.77 109.95 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.378 0.609 . . . . 73.12 110.313 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 mtp85 -85.7 -39.53 17.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.719 -0.673 . . . . 71.31 111.463 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 41.0 t30 -114.74 120.79 41.28 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.928 -0.578 . . . . 61.11 110.455 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' A' ' 56' ' ' ASN . 7.8 p -93.86 11.91 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 N-CA-C 112.488 0.551 . . . . 61.54 112.488 -173.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.52 146.32 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 121.853 -0.529 . . . . 63.01 111.859 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HG3' HG22 ' A' ' 47' ' ' THR . 13.3 pt-20 -75.47 -167.13 0.61 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.194 -0.457 . . . . 75.1 110.964 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -71.03 74.44 0.64 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.266 0.555 . . . . 64.2 111.707 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.513 HG22 ' HG3' ' A' ' 45' ' ' GLU . 9.0 t -177.0 -178.66 0.84 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.96 -0.563 . . . . 71.54 110.795 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.88 -57.98 1.76 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.896 0.379 . . . . 71.53 110.872 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -161.47 88.21 1.58 Allowed Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 112.633 0.605 . . . . 72.4 112.633 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.03 -37.96 30.65 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.219 1.946 . . . . 70.0 111.354 170.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -137.68 172.18 13.34 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.577 -0.738 . . . . 71.33 110.35 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -73.33 87.98 1.53 Allowed 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.297 0.57 . . . . 74.02 111.313 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.0 t -114.68 133.45 60.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.878 -0.601 . . . . 74.21 111.152 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.5 mtp180 -67.67 168.33 11.45 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.1 0.476 . . . . 64.21 111.948 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.2 mtp85 -66.6 167.73 10.5 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.132 -0.486 . . . . 71.54 111.44 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.525 ' HA ' HG21 ' A' ' 43' ' ' VAL . 85.7 m-20 62.73 62.28 1.09 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.443 0.639 . . . . 63.01 110.529 -170.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.444 HG22 ' O ' ' A' ' 57' ' ' ILE . 17.3 mt -83.04 19.8 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-O 121.685 0.755 . . . . 72.14 111.556 -175.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.653 HG21 HD13 ' A' ' 83' ' ' ILE . 49.4 mt -68.6 103.35 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.073 -0.512 . . . . 64.33 111.43 -178.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.1 t -147.18 167.94 22.91 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.699 -0.228 . . . . 72.4 110.753 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 42.5 ttm180 -59.47 126.45 27.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.133 0.492 . . . . 72.53 111.536 -176.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.32 -24.06 31.31 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.139 -0.553 . . . . 60.11 112.724 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.8 139.8 38.32 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.493 -0.416 . . . . 55.34 111.186 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 m -106.31 119.11 55.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.435 0.636 . . . . 61.11 111.441 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.457 ' HB ' HG23 ' A' ' 40' ' ' ILE . 35.7 m -106.33 152.57 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.241 -0.436 . . . . 74.33 111.378 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 44.0 tt0 -95.01 120.0 34.49 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.124 0.488 . . . . 75.44 111.045 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 p -113.39 179.31 4.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.02 -0.536 . . . . 63.23 110.632 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.467 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 3.2 p-10 -65.87 -11.84 49.86 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.798 0.333 . . . . 73.41 111.481 174.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.438 ' O ' HD11 ' A' ' 87' ' ' LEU . 87.3 mt -102.7 2.36 35.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.817 0.342 . . . . 72.34 111.417 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.478 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 104.07 -162.98 15.16 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.477 -0.392 . . . . 74.2 112.961 -178.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -66.05 130.3 42.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.264 0.554 . . . . 63.33 112.098 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.8 t -126.99 127.28 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.022 -0.536 . . . . 64.33 110.374 177.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -88.4 117.31 27.24 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.294 -0.254 . . . . 75.44 110.807 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.49 HG21 HG23 ' A' ' 58' ' ' ILE . 46.1 t -66.42 127.84 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.931 0.396 . . . . 74.3 111.699 -177.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.6 p -112.42 -49.6 2.95 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.274 -0.421 . . . . 71.03 111.792 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.0 p -84.54 154.69 22.51 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.126 0.489 . . . . 71.33 111.685 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.92 118.44 65.42 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.703 -0.48 . . . . 73.42 109.703 175.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.446 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 75.9 Cg_exo -50.85 121.21 7.72 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.626 2.217 . . . . 63.33 113.25 -178.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.03 -20.72 3.38 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.101 -0.571 . . . . 74.3 112.879 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.472 ' O ' HG12 ' A' ' 82' ' ' VAL . 87.2 mm-40 -55.47 112.09 1.04 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 111.859 0.318 . . . . 54.11 111.859 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 56.64 20.34 4.94 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.788 0.435 . . . . 71.01 112.077 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.02 33.38 45.71 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.166 -0.54 . . . . 52.12 113.114 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 79' ' ' GLN . 9.0 p -151.64 167.89 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.127 0.489 . . . . 44.3 111.439 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 58' ' ' ILE . 29.3 mt -118.46 148.15 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.013 0.525 . . . . 70.34 109.812 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -121.82 140.85 51.85 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.779 -0.575 . . . . 62.32 111.532 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.19 176.17 38.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 121.081 -0.58 . . . . 73.22 113.518 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.53 145.28 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 117.069 0.434 . . . . 60.41 111.253 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.524 HD11 HH12 ' A' ' 89' ' ' ARG . 37.7 tp -81.3 111.87 18.08 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.998 0.428 . . . . 63.13 111.952 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.0 pt -128.37 -178.95 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.182 0.515 . . . . 75.53 111.499 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.524 HH12 HD11 ' A' ' 87' ' ' LEU . 26.0 mmt180 -136.2 86.2 2.21 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.157 -0.339 . . . . 64.04 111.675 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -88.72 -45.12 10.06 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 122.054 -0.404 . . . . 71.4 111.639 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.82 174.88 7.08 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.115 0.483 . . . . 73.22 111.564 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -64.17 134.02 54.03 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.127 -0.488 . . . . 64.0 112.021 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -69.6 100.85 1.51 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.887 -0.783 . . . . 74.23 108.887 170.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -77.44 37.09 0.21 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.233 0.827 . . . . 73.01 113.233 -169.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -112.97 76.64 0.99 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.227 0.537 . . . . 73.1 110.565 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -86.09 -18.96 30.98 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.144 0.424 . . . . 63.23 112.144 -174.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -78.71 70.94 5.14 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.56 0.695 . . . . 72.35 111.886 -173.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 . . . . . 0 C--O 1.252 1.208 0 CA-C-N 115.401 -0.818 . . . . 75.25 110.095 176.592 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 CA-C-O 120.453 -0.082 . . . . 75.02 113.117 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -99.99 -1.23 37.62 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.394 0.516 . . . . 70.32 112.394 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.436 ' N ' ' HD2' ' A' ' 3' ' ' ARG . 3.7 mpt_? -79.16 127.95 32.68 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.922 0.391 . . . . 64.1 111.3 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.549 ' H ' ' HD2' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -101.66 110.66 22.7 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.403 0.62 . . . . 73.11 110.84 -179.262 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.18 42.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 112.898 0.703 . . . . 75.31 112.898 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.3 ptt85 -159.58 98.93 1.41 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.121 0.486 . . . . 54.44 111.779 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.01 -0.5 28.75 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.452 -0.34 . . . . 73.43 111.516 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.403 HD13 ' N ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -72.76 134.06 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 121.114 0.483 . . . . 73.51 111.029 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.403 ' N ' HD13 ' A' ' 8' ' ' ILE . 18.3 mmm180 -126.87 130.51 50.33 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.431 0.53 . . . . 73.35 112.431 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 t -143.1 163.6 32.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.85 -0.614 . . . . 74.2 110.64 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -162.28 115.64 1.76 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.009 0.433 . . . . 75.34 111.621 -177.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.9 96.19 0.78 Allowed Glycine 0 CA--C 1.527 0.801 0 CA-C-N 116.361 -0.381 . . . . 55.24 112.511 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.84 -152.81 7.06 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.903 -0.665 . . . . 70.21 113.474 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -72.97 121.81 20.68 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.964 0.412 . . . . 62.42 112.086 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -90.97 171.01 9.58 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.098 0.475 . . . . 62.41 111.565 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.48 ' O ' ' HD3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -73.89 146.97 43.62 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.077 -0.51 . . . . 72.32 111.64 178.635 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.4 153.02 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 120.866 0.365 . . . . 74.33 111.313 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.474 ' NH2' ' HB2' ' A' ' 77' ' ' PRO . 9.7 ptm180 -55.84 -32.11 63.32 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.542 0.571 . . . . 73.13 112.542 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 tt -163.76 128.16 2.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.546 -0.297 . . . . 74.23 110.463 -175.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.07 80.2 1.9 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.577 0.227 . . . . 53.12 111.52 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.6 m 72.2 -45.26 0.62 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.496 0.718 . . . . 73.13 112.353 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -76.43 131.06 38.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.487 0.315 . . . . 53.12 110.554 176.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.3 m -120.87 114.83 22.14 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.802 0.334 . . . . 75.33 111.84 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -115.7 159.95 20.7 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.281 0.474 . . . . 72.43 112.281 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.438 ' HB ' HD11 ' A' ' 40' ' ' ILE . 12.5 tt -155.4 133.97 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.098 -0.501 . . . . 73.33 111.225 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -77.02 102.81 6.63 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.041 0.448 . . . . 70.13 110.196 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.2 t -94.08 119.14 41.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 70.31 111.686 -176.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 35' ' ' VAL . 42.3 t -95.47 115.43 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.383 -0.372 . . . . 74.3 110.709 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.506 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 33.3 t70 -82.75 119.88 75.34 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-O 120.542 0.21 . . . . 62.52 110.696 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.61 -17.07 30.13 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.685 2.257 . . . . 62.55 113.411 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -82.13 -44.45 16.46 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 111.9 0.333 . . . . 60.45 111.9 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.4 p -100.06 -28.26 13.14 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.016 0.436 . . . . 73.33 111.714 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.75 22.49 49.77 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.268 -0.492 . . . . 62.22 112.979 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.506 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 63.6 pttt -87.34 145.89 26.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.922 0.361 . . . . 73.25 111.834 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 28' ' ' VAL . 48.8 t -105.32 94.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 109.746 -0.465 . . . . 74.43 109.746 170.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.02 124.38 52.06 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.282 -0.417 . . . . 62.21 111.384 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.0 mt -79.37 113.06 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.495 -0.32 . . . . 75.04 111.629 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -113.86 170.99 7.86 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.912 0.387 . . . . 71.31 111.916 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.85 137.16 37.83 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.496 -0.32 . . . . 71.54 111.001 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.438 HD11 ' HB ' ' A' ' 25' ' ' ILE . 63.5 mt -90.71 114.61 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.741 0.305 . . . . 74.23 111.424 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -83.51 -45.44 13.59 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.263 0.468 . . . . 63.33 112.263 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.567 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 41.7 m-80 -123.57 115.39 21.43 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.788 0.328 . . . . 52.2 111.76 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 58' ' ' ILE . 82.0 t -70.83 -30.13 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.176 0.512 . . . . 73.42 110.814 174.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.71 140.45 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 116.23 -0.441 . . . . 64.54 111.02 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -75.71 32.05 0.11 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.258 0.466 . . . . 52.24 112.258 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.7 m120 56.46 29.25 15.0 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.201 0.524 . . . . 63.43 112.001 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.0 t -127.41 -179.87 5.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.16 -0.473 . . . . 60.43 111.148 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.43 177.28 2.44 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.301 0.572 . . . . 71.53 111.789 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -92.57 119.4 68.0 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.371 -0.377 . . . . 70.03 111.287 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.51 -28.14 82.97 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.397 2.065 . . . . 65.4 111.83 173.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -143.74 140.75 30.13 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.903 -0.59 . . . . 63.31 110.666 171.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -69.05 1.9 3.16 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.968 0.729 . . . . 74.31 112.968 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.63 HG13 ' H ' ' A' ' 55' ' ' ARG . 12.2 p -63.62 -20.23 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 120.867 0.365 . . . . 74.15 111.836 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 62.76 22.42 13.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.709 0.403 . . . . 63.24 112.028 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.63 ' H ' HG13 ' A' ' 53' ' ' VAL . 44.1 ttm180 -68.94 93.16 0.54 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.191 0.519 . . . . 75.22 111.551 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -77.45 101.12 6.27 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.256 -0.429 . . . . 52.25 110.741 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.0 tt -128.65 132.56 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 121.114 0.483 . . . . 63.43 111.406 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.527 ' HB ' ' HG3' ' A' ' 77' ' ' PRO . 68.7 mt -87.61 134.99 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.994 -0.548 . . . . 72.03 110.81 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -147.8 172.2 14.49 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.262 0.467 . . . . 65.44 112.262 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -72.49 116.03 12.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.209 -0.45 . . . . 71.45 111.368 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 109.42 -7.65 32.34 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.258 -0.496 . . . . 34.01 112.88 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.18 139.46 30.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.763 0.316 . . . . 73.32 111.405 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.64 114.07 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.988 0.423 . . . . 64.43 111.307 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -102.56 154.42 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.987 0.423 . . . . 73.21 111.582 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 8.8 tp10 -95.6 120.71 36.33 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.874 0.369 . . . . 74.24 111.386 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.9 p -122.82 172.89 8.12 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.841 0.353 . . . . 74.12 111.421 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.411 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 32.2 p30 -57.59 -33.22 67.96 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.885 0.374 . . . . 75.13 111.627 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.9 mt -75.63 -33.15 60.46 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.9 0.381 . . . . 70.13 111.02 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 140.7 -156.49 25.37 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.137 -0.483 . . . . 75.32 112.983 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -68.63 125.76 27.55 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.746 0.308 . . . . 61.14 111.214 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.7 t -125.98 119.28 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.046 0.388 . . . . 74.31 112.046 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.455 ' HB2' HD13 ' A' ' 88' ' ' ILE . 59.0 ttp180 -84.19 111.31 19.24 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.66 0.267 . . . . 73.43 110.925 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.443 HG21 HG23 ' A' ' 58' ' ' ILE . 58.5 t -71.55 131.16 34.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.559 0.578 . . . . 55.13 112.559 -174.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.0 p -106.04 -33.09 8.0 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.965 -0.561 . . . . 63.55 111.826 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t -112.91 134.71 54.3 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.654 0.264 . . . . 74.35 111.478 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.2 mtm-85 -80.75 142.81 53.26 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 112.383 0.512 . . . . 72.43 112.383 -175.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.527 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 37.9 Cg_endo -63.52 97.24 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.261 2.641 . . . . 74.1 113.66 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.93 -28.59 2.13 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.866 -0.683 . . . . 60.3 113.565 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -53.81 -68.26 0.19 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.037 0.446 . . . . 74.2 111.67 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -99.1 18.25 17.84 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.931 0.396 . . . . 72.02 110.977 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.8 -33.33 1.67 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 121.227 -0.511 . . . . 73.04 112.805 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 83' ' ' ILE . 14.5 p -99.85 158.47 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.14 0.495 . . . . 73.54 111.631 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.41 ' N ' HG22 ' A' ' 82' ' ' VAL . 46.4 mt -105.86 143.57 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.437 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -126.28 146.3 50.07 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.297 -0.252 . . . . 70.22 111.287 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.22 -179.02 30.05 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.201 -0.523 . . . . 53.32 113.039 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 t -124.35 129.88 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.838 0.319 . . . . 64.11 110.935 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.9 tp -74.45 106.34 6.01 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.101 0.477 . . . . 70.02 111.488 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 72' ' ' ARG . 7.9 pt -120.05 176.53 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.313 0.578 . . . . 73.33 111.408 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' A' ' 88' ' ' ILE . 15.6 mmm180 -128.81 91.06 3.15 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.313 -0.403 . . . . 74.15 110.667 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -106.37 -50.14 3.2 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.223 0.535 . . . . 75.43 111.481 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.6 178.16 4.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.565 0.698 . . . . 64.43 112.431 -176.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -56.55 116.88 3.37 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.608 -0.724 . . . . 72.24 112.283 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -90.71 136.11 33.28 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.826 0.346 . . . . 55.44 110.764 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -107.74 139.23 42.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.026 0.441 . . . . 71.31 111.608 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -106.55 -50.18 3.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.343 -0.39 . . . . 73.53 112.013 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.3 t-80 -78.1 84.14 4.36 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.34 0.591 . . . . 73.23 110.339 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -100.48 171.95 7.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.436 -0.802 . . . . 74.33 112.4 -172.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 80.9 t60 . . . . . 0 C--O 1.25 1.084 0 CA-C-N 116.053 -0.521 . . . . 63.03 110.95 176.555 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.429 -0.268 . . . . 74.21 112.429 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -85.48 -175.79 5.82 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.934 0.397 . . . . 44.33 111.373 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.556 ' HD3' ' N ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -113.94 -53.5 2.67 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.092 0.405 . . . . 73.5 112.092 -175.758 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.32 142.19 4.75 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.837 0.351 . . . . 73.43 111.437 176.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.9 t -107.87 113.89 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.013 0.435 . . . . 73.13 111.262 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.506 ' NE ' ' HA ' ' A' ' 6' ' ' ARG . 3.9 mmp_? -112.32 80.08 1.29 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.954 0.407 . . . . 75.53 111.793 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.19 -68.7 0.38 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.084 0.468 . . . . 71.12 109.896 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.7 tt -98.78 127.9 50.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.967 0.413 . . . . 64.14 110.722 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.451 ' N ' ' HD3' ' A' ' 9' ' ' ARG . 1.3 mpp_? -105.31 -49.66 3.4 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.814 0.34 . . . . 75.13 111.076 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.9 t -96.25 126.05 41.2 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.13 0.49 . . . . 64.41 111.675 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.425 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -120.66 19.51 11.87 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.178 0.513 . . . . 70.41 110.608 177.701 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.97 -112.99 0.81 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 116.028 -0.533 . . . . 74.13 113.52 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.65 -89.52 0.12 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.283 -0.484 . . . . 64.33 112.994 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -90.26 1.4 56.53 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.053 0.454 . . . . 72.23 111.193 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.5 m -131.03 154.33 48.33 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.17 -0.468 . . . . 74.02 111.06 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -57.86 153.86 13.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.187 0.518 . . . . 64.23 112.067 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 19' ' ' LEU . 7.6 p -73.82 78.6 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 CA-C-O 121.399 0.619 . . . . 73.43 111.953 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.447 ' HD3' ' N ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 45.9 -68.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.174 1.546 . . . . 72.13 115.174 176.86 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.594 HD21 ' H ' ' A' ' 23' ' ' THR . 7.4 tt -141.13 114.4 8.68 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.679 -0.638 . . . . 74.12 111.091 -175.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.28 125.86 11.75 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.558 -0.292 . . . . 74.23 111.159 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.3 t 65.64 10.25 6.57 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.129 0.49 . . . . 71.33 111.74 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -96.05 -77.03 0.49 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.236 -0.438 . . . . 55.12 111.579 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.594 ' H ' HD21 ' A' ' 19' ' ' LEU . 86.6 m -95.58 113.95 25.65 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.007 0.432 . . . . 72.14 110.8 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -138.58 154.89 48.73 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.016 0.436 . . . . 73.12 111.738 -173.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.436 ' HB ' HD11 ' A' ' 40' ' ' ILE . 15.3 tt -143.77 138.4 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.089 0.471 . . . . 73.14 111.618 -177.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -90.46 112.76 24.52 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.274 0.559 . . . . 71.44 110.102 175.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.0 t -106.28 144.12 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.649 0.611 . . . . 75.4 112.649 -169.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 t -104.87 129.91 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.234 -0.439 . . . . 60.31 111.058 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -84.63 122.8 74.89 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 116.428 -0.351 . . . . 71.34 110.945 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.58 -17.12 11.43 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.784 2.322 . . . . 72.22 114.283 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.23 -43.81 11.32 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.281 0.563 . . . . 63.41 111.558 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 p -105.64 -31.26 9.0 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.885 -0.598 . . . . 64.21 112.084 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.26 12.97 56.81 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.022 -0.608 . . . . 60.41 113.617 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -86.56 143.14 27.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.007 0.404 . . . . 72.51 111.34 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.78 103.53 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.074 0.464 . . . . 65.41 110.656 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -108.43 135.81 49.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.952 0.406 . . . . 73.41 111.363 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.6 mt -90.6 129.04 42.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.86 0.362 . . . . 73.34 111.229 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -126.99 159.14 35.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.893 0.378 . . . . 45.15 111.713 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -107.5 139.97 41.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.853 0.359 . . . . 73.43 110.759 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.576 ' HB ' HG22 ' A' ' 23' ' ' THR . 58.0 mt -93.04 116.41 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.286 0.565 . . . . 73.53 112.485 -172.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 41' ' ' ARG . 8.0 mtp180 -82.48 -53.35 6.05 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.668 -0.696 . . . . 71.25 111.639 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 92.1 m-20 -116.56 122.86 45.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.431 -0.35 . . . . 74.12 111.144 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.83 21.95 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 112.095 0.406 . . . . 71.11 112.095 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.54 139.04 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.103 0.478 . . . . 74.14 112.021 -176.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.2 -174.43 5.23 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 116.166 -0.47 . . . . 61.32 111.908 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -89.28 67.42 7.83 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.547 0.689 . . . . 73.33 112.479 -172.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.9 p -83.39 110.99 18.61 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.174 -0.466 . . . . 70.43 111.069 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.98 -53.95 48.46 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.956 0.354 . . . . 71.11 111.956 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -113.64 93.99 30.62 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 120.854 0.359 . . . . 60.22 110.268 172.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.59 156.7 36.07 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.706 2.271 . . . . 71.04 113.858 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -85.84 154.43 21.56 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.384 -0.371 . . . . 72.31 110.908 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -61.87 -16.64 52.09 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.453 0.538 . . . . 75.34 112.453 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.02 123.82 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.621 0.248 . . . . 63.21 111.304 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -166.01 137.34 3.73 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.783 0.325 . . . . 74.21 111.064 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -127.03 -178.01 4.26 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.986 0.422 . . . . 75.22 111.802 -177.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -90.15 -8.71 50.56 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.263 -0.426 . . . . 70.42 111.894 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.4 mm -79.61 116.55 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.266 0.555 . . . . 64.42 112.291 -177.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.4 HD13 HG11 ' A' ' 64' ' ' VAL . 68.5 mt -70.29 148.85 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.717 -0.674 . . . . 74.41 111.288 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -132.36 166.76 21.23 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.959 0.409 . . . . 72.45 111.934 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -64.19 126.88 29.16 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.241 -0.436 . . . . 71.31 111.386 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.19 5.25 65.87 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.217 -0.516 . . . . 72.52 113.44 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.28 153.15 19.42 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.013 0.435 . . . . 71.43 111.367 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.67 HG11 ' HG3' ' A' ' 90' ' ' GLU . 59.8 t -112.69 128.83 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.419 -0.355 . . . . 75.33 110.906 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.4 HG11 HD13 ' A' ' 58' ' ' ILE . 35.9 m -115.28 154.26 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.764 0.653 . . . . 73.43 112.764 -176.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 29.9 tt0 -89.32 109.29 20.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.892 -0.594 . . . . 74.55 110.789 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.465 HG22 HG12 ' A' ' 40' ' ' ILE . 45.5 p -110.96 168.43 9.49 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.954 0.407 . . . . 75.04 111.336 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -60.26 -19.32 54.28 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.128 0.418 . . . . 74.25 112.128 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' A' ' 38' ' ' ALA . 83.9 mt -93.44 -30.63 14.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.85 0.315 . . . . 73.32 111.85 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.72 -149.59 21.23 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.013 -0.613 . . . . 70.31 113.105 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -91.27 119.47 31.36 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.354 -0.497 . . . . 64.32 110.83 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.08 124.78 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.982 0.42 . . . . 64.14 111.608 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.42 ' HB2' HD11 ' A' ' 88' ' ' ILE . 21.5 ttm180 -91.76 115.05 27.73 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.241 -0.436 . . . . 65.51 110.617 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.16 121.91 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.064 0.459 . . . . 74.23 112.143 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.1 p -103.45 -43.56 5.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.16 -0.473 . . . . 61.42 111.902 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 t -93.66 -176.77 4.17 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.101 0.477 . . . . 63.01 111.972 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -84.37 126.26 69.81 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.268 -0.424 . . . . 52.35 111.806 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.446 ' HA ' HG12 ' A' ' 83' ' ' ILE . 17.9 Cg_endo -60.99 125.32 16.8 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.989 1.793 . . . . 64.1 111.692 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.08 -4.32 77.77 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.993 -0.623 . . . . 71.32 113.734 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -50.24 -64.07 0.92 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 117.271 0.535 . . . . 62.44 110.905 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -101.99 24.8 9.51 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.85 0.833 . . . . 71.2 109.636 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.43 -29.52 5.24 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 115.821 -0.627 . . . . 60.5 112.438 -173.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.434 HG22 ' N ' ' A' ' 83' ' ' ILE . 8.2 p -109.97 165.74 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 122.74 0.416 . . . . 73.45 111.172 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 77' ' ' PRO . 34.4 mt -101.85 148.19 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.844 0.354 . . . . 61.33 111.225 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -119.3 134.75 55.05 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.668 0.271 . . . . 73.14 111.485 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.24 178.31 31.96 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.001 -0.618 . . . . 54.15 113.4 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 t -110.44 141.48 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 111.964 0.357 . . . . 71.11 111.964 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.0 tp -82.78 111.33 18.6 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.032 0.382 . . . . 63.33 112.032 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 72' ' ' ARG . 13.8 pt -143.57 -169.62 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.22 0.533 . . . . 61.41 111.593 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -137.92 99.14 3.82 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.264 -0.425 . . . . 73.45 111.0 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.67 ' HG3' HG11 ' A' ' 63' ' ' VAL . 11.8 mm-40 -78.3 -34.35 48.84 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.236 0.541 . . . . 74.53 111.242 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.463 ' N ' HD23 ' A' ' 91' ' ' LEU . 1.7 pt? -137.14 146.88 45.54 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.843 -0.617 . . . . 72.42 110.72 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HG2' ' N ' ' A' ' 93' ' ' HIS . 32.2 tt0 -77.7 165.27 24.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.946 0.403 . . . . 70.34 111.075 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.583 ' N ' ' HG2' ' A' ' 92' ' ' GLU . 21.3 t-80 -45.52 -33.33 2.67 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.84 0.456 . . . . 74.41 111.745 173.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -125.64 105.75 9.23 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.498 -0.319 . . . . 33.51 110.65 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -78.78 -175.12 4.27 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.812 0.339 . . . . 62.04 111.884 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -48.73 128.51 15.52 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.673 0.62 . . . . 75.42 112.673 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -120.91 -31.19 4.25 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.455 0.539 . . . . 72.12 112.455 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.798 -0.62 . . . . 73.54 112.601 -176.282 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.582 -0.207 . . . . 65.31 112.582 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -92.49 108.56 20.06 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.073 0.463 . . . . 64.45 111.374 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -142.54 81.77 1.75 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.368 0.604 . . . . 74.51 109.617 174.38 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.5 mtm-85 -80.92 99.37 8.34 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.356 0.598 . . . . 72.23 112.291 -172.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 p -79.14 137.53 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 115.909 -0.587 . . . . 61.03 111.474 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -124.19 106.17 10.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.741 -0.466 . . . . 74.54 109.741 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.8 tp -127.16 76.95 1.7 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.557 0.694 . . . . 72.01 111.455 -170.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.64 136.1 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.555 -0.748 . . . . 51.41 110.258 174.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -115.21 145.89 41.97 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.058 0.456 . . . . 74.34 111.43 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.0 p -118.19 164.57 14.96 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.102 -0.499 . . . . 72.51 111.081 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -146.9 154.16 40.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.829 0.347 . . . . 72.42 111.37 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.99 -178.4 15.29 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.023 -0.608 . . . . 71.44 113.386 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -124.28 140.06 12.36 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.4 -0.429 . . . . 70.14 112.283 177.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -67.41 90.51 0.24 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.064 0.459 . . . . 64.54 111.358 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.8 m -119.71 113.75 21.12 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.243 -0.435 . . . . 73.4 110.654 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.502 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -134.65 155.64 50.14 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.961 0.41 . . . . 61.45 111.755 -176.506 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.05 150.82 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 116.47 -0.332 . . . . 70.13 111.244 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -60.38 165.58 3.55 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.134 0.492 . . . . 75.42 112.022 176.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 tt -61.65 112.16 2.13 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.18 0.514 . . . . 71.52 111.016 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.11 -54.95 1.69 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.871 -0.604 . . . . 54.32 110.923 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.2 m -117.03 -49.19 2.62 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.167 -0.47 . . . . 75.35 110.576 175.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.36 105.63 0.37 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.218 -0.446 . . . . 75.5 111.112 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.411 ' CG2' ' HB ' ' A' ' 40' ' ' ILE . 90.4 m -89.87 114.86 26.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.929 0.395 . . . . 75.13 111.878 -175.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -149.81 148.18 28.87 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.287 -0.415 . . . . 72.42 110.771 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.6 tt -143.08 139.48 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 121.192 0.52 . . . . 54.34 112.018 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -83.92 105.32 14.71 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.187 0.517 . . . . 72.41 110.781 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.503 HG22 HG11 ' A' ' 71' ' ' VAL . 48.7 t -105.61 120.53 56.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 112.49 0.552 . . . . 75.31 112.49 -172.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -95.59 122.46 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 116.587 -0.279 . . . . 74.34 110.876 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 31.6 t70 -82.53 116.47 63.98 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 120.547 0.213 . . . . 61.22 110.733 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.03 -15.07 29.27 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.606 2.204 . . . . 71.1 113.249 -177.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -78.71 -45.44 21.25 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.786 0.327 . . . . 54.02 111.742 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.3 p -104.12 -20.69 13.74 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.017 0.377 . . . . 74.0 112.017 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.28 20.8 66.22 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.199 -0.524 . . . . 71.32 112.973 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 65.5 pttt -88.07 139.39 30.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.044 0.45 . . . . 65.14 111.628 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.8 t -86.72 95.58 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.076 0.465 . . . . 54.43 110.21 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -99.87 165.97 11.3 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.085 0.469 . . . . 73.23 111.179 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.09 129.87 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.164 -0.335 . . . . 65.23 110.621 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.38 170.2 15.43 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.485 0.66 . . . . 43.52 112.38 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.73 131.86 56.84 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.665 -0.698 . . . . 72.53 110.431 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.411 ' HB ' ' CG2' ' A' ' 23' ' ' THR . 59.9 mt -77.32 114.52 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.142 0.496 . . . . 75.25 112.275 -175.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HE ' ' HA ' ' A' ' 41' ' ' ARG . 2.5 mmp_? -71.26 -50.05 36.81 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.915 -0.584 . . . . 71.43 110.695 173.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -133.11 130.94 39.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.952 -0.567 . . . . 73.42 110.754 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.5 m -87.73 14.18 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 112.598 0.592 . . . . 73.52 112.598 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.57 131.59 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-O 121.342 0.592 . . . . 74.12 112.546 -175.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 63' ' ' VAL . 5.9 pt-20 -91.53 -157.57 0.51 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.769 -0.65 . . . . 75.41 110.897 176.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -77.96 58.62 1.98 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.249 0.547 . . . . 65.24 111.323 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.9 p -72.58 99.09 2.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.072 0.463 . . . . 72.43 111.463 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.15 73.12 2.28 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.188 0.518 . . . . 73.53 110.729 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 52' ' ' PHE . 79.9 m-20 -131.94 65.2 74.92 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 116.272 -0.422 . . . . 71.35 111.852 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 51' ' ' HIS . 59.3 Cg_endo -71.06 118.19 5.56 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.199 1.933 . . . . 63.14 112.182 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 50' ' ' PRO . 73.3 m80 70.47 7.05 6.07 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.869 0.468 . . . . 61.35 111.787 -173.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 47.3 m-85 -116.73 16.11 15.36 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.892 0.377 . . . . 71.21 110.769 177.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.1 t -55.99 129.09 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.983 -0.553 . . . . 71.31 112.471 -175.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -106.84 -160.79 0.75 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.939 -0.573 . . . . 71.11 111.145 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -78.09 166.33 22.91 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.18 0.514 . . . . 73.11 111.969 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -77.68 49.17 0.73 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 116.121 -0.491 . . . . 74.54 111.787 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.9 tp -92.15 106.22 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.524 0.678 . . . . 65.14 111.593 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.409 ' HB ' ' HG3' ' A' ' 77' ' ' PRO . 66.6 mt -70.8 105.64 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.004 -0.544 . . . . 74.44 110.809 177.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -87.57 165.76 15.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.062 0.458 . . . . 73.34 112.033 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 74' ' ' THR . 63.0 ttt180 -67.79 116.71 8.77 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.424 -0.353 . . . . 61.21 110.694 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.39 -6.72 46.1 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.281 -0.485 . . . . 72.32 112.927 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.49 138.79 49.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.83 0.348 . . . . 70.44 111.168 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 55.1 t -96.3 116.26 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.999 0.428 . . . . 60.34 111.606 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.9 m -103.52 148.11 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.125 0.488 . . . . 50.32 111.678 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' ARG . 9.6 tp10 -84.91 127.99 34.42 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.086 -0.506 . . . . 73.23 110.179 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.0 p -129.73 174.78 9.38 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.933 0.397 . . . . 72.43 111.794 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.33 -18.48 64.67 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.649 0.261 . . . . 72.01 111.687 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.41 -27.77 18.1 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.991 0.424 . . . . 73.03 111.155 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.55 -150.09 21.15 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.982 -0.554 . . . . 33.44 112.242 -175.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -77.91 128.85 34.58 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.98 0.419 . . . . 74.12 111.239 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.503 HG11 HG22 ' A' ' 27' ' ' VAL . 91.7 t -126.45 119.42 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 122.113 -0.367 . . . . 73.23 111.654 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -85.16 113.0 21.21 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.713 0.292 . . . . 61.5 110.902 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.12 127.83 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 112.386 0.513 . . . . 73.12 112.386 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.46 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 77.8 p -98.79 -62.61 1.21 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.219 -0.446 . . . . 74.43 111.0 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.523 ' HB2' ' H ' ' A' ' 84' ' ' ASN . 55.3 m -76.45 117.1 17.76 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.432 -0.349 . . . . 44.33 111.396 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -59.8 130.12 88.19 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 116.58 -0.282 . . . . 75.41 110.877 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.409 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 10.6 Cg_endo -52.04 122.59 10.81 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.312 2.675 . . . . 73.44 113.533 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.38 -36.18 1.88 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.069 -0.586 . . . . 75.02 113.009 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.532 ' O ' HG12 ' A' ' 82' ' ' VAL . 48.3 mt-30 -59.21 100.91 0.08 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.644 0.259 . . . . 63.43 111.301 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 57.41 19.31 5.05 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.061 0.393 . . . . 71.05 112.061 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.04 4.5 78.09 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.315 -0.469 . . . . 55.54 114.176 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 79' ' ' GLN . 13.8 p -100.54 141.49 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 117.53 0.665 . . . . 73.33 111.668 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.28 116.6 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.099 -0.5 . . . . 64.14 110.361 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.523 ' H ' ' HB2' ' A' ' 75' ' ' SER . 13.7 m120 -103.51 154.27 19.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.808 0.337 . . . . 74.24 111.531 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.93 178.75 35.88 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.177 -0.535 . . . . 63.04 113.135 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.19 133.11 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 122.719 -0.283 . . . . 65.42 111.204 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.9 tp -76.42 106.22 7.93 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.036 0.446 . . . . 70.13 111.472 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.8 pt -122.81 179.7 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.133 0.492 . . . . 75.21 111.405 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -138.27 91.56 2.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.525 -0.307 . . . . 75.43 110.617 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -105.53 -50.94 3.1 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.811 0.3 . . . . 72.45 111.811 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.6 mt -56.58 150.21 15.95 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.866 0.365 . . . . 72.42 111.271 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.55 109.78 0.86 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.654 0.613 . . . . 60.0 112.654 -171.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -71.55 -30.31 65.74 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.054 -0.521 . . . . 73.12 112.279 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -75.03 94.34 2.86 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 110.285 -0.265 . . . . 62.51 110.285 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -47.21 105.8 0.07 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.515 0.674 . . . . 74.52 112.516 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -90.67 119.81 31.21 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.865 -0.607 . . . . 75.33 112.118 -175.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -140.57 134.72 30.96 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.234 -0.439 . . . . 73.3 110.121 172.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.903 -0.57 . . . . 62.14 111.378 -176.484 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.474 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 42.3 m . . . . . 0 N--CA 1.471 0.605 0 CA-C-O 120.549 0.214 . . . . 55.310000000000002 111.505 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 23' ' ' THR . 50.4 mtm180 -162.83 169.96 19.01 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.249 0.62 . . . . 63.229999999999997 111.19 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.0 tt -147.03 139.26 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.386 -0.37 . . . . 71.319999999999993 111.51 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.426 ' OD1' HG12 ' A' ' 37' ' ' ILE . 75.5 m-20 -74.03 106.84 5.89 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.788 0.328 . . . . 72.140000000000001 110.659 176.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -97.56 123.62 50.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.109 0.481 . . . . 75.340000000000003 112.07 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.6 t -95.23 112.83 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.995 0.426 . . . . 60.43 110.594 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.53 114.99 50.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.01 -0.541 . . . . 75.140000000000001 111.077 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -82.58 -11.78 10.34 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.706 2.271 . . . . 75.310000000000002 113.007 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.461 ' CD ' HH12 ' A' ' 89' ' ' ARG . 10.9 mm-40 -77.57 -39.63 45.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.161 0.505 . . . . 75.310000000000002 110.863 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.1 p -121.27 -27.08 4.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.712 -0.677 . . . . 75.040000000000006 112.258 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.96 29.21 11.95 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.38 -0.438 . . . . 40.340000000000003 113.302 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -99.44 142.02 31.47 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 122.478 -0.425 . . . . 74.109999999999999 111.182 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.1 t -107.46 112.05 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.841 0.353 . . . . 63.049999999999997 110.774 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -133.52 141.64 47.84 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.915 0.388 . . . . 71.329999999999998 111.496 -177.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.426 HG12 ' OD1' ' A' ' 26' ' ' ASN . 45.9 mt -83.06 111.34 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.85 0.357 . . . . 71.329999999999998 111.331 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.38 157.17 17.21 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.027 0.441 . . . . 62.119999999999997 112.046 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -83.25 135.31 34.81 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.185 -0.461 . . . . 72.450000000000003 110.986 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -83.73 112.06 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 121.267 0.556 . . . . 60.140000000000001 111.016 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.451 ' HD2' HH11 ' A' ' 41' ' ' ARG . 44.4 mtp85 -82.83 -53.41 5.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.027 -0.533 . . . . 72.439999999999998 111.018 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -124.8 132.31 53.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.261 -0.427 . . . . 74.019999999999996 110.842 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 120.929 0.395 . . . . 65.109999999999999 111.928 179.173 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.612 HG21 HD13 ' A' ' 83' ' ' ILE . 69.9 mt . . . . . 0 CA--C 1.544 0.731 0 CA-C-O 121.314 0.578 . . . . 74.030000000000001 111.226 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.6 p -135.26 159.6 41.04 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.208 -0.451 . . . . 53.240000000000002 112.078 -174.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -54.51 129.06 34.71 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.122 -0.49 . . . . 65.019999999999996 111.725 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.11 -11.41 72.18 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.137 -0.554 . . . . 23.120000000000001 113.465 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 145.38 31.62 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.859 0.361 . . . . 63.140000000000001 111.124 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.0 t -109.02 124.59 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.025 0.44 . . . . 74.420000000000002 111.593 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -107.43 154.93 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.982 0.42 . . . . 64.329999999999998 111.39 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.53 133.38 38.21 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.503 -0.317 . . . . 61.240000000000002 110.782 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.5 p -136.8 179.14 6.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.989 0.423 . . . . 65.219999999999999 111.637 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -69.09 -15.38 63.43 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.757 0.313 . . . . 74.409999999999997 111.78 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.71 -13.9 20.03 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.684 0.278 . . . . 73.010000000000005 111.512 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.44 -151.94 18.63 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.383 -0.437 . . . . 53.439999999999998 112.733 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -82.81 129.18 34.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.463 -0.434 . . . . 75.329999999999998 111.162 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.78 133.66 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.8 0.333 . . . . 74.329999999999998 111.459 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.478 ' HB2' HD13 ' A' ' 88' ' ' ILE . 42.1 ttm180 -94.56 121.1 35.77 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.756 0.28 . . . . 72.340000000000003 111.756 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.491 HG21 HG23 ' A' ' 58' ' ' ILE . 39.0 t -65.9 111.32 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 116.415 -0.357 . . . . 75.319999999999993 111.08 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.493 HG23 ' HA2' ' A' ' 85' ' ' GLY . 44.1 p -91.54 -39.26 12.02 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.861 0.363 . . . . 50.420000000000002 111.808 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.246 0.546 . . . . 74.140000000000001 112.22 -178.78 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 83' ' ' ILE . 8.3 p . . . . . 0 CA--C 1.545 0.763 0 CA-C-O 121.144 0.497 . . . . 60.25 111.576 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.612 HD13 HG21 ' A' ' 58' ' ' ILE . 48.2 mt -105.0 143.75 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.366 -0.379 . . . . 75.230000000000004 110.37 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -123.55 135.84 54.22 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.827 0.346 . . . . 73.340000000000003 111.239 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.493 ' HA2' HG23 ' A' ' 74' ' ' THR . . . -154.23 179.33 30.5 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.922 -0.656 . . . . 63.539999999999999 113.801 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.26 141.52 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 122.564 -0.374 . . . . 61.140000000000001 111.049 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 tp -77.06 124.42 27.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.817 0.341 . . . . 55.109999999999999 110.854 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' A' ' 72' ' ' ARG . 10.6 pt -140.31 -175.87 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.03 0.443 . . . . 73.209999999999994 111.4 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.461 HH12 ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.665 0 CA-C-N 116.368 -0.378 . . . . 70.040000000000006 110.903 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.524 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 42.9 p . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 121.163 0.506 . . . . 65.420000000000002 111.386 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HG2' ' HG2' ' A' ' 39' ' ' GLU . 68.5 mtt180 -152.42 151.94 31.4 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.725 -0.67 . . . . 73.140000000000001 110.6 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.533 ' HB ' HD11 ' A' ' 40' ' ' ILE . 10.8 tt -138.03 141.06 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.063 0.459 . . . . 74.140000000000001 112.17 -174.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -74.19 103.48 4.63 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.049 -0.523 . . . . 73.040000000000006 110.114 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.524 HG22 HG11 ' A' ' 71' ' ' VAL . 22.6 t -102.62 136.96 32.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.335 0.495 . . . . 74.319999999999993 112.335 -173.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.55 113.52 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.881 0.372 . . . . 62.420000000000002 110.387 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -77.15 114.03 36.2 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.153 -0.476 . . . . 52.509999999999998 110.452 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.85 -8.99 15.73 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.595 2.196 . . . . 75.450000000000003 113.399 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -89.42 -33.28 16.89 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.937 0.399 . . . . 75.310000000000002 111.574 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 68.0 p -116.76 -31.41 5.48 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.356 0.502 . . . . 64.310000000000002 112.356 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.55 12.58 50.52 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.138 -0.553 . . . . 62.140000000000001 113.872 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 16.1 ptpt -89.88 162.32 15.51 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.183 0.516 . . . . 71.010000000000005 111.995 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.71 95.57 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-O 121.203 0.525 . . . . 73.299999999999997 109.938 171.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.24 138.55 41.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.321 -0.4 . . . . 74.450000000000003 111.215 -174.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -84.96 121.42 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.687 0.279 . . . . 72.409999999999997 111.216 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.534 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -108.05 150.47 27.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.73 0.3 . . . . 64.040000000000006 111.648 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 24' ' ' ARG . 33.9 mt-10 -94.03 120.93 34.96 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.778 0.323 . . . . 75.040000000000006 110.76 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.533 HD11 ' HB ' ' A' ' 25' ' ' ILE . 57.8 mt -81.86 119.95 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 112.403 0.519 . . . . 63.399999999999999 112.403 -173.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.8 mmm-85 -81.68 -56.11 4.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.044 0.449 . . . . 60.43 111.048 174.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -144.61 155.45 43.64 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.199 -0.455 . . . . 71.200000000000003 111.365 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 43' ' ' VAL . 12.2 p . . . . . 0 CA--C 1.55 0.943 0 CA-C-O 121.913 0.863 . . . . 75.040000000000006 110.818 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.7 mt . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 109.946 -0.391 . . . . 72.209999999999994 109.946 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 t -133.11 167.48 20.24 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.05 0.452 . . . . 71.109999999999999 112.157 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -61.46 128.0 34.18 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.236 -0.438 . . . . 71.209999999999994 111.297 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.25 -13.51 67.17 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.229 -0.51 . . . . 52.520000000000003 112.951 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.89 132.15 43.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.021 0.438 . . . . 74.340000000000003 111.281 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.9 t -97.13 120.23 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.844 0.354 . . . . 74.129999999999995 111.319 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 43' ' ' VAL . 34.9 m -103.53 136.23 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.034 0.445 . . . . 73.319999999999993 111.337 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.27 119.49 25.12 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.955 0.407 . . . . 44.109999999999999 110.435 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 40' ' ' ILE . 34.0 p -125.72 175.73 7.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.367 -0.378 . . . . 63.43 111.471 -175.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -61.41 -28.68 69.43 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.331 -0.395 . . . . 71.25 111.739 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 38' ' ' ALA . 83.9 mt -86.72 -22.82 25.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.755 0.312 . . . . 71.200000000000003 111.45 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.57 -153.13 21.9 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.923 -0.656 . . . . 75.319999999999993 113.511 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.495 ' H ' ' HD2' ' A' ' 89' ' ' ARG . 15.1 m120 -83.66 102.87 12.53 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.922 0.391 . . . . 72.430000000000007 111.098 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.524 HG11 HG22 ' A' ' 27' ' ' VAL . 47.6 t -97.62 119.73 46.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.962 0.41 . . . . 61.020000000000003 111.326 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -86.93 117.61 25.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.495 -0.321 . . . . 64.239999999999995 111.171 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.75 121.1 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.178 -0.464 . . . . 71.120000000000005 112.111 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -107.3 -41.79 5.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.249 -0.432 . . . . 71.400000000000006 111.799 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.9 m . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 121.283 0.564 . . . . 71.420000000000002 112.176 -179.279 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.799 0.333 . . . . 64.109999999999999 110.615 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.2 mt -96.08 143.87 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.299 -0.41 . . . . 62.399999999999999 111.588 -177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -118.92 148.96 42.37 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.301 0.24 . . . . 62.520000000000003 110.749 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.3 -170.25 26.82 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 121.089 -0.576 . . . . 53.420000000000002 113.641 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 2.3 t -121.08 147.73 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 122.487 -0.419 . . . . 72.230000000000004 111.126 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 50.5 tp -89.74 113.55 25.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.412 0.523 . . . . 73.420000000000002 112.412 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.5 pt -136.75 -173.51 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.077 0.465 . . . . 51.210000000000001 110.815 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HD2' ' H ' ' A' ' 70' ' ' ASN . 24.0 mmm180 . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.111 0.481 . . . . 75.409999999999997 111.35 176.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 m . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 120.88 0.371 . . . . 60.020000000000003 111.134 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 24' ' ' ARG . 21.1 mtp180 -145.36 166.86 24.35 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.159 -0.473 . . . . 64.0 111.369 -176.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 tt -151.85 131.9 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.088 0.471 . . . . 62.030000000000001 112.265 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -72.03 104.63 3.62 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.296 -0.411 . . . . 74.439999999999998 110.687 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -100.72 129.35 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.007 0.432 . . . . 63.329999999999998 111.817 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.2 t -95.6 117.64 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.351 -0.386 . . . . 75.400000000000006 111.062 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -75.58 115.01 41.88 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.251 -0.431 . . . . 74.430000000000007 110.345 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.26 -19.46 15.29 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.571 2.181 . . . . 72.040000000000006 112.727 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -85.43 -43.03 13.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.178 -0.465 . . . . 71.430000000000007 111.675 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.6 p -105.57 -19.5 13.75 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.325 0.491 . . . . 65.150000000000006 112.325 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.67 11.37 79.84 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.088 -0.577 . . . . 63.0 113.638 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -88.7 162.72 16.13 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.954 0.407 . . . . 73.329999999999998 111.63 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.3 t -112.5 115.64 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.776 0.322 . . . . 72.239999999999995 110.473 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -126.31 141.35 51.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 122.56 0.344 . . . . 64.340000000000003 110.833 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 mt -94.0 120.07 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.83 0.347 . . . . 71.519999999999996 111.657 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.508 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -107.32 160.91 15.26 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.166 0.508 . . . . 62.439999999999998 112.188 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -102.77 124.32 48.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.311 -0.404 . . . . 73.439999999999998 110.55 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.433 ' HA ' HG22 ' A' ' 66' ' ' THR . 68.2 mt -78.58 112.65 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.356 0.598 . . . . 73.150000000000006 112.411 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -83.55 -53.8 5.41 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.033 -0.53 . . . . 74.040000000000006 111.517 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 38.5 m-80 -120.98 152.88 38.03 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.893 0.378 . . . . 71.439999999999998 111.709 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.544 0.733 0 CA-C-O 121.33 0.586 . . . . 64.230000000000004 110.97 174.673 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 61.1 mt . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 120.948 0.404 . . . . 74.239999999999995 110.216 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -106.69 163.71 12.69 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.668 0.618 . . . . 53.219999999999999 112.668 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.6 ttp-105 -56.99 116.65 3.34 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.392 -0.822 . . . . 74.239999999999995 111.837 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.23 -12.45 55.27 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.157 -0.544 . . . . 51.43 113.749 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.03 159.71 32.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.32 0.56 . . . . 32.240000000000002 111.47 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.6 t -118.15 124.41 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.128 0.49 . . . . 61.310000000000002 111.226 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.418 ' HB ' HG23 ' A' ' 40' ' ' ILE . 35.3 m -108.14 147.45 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.931 0.396 . . . . 62.039999999999999 111.761 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 28.5 tt0 -87.7 126.67 35.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.428 -0.351 . . . . 72.519999999999996 110.138 174.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 40' ' ' ILE . 33.6 p -129.46 176.0 8.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.996 0.427 . . . . 74.010000000000005 111.387 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -62.23 -20.68 64.46 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.404 -0.362 . . . . 71.450000000000003 111.553 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' A' ' 38' ' ' ALA . 71.7 mt -101.18 8.61 42.56 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.655 0.264 . . . . 64.430000000000007 111.696 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.09 -154.74 16.88 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.301 -0.476 . . . . 54.130000000000003 112.907 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -80.78 137.69 36.24 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.258 -0.554 . . . . 60.25 111.571 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.2 t -126.51 130.63 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.337 -0.392 . . . . 75.329999999999998 111.105 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.585 ' HB2' HD13 ' A' ' 88' ' ' ILE . 41.5 ttm180 -91.32 114.21 26.68 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.711 0.291 . . . . 73.340000000000003 110.739 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.7 t -66.54 131.35 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 112.834 0.679 . . . . 74.450000000000003 112.834 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.4 p -108.98 -61.33 1.63 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.942 -0.572 . . . . 51.539999999999999 111.627 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 N--CA 1.475 0.791 0 CA-C-O 121.125 0.488 . . . . 73.129999999999995 112.128 -178.394 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 121.063 0.459 . . . . 63.439999999999998 111.683 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.4 mt -123.15 147.53 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.681 -0.488 . . . . 75.25 109.681 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -128.54 145.94 50.98 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.892 -0.505 . . . . 75.329999999999998 112.276 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.38 -179.39 38.5 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 121.386 -0.435 . . . . 72.340000000000003 113.205 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.6 t -116.64 142.41 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 116.962 0.381 . . . . 65.150000000000006 111.381 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.469 HD11 HH12 ' A' ' 89' ' ' ARG . 51.5 tp -76.99 115.31 16.68 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.675 0.274 . . . . 72.340000000000003 111.621 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 72' ' ' ARG . 22.2 pt -133.82 -176.59 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.297 0.57 . . . . 73.200000000000003 111.844 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.469 HH12 HD11 ' A' ' 87' ' ' LEU . 31.8 mmt180 . . . . . 0 CA--C 1.539 0.541 0 CA-C-N 116.094 -0.503 . . . . 74.140000000000001 111.451 178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.435 HG22 ' HB ' ' A' ' 40' ' ' ILE . 17.8 m . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 120.624 0.25 . . . . 64.010000000000005 110.81 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 34.6 ttm180 -148.02 154.0 39.69 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.929 0.395 . . . . 74.120000000000005 111.968 -172.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.0 tt -148.87 146.16 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.945 0.402 . . . . 73.230000000000004 111.619 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.637 ' ND2' HG23 ' A' ' 82' ' ' VAL . 29.9 m-80 -94.16 112.71 24.55 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.88 0.371 . . . . 72.540000000000006 110.064 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.3 t -102.39 130.99 51.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.053 -0.521 . . . . 72.540000000000006 112.055 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.7 t -95.11 120.47 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.073 0.464 . . . . 64.349999999999994 110.882 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.21 116.71 61.16 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.974 -0.557 . . . . 73.150000000000006 111.028 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.9 -17.04 11.06 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.693 2.262 . . . . 74.040000000000006 112.927 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -87.96 -43.17 11.95 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.834 0.35 . . . . 55.229999999999997 111.559 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 p -106.25 -26.9 11.34 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.583 0.586 . . . . 74.340000000000003 112.583 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.61 15.97 57.5 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.126 -0.559 . . . . 70.349999999999994 114.325 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -97.41 143.86 27.73 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.243 -0.563 . . . . 74.400000000000006 111.397 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.4 t -88.51 98.33 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.171 0.51 . . . . 71.010000000000005 109.894 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -101.32 138.61 38.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.933 -0.576 . . . . 62.109999999999999 110.94 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 55.1 mt -92.31 127.72 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.071 0.462 . . . . 64.430000000000007 111.439 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.89 160.0 35.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 53.520000000000003 110.995 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 39.0 mt-10 -109.17 134.69 51.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.873 0.368 . . . . 64.239999999999995 110.48 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.504 ' HA ' HG22 ' A' ' 66' ' ' THR . 60.6 mt -71.52 113.68 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.512 0.672 . . . . 72.439999999999998 112.046 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -37.32 41.45 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.107 -0.951 . . . . 73.010000000000005 110.302 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.667 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 59.9 t30 -141.04 119.12 11.95 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.939 -0.573 . . . . 64.409999999999997 110.545 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 112.619 0.6 . . . . 64.129999999999995 112.619 -176.878 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.508 HG23 HG21 ' A' ' 73' ' ' VAL . 62.9 mt . . . . . 0 CA--C 1.545 0.759 0 CA-C-O 121.207 0.527 . . . . 74.519999999999996 111.852 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.428 ' O ' ' HB ' ' A' ' 73' ' ' VAL . 30.2 p -128.21 162.73 26.3 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.461 0.541 . . . . 74.340000000000003 112.461 -175.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -57.32 116.92 3.6 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.123 -0.489 . . . . 74.209999999999994 111.717 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.1 -11.36 60.38 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.211 -0.519 . . . . 63.32 113.217 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.02 131.06 40.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.817 0.341 . . . . 74.439999999999998 111.137 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -94.3 112.37 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 120.774 0.321 . . . . 61.329999999999998 111.348 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -103.04 148.52 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.119 0.485 . . . . 71.340000000000003 111.253 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 43.8 tt0 -92.52 123.99 36.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.386 -0.37 . . . . 53.549999999999997 110.885 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 40' ' ' ILE . 44.1 p -126.24 176.16 7.28 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.071 0.462 . . . . 61.200000000000003 111.879 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -65.09 -15.39 62.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.337 -0.392 . . . . 73.200000000000003 111.962 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -92.31 -32.35 15.04 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.221 0.534 . . . . 73.329999999999998 111.085 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.81 -150.05 21.88 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.905 -0.588 . . . . 62.409999999999997 112.26 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -80.53 130.49 35.17 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.444 -0.445 . . . . 63.310000000000002 111.193 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.4 t -126.41 128.66 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.417 -0.356 . . . . 74.230000000000004 111.457 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.477 ' HB2' HD13 ' A' ' 88' ' ' ILE . 42.0 ttm180 -91.29 117.44 29.65 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.251 -0.28 . . . . 44.420000000000002 110.91 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.508 HG21 HG23 ' A' ' 58' ' ' ILE . 45.9 t -66.3 133.83 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.73 0.3 . . . . 43.200000000000003 111.754 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -110.39 -73.2 0.69 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.707 0.289 . . . . 73.040000000000006 111.61 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 121.231 0.539 . . . . 64.329999999999998 111.81 -179.202 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.637 HG23 ' ND2' ' A' ' 26' ' ' ASN . 10.9 p . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 112.834 0.679 . . . . 73.230000000000004 112.834 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.0 mt -122.98 147.4 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.479 -0.782 . . . . 73.409999999999997 109.588 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -122.21 139.95 53.17 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.471 0.545 . . . . 72.329999999999998 112.471 -175.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.72 171.43 37.67 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 116.133 -0.485 . . . . 54.299999999999997 112.915 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.38 141.24 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 122.522 -0.399 . . . . 71.319999999999993 111.424 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.07 117.53 18.72 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.751 0.31 . . . . 60.310000000000002 111.311 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.477 HD13 ' HB2' ' A' ' 72' ' ' ARG . 18.0 pt -132.2 175.07 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.25 0.548 . . . . 73.129999999999995 111.314 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 . . . . . 0 N--CA 1.472 0.665 0 CA-C-N 116.051 -0.522 . . . . 65.549999999999997 111.418 -178.127 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 112.189 0.44 . . . . 75.420000000000002 112.189 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 24' ' ' ARG . 55.9 mtt180 -151.04 161.6 42.42 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.05 0.452 . . . . 72.209999999999994 111.918 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.5 tt -149.15 144.12 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 115.883 -0.599 . . . . 73.200000000000003 111.308 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -79.04 108.25 12.4 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.297 -0.41 . . . . 74.219999999999999 110.989 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 71' ' ' VAL . 28.5 t -94.63 120.44 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.312 -0.404 . . . . 72.230000000000004 111.865 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.02 118.17 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.935 0.398 . . . . 74.200000000000003 111.053 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 14.9 t0 -73.86 118.87 72.87 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.455 -0.339 . . . . 74.030000000000001 111.147 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 29' ' ' ASP . 12.9 Cg_exo -70.58 -28.13 21.68 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.885 2.39 . . . . 74.400000000000006 113.391 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.23 -44.06 11.73 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.41 0.522 . . . . 73.340000000000003 112.41 -173.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.7 p -104.73 -15.36 15.26 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.326 0.491 . . . . 71.530000000000001 112.326 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.04 28.15 69.03 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.144 -0.55 . . . . 63.25 114.021 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -100.38 145.69 27.88 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.152 0.476 . . . . 72.129999999999995 111.445 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -110.73 133.09 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 120.892 0.377 . . . . 72.519999999999996 111.352 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -147.24 139.69 24.71 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.47 -0.332 . . . . 73.299999999999997 111.074 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 61.3 mt -86.88 125.61 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.962 0.411 . . . . 74.219999999999999 111.11 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.468 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -122.51 154.38 37.93 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.381 0.512 . . . . 43.25 112.381 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -90.55 133.24 35.22 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.743 0.306 . . . . 42.039999999999999 110.502 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.474 ' HA ' HG22 ' A' ' 66' ' ' THR . 57.9 mt -83.1 114.71 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.838 0.352 . . . . 61.299999999999997 111.563 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -73.95 -46.68 42.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.392 -0.367 . . . . 74.299999999999997 111.208 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -140.18 139.59 35.72 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.563 -0.29 . . . . 62.509999999999998 110.815 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 t . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 112.585 0.587 . . . . 64.519999999999996 112.585 -175.798 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.762 HG21 HD13 ' A' ' 83' ' ' ILE . 59.5 mt . . . . . 0 CA--C 1.542 0.641 0 CA-C-O 121.367 0.603 . . . . 62.219999999999999 110.759 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -134.06 173.05 12.0 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.145 -0.479 . . . . 71.409999999999997 111.338 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -58.74 115.95 3.41 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.999 0.428 . . . . 62.310000000000002 111.277 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.22 -13.19 52.01 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.228 -0.511 . . . . 63.439999999999998 113.665 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.25 139.31 48.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 117.061 0.43 . . . . 73.439999999999998 111.683 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.9 t -110.78 119.5 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 116.359 -0.382 . . . . 72.329999999999998 111.703 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 70' ' ' ASN . 32.6 m -114.8 159.23 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.77 0.319 . . . . 72.310000000000002 111.85 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.22 126.8 43.85 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.814 0.34 . . . . 71.140000000000001 110.806 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 40' ' ' ILE . 34.7 p -125.59 178.81 5.45 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.504 -0.316 . . . . 42.5 111.067 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.468 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 16.9 p-10 -67.68 -16.1 63.98 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.725 0.298 . . . . 72.329999999999998 111.771 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.4 mt -95.73 -22.31 17.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.984 0.421 . . . . 61.340000000000003 111.193 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.27 -154.76 21.78 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 112.079 -0.408 . . . . 72.219999999999999 112.079 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 13.4 m120 -81.18 133.34 35.44 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 122.094 -0.65 . . . . 65.230000000000004 111.711 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 27' ' ' VAL . 23.8 t -121.63 119.5 59.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.922 -0.581 . . . . 61.25 110.594 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.539 ' HB2' HD13 ' A' ' 88' ' ' ILE . 33.4 ttt-85 -91.21 116.52 28.88 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.675 0.274 . . . . 74.329999999999998 110.375 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.428 HG21 HG23 ' A' ' 58' ' ' ILE . 45.7 t -61.02 118.27 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.049 0.452 . . . . 63.229999999999997 112.141 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.6 p -97.21 -47.1 5.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.205 -0.452 . . . . 71.239999999999995 111.427 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.471 0.593 0 CA-C-N 116.253 -0.43 . . . . 62.210000000000001 111.377 179.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 83' ' ' ILE . 11.5 p . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 120.897 0.38 . . . . 72.209999999999994 111.413 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.762 HD13 HG21 ' A' ' 58' ' ' ILE . 37.1 mt -106.51 129.15 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 122.52 0.328 . . . . 74.319999999999993 111.273 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -113.73 141.24 47.51 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.977 0.417 . . . . 72.340000000000003 111.465 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.55 173.69 34.32 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.36 -0.448 . . . . 73.310000000000002 113.049 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -105.05 150.76 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 113.082 0.771 . . . . 64.109999999999999 113.082 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 29' ' ' ASP . 66.4 tp -82.02 107.62 14.87 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.188 -0.914 . . . . 74.319999999999993 111.893 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 72' ' ' ARG . 10.2 pt -120.5 173.31 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.005 0.431 . . . . 73.030000000000001 110.492 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.457 ' HD2' ' O ' ' A' ' 88' ' ' ILE . 19.3 mmm180 . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 120.954 0.407 . . . . 73.109999999999999 110.855 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.649 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 77.8 p . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 120.85 0.357 . . . . 72.239999999999995 110.791 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -118.86 118.75 32.39 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.995 0.426 . . . . 75.5 111.749 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.8 tt -126.59 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.04 0.448 . . . . 74.299999999999997 112.065 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -70.21 103.82 2.46 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.309 -0.405 . . . . 63.299999999999997 110.831 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.04 115.58 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.125 0.488 . . . . 70.5 111.592 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.3 t -102.61 126.67 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.043 -0.526 . . . . 74.219999999999999 111.054 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.645 ' HB2' ' HG2' ' A' ' 34' ' ' LYS . 10.7 t0 -83.33 121.82 76.96 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 120.623 0.249 . . . . 72.340000000000003 110.443 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.476 ' HD3' HG12 ' A' ' 86' ' ' VAL . 59.7 Cg_endo -69.87 -32.08 18.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.756 2.304 . . . . 72.319999999999993 112.843 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -89.63 -43.46 10.73 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.688 0.625 . . . . 75.019999999999996 112.688 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.6 p -97.54 -31.83 12.12 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.396 0.517 . . . . 73.310000000000002 112.396 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.96 29.75 16.88 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.984 -0.626 . . . . 71.150000000000006 113.985 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.645 ' HG2' ' HB2' ' A' ' 29' ' ' ASP . 10.6 ptpp? -90.29 137.86 32.01 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.399 0.599 . . . . 64.120000000000005 111.074 177.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.8 t -115.17 102.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.019 0.438 . . . . 61.350000000000001 110.693 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -131.69 140.64 49.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.448 -0.342 . . . . 60.219999999999999 111.13 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.3 mt -86.5 121.04 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.858 0.361 . . . . 61.009999999999998 110.542 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.17 152.83 32.93 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.861 0.689 . . . . 62.439999999999998 112.861 -175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 23' ' ' THR . 1.9 mp0 -83.4 130.76 35.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.002 -0.544 . . . . 74.349999999999994 110.831 175.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.464 HG12 HG22 ' A' ' 66' ' ' THR . 60.6 mt -88.31 114.4 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.689 0.28 . . . . 64.420000000000002 111.443 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -83.41 -53.67 5.54 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.126 0.489 . . . . 71.319999999999993 111.831 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 84.7 m-20 -122.42 135.69 54.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.989 0.424 . . . . 73.319999999999993 111.82 -174.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 121.174 0.511 . . . . 71.150000000000006 111.148 176.879 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.8 mt . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 120.658 0.266 . . . . 73.299999999999997 111.064 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 54.4 p -134.63 160.38 38.27 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.296 0.238 . . . . 64.120000000000005 111.514 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 48.8 ttp180 -53.83 119.69 5.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.84 0.353 . . . . 65.310000000000002 111.316 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.91 -20.45 14.63 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.215 -0.448 . . . . 45.200000000000003 112.646 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.99 153.9 29.94 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.089 0.471 . . . . 64.129999999999995 112.23 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.8 t -105.99 114.19 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.097 -0.501 . . . . 71.510000000000005 111.636 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.434 ' HB ' HG23 ' A' ' 40' ' ' ILE . 30.6 m -103.33 118.79 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.374 0.607 . . . . 52.200000000000003 111.368 177.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 32.4 tt0 -77.72 108.63 11.07 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.995 0.426 . . . . 72.430000000000007 111.169 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.464 HG22 HG12 ' A' ' 40' ' ' ILE . 24.1 p -102.96 169.81 8.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.287 -0.415 . . . . 41.439999999999998 111.124 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.434 HD22 ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -59.01 -20.89 57.28 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.616 0.598 . . . . 64.329999999999998 112.616 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.7 mt -89.62 -25.3 21.36 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.965 0.412 . . . . 73.040000000000006 111.269 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 147.95 -176.61 26.7 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 116.103 -0.499 . . . . 73.299999999999997 112.738 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -72.74 119.46 17.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.22 0.533 . . . . 61.200000000000003 111.773 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.57 135.14 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.03 -0.532 . . . . 72.439999999999998 111.213 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.533 ' HB2' HD13 ' A' ' 88' ' ' ILE . 30.9 ttm180 -91.94 126.91 37.2 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.204 -0.31 . . . . 73.040000000000006 111.001 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 30.2 t -68.86 100.64 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.767 0.318 . . . . 70.219999999999999 110.255 174.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.8 p -102.18 -26.01 13.5 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 122.052 -0.405 . . . . 71.200000000000003 111.666 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.405 ' CB ' ' HB2' ' A' ' 84' ' ' ASN . 37.4 t . . . . . 0 C--N 1.327 -0.38 0 CA-C-O 120.898 0.38 . . . . 63.130000000000003 110.623 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 83' ' ' ILE . 7.2 p . . . . . 0 CA--C 1.547 0.829 0 CA-C-O 121.103 0.477 . . . . 74.540000000000006 111.897 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.435 ' N ' HG22 ' A' ' 82' ' ' VAL . 29.5 mt -116.62 136.37 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.421 -0.354 . . . . 74.519999999999996 110.721 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.405 ' HB2' ' CB ' ' A' ' 75' ' ' SER . 4.4 m-20 -115.9 141.82 47.59 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.079 0.466 . . . . 64.439999999999998 111.741 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.58 174.2 30.76 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 116.102 -0.499 . . . . 43.450000000000003 112.968 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.476 HG12 ' HD3' ' A' ' 30' ' ' PRO . 6.3 t -120.46 132.31 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 122.299 -0.53 . . . . 75.409999999999997 111.813 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.65 105.76 3.81 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.88 0.371 . . . . 73.319999999999993 111.033 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.533 HD13 ' HB2' ' A' ' 72' ' ' ARG . 11.5 pt -104.69 172.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.452 0.644 . . . . 71.209999999999994 112.194 -174.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.425 ' HD2' ' C ' ' A' ' 88' ' ' ILE . 7.8 mpt_? . . . . . 0 N--CA 1.473 0.721 0 CA-C-N 115.791 -0.641 . . . . 72.0 112.195 -175.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.7 p . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.009 0.433 . . . . 73.400000000000006 111.891 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 24' ' ' ARG . 49.1 mtm180 -143.9 163.46 33.35 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.374 -0.375 . . . . 65.099999999999994 111.019 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.482 ' HB ' HD11 ' A' ' 40' ' ' ILE . 14.0 tt -150.5 143.78 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.884 0.373 . . . . 63.340000000000003 111.767 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.448 ' HB2' HD22 ' A' ' 84' ' ' ASN . 3.8 m-20 -72.82 103.4 3.67 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.044 0.45 . . . . 64.430000000000007 110.262 173.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 55.2 t -91.25 113.79 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 63.520000000000003 111.904 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.9 t -95.62 113.02 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.021 -0.536 . . . . 74.310000000000002 110.774 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.79 118.72 74.08 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 61.109999999999999 111.56 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.61 -1.73 10.7 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.832 2.355 . . . . 73.430000000000007 113.705 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.87 -44.0 13.61 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.252 -0.28 . . . . 64.329999999999998 111.664 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.4 p -124.55 -11.41 7.32 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.803 0.668 . . . . 64.299999999999997 112.803 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.22 24.66 39.61 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 120.974 -0.631 . . . . 64.329999999999998 113.785 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -93.01 145.59 24.25 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.411 -0.464 . . . . 72.519999999999996 111.21 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.51 132.96 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.772 0.32 . . . . 73.409999999999997 111.196 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -147.83 143.03 27.18 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.6 0.238 . . . . 75.25 111.161 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.8 mt -86.22 111.41 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 122.25 -0.281 . . . . 64.319999999999993 111.12 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.485 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -110.54 155.2 22.63 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.118 0.414 . . . . 74.129999999999995 112.118 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -85.46 122.65 29.9 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.896 0.379 . . . . 62.140000000000001 111.495 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.563 ' HA ' HG22 ' A' ' 66' ' ' THR . 62.2 mt -73.04 116.59 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.423 -0.353 . . . . 61.210000000000001 110.726 176.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -81.04 -54.33 5.64 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.817 0.341 . . . . 75.530000000000001 111.367 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -145.41 152.8 40.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.872 0.368 . . . . 74.349999999999994 111.254 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.475 ' O ' HG22 ' A' ' 43' ' ' VAL . 13.8 p . . . . . 0 CA--C 1.549 0.917 0 CA-C-O 121.443 0.64 . . . . 74.129999999999995 111.712 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.559 HG21 HD13 ' A' ' 83' ' ' ILE . 46.4 mm . . . . . 0 CA--C 1.541 0.628 0 CA-C-O 120.714 0.292 . . . . 75.219999999999999 111.337 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -147.85 167.57 24.43 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.184 -0.322 . . . . 70.219999999999999 111.586 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -62.35 127.29 30.66 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.057 0.456 . . . . 65.239999999999995 111.675 -176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.55 -22.09 42.18 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.286 -0.483 . . . . 42.5 112.909 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.86 129.36 37.75 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.911 0.386 . . . . 54.32 111.3 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.03 115.27 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.307 -0.406 . . . . 65.439999999999998 111.396 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' A' ' 40' ' ' ILE . 35.2 m -103.59 129.02 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.232 0.539 . . . . 72.540000000000006 111.341 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -76.44 110.27 10.85 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.891 0.377 . . . . 42.340000000000003 110.767 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 40' ' ' ILE . 33.3 p -107.78 171.9 7.13 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.841 0.353 . . . . 73.219999999999999 111.267 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.485 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 10.1 p-10 -55.78 -33.9 64.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.439 -0.346 . . . . 73.420000000000002 111.545 176.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' A' ' 38' ' ' ALA . 74.9 mt -81.23 -29.82 34.36 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.744 0.276 . . . . 62.210000000000001 111.744 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.01 -166.96 29.42 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.528 -0.844 . . . . 52.530000000000001 113.921 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -71.17 101.69 2.34 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.841 0.353 . . . . 61.340000000000003 111.523 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.9 t -99.61 117.0 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.086 0.47 . . . . 61.140000000000001 111.342 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -87.16 117.76 26.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.839 0.352 . . . . 61.149999999999999 110.61 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.432 HG21 HG23 ' A' ' 58' ' ' ILE . 51.8 t -67.95 140.17 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 112.61 0.596 . . . . 51.219999999999999 112.61 -173.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.0 p -117.95 -43.47 2.76 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.404 0.52 . . . . 75.099999999999994 112.404 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 121.099 0.476 . . . . 61.420000000000002 112.139 -177.175 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.472 0.65 0 CA-C-O 121.078 0.466 . . . . 63.109999999999999 111.533 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.559 HD13 HG21 ' A' ' 58' ' ' ILE . 62.9 mt -121.69 145.43 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 120.988 0.423 . . . . 72.329999999999998 110.985 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.448 HD22 ' HB2' ' A' ' 26' ' ' ASN . 9.8 m120 -120.04 147.52 44.72 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.117 -0.364 . . . . 74.120000000000005 111.206 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.23 176.81 40.13 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.221 -0.514 . . . . 54.520000000000003 112.915 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.82 146.88 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.579 0.704 . . . . 63.240000000000002 112.899 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 63.8 tp -85.68 112.66 21.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.294 -0.866 . . . . 74.129999999999995 112.204 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.4 pt -134.43 -174.78 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.954 0.407 . . . . 53.219999999999999 111.182 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.82 0.343 . . . . 73.299999999999997 111.089 177.002 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 30.6 p . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.143 0.497 . . . . 75.329999999999998 111.947 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -144.63 155.59 43.69 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.208 -0.451 . . . . 62.409999999999997 111.101 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.446 ' HB ' HD11 ' A' ' 40' ' ' ILE . 13.1 tt -145.45 145.82 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.792 0.33 . . . . 52.32 111.537 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.524 HD22 ' N ' ' A' ' 26' ' ' ASN . 0.8 OUTLIER -80.3 103.78 10.41 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.425 0.631 . . . . 73.230000000000004 110.506 174.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' A' ' 87' ' ' LEU . 23.0 t -95.36 121.88 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.429 -0.805 . . . . 74.030000000000001 111.922 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.5 112.28 26.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.931 0.396 . . . . 64.409999999999997 110.571 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -74.26 118.24 68.16 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.477 -0.329 . . . . 61.310000000000002 111.142 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.93 -12.36 17.85 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.554 2.17 . . . . 71.150000000000006 113.116 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -81.67 -44.73 16.75 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.818 0.342 . . . . 63.340000000000003 111.907 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -107.18 -31.0 8.43 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.785 0.291 . . . . 61.509999999999998 111.785 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.8 16.96 34.36 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.333 -0.461 . . . . 71.510000000000005 113.733 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -87.21 150.67 23.76 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 117.234 0.517 . . . . 74.329999999999998 111.813 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.86 95.31 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.522 0.677 . . . . 63.109999999999999 110.49 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -93.02 170.03 9.97 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.504 -0.771 . . . . 75.239999999999995 110.868 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 mt -125.16 124.77 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 122.035 -0.416 . . . . 73.329999999999998 111.09 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.85 163.13 19.73 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.554 0.576 . . . . 75.340000000000003 112.554 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.82 123.39 36.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.01 -0.541 . . . . 71.530000000000001 110.648 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 23' ' ' THR . 57.7 mt -78.79 106.19 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 120.022 -0.671 . . . . 64.430000000000007 110.341 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -88.08 -37.05 16.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.789 -0.641 . . . . 74.450000000000003 112.573 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.557 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 46.2 m-80 -133.31 146.84 51.72 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.115 0.483 . . . . 72.209999999999994 111.322 173.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 112.44 0.533 . . . . 74.230000000000004 112.44 -176.443 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 120.823 0.344 . . . . 70.120000000000005 111.165 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -147.81 174.12 12.14 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.009 0.433 . . . . 72.310000000000002 111.827 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -71.89 118.72 15.09 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 111.381 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.93 30.68 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.42 -0.419 . . . . 54.520000000000003 112.914 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.08 142.34 31.35 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.968 0.413 . . . . 63.350000000000001 111.927 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.07 141.13 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.78 0.324 . . . . 64.519999999999996 111.155 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.62 173.34 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.971 0.415 . . . . 71.319999999999993 111.469 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 34.5 tt0 -112.52 133.26 54.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.41 -0.359 . . . . 72.420000000000002 110.791 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.421 HG22 ' HA ' ' A' ' 40' ' ' ILE . 41.6 p -135.68 178.67 6.86 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.328 0.585 . . . . 52.340000000000003 111.804 -176.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -69.89 -14.41 62.72 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.99 -0.55 . . . . 62.329999999999998 112.383 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.58 -17.23 18.77 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.809 0.338 . . . . 74.430000000000007 111.247 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.99 -149.29 20.17 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.41 -0.676 . . . . 72.140000000000001 111.41 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -94.16 148.53 22.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 117.646 0.723 . . . . 71.010000000000005 111.276 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.6 t -133.89 127.07 51.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.65 -0.25 . . . . 74.340000000000003 111.241 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 72' ' ' ARG . 15.5 ttm180 -96.28 115.95 28.24 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.557 0.217 . . . . 65.430000000000007 110.832 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.76 126.99 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.448 0.536 . . . . 74.109999999999999 112.448 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.5 p -100.96 -41.37 6.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.634 0.605 . . . . 74.019999999999996 112.634 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 121.018 0.437 . . . . 75.310000000000002 111.855 -177.792 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 120.849 0.357 . . . . 62.240000000000002 111.269 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.2 mt -102.83 144.99 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.734 0.302 . . . . 72.010000000000005 110.71 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -126.94 151.23 48.77 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.584 0.231 . . . . 70.129999999999995 111.421 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -167.44 175.88 42.38 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.277 -0.487 . . . . 74.219999999999999 113.239 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.1 t -106.3 142.11 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 117.078 0.439 . . . . 71.340000000000003 111.405 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.495 ' HB2' HG12 ' A' ' 27' ' ' VAL . 40.7 tp -76.36 114.35 14.95 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.157 0.503 . . . . 74.040000000000006 111.456 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' A' ' 72' ' ' ARG . 8.0 pt -133.51 179.22 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.189 0.518 . . . . 64.019999999999996 111.166 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 . . . . . 0 N--CA 1.473 0.696 0 O-C-N 122.207 -0.308 . . . . 62.43 111.239 -176.807 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.517 HG22 ' HB ' ' A' ' 40' ' ' ILE . 25.8 m . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 120.914 0.387 . . . . 63.5 111.729 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -129.11 165.83 20.49 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.521 -0.308 . . . . 71.230000000000004 111.485 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.541 ' HB ' HD11 ' A' ' 40' ' ' ILE . 15.5 tt -155.17 139.74 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.762 0.315 . . . . 74.140000000000001 111.419 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.459 ' OD1' HG12 ' A' ' 37' ' ' ILE . 90.3 m-20 -80.93 103.61 10.87 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.015 0.436 . . . . 70.219999999999999 110.841 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.447 HG22 HG21 ' A' ' 71' ' ' VAL . 60.3 t -85.35 121.44 37.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.98 -0.554 . . . . 73.5 112.013 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.01 111.37 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.113 -0.494 . . . . 65.329999999999998 110.788 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.425 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 11.2 t70 -77.77 115.8 53.08 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.413 -0.358 . . . . 63.119999999999997 110.283 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.28 -20.05 21.66 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.388 2.058 . . . . 73.109999999999999 113.791 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -86.01 -33.54 21.02 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.942 0.401 . . . . 65.019999999999996 111.885 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.5 p -116.4 -21.27 9.34 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.155 0.428 . . . . 62.109999999999999 112.155 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.34 25.72 50.21 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.391 0.516 . . . . 61.310000000000002 114.391 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 58.0 pttt -87.6 155.97 19.71 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.52 0.66 . . . . 75.549999999999997 111.705 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.1 t -118.7 111.5 34.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.138 -0.483 . . . . 64.510000000000005 109.909 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -133.38 136.6 45.4 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.132 0.419 . . . . 73.219999999999999 112.132 -173.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.459 HG12 ' OD1' ' A' ' 26' ' ' ASN . 61.5 mt -76.76 123.84 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.269 0.557 . . . . 50.240000000000002 112.105 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.526 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -117.81 170.32 8.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.032 -0.531 . . . . 70.140000000000001 111.606 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -104.69 127.27 52.4 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.418 -0.356 . . . . 73.450000000000003 110.466 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.541 HD11 ' HB ' ' A' ' 25' ' ' ILE . 53.8 mt -83.91 124.23 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.093 0.473 . . . . 64.349999999999994 111.617 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -81.11 -53.8 6.08 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.007 -0.542 . . . . 71.319999999999993 111.301 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -143.93 152.47 41.14 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.923 0.392 . . . . 71.400000000000006 111.553 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.516 HG13 HG12 ' A' ' 64' ' ' VAL . 48.6 t . . . . . 0 N--CA 1.468 0.464 0 N-CA-C 109.555 -0.535 . . . . 72.430000000000007 109.555 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.589 HG21 HD13 ' A' ' 83' ' ' ILE . 62.2 mt . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.075 0.464 . . . . 74.019999999999996 110.726 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.3 t -142.24 169.4 17.65 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.051 0.453 . . . . 73.120000000000005 111.574 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -61.51 126.15 26.34 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.288 -0.415 . . . . 74.420000000000002 111.753 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.06 -24.91 21.98 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.387 -0.435 . . . . 64.209999999999994 112.97 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.24 141.64 35.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.874 0.368 . . . . 51.210000000000001 111.694 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.3 m -100.57 133.11 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.296 0.57 . . . . 60.399999999999999 111.833 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.516 HG12 HG13 ' A' ' 43' ' ' VAL . 32.1 m -111.92 146.76 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.177 0.513 . . . . 74.109999999999999 111.685 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -89.84 112.65 24.05 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.254 -0.43 . . . . 74.230000000000004 110.259 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 p -115.01 174.84 5.77 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.962 0.411 . . . . 53.109999999999999 111.593 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.526 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 19.5 p-10 -62.9 -31.78 72.9 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.992 0.425 . . . . 72.140000000000001 111.444 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 38' ' ' ALA . 88.5 mt -82.6 -19.03 39.21 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.291 -0.413 . . . . 62.130000000000003 111.464 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.18 -150.32 19.6 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.828 -0.701 . . . . 74.430000000000007 113.853 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -83.44 119.26 24.44 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.563 -0.375 . . . . 73.450000000000003 111.207 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.447 HG21 HG22 ' A' ' 27' ' ' VAL . 47.6 t -123.69 122.93 66.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.608 0.242 . . . . 73.019999999999996 111.494 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -91.22 116.09 28.55 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.284 -0.26 . . . . 63.439999999999998 111.407 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.63 134.02 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 112.336 0.495 . . . . 74.109999999999999 112.336 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.3 p -118.65 -66.9 1.03 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.331 -0.395 . . . . 61.350000000000001 111.916 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 120.787 0.327 . . . . 54.140000000000001 111.737 179.813 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.421 HG11 HD21 ' A' ' 26' ' ' ASN . 12.7 p . . . . . 0 CA--C 1.543 0.69 0 CA-C-O 120.857 0.361 . . . . 60.5 110.956 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.589 HD13 HG21 ' A' ' 58' ' ' ILE . 60.2 mt -91.75 126.98 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.533 -0.303 . . . . 74.340000000000003 111.3 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -119.31 157.41 28.14 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.774 0.321 . . . . 73.409999999999997 111.337 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.33 177.94 39.12 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.107 -0.568 . . . . 30.0 113.407 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.5 t -111.08 138.98 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 122.454 -0.439 . . . . 71.340000000000003 111.627 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.8 tp -81.08 115.66 20.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.94 0.4 . . . . 52.420000000000002 111.362 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.6 pt -141.29 -166.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 120.94 0.4 . . . . 65.140000000000001 111.759 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 120.821 0.343 . . . . 73.239999999999995 111.295 178.663 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.551 HG22 ' HB ' ' A' ' 40' ' ' ILE . 18.9 m . . . . . 0 CA--C 1.538 0.481 0 CA-C-O 121.262 0.553 . . . . 45.409999999999997 112.373 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -148.14 162.9 38.5 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.713 -0.676 . . . . 70.140000000000001 110.487 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 tt -150.55 141.81 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 112.047 0.388 . . . . 64.310000000000002 112.047 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -80.45 103.24 10.18 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.102 0.477 . . . . 73.420000000000002 110.035 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.413 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 61.3 t -90.81 125.22 43.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.506 . . . . 70.230000000000004 111.847 -175.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.38 119.86 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.066 -0.515 . . . . 62.140000000000001 110.834 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -77.49 121.45 84.41 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 116.122 -0.49 . . . . 72.319999999999993 110.98 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.32 -17.56 8.94 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.579 2.186 . . . . 71.109999999999999 112.951 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -85.21 -43.68 13.58 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.911 0.386 . . . . 54.43 111.476 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.517 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 37.2 p -114.32 -10.83 12.64 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.154 0.798 . . . . 74.140000000000001 113.154 -176.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.84 22.87 78.78 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 120.86 -0.686 . . . . 54.399999999999999 114.202 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 21.2 pttp -102.82 142.6 33.67 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.27 0.535 . . . . 70.409999999999997 111.49 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.8 t -102.88 119.86 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.824 0.345 . . . . 74.209999999999994 111.081 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -132.38 146.09 51.71 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.983 0.42 . . . . 75.430000000000007 111.579 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 53.4 mt -82.71 125.78 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.844 0.354 . . . . 75.439999999999998 111.589 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.533 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -118.55 162.41 18.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.245 0.545 . . . . 65.200000000000003 112.195 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -102.86 114.36 28.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.966 -0.561 . . . . 64.239999999999995 110.511 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.551 ' HB ' HG22 ' A' ' 23' ' ' THR . 58.7 mt -76.1 113.38 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.738 0.304 . . . . 61.229999999999997 111.372 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -83.1 -53.87 5.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.037 0.446 . . . . 45.409999999999997 111.368 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -121.32 151.47 40.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.109 -0.496 . . . . 70.200000000000003 111.69 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.1 m . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 121.141 0.496 . . . . 74.040000000000006 112.05 -177.146 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.483 HG23 HG21 ' A' ' 73' ' ' VAL . 61.5 mt . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.143 0.497 . . . . 71.430000000000007 111.095 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.0 t -135.56 160.25 39.07 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.13 -0.486 . . . . 74.409999999999997 111.25 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -58.66 127.08 30.4 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.001 0.429 . . . . 74.140000000000001 111.876 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.37 -22.14 37.15 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.137 -0.483 . . . . 33.240000000000002 112.7 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.27 150.71 35.29 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.924 0.392 . . . . 74.099999999999994 111.529 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -107.19 116.26 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 120.945 0.402 . . . . 75.430000000000007 111.152 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 m -103.46 137.71 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 120.898 0.38 . . . . 70.409999999999997 110.65 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -90.82 110.68 21.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.264 0.554 . . . . 64.230000000000004 111.377 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.465 HG22 HG12 ' A' ' 40' ' ' ILE . 32.5 p -102.6 170.32 8.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.622 -0.717 . . . . 74.219999999999999 110.862 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -56.22 -33.56 65.48 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.986 0.422 . . . . 63.439999999999998 111.465 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.533 HD12 ' HB2' ' A' ' 38' ' ' ALA . 65.4 mt -79.91 -15.31 57.59 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.411 -0.359 . . . . 71.519999999999996 111.806 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.14 -161.08 23.83 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.321 -0.466 . . . . 74.450000000000003 113.235 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -70.0 134.35 48.21 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.563 -0.375 . . . . 64.349999999999994 111.235 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 96.0 t -130.64 125.7 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.778 0.323 . . . . 73.310000000000002 111.328 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.679 ' HB2' HD13 ' A' ' 88' ' ' ILE . 43.0 ttm180 -89.81 117.41 28.63 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.712 -0.222 . . . . 74.140000000000001 110.597 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.483 HG21 HG23 ' A' ' 58' ' ' ILE . 42.5 t -66.78 133.53 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.815 0.341 . . . . 63.43 111.767 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.4 p -109.9 -50.05 3.02 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.171 0.51 . . . . 72.409999999999997 111.908 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 121.078 0.466 . . . . 74.040000000000006 111.757 -178.352 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 112.407 0.521 . . . . 74.420000000000002 112.407 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.0 mt -122.38 140.07 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 122.879 0.472 . . . . 71.430000000000007 110.224 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -124.29 141.35 52.14 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.202 0.445 . . . . 72.439999999999998 112.202 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.1 176.36 37.68 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.113 -0.565 . . . . 41.240000000000002 113.377 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 18.0 t -118.63 135.81 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 122.64 -0.33 . . . . 73.430000000000007 111.57 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 38.7 tp -72.87 106.05 4.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.795 0.331 . . . . 74.310000000000002 111.077 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.679 HD13 ' HB2' ' A' ' 72' ' ' ARG . 30.5 pt -118.65 -175.92 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.169 0.509 . . . . 72.140000000000001 111.785 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.175 -0.466 . . . . 73.010000000000005 111.09 178.618 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.617 HG22 ' HB ' ' A' ' 40' ' ' ILE . 75.0 m . . . . . 0 N--CA 1.472 0.635 0 CA-C-O 120.817 0.341 . . . . 71.019999999999996 111.822 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.493 ' O ' HD12 ' A' ' 83' ' ' ILE . 59.1 mtt180 -142.58 168.94 18.54 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.734 0.302 . . . . 63.399999999999999 111.288 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.05 145.71 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.947 0.403 . . . . 64.299999999999997 111.758 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.489 HD22 ' N ' ' A' ' 26' ' ' ASN . 0.8 OUTLIER -79.35 104.28 9.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.077 0.465 . . . . 65.239999999999995 110.298 174.055 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.402 HG22 HG21 ' A' ' 71' ' ' VAL . 38.3 t -90.1 123.4 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.986 -0.552 . . . . 70.120000000000005 111.841 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.6 t -107.72 116.82 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.299 -0.409 . . . . 63.299999999999997 111.353 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.557 ' HB2' ' HG2' ' A' ' 34' ' ' LYS . 9.8 t70 -71.56 122.53 87.43 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 110.276 -0.268 . . . . 74.019999999999996 110.276 176.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.96 -30.86 32.03 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.075 1.85 . . . . 74.310000000000002 113.19 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -89.62 -43.87 10.46 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.814 0.672 . . . . 74.049999999999997 112.814 -175.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.0 p -96.61 -26.55 15.18 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.147 0.425 . . . . 61.240000000000002 112.147 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.71 22.0 58.83 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.915 -0.659 . . . . 64.239999999999995 113.901 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.557 ' HG2' ' HB2' ' A' ' 29' ' ' ASP . 10.7 ptpp? -78.06 135.3 37.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.359 0.579 . . . . 71.329999999999998 110.596 177.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -115.66 101.34 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.906 0.384 . . . . 72.040000000000006 110.943 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -125.15 144.41 50.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.902 0.382 . . . . 70.129999999999995 111.417 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.0 mt -84.92 111.34 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.897 0.379 . . . . 74.510000000000005 111.191 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.48 148.38 32.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.976 0.417 . . . . 65.409999999999997 112.015 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -80.27 130.97 35.57 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.336 -0.393 . . . . 63.539999999999999 110.668 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.617 ' HB ' HG22 ' A' ' 23' ' ' THR . 69.4 mt -80.99 113.65 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.049 0.452 . . . . 64.129999999999995 111.053 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.415 HH21 ' HB3' ' A' ' 67' ' ' ASN . 28.0 mmt180 -82.56 -48.66 10.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.201 0.524 . . . . 64.400000000000006 111.192 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -125.21 145.22 50.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.988 -0.551 . . . . 72.420000000000002 110.526 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.413 ' HA ' HG12 ' A' ' 64' ' ' VAL . 32.6 m . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 113.37 0.878 . . . . 73.239999999999995 113.37 -173.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.5 mm . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 120.61 0.243 . . . . 43.009999999999998 110.968 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.1 t -147.39 169.71 18.89 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.981 0.42 . . . . 73.530000000000001 111.896 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -63.16 125.05 22.79 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.131 -0.486 . . . . 75.030000000000001 111.132 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.55 -14.88 57.71 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.193 -0.527 . . . . 61.439999999999998 113.139 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.43 137.88 41.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.878 0.371 . . . . 35.039999999999999 111.569 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.97 112.11 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.909 0.385 . . . . 74.109999999999999 110.987 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.526 ' HB ' HG23 ' A' ' 40' ' ' ILE . 32.5 m -105.65 139.58 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.548 0.573 . . . . 74.120000000000005 112.548 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -82.54 116.43 21.96 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.511 -0.313 . . . . 75.510000000000005 110.674 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.597 HG22 ' HA ' ' A' ' 40' ' ' ILE . 32.1 p -121.16 179.42 4.4 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 120.905 0.383 . . . . 71.209999999999994 111.741 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.415 ' HB3' HH21 ' A' ' 41' ' ' ARG . 4.0 p-10 -65.58 -19.43 65.92 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.91 0.337 . . . . 71.030000000000001 111.91 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.6 mt -93.27 -23.69 18.42 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.946 0.403 . . . . 72.109999999999999 111.045 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.454 ' HA2' ' NH1' ' A' ' 89' ' ' ARG . . . 135.87 -162.03 24.91 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.134 -0.555 . . . . 65.140000000000001 113.381 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -71.29 117.39 12.76 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.805 0.336 . . . . 61.399999999999999 110.596 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 40.6 t -110.96 120.75 62.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.854 0.359 . . . . 63.219999999999999 111.118 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 72' ' ' ARG . 42.5 ttm180 -84.87 109.67 18.28 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.876 0.37 . . . . 74.409999999999997 110.421 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -65.2 120.15 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.456 0.539 . . . . 74.010000000000005 112.456 -173.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.3 p -89.86 -40.43 12.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.129 -0.487 . . . . 63.119999999999997 111.633 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.936 0.398 . . . . 64.030000000000001 111.659 -178.346 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 120.991 0.424 . . . . 54.149999999999999 111.856 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.493 HD12 ' O ' ' A' ' 24' ' ' ARG . 20.6 mt -92.75 135.1 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.3 -0.409 . . . . 74.219999999999999 110.739 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -128.36 145.15 51.16 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 122.212 -0.305 . . . . 72.530000000000001 111.514 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.55 172.46 39.48 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.022 -0.608 . . . . 53.439999999999998 113.515 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.6 t -109.15 147.41 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 122.545 -0.386 . . . . 73.140000000000001 111.754 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 tp -84.65 119.27 25.04 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.129 0.49 . . . . 73.409999999999997 112.089 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.495 ' O ' ' HD2' ' A' ' 89' ' ' ARG . 17.3 pt -144.64 -173.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 122.996 0.518 . . . . 73.409999999999997 110.595 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HD2' ' O ' ' A' ' 88' ' ' ILE . 18.2 mmm180 . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 120.789 0.328 . . . . 64.310000000000002 110.739 171.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 94.1 m . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 121.016 0.436 . . . . 73.340000000000003 111.68 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HG2' HG22 ' A' ' 37' ' ' ILE . 2.3 ttm105 -166.85 155.64 10.38 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.282 -0.417 . . . . 75.549999999999997 110.943 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.521 ' HB ' HD11 ' A' ' 40' ' ' ILE . 9.8 tt -133.71 142.85 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.101 0.408 . . . . 73.219999999999999 112.101 -175.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 26' ' ' ASN . 0.9 OUTLIER -76.61 103.61 6.68 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.076 0.465 . . . . 74.319999999999993 110.634 174.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.47 HG22 HG11 ' A' ' 71' ' ' VAL . 45.3 t -104.75 125.35 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.177 0.513 . . . . 71.549999999999997 111.576 -176.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.48 118.53 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.19 -0.459 . . . . 75.219999999999999 110.782 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -75.59 112.69 20.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.29 -0.414 . . . . 51.100000000000001 109.897 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.58 -14.6 15.9 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.359 2.039 . . . . 63.109999999999999 112.833 -177.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.97 -42.97 12.1 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.777 0.322 . . . . 74.439999999999998 111.26 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.411 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 25.9 p -107.19 -15.35 14.68 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.234 0.457 . . . . 73.319999999999993 112.234 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.54 18.38 73.62 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.361 -0.447 . . . . 71.140000000000001 114.099 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 21.7 pttm -92.36 159.56 15.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.494 0.647 . . . . 74.310000000000002 111.946 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.6 t -107.24 109.26 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.402 -0.363 . . . . 72.200000000000003 110.722 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -117.01 141.6 48.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.543 -0.298 . . . . 74.120000000000005 111.021 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.506 HG22 ' HG2' ' A' ' 24' ' ' ARG . 38.1 mt -100.04 105.94 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.921 0.391 . . . . 54.420000000000002 110.852 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.08 151.92 19.28 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.999 0.74 . . . . 62.229999999999997 112.999 -172.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.61 126.35 34.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.243 -0.435 . . . . 54.130000000000003 110.955 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.521 HD11 ' HB ' ' A' ' 25' ' ' ILE . 56.2 mt -83.44 113.35 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.199 0.444 . . . . 63.049999999999997 112.199 -176.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -82.84 -53.62 5.74 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.034 0.445 . . . . 72.239999999999995 110.583 176.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 40.4 t30 -118.99 147.57 43.93 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.107 -0.497 . . . . 61.100000000000001 110.686 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 113.024 0.75 . . . . 64.340000000000003 113.024 -172.915 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.5 mt . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.592 0.234 . . . . 73.420000000000002 110.522 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.0 p -118.26 159.68 22.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.245 0.545 . . . . 73.150000000000006 112.184 -174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.81 136.47 56.92 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.317 -0.401 . . . . 62.039999999999999 111.23 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 -14.51 45.67 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.071 -0.585 . . . . 60.109999999999999 113.183 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.47 147.95 33.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.026 0.441 . . . . 75.420000000000002 111.386 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.9 t -101.11 119.5 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.94 0.4 . . . . 61.32 111.319 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.96 156.63 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.108 0.48 . . . . 72.340000000000003 111.317 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.684 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 36.1 tt0 -97.88 105.92 18.14 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.863 0.363 . . . . 72.109999999999999 110.964 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.0 p -103.38 170.72 7.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.856 0.36 . . . . 72.420000000000002 111.576 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -57.52 -30.85 65.49 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.33 -0.395 . . . . 73.349999999999994 111.473 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.4 mt -77.91 -36.82 49.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.035 0.445 . . . . 73.329999999999998 111.014 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.99 -150.87 23.08 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.265 -0.493 . . . . 14.15 112.7 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -75.88 128.77 35.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.932 0.396 . . . . 61.130000000000003 111.314 -178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.47 HG11 HG22 ' A' ' 27' ' ' VAL . 90.1 t -129.01 126.93 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.535 -0.302 . . . . 74.109999999999999 111.297 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -95.98 120.6 36.55 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.626 0.251 . . . . 72.540000000000006 111.508 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.5 t -65.12 133.85 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 112.051 0.389 . . . . 62.049999999999997 112.051 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.4 p -96.9 -50.12 4.77 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.259 0.466 . . . . 71.310000000000002 112.259 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 112.096 0.406 . . . . 72.310000000000002 112.096 -179.122 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 121.298 0.57 . . . . 73.329999999999998 112.509 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.456 HD12 ' N ' ' A' ' 83' ' ' ILE . 3.9 mp -113.11 125.34 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.096 -0.502 . . . . 74.140000000000001 110.266 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -102.22 143.07 32.48 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.836 0.351 . . . . 74.25 111.825 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.86 173.96 36.62 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 121.282 -0.485 . . . . 63.119999999999997 113.446 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.8 139.09 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 117.001 0.4 . . . . 54.149999999999999 111.548 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HB2' HG12 ' A' ' 27' ' ' VAL . 50.6 tp -79.16 106.95 11.56 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.737 0.303 . . . . 75.329999999999998 111.4 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 pt -133.67 -171.24 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.252 0.548 . . . . 64.530000000000001 111.789 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 76.7 mmt-85 . . . . . 0 CA--C 1.536 0.432 0 CA-C-N 116.039 -0.528 . . . . 61.350000000000001 110.983 176.025 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.8 m . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.853 0.358 . . . . 62.340000000000003 111.463 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.42 151.14 48.1 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.85 0.357 . . . . 75.439999999999998 111.586 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.9 tt -146.26 139.08 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.028 0.442 . . . . 50.32 111.374 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.57 103.69 9.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.438 -0.346 . . . . 71.010000000000005 110.429 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.82 113.91 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.898 0.38 . . . . 72.420000000000002 111.549 -177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.7 t -95.16 118.09 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.396 -0.365 . . . . 74.400000000000006 110.688 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.23 128.93 81.65 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 120.536 0.208 . . . . 52.420000000000002 110.982 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.79 -22.79 11.51 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.426 2.084 . . . . 73.519999999999996 113.592 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -88.27 -35.32 17.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.969 0.414 . . . . 32.229999999999997 111.859 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.7 p -107.91 -31.72 7.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.373 -0.376 . . . . 65.239999999999995 111.803 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.91 10.19 65.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.208 -0.52 . . . . 61.340000000000003 113.603 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -79.63 138.12 37.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.192 0.496 . . . . 71.540000000000006 111.919 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.9 t -97.66 106.42 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 116.27 -0.423 . . . . 74.430000000000007 110.319 176.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -128.65 132.87 48.12 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.952 0.406 . . . . 62.439999999999998 111.583 -173.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 57.0 mt -81.06 140.43 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 112.427 0.528 . . . . 62.43 112.427 -175.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.47 167.14 22.91 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.239 -0.437 . . . . 43.539999999999999 111.124 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.485 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 3.3 mp0 -98.24 140.56 32.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.819 0.343 . . . . 73.099999999999994 111.081 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.16 115.1 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.969 0.414 . . . . 52.140000000000001 111.687 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.562 HH21 ' HB3' ' A' ' 67' ' ' ASN . 21.4 mmt180 -81.21 -53.83 6.03 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.222 0.534 . . . . 72.5 110.802 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 15.7 m120 -119.5 131.17 55.52 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 111.657 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.462 HG23 HG12 ' A' ' 58' ' ' ILE . 10.5 p . . . . . 0 CA--C 1.548 0.897 0 N-CA-C 113.046 0.758 . . . . 74.5 113.046 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.462 HG12 HG23 ' A' ' 43' ' ' VAL . 64.2 mt . . . . . 0 CA--C 1.542 0.644 0 CA-C-O 120.611 0.243 . . . . 72.129999999999995 111.132 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -147.53 166.31 27.7 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.833 0.349 . . . . 71.409999999999997 111.584 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.411 ' HD3' HH11 ' A' ' 60' ' ' ARG . 44.7 ttp180 -65.01 134.38 53.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.973 0.416 . . . . 72.329999999999998 111.37 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.87 -26.4 24.6 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.271 -0.422 . . . . 73.430000000000007 112.462 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.77 156.93 38.77 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.936 0.398 . . . . 75.409999999999997 111.804 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.1 114.1 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.907 0.385 . . . . 73.510000000000005 111.361 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.56 154.47 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.973 0.416 . . . . 74.430000000000007 112.012 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 34.0 tt0 -92.96 127.31 38.42 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.224 -0.298 . . . . 73.319999999999993 110.771 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.6 p -129.63 176.35 8.07 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.609 0.364 . . . . 74.400000000000006 110.717 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.562 ' HB3' HH21 ' A' ' 41' ' ' ARG . 3.8 p-10 -65.09 -27.47 68.78 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.782 0.325 . . . . 75.450000000000003 111.863 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.74 -22.75 37.12 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.081 0.467 . . . . 73.400000000000006 111.103 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.63 -152.16 21.52 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 116.241 -0.436 . . . . 44.140000000000001 112.504 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -85.91 131.21 34.34 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 122.241 -0.564 . . . . 63.219999999999999 110.994 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.27 122.34 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 111.851 0.315 . . . . 73.420000000000002 111.851 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HB2' HD13 ' A' ' 88' ' ' ILE . 40.7 ttm180 -86.36 112.16 21.18 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.655 0.264 . . . . 72.439999999999998 110.402 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -63.98 127.14 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.568 0.581 . . . . 61.520000000000003 112.568 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 73.8 p -103.04 -33.09 9.39 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.056 0.455 . . . . 65.519999999999996 111.656 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.662 ' HB3' ' H ' ' A' ' 84' ' ' ASN . 35.8 t . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 121.36 0.6 . . . . 63.439999999999998 111.831 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 83' ' ' ILE . 7.5 p . . . . . 0 CA--C 1.545 0.762 0 CA-C-O 120.971 0.415 . . . . 73.219999999999999 111.628 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.409 ' N ' HG22 ' A' ' 82' ' ' VAL . 57.7 mt -121.53 143.06 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 122.526 0.33 . . . . 75.209999999999994 110.835 178.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.662 ' H ' ' HB3' ' A' ' 75' ' ' SER . 2.4 m-20 -119.72 153.08 36.16 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.731 0.301 . . . . 71.439999999999998 111.257 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.9 177.83 37.98 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.453 -0.34 . . . . 44.009999999999998 112.887 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 t -116.39 138.86 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 117.218 0.509 . . . . 74.409999999999997 111.279 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.0 tp -78.93 106.54 11.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.036 0.446 . . . . 72.530000000000001 111.807 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.443 HD13 ' HB2' ' A' ' 72' ' ' ARG . 16.5 pt -121.5 179.91 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.188 0.518 . . . . 53.329999999999998 111.236 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.59 0 CA-C-N 116.368 -0.378 . . . . 73.239999999999995 110.983 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.56 HG22 ' HB ' ' A' ' 40' ' ' ILE . 51.6 m . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 120.893 0.377 . . . . 51.210000000000001 111.385 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -139.49 170.01 16.7 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.12 0.486 . . . . 60.340000000000003 111.881 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.451 ' HB ' HD11 ' A' ' 40' ' ' ILE . 13.2 tt -152.0 142.8 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.97 -0.559 . . . . 65.129999999999995 111.111 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -77.21 103.7 7.29 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.248 0.547 . . . . 73.129999999999995 110.573 174.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.481 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 39.3 t -86.24 136.68 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.718 . . . . 74.430000000000007 111.263 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 35' ' ' VAL . 47.2 t -110.85 104.83 17.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.66 0.267 . . . . 63.219999999999999 111.053 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.514 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 35.2 t70 -65.09 115.43 21.1 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.48 -0.327 . . . . 72.239999999999995 111.16 176.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.37 -11.71 22.77 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.34 2.027 . . . . 72.340000000000003 113.733 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -80.78 -43.19 20.52 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.1 0.476 . . . . 75.230000000000004 111.4 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.419 ' OG1' ' HE3' ' A' ' 34' ' ' LYS . 59.6 p -101.24 -29.49 12.06 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.132 -0.485 . . . . 71.310000000000002 111.67 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.79 63.13 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 116.248 -0.433 . . . . 44.130000000000003 112.739 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 17.6 ptpt -82.82 163.12 21.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.867 0.365 . . . . 71.209999999999994 111.322 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 28' ' ' VAL . 47.9 t -117.63 97.39 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.38 -0.373 . . . . 73.549999999999997 111.164 174.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' HG2' ' HB ' ' A' ' 27' ' ' VAL . 1.5 pm0 -93.79 170.86 9.25 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.051 0.453 . . . . 64.120000000000005 111.33 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.7 mt -111.78 134.51 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 121.849 -0.532 . . . . 62.450000000000003 111.098 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -130.99 153.56 49.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.96 0.41 . . . . 72.099999999999994 111.977 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -91.91 126.11 36.87 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.13 -0.486 . . . . 71.340000000000003 110.485 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.56 ' HB ' HG22 ' A' ' 23' ' ' THR . 61.2 mt -79.13 113.54 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.042 0.448 . . . . 75.129999999999995 111.458 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -83.05 -47.83 11.26 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.063 0.458 . . . . 74.25 111.383 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.532 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 51.7 m-80 -138.15 163.94 30.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.265 -0.425 . . . . 71.340000000000003 111.443 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.273 0.558 . . . . 74.030000000000001 111.312 179.776 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.8 mt . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 121.011 0.434 . . . . 74.409999999999997 111.281 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -147.83 -179.96 7.28 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.226 -0.443 . . . . 75.349999999999994 111.085 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -64.18 135.99 56.81 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.828 0.347 . . . . 74.209999999999994 111.807 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.06 -20.89 47.07 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.29 -0.481 . . . . 53.350000000000001 113.251 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.82 153.11 29.34 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.028 0.442 . . . . 72.439999999999998 111.676 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.7 t -110.91 119.3 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.354 -0.384 . . . . 75.400000000000006 110.793 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.47 ' HB ' HG23 ' A' ' 40' ' ' ILE . 27.6 m -103.39 131.49 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.42 0.628 . . . . 63.210000000000001 112.17 -177.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 9.7 tp10 -79.81 102.32 9.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.931 -0.577 . . . . 63.32 110.894 177.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.6 p -100.74 173.21 6.63 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.774 0.321 . . . . 64.310000000000002 111.045 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -61.12 -29.07 69.54 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.87 0.367 . . . . 63.420000000000002 111.655 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 38' ' ' ALA . 92.6 mt -80.78 -31.14 35.88 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.926 0.393 . . . . 70.319999999999993 111.088 176.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.18 -162.9 28.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.915 -0.66 . . . . 44.520000000000003 112.889 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -80.93 120.05 24.25 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.216 0.531 . . . . 74.310000000000002 111.713 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.476 HG21 HG22 ' A' ' 27' ' ' VAL . 47.6 t -113.56 120.52 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.208 -0.451 . . . . 70.540000000000006 111.509 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -86.7 116.19 24.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.851 0.358 . . . . 74.239999999999995 111.21 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.36 109.84 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.19 -0.459 . . . . 62.43 112.123 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.7 p -87.75 -59.29 2.28 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.254 0.549 . . . . 72.420000000000002 110.729 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.561 ' HB2' ' HB2' ' A' ' 84' ' ' ASN . 54.8 m . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.846 -0.616 . . . . 72.409999999999997 111.082 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 83' ' ' ILE . 12.7 p . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 120.906 0.384 . . . . 60.420000000000002 111.307 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.484 ' N ' HG22 ' A' ' 82' ' ' VAL . 40.1 mt -97.26 144.75 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.579 0.351 . . . . 63.109999999999999 110.438 175.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 75' ' ' SER . 16.2 m-80 -135.19 142.49 46.09 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 122.252 -0.28 . . . . 52.210000000000001 111.329 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.81 175.79 39.16 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.038 -0.601 . . . . 72.140000000000001 113.647 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.0 t -99.27 144.49 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.088 0.403 . . . . 65.310000000000002 112.088 -177.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.414 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 49.5 tp -79.59 106.63 11.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.824 0.345 . . . . 61.100000000000001 110.973 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.0 pt -126.88 -179.65 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.178 0.513 . . . . 65.219999999999999 111.153 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 120.911 0.386 . . . . 73.099999999999994 111.456 -179.886 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.557 HG22 ' HB ' ' A' ' 40' ' ' ILE . 27.1 m . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 110.213 -0.292 . . . . 71.310000000000002 110.213 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -133.83 165.39 25.09 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.23 0.456 . . . . 74.010000000000005 112.23 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.526 ' HB ' HD11 ' A' ' 40' ' ' ILE . 12.7 tt -151.46 131.29 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.127 -0.488 . . . . 71.109999999999999 111.782 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -72.81 103.82 3.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.072 0.463 . . . . 55.340000000000003 110.328 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.529 HG22 HG11 ' A' ' 71' ' ' VAL . 46.8 t -95.92 126.97 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.029 -0.532 . . . . 75.129999999999995 112.349 -174.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.01 114.17 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.224 -0.444 . . . . 73.0 110.82 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.429 ' HA ' ' HB3' ' A' ' 87' ' ' LEU . 11.3 t70 -76.84 126.12 86.16 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.558 -0.292 . . . . 62.240000000000002 111.624 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.99 -9.89 9.5 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.949 2.433 . . . . 75.400000000000006 113.226 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -75.03 -43.7 52.09 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.929 0.395 . . . . 75.209999999999994 111.685 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.9 p -123.28 -31.5 3.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.463 -0.335 . . . . 70.450000000000003 111.686 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.07 3.49 29.73 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.406 -0.426 . . . . 71.239999999999995 113.125 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -71.53 143.63 49.87 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.933 0.397 . . . . 61.32 112.002 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.4 t -114.91 129.28 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.897 0.38 . . . . 72.120000000000005 111.514 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -140.38 145.83 37.6 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.345 -0.389 . . . . 74.409999999999997 110.818 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.4 mt -87.94 101.82 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.263 0.554 . . . . 72.129999999999995 111.515 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.51 165.14 16.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.315 0.578 . . . . 72.040000000000006 112.273 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -103.69 123.79 47.66 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.842 -0.617 . . . . 72.040000000000006 110.651 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.557 ' HB ' HG22 ' A' ' 23' ' ' THR . 70.0 mt -84.09 115.94 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.609 0.596 . . . . 74.120000000000005 112.609 -174.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.456 HH11 ' HD2' ' A' ' 41' ' ' ARG . 56.2 mtt180 -83.64 -54.12 5.16 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.073 0.463 . . . . 53.310000000000002 111.49 172.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -130.78 167.86 18.18 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.284 0.476 . . . . 73.510000000000005 112.284 -173.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.67 HG12 HG12 ' A' ' 64' ' ' VAL . 17.1 m . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 121.534 0.683 . . . . 71.129999999999995 111.027 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.6 mt . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 120.721 0.296 . . . . 73.329999999999998 110.829 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -147.74 173.16 13.05 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.613 -0.267 . . . . 73.120000000000005 111.367 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -56.85 140.42 48.23 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.851 0.358 . . . . 72.200000000000003 111.697 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.5 -26.44 15.83 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.144 -0.551 . . . . 62.310000000000002 113.454 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.72 155.75 29.25 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.09 0.445 . . . . 75.319999999999993 111.281 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -113.36 127.85 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.626 0.727 . . . . 73.25 111.908 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.67 HG12 HG12 ' A' ' 43' ' ' VAL . 28.9 m -103.17 127.7 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 121.185 0.516 . . . . 73.439999999999998 111.077 177.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.02 110.86 12.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.218 -0.446 . . . . 74.319999999999993 110.362 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.9 p -115.61 176.04 5.26 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.364 0.602 . . . . 71.439999999999998 112.431 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.432 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 19.3 p-10 -59.25 -30.21 68.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.017 -0.538 . . . . 74.519999999999996 111.225 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.4 mt -81.28 -28.94 34.46 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.16 0.505 . . . . 63.229999999999997 110.728 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.419 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 131.08 -150.5 19.41 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.204 -0.453 . . . . 75.439999999999998 113.161 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.503 HD22 ' N ' ' A' ' 70' ' ' ASN . 1.0 OUTLIER -67.07 120.36 13.55 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.784 0.326 . . . . 64.439999999999998 111.777 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.529 HG11 HG22 ' A' ' 27' ' ' VAL . 57.4 t -125.71 121.87 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.618 0.246 . . . . 70.319999999999993 111.478 178.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.551 ' HB2' HD13 ' A' ' 88' ' ' ILE . 38.1 ttm180 -89.55 118.09 28.93 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.276 -0.265 . . . . 71.430000000000007 111.439 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.95 128.43 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.261 0.467 . . . . 51.310000000000002 112.261 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -109.86 -63.04 1.42 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.185 -0.462 . . . . 75.420000000000002 111.996 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 84' ' ' ASN . 43.5 t . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 120.649 0.261 . . . . 74.409999999999997 111.233 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 120.747 0.308 . . . . 74.310000000000002 111.277 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.3 mt -116.56 140.36 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 122.572 0.349 . . . . 72.230000000000004 110.361 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 13.4 m120 -127.57 146.73 50.43 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.155 -0.341 . . . . 75.25 111.461 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.99 179.83 38.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.898 -0.668 . . . . 73.329999999999998 113.598 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 t -113.2 139.71 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 116.831 0.315 . . . . 73.439999999999998 111.402 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 29' ' ' ASP . 62.5 tp -74.16 106.8 5.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.08 0.467 . . . . 35.520000000000003 110.923 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 72' ' ' ARG . 20.2 pt -124.48 -178.96 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.308 0.575 . . . . 42.149999999999999 111.182 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.419 ' NH1' ' HA3' ' A' ' 69' ' ' GLY . 40.5 mmt180 . . . . . 0 CA--C 1.538 0.511 0 CA-C-N 116.232 -0.44 . . . . 62.530000000000001 111.002 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.485 HG22 ' HB ' ' A' ' 40' ' ' ILE . 91.3 m . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 121.052 0.453 . . . . 72.129999999999995 110.857 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -145.15 163.16 35.2 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.31 -0.404 . . . . 71.420000000000002 111.27 -173.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 tt -147.9 135.9 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.111 0.481 . . . . 71.329999999999998 111.86 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -74.84 103.47 5.09 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.027 0.441 . . . . 75.219999999999999 110.356 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 48.8 t -93.87 145.81 7.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.954 -0.566 . . . . 53.100000000000001 111.528 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 35' ' ' VAL . 48.6 t -117.16 106.9 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.044 -0.526 . . . . 72.140000000000001 110.806 176.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.489 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 12.9 t70 -70.04 112.83 13.8 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.611 0.243 . . . . 75.209999999999994 110.659 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.82 -14.21 11.32 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.774 2.316 . . . . 75.540000000000006 113.286 -176.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -74.71 -37.37 62.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.311 0.577 . . . . 72.549999999999997 110.838 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.8 p -110.1 -32.36 7.03 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.878 -0.601 . . . . 72.310000000000002 111.475 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.81 45.05 4.34 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.299 -0.477 . . . . 74.340000000000003 112.514 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 19.7 ptpt -118.39 162.92 17.51 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.594 -0.356 . . . . 71.049999999999997 111.1 177.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 28' ' ' VAL . 58.1 t -120.51 113.85 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.932 0.396 . . . . 63.5 111.202 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -117.26 170.14 8.92 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.073 0.464 . . . . 53.399999999999999 111.731 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.2 mt -107.46 116.61 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.554 -0.294 . . . . 73.319999999999993 110.822 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.414 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -111.44 157.72 19.95 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.185 0.517 . . . . 63.119999999999997 112.208 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -97.34 124.14 41.38 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 54.530000000000001 110.719 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.485 ' HB ' HG22 ' A' ' 23' ' ' THR . 60.0 mt -75.34 114.07 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.057 0.455 . . . . 72.109999999999999 111.468 -178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -82.92 -44.09 15.75 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.246 -0.434 . . . . 74.329999999999998 111.183 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 44.0 m-80 -138.89 146.09 40.72 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.717 0.294 . . . . 74.430000000000007 111.351 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.473 0.718 0 CA-C-O 121.214 0.53 . . . . 75.430000000000007 111.702 179.6 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.502 ' CG2' HG21 ' A' ' 73' ' ' VAL . 60.8 mt . . . . . 0 CA--C 1.54 0.562 0 CA-C-O 120.911 0.386 . . . . 61.119999999999997 111.016 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -94.5 156.01 16.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.995 0.426 . . . . 71.340000000000003 111.74 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -64.33 116.33 5.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.815 0.341 . . . . 74.109999999999999 111.149 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.0 -16.04 23.13 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.406 -0.426 . . . . 55.420000000000002 112.68 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.82 150.87 48.06 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.046 0.451 . . . . 74.230000000000004 111.907 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.16 115.31 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.3 -0.409 . . . . 62.219999999999999 111.276 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.69 143.36 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.123 0.487 . . . . 74.329999999999998 111.908 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 8.0 tp10 -87.97 116.52 26.2 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.294 -0.412 . . . . 54.420000000000002 110.509 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.9 p -115.74 176.07 5.25 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.107 0.479 . . . . 74.519999999999996 111.81 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -65.67 -13.22 58.75 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.23 0.456 . . . . 63.219999999999999 112.23 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.414 HD12 ' HB2' ' A' ' 38' ' ' ALA . 85.8 mt -104.98 -18.18 14.26 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.2 0.524 . . . . 74.019999999999996 111.369 177.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.459 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 139.07 -161.18 25.94 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.282 -0.485 . . . . 73.409999999999997 112.977 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -77.08 137.61 39.04 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.405 -0.468 . . . . 63.049999999999997 110.949 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 58.5 t -130.58 127.98 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.372 -0.205 . . . . 72.019999999999996 111.549 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.463 ' HB2' HD13 ' A' ' 88' ' ' ILE . 59.2 ttm-85 -92.67 113.23 25.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.646 0.26 . . . . 71.549999999999997 110.742 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.502 HG21 ' CG2' ' A' ' 58' ' ' ILE . 48.5 t -61.37 120.14 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.497 0.554 . . . . 75.230000000000004 112.497 -176.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.3 p -96.58 -32.3 12.31 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.438 0.533 . . . . 65.310000000000002 112.438 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.891 0.376 . . . . 75.239999999999995 111.786 -176.874 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 83' ' ' ILE . 8.0 p . . . . . 0 CA--C 1.545 0.764 0 CA-C-O 120.961 0.41 . . . . 75.209999999999994 111.995 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.405 ' N ' HG22 ' A' ' 82' ' ' VAL . 31.9 mt -123.51 147.79 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.798 0.439 . . . . 64.420000000000002 110.874 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -121.23 148.93 43.61 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.3 -0.25 . . . . 64.120000000000005 111.03 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -168.54 167.15 40.11 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.861 -0.685 . . . . 53.310000000000002 114.078 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 24.2 t -101.85 140.34 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.68 0.392 . . . . 52.240000000000002 111.672 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.437 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 43.0 tp -78.58 106.88 10.85 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.284 0.564 . . . . 63.530000000000001 111.445 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 72' ' ' ARG . 16.5 pt -128.25 -177.5 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.063 0.459 . . . . 73.349999999999994 110.947 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.459 ' NH1' ' HA3' ' A' ' 69' ' ' GLY . 28.1 mmt180 . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 120.698 0.285 . . . . 73.310000000000002 110.856 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.591 HG22 ' HB ' ' A' ' 40' ' ' ILE . 38.4 m . . . . . 0 CA--C 1.536 0.436 0 CA-C-O 121.049 0.452 . . . . 55.219999999999999 110.725 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.1 mtm-85 -148.68 163.55 36.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.253 -0.43 . . . . 54.340000000000003 111.384 -175.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.6 tt -147.6 132.7 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.219 -0.446 . . . . 73.200000000000003 111.764 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.505 ' OD1' HG12 ' A' ' 37' ' ' ILE . 77.3 m-20 -65.99 103.23 0.91 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.111 0.481 . . . . 54.219999999999999 110.209 171.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.77 121.99 37.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.024 -0.535 . . . . 62.140000000000001 111.601 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.4 t -94.95 106.79 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.159 0.504 . . . . 75.409999999999997 110.669 176.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.76 113.56 24.05 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 115.843 -0.617 . . . . 61.030000000000001 110.794 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.23 -11.31 17.63 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.589 2.193 . . . . 75.319999999999993 113.431 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -88.05 -37.3 16.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.009 0.433 . . . . 73.219999999999999 111.879 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 30.5 p -115.17 -26.25 7.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.101 -0.499 . . . . 65.219999999999999 112.24 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.43 15.87 57.96 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.328 -0.463 . . . . 75.209999999999994 113.704 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.409 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 22.8 pttm -90.31 152.41 21.04 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.406 -0.467 . . . . 54.130000000000003 111.512 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.5 t -116.42 119.97 63.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.417 -0.356 . . . . 74.030000000000001 110.737 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -133.37 136.73 45.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.912 0.387 . . . . 71.129999999999995 111.614 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.505 HG12 ' OD1' ' A' ' 26' ' ' ASN . 41.8 mt -77.65 112.66 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.914 0.388 . . . . 53.350000000000001 111.258 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.467 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -112.23 145.8 39.28 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.474 -0.33 . . . . 71.010000000000005 111.393 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.78 133.83 36.33 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.667 0.27 . . . . 74.25 110.737 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.591 ' HB ' HG22 ' A' ' 23' ' ' THR . 68.2 mt -82.77 109.95 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.378 0.609 . . . . 73.120000000000005 110.313 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 mtp85 -85.7 -39.53 17.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.719 -0.673 . . . . 71.310000000000002 111.463 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 41.0 t30 -114.74 120.79 41.28 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.928 -0.578 . . . . 61.109999999999999 110.455 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.437 ' O ' HG22 ' A' ' 43' ' ' VAL . 7.8 p . . . . . 0 CA--C 1.547 0.853 0 N-CA-C 112.488 0.551 . . . . 61.539999999999999 112.488 -173.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.653 HG21 HD13 ' A' ' 83' ' ' ILE . 49.4 mt . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 120.752 0.31 . . . . 64.329999999999998 111.43 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.1 t -147.18 167.94 22.91 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.699 -0.228 . . . . 72.400000000000006 110.753 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 42.5 ttm180 -59.47 126.45 27.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.133 0.492 . . . . 72.530000000000001 111.536 -176.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.32 -24.06 31.31 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.139 -0.553 . . . . 60.109999999999999 112.724 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.8 139.8 38.32 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.493 -0.416 . . . . 55.340000000000003 111.186 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 m -106.31 119.11 55.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.435 0.636 . . . . 61.109999999999999 111.441 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.457 ' HB ' HG23 ' A' ' 40' ' ' ILE . 35.7 m -106.33 152.57 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.241 -0.436 . . . . 74.329999999999998 111.378 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 44.0 tt0 -95.01 120.0 34.49 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.124 0.488 . . . . 75.439999999999998 111.045 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 p -113.39 179.31 4.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.02 -0.536 . . . . 63.229999999999997 110.632 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.467 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 3.2 p-10 -65.87 -11.84 49.86 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.798 0.333 . . . . 73.409999999999997 111.481 174.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.438 ' O ' HD11 ' A' ' 87' ' ' LEU . 87.3 mt -102.7 2.36 35.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.817 0.342 . . . . 72.340000000000003 111.417 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.478 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 104.07 -162.98 15.16 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.477 -0.392 . . . . 74.200000000000003 112.961 -178.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -66.05 130.3 42.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.264 0.554 . . . . 63.329999999999998 112.098 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.8 t -126.99 127.28 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.022 -0.536 . . . . 64.329999999999998 110.374 177.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -88.4 117.31 27.24 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.294 -0.254 . . . . 75.439999999999998 110.807 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.49 HG21 HG23 ' A' ' 58' ' ' ILE . 46.1 t -66.42 127.84 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.931 0.396 . . . . 74.299999999999997 111.699 -177.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.6 p -112.42 -49.6 2.95 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.274 -0.421 . . . . 71.030000000000001 111.792 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.0 p . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.126 0.489 . . . . 71.329999999999998 111.685 -179.203 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 83' ' ' ILE . 9.0 p . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 121.127 0.489 . . . . 44.299999999999997 111.439 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 58' ' ' ILE . 29.3 mt -118.46 148.15 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.013 0.525 . . . . 70.340000000000003 109.812 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -121.82 140.85 51.85 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.779 -0.575 . . . . 62.32 111.532 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.19 176.17 38.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 121.081 -0.58 . . . . 73.219999999999999 113.518 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.53 145.28 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 117.069 0.434 . . . . 60.409999999999997 111.253 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.524 HD11 HH12 ' A' ' 89' ' ' ARG . 37.7 tp -81.3 111.87 18.08 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.998 0.428 . . . . 63.130000000000003 111.952 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.0 pt -128.37 -178.95 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.182 0.515 . . . . 75.530000000000001 111.499 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.524 HH12 HD11 ' A' ' 87' ' ' LEU . 26.0 mmt180 . . . . . 0 CA--C 1.542 0.645 0 O-C-N 122.157 -0.339 . . . . 64.040000000000006 111.675 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.3 m . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 120.802 0.334 . . . . 75.329999999999998 111.84 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -115.7 159.95 20.7 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.281 0.474 . . . . 72.430000000000007 112.281 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.438 ' HB ' HD11 ' A' ' 40' ' ' ILE . 12.5 tt -155.4 133.97 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.098 -0.501 . . . . 73.329999999999998 111.225 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -77.02 102.81 6.63 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.041 0.448 . . . . 70.129999999999995 110.196 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.2 t -94.08 119.14 41.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 70.310000000000002 111.686 -176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 35' ' ' VAL . 42.3 t -95.47 115.43 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.383 -0.372 . . . . 74.299999999999997 110.709 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.506 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 33.3 t70 -82.75 119.88 75.34 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-O 120.542 0.21 . . . . 62.520000000000003 110.696 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.61 -17.07 30.13 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.685 2.257 . . . . 62.549999999999997 113.411 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -82.13 -44.45 16.46 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 111.9 0.333 . . . . 60.450000000000003 111.9 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.4 p -100.06 -28.26 13.14 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.016 0.436 . . . . 73.329999999999998 111.714 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.75 22.49 49.77 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.268 -0.492 . . . . 62.219999999999999 112.979 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.506 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 63.6 pttt -87.34 145.89 26.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.922 0.361 . . . . 73.25 111.834 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 28' ' ' VAL . 48.8 t -105.32 94.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 109.746 -0.465 . . . . 74.430000000000007 109.746 170.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.02 124.38 52.06 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.282 -0.417 . . . . 62.210000000000001 111.384 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.0 mt -79.37 113.06 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.495 -0.32 . . . . 75.040000000000006 111.629 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -113.86 170.99 7.86 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.912 0.387 . . . . 71.310000000000002 111.916 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.85 137.16 37.83 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.496 -0.32 . . . . 71.540000000000006 111.001 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.438 HD11 ' HB ' ' A' ' 25' ' ' ILE . 63.5 mt -90.71 114.61 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.741 0.305 . . . . 74.230000000000004 111.424 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -83.51 -45.44 13.59 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.263 0.468 . . . . 63.329999999999998 112.263 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.567 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 41.7 m-80 -123.57 115.39 21.43 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.788 0.328 . . . . 52.200000000000003 111.76 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 58' ' ' ILE . 82.0 t . . . . . 0 N--CA 1.472 0.646 0 CA-C-O 121.176 0.512 . . . . 73.420000000000002 110.814 174.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.443 HG23 HG21 ' A' ' 73' ' ' VAL . 68.7 mt . . . . . 0 CA--C 1.54 0.578 0 CA-C-O 120.523 0.201 . . . . 72.030000000000001 110.81 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -147.8 172.2 14.49 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.262 0.467 . . . . 65.439999999999998 112.262 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -72.49 116.03 12.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.209 -0.45 . . . . 71.450000000000003 111.368 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 109.42 -7.65 32.34 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.258 -0.496 . . . . 34.009999999999998 112.88 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.18 139.46 30.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.763 0.316 . . . . 73.319999999999993 111.405 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.64 114.07 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.988 0.423 . . . . 64.430000000000007 111.307 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -102.56 154.42 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.987 0.423 . . . . 73.209999999999994 111.582 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 8.8 tp10 -95.6 120.71 36.33 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.874 0.369 . . . . 74.239999999999995 111.386 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.9 p -122.82 172.89 8.12 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.841 0.353 . . . . 74.120000000000005 111.421 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.411 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 32.2 p30 -57.59 -33.22 67.96 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.885 0.374 . . . . 75.129999999999995 111.627 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.9 mt -75.63 -33.15 60.46 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.9 0.381 . . . . 70.129999999999995 111.02 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 140.7 -156.49 25.37 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.137 -0.483 . . . . 75.319999999999993 112.983 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -68.63 125.76 27.55 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.746 0.308 . . . . 61.140000000000001 111.214 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.7 t -125.98 119.28 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.046 0.388 . . . . 74.310000000000002 112.046 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.455 ' HB2' HD13 ' A' ' 88' ' ' ILE . 59.0 ttp180 -84.19 111.31 19.24 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.66 0.267 . . . . 73.430000000000007 110.925 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.443 HG21 HG23 ' A' ' 58' ' ' ILE . 58.5 t -71.55 131.16 34.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.559 0.578 . . . . 55.130000000000003 112.559 -174.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.0 p -106.04 -33.09 8.0 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.965 -0.561 . . . . 63.549999999999997 111.826 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 120.654 0.264 . . . . 74.349999999999994 111.478 -178.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 83' ' ' ILE . 14.5 p . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.14 0.495 . . . . 73.540000000000006 111.631 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.41 ' N ' HG22 ' A' ' 82' ' ' VAL . 46.4 mt -105.86 143.57 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.437 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -126.28 146.3 50.07 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.297 -0.252 . . . . 70.219999999999999 111.287 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.22 -179.02 30.05 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.201 -0.523 . . . . 53.32 113.039 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 t -124.35 129.88 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.838 0.319 . . . . 64.109999999999999 110.935 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.9 tp -74.45 106.34 6.01 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.101 0.477 . . . . 70.019999999999996 111.488 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 72' ' ' ARG . 7.9 pt -120.05 176.53 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.313 0.578 . . . . 73.329999999999998 111.408 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' A' ' 88' ' ' ILE . 15.6 mmm180 . . . . . 0 N--CA 1.469 0.508 0 CA-C-N 116.313 -0.403 . . . . 74.150000000000006 110.667 -178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.576 HG22 ' HB ' ' A' ' 40' ' ' ILE . 86.6 m . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.007 0.432 . . . . 72.140000000000001 110.8 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -138.58 154.89 48.73 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.016 0.436 . . . . 73.120000000000005 111.738 -173.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.436 ' HB ' HD11 ' A' ' 40' ' ' ILE . 15.3 tt -143.77 138.4 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.089 0.471 . . . . 73.140000000000001 111.618 -177.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -90.46 112.76 24.52 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.274 0.559 . . . . 71.439999999999998 110.102 175.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.0 t -106.28 144.12 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.649 0.611 . . . . 75.400000000000006 112.649 -169.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 t -104.87 129.91 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.234 -0.439 . . . . 60.310000000000002 111.058 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -84.63 122.8 74.89 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 116.428 -0.351 . . . . 71.340000000000003 110.945 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.58 -17.12 11.43 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.784 2.322 . . . . 72.219999999999999 114.283 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.23 -43.81 11.32 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.281 0.563 . . . . 63.409999999999997 111.558 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 p -105.64 -31.26 9.0 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.885 -0.598 . . . . 64.209999999999994 112.084 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.26 12.97 56.81 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.022 -0.608 . . . . 60.409999999999997 113.617 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -86.56 143.14 27.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.007 0.404 . . . . 72.510000000000005 111.34 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.78 103.53 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.074 0.464 . . . . 65.409999999999997 110.656 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -108.43 135.81 49.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.952 0.406 . . . . 73.409999999999997 111.363 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.6 mt -90.6 129.04 42.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.86 0.362 . . . . 73.340000000000003 111.229 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -126.99 159.14 35.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.893 0.378 . . . . 45.149999999999999 111.713 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -107.5 139.97 41.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.853 0.359 . . . . 73.430000000000007 110.759 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.576 ' HB ' HG22 ' A' ' 23' ' ' THR . 58.0 mt -93.04 116.41 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.286 0.565 . . . . 73.530000000000001 112.485 -172.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 41' ' ' ARG . 8.0 mtp180 -82.48 -53.35 6.05 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.668 -0.696 . . . . 71.25 111.639 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 92.1 m-20 -116.56 122.86 45.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.431 -0.35 . . . . 74.120000000000005 111.144 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.543 0.69 0 N-CA-C 112.095 0.406 . . . . 71.109999999999999 112.095 -179.013 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.4 HD13 HG11 ' A' ' 64' ' ' VAL . 68.5 mt . . . . . 0 CA--C 1.539 0.533 0 CA-C-O 120.804 0.335 . . . . 74.409999999999997 111.288 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -132.36 166.76 21.23 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.959 0.409 . . . . 72.450000000000003 111.934 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -64.19 126.88 29.16 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.241 -0.436 . . . . 71.310000000000002 111.386 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.19 5.25 65.87 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.217 -0.516 . . . . 72.519999999999996 113.44 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.28 153.15 19.42 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.013 0.435 . . . . 71.430000000000007 111.367 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.8 t -112.69 128.83 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.419 -0.355 . . . . 75.329999999999998 110.906 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.4 HG11 HD13 ' A' ' 58' ' ' ILE . 35.9 m -115.28 154.26 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.764 0.653 . . . . 73.430000000000007 112.764 -176.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 29.9 tt0 -89.32 109.29 20.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.892 -0.594 . . . . 74.549999999999997 110.789 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.465 HG22 HG12 ' A' ' 40' ' ' ILE . 45.5 p -110.96 168.43 9.49 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.954 0.407 . . . . 75.040000000000006 111.336 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -60.26 -19.32 54.28 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.128 0.418 . . . . 74.25 112.128 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' A' ' 38' ' ' ALA . 83.9 mt -93.44 -30.63 14.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.85 0.315 . . . . 73.319999999999993 111.85 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.72 -149.59 21.23 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.013 -0.613 . . . . 70.310000000000002 113.105 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -91.27 119.47 31.36 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.354 -0.497 . . . . 64.319999999999993 110.83 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.08 124.78 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.982 0.42 . . . . 64.140000000000001 111.608 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.42 ' HB2' HD11 ' A' ' 88' ' ' ILE . 21.5 ttm180 -91.76 115.05 27.73 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.241 -0.436 . . . . 65.510000000000005 110.617 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.16 121.91 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.064 0.459 . . . . 74.230000000000004 112.143 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.1 p -103.45 -43.56 5.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.16 -0.473 . . . . 61.420000000000002 111.902 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 t . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 121.101 0.477 . . . . 63.009999999999998 111.972 -176.862 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.434 HG22 ' N ' ' A' ' 83' ' ' ILE . 8.2 p . . . . . 0 CA--C 1.545 0.753 0 CA-C-O 120.795 0.331 . . . . 73.450000000000003 111.172 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.434 ' N ' HG22 ' A' ' 82' ' ' VAL . 34.4 mt -101.85 148.19 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.844 0.354 . . . . 61.329999999999998 111.225 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -119.3 134.75 55.05 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.668 0.271 . . . . 73.140000000000001 111.485 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.24 178.31 31.96 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.001 -0.618 . . . . 54.149999999999999 113.4 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 t -110.44 141.48 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 111.964 0.357 . . . . 71.109999999999999 111.964 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.0 tp -82.78 111.33 18.6 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.032 0.382 . . . . 63.329999999999998 112.032 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 72' ' ' ARG . 13.8 pt -143.57 -169.62 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.22 0.533 . . . . 61.409999999999997 111.593 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 . . . . . 0 N--CA 1.473 0.678 0 CA-C-N 116.264 -0.425 . . . . 73.450000000000003 111.0 176.19 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.411 ' CG2' ' HB ' ' A' ' 40' ' ' ILE . 90.4 m . . . . . 0 N--CA 1.469 0.485 0 CA-C-O 120.929 0.395 . . . . 75.129999999999995 111.878 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -149.81 148.18 28.87 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.287 -0.415 . . . . 72.420000000000002 110.771 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.6 tt -143.08 139.48 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 121.192 0.52 . . . . 54.340000000000003 112.018 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -83.92 105.32 14.71 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.187 0.517 . . . . 72.409999999999997 110.781 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.503 HG22 HG11 ' A' ' 71' ' ' VAL . 48.7 t -105.61 120.53 56.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 112.49 0.552 . . . . 75.310000000000002 112.49 -172.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -95.59 122.46 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 116.587 -0.279 . . . . 74.340000000000003 110.876 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 31.6 t70 -82.53 116.47 63.98 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 120.547 0.213 . . . . 61.219999999999999 110.733 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.03 -15.07 29.27 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.606 2.204 . . . . 71.099999999999994 113.249 -177.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -78.71 -45.44 21.25 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.786 0.327 . . . . 54.020000000000003 111.742 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.3 p -104.12 -20.69 13.74 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.017 0.377 . . . . 74.0 112.017 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.28 20.8 66.22 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.199 -0.524 . . . . 71.319999999999993 112.973 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 65.5 pttt -88.07 139.39 30.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.044 0.45 . . . . 65.140000000000001 111.628 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.8 t -86.72 95.58 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.076 0.465 . . . . 54.43 110.21 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -99.87 165.97 11.3 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.085 0.469 . . . . 73.230000000000004 111.179 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.09 129.87 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.164 -0.335 . . . . 65.230000000000004 110.621 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.38 170.2 15.43 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.485 0.66 . . . . 43.520000000000003 112.38 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.73 131.86 56.84 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.665 -0.698 . . . . 72.530000000000001 110.431 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.411 ' HB ' ' CG2' ' A' ' 23' ' ' THR . 59.9 mt -77.32 114.52 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.142 0.496 . . . . 75.25 112.275 -175.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HA ' ' HE ' ' A' ' 41' ' ' ARG . 2.5 mmp_? -71.26 -50.05 36.81 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.915 -0.584 . . . . 71.430000000000007 110.695 173.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -133.11 130.94 39.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.952 -0.567 . . . . 73.420000000000002 110.754 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 112.598 0.592 . . . . 73.519999999999996 112.598 -177.808 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.6 mt . . . . . 0 CA--C 1.538 0.511 0 CA-C-O 121.024 0.44 . . . . 74.439999999999998 110.809 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -87.57 165.76 15.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.062 0.458 . . . . 73.340000000000003 112.033 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 74' ' ' THR . 63.0 ttt180 -67.79 116.71 8.77 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.424 -0.353 . . . . 61.210000000000001 110.694 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.39 -6.72 46.1 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.281 -0.485 . . . . 72.319999999999993 112.927 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.49 138.79 49.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.83 0.348 . . . . 70.439999999999998 111.168 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.1 t -96.3 116.26 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.999 0.428 . . . . 60.340000000000003 111.606 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.9 m -103.52 148.11 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.125 0.488 . . . . 50.32 111.678 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' ARG . 9.6 tp10 -84.91 127.99 34.42 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.086 -0.506 . . . . 73.230000000000004 110.179 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.0 p -129.73 174.78 9.38 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.933 0.397 . . . . 72.430000000000007 111.794 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.33 -18.48 64.67 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.649 0.261 . . . . 72.010000000000005 111.687 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.41 -27.77 18.1 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.991 0.424 . . . . 73.030000000000001 111.155 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.55 -150.09 21.15 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.982 -0.554 . . . . 33.439999999999998 112.242 -175.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -77.91 128.85 34.58 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.98 0.419 . . . . 74.120000000000005 111.239 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.503 HG11 HG22 ' A' ' 27' ' ' VAL . 91.7 t -126.45 119.42 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 122.113 -0.367 . . . . 73.230000000000004 111.654 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -85.16 113.0 21.21 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.713 0.292 . . . . 61.5 110.902 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.12 127.83 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 112.386 0.513 . . . . 73.120000000000005 112.386 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.46 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 77.8 p -98.79 -62.61 1.21 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 111.0 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.523 ' HB2' ' H ' ' A' ' 84' ' ' ASN . 55.3 m . . . . . 0 N--CA 1.472 0.664 0 CA-C-N 116.432 -0.349 . . . . 44.329999999999998 111.396 178.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 CA--C 1.542 0.639 0 CA-C-O 121.195 0.521 . . . . 73.329999999999998 111.668 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.28 116.6 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.099 -0.5 . . . . 64.140000000000001 110.361 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.523 ' H ' ' HB2' ' A' ' 75' ' ' SER . 13.7 m120 -103.51 154.27 19.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.808 0.337 . . . . 74.239999999999995 111.531 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.93 178.75 35.88 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.177 -0.535 . . . . 63.039999999999999 113.135 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.19 133.11 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 122.719 -0.283 . . . . 65.420000000000002 111.204 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.9 tp -76.42 106.22 7.93 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.036 0.446 . . . . 70.129999999999995 111.472 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.8 pt -122.81 179.7 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.133 0.492 . . . . 75.209999999999994 111.405 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 . . . . . 0 N--CA 1.468 0.463 0 CA-C-N 116.525 -0.307 . . . . 75.430000000000007 110.617 -178.874 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.491 ' O ' ' N ' ' A' ' 3' ' ' ARG . . . . . . . . 0 N--CA 1.491 2.308 0 CA-C-O 119.802 -0.443 . . . . 72.140000000000001 112.756 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 43.57 -67.99 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 114.891 1.441 . . . . 73.209999999999994 114.891 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 1' ' ' GLY . 7.8 mmt180 -57.0 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.475 0.546 . . . . 71.239999999999995 112.475 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 50.1 mtm105 -102.52 123.35 46.1 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.773 0.32 . . . . 71.349999999999994 111.039 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -99.5 -176.95 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 121.018 0.437 . . . . 75.099999999999994 112.128 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.418 ' HB3' HG22 ' A' ' 8' ' ' ILE . 45.8 mtm180 -74.0 -41.52 61.77 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.037 0.754 . . . . 75.510000000000005 113.037 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.9 mt 72.28 -27.3 0.18 Allowed 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 113.778 1.029 . . . . 74.409999999999997 113.778 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.418 HG22 ' HB3' ' A' ' 6' ' ' ARG . 5.4 tp -51.81 122.43 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 N-CA-C 112.927 0.714 . . . . 63.0 112.927 -178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.2 mtt85 -100.42 -72.22 0.68 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.015 -0.539 . . . . 74.239999999999995 111.685 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.5 p -106.75 150.38 26.36 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.617 0.599 . . . . 43.299999999999997 112.617 -172.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.413 ' HE ' ' HB3' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -169.24 122.8 0.79 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.687 -0.688 . . . . 60.340000000000003 110.35 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.69 156.46 8.2 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.603 -0.332 . . . . 71.510000000000005 112.524 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.96 -153.0 15.45 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.232 -0.508 . . . . 64.239999999999995 114.082 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -158.43 -169.89 2.91 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 110.092 -0.336 . . . . 73.310000000000002 110.092 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.6 m -65.03 114.58 4.68 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.946 -0.471 . . . . 71.099999999999994 111.137 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.94 158.19 29.45 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.166 0.508 . . . . 75.329999999999998 111.775 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.423 HG22 ' N ' ' A' ' 18' ' ' ARG . 14.9 p -85.48 161.95 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.026 -0.534 . . . . 44.119999999999997 110.35 174.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.423 ' N ' HG22 ' A' ' 17' ' ' VAL . 45.0 ptt85 -66.33 168.82 8.18 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.169 0.509 . . . . 65.239999999999995 111.897 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.1 tt -58.57 101.61 0.09 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.239 0.542 . . . . 70.420000000000002 110.285 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -159.9 -53.85 0.06 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.532 -0.758 . . . . 53.530000000000001 110.201 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.9 m -91.75 14.46 15.27 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.883 -0.598 . . . . 73.209999999999994 111.033 174.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -163.08 158.64 22.24 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.274 -0.421 . . . . 74.129999999999995 110.781 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.474 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 42.3 m -131.96 113.55 13.56 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.549 0.214 . . . . 55.310000000000002 111.505 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 23' ' ' THR . 50.4 mtm180 -162.83 169.96 19.01 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.249 0.62 . . . . 63.229999999999997 111.19 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.0 tt -147.03 139.26 19.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.386 -0.37 . . . . 71.319999999999993 111.51 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.426 ' OD1' HG12 ' A' ' 37' ' ' ILE . 75.5 m-20 -74.03 106.84 5.89 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.788 0.328 . . . . 72.140000000000001 110.659 176.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -97.56 123.62 50.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.109 0.481 . . . . 75.340000000000003 112.07 -176.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.6 t -95.23 112.83 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 120.995 0.426 . . . . 60.43 110.594 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.53 114.99 50.09 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.01 -0.541 . . . . 75.140000000000001 111.077 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -82.58 -11.78 10.34 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.706 2.271 . . . . 75.310000000000002 113.007 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.461 ' CD ' HH12 ' A' ' 89' ' ' ARG . 10.9 mm-40 -77.57 -39.63 45.06 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.161 0.505 . . . . 75.310000000000002 110.863 -178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.1 p -121.27 -27.08 4.93 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.712 -0.677 . . . . 75.040000000000006 112.258 -178.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.96 29.21 11.95 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.38 -0.438 . . . . 40.340000000000003 113.302 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -99.44 142.02 31.47 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 122.478 -0.425 . . . . 74.109999999999999 111.182 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.1 t -107.46 112.05 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.841 0.353 . . . . 63.049999999999997 110.774 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -133.52 141.64 47.84 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.915 0.388 . . . . 71.329999999999998 111.496 -177.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.426 HG12 ' OD1' ' A' ' 26' ' ' ASN . 45.9 mt -83.06 111.34 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 120.85 0.357 . . . . 71.329999999999998 111.331 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -103.38 157.17 17.21 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.027 0.441 . . . . 62.119999999999997 112.046 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -83.25 135.31 34.81 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.185 -0.461 . . . . 72.450000000000003 110.986 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.2 mt -83.73 112.06 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 121.267 0.556 . . . . 60.140000000000001 111.016 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.451 ' HD2' HH11 ' A' ' 41' ' ' ARG . 44.4 mtp85 -82.83 -53.41 5.89 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.027 -0.533 . . . . 72.439999999999998 111.018 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -124.8 132.31 53.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.261 -0.427 . . . . 74.019999999999996 110.842 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.5 m -88.08 11.95 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.929 0.395 . . . . 65.109999999999999 111.928 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.73 136.45 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.291 0.567 . . . . 64.420000000000002 111.745 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 63' ' ' VAL . 9.6 pt-20 -79.81 34.55 0.28 Allowed 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.846 0.684 . . . . 75.129999999999995 112.846 -177.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.5 t30 57.42 26.14 12.2 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.132 0.491 . . . . 70.400000000000006 112.217 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.4 t -82.09 167.98 18.23 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.885 -0.51 . . . . 74.540000000000006 111.564 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.2 109.63 21.49 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.745 0.276 . . . . 74.230000000000004 111.745 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 55.39 88.17 0.13 Allowed Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 122.815 0.446 . . . . 62.439999999999998 111.679 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.38 110.3 1.03 Allowed 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.59 2.193 . . . . 73.510000000000005 112.837 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -76.52 -1.14 25.85 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.244 0.461 . . . . 74.0 112.244 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -96.02 16.77 17.0 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.134 0.492 . . . . 72.209999999999994 111.019 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.465 ' O ' HG12 ' A' ' 53' ' ' VAL . 11.5 t 62.4 26.94 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.723 0.773 . . . . 52.549999999999997 111.366 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -77.97 72.62 4.51 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.755 -0.591 . . . . 75.040000000000006 111.727 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -73.2 75.06 1.29 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.192 0.52 . . . . 72.200000000000003 110.496 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 54.39 17.41 1.56 Allowed 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.748 -0.66 . . . . 44.439999999999998 112.44 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.4 tt -92.49 125.5 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 121.446 0.641 . . . . 62.200000000000003 111.649 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.612 HG21 HD13 ' A' ' 83' ' ' ILE . 69.9 mt -68.05 113.59 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.75 -0.659 . . . . 74.030000000000001 111.226 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.6 p -135.26 159.6 41.04 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.208 -0.451 . . . . 53.240000000000002 112.078 -174.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -54.51 129.06 34.71 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.122 -0.49 . . . . 65.019999999999996 111.725 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.11 -11.41 72.18 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.137 -0.554 . . . . 23.120000000000001 113.465 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.7 145.38 31.62 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.859 0.361 . . . . 63.140000000000001 111.124 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.67 HG21 ' HG3' ' A' ' 90' ' ' GLU . 54.0 t -109.02 124.59 65.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.025 0.44 . . . . 74.420000000000002 111.593 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -107.43 154.93 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.982 0.42 . . . . 64.329999999999998 111.39 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -94.53 133.38 38.21 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.503 -0.317 . . . . 61.240000000000002 110.782 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.5 p -136.8 179.14 6.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.989 0.423 . . . . 65.219999999999999 111.637 -176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -69.09 -15.38 63.43 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.757 0.313 . . . . 74.409999999999997 111.78 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.1 mt -98.71 -13.9 20.03 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.684 0.278 . . . . 73.010000000000005 111.512 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 127.44 -151.94 18.63 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.383 -0.437 . . . . 53.439999999999998 112.733 -178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -82.81 129.18 34.95 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 122.463 -0.434 . . . . 75.329999999999998 111.162 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.2 t -122.78 133.66 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 120.8 0.333 . . . . 74.329999999999998 111.459 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.478 ' HB2' HD13 ' A' ' 88' ' ' ILE . 42.1 ttm180 -94.56 121.1 35.77 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 111.756 0.28 . . . . 72.340000000000003 111.756 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.491 HG21 HG23 ' A' ' 58' ' ' ILE . 39.0 t -65.9 111.32 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 116.415 -0.357 . . . . 75.319999999999993 111.08 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.493 HG23 ' HA2' ' A' ' 85' ' ' GLY . 44.1 p -91.54 -39.26 12.02 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.861 0.363 . . . . 50.420000000000002 111.808 -178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 75.7 m -118.25 162.46 18.22 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.246 0.546 . . . . 74.140000000000001 112.22 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -68.46 138.16 91.29 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 115.867 -0.606 . . . . 74.239999999999995 111.803 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.77 100.37 0.19 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.59 2.194 . . . . 70.129999999999995 112.853 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.74 -25.66 0.37 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.228 -0.511 . . . . 63.420000000000002 112.888 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -60.15 119.41 7.79 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.563 0.22 . . . . 72.340000000000003 111.112 177.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.49 13.02 5.82 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.332 0.586 . . . . 75.310000000000002 111.096 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.04 8.31 87.4 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 116.217 -0.447 . . . . 41.520000000000003 113.094 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 83' ' ' ILE . 8.3 p -135.02 168.19 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.144 0.497 . . . . 60.25 111.576 -175.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.612 HD13 HG21 ' A' ' 58' ' ' ILE . 48.2 mt -105.0 143.75 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.366 -0.379 . . . . 75.230000000000004 110.37 175.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -123.55 135.84 54.22 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.827 0.346 . . . . 73.340000000000003 111.239 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.493 ' HA2' HG23 ' A' ' 74' ' ' THR . . . -154.23 179.33 30.5 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.922 -0.656 . . . . 63.539999999999999 113.801 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.26 141.52 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 O-C-N 122.564 -0.374 . . . . 61.140000000000001 111.049 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 tp -77.06 124.42 27.77 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.817 0.341 . . . . 55.109999999999999 110.854 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' A' ' 72' ' ' ARG . 10.6 pt -140.31 -175.87 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.03 0.443 . . . . 73.209999999999994 111.4 -176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.461 HH12 ' CD ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -122.68 99.83 6.6 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.368 -0.378 . . . . 70.040000000000006 110.903 178.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.67 ' HG3' HG21 ' A' ' 63' ' ' VAL . 27.8 mm-40 -111.32 -57.08 2.3 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.178 -0.327 . . . . 74.129999999999995 111.766 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 84.7 mt -81.37 155.78 25.78 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.033 0.444 . . . . 74.5 111.747 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -90.6 136.67 32.91 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.343 -0.614 . . . . 73.239999999999995 109.343 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -150.09 83.64 1.38 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.207 0.447 . . . . 74.400000000000006 112.207 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -110.83 169.44 8.76 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.567 -0.288 . . . . 73.230000000000004 110.361 170.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -76.52 147.94 37.44 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.961 0.41 . . . . 73.430000000000007 112.009 -175.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -117.01 117.54 29.94 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.921 0.391 . . . . 75.409999999999997 111.803 -178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -64.07 90.92 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.822 0.344 . . . . 75.510000000000005 110.85 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 19.7 p80 . . . . . 0 C--O 1.247 0.937 0 CA-C-O 119.11 -0.472 . . . . 71.019999999999996 112.172 178.486 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.576 -0.21 . . . . 74.329999999999998 112.576 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 45.09 73.0 0.17 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.288 0.566 . . . . 32.399999999999999 112.463 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 3' ' ' ARG . 16.7 mmm180 -80.24 0.2 33.62 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.123 0.487 . . . . 75.109999999999999 111.192 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -68.54 143.7 54.84 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.622 -0.717 . . . . 74.549999999999997 111.759 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.0 t 65.51 126.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.724 0.639 . . . . 70.200000000000003 112.724 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -100.42 117.99 35.73 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.361 0.6 . . . . 61.409999999999997 111.131 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 22.4 tp -105.84 4.22 29.51 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.105 -0.498 . . . . 75.299999999999997 111.681 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.1 tp -59.31 136.16 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.302 0.572 . . . . 75.5 112.241 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -110.25 174.54 5.81 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.941 0.401 . . . . 70.200000000000003 111.339 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.6 t -142.34 167.02 23.1 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.364 -0.38 . . . . 61.310000000000002 111.185 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -99.93 154.63 18.21 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.195 0.443 . . . . 71.349999999999994 112.195 -174.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.2 141.34 15.23 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.368 -0.444 . . . . 50.229999999999997 112.489 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -99.57 123.22 7.84 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.04 -0.6 . . . . 54.140000000000001 113.769 -176.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -117.59 159.8 22.31 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.095 0.474 . . . . 71.400000000000006 111.538 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.8 m -81.65 132.68 35.3 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.31 -0.405 . . . . 71.329999999999998 110.392 174.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -95.48 179.08 5.28 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.536 0.684 . . . . 75.209999999999994 112.37 -174.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -80.03 162.16 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 115.437 -0.801 . . . . 72.109999999999999 109.9 169.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? -53.07 143.57 17.27 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.439 0.533 . . . . 73.540000000000006 112.439 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 23' ' ' THR . 10.1 tt -35.28 106.18 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.852 0.861 . . . . 73.430000000000007 112.952 -174.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.61 74.99 9.13 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.005 -0.543 . . . . 63.340000000000003 112.076 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.6 m 74.35 -41.97 0.49 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.408 0.892 . . . . 54.43 113.408 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -66.17 97.92 0.42 Allowed 'General case' 0 CA--C 1.536 0.415 0 O-C-N 122.179 -0.326 . . . . 65.439999999999998 110.897 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.524 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 42.9 p -71.02 110.74 5.89 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.163 0.506 . . . . 65.420000000000002 111.386 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HG2' ' HG2' ' A' ' 39' ' ' GLU . 68.5 mtt180 -152.42 151.94 31.4 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.725 -0.67 . . . . 73.140000000000001 110.6 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.533 ' HB ' HD11 ' A' ' 40' ' ' ILE . 10.8 tt -138.03 141.06 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.063 0.459 . . . . 74.140000000000001 112.17 -174.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -74.19 103.48 4.63 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.049 -0.523 . . . . 73.040000000000006 110.114 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.524 HG22 HG11 ' A' ' 71' ' ' VAL . 22.6 t -102.62 136.96 32.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.335 0.495 . . . . 74.319999999999993 112.335 -173.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.55 113.52 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.881 0.372 . . . . 62.420000000000002 110.387 173.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -77.15 114.03 36.2 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.153 -0.476 . . . . 52.509999999999998 110.452 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.85 -8.99 15.73 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.595 2.196 . . . . 75.450000000000003 113.399 -176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -89.42 -33.28 16.89 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.937 0.399 . . . . 75.310000000000002 111.574 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.465 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 68.0 p -116.76 -31.41 5.48 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.356 0.502 . . . . 64.310000000000002 112.356 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.55 12.58 50.52 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.138 -0.553 . . . . 62.140000000000001 113.872 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 16.1 ptpt -89.88 162.32 15.51 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.183 0.516 . . . . 71.010000000000005 111.995 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.71 95.57 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 CA-C-O 121.203 0.525 . . . . 73.299999999999997 109.938 171.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.24 138.55 41.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.321 -0.4 . . . . 74.450000000000003 111.215 -174.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 66.6 mt -84.96 121.42 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-O 120.687 0.279 . . . . 72.409999999999997 111.216 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.534 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -108.05 150.47 27.12 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.73 0.3 . . . . 64.040000000000006 111.648 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 24' ' ' ARG . 33.9 mt-10 -94.03 120.93 34.96 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.778 0.323 . . . . 75.040000000000006 110.76 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.533 HD11 ' HB ' ' A' ' 25' ' ' ILE . 57.8 mt -81.86 119.95 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 112.403 0.519 . . . . 63.399999999999999 112.403 -173.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.8 mmm-85 -81.68 -56.11 4.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.044 0.449 . . . . 60.43 111.048 174.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -144.61 155.45 43.64 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.199 -0.455 . . . . 71.200000000000003 111.365 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.438 ' O ' HG22 ' A' ' 43' ' ' VAL . 12.2 p -97.0 32.14 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-O 121.913 0.863 . . . . 75.040000000000006 110.818 176.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 44' ' ' VAL . 7.3 p -74.71 82.3 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-O 121.842 0.829 . . . . 71.510000000000005 111.768 -176.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -76.01 85.77 2.91 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.991 0.737 . . . . 74.310000000000002 112.991 -175.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 m120 49.54 37.35 12.16 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.04 0.448 . . . . 54.420000000000002 111.79 174.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 72.9 p -73.12 81.09 1.26 Allowed 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.709 0.633 . . . . 64.340000000000003 112.709 -170.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.61 -11.03 38.31 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.038 0.447 . . . . 64.439999999999998 110.76 171.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -67.14 119.39 64.24 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 115.796 -0.638 . . . . 72.340000000000003 111.718 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.28 -23.11 39.11 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.514 2.143 . . . . 74.010000000000005 112.822 177.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -93.42 11.75 27.34 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.058 0.456 . . . . 53.219999999999999 111.377 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -69.65 105.02 2.55 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.023 0.44 . . . . 75.030000000000001 111.724 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.7 p -136.63 115.43 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.182 0.515 . . . . 74.329999999999998 110.596 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -164.2 147.25 9.35 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 122.15 -0.344 . . . . 71.239999999999995 111.234 -174.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.5 mtm180 -75.91 -170.91 1.48 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.149 0.5 . . . . 74.450000000000003 111.288 177.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -71.08 77.91 0.67 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.02 0.438 . . . . 64.099999999999994 111.791 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.16 96.82 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 121.293 0.568 . . . . 73.239999999999995 110.986 174.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.7 mt -78.79 123.01 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.953 -0.567 . . . . 72.209999999999994 109.946 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 t -133.11 167.48 20.24 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.05 0.452 . . . . 71.109999999999999 112.157 -174.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 -61.46 128.0 34.18 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.236 -0.438 . . . . 71.209999999999994 111.297 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.25 -13.51 67.17 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.229 -0.51 . . . . 52.520000000000003 112.951 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.89 132.15 43.98 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.021 0.438 . . . . 74.340000000000003 111.281 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 71.9 t -97.13 120.23 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.844 0.354 . . . . 74.129999999999995 111.319 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 43' ' ' VAL . 34.9 m -103.53 136.23 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.034 0.445 . . . . 73.319999999999993 111.337 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.27 119.49 25.12 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.955 0.407 . . . . 44.109999999999999 110.435 178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 40' ' ' ILE . 34.0 p -125.72 175.73 7.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.367 -0.378 . . . . 63.43 111.471 -175.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -61.41 -28.68 69.43 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.331 -0.395 . . . . 71.25 111.739 177.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 38' ' ' ALA . 83.9 mt -86.72 -22.82 25.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.755 0.312 . . . . 71.200000000000003 111.45 177.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.57 -153.13 21.9 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.923 -0.656 . . . . 75.319999999999993 113.511 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.495 ' H ' ' HD2' ' A' ' 89' ' ' ARG . 15.1 m120 -83.66 102.87 12.53 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.922 0.391 . . . . 72.430000000000007 111.098 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.524 HG11 HG22 ' A' ' 27' ' ' VAL . 47.6 t -97.62 119.73 46.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.962 0.41 . . . . 61.020000000000003 111.326 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -86.93 117.61 25.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.495 -0.321 . . . . 64.239999999999995 111.171 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.75 121.1 14.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.178 -0.464 . . . . 71.120000000000005 112.111 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -107.3 -41.79 5.01 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.249 -0.432 . . . . 71.400000000000006 111.799 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.9 m -93.14 162.43 14.03 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.283 0.564 . . . . 71.420000000000002 112.176 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -76.59 128.54 81.8 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 115.856 -0.611 . . . . 72.310000000000002 111.222 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.568 ' HA ' HG12 ' A' ' 83' ' ' ILE . 73.1 Cg_exo -49.35 -41.41 43.05 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.863 2.375 . . . . 71.319999999999993 113.6 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -94.28 34.44 4.7 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.895 -0.669 . . . . 74.200000000000003 113.335 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -77.7 -81.14 0.1 Allowed 'General case' 0 CA--C 1.541 0.609 0 O-C-N 122.592 -0.357 . . . . 63.0 110.796 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -100.9 22.21 12.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.956 0.408 . . . . 74.030000000000001 110.773 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 78.74 7.99 87.95 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.178 -0.534 . . . . 53.149999999999999 112.434 -175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 p -145.4 151.64 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 122.859 0.464 . . . . 64.109999999999999 110.615 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.568 HG12 ' HA ' ' A' ' 77' ' ' PRO . 54.2 mt -96.08 143.87 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.299 -0.41 . . . . 62.399999999999999 111.588 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -118.92 148.96 42.37 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.301 0.24 . . . . 62.520000000000003 110.749 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.3 -170.25 26.82 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 121.089 -0.576 . . . . 53.420000000000002 113.641 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 2.3 t -121.08 147.73 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 O-C-N 122.487 -0.419 . . . . 72.230000000000004 111.126 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 50.5 tp -89.74 113.55 25.09 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.412 0.523 . . . . 73.420000000000002 112.412 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 20.5 pt -136.75 -173.51 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.077 0.465 . . . . 51.210000000000001 110.815 174.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HD2' ' H ' ' A' ' 70' ' ' ASN . 24.0 mmm180 -144.7 95.36 2.69 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.111 0.481 . . . . 75.409999999999997 111.35 176.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -94.37 -5.2 47.01 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.381 0.61 . . . . 74.030000000000001 110.431 174.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.8 mt -116.3 174.45 6.05 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.75 -0.659 . . . . 72.409999999999997 110.921 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -41.0 118.32 0.98 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 113.881 1.067 . . . . 72.140000000000001 113.881 -177.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -119.01 12.92 12.9 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.414 0.626 . . . . 64.150000000000006 110.566 174.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -82.77 8.61 11.76 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.197 -0.456 . . . . 71.319999999999993 112.206 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -61.56 -18.71 60.41 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.153 0.427 . . . . 71.329999999999998 112.153 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -76.26 -15.75 59.95 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.936 0.398 . . . . 52.210000000000001 111.461 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -115.4 147.25 40.76 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.049 0.452 . . . . 71.150000000000006 111.678 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.888 -0.577 . . . . 71.25 111.143 173.279 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.44 0 CA-C-O 120.656 0.031 . . . . 33.43 113.162 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.487 ' HB2' ' HG2' ' A' ' 4' ' ' ARG . 4.3 p-10 -165.29 -40.29 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 111.887 0.328 . . . . 74.010000000000005 111.887 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 57.22 26.27 12.04 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.005 0.431 . . . . 71.310000000000002 112.04 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.487 ' HG2' ' HB2' ' A' ' 2' ' ' ASP . 13.3 mmt180 -80.89 49.8 1.27 Allowed 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.099 0.476 . . . . 74.540000000000006 111.269 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.8 m -82.92 143.56 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.258 -0.428 . . . . 72.140000000000001 111.366 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -60.83 114.21 2.92 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.01 0.434 . . . . 72.310000000000002 111.441 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 mp -55.17 -39.69 69.82 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.148 -0.478 . . . . 62.350000000000001 111.316 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.437 ' O ' HG23 ' A' ' 8' ' ' ILE . 6.9 tp -91.48 95.15 5.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 121.587 0.708 . . . . 74.150000000000006 110.817 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.04 72.14 1.29 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.626 0.727 . . . . 63.420000000000002 112.237 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.9 p -85.46 32.41 0.57 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.003 -0.544 . . . . 64.209999999999994 111.609 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.58 32.33 0.19 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.821 0.675 . . . . 71.109999999999999 112.821 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.72 144.16 47.83 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.3 -0.476 . . . . 43.310000000000002 113.445 -177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 81.75 -69.44 3.3 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.016 -0.611 . . . . 41.149999999999999 113.426 178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -80.65 89.27 5.71 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.303 0.573 . . . . 74.019999999999996 111.78 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.9 m -157.51 102.07 1.88 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.898 -0.592 . . . . 72.420000000000002 109.903 176.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.443 ' O ' ' HD2' ' A' ' 16' ' ' LYS . 1.5 tmmm? -67.3 -47.51 70.37 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.033 0.444 . . . . 43.119999999999997 110.832 -177.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.673 HG22 ' H ' ' A' ' 19' ' ' LEU . 11.4 p -64.97 137.85 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.228 0.537 . . . . 62.530000000000001 111.218 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -61.32 -22.76 65.19 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.469 0.544 . . . . 72.329999999999998 112.469 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.673 ' H ' HG22 ' A' ' 17' ' ' VAL . 8.6 tt -152.87 119.59 5.69 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.895 0.378 . . . . 61.240000000000002 111.195 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.19 -72.22 0.73 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.959 0.409 . . . . 43.549999999999997 111.495 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.6 t -133.51 11.26 4.09 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.437 0.636 . . . . 61.399999999999999 110.121 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.89 144.21 40.28 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.271 -0.877 . . . . 62.329999999999998 110.858 -174.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 63.5 m -144.04 112.64 6.56 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 122.044 -0.41 . . . . 60.020000000000003 111.134 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 24' ' ' ARG . 21.1 mtp180 -145.36 166.86 24.35 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.159 -0.473 . . . . 64.0 111.369 -176.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 tt -151.85 131.9 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.088 0.471 . . . . 62.030000000000001 112.265 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -72.03 104.63 3.62 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.296 -0.411 . . . . 74.439999999999998 110.687 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -100.72 129.35 51.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.007 0.432 . . . . 63.329999999999998 111.817 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.2 t -95.6 117.64 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.351 -0.386 . . . . 75.400000000000006 111.062 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -75.58 115.01 41.88 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.251 -0.431 . . . . 74.430000000000007 110.345 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.26 -19.46 15.29 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.571 2.181 . . . . 72.040000000000006 112.727 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -85.43 -43.03 13.97 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.178 -0.465 . . . . 71.430000000000007 111.675 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 43.6 p -105.57 -19.5 13.75 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.325 0.491 . . . . 65.150000000000006 112.325 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.67 11.37 79.84 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 121.088 -0.577 . . . . 63.0 113.638 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -88.7 162.72 16.13 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.954 0.407 . . . . 73.329999999999998 111.63 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.3 t -112.5 115.64 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 120.776 0.322 . . . . 72.239999999999995 110.473 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -126.31 141.35 51.94 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 122.56 0.344 . . . . 64.340000000000003 110.833 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.3 mt -94.0 120.07 42.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.83 0.347 . . . . 71.519999999999996 111.657 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.508 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -107.32 160.91 15.26 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.166 0.508 . . . . 62.439999999999998 112.188 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -102.77 124.32 48.07 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.311 -0.404 . . . . 73.439999999999998 110.55 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.433 ' HA ' HG22 ' A' ' 66' ' ' THR . 68.2 mt -78.58 112.65 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.356 0.598 . . . . 73.150000000000006 112.411 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 29.2 mtp-105 -83.55 -53.8 5.41 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 116.033 -0.53 . . . . 74.040000000000006 111.517 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 38.5 m-80 -120.98 152.88 38.03 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.893 0.378 . . . . 71.439999999999998 111.709 177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.412 ' O ' ' HB ' ' A' ' 44' ' ' VAL . 3.9 p -123.61 82.22 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-O 121.33 0.586 . . . . 64.230000000000004 110.97 174.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 43' ' ' VAL . 12.0 p 175.8 142.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 115.958 -0.565 . . . . 62.009999999999998 111.447 -177.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.64 ' HG3' ' HB ' ' A' ' 63' ' ' VAL . 3.3 mp0 -84.92 141.07 30.65 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 110.297 -0.26 . . . . 73.209999999999994 110.297 172.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -74.12 89.57 1.99 Allowed 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.103 0.478 . . . . 60.100000000000001 110.621 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 t -159.66 140.72 12.54 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.219 -0.446 . . . . 61.450000000000003 111.563 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.12 111.86 11.96 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.343 0.497 . . . . 73.010000000000005 112.343 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 54.15 74.95 0.67 Allowed Pre-proline 0 N--CA 1.474 0.745 0 N-CA-C 112.582 0.586 . . . . 65.299999999999997 112.582 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.21 -51.79 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.002 1.802 . . . . 74.019999999999996 112.419 175.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -159.45 150.37 19.62 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.06 -0.518 . . . . 74.420000000000002 110.081 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -64.43 99.48 0.3 Allowed 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.388 0.613 . . . . 71.439999999999998 111.808 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 p -142.46 146.94 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.496 -0.774 . . . . 75.019999999999996 110.566 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -125.05 -23.04 4.31 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 111.901 0.334 . . . . 71.340000000000003 111.901 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -108.2 149.24 28.82 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.8 0.333 . . . . 70.239999999999995 111.244 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -74.95 108.02 7.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.735 0.303 . . . . 74.239999999999995 111.139 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.0 tp -131.35 113.74 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.43 0.633 . . . . 72.219999999999999 111.822 -178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.731 ' HB ' ' HG3' ' A' ' 77' ' ' PRO . 61.1 mt -70.64 91.62 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.101 -0.499 . . . . 74.239999999999995 110.216 175.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -106.69 163.71 12.69 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.668 0.618 . . . . 53.219999999999999 112.668 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.6 ttp-105 -56.99 116.65 3.34 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.392 -0.822 . . . . 74.239999999999995 111.837 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.23 -12.45 55.27 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.157 -0.544 . . . . 51.43 113.749 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.03 159.71 32.31 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 117.32 0.56 . . . . 32.240000000000002 111.47 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.64 ' HB ' ' HG3' ' A' ' 45' ' ' GLU . 63.6 t -118.15 124.41 73.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-O 121.128 0.49 . . . . 61.310000000000002 111.226 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.418 ' HB ' HG23 ' A' ' 40' ' ' ILE . 35.3 m -108.14 147.45 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 120.931 0.396 . . . . 62.039999999999999 111.761 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 28.5 tt0 -87.7 126.67 35.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.428 -0.351 . . . . 72.519999999999996 110.138 174.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 40' ' ' ILE . 33.6 p -129.46 176.0 8.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.996 0.427 . . . . 74.010000000000005 111.387 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -62.23 -20.68 64.46 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.404 -0.362 . . . . 71.450000000000003 111.553 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' A' ' 38' ' ' ALA . 71.7 mt -101.18 8.61 42.56 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.655 0.264 . . . . 64.430000000000007 111.696 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.09 -154.74 16.88 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.301 -0.476 . . . . 54.130000000000003 112.907 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -80.78 137.69 36.24 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.258 -0.554 . . . . 60.25 111.571 -179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 66.2 t -126.51 130.63 71.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.337 -0.392 . . . . 75.329999999999998 111.105 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.585 ' HB2' HD13 ' A' ' 88' ' ' ILE . 41.5 ttm180 -91.32 114.21 26.68 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.711 0.291 . . . . 73.340000000000003 110.739 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.7 t -66.54 131.35 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 112.834 0.679 . . . . 74.450000000000003 112.834 -173.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 80.4 p -108.98 -61.33 1.63 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.942 -0.572 . . . . 51.539999999999999 111.627 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.1 m -91.51 160.15 15.57 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.125 0.488 . . . . 73.129999999999995 112.128 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -76.46 135.95 68.49 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 116.255 -0.43 . . . . 75.150000000000006 111.413 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.731 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 73.5 Cg_endo -72.2 137.91 29.57 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.866 2.377 . . . . 61.539999999999999 113.336 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 110.2 -31.5 7.39 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.053 -0.594 . . . . 62.439999999999998 113.221 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -59.32 118.72 6.28 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.795 0.297 . . . . 73.439999999999998 110.923 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 62.53 10.63 4.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 112.263 0.468 . . . . 74.129999999999995 112.263 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 71.31 31.22 66.24 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.214 -0.517 . . . . 72.409999999999997 113.027 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.2 p -137.97 150.59 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.063 0.459 . . . . 63.439999999999998 111.683 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.4 mt -123.15 147.53 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 109.681 -0.488 . . . . 75.25 109.681 175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -128.54 145.94 50.98 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.892 -0.505 . . . . 75.329999999999998 112.276 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.38 -179.39 38.5 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 121.386 -0.435 . . . . 72.340000000000003 113.205 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.6 t -116.64 142.41 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 116.962 0.381 . . . . 65.150000000000006 111.381 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.469 HD11 HH12 ' A' ' 89' ' ' ARG . 51.5 tp -76.99 115.31 16.68 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.675 0.274 . . . . 72.340000000000003 111.621 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 72' ' ' ARG . 22.2 pt -133.82 -176.59 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.297 0.57 . . . . 73.200000000000003 111.844 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.469 HH12 HD11 ' A' ' 87' ' ' LEU . 31.8 mmt180 -135.21 94.83 3.18 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.094 -0.503 . . . . 74.140000000000001 111.451 178.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.482 ' HG3' HG11 ' A' ' 63' ' ' VAL . 12.0 mm-40 -91.4 -34.62 14.79 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.45 0.643 . . . . 70.209999999999994 110.43 175.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.4 mt -102.15 137.4 40.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.68 -0.691 . . . . 71.25 110.235 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.74 133.43 36.34 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.78 0.324 . . . . 74.140000000000001 110.451 -178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -73.91 75.44 1.65 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.82 0.819 . . . . 65.510000000000005 112.072 -173.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -73.37 -45.76 53.02 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.822 -0.626 . . . . 74.540000000000006 111.233 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -78.79 114.3 17.6 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.956 -0.565 . . . . 72.239999999999995 111.484 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -82.58 165.34 20.17 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.866 0.365 . . . . 62.020000000000003 111.323 177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -96.86 -179.65 4.64 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.9 0.381 . . . . 74.439999999999998 111.191 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.6 t60 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 119.047 -0.502 . . . . 70.129999999999995 110.82 175.611 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 113.687 0.235 . . . . 23.25 113.687 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -78.96 102.48 8.33 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 117.109 0.455 . . . . 63.200000000000003 110.593 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 76.9 mtt85 -114.3 98.09 6.72 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.95 0.405 . . . . 73.420000000000002 111.768 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -87.05 109.3 19.32 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.809 0.338 . . . . 73.510000000000005 110.152 176.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.5 t -62.24 117.87 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 120.791 0.329 . . . . 61.119999999999997 111.494 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -108.14 -55.35 2.38 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.603 0.239 . . . . 71.329999999999998 110.918 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 26.2 tp 61.86 6.5 1.68 Allowed 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 112.81 0.67 . . . . 75.209999999999994 112.81 175.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.4 tp -54.74 124.31 7.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 112.794 0.664 . . . . 72.530000000000001 112.794 -175.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -149.38 146.65 27.59 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.251 -0.431 . . . . 75.409999999999997 110.972 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -62.32 166.03 5.4 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.282 0.845 . . . . 63.310000000000002 113.282 -174.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -85.84 133.58 33.96 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.839 -0.619 . . . . 75.5 111.71 -176.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.55 148.19 5.36 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.143 -0.551 . . . . 72.109999999999999 112.923 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.86 55.68 0.31 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.524 -0.369 . . . . 55.210000000000001 113.468 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -60.94 120.4 10.12 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 122.303 -0.528 . . . . 74.409999999999997 111.364 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.0 m -69.01 105.68 2.5 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.03 0.443 . . . . 71.209999999999994 111.935 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.9 pttm -88.87 151.26 22.46 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.313 0.578 . . . . 63.439999999999998 111.787 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -95.12 144.27 10.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.104 0.478 . . . . 64.239999999999995 111.784 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HD3' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -66.41 -172.76 0.17 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.094 0.473 . . . . 74.120000000000005 111.892 173.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.529 ' HB2' ' HA ' ' A' ' 23' ' ' THR . 2.6 pt? -56.76 -2.4 0.08 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.068 1.136 . . . . 71.219999999999999 114.068 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.52 -42.55 78.61 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.182 0.438 . . . . 41.100000000000001 112.182 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.1 m -96.43 -35.07 11.29 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.982 0.42 . . . . 45.140000000000001 111.36 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 19' ' ' LEU . 5.2 p-10 -128.69 96.43 4.38 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.547 0.689 . . . . 73.200000000000003 111.044 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.529 ' HA ' ' HB2' ' A' ' 19' ' ' LEU . 17.8 m -76.24 113.47 13.84 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.946 -0.57 . . . . 64.010000000000005 110.81 -178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 39' ' ' GLU . 34.6 ttm180 -148.02 154.0 39.69 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.929 0.395 . . . . 74.120000000000005 111.968 -172.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.0 tt -148.87 146.16 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.945 0.402 . . . . 73.230000000000004 111.619 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.637 ' ND2' HG23 ' A' ' 82' ' ' VAL . 29.9 m-80 -94.16 112.71 24.55 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.88 0.371 . . . . 72.540000000000006 110.064 176.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.3 t -102.39 130.99 51.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.053 -0.521 . . . . 72.540000000000006 112.055 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.7 t -95.11 120.47 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.073 0.464 . . . . 64.349999999999994 110.882 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -78.21 116.71 61.16 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.974 -0.557 . . . . 73.150000000000006 111.028 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -79.9 -17.04 11.06 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 122.693 2.262 . . . . 74.040000000000006 112.927 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -87.96 -43.17 11.95 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.834 0.35 . . . . 55.229999999999997 111.559 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.1 p -106.25 -26.9 11.34 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 112.583 0.586 . . . . 74.340000000000003 112.583 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.61 15.97 57.5 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 121.126 -0.559 . . . . 70.349999999999994 114.325 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -97.41 143.86 27.73 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.243 -0.563 . . . . 74.400000000000006 111.397 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.4 t -88.51 98.33 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.171 0.51 . . . . 71.010000000000005 109.894 171.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -101.32 138.61 38.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.933 -0.576 . . . . 62.109999999999999 110.94 -176.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 55.1 mt -92.31 127.72 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.071 0.462 . . . . 64.430000000000007 111.439 -178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.89 160.0 35.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 53.520000000000003 110.995 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 39.0 mt-10 -109.17 134.69 51.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.873 0.368 . . . . 64.239999999999995 110.48 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.504 ' HA ' HG22 ' A' ' 66' ' ' THR . 60.6 mt -71.52 113.68 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.512 0.672 . . . . 72.439999999999998 112.046 -172.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -37.32 41.45 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.107 -0.951 . . . . 73.010000000000005 110.302 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.667 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 59.9 t30 -141.04 119.12 11.95 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.939 -0.573 . . . . 64.409999999999997 110.545 178.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 m -74.34 -26.69 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 112.619 0.6 . . . . 64.129999999999995 112.619 -176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.8 p -93.57 144.93 8.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.941 0.4 . . . . 53.140000000000001 111.205 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.97 147.96 32.4 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.109 0.48 . . . . 75.129999999999995 112.045 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -72.52 63.15 0.56 Allowed 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 116.372 -0.376 . . . . 75.200000000000003 110.78 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.4 t -134.77 -172.82 3.13 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.838 0.351 . . . . 72.299999999999997 111.871 -173.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.62 -73.99 0.62 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.804 0.668 . . . . 70.230000000000004 112.804 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.3 m120 60.74 90.6 0.09 OUTLIER Pre-proline 0 N--CA 1.474 0.745 0 C-N-CA 122.632 0.373 . . . . 71.019999999999996 111.477 -174.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -58.22 -24.94 69.77 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 123.023 2.482 . . . . 65.400000000000006 113.474 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -104.89 162.76 13.05 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.018 0.437 . . . . 64.200000000000003 111.349 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -58.54 -18.68 31.49 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.309 0.485 . . . . 74.329999999999998 112.309 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 43.3 t -70.81 84.84 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.458 0.646 . . . . 72.140000000000001 111.617 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.9 ptp85 -136.82 138.12 40.49 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.792 -0.64 . . . . 75.230000000000004 109.918 176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -81.06 86.18 6.18 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.844 0.83 . . . . 65.030000000000001 112.261 -173.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -83.9 -23.64 31.12 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.398 -0.819 . . . . 63.299999999999997 111.155 173.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 25.1 pt -74.33 130.12 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 115.784 -0.644 . . . . 72.319999999999993 111.98 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.508 HG23 HG21 ' A' ' 73' ' ' VAL . 62.9 mt -57.68 92.24 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 115.78 -0.645 . . . . 74.519999999999996 111.852 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.588 ' HA ' ' NH2' ' A' ' 76' ' ' ARG . 30.2 p -128.21 162.73 26.3 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.461 0.541 . . . . 74.340000000000003 112.461 -175.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 -57.32 116.92 3.6 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.123 -0.489 . . . . 74.209999999999994 111.717 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.1 -11.36 60.38 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.211 -0.519 . . . . 63.32 113.217 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.02 131.06 40.34 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.817 0.341 . . . . 74.439999999999998 111.137 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -94.3 112.37 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 120.774 0.321 . . . . 61.329999999999998 111.348 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.0 m -103.04 148.52 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.119 0.485 . . . . 71.340000000000003 111.253 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 43.8 tt0 -92.52 123.99 36.23 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.386 -0.37 . . . . 53.549999999999997 110.885 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.504 HG22 ' HA ' ' A' ' 40' ' ' ILE . 44.1 p -126.24 176.16 7.28 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.071 0.462 . . . . 61.200000000000003 111.879 -177.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -65.09 -15.39 62.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.337 -0.392 . . . . 73.200000000000003 111.962 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.9 mt -92.31 -32.35 15.04 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.221 0.534 . . . . 73.329999999999998 111.085 174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 142.81 -150.05 21.88 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.905 -0.588 . . . . 62.409999999999997 112.26 -174.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -80.53 130.49 35.17 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 122.444 -0.445 . . . . 63.310000000000002 111.193 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.4 t -126.41 128.66 71.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.417 -0.356 . . . . 74.230000000000004 111.457 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.477 ' HB2' HD13 ' A' ' 88' ' ' ILE . 42.0 ttm180 -91.29 117.44 29.65 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.251 -0.28 . . . . 44.420000000000002 110.91 177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.508 HG21 HG23 ' A' ' 58' ' ' ILE . 45.9 t -66.3 133.83 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 120.73 0.3 . . . . 43.200000000000003 111.754 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 75.3 p -110.39 -73.2 0.69 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.707 0.289 . . . . 73.040000000000006 111.61 178.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.1 m -73.27 -177.05 2.4 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.231 0.539 . . . . 64.329999999999998 111.81 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.588 ' NH2' ' HA ' ' A' ' 59' ' ' THR . 2.8 mmp_? -94.19 132.33 29.5 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-N 116.431 -0.349 . . . . 74.120000000000005 111.327 177.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -72.95 150.81 49.57 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.689 2.259 . . . . 74.109999999999999 113.291 -175.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.95 11.43 46.34 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.937 -0.649 . . . . 43.340000000000003 114.053 175.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.645 ' O ' HG12 ' A' ' 82' ' ' VAL . 59.1 mm-40 -71.66 78.23 0.83 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 117.537 0.668 . . . . 74.310000000000002 110.038 176.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.7 t70 64.81 13.19 8.3 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.425 0.631 . . . . 64.040000000000006 111.128 -172.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 120.83 -35.41 3.7 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 116.2 -0.455 . . . . 33.399999999999999 113.529 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.645 HG12 ' O ' ' A' ' 79' ' ' GLN . 10.9 p -68.87 136.07 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 112.834 0.679 . . . . 73.230000000000004 112.834 -174.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.0 mt -122.98 147.4 27.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.479 -0.782 . . . . 73.409999999999997 109.588 172.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -122.21 139.95 53.17 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 112.471 0.545 . . . . 72.329999999999998 112.471 -175.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.72 171.43 37.67 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 116.133 -0.485 . . . . 54.299999999999997 112.915 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.38 141.24 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 122.522 -0.399 . . . . 71.319999999999993 111.424 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.3 tp -77.07 117.53 18.72 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.751 0.31 . . . . 60.310000000000002 111.311 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.477 HD13 ' HB2' ' A' ' 72' ' ' ARG . 18.0 pt -132.2 175.07 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.25 0.548 . . . . 73.129999999999995 111.314 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -149.27 70.17 1.08 Allowed 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.051 -0.522 . . . . 65.549999999999997 111.418 -178.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.96 -11.25 59.92 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.317 -0.401 . . . . 70.030000000000001 111.887 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.0 mt -89.93 -175.86 4.73 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.899 0.38 . . . . 64.140000000000001 111.315 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -58.88 129.26 41.27 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.507 0.67 . . . . 73.420000000000002 111.798 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -85.54 35.39 0.61 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.761 -0.654 . . . . 74.109999999999999 111.368 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.3 p80 39.73 72.69 0.14 Allowed 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.712 1.004 . . . . 60.310000000000002 113.712 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -145.31 129.21 17.38 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.797 -0.638 . . . . 72.430000000000007 110.621 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -65.87 118.41 9.65 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.868 0.366 . . . . 62.310000000000002 111.503 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -91.88 169.03 11.01 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.032 0.382 . . . . 72.450000000000003 112.032 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.697 -0.668 . . . . 74.450000000000003 111.269 177.316 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 113.467 0.147 . . . . 63.100000000000001 113.467 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -98.13 83.86 3.18 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.55 0.69 . . . . 73.430000000000007 112.462 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -114.33 38.01 3.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.767 0.794 . . . . 73.340000000000003 109.782 171.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -66.42 96.44 0.36 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.91 -1.041 . . . . 44.119999999999997 111.992 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.8 m -98.3 152.23 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.403 -0.362 . . . . 63.520000000000003 110.464 174.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 6' ' ' ARG . 12.2 ptt180 -109.79 -10.4 14.78 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.303 0.482 . . . . 72.519999999999996 112.303 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tt 53.43 82.66 0.08 Allowed 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.389 0.614 . . . . 72.409999999999997 110.89 175.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.73 126.58 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.522 0.677 . . . . 74.340000000000003 111.267 -177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -128.89 145.45 51.21 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.753 -0.658 . . . . 75.519999999999996 110.51 176.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -178.01 171.83 1.7 Allowed 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.111 0.481 . . . . 43.109999999999999 111.956 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.481 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -160.37 -40.51 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.178 -0.465 . . . . 61.420000000000002 110.955 177.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.14 -176.7 51.34 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.173 -0.537 . . . . 62.140000000000001 113.035 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.25 52.48 4.53 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.049 -0.596 . . . . 75.239999999999995 112.743 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -116.65 -170.13 1.76 Allowed 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.068 0.461 . . . . 73.450000000000003 111.844 -175.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.2 m -78.94 104.82 9.84 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.037 0.446 . . . . 74.219999999999999 112.089 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.443 ' HE2' ' O ' ' A' ' 17' ' ' VAL . 19.3 ptmt -85.26 160.49 19.84 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.0 0.429 . . . . 74.400000000000006 110.958 175.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.443 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 49.1 t -70.53 145.76 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 116.515 -0.311 . . . . 74.299999999999997 110.204 173.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -41.98 -39.87 2.03 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.97 0.73 . . . . 75.409999999999997 112.97 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.473 HD21 ' OG1' ' A' ' 23' ' ' THR . 7.5 tt -145.24 128.43 16.7 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.307 -0.406 . . . . 71.140000000000001 109.934 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.8 -65.54 0.87 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.948 0.404 . . . . 72.120000000000005 111.56 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -142.77 17.19 1.98 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.937 0.875 . . . . 74.209999999999994 110.142 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -112.04 22.77 14.48 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.902 -1.045 . . . . 64.150000000000006 112.011 -173.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.473 ' OG1' HD21 ' A' ' 19' ' ' LEU . 7.5 m -64.72 113.12 3.56 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.128 -0.487 . . . . 75.420000000000002 112.189 -176.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 24' ' ' ARG . 55.9 mtt180 -151.04 161.6 42.42 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.05 0.452 . . . . 72.209999999999994 111.918 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.5 tt -149.15 144.12 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 115.883 -0.599 . . . . 73.200000000000003 111.308 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -79.04 108.25 12.4 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.297 -0.41 . . . . 74.219999999999999 110.989 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.455 HG22 HG21 ' A' ' 71' ' ' VAL . 28.5 t -94.63 120.44 44.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 116.312 -0.404 . . . . 72.230000000000004 111.865 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.02 118.17 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.935 0.398 . . . . 74.200000000000003 111.053 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 14.9 t0 -73.86 118.87 72.87 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 116.455 -0.339 . . . . 74.030000000000001 111.147 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 29' ' ' ASP . 12.9 Cg_exo -70.58 -28.13 21.68 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.885 2.39 . . . . 74.400000000000006 113.391 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.23 -44.06 11.73 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.41 0.522 . . . . 73.340000000000003 112.41 -173.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 42.7 p -104.73 -15.36 15.26 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.326 0.491 . . . . 71.530000000000001 112.326 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.04 28.15 69.03 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.144 -0.55 . . . . 63.25 114.021 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -100.38 145.69 27.88 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.152 0.476 . . . . 72.129999999999995 111.445 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -110.73 133.09 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 120.892 0.377 . . . . 72.519999999999996 111.352 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -147.24 139.69 24.71 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.47 -0.332 . . . . 73.299999999999997 111.074 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 61.3 mt -86.88 125.61 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.962 0.411 . . . . 74.219999999999999 111.11 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.468 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -122.51 154.38 37.93 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.381 0.512 . . . . 43.25 112.381 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -90.55 133.24 35.22 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.743 0.306 . . . . 42.039999999999999 110.502 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.474 ' HA ' HG22 ' A' ' 66' ' ' THR . 57.9 mt -83.1 114.71 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 120.838 0.352 . . . . 61.299999999999997 111.563 -178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 31.4 mtp180 -73.95 -46.68 42.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.392 -0.367 . . . . 74.299999999999997 111.208 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' OD1' HG12 ' A' ' 44' ' ' VAL . 28.2 t-20 -140.18 139.59 35.72 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.563 -0.29 . . . . 62.509999999999998 110.815 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 t -106.23 -4.34 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 112.585 0.587 . . . . 64.519999999999996 112.585 -175.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.438 ' O ' HG13 ' A' ' 44' ' ' VAL . 9.2 p -63.47 104.81 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.626 0.726 . . . . 73.319999999999993 111.253 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -66.44 155.47 37.41 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.703 -0.681 . . . . 73.340000000000003 111.851 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -78.83 41.03 0.41 Allowed 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.427 0.529 . . . . 63.509999999999998 112.427 -175.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 55' ' ' ARG . 1.8 t -63.79 -54.98 26.65 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.165 0.431 . . . . 71.25 112.165 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.429 ' H ' HG23 ' A' ' 47' ' ' THR . . . 66.98 1.58 2.37 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.317 0.858 . . . . 74.239999999999995 113.317 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -139.99 77.75 25.6 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 121.331 0.586 . . . . 63.130000000000003 111.809 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -66.81 108.22 1.43 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.522 2.148 . . . . 74.120000000000005 111.837 175.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -72.79 -40.1 66.17 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.794 0.331 . . . . 51.210000000000001 111.58 -174.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -139.99 -18.42 0.92 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 111.993 0.368 . . . . 75.200000000000003 111.993 176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.25 154.73 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 O-C-N 122.292 -0.255 . . . . 54.310000000000002 111.109 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.438 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -67.22 134.82 52.4 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.023 0.44 . . . . 74.140000000000001 111.131 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.448 ' HB2' HG21 ' A' ' 47' ' ' THR . 31.0 mtp180 -104.02 128.35 51.61 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.366 0.876 . . . . 74.329999999999998 113.366 -173.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -145.84 38.82 1.11 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.924 -1.034 . . . . 55.009999999999998 108.615 171.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 60.7 mt -90.73 118.72 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.217 -0.902 . . . . 75.439999999999998 111.946 -171.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.762 HG21 HD13 ' A' ' 83' ' ' ILE . 59.5 mt -69.53 88.66 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.367 0.603 . . . . 62.219999999999999 110.759 176.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.9 t -134.06 173.05 12.0 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.145 -0.479 . . . . 71.409999999999997 111.338 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -58.74 115.95 3.41 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.999 0.428 . . . . 62.310000000000002 111.277 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.22 -13.19 52.01 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.228 -0.511 . . . . 63.439999999999998 113.665 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.25 139.31 48.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 117.061 0.43 . . . . 73.439999999999998 111.683 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.9 t -110.78 119.5 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 116.359 -0.382 . . . . 72.329999999999998 111.703 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 70' ' ' ASN . 32.6 m -114.8 159.23 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 120.77 0.319 . . . . 72.310000000000002 111.85 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -98.22 126.8 43.85 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.814 0.34 . . . . 71.140000000000001 110.806 177.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.474 HG22 ' HA ' ' A' ' 40' ' ' ILE . 34.7 p -125.59 178.81 5.45 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.504 -0.316 . . . . 42.5 111.067 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.468 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 16.9 p-10 -67.68 -16.1 63.98 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.725 0.298 . . . . 72.329999999999998 111.771 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 82.4 mt -95.73 -22.31 17.61 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.984 0.421 . . . . 61.340000000000003 111.193 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 135.27 -154.76 21.78 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 112.079 -0.408 . . . . 72.219999999999999 112.079 -175.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 64' ' ' VAL . 13.4 m120 -81.18 133.34 35.44 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 122.094 -0.65 . . . . 65.230000000000004 111.711 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.455 HG21 HG22 ' A' ' 27' ' ' VAL . 23.8 t -121.63 119.5 59.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.922 -0.581 . . . . 61.25 110.594 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.539 ' HB2' HD13 ' A' ' 88' ' ' ILE . 33.4 ttt-85 -91.21 116.52 28.88 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.675 0.274 . . . . 74.329999999999998 110.375 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.428 HG21 HG23 ' A' ' 58' ' ' ILE . 45.7 t -61.02 118.27 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.049 0.452 . . . . 63.229999999999997 112.141 -175.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.6 p -97.21 -47.1 5.88 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.205 -0.452 . . . . 71.239999999999995 111.427 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.6 m -101.95 138.33 39.06 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.253 -0.43 . . . . 62.210000000000001 111.377 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -64.39 133.93 95.82 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 111.904 0.335 . . . . 70.230000000000004 111.904 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.8 100.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.803 2.336 . . . . 64.549999999999997 112.863 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.81 -30.98 0.46 Allowed Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.802 -0.635 . . . . 54.219999999999999 111.853 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -60.16 112.97 2.11 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.62 0.248 . . . . 54.109999999999999 110.429 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.452 ' HB3' HG12 ' A' ' 82' ' ' VAL . 31.4 t70 65.13 15.64 10.11 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.45 0.643 . . . . 74.420000000000002 110.89 -175.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.27 2.53 63.08 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 116.001 -0.545 . . . . 71.109999999999999 113.202 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 83' ' ' ILE . 11.5 p -123.38 167.79 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 120.897 0.38 . . . . 72.209999999999994 111.413 -175.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.762 HD13 HG21 ' A' ' 58' ' ' ILE . 37.1 mt -106.51 129.15 60.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 122.52 0.328 . . . . 74.319999999999993 111.273 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -113.73 141.24 47.51 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.977 0.417 . . . . 72.340000000000003 111.465 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.55 173.69 34.32 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.36 -0.448 . . . . 73.310000000000002 113.049 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -105.05 150.76 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 113.082 0.771 . . . . 64.109999999999999 113.082 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 29' ' ' ASP . 66.4 tp -82.02 107.62 14.87 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.188 -0.914 . . . . 74.319999999999993 111.893 -179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 72' ' ' ARG . 10.2 pt -120.5 173.31 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.005 0.431 . . . . 73.030000000000001 110.492 175.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.457 ' HD2' ' O ' ' A' ' 88' ' ' ILE . 19.3 mmm180 -131.35 72.66 1.51 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 120.954 0.407 . . . . 73.109999999999999 110.855 -174.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -83.93 -56.89 3.44 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.948 0.351 . . . . 74.239999999999995 111.948 -176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . 84.8 mt -61.88 146.02 51.02 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.689 0.28 . . . . 62.32 111.369 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.45 ' HG3' ' CD2' ' A' ' 93' ' ' HIS . 14.5 tp10 -53.35 -80.19 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.731 0.641 . . . . 74.209999999999994 112.731 -172.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.45 ' CD2' ' HG3' ' A' ' 92' ' ' GLU . 96.6 m-70 -111.14 117.56 33.58 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.902 -0.499 . . . . 72.540000000000006 111.229 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.453 ' CE1' ' HB2' ' A' ' 91' ' ' LEU . 92.5 m-70 -86.25 18.89 2.93 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.131 0.491 . . . . 75.209999999999994 111.869 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -87.85 26.78 1.26 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.228 0.537 . . . . 74.140000000000001 110.066 175.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -53.73 105.3 0.13 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.808 -0.633 . . . . 74.120000000000005 112.6 -174.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -69.71 -22.11 63.42 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.003 -0.544 . . . . 75.040000000000006 110.586 175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 19.6 p80 . . . . . 0 C--O 1.249 1.072 0 CA-C-N 116.092 -0.504 . . . . 72.109999999999999 111.115 173.685 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.391 0 CA-C-O 120.563 -0.021 . . . . 35.229999999999997 113.141 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.99 71.12 4.45 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.416 0.524 . . . . 71.140000000000001 112.416 -176.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.401 ' HD3' ' N ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -152.63 87.8 1.32 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.23 0.538 . . . . 64.040000000000006 110.714 172.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 4' ' ' ARG . 44.6 mtm180 60.12 87.3 0.09 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.668 -0.696 . . . . 74.530000000000001 112.09 -178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.86 -178.05 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.88 -0.6 . . . . 74.420000000000002 111.097 177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 23.8 mtp180 -58.1 127.43 32.08 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.9 0.381 . . . . 63.210000000000001 111.408 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.53 50.33 1.76 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.453 0.644 . . . . 73.150000000000006 111.4 -172.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.8 tt -81.19 141.6 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.246 -0.434 . . . . 73.409999999999997 110.242 171.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 ptp180 -53.32 162.87 0.66 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.757 0.651 . . . . 75.549999999999997 112.757 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.0 p -62.38 148.66 44.66 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.767 -0.651 . . . . 70.120000000000005 112.298 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -125.71 -176.66 3.67 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.091 -0.504 . . . . 74.219999999999999 111.014 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -64.14 89.33 0.08 OUTLIER Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.339 -0.458 . . . . 64.150000000000006 113.036 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.8 38.45 1.56 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.444 -0.408 . . . . 40.25 112.816 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -134.92 84.95 2.14 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.15 0.5 . . . . 65.25 110.306 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 45.8 m -97.14 123.62 40.96 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.009 0.374 . . . . 63.25 112.009 -174.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -71.11 164.69 25.1 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.201 0.524 . . . . 74.5 111.997 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.8 p -69.01 155.05 7.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-N 115.992 -0.549 . . . . 53.329999999999998 109.896 168.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -45.5 -33.85 2.93 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 112.978 0.733 . . . . 75.299999999999997 112.978 -176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.3 tt -145.63 111.21 5.43 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.477 -0.329 . . . . 74.430000000000007 110.486 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.6 74.5 1.06 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.914 0.387 . . . . 43.399999999999999 110.855 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.0 t 71.7 -38.57 0.42 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.245 0.618 . . . . 71.540000000000006 112.211 -174.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -92.11 130.88 37.74 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.304 0.573 . . . . 70.299999999999997 111.571 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.649 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 77.8 p -98.15 114.48 26.71 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.969 -0.56 . . . . 72.239999999999995 110.791 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -118.86 118.75 32.39 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.995 0.426 . . . . 75.5 111.749 -176.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.8 tt -126.59 136.43 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.04 0.448 . . . . 74.299999999999997 112.065 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -70.21 103.82 2.46 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.309 -0.405 . . . . 63.299999999999997 110.831 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -95.04 115.58 34.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.125 0.488 . . . . 70.5 111.592 -178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 36.3 t -102.61 126.67 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.043 -0.526 . . . . 74.219999999999999 111.054 177.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.645 ' HB2' ' HG2' ' A' ' 34' ' ' LYS . 10.7 t0 -83.33 121.82 76.96 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-O 120.623 0.249 . . . . 72.340000000000003 110.443 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.476 ' HD3' HG12 ' A' ' 86' ' ' VAL . 59.7 Cg_endo -69.87 -32.08 18.78 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.756 2.304 . . . . 72.319999999999993 112.843 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -89.63 -43.46 10.73 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.688 0.625 . . . . 75.019999999999996 112.688 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.6 p -97.54 -31.83 12.12 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.396 0.517 . . . . 73.310000000000002 112.396 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.96 29.75 16.88 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.984 -0.626 . . . . 71.150000000000006 113.985 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.645 ' HG2' ' HB2' ' A' ' 29' ' ' ASP . 10.6 ptpp? -90.29 137.86 32.01 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 117.399 0.599 . . . . 64.120000000000005 111.074 177.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.8 t -115.17 102.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 121.019 0.438 . . . . 61.350000000000001 110.693 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -131.69 140.64 49.36 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.448 -0.342 . . . . 60.219999999999999 111.13 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.3 mt -86.5 121.04 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.858 0.361 . . . . 61.009999999999998 110.542 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.17 152.83 32.93 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.861 0.689 . . . . 62.439999999999998 112.861 -175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 23' ' ' THR . 1.9 mp0 -83.4 130.76 35.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.002 -0.544 . . . . 74.349999999999994 110.831 175.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.464 HG12 HG22 ' A' ' 66' ' ' THR . 60.6 mt -88.31 114.4 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.689 0.28 . . . . 64.420000000000002 111.443 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -83.41 -53.67 5.54 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.126 0.489 . . . . 71.319999999999993 111.831 176.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 84.7 m-20 -122.42 135.69 54.74 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.989 0.424 . . . . 73.319999999999993 111.82 -174.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.7 m -108.8 31.47 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 121.174 0.511 . . . . 71.150000000000006 111.148 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.924 HG21 ' HB3' ' A' ' 50' ' ' PRO . 10.5 p -99.66 138.13 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 113.323 0.861 . . . . 70.239999999999995 113.323 -171.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -81.43 163.21 22.94 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.206 -0.906 . . . . 74.030000000000001 111.803 175.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -70.43 83.42 0.58 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.251 0.548 . . . . 72.140000000000001 110.897 177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.3 p -120.22 168.92 10.74 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.861 -0.609 . . . . 72.430000000000007 111.623 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.77 99.02 0.76 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.668 0.271 . . . . 65.409999999999997 111.289 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 62.28 93.51 0.06 OUTLIER Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 122.947 0.499 . . . . 75.230000000000004 111.583 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.924 ' HB3' HG21 ' A' ' 44' ' ' VAL . 72.5 Cg_exo -52.87 113.18 1.14 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.19 2.593 . . . . 72.430000000000007 113.549 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -141.1 162.43 35.51 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.314 0.578 . . . . 71.230000000000004 112.509 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -70.91 -2.58 15.58 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.518 -0.764 . . . . 74.310000000000002 112.205 -177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.2 p -55.46 -30.85 26.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 112.36 0.504 . . . . 64.230000000000004 112.36 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -105.28 160.36 15.17 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.58 0.229 . . . . 54.439999999999998 110.659 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.633 ' NE ' ' HA ' ' A' ' 55' ' ' ARG . 3.4 mmp_? -74.33 106.79 6.12 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.406 0.622 . . . . 72.200000000000003 112.548 -178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -74.55 60.59 0.89 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.226 -0.897 . . . . 73.5 112.125 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.424 HG13 HG23 ' A' ' 59' ' ' THR . 8.1 tp -94.04 137.32 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.275 0.559 . . . . 74.329999999999998 111.591 -178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.8 mt -86.46 103.09 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.212 -0.449 . . . . 73.299999999999997 111.064 178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.424 HG23 HG13 ' A' ' 57' ' ' ILE . 54.4 p -134.63 160.38 38.27 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.296 0.238 . . . . 64.120000000000005 111.514 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.407 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 48.8 ttp180 -53.83 119.69 5.31 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.84 0.353 . . . . 65.310000000000002 111.316 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 114.91 -20.45 14.63 Favored Glycine 0 CA--C 1.524 0.623 0 CA-C-N 116.215 -0.448 . . . . 45.200000000000003 112.646 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.99 153.9 29.94 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.089 0.471 . . . . 64.129999999999995 112.23 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.8 t -105.99 114.19 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.097 -0.501 . . . . 71.510000000000005 111.636 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.434 ' HB ' HG23 ' A' ' 40' ' ' ILE . 30.6 m -103.33 118.79 50.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-O 121.374 0.607 . . . . 52.200000000000003 111.368 177.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 32.4 tt0 -77.72 108.63 11.07 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.995 0.426 . . . . 72.430000000000007 111.169 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.464 HG22 HG12 ' A' ' 40' ' ' ILE . 24.1 p -102.96 169.81 8.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.287 -0.415 . . . . 41.439999999999998 111.124 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.434 HD22 ' N ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -59.01 -20.89 57.28 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 112.616 0.598 . . . . 64.329999999999998 112.616 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.7 mt -89.62 -25.3 21.36 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.965 0.412 . . . . 73.040000000000006 111.269 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 147.95 -176.61 26.7 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 116.103 -0.499 . . . . 73.299999999999997 112.738 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -72.74 119.46 17.01 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.22 0.533 . . . . 61.200000000000003 111.773 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 88.2 t -112.57 135.14 52.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.03 -0.532 . . . . 72.439999999999998 111.213 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.533 ' HB2' HD13 ' A' ' 88' ' ' ILE . 30.9 ttm180 -91.94 126.91 37.2 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.204 -0.31 . . . . 73.040000000000006 111.001 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 60' ' ' ARG . 30.2 t -68.86 100.64 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.767 0.318 . . . . 70.219999999999999 110.255 174.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.8 p -102.18 -26.01 13.5 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 122.052 -0.405 . . . . 71.200000000000003 111.666 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.405 ' CB ' ' HB2' ' A' ' 84' ' ' ASN . 37.4 t -100.34 -177.41 3.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.898 0.38 . . . . 63.130000000000003 110.623 175.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.496 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 44.2 mtp180 -100.02 130.19 26.79 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 122.264 -0.272 . . . . 73.430000000000007 111.192 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.539 ' HA ' HG12 ' A' ' 83' ' ' ILE . 21.1 Cg_exo -63.89 83.01 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.335 2.023 . . . . 72.349999999999994 112.218 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 159.08 -9.31 0.17 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.894 -0.67 . . . . 74.239999999999995 113.547 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 11.2 mm100 -59.22 103.66 0.2 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.023 0.412 . . . . 72.439999999999998 110.879 178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.8 t70 61.91 23.05 13.5 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 121.727 0.775 . . . . 73.200000000000003 110.681 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.5 -25.51 15.27 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 115.766 -0.652 . . . . 55.399999999999999 113.479 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 83' ' ' ILE . 7.2 p -96.3 165.59 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.103 0.477 . . . . 74.540000000000006 111.897 -174.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.539 HG12 ' HA ' ' A' ' 77' ' ' PRO . 29.5 mt -116.62 136.37 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.421 -0.354 . . . . 74.519999999999996 110.721 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.405 ' HB2' ' CB ' ' A' ' 75' ' ' SER . 4.4 m-20 -115.9 141.82 47.59 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.079 0.466 . . . . 64.439999999999998 111.741 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.58 174.2 30.76 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 116.102 -0.499 . . . . 43.450000000000003 112.968 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.476 HG12 ' HD3' ' A' ' 30' ' ' PRO . 6.3 t -120.46 132.31 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 122.299 -0.53 . . . . 75.409999999999997 111.813 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.65 105.76 3.81 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.88 0.371 . . . . 73.319999999999993 111.033 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.533 HD13 ' HB2' ' A' ' 72' ' ' ARG . 11.5 pt -104.69 172.12 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.452 0.644 . . . . 71.209999999999994 112.194 -174.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.425 ' HD2' ' C ' ' A' ' 88' ' ' ILE . 7.8 mpt_? -141.43 16.33 2.2 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.791 -0.641 . . . . 72.0 112.195 -175.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -73.37 -15.71 61.36 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.862 0.69 . . . . 74.409999999999997 112.862 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.523 HD23 ' H ' ' A' ' 91' ' ' LEU . 2.0 pt? -61.66 -176.07 0.07 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.013 0.745 . . . . 61.350000000000001 113.013 -175.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -46.07 108.08 0.12 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.401 0.68 . . . . 74.310000000000002 112.377 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 -84.99 128.02 34.45 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.28 -0.418 . . . . 73.120000000000005 111.394 -175.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.403 ' C ' ' H ' ' A' ' 96' ' ' HIS . 83.5 t60 -89.79 78.19 6.92 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 120.789 0.328 . . . . 75.209999999999994 110.924 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 68.6 -23.8 0.13 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.094 0.776 . . . . 64.299999999999997 113.094 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.403 ' H ' ' C ' ' A' ' 94' ' ' HIS . 45.0 t-80 -62.26 107.49 0.91 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.364 0.505 . . . . 73.129999999999995 112.364 -175.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -102.0 -43.38 5.79 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.942 0.401 . . . . 74.140000000000001 110.666 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 41.3 t60 . . . . . 0 C--O 1.252 1.227 0 CA-C-O 118.435 -0.793 . . . . 54.409999999999997 110.995 177.987 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 112.622 -0.191 . . . . 45.030000000000001 112.622 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -75.16 166.27 23.9 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.387 0.613 . . . . 73.209999999999994 112.245 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.83 155.28 31.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.626 -0.715 . . . . 73.109999999999999 110.025 174.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -163.99 103.69 0.89 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.147 0.498 . . . . 75.420000000000002 111.438 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 m -72.61 132.24 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.981 -0.554 . . . . 54.340000000000003 111.686 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.54 ' HA ' ' HE ' ' A' ' 6' ' ' ARG . 2.5 mmp_? -124.28 95.94 4.73 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.885 0.374 . . . . 72.150000000000006 111.017 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.459 ' N ' HD22 ' A' ' 7' ' ' LEU . 2.7 mm? -98.36 -5.52 32.62 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.26 -0.427 . . . . 64.219999999999999 111.003 179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.9 tp -65.1 91.39 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-O 121.868 0.842 . . . . 71.510000000000005 112.108 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -104.13 126.11 50.98 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.864 -0.607 . . . . 74.540000000000006 111.866 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.6 t -79.51 142.56 35.67 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.198 0.523 . . . . 75.329999999999998 111.405 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 11' ' ' ARG . 32.4 ttt180 -134.73 128.57 33.19 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.416 -0.356 . . . . 71.420000000000002 110.725 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 164.9 145.01 4.25 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 120.633 -0.794 . . . . 74.120000000000005 113.902 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.1 87.43 0.07 OUTLIER Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.367 -0.444 . . . . 62.229999999999997 112.799 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -116.39 170.73 8.32 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.238 0.542 . . . . 64.120000000000005 111.99 -177.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.9 m -137.08 140.07 41.73 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.849 -0.614 . . . . 70.409999999999997 111.147 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -67.17 151.05 48.26 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.161 0.505 . . . . 71.319999999999993 112.16 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 19' ' ' LEU . 48.7 t -80.21 143.35 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-N 116.036 -0.529 . . . . 73.099999999999994 111.696 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.423 ' HD2' ' N ' ' A' ' 19' ' ' LEU . 3.9 ppt_? -58.52 -17.48 21.69 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.648 0.61 . . . . 74.230000000000004 112.648 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.678 ' H ' HG12 ' A' ' 17' ' ' VAL . 8.6 tt -164.28 107.12 0.91 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.849 -0.426 . . . . 72.0 109.849 175.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.47 24.53 7.26 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.965 0.728 . . . . 72.420000000000002 112.965 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.8 t -155.51 -75.62 0.1 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.57 0.582 . . . . 72.230000000000004 112.57 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -141.98 177.77 7.98 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.212 0.449 . . . . 71.420000000000002 112.212 -174.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 44.7 p -101.83 112.49 25.12 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.009 0.433 . . . . 73.400000000000006 111.891 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 24' ' ' ARG . 49.1 mtm180 -143.9 163.46 33.35 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.374 -0.375 . . . . 65.099999999999994 111.019 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.482 ' HB ' HD11 ' A' ' 40' ' ' ILE . 14.0 tt -150.5 143.78 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.884 0.373 . . . . 63.340000000000003 111.767 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.448 ' HB2' HD22 ' A' ' 84' ' ' ASN . 3.8 m-20 -72.82 103.4 3.67 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.044 0.45 . . . . 64.430000000000007 110.262 173.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 55.2 t -91.25 113.79 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 63.520000000000003 111.904 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.9 t -95.62 113.02 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 116.021 -0.536 . . . . 74.310000000000002 110.774 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.79 118.72 74.08 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-O 121.092 0.472 . . . . 61.109999999999999 111.56 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.61 -1.73 10.7 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.832 2.355 . . . . 73.430000000000007 113.705 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -84.87 -44.0 13.61 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.252 -0.28 . . . . 64.329999999999998 111.664 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.4 p -124.55 -11.41 7.32 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.803 0.668 . . . . 64.299999999999997 112.803 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.22 24.66 39.61 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 120.974 -0.631 . . . . 64.329999999999998 113.785 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -93.01 145.59 24.25 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 122.411 -0.464 . . . . 72.519999999999996 111.21 177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.51 132.96 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.772 0.32 . . . . 73.409999999999997 111.196 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -147.83 143.03 27.18 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.6 0.238 . . . . 75.25 111.161 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.8 mt -86.22 111.41 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 122.25 -0.281 . . . . 64.319999999999993 111.12 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.485 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -110.54 155.2 22.63 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.118 0.414 . . . . 74.129999999999995 112.118 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -85.46 122.65 29.9 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.896 0.379 . . . . 62.140000000000001 111.495 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.563 ' HA ' HG22 ' A' ' 66' ' ' THR . 62.2 mt -73.04 116.59 15.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 116.423 -0.353 . . . . 61.210000000000001 110.726 176.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -81.04 -54.33 5.64 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.817 0.341 . . . . 75.530000000000001 111.367 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -145.41 152.8 40.4 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.872 0.368 . . . . 74.349999999999994 111.254 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.475 ' O ' HG22 ' A' ' 43' ' ' VAL . 13.8 p -90.81 13.09 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-O 121.443 0.64 . . . . 74.129999999999995 111.712 -178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 44' ' ' VAL . 5.9 p -65.81 99.25 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-O 121.489 0.661 . . . . 71.340000000000003 111.166 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' HB3' ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -86.33 -28.79 23.46 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.503 0.557 . . . . 72.140000000000001 112.503 -175.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -174.22 -30.83 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 112.115 0.413 . . . . 64.409999999999997 112.115 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.519 HG21 ' HD3' ' A' ' 54' ' ' ARG . 13.0 t -60.99 157.77 14.81 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.594 0.59 . . . . 63.200000000000003 112.594 -177.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.94 -14.66 27.25 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.293 -0.412 . . . . 52.310000000000002 111.081 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.54 ' N ' ' HD3' ' A' ' 50' ' ' PRO . 14.5 t-20 54.03 56.22 12.68 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 115.669 -0.696 . . . . 73.219999999999999 112.336 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.54 ' HD3' ' N ' ' A' ' 49' ' ' ASN . 6.2 Cg_exo -80.24 -26.61 4.09 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 122.674 2.25 . . . . 55.340000000000003 112.595 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -130.93 132.09 44.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.334 -0.394 . . . . 61.409999999999997 110.58 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -77.21 73.02 3.79 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.607 0.718 . . . . 73.340000000000003 111.957 -175.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.7 p -127.21 -22.34 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.654 -0.703 . . . . 71.420000000000002 110.978 176.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HD3' HG21 ' A' ' 47' ' ' THR . 34.5 ttt85 -79.23 124.54 28.46 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.711 -0.677 . . . . 72.129999999999995 111.406 -176.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -79.69 87.03 5.23 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.215 0.531 . . . . 71.219999999999999 111.157 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -69.52 103.87 2.18 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.124 -0.489 . . . . 70.129999999999995 110.953 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.0 tt -141.98 145.69 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 120.985 0.421 . . . . 63.240000000000002 111.651 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.559 HG21 HD13 ' A' ' 83' ' ' ILE . 46.4 mm -65.12 112.06 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.256 -0.429 . . . . 75.219999999999999 111.337 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.7 t -147.85 167.57 24.43 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.184 -0.322 . . . . 70.219999999999999 111.586 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -62.35 127.29 30.66 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.057 0.456 . . . . 65.239999999999995 111.675 -176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.55 -22.09 42.18 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 121.286 -0.483 . . . . 42.5 112.909 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -73.86 129.36 37.75 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.911 0.386 . . . . 54.32 111.3 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.478 ' H ' ' HB3' ' A' ' 45' ' ' GLU . 57.8 t -94.03 115.27 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.307 -0.406 . . . . 65.439999999999998 111.396 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' A' ' 40' ' ' ILE . 35.2 m -103.59 129.02 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.232 0.539 . . . . 72.540000000000006 111.341 178.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -76.44 110.27 10.85 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.891 0.377 . . . . 42.340000000000003 110.767 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.563 HG22 ' HA ' ' A' ' 40' ' ' ILE . 33.3 p -107.78 171.9 7.13 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.841 0.353 . . . . 73.219999999999999 111.267 179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.485 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 10.1 p-10 -55.78 -33.9 64.78 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 116.439 -0.346 . . . . 73.420000000000002 111.545 176.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' A' ' 38' ' ' ALA . 74.9 mt -81.23 -29.82 34.36 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 111.744 0.276 . . . . 62.210000000000001 111.744 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 149.01 -166.96 29.42 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.528 -0.844 . . . . 52.530000000000001 113.921 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -71.17 101.69 2.34 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.841 0.353 . . . . 61.340000000000003 111.523 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 76.9 t -99.61 117.0 44.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.086 0.47 . . . . 61.140000000000001 111.342 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -87.16 117.76 26.12 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.839 0.352 . . . . 61.149999999999999 110.61 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.432 HG21 HG23 ' A' ' 58' ' ' ILE . 51.8 t -67.95 140.17 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 112.61 0.596 . . . . 51.219999999999999 112.61 -173.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.0 p -117.95 -43.47 2.76 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.404 0.52 . . . . 75.099999999999994 112.404 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.9 p -85.81 -179.35 6.81 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.099 0.476 . . . . 61.420000000000002 112.139 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.8 mmm180 -99.96 132.78 22.29 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 116.337 -0.392 . . . . 71.430000000000007 110.829 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.441 ' HG3' ' O ' ' A' ' 58' ' ' ILE . 60.1 Cg_endo -70.63 108.9 2.35 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.432 2.088 . . . . 65.409999999999997 112.877 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 153.57 -33.51 0.76 Allowed Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.906 -0.664 . . . . 75.25 113.363 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.506 ' O ' HG12 ' A' ' 82' ' ' VAL . 85.4 mm-40 -57.59 97.67 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.719 0.26 . . . . 75.319999999999993 111.532 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 56.82 17.08 3.03 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.558 0.577 . . . . 73.25 112.558 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.56 25.16 70.84 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 121.398 -0.429 . . . . 63.32 114.041 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.506 HG12 ' O ' ' A' ' 79' ' ' GLN . 9.1 p -121.37 140.43 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 117.237 0.519 . . . . 63.109999999999999 111.533 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.559 HD13 HG21 ' A' ' 58' ' ' ILE . 62.9 mt -121.69 145.43 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 120.988 0.423 . . . . 72.329999999999998 110.985 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.448 HD22 ' HB2' ' A' ' 26' ' ' ASN . 9.8 m120 -120.04 147.52 44.72 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.117 -0.364 . . . . 74.120000000000005 111.206 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -164.23 176.81 40.13 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.221 -0.514 . . . . 54.520000000000003 112.915 177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.82 146.88 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 121.579 0.704 . . . . 63.240000000000002 112.899 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 63.8 tp -85.68 112.66 21.23 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.294 -0.866 . . . . 74.129999999999995 112.204 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.4 pt -134.43 -174.78 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 120.954 0.407 . . . . 53.219999999999999 111.182 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -136.58 90.48 2.56 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.82 0.343 . . . . 73.299999999999997 111.089 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -80.96 -27.2 36.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.181 0.515 . . . . 75.420000000000002 110.615 176.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.6 mt -90.54 138.17 31.77 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.323 0.583 . . . . 74.099999999999994 111.497 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.803 ' HB3' ' HB2' ' A' ' 95' ' ' HIS . 36.0 tt0 -52.73 142.13 19.4 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.375 -0.83 . . . . 75.209999999999994 111.832 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -67.53 -22.11 65.44 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.91 0.707 . . . . 75.230000000000004 112.91 -172.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.477 ' H ' ' HG2' ' A' ' 92' ' ' GLU . 27.8 p-80 -122.99 37.33 4.44 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.225 0.536 . . . . 64.209999999999994 110.462 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.803 ' HB2' ' HB3' ' A' ' 92' ' ' GLU . 56.6 t60 -86.83 123.53 32.07 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.142 -0.481 . . . . 73.519999999999996 112.245 -172.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.446 ' O ' ' HB2' ' A' ' 97' ' ' HIS . 23.1 p-80 -153.87 156.28 37.29 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.113 -0.494 . . . . 63.32 111.297 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 96' ' ' HIS . 35.7 m80 73.66 29.5 1.51 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.467 0.707 . . . . 65.329999999999998 112.022 -175.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 . . . . . 0 C--O 1.253 1.263 0 CA-C-O 118.773 -0.632 . . . . 74.420000000000002 111.587 174.011 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 CA-C-O 120.669 0.038 . . . . 53.399999999999999 113.145 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.31 -160.36 0.78 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 120.963 0.411 . . . . 73.340000000000003 111.301 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -86.24 82.85 7.87 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.158 -0.338 . . . . 63.109999999999999 111.245 -177.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -123.38 152.97 41.0 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 111.91 0.337 . . . . 74.129999999999995 111.91 178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.436 ' O ' HG22 ' A' ' 8' ' ' ILE . 10.3 m 48.74 11.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 114.952 1.464 . . . . 65.239999999999995 114.952 174.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -82.58 -0.69 48.06 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.758 -0.589 . . . . 63.109999999999999 111.635 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.505 HD12 ' N ' ' A' ' 7' ' ' LEU . 5.4 mp -86.55 2.04 49.52 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.423 -0.353 . . . . 74.129999999999995 111.929 -176.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 5' ' ' VAL . 11.4 tt -98.11 118.86 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.323 0.582 . . . . 74.219999999999999 111.472 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -117.07 147.32 42.48 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.167 -0.47 . . . . 75.430000000000007 111.141 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -101.95 179.66 4.26 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.43 0.633 . . . . 75.319999999999993 112.376 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -79.24 -32.04 43.75 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.782 -0.644 . . . . 63.329999999999998 110.772 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.42 39.86 6.21 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.999 -0.546 . . . . 60.329999999999998 112.398 -176.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.68 137.14 24.04 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.734 -0.27 . . . . 53.200000000000003 113.684 -176.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -149.07 124.34 10.2 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.619 -0.342 . . . . 73.040000000000006 110.86 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.7 m -81.73 121.2 26.1 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.554 -0.294 . . . . 71.409999999999997 111.438 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -91.43 169.2 10.98 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 120.756 0.312 . . . . 71.25 111.245 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.456 HG22 ' N ' ' A' ' 18' ' ' ARG . 12.5 p -118.01 165.06 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-O 120.855 0.36 . . . . 72.109999999999999 111.735 -175.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.456 ' N ' HG22 ' A' ' 17' ' ' VAL . 74.7 mtp180 -60.4 170.97 1.18 Allowed 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 121.226 0.536 . . . . 62.509999999999998 112.109 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.5 pt? -58.64 -9.69 1.85 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.979 0.733 . . . . 64.540000000000006 112.979 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.61 -23.96 12.58 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.12 0.415 . . . . 64.430000000000007 112.12 175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.9 t -108.06 -37.17 6.13 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.415 -0.357 . . . . 74.219999999999999 111.94 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -136.42 116.23 13.11 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.969 0.414 . . . . 71.420000000000002 111.458 -175.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 30.6 p -109.94 112.36 24.33 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.143 0.497 . . . . 75.329999999999998 111.947 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -144.63 155.59 43.69 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.208 -0.451 . . . . 62.409999999999997 111.101 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.446 ' HB ' HD11 ' A' ' 40' ' ' ILE . 13.1 tt -145.45 145.82 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.792 0.33 . . . . 52.32 111.537 -177.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.524 HD22 ' N ' ' A' ' 26' ' ' ASN . 0.8 OUTLIER -80.3 103.78 10.41 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.425 0.631 . . . . 73.230000000000004 110.506 174.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' A' ' 87' ' ' LEU . 23.0 t -95.36 121.88 46.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.429 -0.805 . . . . 74.030000000000001 111.922 -175.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.9 t -94.5 112.28 26.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.931 0.396 . . . . 64.409999999999997 110.571 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -74.26 118.24 68.16 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.477 -0.329 . . . . 61.310000000000002 111.142 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.93 -12.36 17.85 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.554 2.17 . . . . 71.150000000000006 113.116 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -81.67 -44.73 16.75 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.818 0.342 . . . . 63.340000000000003 111.907 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 40.9 p -107.18 -31.0 8.43 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 111.785 0.291 . . . . 61.509999999999998 111.785 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.8 16.96 34.36 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.333 -0.461 . . . . 71.510000000000005 113.733 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -87.21 150.67 23.76 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 117.234 0.517 . . . . 74.329999999999998 111.813 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.86 95.31 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.522 0.677 . . . . 63.109999999999999 110.49 175.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -93.02 170.03 9.97 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.504 -0.771 . . . . 75.239999999999995 110.868 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.6 mt -125.16 124.77 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 122.035 -0.416 . . . . 73.329999999999998 111.09 174.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.85 163.13 19.73 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.554 0.576 . . . . 75.340000000000003 112.554 -177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -92.82 123.39 36.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.01 -0.541 . . . . 71.530000000000001 110.648 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 23' ' ' THR . 57.7 mt -78.79 106.19 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 120.022 -0.671 . . . . 64.430000000000007 110.341 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -88.08 -37.05 16.58 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.789 -0.641 . . . . 74.450000000000003 112.573 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.557 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 46.2 m-80 -133.31 146.84 51.72 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.115 0.483 . . . . 72.209999999999994 111.322 173.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.7 m -104.99 10.81 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 112.44 0.533 . . . . 74.230000000000004 112.44 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.1 p -85.23 140.96 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.94 0.4 . . . . 74.230000000000004 111.679 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -118.53 172.82 7.21 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.327 -0.397 . . . . 74.439999999999998 111.173 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.412 HD21 ' HB3' ' A' ' 90' ' ' GLU . 1.9 m120 -63.61 99.23 0.21 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.005 0.431 . . . . 71.310000000000002 111.005 175.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.7 t -160.19 167.41 27.7 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.265 -0.425 . . . . 60.100000000000001 111.734 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.64 20.85 0.55 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.319 0.488 . . . . 62.119999999999997 112.319 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -113.11 82.64 5.61 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-O 120.758 0.313 . . . . 51.140000000000001 111.393 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -82.74 -60.03 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.486 2.124 . . . . 73.129999999999995 113.737 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -89.11 12.87 14.49 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.077 0.399 . . . . 72.540000000000006 112.077 -176.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -88.23 122.0 31.26 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.767 0.318 . . . . 75.150000000000006 110.756 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 p -90.18 13.06 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 121.351 0.596 . . . . 65.530000000000001 111.54 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -111.42 -177.95 3.33 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.153 -0.342 . . . . 74.430000000000007 111.227 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.504 ' NE ' ' O ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER 77.4 -13.27 0.97 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.257 0.623 . . . . 73.019999999999996 110.722 -171.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -41.64 -21.56 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.223 1.194 . . . . 71.129999999999995 114.223 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 55' ' ' ARG . 69.1 mt -52.49 120.21 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 120.946 0.403 . . . . 73.109999999999999 111.717 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.6 mm -75.03 131.7 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.823 0.344 . . . . 70.120000000000005 111.165 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -147.81 174.12 12.14 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.009 0.433 . . . . 72.310000000000002 111.827 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -71.89 118.72 15.09 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 111.381 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.23 -14.93 30.68 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.42 -0.419 . . . . 54.520000000000003 112.914 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.08 142.34 31.35 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.968 0.413 . . . . 63.350000000000001 111.927 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 64.1 t -98.07 141.13 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.78 0.324 . . . . 64.519999999999996 111.155 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.62 173.34 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.971 0.415 . . . . 71.319999999999993 111.469 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 34.5 tt0 -112.52 133.26 54.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.41 -0.359 . . . . 72.420000000000002 110.791 177.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.421 HG22 ' HA ' ' A' ' 40' ' ' ILE . 41.6 p -135.68 178.67 6.86 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.328 0.585 . . . . 52.340000000000003 111.804 -176.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -69.89 -14.41 62.72 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.99 -0.55 . . . . 62.329999999999998 112.383 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.5 mt -98.58 -17.23 18.77 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.809 0.338 . . . . 74.430000000000007 111.247 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.99 -149.29 20.17 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.41 -0.676 . . . . 72.140000000000001 111.41 -172.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' ND2' HD12 ' A' ' 91' ' ' LEU . 23.5 m120 -94.16 148.53 22.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 117.646 0.723 . . . . 71.010000000000005 111.276 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.6 t -133.89 127.07 51.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.65 -0.25 . . . . 74.340000000000003 111.241 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 72' ' ' ARG . 15.5 ttm180 -96.28 115.95 28.24 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.557 0.217 . . . . 65.430000000000007 110.832 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.1 t -61.76 126.99 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 112.448 0.536 . . . . 74.109999999999999 112.448 -175.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.5 p -100.96 -41.37 6.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.634 0.605 . . . . 74.019999999999996 112.634 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 69.5 m -101.5 178.64 4.58 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.018 0.437 . . . . 75.310000000000002 111.855 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -88.35 117.34 68.27 Favored Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 111.986 0.365 . . . . 70.230000000000004 111.986 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.96 140.97 82.16 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.596 2.197 . . . . 71.340000000000003 112.313 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.69 -39.26 3.06 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 120.795 -0.717 . . . . 62.140000000000001 113.471 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -45.42 -74.96 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.984 0.514 . . . . 71.310000000000002 111.447 -177.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -78.67 -13.38 59.85 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.27 0.557 . . . . 72.340000000000003 110.844 175.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.05 -27.44 19.42 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 116.113 -0.494 . . . . 51.240000000000002 112.388 -175.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p -104.02 145.37 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 120.849 0.357 . . . . 62.240000000000002 111.269 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 36.2 mt -102.83 144.99 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.734 0.302 . . . . 72.010000000000005 110.71 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -126.94 151.23 48.77 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.584 0.231 . . . . 70.129999999999995 111.421 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -167.44 175.88 42.38 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 121.277 -0.487 . . . . 74.219999999999999 113.239 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.1 t -106.3 142.11 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 CA-C-N 117.078 0.439 . . . . 71.340000000000003 111.405 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.495 ' HB2' HG12 ' A' ' 27' ' ' VAL . 40.7 tp -76.36 114.35 14.95 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.157 0.503 . . . . 74.040000000000006 111.456 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' A' ' 72' ' ' ARG . 8.0 pt -133.51 179.22 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.189 0.518 . . . . 64.019999999999996 111.166 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -139.26 32.13 2.13 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.207 -0.308 . . . . 62.43 111.239 -176.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.421 ' OE2' HD12 ' A' ' 88' ' ' ILE . 43.2 mt-10 -59.76 -53.91 52.46 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.849 0.685 . . . . 74.129999999999995 112.849 -176.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.459 HD12 ' ND2' ' A' ' 70' ' ' ASN . 81.0 mt -64.75 145.71 55.84 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 109.779 -0.452 . . . . 71.420000000000002 109.779 173.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.78 97.01 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 121.408 0.623 . . . . 72.340000000000003 111.689 -170.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -144.11 99.01 3.31 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.688 -0.687 . . . . 55.43 110.68 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -64.25 115.98 5.56 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 111.783 0.29 . . . . 74.430000000000007 111.783 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -71.24 -17.48 62.49 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.401 0.619 . . . . 75.310000000000002 110.563 175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -130.84 125.34 33.39 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.388 -0.823 . . . . 71.409999999999997 109.323 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -54.3 131.68 42.26 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.992 0.367 . . . . 73.439999999999998 111.992 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.8 p80 . . . . . 0 C--O 1.254 1.334 0 CA-C-O 118.649 -0.691 . . . . 71.030000000000001 112.574 -178.028 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 112.972 -0.051 . . . . 73.409999999999997 112.972 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -81.31 -179.77 7.51 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 112.351 0.5 . . . . 74.019999999999996 112.351 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -129.44 175.66 8.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.344 -0.389 . . . . 73.219999999999999 111.286 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? 61.82 78.86 0.27 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.964 0.506 . . . . 53.549999999999997 111.622 -177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -86.53 157.15 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.963 0.411 . . . . 73.109999999999999 111.865 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 58.79 23.81 11.63 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.072 -0.513 . . . . 74.219999999999999 111.804 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 36.6 tp -72.3 -14.75 61.83 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 116.272 -0.422 . . . . 74.319999999999993 111.682 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.507 HD13 ' N ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -95.74 140.46 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.278 0.561 . . . . 74.340000000000003 111.251 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.507 ' N ' HD13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -159.3 155.39 26.81 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.005 -0.543 . . . . 74.239999999999995 111.174 178.379 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.8 m -153.05 146.47 24.91 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 111.937 0.347 . . . . 74.219999999999999 111.937 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -120.98 -20.0 7.02 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.084 0.402 . . . . 73.219999999999999 112.084 175.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.03 -99.82 0.89 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.23 -0.509 . . . . 75.040000000000006 113.273 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.88 114.59 1.32 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.42 -0.419 . . . . 31.350000000000001 113.429 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -148.38 174.88 11.6 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 122.737 -0.273 . . . . 72.409999999999997 110.374 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.2 m -63.73 108.01 1.32 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 121.102 0.477 . . . . 72.400000000000006 111.495 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -123.3 179.06 4.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.148 0.499 . . . . 73.510000000000005 112.009 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.2 p -68.53 160.33 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.886 -0.597 . . . . 64.150000000000006 110.795 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 18' ' ' ARG . 5.8 ptp180 -46.9 -32.53 3.86 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 113.237 0.829 . . . . 64.540000000000006 113.237 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 tt -160.94 109.0 1.55 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.9 0.381 . . . . 72.299999999999997 110.477 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.35 79.93 1.64 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.087 0.47 . . . . 74.340000000000003 111.635 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.4 m 62.94 14.9 7.89 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.377 0.88 . . . . 65.129999999999995 113.377 173.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -141.31 129.85 22.64 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 122.006 -0.434 . . . . 71.319999999999993 110.388 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.517 HG22 ' HB ' ' A' ' 40' ' ' ILE . 25.8 m -90.42 113.57 25.52 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.914 0.387 . . . . 63.5 111.729 -175.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -129.11 165.83 20.49 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.521 -0.308 . . . . 71.230000000000004 111.485 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.541 ' HB ' HD11 ' A' ' 40' ' ' ILE . 15.5 tt -155.17 139.74 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 120.762 0.315 . . . . 74.140000000000001 111.419 177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.459 ' OD1' HG12 ' A' ' 37' ' ' ILE . 90.3 m-20 -80.93 103.61 10.87 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.015 0.436 . . . . 70.219999999999999 110.841 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.447 HG22 HG21 ' A' ' 71' ' ' VAL . 60.3 t -85.35 121.44 37.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.98 -0.554 . . . . 73.5 112.013 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.01 111.37 26.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.113 -0.494 . . . . 65.329999999999998 110.788 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.425 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 11.2 t70 -77.77 115.8 53.08 Favored Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.413 -0.358 . . . . 63.119999999999997 110.283 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.28 -20.05 21.66 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.388 2.058 . . . . 73.109999999999999 113.791 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -86.01 -33.54 21.02 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.942 0.401 . . . . 65.019999999999996 111.885 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.5 p -116.4 -21.27 9.34 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.155 0.428 . . . . 62.109999999999999 112.155 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.34 25.72 50.21 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 114.391 0.516 . . . . 61.310000000000002 114.391 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 58.0 pttt -87.6 155.97 19.71 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.52 0.66 . . . . 75.549999999999997 111.705 177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.1 t -118.7 111.5 34.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.138 -0.483 . . . . 64.510000000000005 109.909 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -133.38 136.6 45.4 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.132 0.419 . . . . 73.219999999999999 112.132 -173.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.459 HG12 ' OD1' ' A' ' 26' ' ' ASN . 61.5 mt -76.76 123.84 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.269 0.557 . . . . 50.240000000000002 112.105 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.526 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -117.81 170.32 8.89 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.032 -0.531 . . . . 70.140000000000001 111.606 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -104.69 127.27 52.4 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.418 -0.356 . . . . 73.450000000000003 110.466 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.541 HD11 ' HB ' ' A' ' 25' ' ' ILE . 53.8 mt -83.91 124.23 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 121.093 0.473 . . . . 64.349999999999994 111.617 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -81.11 -53.8 6.08 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.007 -0.542 . . . . 71.319999999999993 111.301 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -143.93 152.47 41.14 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.923 0.392 . . . . 71.400000000000006 111.553 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.516 HG13 HG12 ' A' ' 64' ' ' VAL . 48.6 t -120.08 88.87 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 N-CA-C 109.555 -0.535 . . . . 72.430000000000007 109.555 176.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 p -160.2 142.4 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 112.522 0.564 . . . . 72.129999999999995 112.522 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -147.45 133.72 19.51 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.207 0.527 . . . . 63.420000000000002 112.11 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 61.62 13.89 5.59 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.061 1.134 . . . . 74.5 114.061 171.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 p -88.01 -169.6 2.64 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.829 -0.544 . . . . 64.019999999999996 111.571 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.38 -44.38 65.09 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.06 0.393 . . . . 71.200000000000003 112.06 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -125.06 128.02 24.92 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 116.638 -0.256 . . . . 71.099999999999994 111.682 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.02 51.82 3.58 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 122.921 2.414 . . . . 73.329999999999998 113.095 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -132.76 -169.93 2.34 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 122.494 0.318 . . . . 71.310000000000002 110.42 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -66.43 84.46 0.1 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.339 0.59 . . . . 75.409999999999997 110.428 173.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 56' ' ' ASN . 11.4 p -106.78 152.25 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 115.733 -0.667 . . . . 73.530000000000001 110.43 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -54.12 158.15 2.32 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 111.844 0.313 . . . . 72.540000000000006 111.844 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 55' ' ' ARG . 2.0 tpm_? 76.6 12.74 2.46 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.477 0.656 . . . . 72.129999999999995 110.15 -171.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 53' ' ' VAL . 3.4 p-10 -74.71 53.82 0.59 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.443 -0.799 . . . . 75.420000000000002 112.485 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.429 ' O ' HG13 ' A' ' 57' ' ' ILE . 37.8 pt -83.35 116.31 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.318 0.58 . . . . 75.200000000000003 111.885 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.589 HG21 HD13 ' A' ' 83' ' ' ILE . 62.2 mt -74.23 100.47 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 121.075 0.464 . . . . 74.019999999999996 110.726 176.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.3 t -142.24 169.4 17.65 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.051 0.453 . . . . 73.120000000000005 111.574 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -61.51 126.15 26.34 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.288 -0.415 . . . . 74.420000000000002 111.753 -177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.06 -24.91 21.98 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.387 -0.435 . . . . 64.209999999999994 112.97 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.24 141.64 35.39 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.874 0.368 . . . . 51.210000000000001 111.694 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.527 HG11 ' HG3' ' A' ' 90' ' ' GLU . 35.3 m -100.57 133.11 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-O 121.296 0.57 . . . . 60.399999999999999 111.833 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.516 HG12 HG13 ' A' ' 43' ' ' VAL . 32.1 m -111.92 146.76 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.177 0.513 . . . . 74.109999999999999 111.685 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -89.84 112.65 24.05 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.254 -0.43 . . . . 74.230000000000004 110.259 175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.4 p -115.01 174.84 5.77 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 120.962 0.411 . . . . 53.109999999999999 111.593 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.526 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 19.5 p-10 -62.9 -31.78 72.9 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.992 0.425 . . . . 72.140000000000001 111.444 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 38' ' ' ALA . 88.5 mt -82.6 -19.03 39.21 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.291 -0.413 . . . . 62.130000000000003 111.464 177.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.18 -150.32 19.6 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.828 -0.701 . . . . 74.430000000000007 113.853 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -83.44 119.26 24.44 Favored 'General case' 0 N--CA 1.468 0.436 0 O-C-N 122.563 -0.375 . . . . 73.450000000000003 111.207 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.447 HG21 HG22 ' A' ' 27' ' ' VAL . 47.6 t -123.69 122.93 66.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.608 0.242 . . . . 73.019999999999996 111.494 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -91.22 116.09 28.55 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.284 -0.26 . . . . 63.439999999999998 111.407 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.63 134.02 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 112.336 0.495 . . . . 74.109999999999999 112.336 -177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 68.3 p -118.65 -66.9 1.03 Allowed 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.331 -0.395 . . . . 61.350000000000001 111.916 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.3 m -64.24 133.43 52.78 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.787 0.327 . . . . 54.140000000000001 111.737 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -59.75 120.65 51.49 Favored Pre-proline 0 N--CA 1.472 0.642 0 CA-C-N 116.353 -0.385 . . . . 72.239999999999995 111.922 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.535 ' HB3' HG12 ' A' ' 83' ' ' ILE . 27.8 Cg_exo -61.56 94.94 0.12 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.769 2.313 . . . . 75.239999999999995 112.585 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.86 -63.71 0.42 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.556 -0.83 . . . . 55.119999999999997 113.168 178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -53.71 -55.59 24.84 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 111.888 0.329 . . . . 75.129999999999995 111.888 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -66.21 -25.79 67.08 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.299 0.571 . . . . 64.319999999999993 110.902 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.91 -25.57 26.94 Favored Glycine 0 CA--C 1.524 0.595 0 CA-C-N 116.045 -0.525 . . . . 34.32 112.936 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.421 HG11 HD21 ' A' ' 26' ' ' ASN . 12.7 p -135.08 160.94 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 120.857 0.361 . . . . 60.5 110.956 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.589 HD13 HG21 ' A' ' 58' ' ' ILE . 60.2 mt -91.75 126.98 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.533 -0.303 . . . . 74.340000000000003 111.3 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -119.31 157.41 28.14 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.774 0.321 . . . . 73.409999999999997 111.337 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.33 177.94 39.12 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.107 -0.568 . . . . 30.0 113.407 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.5 t -111.08 138.98 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 122.454 -0.439 . . . . 71.340000000000003 111.627 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.8 tp -81.08 115.66 20.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.94 0.4 . . . . 52.420000000000002 111.362 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.562 HG13 ' HG2' ' A' ' 90' ' ' GLU . 5.6 pt -141.29 -166.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 120.94 0.4 . . . . 65.140000000000001 111.759 -176.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -122.8 100.87 7.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.821 0.343 . . . . 73.239999999999995 111.295 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.562 ' HG2' HG13 ' A' ' 88' ' ' ILE . 6.8 mm-40 -120.82 -64.0 1.29 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.392 0.615 . . . . 42.240000000000002 111.398 -177.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.9 mt -97.44 -158.29 0.66 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.746 -0.661 . . . . 72.409999999999997 112.102 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.21 168.22 0.25 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.273 0.559 . . . . 72.019999999999996 112.403 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -98.17 31.5 2.74 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.75 0.648 . . . . 62.549999999999997 112.75 -171.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -69.71 89.98 0.57 Allowed 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.939 -0.475 . . . . 74.530000000000001 111.349 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -118.21 133.42 55.91 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.211 -0.449 . . . . 63.539999999999999 111.192 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -175.43 125.93 0.24 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.022 0.439 . . . . 64.030000000000001 111.286 172.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -82.33 -18.08 43.44 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.306 -0.407 . . . . 74.400000000000006 110.731 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 . . . . . 0 C--O 1.254 1.308 0 CA-C-O 118.537 -0.744 . . . . 74.319999999999993 111.143 -179.566 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 CA-C-O 120.571 -0.016 . . . . 72.329999999999998 113.105 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -117.28 126.38 52.63 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.946 0.403 . . . . 74.209999999999994 111.963 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.479 ' HD3' ' O ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -153.22 143.73 22.57 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.977 0.417 . . . . 72.329999999999998 110.918 173.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.405 ' HD3' HH11 ' A' ' 4' ' ' ARG . 22.2 mtm180 -123.62 171.26 9.69 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.987 0.422 . . . . 65.120000000000005 111.382 -177.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 6' ' ' ARG . 14.0 p -132.25 163.03 38.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 116.106 -0.497 . . . . 74.340000000000003 110.671 -177.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' N ' HG22 ' A' ' 5' ' ' VAL . 96.5 mtt180 -77.29 118.05 19.4 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.783 0.325 . . . . 65.239999999999995 111.122 175.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 7' ' ' LEU . 6.8 mp -83.51 39.02 0.65 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.406 0.622 . . . . 75.319999999999993 110.736 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.1 tt -71.36 127.29 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.031 -0.531 . . . . 72.109999999999999 111.718 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -96.35 94.95 7.74 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.84 0.352 . . . . 74.530000000000001 110.658 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.2 m -67.75 87.78 0.23 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.139 0.495 . . . . 75.230000000000004 111.205 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -94.79 153.61 17.66 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.261 0.553 . . . . 74.349999999999994 112.289 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.02 -153.94 11.52 Favored Glycine 0 CA--C 1.528 0.87 0 CA-C-N 115.759 -0.655 . . . . 60.409999999999997 112.168 172.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.22 151.79 6.05 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.82 -0.705 . . . . 72.230000000000004 113.579 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -139.99 170.56 15.63 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.352 0.261 . . . . 63.32 110.481 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 93.8 m -48.44 121.92 4.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.18 0.514 . . . . 64.310000000000002 112.332 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -97.54 -170.51 2.02 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.137 -0.483 . . . . 55.219999999999999 111.175 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 19' ' ' LEU . 7.3 p -67.68 130.28 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.013 0.435 . . . . 71.109999999999999 110.903 173.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.504 ' HD3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -68.7 -25.12 64.61 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.007 0.743 . . . . 72.200000000000003 113.007 -176.174 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.571 HD11 ' HA ' ' A' ' 23' ' ' THR . 7.7 tt -176.87 135.71 0.22 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.866 0.365 . . . . 73.409999999999997 111.307 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.16 -63.27 1.43 Allowed 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.12 0.485 . . . . 65.219999999999999 111.125 175.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 98.6 p -139.43 20.01 2.56 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.409 0.623 . . . . 73.109999999999999 110.207 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.0 28.2 2.86 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.439 -0.801 . . . . 65.439999999999998 111.812 -171.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.571 ' HA ' HD11 ' A' ' 19' ' ' LEU . 18.9 m -64.66 112.11 3.05 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.262 0.553 . . . . 45.409999999999997 112.373 -172.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -148.14 162.9 38.5 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.713 -0.676 . . . . 70.140000000000001 110.487 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 tt -150.55 141.81 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 112.047 0.388 . . . . 64.310000000000002 112.047 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -80.45 103.24 10.18 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.102 0.477 . . . . 73.420000000000002 110.035 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.413 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 61.3 t -90.81 125.22 43.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.506 . . . . 70.230000000000004 111.847 -175.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.38 119.86 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 116.066 -0.515 . . . . 62.140000000000001 110.834 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -77.49 121.45 84.41 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 116.122 -0.49 . . . . 72.319999999999993 110.98 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.32 -17.56 8.94 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.579 2.186 . . . . 71.109999999999999 112.951 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -85.21 -43.68 13.58 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.911 0.386 . . . . 54.43 111.476 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.517 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 37.2 p -114.32 -10.83 12.64 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.154 0.798 . . . . 74.140000000000001 113.154 -176.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 72.84 22.87 78.78 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 120.86 -0.686 . . . . 54.399999999999999 114.202 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 21.2 pttp -102.82 142.6 33.67 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.27 0.535 . . . . 70.409999999999997 111.49 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.8 t -102.88 119.86 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.824 0.345 . . . . 74.209999999999994 111.081 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -132.38 146.09 51.71 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.983 0.42 . . . . 75.430000000000007 111.579 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 53.4 mt -82.71 125.78 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.844 0.354 . . . . 75.439999999999998 111.589 -177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.533 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -118.55 162.41 18.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.245 0.545 . . . . 65.200000000000003 112.195 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -102.86 114.36 28.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.966 -0.561 . . . . 64.239999999999995 110.511 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.551 ' HB ' HG22 ' A' ' 23' ' ' THR . 58.7 mt -76.1 113.38 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 120.738 0.304 . . . . 61.229999999999997 111.372 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -83.1 -53.87 5.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.037 0.446 . . . . 45.409999999999997 111.368 178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -121.32 151.47 40.05 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.109 -0.496 . . . . 70.200000000000003 111.69 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 56' ' ' ASN . 9.1 m -129.8 93.59 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 121.141 0.496 . . . . 74.040000000000006 112.05 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 p -178.87 139.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 116.03 -0.532 . . . . 74.329999999999998 110.636 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.07 -178.56 6.0 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.22 0.533 . . . . 75.319999999999993 112.053 -176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -55.97 110.5 0.75 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.22 0.533 . . . . 74.030000000000001 111.461 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.632 HG21 HG11 ' A' ' 53' ' ' VAL . 50.4 p -127.93 134.74 49.34 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.126 -0.488 . . . . 72.439999999999998 111.567 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -139.71 138.44 35.99 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.174 -0.466 . . . . 52.030000000000001 111.04 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 62.74 107.63 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 123.057 0.543 . . . . 52.020000000000003 111.391 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -50.59 101.04 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.194 2.596 . . . . 74.310000000000002 114.343 -173.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -123.66 73.59 1.21 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.153 0.502 . . . . 73.329999999999998 111.888 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.1 t80 57.26 18.02 4.01 Favored 'General case' 0 CA--C 1.554 1.098 0 N-CA-C 113.093 0.775 . . . . 73.510000000000005 113.093 174.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.632 HG11 HG21 ' A' ' 47' ' ' THR . 75.8 t -82.24 109.13 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 121.434 -0.791 . . . . 70.019999999999996 112.769 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -137.72 27.45 2.73 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.241 1.02 . . . . 74.219999999999999 109.02 168.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.531 HH21 HG21 ' A' ' 59' ' ' THR . 21.2 ttt180 -80.22 72.23 7.04 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.892 -1.049 . . . . 74.530000000000001 111.325 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.458 ' HB3' HG23 ' A' ' 43' ' ' VAL . 18.6 m120 -89.72 22.72 2.95 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.188 0.518 . . . . 61.119999999999997 111.161 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 65.6 mt -86.29 129.73 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.291 -0.413 . . . . 72.530000000000001 111.293 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.483 HG23 HG21 ' A' ' 73' ' ' VAL . 61.5 mt -69.45 98.17 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.143 0.497 . . . . 71.430000000000007 111.095 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.531 HG21 HH21 ' A' ' 55' ' ' ARG . 5.0 t -135.56 160.25 39.07 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.13 -0.486 . . . . 74.409999999999997 111.25 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -58.66 127.08 30.4 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.001 0.429 . . . . 74.140000000000001 111.876 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.37 -22.14 37.15 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.137 -0.483 . . . . 33.240000000000002 112.7 -177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -77.27 150.71 35.29 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.924 0.392 . . . . 74.099999999999994 111.529 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.4 t -107.19 116.26 50.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 120.945 0.402 . . . . 75.430000000000007 111.152 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 m -103.46 137.71 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 120.898 0.38 . . . . 70.409999999999997 110.65 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -90.82 110.68 21.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.264 0.554 . . . . 64.230000000000004 111.377 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.465 HG22 HG12 ' A' ' 40' ' ' ILE . 32.5 p -102.6 170.32 8.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.622 -0.717 . . . . 74.219999999999999 110.862 177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -56.22 -33.56 65.48 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.986 0.422 . . . . 63.439999999999998 111.465 176.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.533 HD12 ' HB2' ' A' ' 38' ' ' ALA . 65.4 mt -79.91 -15.31 57.59 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.411 -0.359 . . . . 71.519999999999996 111.806 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 132.14 -161.08 23.83 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.321 -0.466 . . . . 74.450000000000003 113.235 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -70.0 134.35 48.21 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.563 -0.375 . . . . 64.349999999999994 111.235 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 96.0 t -130.64 125.7 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.778 0.323 . . . . 73.310000000000002 111.328 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.679 ' HB2' HD13 ' A' ' 88' ' ' ILE . 43.0 ttm180 -89.81 117.41 28.63 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.712 -0.222 . . . . 74.140000000000001 110.597 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.483 HG21 HG23 ' A' ' 58' ' ' ILE . 42.5 t -66.78 133.53 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 120.815 0.341 . . . . 63.43 111.767 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.4 p -109.9 -50.05 3.02 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.171 0.51 . . . . 72.409999999999997 111.908 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 38.4 t -103.28 -176.53 3.11 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.078 0.466 . . . . 74.040000000000006 111.757 -178.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -79.69 142.53 57.27 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.43 -0.35 . . . . 73.420000000000002 111.191 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.558 ' HA ' HG12 ' A' ' 83' ' ' ILE . 59.6 Cg_endo -71.57 -4.35 14.85 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.549 2.166 . . . . 64.420000000000002 112.979 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -116.82 27.79 7.7 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.402 -0.428 . . . . 54.539999999999999 113.387 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.509 ' O ' HG12 ' A' ' 82' ' ' VAL . 15.7 mm100 -72.62 86.41 1.2 Allowed 'General case' 0 N--CA 1.467 0.402 0 O-C-N 122.36 -0.494 . . . . 72.310000000000002 110.233 175.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.4 t70 63.74 -69.81 0.08 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.269 0.628 . . . . 74.340000000000003 110.998 -175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.09 25.54 0.21 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 121.276 -0.488 . . . . 31.0 112.713 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 79' ' ' GLN . 7.4 p -130.76 149.36 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 112.407 0.521 . . . . 74.420000000000002 112.407 -174.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.558 HG12 ' HA ' ' A' ' 77' ' ' PRO . 36.0 mt -122.38 140.07 47.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 C-N-CA 122.879 0.472 . . . . 71.430000000000007 110.224 176.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -124.29 141.35 52.14 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 112.202 0.445 . . . . 72.439999999999998 112.202 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.1 176.36 37.68 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.113 -0.565 . . . . 41.240000000000002 113.377 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 18.0 t -118.63 135.81 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 122.64 -0.33 . . . . 73.430000000000007 111.57 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 38.7 tp -72.87 106.05 4.65 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.795 0.331 . . . . 74.310000000000002 111.077 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.679 HD13 ' HB2' ' A' ' 72' ' ' ARG . 30.5 pt -118.65 -175.92 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.169 0.509 . . . . 72.140000000000001 111.785 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.511 ' NH2' ' HA ' ' A' ' 92' ' ' GLU . 24.7 mmm180 -137.86 89.65 2.42 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.175 -0.466 . . . . 73.010000000000005 111.09 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -87.63 -39.78 14.75 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.295 0.569 . . . . 73.219999999999999 110.436 175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.6 pp -137.27 148.48 46.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.347 -0.842 . . . . 71.5 110.182 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.511 ' HA ' ' NH2' ' A' ' 89' ' ' ARG . 34.5 tt0 -77.63 -44.58 27.77 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 111.962 0.356 . . . . 75.409999999999997 111.962 -177.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -141.87 127.0 18.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.856 0.36 . . . . 70.129999999999995 111.253 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -70.77 91.02 0.81 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.213 0.53 . . . . 75.430000000000007 112.235 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -138.93 -178.22 5.23 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.211 -0.45 . . . . 72.549999999999997 110.801 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -95.12 98.31 10.56 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.119 0.485 . . . . 72.329999999999998 111.432 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -114.9 115.74 27.42 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.425 -0.352 . . . . 64.310000000000002 110.932 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.4 t60 . . . . . 0 C--O 1.255 1.362 0 CA-C-O 118.82 -0.61 . . . . 70.209999999999994 111.536 -178.301 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 113.306 0.082 . . . . 53.420000000000002 113.306 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -108.63 128.86 55.21 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 122.217 -0.578 . . . . 75.409999999999997 111.239 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.446 ' HE ' ' N ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -82.46 108.48 15.9 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.954 -0.566 . . . . 71.200000000000003 111.759 -172.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -137.43 98.12 3.63 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.737 -0.665 . . . . 74.109999999999999 110.418 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -102.11 163.77 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 121.237 0.541 . . . . 74.530000000000001 112.362 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -86.08 88.54 7.61 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.209 -0.451 . . . . 72.519999999999996 110.972 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 7' ' ' LEU . 2.4 pt? -63.22 -22.19 66.71 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.123 0.416 . . . . 75.030000000000001 112.123 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.5 tp -95.36 108.39 20.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.411 0.624 . . . . 62.240000000000002 111.392 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.96 78.84 3.22 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.55 0.69 . . . . 74.25 112.304 -178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.4 p -69.84 84.42 0.48 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.801 -0.562 . . . . 74.010000000000005 111.327 178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -135.12 128.02 31.35 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.335 -0.393 . . . . 70.400000000000006 110.857 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -112.58 -96.67 2.28 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 121.163 -0.541 . . . . 55.210000000000001 113.021 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.64 75.61 0.05 OUTLIER Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.157 -0.544 . . . . 61.100000000000001 113.185 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -113.23 119.21 36.94 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.426 -0.456 . . . . 72.239999999999995 111.302 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 75.5 m -106.47 125.99 51.7 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.825 0.345 . . . . 62.43 110.314 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -95.3 4.85 53.04 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.092 0.775 . . . . 63.119999999999997 113.092 -171.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.713 HG22 ' H ' ' A' ' 19' ' ' LEU . 13.2 p -149.52 145.44 17.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.098 0.475 . . . . 74.25 112.264 -176.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.677 ' HB3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -64.61 -21.32 66.68 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.972 0.731 . . . . 72.230000000000004 112.972 177.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.713 ' H ' HG22 ' A' ' 17' ' ' VAL . 6.4 tt -177.55 129.02 0.15 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.477 0.311 . . . . 73.209999999999994 110.261 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.45 ' N ' HD23 ' A' ' 19' ' ' LEU . . . -167.19 111.99 0.73 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.838 0.31 . . . . 44.329999999999998 111.838 178.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 p 72.12 -44.37 0.59 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.648 1.179 . . . . 40.450000000000003 113.231 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -102.96 123.37 46.45 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.839 0.352 . . . . 65.010000000000005 110.727 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.617 HG22 ' HB ' ' A' ' 40' ' ' ILE . 75.0 m -104.23 113.0 26.25 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.817 0.341 . . . . 71.019999999999996 111.822 -175.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.493 ' O ' HD12 ' A' ' 83' ' ' ILE . 59.1 mtt180 -142.58 168.94 18.54 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.734 0.302 . . . . 63.399999999999999 111.288 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.05 145.71 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.947 0.403 . . . . 64.299999999999997 111.758 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.489 HD22 ' N ' ' A' ' 26' ' ' ASN . 0.8 OUTLIER -79.35 104.28 9.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.077 0.465 . . . . 65.239999999999995 110.298 174.055 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.402 HG22 HG21 ' A' ' 71' ' ' VAL . 38.3 t -90.1 123.4 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 115.986 -0.552 . . . . 70.120000000000005 111.841 -177.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.6 t -107.72 116.82 52.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 116.299 -0.409 . . . . 63.299999999999997 111.353 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.557 ' HB2' ' HG2' ' A' ' 34' ' ' LYS . 9.8 t70 -71.56 122.53 87.43 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 110.276 -0.268 . . . . 74.019999999999996 110.276 176.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.96 -30.86 32.03 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.075 1.85 . . . . 74.310000000000002 113.19 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -89.62 -43.87 10.46 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.814 0.672 . . . . 74.049999999999997 112.814 -175.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.0 p -96.61 -26.55 15.18 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.147 0.425 . . . . 61.240000000000002 112.147 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.71 22.0 58.83 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 120.915 -0.659 . . . . 64.239999999999995 113.901 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.557 ' HG2' ' HB2' ' A' ' 29' ' ' ASP . 10.7 ptpp? -78.06 135.3 37.71 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 117.359 0.579 . . . . 71.329999999999998 110.596 177.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 48.7 t -115.66 101.34 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 120.906 0.384 . . . . 72.040000000000006 110.943 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -125.15 144.41 50.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.902 0.382 . . . . 70.129999999999995 111.417 -176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.0 mt -84.92 111.34 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.897 0.379 . . . . 74.510000000000005 111.191 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -110.48 148.38 32.19 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.976 0.417 . . . . 65.409999999999997 112.015 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -80.27 130.97 35.57 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.336 -0.393 . . . . 63.539999999999999 110.668 177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.617 ' HB ' HG22 ' A' ' 23' ' ' THR . 69.4 mt -80.99 113.65 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.049 0.452 . . . . 64.129999999999995 111.053 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.415 HH21 ' HB3' ' A' ' 67' ' ' ASN . 28.0 mmt180 -82.56 -48.66 10.74 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.201 0.524 . . . . 64.400000000000006 111.192 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.415 ' OD1' HG12 ' A' ' 44' ' ' VAL . 38.7 t-20 -125.21 145.22 50.08 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.988 -0.551 . . . . 72.420000000000002 110.526 -178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.516 HG21 ' HA ' ' A' ' 56' ' ' ASN . 32.6 m -116.48 2.13 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 113.37 0.878 . . . . 73.239999999999995 113.37 -173.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.415 HG12 ' OD1' ' A' ' 42' ' ' ASN . 9.6 p -76.1 122.26 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 O-C-N 121.786 -0.572 . . . . 72.200000000000003 111.452 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.569 ' HG3' HG23 ' A' ' 47' ' ' THR . 8.7 pt-20 -96.04 -175.58 3.43 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.096 0.474 . . . . 74.019999999999996 111.344 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -67.54 90.62 0.26 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.08 0.467 . . . . 74.409999999999997 110.828 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.569 HG23 ' HG3' ' A' ' 45' ' ' GLU . 52.2 p -130.05 167.85 17.65 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.385 -0.371 . . . . 65.450000000000003 111.148 178.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.36 -30.97 19.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.077 0.465 . . . . 75.409999999999997 110.58 173.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -119.33 95.4 49.26 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.031 -0.531 . . . . 71.140000000000001 111.823 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.18 93.54 0.56 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.659 2.239 . . . . 74.310000000000002 111.713 172.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -132.39 140.64 48.56 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.247 -0.433 . . . . 72.209999999999994 111.832 -174.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.647 ' HD2' HD11 ' A' ' 57' ' ' ILE . 21.0 t80 67.44 12.97 9.18 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.113 0.482 . . . . 74.439999999999998 111.374 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -62.3 -19.82 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 116.164 -0.471 . . . . 73.120000000000005 112.034 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.647 ' HE ' ' HA ' ' A' ' 54' ' ' ARG . 1.7 tpm_? -61.36 -17.93 56.32 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.175 0.512 . . . . 74.420000000000002 111.224 176.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -112.4 118.56 35.53 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.016 -0.735 . . . . 73.439999999999998 109.016 175.509 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.516 ' HA ' HG21 ' A' ' 43' ' ' VAL . 79.5 m-20 -60.13 101.11 0.11 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.152 0.797 . . . . 75.129999999999995 113.152 -170.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.647 HD11 ' HD2' ' A' ' 52' ' ' PHE . 65.8 mt -99.85 100.69 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.958 -0.564 . . . . 53.450000000000003 110.737 174.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.544 ' HB ' ' HG3' ' A' ' 77' ' ' PRO . 48.5 mm -104.59 122.79 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.61 0.243 . . . . 43.009999999999998 110.968 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.1 t -147.39 169.71 18.89 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.981 0.42 . . . . 73.530000000000001 111.896 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -63.16 125.05 22.79 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.131 -0.486 . . . . 75.030000000000001 111.132 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.55 -14.88 57.71 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.193 -0.527 . . . . 61.439999999999998 113.139 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.43 137.88 41.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.878 0.371 . . . . 35.039999999999999 111.569 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.97 112.11 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-O 120.909 0.385 . . . . 74.109999999999999 110.987 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.526 ' HB ' HG23 ' A' ' 40' ' ' ILE . 32.5 m -105.65 139.58 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.548 0.573 . . . . 74.120000000000005 112.548 -175.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -82.54 116.43 21.96 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.511 -0.313 . . . . 75.510000000000005 110.674 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.597 HG22 ' HA ' ' A' ' 40' ' ' ILE . 32.1 p -121.16 179.42 4.4 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 120.905 0.383 . . . . 71.209999999999994 111.741 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.415 ' HB3' HH21 ' A' ' 41' ' ' ARG . 4.0 p-10 -65.58 -19.43 65.92 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 111.91 0.337 . . . . 71.030000000000001 111.91 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.6 mt -93.27 -23.69 18.42 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.946 0.403 . . . . 72.109999999999999 111.045 174.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.454 ' HA2' ' NH1' ' A' ' 89' ' ' ARG . . . 135.87 -162.03 24.91 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 121.134 -0.555 . . . . 65.140000000000001 113.381 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -71.29 117.39 12.76 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.805 0.336 . . . . 61.399999999999999 110.596 178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 40.6 t -110.96 120.75 62.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.854 0.359 . . . . 63.219999999999999 111.118 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 72' ' ' ARG . 42.5 ttm180 -84.87 109.67 18.28 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.876 0.37 . . . . 74.409999999999997 110.421 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 52.5 t -65.2 120.15 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.456 0.539 . . . . 74.010000000000005 112.456 -173.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.3 p -89.86 -40.43 12.43 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.129 -0.487 . . . . 63.119999999999997 111.633 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.8 t -123.44 140.45 53.0 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.936 0.398 . . . . 64.030000000000001 111.659 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.487 ' HB2' HE21 ' A' ' 79' ' ' GLN . 96.8 mtt180 -65.75 154.1 89.54 Favored Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 116.171 -0.468 . . . . 73.409999999999997 112.224 -178.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.544 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 86.7 Cg_endo -75.34 40.14 0.66 Allowed 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.391 2.728 . . . . 62.439999999999998 114.646 -172.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.46 27.15 0.09 OUTLIER Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.496 -0.859 . . . . 53.210000000000001 113.664 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.487 HE21 ' HB2' ' A' ' 76' ' ' ARG . 78.2 mm-40 -93.81 -63.95 1.14 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 117.073 0.436 . . . . 73.409999999999997 111.155 179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -102.58 17.14 24.44 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.313 0.578 . . . . 70.450000000000003 111.207 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.677 ' HA2' ' HB3' ' A' ' 18' ' ' ARG . . . 80.25 17.84 73.11 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.193 -0.527 . . . . 74.099999999999994 113.339 -178.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.2 p -157.43 148.77 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.991 0.424 . . . . 54.149999999999999 111.856 -177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.505 HD11 HD12 ' A' ' 19' ' ' LEU . 20.6 mt -92.75 135.1 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.3 -0.409 . . . . 74.219999999999999 110.739 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -128.36 145.15 51.16 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 122.212 -0.305 . . . . 72.530000000000001 111.514 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.55 172.46 39.48 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.022 -0.608 . . . . 53.439999999999998 113.515 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.6 t -109.15 147.41 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 122.545 -0.386 . . . . 73.140000000000001 111.754 -178.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 45.3 tp -84.65 119.27 25.04 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.129 0.49 . . . . 73.409999999999997 112.089 -177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.495 ' O ' ' HD2' ' A' ' 89' ' ' ARG . 17.3 pt -144.64 -173.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 122.996 0.518 . . . . 73.409999999999997 110.595 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HD2' ' O ' ' A' ' 88' ' ' ILE . 18.2 mmm180 -142.65 89.44 2.14 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.789 0.328 . . . . 64.310000000000002 110.739 171.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.41 -27.06 63.99 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.266 0.555 . . . . 72.349999999999994 110.61 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 91' ' ' LEU . 2.3 pt? -141.72 161.42 37.99 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.583 -0.735 . . . . 51.240000000000002 109.839 172.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -106.06 -64.16 1.19 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.297 0.57 . . . . 75.109999999999999 111.273 177.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -74.18 81.49 1.8 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.771 -0.65 . . . . 54.450000000000003 111.871 -174.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -75.5 70.71 2.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.561 0.696 . . . . 72.209999999999994 110.812 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -177.38 -46.7 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.041 -0.982 . . . . 74.25 109.522 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -69.23 109.34 4.04 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.574 -0.739 . . . . 73.25 111.099 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -80.02 159.42 26.22 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.112 0.482 . . . . 75.239999999999995 111.928 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 . . . . . 0 C--O 1.252 1.208 0 CA-C-N 115.96 -0.564 . . . . 71.150000000000006 111.045 -179.844 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 CA-C-O 120.637 0.021 . . . . 70.329999999999998 113.124 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -84.69 177.01 8.2 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.124 0.488 . . . . 72.219999999999999 111.559 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.1 mmt180 -116.88 92.75 3.95 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.875 0.369 . . . . 54.520000000000003 111.202 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -86.25 125.35 33.51 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.96 0.41 . . . . 52.329999999999998 111.43 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.67 132.45 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.229 0.538 . . . . 72.340000000000003 111.579 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -79.11 110.28 14.22 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.321 0.581 . . . . 72.340000000000003 110.996 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.5 tp -83.63 -23.57 31.79 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.18 -0.464 . . . . 75.319999999999993 111.149 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.0 tt -49.76 121.59 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.169 0.509 . . . . 64.230000000000004 112.059 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -164.43 144.51 7.75 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.25 -0.432 . . . . 72.209999999999994 110.994 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 49.7 p -134.43 163.56 29.4 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.923 0.392 . . . . 72.430000000000007 111.423 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -76.14 -58.72 3.12 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.979 0.419 . . . . 73.430000000000007 111.486 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.76 49.62 75.84 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-N 116.198 -0.456 . . . . 33.109999999999999 113.586 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.65 166.47 32.34 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.686 -0.769 . . . . 73.340000000000003 113.596 -177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -152.58 119.35 5.72 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.632 0.253 . . . . 64.439999999999998 110.665 -178.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 9.1 t -77.32 157.37 30.74 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.184 0.438 . . . . 72.049999999999997 112.184 -175.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -104.21 -178.3 3.62 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.924 0.392 . . . . 74.299999999999997 111.879 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.99 83.63 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 114.026 1.121 . . . . 63.039999999999999 114.026 -171.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.676 ' HG2' ' HA2' ' A' ' 81' ' ' GLY . 96.4 mtt180 55.5 -172.7 0.06 Allowed 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.519 1.304 . . . . 75.140000000000001 114.519 170.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.415 HD23 ' C ' ' A' ' 19' ' ' LEU . 7.3 tt -78.24 128.14 33.29 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.447 -1.252 . . . . 71.409999999999997 110.726 174.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -155.59 -76.79 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.149 -0.478 . . . . 61.43 110.476 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 68.6 m -83.9 -30.6 26.25 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.342 0.592 . . . . 64.409999999999997 110.397 172.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -91.61 92.15 8.34 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.762 -0.653 . . . . 75.040000000000006 109.654 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 94.1 m -97.31 113.69 25.36 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.016 0.436 . . . . 73.340000000000003 111.68 -175.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HG2' HG22 ' A' ' 37' ' ' ILE . 2.3 ttm105 -166.85 155.64 10.38 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.282 -0.417 . . . . 75.549999999999997 110.943 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.521 ' HB ' HD11 ' A' ' 40' ' ' ILE . 9.8 tt -133.71 142.85 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 112.101 0.408 . . . . 73.219999999999999 112.101 -175.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 26' ' ' ASN . 0.9 OUTLIER -76.61 103.61 6.68 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.076 0.465 . . . . 74.319999999999993 110.634 174.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.47 HG22 HG11 ' A' ' 71' ' ' VAL . 45.3 t -104.75 125.35 59.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.177 0.513 . . . . 71.549999999999997 111.576 -176.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.48 118.53 41.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 116.19 -0.459 . . . . 75.219999999999999 110.782 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -75.59 112.69 20.65 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.29 -0.414 . . . . 51.100000000000001 109.897 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.58 -14.6 15.9 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.359 2.039 . . . . 63.109999999999999 112.833 -177.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.97 -42.97 12.1 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.777 0.322 . . . . 74.439999999999998 111.26 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.411 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 25.9 p -107.19 -15.35 14.68 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.234 0.457 . . . . 73.319999999999993 112.234 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.54 18.38 73.62 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.361 -0.447 . . . . 71.140000000000001 114.099 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 21.7 pttm -92.36 159.56 15.52 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.494 0.647 . . . . 74.310000000000002 111.946 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.6 t -107.24 109.26 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.402 -0.363 . . . . 72.200000000000003 110.722 175.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -117.01 141.6 48.03 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.543 -0.298 . . . . 74.120000000000005 111.021 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.506 HG22 ' HG2' ' A' ' 24' ' ' ARG . 38.1 mt -100.04 105.94 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.921 0.391 . . . . 54.420000000000002 110.852 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.08 151.92 19.28 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.999 0.74 . . . . 62.229999999999997 112.999 -172.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.61 126.35 34.44 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.243 -0.435 . . . . 54.130000000000003 110.955 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.521 HD11 ' HB ' ' A' ' 25' ' ' ILE . 56.2 mt -83.44 113.35 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.199 0.444 . . . . 63.049999999999997 112.199 -176.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -82.84 -53.62 5.74 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.034 0.445 . . . . 72.239999999999995 110.583 176.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 40.4 t30 -118.99 147.57 43.93 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.107 -0.497 . . . . 61.100000000000001 110.686 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.29 12.0 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 113.024 0.75 . . . . 64.340000000000003 113.024 -172.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.06 136.02 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 112.497 0.554 . . . . 62.350000000000001 112.497 -178.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.408 ' HG3' ' HB ' ' A' ' 47' ' ' THR . 13.0 pt-20 -84.39 176.33 8.76 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.256 0.55 . . . . 71.439999999999998 111.502 177.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -84.1 39.73 0.72 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.238 0.542 . . . . 72.0 110.902 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.408 ' HB ' ' HG3' ' A' ' 45' ' ' GLU . 7.9 t -59.97 -31.85 70.28 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 113.501 0.926 . . . . 41.039999999999999 113.501 -173.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.86 163.02 40.74 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.6 0.593 . . . . 73.400000000000006 112.6 -174.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -124.21 78.78 60.07 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.712 -0.676 . . . . 64.420000000000002 110.248 173.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -90.61 -166.49 0.2 Allowed 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.916 2.41 . . . . 75.120000000000005 114.103 -173.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -79.87 -159.74 0.23 Allowed 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.767 -0.651 . . . . 73.420000000000002 110.674 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -69.68 72.07 0.35 Allowed 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.093 0.473 . . . . 71.329999999999998 111.059 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -163.31 135.73 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 120.827 0.346 . . . . 64.420000000000002 111.385 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.92 173.22 3.28 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.306 -0.406 . . . . 64.340000000000003 110.276 177.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.1 157.55 43.64 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.848 -0.532 . . . . 74.340000000000003 112.095 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.2 p-10 -98.76 21.1 11.9 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.827 -0.624 . . . . 53.32 112.019 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 62.2 mt -88.04 118.53 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 120.924 0.392 . . . . 73.519999999999996 111.459 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.5 mt -73.41 123.23 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 116.402 -0.363 . . . . 73.420000000000002 110.522 177.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.0 p -118.26 159.68 22.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.245 0.545 . . . . 73.150000000000006 112.184 -174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -64.81 136.47 56.92 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.317 -0.401 . . . . 62.039999999999999 111.23 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.45 -14.51 45.67 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.071 -0.585 . . . . 60.109999999999999 113.183 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.47 147.95 33.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.026 0.441 . . . . 75.420000000000002 111.386 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.501 HG21 ' HG3' ' A' ' 90' ' ' GLU . 61.9 t -101.11 119.5 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 120.94 0.4 . . . . 61.32 111.319 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.0 m -102.96 156.63 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.108 0.48 . . . . 72.340000000000003 111.317 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.684 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 36.1 tt0 -97.88 105.92 18.14 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.863 0.363 . . . . 72.109999999999999 110.964 -178.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.0 p -103.38 170.72 7.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.856 0.36 . . . . 72.420000000000002 111.576 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -57.52 -30.85 65.49 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.33 -0.395 . . . . 73.349999999999994 111.473 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.4 mt -77.91 -36.82 49.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.035 0.445 . . . . 73.329999999999998 111.014 176.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.99 -150.87 23.08 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.265 -0.493 . . . . 14.15 112.7 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -75.88 128.77 35.81 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.932 0.396 . . . . 61.130000000000003 111.314 -178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.47 HG11 HG22 ' A' ' 27' ' ' VAL . 90.1 t -129.01 126.93 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 116.535 -0.302 . . . . 74.109999999999999 111.297 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -95.98 120.6 36.55 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.626 0.251 . . . . 72.540000000000006 111.508 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.553 HG11 ' HG3' ' A' ' 77' ' ' PRO . 23.5 t -65.12 133.85 30.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 112.051 0.389 . . . . 62.049999999999997 112.051 -177.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.4 p -96.9 -50.12 4.77 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.259 0.466 . . . . 71.310000000000002 112.259 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 71.5 m -104.56 -169.63 1.65 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.096 0.406 . . . . 72.310000000000002 112.096 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.63 110.42 22.13 Favored Pre-proline 0 N--CA 1.472 0.66 0 O-C-N 122.253 -0.279 . . . . 73.340000000000003 111.125 176.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.553 ' HG3' HG11 ' A' ' 73' ' ' VAL . 33.0 Cg_exo -60.08 105.59 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.79 2.327 . . . . 53.409999999999997 113.307 -176.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 144.91 -33.38 1.63 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.939 -0.648 . . . . 73.219999999999999 112.694 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -60.45 132.77 54.94 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 120.825 0.345 . . . . 61.520000000000003 111.342 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 60.71 9.26 2.09 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.006 -0.543 . . . . 72.450000000000003 111.907 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.676 ' HA2' ' HG2' ' A' ' 18' ' ' ARG . . . 81.24 -0.9 86.89 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.266 -0.492 . . . . 63.329999999999998 113.59 -178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p -115.09 144.7 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.298 0.57 . . . . 73.329999999999998 112.509 -174.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.456 HD12 ' N ' ' A' ' 83' ' ' ILE . 3.9 mp -113.11 125.34 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.096 -0.502 . . . . 74.140000000000001 110.266 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -102.22 143.07 32.48 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.836 0.351 . . . . 74.25 111.825 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.86 173.96 36.62 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 121.282 -0.485 . . . . 63.119999999999997 113.446 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.6 t -115.8 139.09 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 117.001 0.4 . . . . 54.149999999999999 111.548 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HB2' HG12 ' A' ' 27' ' ' VAL . 50.6 tp -79.16 106.95 11.56 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.737 0.303 . . . . 75.329999999999998 111.4 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 25.7 pt -133.67 -171.24 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.252 0.548 . . . . 64.530000000000001 111.789 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 76.7 mmt-85 -137.78 107.27 6.16 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.039 -0.528 . . . . 61.350000000000001 110.983 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' HG3' HG21 ' A' ' 63' ' ' VAL . 17.8 mm-40 -103.19 -19.7 14.41 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.151 -0.477 . . . . 73.530000000000001 111.081 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 93.9 mt -96.8 -176.01 3.45 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.123 0.487 . . . . 74.409999999999997 111.831 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -61.9 142.82 57.17 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.668 0.618 . . . . 70.150000000000006 112.668 -177.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -90.14 99.16 12.23 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.7 -0.682 . . . . 71.310000000000002 109.407 169.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -62.73 122.25 15.43 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.031 0.382 . . . . 74.099999999999994 112.031 -172.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -149.93 86.69 1.45 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.435 0.636 . . . . 72.219999999999999 111.63 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.3 t60 -101.51 106.97 18.13 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.368 -0.378 . . . . 71.120000000000005 110.403 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -59.79 126.75 28.81 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.082 0.468 . . . . 63.350000000000001 112.19 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.767 -0.635 . . . . 74.239999999999995 111.024 174.64 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 112.869 -0.092 . . . . 72.5 112.869 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -96.42 123.36 40.04 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.996 0.398 . . . . 71.420000000000002 110.87 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -109.85 8.54 24.48 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.182 0.438 . . . . 61.049999999999997 112.182 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -70.9 155.34 40.92 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.657 0.614 . . . . 71.430000000000007 112.657 -174.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -82.09 154.38 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 115.701 -0.681 . . . . 72.120000000000005 112.227 -175.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -65.28 144.51 57.1 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.122 0.486 . . . . 64.120000000000005 112.034 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.4 mt -112.86 1.04 15.37 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.427 -0.351 . . . . 75.129999999999995 111.824 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.4 tp -83.78 124.92 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.27 0.557 . . . . 75.430000000000007 112.403 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.447 ' HD3' ' N ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -112.41 171.21 7.65 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.931 0.396 . . . . 74.5 111.321 175.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.3 p -87.99 -76.38 0.39 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 112.695 0.628 . . . . 53.140000000000001 112.695 -173.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? 68.98 124.9 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.265 0.555 . . . . 71.129999999999995 111.972 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.76 172.16 36.05 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 121.24 -0.505 . . . . 52.509999999999998 112.798 179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 161.11 140.31 2.85 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.762 -0.732 . . . . 44.340000000000003 113.415 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -106.94 164.89 11.75 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.229 0.538 . . . . 72.329999999999998 111.866 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.1 m -117.37 132.18 56.64 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.183 -0.462 . . . . 72.530000000000001 112.103 -173.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -88.8 145.59 25.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.009 0.433 . . . . 64.310000000000002 111.27 174.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.538 HG22 ' H ' ' A' ' 19' ' ' LEU . 8.5 p -72.98 138.36 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.477 0.655 . . . . 75.430000000000007 112.383 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.416 ' H ' ' HG3' ' A' ' 18' ' ' ARG . 3.5 ppt_? -61.01 -7.75 2.73 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.039 1.125 . . . . 72.450000000000003 114.039 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.538 ' H ' HG22 ' A' ' 17' ' ' VAL . 6.2 tt -156.99 114.36 3.12 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 122.022 -0.424 . . . . 72.239999999999995 111.162 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.52 102.79 3.21 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.962 -0.563 . . . . 75.129999999999995 111.115 176.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.9 m 74.43 -45.9 0.6 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.657 0.783 . . . . 72.129999999999995 112.489 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -110.31 149.31 30.37 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.405 0.282 . . . . 65.439999999999998 111.003 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 89.8 m -124.42 114.68 19.81 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.853 0.358 . . . . 62.340000000000003 111.463 -176.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -126.42 151.14 48.1 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.85 0.357 . . . . 75.439999999999998 111.586 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.9 tt -146.26 139.08 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.028 0.442 . . . . 50.32 111.374 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.57 103.69 9.65 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.438 -0.346 . . . . 71.010000000000005 110.429 176.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.82 113.91 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.898 0.38 . . . . 72.420000000000002 111.549 -177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.7 t -95.16 118.09 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.396 -0.365 . . . . 74.400000000000006 110.688 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.23 128.93 81.65 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 120.536 0.208 . . . . 52.420000000000002 110.982 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -76.79 -22.79 11.51 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.426 2.084 . . . . 73.519999999999996 113.592 -176.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -88.27 -35.32 17.34 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.969 0.414 . . . . 32.229999999999997 111.859 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 71.7 p -107.91 -31.72 7.88 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.373 -0.376 . . . . 65.239999999999995 111.803 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.91 10.19 65.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.208 -0.52 . . . . 61.340000000000003 113.603 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -79.63 138.12 37.31 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 117.192 0.496 . . . . 71.540000000000006 111.919 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 51.9 t -97.66 106.42 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 116.27 -0.423 . . . . 74.430000000000007 110.319 176.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -128.65 132.87 48.12 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.952 0.406 . . . . 62.439999999999998 111.583 -173.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 57.0 mt -81.06 140.43 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 112.427 0.528 . . . . 62.43 112.427 -175.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.47 167.14 22.91 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.239 -0.437 . . . . 43.539999999999999 111.124 177.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.485 ' HB2' ' NH1' ' A' ' 41' ' ' ARG . 3.3 mp0 -98.24 140.56 32.35 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 120.819 0.343 . . . . 73.099999999999994 111.081 177.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.16 115.1 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 120.969 0.414 . . . . 52.140000000000001 111.687 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.562 HH21 ' HB3' ' A' ' 67' ' ' ASN . 21.4 mmt180 -81.21 -53.83 6.03 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.222 0.534 . . . . 72.5 110.802 177.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 15.7 m120 -119.5 131.17 55.52 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.184 -0.462 . . . . 74.430000000000007 111.657 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.462 HG23 HG12 ' A' ' 58' ' ' ILE . 10.5 p -83.32 -23.35 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 113.046 0.758 . . . . 74.5 113.046 -178.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.2 p -96.43 147.08 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 112.14 0.422 . . . . 74.340000000000003 112.14 -175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.42 -165.21 1.19 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.377 0.608 . . . . 72.219999999999999 111.902 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.534 ' HB3' HD21 ' A' ' 91' ' ' LEU . 11.8 p-10 -68.06 108.29 3.04 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.428 0.632 . . . . 55.32 111.531 178.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.5 p -84.54 142.69 29.83 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.106 -0.497 . . . . 71.319999999999993 111.981 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.58 -11.74 44.69 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.014 0.376 . . . . 50.140000000000001 112.014 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -147.37 97.93 4.02 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.514 -0.312 . . . . 75.230000000000004 111.003 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.487 ' HB2' ' HD2' ' A' ' 51' ' ' HIS . 9.9 Cg_exo -72.75 166.06 30.99 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.838 2.359 . . . . 62.140000000000001 112.833 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.487 ' HD2' ' HB2' ' A' ' 50' ' ' PRO . 59.3 m-70 72.02 -13.89 0.57 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 112.992 0.738 . . . . 75.140000000000001 112.992 177.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -130.41 107.36 9.18 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 122.162 -0.336 . . . . 74.510000000000005 111.716 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.0 t 68.99 136.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 121.597 0.713 . . . . 62.450000000000003 112.765 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.527 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -151.38 150.25 30.25 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.132 -0.485 . . . . 74.200000000000003 110.651 179.151 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.5 ttt180 -114.22 137.94 51.12 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.758 0.313 . . . . 64.439999999999998 111.227 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.9 p30 -117.13 5.68 12.77 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.835 0.68 . . . . 72.129999999999995 112.835 -175.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.8 tt -112.96 142.62 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.131 0.491 . . . . 64.319999999999993 111.964 -177.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.462 HG12 HG23 ' A' ' 43' ' ' VAL . 64.2 mt -80.79 130.2 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.122 -0.49 . . . . 72.129999999999995 111.132 177.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 t -147.53 166.31 27.7 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.833 0.349 . . . . 71.409999999999997 111.584 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.411 ' HD3' HH11 ' A' ' 60' ' ' ARG . 44.7 ttp180 -65.01 134.38 53.75 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.973 0.416 . . . . 72.329999999999998 111.37 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 99.87 -26.4 24.6 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.271 -0.422 . . . . 73.430000000000007 112.462 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.77 156.93 38.77 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.936 0.398 . . . . 75.409999999999997 111.804 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.536 HG11 ' HG3' ' A' ' 90' ' ' GLU . 48.1 t -119.1 114.1 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 120.907 0.385 . . . . 73.510000000000005 111.361 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 m -103.56 154.47 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.973 0.416 . . . . 74.430000000000007 112.012 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 34.0 tt0 -92.96 127.31 38.42 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.224 -0.298 . . . . 73.319999999999993 110.771 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.6 p -129.63 176.35 8.07 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.609 0.364 . . . . 74.400000000000006 110.717 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.562 ' HB3' HH21 ' A' ' 41' ' ' ARG . 3.8 p-10 -65.09 -27.47 68.78 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.782 0.325 . . . . 75.450000000000003 111.863 177.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.0 mt -81.74 -22.75 37.12 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.081 0.467 . . . . 73.400000000000006 111.103 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.63 -152.16 21.52 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 116.241 -0.436 . . . . 44.140000000000001 112.504 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -85.91 131.21 34.34 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 122.241 -0.564 . . . . 63.219999999999999 110.994 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.27 122.34 65.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 111.851 0.315 . . . . 73.420000000000002 111.851 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HB2' HD13 ' A' ' 88' ' ' ILE . 40.7 ttm180 -86.36 112.16 21.18 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.655 0.264 . . . . 72.439999999999998 110.402 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.6 t -63.98 127.14 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 112.568 0.581 . . . . 61.520000000000003 112.568 -173.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 73.8 p -103.04 -33.09 9.39 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.056 0.455 . . . . 65.519999999999996 111.656 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.662 ' HB3' ' H ' ' A' ' 84' ' ' ASN . 35.8 t -94.76 -177.07 4.07 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.36 0.6 . . . . 63.439999999999998 111.831 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 79' ' ' GLN . 7.7 tpt180 -122.03 126.12 26.42 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.956 -0.565 . . . . 63.310000000000002 109.781 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -47.56 99.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.512 2.141 . . . . 50.210000000000001 113.435 -177.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 149.53 -29.06 1.19 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 115.858 -0.61 . . . . 64.109999999999999 112.642 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 76.0 mm-40 -58.16 105.32 0.27 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.765 0.317 . . . . 74.510000000000005 111.263 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 56.97 21.48 6.28 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.16 0.429 . . . . 64.109999999999999 112.16 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.28 19.4 79.83 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.238 -0.506 . . . . 70.310000000000002 113.988 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.409 HG22 ' N ' ' A' ' 83' ' ' ILE . 7.5 p -139.95 163.22 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 117.536 0.668 . . . . 73.219999999999999 111.628 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.409 ' N ' HG22 ' A' ' 82' ' ' VAL . 57.7 mt -121.53 143.06 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 122.526 0.33 . . . . 75.209999999999994 110.835 178.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.662 ' H ' ' HB3' ' A' ' 75' ' ' SER . 2.4 m-20 -119.72 153.08 36.16 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.731 0.301 . . . . 71.439999999999998 111.257 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.9 177.83 37.98 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 116.453 -0.34 . . . . 44.009999999999998 112.887 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 t -116.39 138.86 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 117.218 0.509 . . . . 74.409999999999997 111.279 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 44.0 tp -78.93 106.54 11.03 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.036 0.446 . . . . 72.530000000000001 111.807 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.443 HD13 ' HB2' ' A' ' 72' ' ' ARG . 16.5 pt -121.5 179.91 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 121.188 0.518 . . . . 53.329999999999998 111.236 178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.62 113.42 20.22 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.368 -0.378 . . . . 73.239999999999995 110.983 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.536 ' HG3' HG11 ' A' ' 63' ' ' VAL . 70.9 mm-40 -122.21 -72.35 0.69 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.16 0.43 . . . . 74.329999999999998 112.16 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.534 HD21 ' HB3' ' A' ' 46' ' ' ASN . 93.6 mt -100.75 -175.37 2.88 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.202 0.525 . . . . 64.340000000000003 112.212 -176.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -71.64 135.66 47.01 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.948 -0.569 . . . . 62.210000000000001 110.938 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 19.0 m-70 -102.08 -14.4 17.12 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 112.398 0.518 . . . . 73.150000000000006 112.398 -176.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -62.0 154.34 26.87 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.164 0.507 . . . . 64.319999999999993 112.214 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -61.74 114.05 3.09 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.264 -0.426 . . . . 74.549999999999997 109.882 175.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -55.59 -74.7 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.53 0.567 . . . . 62.109999999999999 112.53 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -85.77 104.87 15.87 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.194 0.521 . . . . 73.310000000000002 111.151 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 32.7 p-80 . . . . . 0 C--O 1.248 0.984 0 CA-C-N 116.379 -0.373 . . . . 70.409999999999997 111.758 -179.563 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.68 -0.168 . . . . 64.409999999999997 112.68 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.24 171.32 15.23 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.192 0.52 . . . . 64.230000000000004 112.287 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.456 ' HD3' ' N ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -115.97 124.3 50.17 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.106 0.479 . . . . 72.109999999999999 111.41 -176.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.92 6.28 45.26 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.044 -0.525 . . . . 73.219999999999999 112.183 -173.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 5' ' ' VAL . 7.2 p -68.39 87.27 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 CA-C-O 121.522 0.677 . . . . 64.299999999999997 111.982 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? 54.55 48.09 21.22 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.958 -0.565 . . . . 61.219999999999999 111.614 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 52.8 tp -81.45 -47.23 13.46 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.073 -0.512 . . . . 43.439999999999998 112.046 -177.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.7 tp -77.11 133.01 31.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.153 0.502 . . . . 75.010000000000005 111.504 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -130.04 27.15 5.16 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.094 0.405 . . . . 62.329999999999998 112.094 -174.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.8 m -37.41 105.76 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.257 0.836 . . . . 75.409999999999997 113.257 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -149.9 133.86 17.0 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.243 -0.435 . . . . 74.230000000000004 111.172 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.27 147.1 4.5 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.118 -0.563 . . . . 53.109999999999999 113.194 177.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.5 93.94 2.31 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.26 -0.495 . . . . 72.129999999999995 113.611 177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -145.95 113.32 6.26 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.918 0.389 . . . . 53.43 110.867 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.0 t -67.95 164.19 20.47 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.174 0.805 . . . . 71.349999999999994 113.174 -175.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -122.64 -8.12 8.51 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.393 -0.822 . . . . 65.540000000000006 110.614 176.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.599 HG22 ' H ' ' A' ' 19' ' ' LEU . 11.5 p -138.12 150.41 24.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.288 -0.414 . . . . 71.230000000000004 111.722 -174.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -64.99 -33.05 75.12 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.253 -0.431 . . . . 72.019999999999996 112.094 178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.599 ' H ' HG22 ' A' ' 17' ' ' VAL . 7.4 tt -174.23 129.17 0.37 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.922 -0.399 . . . . 73.010000000000005 109.922 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.03 126.4 6.68 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 111.776 0.288 . . . . 61.210000000000001 111.776 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.1 t 74.6 -52.64 0.68 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.649 0.78 . . . . 70.019999999999996 111.841 177.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -106.1 125.17 50.67 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.82 0.343 . . . . 75.239999999999995 110.312 -178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.56 HG22 ' HB ' ' A' ' 40' ' ' ILE . 51.6 m -98.07 112.78 24.61 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.893 0.377 . . . . 51.210000000000001 111.385 -178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -139.49 170.01 16.7 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.12 0.486 . . . . 60.340000000000003 111.881 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.451 ' HB ' HD11 ' A' ' 40' ' ' ILE . 13.2 tt -152.0 142.8 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.97 -0.559 . . . . 65.129999999999995 111.111 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -77.21 103.7 7.29 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.248 0.547 . . . . 73.129999999999995 110.573 174.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.481 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 39.3 t -86.24 136.68 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.619 -0.718 . . . . 74.430000000000007 111.263 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 35' ' ' VAL . 47.2 t -110.85 104.83 17.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.66 0.267 . . . . 63.219999999999999 111.053 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.514 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 35.2 t70 -65.09 115.43 21.1 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.48 -0.327 . . . . 72.239999999999995 111.16 176.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.37 -11.71 22.77 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.34 2.027 . . . . 72.340000000000003 113.733 -176.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -80.78 -43.19 20.52 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.1 0.476 . . . . 75.230000000000004 111.4 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.419 ' OG1' ' HE3' ' A' ' 34' ' ' LYS . 59.6 p -101.24 -29.49 12.06 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.132 -0.485 . . . . 71.310000000000002 111.67 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.79 63.13 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-N 116.248 -0.433 . . . . 44.130000000000003 112.739 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 17.6 ptpt -82.82 163.12 21.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.867 0.365 . . . . 71.209999999999994 111.322 -178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 28' ' ' VAL . 47.9 t -117.63 97.39 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.38 -0.373 . . . . 73.549999999999997 111.164 174.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.481 ' HG2' ' HB ' ' A' ' 27' ' ' VAL . 1.5 pm0 -93.79 170.86 9.25 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.051 0.453 . . . . 64.120000000000005 111.33 175.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 63.7 mt -111.78 134.51 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 O-C-N 121.849 -0.532 . . . . 62.450000000000003 111.098 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -130.99 153.56 49.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.96 0.41 . . . . 72.099999999999994 111.977 178.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -91.91 126.11 36.87 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.13 -0.486 . . . . 71.340000000000003 110.485 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.56 ' HB ' HG22 ' A' ' 23' ' ' THR . 61.2 mt -79.13 113.54 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.042 0.448 . . . . 75.129999999999995 111.458 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -83.05 -47.83 11.26 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.063 0.458 . . . . 74.25 111.383 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.532 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 51.7 m-80 -138.15 163.94 30.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.265 -0.425 . . . . 71.340000000000003 111.443 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -116.32 2.43 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.273 0.558 . . . . 74.030000000000001 111.312 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.441 HG11 ' HB2' ' A' ' 96' ' ' HIS . 6.2 p -70.41 102.35 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-O 121.44 0.638 . . . . 71.319999999999993 112.073 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -72.73 -167.1 0.33 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.89 -0.596 . . . . 54.43 111.678 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -65.61 85.58 0.07 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.266 0.555 . . . . 64.049999999999997 111.114 178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.3 t -162.06 -179.95 7.51 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.763 -0.653 . . . . 55.210000000000001 110.775 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.78 175.18 2.52 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.157 0.503 . . . . 74.019999999999996 112.344 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.426 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 48.8 m-80 -80.47 128.75 71.5 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 116.528 -0.306 . . . . 74.109999999999999 111.099 176.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 7.7 Cg_exo -72.89 138.43 28.59 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.813 2.342 . . . . 73.099999999999994 113.542 -177.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -119.86 -45.21 2.49 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.183 0.516 . . . . 65.109999999999999 110.798 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -101.66 94.88 6.08 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.253 -0.431 . . . . 72.519999999999996 111.153 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.1 p -165.34 147.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 116.072 -0.513 . . . . 72.430000000000007 110.489 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.57 -48.89 4.38 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.438 0.533 . . . . 65.140000000000001 112.438 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 55' ' ' ARG . 15.7 ptt180 -138.14 175.76 9.3 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.452 0.644 . . . . 74.409999999999997 112.647 -177.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -92.42 107.54 19.29 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 115.508 -0.769 . . . . 61.329999999999998 112.187 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 57' ' ' ILE . 2.9 mp -85.16 100.96 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.006 0.431 . . . . 72.439999999999998 111.083 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 59.8 mt -95.98 115.77 36.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.011 0.434 . . . . 74.409999999999997 111.281 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -147.83 -179.96 7.28 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.226 -0.443 . . . . 75.349999999999994 111.085 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -64.18 135.99 56.81 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.828 0.347 . . . . 74.209999999999994 111.807 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.06 -20.89 47.07 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.29 -0.481 . . . . 53.350000000000001 113.251 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.82 153.11 29.34 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.028 0.442 . . . . 72.439999999999998 111.676 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.7 t -110.91 119.3 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 116.354 -0.384 . . . . 75.400000000000006 110.793 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.47 ' HB ' HG23 ' A' ' 40' ' ' ILE . 27.6 m -103.39 131.49 51.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.42 0.628 . . . . 63.210000000000001 112.17 -177.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.726 ' HG2' ' HB3' ' A' ' 95' ' ' HIS . 9.7 tp10 -79.81 102.32 9.01 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.931 -0.577 . . . . 63.32 110.894 177.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.6 p -100.74 173.21 6.63 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.774 0.321 . . . . 64.310000000000002 111.045 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -61.12 -29.07 69.54 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.87 0.367 . . . . 63.420000000000002 111.655 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 38' ' ' ALA . 92.6 mt -80.78 -31.14 35.88 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.926 0.393 . . . . 70.319999999999993 111.088 176.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.18 -162.9 28.87 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.915 -0.66 . . . . 44.520000000000003 112.889 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -80.93 120.05 24.25 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.216 0.531 . . . . 74.310000000000002 111.713 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.476 HG21 HG22 ' A' ' 27' ' ' VAL . 47.6 t -113.56 120.52 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-N 116.208 -0.451 . . . . 70.540000000000006 111.509 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -86.7 116.19 24.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.851 0.358 . . . . 74.239999999999995 111.21 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.36 109.84 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.19 -0.459 . . . . 62.43 112.123 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 60.7 p -87.75 -59.29 2.28 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.254 0.549 . . . . 72.420000000000002 110.729 176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.715 ' HB3' ' HG3' ' A' ' 79' ' ' GLN . 54.8 m -90.35 113.79 25.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.846 -0.616 . . . . 72.409999999999997 111.082 177.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 25.1 ttt85 -54.28 139.95 55.4 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 116.157 -0.474 . . . . 74.319999999999993 112.07 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.499 ' HB3' HG12 ' A' ' 83' ' ' ILE . 4.4 Cg_exo -39.23 107.89 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 123.697 2.931 . . . . 74.140000000000001 113.64 177.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 155.65 -34.9 0.63 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.999 -0.619 . . . . 73.319999999999993 112.798 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.715 ' HG3' ' HB3' ' A' ' 75' ' ' SER . 15.8 mm100 -55.04 114.02 1.59 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.312 0.245 . . . . 71.430000000000007 111.22 177.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.1 t70 62.16 15.56 7.56 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.44 0.638 . . . . 70.25 111.472 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.72 34.12 54.13 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.31 -0.472 . . . . 73.409999999999997 112.785 -176.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 83' ' ' ILE . 12.7 p -154.78 166.88 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 120.906 0.384 . . . . 60.420000000000002 111.307 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.499 HG12 ' HB3' ' A' ' 77' ' ' PRO . 40.1 mt -97.26 144.75 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 122.579 0.351 . . . . 63.109999999999999 110.438 175.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.561 ' HB2' ' HB2' ' A' ' 75' ' ' SER . 16.2 m-80 -135.19 142.49 46.09 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 122.252 -0.28 . . . . 52.210000000000001 111.329 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.81 175.79 39.16 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.038 -0.601 . . . . 72.140000000000001 113.647 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 5.0 t -99.27 144.49 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.088 0.403 . . . . 65.310000000000002 112.088 -177.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.414 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 49.5 tp -79.59 106.63 11.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.824 0.345 . . . . 61.100000000000001 110.973 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.0 pt -126.88 -179.65 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.178 0.513 . . . . 65.219999999999999 111.153 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -130.01 85.68 2.32 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.911 0.386 . . . . 73.099999999999994 111.456 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -84.43 -37.1 21.84 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.653 0.739 . . . . 72.140000000000001 110.349 175.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 43.8 mt -124.9 151.24 45.63 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.977 -1.01 . . . . 52.119999999999997 109.303 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -79.03 58.76 2.51 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.506 0.669 . . . . 54.530000000000001 109.873 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.8 m80 58.48 7.95 0.79 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.528 -0.76 . . . . 74.109999999999999 111.955 -171.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 -79.46 68.01 5.37 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.542 0.687 . . . . 73.540000000000006 110.802 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.726 ' HB3' ' HG2' ' A' ' 65' ' ' GLU . 20.6 p-80 -54.98 125.33 19.94 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.239 -0.891 . . . . 65.439999999999998 111.806 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.441 ' HB2' HG11 ' A' ' 44' ' ' VAL . 53.1 m170 -64.51 139.28 58.75 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.099 0.476 . . . . 73.420000000000002 110.946 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -136.5 133.98 37.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.291 -0.413 . . . . 72.340000000000003 112.038 -173.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.751 -0.643 . . . . 70.430000000000007 111.612 176.134 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.685 -0.166 . . . . 70.030000000000001 112.685 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -151.12 147.41 27.03 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 122.459 -0.436 . . . . 71.219999999999999 111.636 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.447 ' HD2' ' N ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -145.71 81.31 1.61 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.722 0.772 . . . . 73.120000000000005 111.048 177.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.6 86.94 7.25 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.532 0.682 . . . . 75.530000000000001 111.36 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 m -76.14 54.96 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 115.57 -0.741 . . . . 63.119999999999997 112.903 -175.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -83.39 68.27 9.64 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.856 -0.528 . . . . 74.430000000000007 110.728 178.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.8 tt -76.89 -38.65 53.18 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.963 0.411 . . . . 70.200000000000003 110.593 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.4 125.68 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.418 0.628 . . . . 73.040000000000006 112.065 -176.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 -122.52 173.78 7.47 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.722 -0.672 . . . . 62.299999999999997 110.574 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -58.72 146.93 34.85 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.001 0.429 . . . . 62.340000000000003 111.937 175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 55.1 ttp180 -96.68 -22.59 16.91 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.432 0.634 . . . . 73.439999999999998 110.626 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 144.51 -148.26 19.93 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 115.542 -0.753 . . . . 35.130000000000003 112.19 -177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.27 -75.03 0.04 OUTLIER Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.959 -0.638 . . . . 73.409999999999997 112.455 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -86.22 -171.41 3.55 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.52 -0.4 . . . . 42.43 110.636 176.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.7 m -69.74 107.76 3.62 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.862 0.363 . . . . 64.420000000000002 110.892 177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.657 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -66.87 169.85 7.5 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.02 -0.536 . . . . 74.120000000000005 111.972 -177.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.01 146.2 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 116.062 -0.517 . . . . 73.109999999999999 111.918 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.31 168.8 0.98 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.132 0.79 . . . . 75.209999999999994 113.132 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.1 tt -60.42 119.74 8.58 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.887 -0.597 . . . . 75.530000000000001 110.787 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.18 -60.52 0.16 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.2 -0.455 . . . . 75.420000000000002 111.142 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.6 m -80.91 -50.68 9.45 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.451 -0.34 . . . . 71.409999999999997 111.458 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -110.63 138.18 47.35 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.655 0.264 . . . . 72.040000000000006 111.067 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.557 HG22 ' HB ' ' A' ' 40' ' ' ILE . 27.1 m -81.89 112.7 19.25 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 110.213 -0.292 . . . . 71.310000000000002 110.213 175.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -133.83 165.39 25.09 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.23 0.456 . . . . 74.010000000000005 112.23 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.526 ' HB ' HD11 ' A' ' 40' ' ' ILE . 12.7 tt -151.46 131.29 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 116.127 -0.488 . . . . 71.109999999999999 111.782 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -72.81 103.82 3.8 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.072 0.463 . . . . 55.340000000000003 110.328 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.529 HG22 HG11 ' A' ' 71' ' ' VAL . 46.8 t -95.92 126.97 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.029 -0.532 . . . . 75.129999999999995 112.349 -174.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.7 t -99.01 114.17 36.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.224 -0.444 . . . . 73.0 110.82 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.429 ' HA ' ' HB3' ' A' ' 87' ' ' LEU . 11.3 t70 -76.84 126.12 86.16 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.558 -0.292 . . . . 62.240000000000002 111.624 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.99 -9.89 9.5 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.949 2.433 . . . . 75.400000000000006 113.226 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -75.03 -43.7 52.09 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.929 0.395 . . . . 75.209999999999994 111.685 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.9 p -123.28 -31.5 3.55 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.463 -0.335 . . . . 70.450000000000003 111.686 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.07 3.49 29.73 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.406 -0.426 . . . . 71.239999999999995 113.125 -177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -71.53 143.63 49.87 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.933 0.397 . . . . 61.32 112.002 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.4 t -114.91 129.28 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.897 0.38 . . . . 72.120000000000005 111.514 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -140.38 145.83 37.6 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.345 -0.389 . . . . 74.409999999999997 110.818 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.4 mt -87.94 101.82 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.263 0.554 . . . . 72.129999999999995 111.515 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.51 165.14 16.49 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.315 0.578 . . . . 72.040000000000006 112.273 -177.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -103.69 123.79 47.66 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.842 -0.617 . . . . 72.040000000000006 110.651 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.557 ' HB ' HG22 ' A' ' 23' ' ' THR . 70.0 mt -84.09 115.94 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 112.609 0.596 . . . . 74.120000000000005 112.609 -174.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.456 HH11 ' HD2' ' A' ' 41' ' ' ARG . 56.2 mtt180 -83.64 -54.12 5.16 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 121.073 0.463 . . . . 53.310000000000002 111.49 172.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -130.78 167.86 18.18 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.284 0.476 . . . . 73.510000000000005 112.284 -173.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.67 HG12 HG12 ' A' ' 64' ' ' VAL . 17.1 m -134.09 96.26 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.534 0.683 . . . . 71.129999999999995 111.027 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.587 HG22 ' H ' ' A' ' 45' ' ' GLU . 7.4 p -141.03 -179.79 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 CA-C-N 116.039 -0.528 . . . . 75.209999999999994 111.019 -174.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.587 ' H ' HG22 ' A' ' 44' ' ' VAL . 12.1 pt-20 -140.14 169.42 17.73 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.546 -0.721 . . . . 60.520000000000003 111.193 172.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -62.7 87.17 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.527 0.68 . . . . 71.239999999999995 112.205 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.0 t -135.97 159.53 41.4 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.182 -0.463 . . . . 71.430000000000007 111.58 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.6 123.44 31.79 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.497 -0.319 . . . . 22.449999999999999 111.006 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 65.31 94.39 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 CA-C-O 120.931 0.396 . . . . 54.539999999999999 110.677 -174.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.78 44.53 0.95 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.103 2.535 . . . . 73.120000000000005 114.518 -172.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -91.37 2.43 56.41 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.791 -0.568 . . . . 73.430000000000007 111.384 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -87.46 3.21 48.15 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.461 0.541 . . . . 74.230000000000004 112.461 -176.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.4 t -67.39 94.0 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 121.388 0.614 . . . . 73.530000000000001 109.98 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -88.55 -63.7 1.26 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.823 0.675 . . . . 74.040000000000006 112.823 -170.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -127.26 10.11 6.78 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.204 0.446 . . . . 72.030000000000001 112.204 -173.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 61.07 17.91 8.47 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.583 0.957 . . . . 65.25 113.583 171.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 41.6 mt -65.4 106.33 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 121.161 0.505 . . . . 65.319999999999993 111.714 -179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.6 mt -72.06 118.29 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.034 -0.53 . . . . 73.329999999999998 110.829 176.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.1 t -147.74 173.16 13.05 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.613 -0.267 . . . . 73.120000000000005 111.367 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -56.85 140.42 48.23 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.851 0.358 . . . . 72.200000000000003 111.697 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 93.5 -26.44 15.83 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.144 -0.551 . . . . 62.310000000000002 113.454 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.72 155.75 29.25 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.09 0.445 . . . . 75.319999999999993 111.281 179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.7 t -113.36 127.85 70.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 121.626 0.727 . . . . 73.25 111.908 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.67 HG12 HG12 ' A' ' 43' ' ' VAL . 28.9 m -103.17 127.7 56.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-O 121.185 0.516 . . . . 73.439999999999998 111.077 177.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -77.02 110.86 12.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.218 -0.446 . . . . 74.319999999999993 110.362 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.9 p -115.61 176.04 5.26 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.364 0.602 . . . . 71.439999999999998 112.431 -175.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.432 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 19.3 p-10 -59.25 -30.21 68.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.017 -0.538 . . . . 74.519999999999996 111.225 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.4 mt -81.28 -28.94 34.46 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.16 0.505 . . . . 63.229999999999997 110.728 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.419 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 131.08 -150.5 19.41 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 116.204 -0.453 . . . . 75.439999999999998 113.161 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.503 HD22 ' N ' ' A' ' 70' ' ' ASN . 1.0 OUTLIER -67.07 120.36 13.55 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.784 0.326 . . . . 64.439999999999998 111.777 -179.578 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.529 HG11 HG22 ' A' ' 27' ' ' VAL . 57.4 t -125.71 121.87 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.618 0.246 . . . . 70.319999999999993 111.478 178.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.551 ' HB2' HD13 ' A' ' 88' ' ' ILE . 38.1 ttm180 -89.55 118.09 28.93 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.276 -0.265 . . . . 71.430000000000007 111.439 -177.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.4 t -61.95 128.43 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.261 0.467 . . . . 51.310000000000002 112.261 -178.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.9 p -109.86 -63.04 1.42 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.185 -0.462 . . . . 75.420000000000002 111.996 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 84' ' ' ASN . 43.5 t -78.27 154.87 30.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.649 0.261 . . . . 74.409999999999997 111.233 179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.52 109.1 2.2 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-O 120.793 0.33 . . . . 73.400000000000006 110.83 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.514 ' HB3' HG23 ' A' ' 83' ' ' ILE . 30.3 Cg_endo -61.33 129.21 27.43 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.708 2.272 . . . . 73.409999999999997 112.8 -177.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.57 -18.07 51.5 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.113 -0.565 . . . . 54.399999999999999 113.949 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -58.51 -44.9 89.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 117.503 0.652 . . . . 72.549999999999997 111.376 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -106.71 23.44 14.29 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.293 0.568 . . . . 74.310000000000002 110.434 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.59 9.01 73.35 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.347 -0.454 . . . . 25.109999999999999 113.4 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.1 p -136.27 160.7 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 122.495 0.318 . . . . 74.310000000000002 111.277 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.514 HG23 ' HB3' ' A' ' 77' ' ' PRO . 45.3 mt -116.56 140.36 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 122.572 0.349 . . . . 72.230000000000004 110.361 175.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 75' ' ' SER . 13.4 m120 -127.57 146.73 50.43 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 122.155 -0.341 . . . . 75.25 111.461 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.99 179.83 38.68 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.898 -0.668 . . . . 73.329999999999998 113.598 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.7 t -113.2 139.71 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 116.831 0.315 . . . . 73.439999999999998 111.402 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 29' ' ' ASP . 62.5 tp -74.16 106.8 5.98 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.08 0.467 . . . . 35.520000000000003 110.923 176.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 72' ' ' ARG . 20.2 pt -124.48 -178.96 2.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.308 0.575 . . . . 42.149999999999999 111.182 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.419 ' NH1' ' HA3' ' A' ' 69' ' ' GLY . 40.5 mmt180 -139.83 70.71 1.37 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.232 -0.44 . . . . 62.530000000000001 111.002 179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -75.29 -31.76 60.8 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.198 0.523 . . . . 71.200000000000003 109.842 174.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.9 mt -90.56 158.26 17.08 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.687 -0.688 . . . . 73.140000000000001 109.557 164.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.9 160.84 27.68 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.272 0.558 . . . . 60.299999999999997 112.197 -172.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -57.83 108.74 0.61 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.243 0.544 . . . . 73.209999999999994 111.771 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.41 72.57 10.66 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.392 0.515 . . . . 73.019999999999996 112.392 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -146.69 125.04 12.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.306 -0.406 . . . . 74.209999999999994 110.885 173.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -76.11 64.34 1.95 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.408 -0.36 . . . . 63.409999999999997 110.98 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 63.96 -67.72 0.1 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.217 0.607 . . . . 73.519999999999996 112.142 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 86.1 t60 . . . . . 0 C--O 1.254 1.3 0 CA-C-O 118.84 -0.6 . . . . 55.439999999999998 111.317 178.31 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 CA-C-O 120.866 0.148 . . . . 72.340000000000003 113.07 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -96.02 29.27 2.81 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 121.182 0.515 . . . . 72.209999999999994 111.524 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -87.72 91.54 8.79 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.079 0.4 . . . . 73.349999999999994 112.079 -175.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.697 ' HD3' ' H ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -89.38 102.02 14.7 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.312 0.577 . . . . 64.209999999999994 110.18 173.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.8 m -96.0 7.92 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 113.269 0.841 . . . . 52.340000000000003 113.269 -172.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -78.73 82.23 4.98 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.297 0.57 . . . . 73.439999999999998 112.216 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 44.7 tp -94.81 -28.14 15.4 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.999 -0.546 . . . . 73.329999999999998 110.91 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.0 tp -76.44 157.81 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 116.188 -0.46 . . . . 71.439999999999998 111.292 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.84 166.1 24.85 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.05 -0.406 . . . . 74.099999999999994 111.661 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -125.1 177.41 6.1 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.551 0.575 . . . . 73.120000000000005 112.551 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -169.13 147.19 3.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.101 -0.499 . . . . 74.349999999999994 110.624 -177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 170.56 146.17 5.05 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 120.345 -0.931 . . . . 53.539999999999999 114.366 178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -93.65 -34.95 6.35 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 121.53 -0.366 . . . . 42.340000000000003 112.345 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -136.77 155.51 49.73 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.669 -0.493 . . . . 71.319999999999993 109.669 175.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.455 HG22 ' O ' ' A' ' 15' ' ' THR . 11.9 m -133.65 2.58 3.47 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.37 0.878 . . . . 71.310000000000002 113.37 -174.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 17' ' ' VAL . 39.3 ttmt -175.95 91.69 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.52 0.933 . . . . 54.229999999999997 113.52 -175.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.431 HG22 ' N ' ' A' ' 18' ' ' ARG . 5.2 p 48.88 167.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 114.674 1.361 . . . . 62.520000000000003 114.674 168.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.431 ' N ' HG22 ' A' ' 17' ' ' VAL . 5.0 ppt_? -84.77 -171.94 3.91 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.684 -0.635 . . . . 72.030000000000001 111.236 174.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.485 HD12 ' O ' ' A' ' 24' ' ' ARG . 7.4 tt -74.73 109.12 7.94 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.999 0.428 . . . . 64.099999999999994 110.762 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.32 -73.35 0.38 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.158 0.504 . . . . 65.340000000000003 110.049 173.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.2 t -92.19 -28.18 17.21 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.246 0.546 . . . . 62.439999999999998 110.302 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -95.82 99.14 10.99 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.71 -0.677 . . . . 72.439999999999998 111.085 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.485 HG22 ' HB ' ' A' ' 40' ' ' ILE . 91.3 m -69.06 112.64 5.81 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.052 0.453 . . . . 72.129999999999995 110.857 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.485 ' O ' HD12 ' A' ' 19' ' ' LEU . 90.0 mtm180 -145.15 163.16 35.2 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.31 -0.404 . . . . 71.420000000000002 111.27 -173.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.7 tt -147.9 135.9 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.111 0.481 . . . . 71.329999999999998 111.86 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -74.84 103.47 5.09 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.027 0.441 . . . . 75.219999999999999 110.356 174.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' A' ' 87' ' ' LEU . 48.8 t -93.87 145.81 7.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.954 -0.566 . . . . 53.100000000000001 111.528 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 35' ' ' VAL . 48.6 t -117.16 106.9 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.044 -0.526 . . . . 72.140000000000001 110.806 176.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.489 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 12.9 t70 -70.04 112.83 13.8 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 120.611 0.243 . . . . 75.209999999999994 110.659 177.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.82 -14.21 11.32 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.774 2.316 . . . . 75.540000000000006 113.286 -176.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -74.71 -37.37 62.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.311 0.577 . . . . 72.549999999999997 110.838 -179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 58.8 p -110.1 -32.36 7.03 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.878 -0.601 . . . . 72.310000000000002 111.475 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.81 45.05 4.34 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.299 -0.477 . . . . 74.340000000000003 112.514 -177.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 19.7 ptpt -118.39 162.92 17.51 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.594 -0.356 . . . . 71.049999999999997 111.1 177.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 28' ' ' VAL . 58.1 t -120.51 113.85 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.932 0.396 . . . . 63.5 111.202 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -117.26 170.14 8.92 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.073 0.464 . . . . 53.399999999999999 111.731 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 56.2 mt -107.46 116.61 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.554 -0.294 . . . . 73.319999999999993 110.822 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.414 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -111.44 157.72 19.95 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.185 0.517 . . . . 63.119999999999997 112.208 -178.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -97.34 124.14 41.38 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.941 -0.572 . . . . 54.530000000000001 110.719 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.485 ' HB ' HG22 ' A' ' 23' ' ' THR . 60.0 mt -75.34 114.07 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 121.057 0.455 . . . . 72.109999999999999 111.468 -178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -82.92 -44.09 15.75 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.246 -0.434 . . . . 74.329999999999998 111.183 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.542 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 44.0 m-80 -138.89 146.09 40.72 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.717 0.294 . . . . 74.430000000000007 111.351 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.4 m -108.57 18.06 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-O 121.214 0.53 . . . . 75.430000000000007 111.702 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.536 HG22 ' H ' ' A' ' 46' ' ' ASN . 7.5 p -92.74 109.49 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.33 0.586 . . . . 64.239999999999995 112.157 -177.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.458 ' HG2' HH21 ' A' ' 55' ' ' ARG . 9.3 pt-20 -86.62 27.05 1.01 Allowed 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.993 0.425 . . . . 73.319999999999993 111.083 177.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.536 ' H ' HG22 ' A' ' 44' ' ' VAL . 7.8 t30 60.51 72.48 0.52 Allowed 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.403 0.621 . . . . 75.349999999999994 111.558 -173.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.4 p -89.79 -73.1 0.53 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.071 -0.513 . . . . 72.5 109.972 175.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.13 -140.73 0.19 Allowed 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 109.217 -0.66 . . . . 52.43 109.217 168.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.51 ' HB2' ' CD1' ' A' ' 52' ' ' PHE . 14.0 m120 -69.08 147.3 97.59 Favored Pre-proline 0 CA--C 1.543 0.708 0 O-C-N 121.973 -0.454 . . . . 74.319999999999993 110.364 171.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.34 -29.09 37.35 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.205 2.603 . . . . 71.310000000000002 114.874 -171.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -102.23 9.47 40.01 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.53 0.567 . . . . 75.409999999999997 112.53 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.51 ' CD1' ' HB2' ' A' ' 49' ' ' ASN . 35.8 m-85 -104.97 43.31 1.12 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.401 0.62 . . . . 72.420000000000002 111.488 178.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.513 ' HB ' ' HB ' ' A' ' 44' ' ' VAL . 4.4 p -86.87 96.93 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.589 0.709 . . . . 75.230000000000004 111.818 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -95.09 -42.68 8.48 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.108 -0.497 . . . . 75.150000000000006 111.686 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.458 HH21 ' HG2' ' A' ' 45' ' ' GLU . 21.6 ptt180 -67.45 128.14 35.32 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.235 0.54 . . . . 71.049999999999997 111.306 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.9 p30 -106.11 14.92 27.08 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.173 0.511 . . . . 74.310000000000002 110.599 173.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.3 mp -83.57 98.14 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.959 -0.564 . . . . 71.510000000000005 110.751 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.502 ' CG2' HG21 ' A' ' 73' ' ' VAL . 60.8 mt -80.26 107.38 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.243 -0.435 . . . . 61.119999999999997 111.016 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -94.5 156.01 16.66 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.995 0.426 . . . . 71.340000000000003 111.74 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.4 ttt-85 -64.33 116.33 5.94 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.815 0.341 . . . . 74.109999999999999 111.149 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.0 -16.04 23.13 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.406 -0.426 . . . . 55.420000000000002 112.68 -176.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.82 150.87 48.06 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.046 0.451 . . . . 74.230000000000004 111.907 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.564 HG21 ' HG3' ' A' ' 90' ' ' GLU . 60.5 t -104.16 115.31 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.3 -0.409 . . . . 62.219999999999999 111.276 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.69 143.36 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.123 0.487 . . . . 74.329999999999998 111.908 178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 8.0 tp10 -87.97 116.52 26.2 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.294 -0.412 . . . . 54.420000000000002 110.509 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.9 p -115.74 176.07 5.25 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.107 0.479 . . . . 74.519999999999996 111.81 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -65.67 -13.22 58.75 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.23 0.456 . . . . 63.219999999999999 112.23 179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.414 HD12 ' HB2' ' A' ' 38' ' ' ALA . 85.8 mt -104.98 -18.18 14.26 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.2 0.524 . . . . 74.019999999999996 111.369 177.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.459 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 139.07 -161.18 25.94 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.282 -0.485 . . . . 73.409999999999997 112.977 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -77.08 137.61 39.04 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.405 -0.468 . . . . 63.049999999999997 110.949 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 58.5 t -130.58 127.98 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 122.372 -0.205 . . . . 72.019999999999996 111.549 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.463 ' HB2' HD13 ' A' ' 88' ' ' ILE . 59.2 ttm-85 -92.67 113.23 25.45 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.646 0.26 . . . . 71.549999999999997 110.742 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.502 HG21 ' CG2' ' A' ' 58' ' ' ILE . 48.5 t -61.37 120.14 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 112.497 0.554 . . . . 75.230000000000004 112.497 -176.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.3 p -96.58 -32.3 12.31 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.438 0.533 . . . . 65.310000000000002 112.438 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.2 t -108.76 -174.44 2.51 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.891 0.376 . . . . 75.239999999999995 111.786 -176.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.457 HH11 ' HD2' ' A' ' 76' ' ' ARG . 9.5 mmt180 -97.29 113.88 63.91 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 116.399 -0.364 . . . . 65.310000000000002 111.573 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.457 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 50.4 Cg_exo -56.72 120.79 8.93 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.596 2.197 . . . . 72.25 112.682 176.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 130.22 -33.03 2.99 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.187 -0.53 . . . . 61.219999999999999 112.369 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -61.09 114.59 3.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.575 0.226 . . . . 74.239999999999995 110.739 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 60.94 15.57 6.18 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.168 0.509 . . . . 62.109999999999999 111.303 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 65.85 40.21 95.41 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-N 116.157 -0.474 . . . . 75.019999999999996 113.315 -177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.405 HG22 ' N ' ' A' ' 83' ' ' ILE . 8.0 p -146.08 160.36 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 117.198 0.499 . . . . 75.209999999999994 111.995 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.405 ' N ' HG22 ' A' ' 82' ' ' VAL . 31.9 mt -123.51 147.79 27.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.798 0.439 . . . . 64.420000000000002 110.874 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -121.23 148.93 43.61 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.3 -0.25 . . . . 64.120000000000005 111.03 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -168.54 167.15 40.11 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.861 -0.685 . . . . 53.310000000000002 114.078 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 24.2 t -101.85 140.34 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.68 0.392 . . . . 52.240000000000002 111.672 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.437 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . 43.0 tp -78.58 106.88 10.85 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.284 0.564 . . . . 63.530000000000001 111.445 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 72' ' ' ARG . 16.5 pt -128.25 -177.5 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.063 0.459 . . . . 73.349999999999994 110.947 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.459 ' NH1' ' HA3' ' A' ' 69' ' ' GLY . 28.1 mmt180 -134.54 76.21 1.63 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.698 0.285 . . . . 73.310000000000002 110.856 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.564 ' HG3' HG21 ' A' ' 63' ' ' VAL . 11.2 mm-40 -79.5 -47.63 15.27 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.2 0.524 . . . . 64.329999999999998 110.926 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.4 mt -70.76 178.66 2.97 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.962 -0.563 . . . . 71.439999999999998 111.014 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.95 91.59 0.09 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.383 0.611 . . . . 73.140000000000001 111.179 -178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -62.34 117.58 6.32 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.76 -0.655 . . . . 74.329999999999998 111.785 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -86.71 85.06 7.27 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.985 -0.552 . . . . 62.509999999999998 112.277 -173.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -174.87 124.05 0.26 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.518 -0.31 . . . . 75.099999999999994 111.288 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -84.06 133.23 34.66 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.846 0.355 . . . . 65.230000000000004 111.427 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -158.07 155.37 29.14 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.429 -0.35 . . . . 63.140000000000001 111.202 -177.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.54 -0.743 . . . . 73.219999999999999 111.308 175.165 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 112.825 -0.11 . . . . 60.229999999999997 112.825 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -88.11 171.97 9.86 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.063 0.458 . . . . 75.549999999999997 111.611 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 -115.27 135.68 53.9 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.656 0.613 . . . . 74.209999999999994 112.656 -175.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.42 ' HD2' ' N ' ' A' ' 4' ' ' ARG . 2.2 mpt_? -119.17 161.74 19.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.089 -0.505 . . . . 73.319999999999993 110.499 173.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.71 102.61 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.118 0.485 . . . . 74.510000000000005 111.244 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 64.1 mtp180 -87.68 94.08 9.63 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.269 -0.423 . . . . 73.140000000000001 111.345 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.3 pp -115.84 11.94 15.71 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.131 0.419 . . . . 60.130000000000003 112.131 -178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.4 tt -68.91 112.7 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-O 121.497 0.665 . . . . 64.049999999999997 110.936 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.439 HH11 ' HG3' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -119.23 160.32 22.4 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.248 0.547 . . . . 73.310000000000002 112.425 -172.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 t -75.78 107.39 7.92 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.833 -0.621 . . . . 71.409999999999997 112.388 -178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.439 ' HD3' ' HA ' ' A' ' 11' ' ' ARG . 29.0 mmt180 -146.72 146.84 30.46 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.125 0.488 . . . . 70.439999999999998 111.187 175.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.4 92.63 0.27 Allowed Glycine 0 CA--C 1.527 0.83 0 CA-C-N 116.085 -0.507 . . . . 54.530000000000001 113.045 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 142.96 66.19 0.02 OUTLIER Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.174 -0.536 . . . . 52.130000000000003 113.258 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -153.31 -74.37 0.13 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.807 0.336 . . . . 71.409999999999997 110.996 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -153.04 156.47 38.83 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.203 0.525 . . . . 73.140000000000001 111.944 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.575 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 9.9 mmpt? -99.4 -178.66 3.97 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.942 -0.572 . . . . 74.439999999999998 110.5 175.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.6 p -76.07 155.09 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.949 0.404 . . . . 74.219999999999999 110.803 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -63.99 161.58 15.59 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.246 0.546 . . . . 75.140000000000001 112.141 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -64.01 4.67 0.29 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.148 1.166 . . . . 75.239999999999995 114.148 -172.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.67 -54.89 10.69 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.162 0.43 . . . . 63.439999999999998 112.162 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.5 m -110.46 10.96 23.22 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.236 0.541 . . . . 65.129999999999995 110.898 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' HB3' ' NH2' ' A' ' 24' ' ' ARG . 3.5 m-20 -132.82 42.08 3.1 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.683 -0.69 . . . . 73.409999999999997 111.409 -176.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.591 HG22 ' HB ' ' A' ' 40' ' ' ILE . 38.4 m -67.93 110.89 4.07 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.049 0.452 . . . . 55.219999999999999 110.725 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.482 ' NH2' ' HB3' ' A' ' 22' ' ' ASP . 43.1 mtm-85 -148.68 163.55 36.98 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.253 -0.43 . . . . 54.340000000000003 111.384 -175.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.6 tt -147.6 132.7 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.219 -0.446 . . . . 73.200000000000003 111.764 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.505 ' OD1' HG12 ' A' ' 37' ' ' ILE . 77.3 m-20 -65.99 103.23 0.91 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.111 0.481 . . . . 54.219999999999999 110.209 171.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.77 121.99 37.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.024 -0.535 . . . . 62.140000000000001 111.601 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.4 t -94.95 106.79 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.159 0.504 . . . . 75.409999999999997 110.669 176.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.76 113.56 24.05 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 115.843 -0.617 . . . . 61.030000000000001 110.794 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -77.23 -11.31 17.63 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.589 2.193 . . . . 75.319999999999993 113.431 -177.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -88.05 -37.3 16.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.009 0.433 . . . . 73.219999999999999 111.879 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.409 ' OG1' ' HG2' ' A' ' 34' ' ' LYS . 30.5 p -115.17 -26.25 7.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.101 -0.499 . . . . 65.219999999999999 112.24 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.43 15.87 57.96 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 121.328 -0.463 . . . . 75.209999999999994 113.704 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.409 ' HG2' ' OG1' ' A' ' 32' ' ' THR . 22.8 pttm -90.31 152.41 21.04 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.406 -0.467 . . . . 54.130000000000003 111.512 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.5 t -116.42 119.97 63.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.417 -0.356 . . . . 74.030000000000001 110.737 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -133.37 136.73 45.51 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.912 0.387 . . . . 71.129999999999995 111.614 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.505 HG12 ' OD1' ' A' ' 26' ' ' ASN . 41.8 mt -77.65 112.66 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.914 0.388 . . . . 53.350000000000001 111.258 -179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.467 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -112.23 145.8 39.28 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.474 -0.33 . . . . 71.010000000000005 111.393 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.78 133.83 36.33 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.667 0.27 . . . . 74.25 110.737 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.591 ' HB ' HG22 ' A' ' 23' ' ' THR . 68.2 mt -82.77 109.95 17.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.378 0.609 . . . . 73.120000000000005 110.313 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 24.4 mtp85 -85.7 -39.53 17.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.719 -0.673 . . . . 71.310000000000002 111.463 -177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.665 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 41.0 t30 -114.74 120.79 41.28 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.928 -0.578 . . . . 61.109999999999999 110.455 175.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' A' ' 56' ' ' ASN . 7.8 p -93.86 11.91 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 N-CA-C 112.488 0.551 . . . . 61.539999999999999 112.488 -173.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.52 146.32 27.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 121.853 -0.529 . . . . 63.009999999999998 111.859 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HG3' HG22 ' A' ' 47' ' ' THR . 13.3 pt-20 -75.47 -167.13 0.61 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 116.194 -0.457 . . . . 75.099999999999994 110.964 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -71.03 74.44 0.64 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.266 0.555 . . . . 64.200000000000003 111.707 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.513 HG22 ' HG3' ' A' ' 45' ' ' GLU . 9.0 t -177.0 -178.66 0.84 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.96 -0.563 . . . . 71.540000000000006 110.795 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -121.88 -57.98 1.76 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.896 0.379 . . . . 71.530000000000001 110.872 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -161.47 88.21 1.58 Allowed Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 112.633 0.605 . . . . 72.400000000000006 112.633 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.03 -37.96 30.65 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.219 1.946 . . . . 70.0 111.354 170.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -137.68 172.18 13.34 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.577 -0.738 . . . . 71.329999999999998 110.35 173.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -73.33 87.98 1.53 Allowed 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.297 0.57 . . . . 74.019999999999996 111.313 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.0 t -114.68 133.45 60.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.878 -0.601 . . . . 74.209999999999994 111.152 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.5 mtp180 -67.67 168.33 11.45 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.1 0.476 . . . . 64.209999999999994 111.948 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.2 mtp85 -66.6 167.73 10.5 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.132 -0.486 . . . . 71.540000000000006 111.44 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.525 ' HA ' HG21 ' A' ' 43' ' ' VAL . 85.7 m-20 62.73 62.28 1.09 Allowed 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.443 0.639 . . . . 63.009999999999998 110.529 -170.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.444 ' O ' HG22 ' A' ' 57' ' ' ILE . 17.3 mt -83.04 19.8 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-O 121.685 0.755 . . . . 72.140000000000001 111.556 -175.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.653 HG21 HD13 ' A' ' 83' ' ' ILE . 49.4 mt -68.6 103.35 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 116.073 -0.512 . . . . 64.329999999999998 111.43 -178.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.1 t -147.18 167.94 22.91 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.699 -0.228 . . . . 72.400000000000006 110.753 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 73' ' ' VAL . 42.5 ttm180 -59.47 126.45 27.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.133 0.492 . . . . 72.530000000000001 111.536 -176.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.32 -24.06 31.31 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.139 -0.553 . . . . 60.109999999999999 112.724 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.8 139.8 38.32 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.493 -0.416 . . . . 55.340000000000003 111.186 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 m -106.31 119.11 55.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.435 0.636 . . . . 61.109999999999999 111.441 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.457 ' HB ' HG23 ' A' ' 40' ' ' ILE . 35.7 m -106.33 152.57 7.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.241 -0.436 . . . . 74.329999999999998 111.378 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' A' ' 42' ' ' ASN . 44.0 tt0 -95.01 120.0 34.49 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.124 0.488 . . . . 75.439999999999998 111.045 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 p -113.39 179.31 4.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.02 -0.536 . . . . 63.229999999999997 110.632 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.467 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 3.2 p-10 -65.87 -11.84 49.86 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 120.798 0.333 . . . . 73.409999999999997 111.481 174.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.438 ' O ' HD11 ' A' ' 87' ' ' LEU . 87.3 mt -102.7 2.36 35.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.817 0.342 . . . . 72.340000000000003 111.417 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.478 ' HA3' ' NH1' ' A' ' 89' ' ' ARG . . . 104.07 -162.98 15.16 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.477 -0.392 . . . . 74.200000000000003 112.961 -178.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -66.05 130.3 42.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.264 0.554 . . . . 63.329999999999998 112.098 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.8 t -126.99 127.28 69.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 116.022 -0.536 . . . . 64.329999999999998 110.374 177.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -88.4 117.31 27.24 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 122.294 -0.254 . . . . 75.439999999999998 110.807 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.49 HG21 HG23 ' A' ' 58' ' ' ILE . 46.1 t -66.42 127.84 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.931 0.396 . . . . 74.299999999999997 111.699 -177.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 69.6 p -112.42 -49.6 2.95 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.274 -0.421 . . . . 71.030000000000001 111.792 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.0 p -84.54 154.69 22.51 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.126 0.489 . . . . 71.329999999999998 111.685 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.92 118.44 65.42 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 109.703 -0.48 . . . . 73.420000000000002 109.703 175.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.446 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 75.9 Cg_exo -50.85 121.21 7.72 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.626 2.217 . . . . 63.329999999999998 113.25 -178.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 137.03 -20.72 3.38 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.101 -0.571 . . . . 74.299999999999997 112.879 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.472 ' O ' HG12 ' A' ' 82' ' ' VAL . 87.2 mm-40 -55.47 112.09 1.04 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 111.859 0.318 . . . . 54.109999999999999 111.859 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 56.64 20.34 4.94 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.788 0.435 . . . . 71.010000000000005 112.077 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.02 33.38 45.71 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.166 -0.54 . . . . 52.119999999999997 113.114 -176.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 79' ' ' GLN . 9.0 p -151.64 167.89 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.127 0.489 . . . . 44.299999999999997 111.439 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.653 HD13 HG21 ' A' ' 58' ' ' ILE . 29.3 mt -118.46 148.15 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 123.013 0.525 . . . . 70.340000000000003 109.812 176.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -121.82 140.85 51.85 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 121.779 -0.575 . . . . 62.32 111.532 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.19 176.17 38.61 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 121.081 -0.58 . . . . 73.219999999999999 113.518 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -108.53 145.28 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 117.069 0.434 . . . . 60.409999999999997 111.253 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.524 HD11 HH12 ' A' ' 89' ' ' ARG . 37.7 tp -81.3 111.87 18.08 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.998 0.428 . . . . 63.130000000000003 111.952 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.0 pt -128.37 -178.95 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.182 0.515 . . . . 75.530000000000001 111.499 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.524 HH12 HD11 ' A' ' 87' ' ' LEU . 26.0 mmt180 -136.2 86.2 2.21 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.157 -0.339 . . . . 64.040000000000006 111.675 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -88.72 -45.12 10.06 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 122.054 -0.404 . . . . 71.400000000000006 111.639 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt -72.82 174.88 7.08 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.115 0.483 . . . . 73.219999999999999 111.564 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -64.17 134.02 54.03 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.127 -0.488 . . . . 64.0 112.021 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -69.6 100.85 1.51 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.887 -0.783 . . . . 74.230000000000004 108.887 170.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -77.44 37.09 0.21 Allowed 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.233 0.827 . . . . 73.010000000000005 113.233 -169.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -112.97 76.64 0.99 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.227 0.537 . . . . 73.099999999999994 110.565 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.4 m80 -86.09 -18.96 30.98 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.144 0.424 . . . . 63.229999999999997 112.144 -174.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.6 m80 -78.71 70.94 5.14 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.56 0.695 . . . . 72.349999999999994 111.886 -173.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 . . . . . 0 C--O 1.252 1.208 0 CA-C-N 115.401 -0.818 . . . . 75.25 110.095 176.592 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 CA-C-O 120.453 -0.082 . . . . 75.019999999999996 113.117 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -99.99 -1.23 37.62 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.394 0.516 . . . . 70.319999999999993 112.394 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.436 ' HD2' ' N ' ' A' ' 3' ' ' ARG . 3.7 mpt_? -79.16 127.95 32.68 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.922 0.391 . . . . 64.099999999999994 111.3 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.549 ' HD2' ' H ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -101.66 110.66 22.7 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.403 0.62 . . . . 73.109999999999999 110.84 -179.262 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -79.18 42.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 112.898 0.703 . . . . 75.310000000000002 112.898 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 29.3 ptt85 -159.58 98.93 1.41 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.121 0.486 . . . . 54.439999999999998 111.779 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.01 -0.5 28.75 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.452 -0.34 . . . . 73.430000000000007 111.516 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.403 HD13 ' N ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -72.76 134.06 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-O 121.114 0.483 . . . . 73.510000000000005 111.029 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.403 ' N ' HD13 ' A' ' 8' ' ' ILE . 18.3 mmm180 -126.87 130.51 50.33 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.431 0.53 . . . . 73.349999999999994 112.431 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 t -143.1 163.6 32.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.85 -0.614 . . . . 74.200000000000003 110.64 174.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 56.7 ttm-85 -162.28 115.64 1.76 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.009 0.433 . . . . 75.340000000000003 111.621 -177.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.9 96.19 0.78 Allowed Glycine 0 CA--C 1.527 0.801 0 CA-C-N 116.361 -0.381 . . . . 55.240000000000002 112.511 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -163.84 -152.81 7.06 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.903 -0.665 . . . . 70.209999999999994 113.474 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -72.97 121.81 20.68 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.964 0.412 . . . . 62.420000000000002 112.086 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.8 t -90.97 171.01 9.58 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.098 0.475 . . . . 62.409999999999997 111.565 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.48 ' HD3' ' O ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -73.89 146.97 43.62 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.077 -0.51 . . . . 72.319999999999993 111.64 178.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 p -78.4 153.02 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 120.866 0.365 . . . . 74.329999999999998 111.313 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.474 ' NH2' ' HB2' ' A' ' 77' ' ' PRO . 9.7 ptm180 -55.84 -32.11 63.32 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.542 0.571 . . . . 73.129999999999995 112.542 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 tt -163.76 128.16 2.82 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.546 -0.297 . . . . 74.230000000000004 110.463 -175.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.07 80.2 1.9 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.577 0.227 . . . . 53.119999999999997 111.52 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.6 m 72.2 -45.26 0.62 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.496 0.718 . . . . 73.129999999999995 112.353 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -76.43 131.06 38.86 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.487 0.315 . . . . 53.119999999999997 110.554 176.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.3 m -120.87 114.83 22.14 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.802 0.334 . . . . 75.329999999999998 111.84 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -115.7 159.95 20.7 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 112.281 0.474 . . . . 72.430000000000007 112.281 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.438 ' HB ' HD11 ' A' ' 40' ' ' ILE . 12.5 tt -155.4 133.97 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.098 -0.501 . . . . 73.329999999999998 111.225 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -77.02 102.81 6.63 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.041 0.448 . . . . 70.129999999999995 110.196 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.2 t -94.08 119.14 41.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.149 -0.478 . . . . 70.310000000000002 111.686 -176.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 35' ' ' VAL . 42.3 t -95.47 115.43 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.383 -0.372 . . . . 74.299999999999997 110.709 177.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.506 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 33.3 t70 -82.75 119.88 75.34 Favored Pre-proline 0 CA--C 1.539 0.552 0 CA-C-O 120.542 0.21 . . . . 62.520000000000003 110.696 177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.61 -17.07 30.13 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 122.685 2.257 . . . . 62.549999999999997 113.411 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -82.13 -44.45 16.46 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 111.9 0.333 . . . . 60.450000000000003 111.9 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 79.4 p -100.06 -28.26 13.14 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.016 0.436 . . . . 73.329999999999998 111.714 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.75 22.49 49.77 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.268 -0.492 . . . . 62.219999999999999 112.979 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.506 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 63.6 pttt -87.34 145.89 26.14 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.922 0.361 . . . . 73.25 111.834 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 28' ' ' VAL . 48.8 t -105.32 94.04 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 109.746 -0.465 . . . . 74.430000000000007 109.746 170.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -111.02 124.38 52.06 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.282 -0.417 . . . . 62.210000000000001 111.384 -174.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.0 mt -79.37 113.06 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 116.495 -0.32 . . . . 75.040000000000006 111.629 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HB1' ' OD1' ' A' ' 67' ' ' ASN . . . -113.86 170.99 7.86 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.912 0.387 . . . . 71.310000000000002 111.916 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -98.85 137.16 37.83 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.496 -0.32 . . . . 71.540000000000006 111.001 177.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.438 HD11 ' HB ' ' A' ' 25' ' ' ILE . 63.5 mt -90.71 114.61 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 120.741 0.305 . . . . 74.230000000000004 111.424 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -83.51 -45.44 13.59 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.263 0.468 . . . . 63.329999999999998 112.263 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.567 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 41.7 m-80 -123.57 115.39 21.43 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.788 0.328 . . . . 52.200000000000003 111.76 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 58' ' ' ILE . 82.0 t -70.83 -30.13 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.176 0.512 . . . . 73.420000000000002 110.814 174.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.71 140.45 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-N 116.23 -0.441 . . . . 64.540000000000006 111.02 176.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -75.71 32.05 0.11 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.258 0.466 . . . . 52.240000000000002 112.258 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 56.46 29.25 15.0 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.201 0.524 . . . . 63.43 112.001 -178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.0 t -127.41 -179.87 5.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.16 -0.473 . . . . 60.43 111.148 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.43 177.28 2.44 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.301 0.572 . . . . 71.530000000000001 111.789 179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -92.57 119.4 68.0 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 116.371 -0.377 . . . . 70.030000000000001 111.287 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.51 -28.14 82.97 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.397 2.065 . . . . 65.400000000000006 111.83 173.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -143.74 140.75 30.13 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.903 -0.59 . . . . 63.310000000000002 110.666 171.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -69.05 1.9 3.16 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.968 0.729 . . . . 74.310000000000002 112.968 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.63 HG13 ' H ' ' A' ' 55' ' ' ARG . 12.2 p -63.62 -20.23 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-O 120.867 0.365 . . . . 74.150000000000006 111.836 177.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 62.76 22.42 13.36 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.709 0.403 . . . . 63.240000000000002 112.028 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.63 ' H ' HG13 ' A' ' 53' ' ' VAL . 44.1 ttm180 -68.94 93.16 0.54 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.191 0.519 . . . . 75.219999999999999 111.551 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -77.45 101.12 6.27 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.256 -0.429 . . . . 52.25 110.741 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 10.0 tt -128.65 132.56 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 121.114 0.483 . . . . 63.43 111.406 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.527 ' HB ' ' HG3' ' A' ' 77' ' ' PRO . 68.7 mt -87.61 134.99 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 115.994 -0.548 . . . . 72.030000000000001 110.81 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 14.7 t -147.8 172.2 14.49 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.262 0.467 . . . . 65.439999999999998 112.262 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -72.49 116.03 12.46 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.209 -0.45 . . . . 71.450000000000003 111.368 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 109.42 -7.65 32.34 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.258 -0.496 . . . . 34.009999999999998 112.88 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -91.18 139.46 30.72 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.763 0.316 . . . . 73.319999999999993 111.405 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.64 114.07 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.988 0.423 . . . . 64.430000000000007 111.307 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -102.56 154.42 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 120.987 0.423 . . . . 73.209999999999994 111.582 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 8.8 tp10 -95.6 120.71 36.33 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.874 0.369 . . . . 74.239999999999995 111.386 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.9 p -122.82 172.89 8.12 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.841 0.353 . . . . 74.120000000000005 111.421 -177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.411 ' OD1' ' HB1' ' A' ' 38' ' ' ALA . 32.2 p30 -57.59 -33.22 67.96 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 120.885 0.374 . . . . 75.129999999999995 111.627 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.9 mt -75.63 -33.15 60.46 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.9 0.381 . . . . 70.129999999999995 111.02 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 140.7 -156.49 25.37 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 116.137 -0.483 . . . . 75.319999999999993 112.983 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -68.63 125.76 27.55 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.746 0.308 . . . . 61.140000000000001 111.214 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.7 t -125.98 119.28 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.046 0.388 . . . . 74.310000000000002 112.046 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.455 ' HB2' HD13 ' A' ' 88' ' ' ILE . 59.0 ttp180 -84.19 111.31 19.24 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.66 0.267 . . . . 73.430000000000007 110.925 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.443 HG21 HG23 ' A' ' 58' ' ' ILE . 58.5 t -71.55 131.16 34.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 112.559 0.578 . . . . 55.130000000000003 112.559 -174.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 58.0 p -106.04 -33.09 8.0 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.965 -0.561 . . . . 63.549999999999997 111.826 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t -112.91 134.71 54.3 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.654 0.264 . . . . 74.349999999999994 111.478 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.2 mtm-85 -80.75 142.81 53.26 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 112.383 0.512 . . . . 72.430000000000007 112.383 -175.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.527 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 37.9 Cg_endo -63.52 97.24 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.261 2.641 . . . . 74.099999999999994 113.66 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 142.93 -28.59 2.13 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.866 -0.683 . . . . 60.299999999999997 113.565 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 80.6 mm-40 -53.81 -68.26 0.19 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.037 0.446 . . . . 74.200000000000003 111.67 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -99.1 18.25 17.84 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.931 0.396 . . . . 72.019999999999996 110.977 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 77.8 -33.33 1.67 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 121.227 -0.511 . . . . 73.040000000000006 112.805 -175.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 83' ' ' ILE . 14.5 p -99.85 158.47 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-O 121.14 0.495 . . . . 73.540000000000006 111.631 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.41 ' N ' HG22 ' A' ' 82' ' ' VAL . 46.4 mt -105.86 143.57 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.437 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -126.28 146.3 50.07 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.297 -0.252 . . . . 70.219999999999999 111.287 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.22 -179.02 30.05 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.201 -0.523 . . . . 53.32 113.039 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.2 t -124.35 129.88 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 116.838 0.319 . . . . 64.109999999999999 110.935 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.9 tp -74.45 106.34 6.01 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.101 0.477 . . . . 70.019999999999996 111.488 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.455 HD13 ' HB2' ' A' ' 72' ' ' ARG . 7.9 pt -120.05 176.53 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.313 0.578 . . . . 73.329999999999998 111.408 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' A' ' 88' ' ' ILE . 15.6 mmm180 -128.81 91.06 3.15 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.313 -0.403 . . . . 74.150000000000006 110.667 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -106.37 -50.14 3.2 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.223 0.535 . . . . 75.430000000000007 111.481 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.5 mt -72.6 178.16 4.27 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.565 0.698 . . . . 64.430000000000007 112.431 -176.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -56.55 116.88 3.37 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.608 -0.724 . . . . 72.239999999999995 112.283 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -90.71 136.11 33.28 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.826 0.346 . . . . 55.439999999999998 110.764 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -107.74 139.23 42.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.026 0.441 . . . . 71.310000000000002 111.608 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -106.55 -50.18 3.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.343 -0.39 . . . . 73.530000000000001 112.013 -176.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.3 t-80 -78.1 84.14 4.36 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.34 0.591 . . . . 73.230000000000004 110.339 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -100.48 171.95 7.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.436 -0.802 . . . . 74.329999999999998 112.4 -172.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 80.9 t60 . . . . . 0 C--O 1.25 1.084 0 CA-C-N 116.053 -0.521 . . . . 63.030000000000001 110.95 176.555 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.429 -0.268 . . . . 74.209999999999994 112.429 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -85.48 -175.79 5.82 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.934 0.397 . . . . 44.329999999999998 111.373 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.556 ' HD3' ' N ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -113.94 -53.5 2.67 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.092 0.405 . . . . 73.5 112.092 -175.758 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.32 142.19 4.75 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.837 0.351 . . . . 73.430000000000007 111.437 176.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.9 t -107.87 113.89 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.013 0.435 . . . . 73.129999999999995 111.262 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.506 ' HA ' ' NE ' ' A' ' 6' ' ' ARG . 3.9 mmp_? -112.32 80.08 1.29 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.954 0.407 . . . . 75.530000000000001 111.793 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.9 tt -69.19 -68.7 0.38 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.084 0.468 . . . . 71.120000000000005 109.896 176.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.7 tt -98.78 127.9 50.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.967 0.413 . . . . 64.140000000000001 110.722 176.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.451 ' HD3' ' N ' ' A' ' 9' ' ' ARG . 1.3 mpp_? -105.31 -49.66 3.4 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.814 0.34 . . . . 75.129999999999995 111.076 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.9 t -96.25 126.05 41.2 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.13 0.49 . . . . 64.409999999999997 111.675 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -120.66 19.51 11.87 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.178 0.513 . . . . 70.409999999999997 110.608 177.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -85.97 -112.99 0.81 Allowed Glycine 0 CA--C 1.528 0.887 0 CA-C-N 116.028 -0.533 . . . . 74.129999999999995 113.52 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 65.65 -89.52 0.12 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.283 -0.484 . . . . 64.329999999999998 112.994 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -90.26 1.4 56.53 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.053 0.454 . . . . 72.230000000000004 111.193 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.5 m -131.03 154.33 48.33 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.17 -0.468 . . . . 74.019999999999996 111.06 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -57.86 153.86 13.21 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.187 0.518 . . . . 64.230000000000004 112.067 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 19' ' ' LEU . 7.6 p -73.82 78.6 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 CA-C-O 121.399 0.619 . . . . 73.430000000000007 111.953 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.447 ' HD3' ' N ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 45.9 -68.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 115.174 1.546 . . . . 72.129999999999995 115.174 176.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.594 HD21 ' H ' ' A' ' 23' ' ' THR . 7.4 tt -141.13 114.4 8.68 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.679 -0.638 . . . . 74.120000000000005 111.091 -175.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.28 125.86 11.75 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.558 -0.292 . . . . 74.230000000000004 111.159 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.3 t 65.64 10.25 6.57 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.129 0.49 . . . . 71.329999999999998 111.74 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -96.05 -77.03 0.49 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.236 -0.438 . . . . 55.119999999999997 111.579 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.594 ' H ' HD21 ' A' ' 19' ' ' LEU . 86.6 m -95.58 113.95 25.65 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.007 0.432 . . . . 72.140000000000001 110.8 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -138.58 154.89 48.73 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.016 0.436 . . . . 73.120000000000005 111.738 -173.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.436 ' HB ' HD11 ' A' ' 40' ' ' ILE . 15.3 tt -143.77 138.4 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.089 0.471 . . . . 73.140000000000001 111.618 -177.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -90.46 112.76 24.52 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.274 0.559 . . . . 71.439999999999998 110.102 175.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 24.0 t -106.28 144.12 16.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.649 0.611 . . . . 75.400000000000006 112.649 -169.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 t -104.87 129.91 56.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.234 -0.439 . . . . 60.310000000000002 111.058 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -84.63 122.8 74.89 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 116.428 -0.351 . . . . 71.340000000000003 110.945 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.58 -17.12 11.43 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.784 2.322 . . . . 72.219999999999999 114.283 -177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -88.23 -43.81 11.32 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.281 0.563 . . . . 63.409999999999997 111.558 -176.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 49.8 p -105.64 -31.26 9.0 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.885 -0.598 . . . . 64.209999999999994 112.084 -176.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.26 12.97 56.81 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.022 -0.608 . . . . 60.409999999999997 113.617 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -86.56 143.14 27.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 117.007 0.404 . . . . 72.510000000000005 111.34 178.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 57.3 t -94.78 103.53 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 121.074 0.464 . . . . 65.409999999999997 110.656 176.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -108.43 135.81 49.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.952 0.406 . . . . 73.409999999999997 111.363 -176.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 50.6 mt -90.6 129.04 42.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.86 0.362 . . . . 73.340000000000003 111.229 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.47 ' HB2' HD12 ' A' ' 68' ' ' LEU . . . -126.99 159.14 35.0 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.893 0.378 . . . . 45.149999999999999 111.713 -178.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -107.5 139.97 41.2 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.853 0.359 . . . . 73.430000000000007 110.759 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.576 ' HB ' HG22 ' A' ' 23' ' ' THR . 58.0 mt -93.04 116.41 34.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.286 0.565 . . . . 73.530000000000001 112.485 -172.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 41' ' ' ARG . 8.0 mtp180 -82.48 -53.35 6.05 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.668 -0.696 . . . . 71.25 111.639 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 65' ' ' GLU . 92.1 m-20 -116.56 122.86 45.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.431 -0.35 . . . . 74.120000000000005 111.144 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.3 m -87.83 21.95 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 112.095 0.406 . . . . 71.109999999999999 112.095 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.8 p -122.54 139.04 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.103 0.478 . . . . 74.140000000000001 112.021 -176.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.2 -174.43 5.23 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 116.166 -0.47 . . . . 61.32 111.908 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -89.28 67.42 7.83 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.547 0.689 . . . . 73.329999999999998 112.479 -172.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.9 p -83.39 110.99 18.61 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.174 -0.466 . . . . 70.430000000000007 111.069 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.98 -53.95 48.46 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.956 0.354 . . . . 71.109999999999999 111.956 -178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -113.64 93.99 30.62 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 120.854 0.359 . . . . 60.219999999999999 110.268 172.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.59 156.7 36.07 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.706 2.271 . . . . 71.040000000000006 113.858 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -85.84 154.43 21.56 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.384 -0.371 . . . . 72.310000000000002 110.908 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -61.87 -16.64 52.09 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.453 0.538 . . . . 75.340000000000003 112.453 -178.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.02 123.82 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.621 0.248 . . . . 63.210000000000001 111.304 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -166.01 137.34 3.73 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.783 0.325 . . . . 74.209999999999994 111.064 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -127.03 -178.01 4.26 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.986 0.422 . . . . 75.219999999999999 111.802 -177.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -90.15 -8.71 50.56 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.263 -0.426 . . . . 70.420000000000002 111.894 -177.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.4 mm -79.61 116.55 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.266 0.555 . . . . 64.420000000000002 112.291 -177.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.4 HD13 HG11 ' A' ' 64' ' ' VAL . 68.5 mt -70.29 148.85 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.717 -0.674 . . . . 74.409999999999997 111.288 176.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 9.0 t -132.36 166.76 21.23 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.959 0.409 . . . . 72.450000000000003 111.934 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -64.19 126.88 29.16 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.241 -0.436 . . . . 71.310000000000002 111.386 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.19 5.25 65.87 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.217 -0.516 . . . . 72.519999999999996 113.44 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -92.28 153.15 19.42 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.013 0.435 . . . . 71.430000000000007 111.367 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.67 HG11 ' HG3' ' A' ' 90' ' ' GLU . 59.8 t -112.69 128.83 69.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.419 -0.355 . . . . 75.329999999999998 110.906 177.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.4 HG11 HD13 ' A' ' 58' ' ' ILE . 35.9 m -115.28 154.26 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 112.764 0.653 . . . . 73.430000000000007 112.764 -176.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 42' ' ' ASN . 29.9 tt0 -89.32 109.29 20.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.892 -0.594 . . . . 74.549999999999997 110.789 176.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.465 HG22 HG12 ' A' ' 40' ' ' ILE . 45.5 p -110.96 168.43 9.49 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.954 0.407 . . . . 75.040000000000006 111.336 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -60.26 -19.32 54.28 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 112.128 0.418 . . . . 74.25 112.128 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' A' ' 38' ' ' ALA . 83.9 mt -93.44 -30.63 14.96 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.85 0.315 . . . . 73.319999999999993 111.85 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 152.72 -149.59 21.23 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.013 -0.613 . . . . 70.310000000000002 113.105 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -91.27 119.47 31.36 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 122.354 -0.497 . . . . 64.319999999999993 110.83 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.08 124.78 67.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.982 0.42 . . . . 64.140000000000001 111.608 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.42 ' HB2' HD11 ' A' ' 88' ' ' ILE . 21.5 ttm180 -91.76 115.05 27.73 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.241 -0.436 . . . . 65.510000000000005 110.617 178.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.16 121.91 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.064 0.459 . . . . 74.230000000000004 112.143 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 81.1 p -103.45 -43.56 5.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.16 -0.473 . . . . 61.420000000000002 111.902 -178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.9 t -93.66 -176.77 4.17 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.101 0.477 . . . . 63.009999999999998 111.972 -176.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -84.37 126.26 69.81 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.268 -0.424 . . . . 52.350000000000001 111.806 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.446 ' HA ' HG12 ' A' ' 83' ' ' ILE . 17.9 Cg_endo -60.99 125.32 16.8 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.989 1.793 . . . . 64.099999999999994 111.692 173.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.08 -4.32 77.77 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.993 -0.623 . . . . 71.319999999999993 113.734 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -50.24 -64.07 0.92 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 117.271 0.535 . . . . 62.439999999999998 110.905 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -101.99 24.8 9.51 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.85 0.833 . . . . 71.200000000000003 109.636 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.43 -29.52 5.24 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 115.821 -0.627 . . . . 60.5 112.438 -173.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.434 HG22 ' N ' ' A' ' 83' ' ' ILE . 8.2 p -109.97 165.74 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 122.74 0.416 . . . . 73.450000000000003 111.172 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.446 HG12 ' HA ' ' A' ' 77' ' ' PRO . 34.4 mt -101.85 148.19 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-O 120.844 0.354 . . . . 61.329999999999998 111.225 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -119.3 134.75 55.05 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.668 0.271 . . . . 73.140000000000001 111.485 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.24 178.31 31.96 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.001 -0.618 . . . . 54.149999999999999 113.4 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.7 t -110.44 141.48 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 111.964 0.357 . . . . 71.109999999999999 111.964 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 59.0 tp -82.78 111.33 18.6 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.032 0.382 . . . . 63.329999999999998 112.032 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 72' ' ' ARG . 13.8 pt -143.57 -169.62 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.22 0.533 . . . . 61.409999999999997 111.593 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -137.92 99.14 3.82 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.264 -0.425 . . . . 73.450000000000003 111.0 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.67 ' HG3' HG11 ' A' ' 63' ' ' VAL . 11.8 mm-40 -78.3 -34.35 48.84 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.236 0.541 . . . . 74.530000000000001 111.242 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 91' ' ' LEU . 1.7 pt? -137.14 146.88 45.54 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.843 -0.617 . . . . 72.420000000000002 110.72 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.583 ' HG2' ' N ' ' A' ' 93' ' ' HIS . 32.2 tt0 -77.7 165.27 24.45 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.946 0.403 . . . . 70.340000000000003 111.075 178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.583 ' N ' ' HG2' ' A' ' 92' ' ' GLU . 21.3 t-80 -45.52 -33.33 2.67 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.84 0.456 . . . . 74.409999999999997 111.745 173.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -125.64 105.75 9.23 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.498 -0.319 . . . . 33.509999999999998 110.65 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -78.78 -175.12 4.27 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.812 0.339 . . . . 62.039999999999999 111.884 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.3 t60 -48.73 128.51 15.52 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.673 0.62 . . . . 75.420000000000002 112.673 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -120.91 -31.19 4.25 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.455 0.539 . . . . 72.120000000000005 112.455 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.798 -0.62 . . . . 73.540000000000006 112.601 -176.282 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 112.582 -0.207 . . . . 65.310000000000002 112.582 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -92.49 108.56 20.06 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.073 0.463 . . . . 64.450000000000003 111.374 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -142.54 81.77 1.75 Allowed 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.368 0.604 . . . . 74.510000000000005 109.617 174.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 24.5 mtm-85 -80.92 99.37 8.34 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.356 0.598 . . . . 72.230000000000004 112.291 -172.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 p -79.14 137.53 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 115.909 -0.587 . . . . 61.030000000000001 111.474 178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 48.4 mtp180 -124.19 106.17 10.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 109.741 -0.466 . . . . 74.540000000000006 109.741 176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 51.8 tp -127.16 76.95 1.7 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.557 0.694 . . . . 72.010000000000005 111.455 -170.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.64 136.1 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.555 -0.748 . . . . 51.409999999999997 110.258 174.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -115.21 145.89 41.97 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.058 0.456 . . . . 74.340000000000003 111.43 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.0 p -118.19 164.57 14.96 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.102 -0.499 . . . . 72.510000000000005 111.081 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.6 ppt_? -146.9 154.16 40.97 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.829 0.347 . . . . 72.420000000000002 111.37 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -124.99 -178.4 15.29 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 121.023 -0.608 . . . . 71.439999999999998 113.386 -178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -124.28 140.06 12.36 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 121.4 -0.429 . . . . 70.140000000000001 112.283 177.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -67.41 90.51 0.24 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.064 0.459 . . . . 64.540000000000006 111.358 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.8 m -119.71 113.75 21.12 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.243 -0.435 . . . . 73.400000000000006 110.654 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.502 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -134.65 155.64 50.14 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.961 0.41 . . . . 61.450000000000003 111.755 -176.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.05 150.82 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 116.47 -0.332 . . . . 70.129999999999995 111.244 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -60.38 165.58 3.55 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.134 0.492 . . . . 75.420000000000002 112.022 176.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.4 tt -61.65 112.16 2.13 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.18 0.514 . . . . 71.519999999999996 111.016 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.11 -54.95 1.69 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.871 -0.604 . . . . 54.32 110.923 177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.2 m -117.03 -49.19 2.62 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.167 -0.47 . . . . 75.349999999999994 110.576 175.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -59.36 105.63 0.37 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.218 -0.446 . . . . 75.5 111.112 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.411 ' CG2' ' HB ' ' A' ' 40' ' ' ILE . 90.4 m -89.87 114.86 26.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.929 0.395 . . . . 75.129999999999995 111.878 -175.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -149.81 148.18 28.87 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.287 -0.415 . . . . 72.420000000000002 110.771 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.6 tt -143.08 139.48 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 121.192 0.52 . . . . 54.340000000000003 112.018 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -83.92 105.32 14.71 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.187 0.517 . . . . 72.409999999999997 110.781 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.503 HG22 HG11 ' A' ' 71' ' ' VAL . 48.7 t -105.61 120.53 56.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 112.49 0.552 . . . . 75.310000000000002 112.49 -172.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.0 t -95.59 122.46 47.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 116.587 -0.279 . . . . 74.340000000000003 110.876 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB3' ' HG2' ' A' ' 34' ' ' LYS . 31.6 t70 -82.53 116.47 63.98 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 120.547 0.213 . . . . 61.219999999999999 110.733 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.03 -15.07 29.27 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.606 2.204 . . . . 71.099999999999994 113.249 -177.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -78.71 -45.44 21.25 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.786 0.327 . . . . 54.020000000000003 111.742 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 80.3 p -104.12 -20.69 13.74 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.017 0.377 . . . . 74.0 112.017 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.28 20.8 66.22 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.199 -0.524 . . . . 71.319999999999993 112.973 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HG2' ' HB3' ' A' ' 29' ' ' ASP . 65.5 pttt -88.07 139.39 30.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.044 0.45 . . . . 65.140000000000001 111.628 -179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.8 t -86.72 95.58 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.076 0.465 . . . . 54.43 110.21 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -99.87 165.97 11.3 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.085 0.469 . . . . 73.230000000000004 111.179 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 64.6 mt -123.09 129.87 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 122.164 -0.335 . . . . 65.230000000000004 110.621 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -132.38 170.2 15.43 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.485 0.66 . . . . 43.520000000000003 112.38 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -116.73 131.86 56.84 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.665 -0.698 . . . . 72.530000000000001 110.431 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.411 ' HB ' ' CG2' ' A' ' 23' ' ' THR . 59.9 mt -77.32 114.52 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.142 0.496 . . . . 75.25 112.275 -175.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.485 ' HA ' ' HE ' ' A' ' 41' ' ' ARG . 2.5 mmp_? -71.26 -50.05 36.81 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.915 -0.584 . . . . 71.430000000000007 110.695 173.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -133.11 130.94 39.94 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.952 -0.567 . . . . 73.420000000000002 110.754 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.5 m -87.73 14.18 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 112.598 0.592 . . . . 73.519999999999996 112.598 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.57 131.59 71.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-O 121.342 0.592 . . . . 74.120000000000005 112.546 -175.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 63' ' ' VAL . 5.9 pt-20 -91.53 -157.57 0.51 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.769 -0.65 . . . . 75.409999999999997 110.897 176.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -77.96 58.62 1.98 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.249 0.547 . . . . 65.239999999999995 111.323 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.9 p -72.58 99.09 2.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.072 0.463 . . . . 72.430000000000007 111.463 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -75.15 73.12 2.28 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.188 0.518 . . . . 73.530000000000001 110.729 176.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.456 ' HB3' ' HB2' ' A' ' 52' ' ' PHE . 14.7 m120 -131.94 65.2 74.92 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 116.272 -0.422 . . . . 71.349999999999994 111.852 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 51' ' ' HIS . 59.3 Cg_endo -71.06 118.19 5.56 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.199 1.933 . . . . 63.140000000000001 112.182 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 50' ' ' PRO . 73.3 m80 70.47 7.05 6.07 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.869 0.468 . . . . 61.350000000000001 111.787 -173.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 47.3 m-85 -116.73 16.11 15.36 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.892 0.377 . . . . 71.209999999999994 110.769 177.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 46.1 t -55.99 129.09 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.983 -0.553 . . . . 71.310000000000002 112.471 -175.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -106.84 -160.79 0.75 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.939 -0.573 . . . . 71.109999999999999 111.145 178.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.2 mtm180 -78.09 166.33 22.91 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.18 0.514 . . . . 73.109999999999999 111.969 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -77.68 49.17 0.73 Allowed 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 116.121 -0.491 . . . . 74.540000000000006 111.787 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.9 tp -92.15 106.22 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.524 0.678 . . . . 65.140000000000001 111.593 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.409 ' HB ' ' HG3' ' A' ' 77' ' ' PRO . 66.6 mt -70.8 105.64 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.004 -0.544 . . . . 74.439999999999998 110.809 177.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 t -87.57 165.76 15.23 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.062 0.458 . . . . 73.340000000000003 112.033 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 74' ' ' THR . 63.0 ttt180 -67.79 116.71 8.77 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.424 -0.353 . . . . 61.210000000000001 110.694 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.39 -6.72 46.1 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.281 -0.485 . . . . 72.319999999999993 112.927 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.49 138.79 49.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.83 0.348 . . . . 70.439999999999998 111.168 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 55.1 t -96.3 116.26 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.999 0.428 . . . . 60.340000000000003 111.606 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.9 m -103.52 148.11 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.125 0.488 . . . . 50.32 111.678 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 41' ' ' ARG . 9.6 tp10 -84.91 127.99 34.42 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.086 -0.506 . . . . 73.230000000000004 110.179 177.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.0 p -129.73 174.78 9.38 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.933 0.397 . . . . 72.430000000000007 111.794 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -64.33 -18.48 64.67 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.649 0.261 . . . . 72.010000000000005 111.687 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.9 mt -91.41 -27.77 18.1 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.991 0.424 . . . . 73.030000000000001 111.155 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.55 -150.09 21.15 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.982 -0.554 . . . . 33.439999999999998 112.242 -175.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -77.91 128.85 34.58 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.98 0.419 . . . . 74.120000000000005 111.239 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.503 HG11 HG22 ' A' ' 27' ' ' VAL . 91.7 t -126.45 119.42 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 122.113 -0.367 . . . . 73.230000000000004 111.654 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 -85.16 113.0 21.21 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.713 0.292 . . . . 61.5 110.902 178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.12 127.83 26.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 112.386 0.513 . . . . 73.120000000000005 112.386 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.46 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 77.8 p -98.79 -62.61 1.21 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.219 -0.446 . . . . 74.430000000000007 111.0 176.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.523 ' HB2' ' H ' ' A' ' 84' ' ' ASN . 55.3 m -76.45 117.1 17.76 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.432 -0.349 . . . . 44.329999999999998 111.396 178.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.9 ttt-85 -59.8 130.12 88.19 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 116.58 -0.282 . . . . 75.409999999999997 110.877 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.409 ' HG3' ' HB ' ' A' ' 58' ' ' ILE . 10.6 Cg_endo -52.04 122.59 10.81 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.312 2.675 . . . . 73.439999999999998 113.533 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 139.38 -36.18 1.88 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.069 -0.586 . . . . 75.019999999999996 113.009 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.532 ' O ' HG12 ' A' ' 82' ' ' VAL . 48.3 mt-30 -59.21 100.91 0.08 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.644 0.259 . . . . 63.43 111.301 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 57.41 19.31 5.05 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.061 0.393 . . . . 71.049999999999997 112.061 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 76.04 4.5 78.09 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.315 -0.469 . . . . 55.539999999999999 114.176 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 79' ' ' GLN . 13.8 p -100.54 141.49 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 117.53 0.665 . . . . 73.329999999999998 111.668 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.2 mt -123.28 116.6 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 116.099 -0.5 . . . . 64.140000000000001 110.361 177.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.523 ' H ' ' HB2' ' A' ' 75' ' ' SER . 13.7 m120 -103.51 154.27 19.64 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.808 0.337 . . . . 74.239999999999995 111.531 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -159.93 178.75 35.88 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.177 -0.535 . . . . 63.039999999999999 113.135 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.19 133.11 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 122.719 -0.283 . . . . 65.420000000000002 111.204 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 54.9 tp -76.42 106.22 7.93 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.036 0.446 . . . . 70.129999999999995 111.472 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.8 pt -122.81 179.7 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.133 0.492 . . . . 75.209999999999994 111.405 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -138.27 91.56 2.57 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.525 -0.307 . . . . 75.430000000000007 110.617 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -105.53 -50.94 3.1 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 111.811 0.3 . . . . 72.450000000000003 111.811 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.6 mt -56.58 150.21 15.95 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.866 0.365 . . . . 72.420000000000002 111.271 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -58.55 109.78 0.86 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.654 0.613 . . . . 60.0 112.654 -171.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -71.55 -30.31 65.74 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.054 -0.521 . . . . 73.120000000000005 112.279 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -75.03 94.34 2.86 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 110.285 -0.265 . . . . 62.509999999999998 110.285 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -47.21 105.8 0.07 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.515 0.674 . . . . 74.519999999999996 112.516 -175.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -90.67 119.81 31.21 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.865 -0.607 . . . . 75.329999999999998 112.118 -175.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -140.57 134.72 30.96 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.234 -0.439 . . . . 73.299999999999997 110.121 172.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.903 -0.57 . . . . 62.140000000000001 111.378 -176.484 . . . . . . . . 0 0 . 1 stop_ save_